data_4aka_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 4aka _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 . . . . . 0 N--CA 1.476 0.834 0 CA-C-O 121.254 0.549 . . . . 0.0 112.217 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.7 m -144.76 167.76 21.82 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.617 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 59.6 tp -111.96 124.63 52.8 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 169.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.453 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 70.5 mt-30 -113.72 124.37 52.13 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.555 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 3.2 mp -109.84 129.08 55.68 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.015 176.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.432 ' HB3' ' O ' ' A' ' 36' ' ' ARG . 94.9 m-85 -99.59 148.88 23.84 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 123.832 0.708 . . . . 0.0 110.852 -174.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -70.37 -38.1 74.69 Favored 'General case' 0 C--N 1.307 -1.249 0 O-C-N 123.663 0.602 . . . . 0.0 111.275 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -107.98 177.66 4.74 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -177.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.6 p -84.28 175.53 9.34 Favored 'General case' 0 N--CA 1.407 -2.612 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.274 15.5 p90 47.29 42.3 13.47 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 177.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 66.82 23.06 10.12 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.757 -1.111 . . . . 0.0 112.887 175.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.432 ' O ' ' HB3' ' A' ' 30' ' ' TYR . 18.1 mtm180 -102.24 173.38 6.39 Favored 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 119.653 -0.819 . . . . 0.0 112.106 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.69 179.8 51.32 Favored Glycine 0 N--CA 1.419 -2.45 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.52 -178.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.2 m -78.4 167.78 20.8 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 174.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 11.0 p90 -140.54 163.53 32.59 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -176.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.3 tt -114.59 152.98 16.16 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -107.23 125.54 51.26 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 176.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.516 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 84.3 t -117.91 133.38 64.89 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.369 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 176.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -114.81 -31.84 6.0 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 123.337 0.398 . . . . 0.0 110.159 -176.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.99 160.59 33.17 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -177.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.9 m -69.43 139.62 54.05 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 123.645 0.778 . . . . 0.0 112.186 -173.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.1 p -113.71 131.19 66.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 176.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.33 -15.41 51.06 Favored Glycine 0 N--CA 1.433 -1.549 0 C-N-CA 119.546 -1.312 . . . . 0.0 113.154 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.7 p -154.88 124.13 6.35 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.309 0.576 . . . . 0.0 112.474 -178.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 82.8 mt -118.77 117.99 30.37 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.615 175.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.0 p -132.84 110.13 13.16 Favored Pre-proline 0 N--CA 1.428 -1.548 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.636 174.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.5 162.11 92.48 Favored 'Cis proline' 0 C--O 1.252 1.204 0 C-N-CA 123.729 -1.363 . . . . 0.0 111.236 -2.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.76 158.47 37.47 Favored 'Trans proline' 0 C--O 1.244 0.785 0 C-N-CA 122.783 2.322 . . . . 0.0 110.751 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.458 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 47.8 m0 -89.22 138.25 31.59 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 11.0 p -116.74 76.94 8.01 Favored Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 123.576 0.547 . . . . 0.0 111.874 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.456 ' HD2' ' O ' ' A' ' 103' ' ' LYS . 92.8 Cg_endo -76.4 158.57 36.66 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.584 2.189 . . . . 0.0 112.849 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.69 -36.92 8.97 Favored Glycine 0 N--CA 1.435 -1.37 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 175.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.2 p -151.1 159.8 44.27 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.5 t -134.77 143.11 38.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 38.4 t -145.48 148.74 33.58 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.784 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 67.3 t -113.0 121.01 39.31 Favored Pre-proline 0 C--N 1.309 -1.153 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 176.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -57.79 138.4 85.88 Favored 'Trans proline' 0 C--O 1.244 0.799 0 C-N-CA 122.877 2.385 . . . . 0.0 111.498 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.456 ' CE2' ' HB3' ' A' ' 64' ' ' ASN . 40.5 t80 -67.67 136.64 54.67 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-O 121.699 0.761 . . . . 0.0 111.071 -177.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 70.2 t -131.61 114.87 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.456 ' HB3' ' CE2' ' A' ' 62' ' ' PHE . 9.4 p30 -111.95 5.01 18.57 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 175.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.19 145.13 32.52 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 112.615 -2.084 . . . . 0.0 112.931 -172.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.48 -5.64 0.06 Allowed 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 128.991 2.916 . . . . 0.0 115.162 -173.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -59.62 171.55 0.84 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.295 1.038 . . . . 0.0 109.614 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 28.3 mtm180 -90.7 -28.09 18.56 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 118.093 -1.443 . . . . 0.0 107.955 173.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -103.61 132.26 50.02 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.582 -174.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -106.38 153.78 40.24 Favored Pre-proline 0 C--N 1.289 -2.033 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 169.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.61 135.71 10.52 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 121.648 1.566 . . . . 0.0 113.012 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -133.88 118.58 18.11 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 177.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.617 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 82.9 m95 -107.55 136.77 46.76 Favored 'General case' 0 C--N 1.278 -2.525 0 O-C-N 122.052 -0.405 . . . . 0.0 111.977 -172.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.508 ' HD2' ' SG ' ' A' ' 111' ' ' CYS . 29.3 m-85 -113.52 141.21 47.42 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.765 177.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.5 mt -126.01 142.33 51.57 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 -176.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 88.0 m-85 -131.75 139.63 49.01 Favored 'General case' 0 C--N 1.31 -1.119 0 O-C-N 123.499 0.5 . . . . 0.0 110.993 -176.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.668 ' HB2' ' CD2' ' A' ' 102' ' ' PHE . 11.8 t70 -85.44 0.9 50.88 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 123.673 0.789 . . . . 0.0 111.224 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -136.58 158.49 44.32 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 172.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.1 m -72.0 169.26 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 C-N-CA 122.316 0.246 . . . . 0.0 110.405 -178.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.48 29.87 19.34 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.168 0.587 . . . . 0.0 110.575 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.413 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 18.9 m-85 56.37 46.82 20.23 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.973 0.909 . . . . 0.0 110.95 177.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 72.9 p -123.32 176.63 6.02 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.475 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.6 -140.8 18.38 Favored Glycine 0 N--CA 1.429 -1.821 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.79 177.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 61.8 mtt180 -73.61 143.46 46.34 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.1 tt -125.33 137.63 57.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 O-C-N 123.572 0.545 . . . . 0.0 110.269 -174.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 52.0 m -131.79 125.11 31.09 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 121.984 -0.448 . . . . 0.0 110.658 175.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -112.22 124.82 6.89 Favored Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.829 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -119.13 146.0 45.5 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 123.251 0.62 . . . . 0.0 110.251 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.29 166.95 12.39 Favored Glycine 0 N--CA 1.431 -1.664 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.362 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -53.3 124.79 15.6 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 124.337 1.055 . . . . 0.0 112.357 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.34 -6.47 82.39 Favored Glycine 0 N--CA 1.435 -1.424 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.612 175.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.9 m -106.44 146.42 30.55 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -178.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.9 m -139.8 152.3 46.44 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 50.8 mt -93.48 133.76 33.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 176.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -71.1 -47.9 55.43 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.205 0.526 . . . . 0.0 110.36 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.435 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 1.9 m-20 -135.0 100.15 4.49 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.25 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -64.4 -38.93 92.75 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.359 0.6 . . . . 0.0 110.375 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.4 t -65.62 -29.76 70.38 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.641 -1.163 . . . . 0.0 112.192 -175.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.435 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 27.5 mmtp -86.31 -14.88 42.34 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 121.988 -0.445 . . . . 0.0 109.963 -176.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.1 m -77.88 -8.08 57.59 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 144.0 -77.26 0.28 Allowed Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.668 ' CD2' ' HB2' ' A' ' 77' ' ' ASP . 37.8 p90 -110.05 147.89 32.73 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.03 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.94 -9.9 12.98 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -109.67 115.71 4.29 Favored Glycine 0 N--CA 1.428 -1.874 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.596 -175.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 64.0 mt -101.17 116.07 44.05 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.7 m -85.28 -26.4 26.65 Favored 'General case' 0 N--CA 1.391 -3.414 0 CA-C-N 112.432 -2.167 . . . . 0.0 114.067 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 77.8 p -156.75 156.35 33.18 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.3 mt -134.24 133.94 55.32 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.768 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -176.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.413 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 31.9 ttmt -122.52 131.42 53.84 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -96.08 122.23 38.7 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.379 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . 0.508 ' SG ' ' HD2' ' A' ' 74' ' ' TYR . 56.3 m -118.86 167.74 11.43 Favored 'General case' 0 N--CA 1.405 -2.7 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 9.2 pt -127.74 145.82 34.43 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 61.5 tt0 -122.6 118.93 29.35 Favored 'General case' 0 C--N 1.274 -2.712 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 27.1 p -79.78 179.16 7.69 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -175.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -66.25 -19.53 65.85 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.727 0.775 . . . . 0.0 110.203 177.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -83.34 -1.67 53.87 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.84 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.55 -5.63 82.89 Favored Glycine 0 CA--C 1.506 -0.483 0 CA-C-N 116.208 -0.451 . . . . 0.0 113.618 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 113' ' ' GLN . 19.0 ptpt -75.96 134.91 40.07 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 39.4 t -104.71 110.57 31.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -100.3 154.49 18.44 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.288 -2.097 0 C-N-CA 118.642 -1.223 . . . . 0.0 110.376 -177.206 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 121.565 0.698 . . . . 0.0 111.349 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.8 m -124.33 155.09 39.32 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.267 -0.878 . . . . 0.0 108.925 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.597 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 55.2 tp -110.18 117.58 34.06 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 172.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.51 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 77.7 mt-30 -110.22 124.2 51.15 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.579 -0.849 . . . . 0.0 109.618 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 3.2 mp -110.06 125.6 53.12 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.945 178.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -92.91 152.89 19.11 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 123.574 0.546 . . . . 0.0 110.1 -177.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -77.83 -37.9 47.51 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.868 -176.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -108.56 178.31 4.52 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.439 HG21 ' HA ' ' A' ' 96' ' ' ASP . 1.4 p -78.17 169.04 18.92 Favored 'General case' 0 N--CA 1.413 -2.292 0 C-N-CA 122.404 0.282 . . . . 0.0 110.4 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 25.3 p90 46.87 42.51 12.2 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.914 1.286 . . . . 0.0 114.232 176.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 67.65 23.46 8.73 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.414 1.086 . . . . 0.0 112.995 177.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.517 ' NE ' ' HA ' ' A' ' 36' ' ' ARG . 4.4 mmp_? -98.22 165.2 11.99 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.41 -157.8 33.47 Favored Glycine 0 N--CA 1.434 -1.436 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.5 p -85.99 176.64 7.93 Favored 'General case' 0 N--CA 1.421 -1.892 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 174.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 11.7 p90 -149.36 165.79 30.98 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.51 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 13.4 tt -123.03 150.81 27.07 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.747 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -106.88 125.21 50.71 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 174.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.439 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 94.8 t -118.13 133.69 64.13 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -117.86 -26.4 6.5 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.282 0.563 . . . . 0.0 110.569 -176.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -115.73 163.14 16.27 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.334 -174.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.2 p -84.06 143.53 29.67 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 175.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.5 p -120.75 132.38 70.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.56 -16.96 54.12 Favored Glycine 0 N--CA 1.433 -1.536 0 C-N-CA 119.77 -1.205 . . . . 0.0 113.457 -177.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.4 p -157.4 124.29 5.06 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 81.8 mt -117.73 118.65 32.64 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.9 m -133.09 116.85 14.56 Favored Pre-proline 0 N--CA 1.42 -1.942 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.154 175.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -75.62 160.08 96.49 Favored 'Cis proline' 0 C--O 1.251 1.14 0 C-N-CA 122.779 -1.759 . . . . 0.0 110.438 -4.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.0 157.33 29.61 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 122.69 2.26 . . . . 0.0 111.483 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 48.4 m0 -89.66 132.34 35.19 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -178.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.602 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 41.6 p -113.28 78.67 3.45 Favored Pre-proline 0 C--N 1.304 -1.375 0 O-C-N 123.252 0.345 . . . . 0.0 111.144 177.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.468 ' HG2' ' CD2' ' A' ' 97' ' ' PHE . 73.7 Cg_endo -76.37 153.44 35.43 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 122.198 1.932 . . . . 0.0 112.691 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -87.44 -28.53 24.46 Favored Glycine 0 N--CA 1.431 -1.638 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 178.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.7 p -155.08 154.96 33.21 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.6 t -134.01 142.25 41.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -178.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 31.6 t -146.11 149.64 34.42 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 119.637 -0.825 . . . . 0.0 111.52 176.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.7 t -118.03 124.11 28.99 Favored Pre-proline 0 N--CA 1.437 -1.117 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 175.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.89 143.52 79.87 Favored 'Trans proline' 0 C--O 1.246 0.877 0 C-N-CA 122.604 2.203 . . . . 0.0 112.281 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -66.89 136.37 55.29 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.172 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 84.5 t -120.61 129.76 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.9 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -121.48 27.59 8.19 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 124.125 0.97 . . . . 0.0 108.818 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -59.73 144.99 46.67 Favored 'General case' 0 C--O 1.248 1.014 0 C-N-CA 125.887 1.675 . . . . 0.0 111.054 -177.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.3 m -63.74 -14.88 56.33 Favored 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 124.325 1.05 . . . . 0.0 111.315 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -63.68 166.68 6.66 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.977 0.418 . . . . 0.0 110.763 175.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 57.3 mtm180 -90.97 -28.53 17.97 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.293 1.044 . . . . 0.0 109.152 -173.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -109.76 131.16 55.32 Favored 'General case' 0 N--CA 1.409 -2.501 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.661 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -106.18 153.96 39.97 Favored Pre-proline 0 C--N 1.301 -1.522 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.485 177.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -71.94 141.94 37.82 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.26 1.974 . . . . 0.0 113.464 -176.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -133.84 144.35 48.89 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.597 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 88.0 m95 -123.76 137.26 54.72 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.5 -0.75 . . . . 0.0 111.968 -175.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.427 ' HA ' ' O ' ' A' ' 86' ' ' THR . 29.6 m-85 -117.81 141.52 48.32 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.38 177.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.8 mt -125.73 143.07 51.2 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 74.8 m-85 -134.08 143.18 47.86 Favored 'General case' 0 C--O 1.242 0.688 0 O-C-N 123.518 0.512 . . . . 0.0 110.24 -176.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.494 ' HB3' ' CG ' ' A' ' 102' ' ' PHE . 4.3 p-10 -89.17 -0.63 57.6 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -131.21 157.4 43.31 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 174.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.415 HG21 HD21 ' A' ' 80' ' ' ASN . 35.3 m -67.98 169.19 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 120.732 0.301 . . . . 0.0 110.947 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.415 HD21 HG21 ' A' ' 79' ' ' VAL . 64.6 m-80 58.67 30.31 19.73 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 123.825 0.85 . . . . 0.0 111.335 178.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.459 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 13.4 m-85 57.51 38.7 28.13 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 124.659 1.184 . . . . 0.0 111.439 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 72.6 p -111.93 171.27 7.6 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.592 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.32 -138.65 14.78 Favored Glycine 0 N--CA 1.429 -1.833 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 59.1 mtt180 -79.21 153.34 30.06 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.5 tt -128.35 138.71 53.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -177.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 75.2 m -131.52 127.47 37.33 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 175.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -112.38 125.7 7.25 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.149 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -118.2 145.99 44.56 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 123.061 0.544 . . . . 0.0 110.749 178.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -117.45 168.74 12.98 Favored Glycine 0 N--CA 1.428 -1.899 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.95 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 23.5 p80 -62.71 122.17 15.22 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 123.6 0.76 . . . . 0.0 111.895 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.38 17.8 58.21 Favored Glycine 0 N--CA 1.431 -1.669 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.656 177.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.2 m -129.67 146.71 51.43 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.5 m -139.53 152.93 47.32 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 52.1 mt -93.63 122.15 44.87 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.448 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 171.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -70.57 -46.81 62.78 Favored 'General case' 0 C--N 1.289 -2.063 0 O-C-N 123.67 0.606 . . . . 0.0 110.809 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.524 ' HB3' ' CG ' ' A' ' 99' ' ' LYS . 5.4 m-20 -127.06 86.95 2.57 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.159 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.468 ' CD2' ' HG2' ' A' ' 55' ' ' PRO . 69.5 t80 -65.59 -36.17 82.95 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.359 0.599 . . . . 0.0 110.592 177.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.0 t -75.67 -15.85 60.26 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.976 -173.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.524 ' CG ' ' HB3' ' A' ' 96' ' ' ASP . 30.7 mmtp -94.35 -8.91 37.48 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.1 m -82.29 -168.16 1.86 Allowed 'General case' 0 C--O 1.248 0.982 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.961 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.47 -69.42 1.25 Allowed Glycine 0 C--O 1.242 0.64 0 O-C-N 123.109 0.256 . . . . 0.0 113.112 -177.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.494 ' CG ' ' HB3' ' A' ' 77' ' ' ASP . 42.3 p90 -110.39 146.17 36.28 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.343 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.602 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.66 -11.65 12.94 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 176.41 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.34 104.27 2.2 Favored Glycine 0 N--CA 1.44 -1.068 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.462 -176.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 70.4 mt -88.95 115.37 28.67 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.586 0 CA-C-O 122.533 1.159 . . . . 0.0 109.115 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 52.7 m -85.83 -27.44 25.1 Favored 'General case' 0 N--CA 1.395 -3.222 0 CA-C-N 112.108 -2.315 . . . . 0.0 113.934 177.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 81.0 p -157.4 155.58 30.76 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.1 mt -135.09 131.2 52.41 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -175.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.459 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 38.2 ttmt -117.45 133.51 55.89 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -100.43 130.02 46.46 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 61.3 m -130.06 172.88 11.27 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.571 -178.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.5 pt -131.77 143.55 39.98 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -113.79 121.1 43.03 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-O 121.382 0.61 . . . . 0.0 109.801 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.494 ' OG1' ' HG2' ' A' ' 118' ' ' LYS . 70.6 p -76.91 -179.97 5.8 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 114.316 -1.311 . . . . 0.0 112.155 -174.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -66.4 -30.97 71.45 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.81 172.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -76.76 -8.89 58.15 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.982 0.896 . . . . 0.0 110.199 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.89 -4.48 83.33 Favored Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.253 176.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.494 ' HG2' ' OG1' ' A' ' 114' ' ' THR . 10.7 ptmm? -76.13 135.13 39.83 Favored 'General case' 0 C--O 1.258 1.511 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.0 t -100.39 111.09 29.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 -177.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -96.69 149.44 21.81 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 -177.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 84.0 m . . . . . 0 C--N 1.287 -2.147 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.755 -175.85 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.4 ' CE1' HG13 ' A' ' 63' ' ' VAL . 9.7 m-85 . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 121.069 0.461 . . . . 0.0 112.207 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 34.7 m -124.41 145.73 49.31 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.605 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 57.3 tp -99.87 116.18 31.33 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 172.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.439 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 38.0 mt-30 -110.62 124.28 51.58 Favored 'General case' 0 CA--C 1.485 -1.529 0 C-N-CA 119.329 -0.948 . . . . 0.0 109.288 -177.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 mp -109.71 131.21 55.27 Favored 'General case' 0 N--CA 1.409 -2.521 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.238 176.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.527 ' CE2' ' HG3' ' A' ' 35' ' ' GLU . 97.8 m-85 -98.14 154.86 17.45 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 123.354 0.409 . . . . 0.0 110.568 -176.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -77.79 -43.61 30.09 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.481 0.657 . . . . 0.0 109.501 -176.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -108.43 178.45 4.49 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.302 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.595 ' HA ' ' OG ' ' A' ' 57' ' ' SER . 0.5 OUTLIER -83.43 179.94 7.53 Favored 'General case' 0 N--CA 1.401 -2.915 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.582 -177.546 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 48.47 40.42 14.97 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.867 0.867 . . . . 0.0 113.258 176.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.527 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 1.0 OUTLIER 57.9 23.7 10.08 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 115.232 1.568 . . . . 0.0 115.232 178.912 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -105.51 173.27 6.38 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 118.012 -1.475 . . . . 0.0 111.016 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.23 -177.39 45.84 Favored Glycine 0 N--CA 1.428 -1.873 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 -178.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 44.4 m -84.41 143.67 29.28 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.393 176.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -116.13 165.92 12.6 Favored 'General case' 0 C--N 1.272 -2.781 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -174.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.0 tt -114.9 152.08 16.56 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.543 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -106.8 125.55 51.14 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 175.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 94.4 t -122.84 133.46 68.88 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -122.61 -14.2 7.81 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp -110.1 162.24 14.76 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.646 -171.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.3 p -97.98 133.19 42.8 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 171.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.8 p -116.74 137.48 50.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -174.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.35 -18.49 35.95 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 119.755 -1.212 . . . . 0.0 113.321 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.5 p -155.81 121.34 4.91 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 86.0 mt -113.06 118.45 34.82 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.043 -0.981 . . . . 0.0 108.741 176.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.0 m -133.15 112.72 13.3 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 174.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.03 161.84 93.53 Favored 'Cis proline' 0 C--O 1.248 0.997 0 C-N-CA 123.313 -1.536 . . . . 0.0 111.255 -0.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -63.12 158.24 45.0 Favored 'Trans proline' 0 C--O 1.246 0.882 0 C-N-CA 122.387 2.058 . . . . 0.0 110.509 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -89.24 133.58 34.39 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 8.0 p -115.64 77.68 6.33 Favored Pre-proline 0 C--N 1.295 -1.799 0 O-C-N 123.628 0.58 . . . . 0.0 111.031 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.415 ' HG2' ' CD1' ' A' ' 97' ' ' PHE . 95.7 Cg_endo -77.65 158.09 32.0 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.286 1.991 . . . . 0.0 112.961 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.89 -39.45 11.77 Favored Glycine 0 N--CA 1.433 -1.55 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 176.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.595 ' OG ' ' HA ' ' A' ' 33' ' ' THR . 55.7 m -149.58 161.21 42.6 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.477 1.111 . . . . 0.0 108.26 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.9 t -135.35 142.33 40.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 48.8 t -146.1 147.99 32.16 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.435 176.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.7 t -116.29 122.34 32.23 Favored Pre-proline 0 N--CA 1.438 -1.066 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.68 147.41 89.9 Favored 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 122.57 2.18 . . . . 0.0 111.108 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -70.1 134.61 48.37 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.4 HG13 ' CE1' ' A' ' 25' ' ' TYR . 57.9 t -121.08 123.51 70.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -120.72 26.27 9.21 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -58.4 144.85 40.46 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.319 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.5 m -60.22 -20.57 59.37 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 123.3 0.64 . . . . 0.0 111.616 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -58.79 139.5 56.25 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -68.63 -24.14 64.52 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.77 -175.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.41 130.52 55.67 Favored 'General case' 0 N--CA 1.418 -2.032 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.95 154.97 40.68 Favored Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.951 175.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.47 134.91 14.32 Favored 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 121.779 1.653 . . . . 0.0 110.662 177.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -129.26 143.7 50.95 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.605 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 88.9 m95 -125.47 132.76 52.62 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 120.204 -0.598 . . . . 0.0 112.131 -173.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.438 ' HD2' ' SG ' ' A' ' 111' ' ' CYS . 27.2 m-85 -114.98 141.61 47.75 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.893 176.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.8 mt -125.72 142.72 51.37 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -175.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.415 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 77.5 m-85 -133.82 143.03 48.11 Favored 'General case' 0 C--N 1.317 -0.813 0 O-C-N 123.634 0.584 . . . . 0.0 109.923 -177.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.554 ' HB3' ' CG ' ' A' ' 102' ' ' PHE . 2.8 p-10 -88.39 0.87 55.75 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.652 -178.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -134.49 160.12 39.01 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.8 m -73.18 167.14 2.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-O 120.61 0.243 . . . . 0.0 111.427 -176.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 57.96 31.1 20.15 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 123.771 0.829 . . . . 0.0 111.421 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.548 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 10.9 m-85 59.64 39.37 21.32 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.893 1.277 . . . . 0.0 111.465 177.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 74.3 p -111.58 176.19 5.12 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.12 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.91 -137.43 15.16 Favored Glycine 0 N--CA 1.429 -1.825 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.835 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 56.2 mtt180 -83.81 150.86 25.49 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 123.547 0.739 . . . . 0.0 109.471 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.9 tt -124.84 139.39 51.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 121.179 0.514 . . . . 0.0 110.667 -176.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 90.7 m -131.47 128.2 38.93 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 174.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -115.06 117.43 4.01 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.541 -0.838 . . . . 0.0 113.194 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -109.9 145.55 36.65 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.017 0.437 . . . . 0.0 110.964 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -122.58 170.9 15.34 Favored Glycine 0 N--CA 1.419 -2.495 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.467 -177.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -63.6 121.5 14.06 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.299 0.571 . . . . 0.0 111.734 -176.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.6 14.72 61.05 Favored Glycine 0 N--CA 1.434 -1.479 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.908 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.6 m -125.09 146.14 49.6 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.9 m -139.15 160.06 40.69 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 50.0 mt -94.06 132.18 38.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 173.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -69.93 -48.41 58.57 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.033 0.444 . . . . 0.0 110.563 -177.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -142.82 93.18 2.48 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.573 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.415 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 49.1 t80 -64.63 -30.06 71.07 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.573 0.701 . . . . 0.0 109.391 178.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.0 t -63.65 -25.07 68.05 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.537 177.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -94.88 -5.59 44.61 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.936 -0.477 . . . . 0.0 110.837 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.9 m -79.61 -176.84 5.54 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -56.37 -63.8 4.98 Favored Glycine 0 C--O 1.249 1.052 0 CA-C-O 121.017 0.232 . . . . 0.0 112.781 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.554 ' CG ' ' HB3' ' A' ' 77' ' ' ASP . 39.9 p90 -110.92 147.23 35.07 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 177.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.94 -9.89 12.98 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.586 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -107.45 113.62 4.02 Favored Glycine 0 N--CA 1.431 -1.66 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.474 -177.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 62.6 mt -96.94 115.18 35.81 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.641 0 CA-C-O 122.336 1.065 . . . . 0.0 108.919 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.7 m -85.61 -29.68 23.89 Favored 'General case' 0 N--CA 1.392 -3.335 0 CA-C-N 112.242 -2.253 . . . . 0.0 113.685 177.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 89.2 p -153.11 155.52 36.93 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.0 mt -135.29 130.17 50.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -176.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.548 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 35.8 ttmt -117.32 131.15 56.86 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -101.76 123.14 45.23 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -177.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . 0.438 ' SG ' ' HD2' ' A' ' 74' ' ' TYR . 60.0 m -119.69 172.5 7.64 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -177.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.6 pt -128.12 141.95 45.1 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -115.68 120.29 38.89 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 108.39 -0.966 . . . . 0.0 108.39 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 44.1 p -76.93 175.53 9.44 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.799 -174.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -67.51 -20.68 65.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.628 0.727 . . . . 0.0 109.043 176.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -77.43 -9.59 58.97 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.512 177.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.28 -9.7 76.81 Favored Glycine 0 N--CA 1.439 -1.163 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.187 176.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -74.56 141.47 44.77 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 117.345 0.573 . . . . 0.0 110.225 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.7 t -106.68 111.28 34.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -105.85 148.09 27.96 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.285 -2.207 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.464 -178.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 34.5 m -123.08 145.56 48.44 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.471 ' HB3' ' HB ' ' A' ' 42' ' ' VAL . 49.6 tp -93.68 116.8 29.31 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 174.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 37.0 mt-30 -111.69 124.78 53.05 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -177.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 3.9 mp -109.6 129.06 55.61 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.24 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.545 ' CE1' ' HG3' ' A' ' 35' ' ' GLU . 94.6 m-85 -97.16 153.66 17.84 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 123.907 0.754 . . . . 0.0 111.644 -174.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -74.48 -41.64 60.4 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.058 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -107.83 177.65 4.76 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.453 HG21 ' O ' ' A' ' 56' ' ' GLY . 3.4 p -82.11 173.01 12.55 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 19.2 p90 47.46 38.76 8.19 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.545 ' HG3' ' CE1' ' A' ' 30' ' ' TYR . 0.7 OUTLIER 67.43 25.76 8.49 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 124.805 1.242 . . . . 0.0 113.637 177.229 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.7 mtp85 -90.74 159.22 16.44 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 177.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.99 -136.89 13.74 Favored Glycine 0 N--CA 1.422 -2.242 0 CA-C-N 114.365 -1.288 . . . . 0.0 109.911 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.2 m -116.68 -179.49 3.7 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 175.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.462 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 33.8 p90 -141.36 165.29 27.91 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -178.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 17.3 tt -114.63 152.65 16.24 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 177.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -106.71 126.11 51.87 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.471 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 88.2 t -123.43 133.15 69.98 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 176.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -115.53 -35.7 4.49 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-O 121.604 0.716 . . . . 0.0 109.397 -175.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.25 161.03 24.02 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.113 -177.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.9 p -69.03 147.83 50.98 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 123.579 0.549 . . . . 0.0 111.517 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.4 p -121.4 131.19 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.06 -15.86 55.24 Favored Glycine 0 N--CA 1.432 -1.633 0 C-N-CA 119.749 -1.215 . . . . 0.0 113.08 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.5 p -156.74 127.54 6.74 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 83.3 mt -122.57 118.36 28.02 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.474 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.5 m -133.5 113.46 13.12 Favored Pre-proline 0 C--N 1.306 -1.302 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.103 174.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.22 162.1 93.38 Favored 'Cis proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.27 -1.554 . . . . 0.0 111.168 -0.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -63.6 156.84 54.62 Favored 'Trans proline' 0 C--O 1.238 0.505 0 C-N-CA 121.928 1.752 . . . . 0.0 110.695 177.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.4 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 49.2 m0 -89.46 134.83 33.92 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -177.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.606 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 58.0 p -113.87 81.0 5.59 Favored Pre-proline 0 N--CA 1.434 -1.236 0 O-C-N 123.431 0.457 . . . . 0.0 111.199 176.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -79.47 158.42 25.63 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.699 2.266 . . . . 0.0 112.447 177.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.453 ' O ' HG21 ' A' ' 33' ' ' THR . . . -87.93 -35.85 8.8 Favored Glycine 0 N--CA 1.429 -1.814 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 176.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.4 p -150.3 158.15 43.85 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.2 t -132.09 142.57 42.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 38.4 t -145.43 149.55 34.92 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.614 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.1 t -117.28 126.63 27.27 Favored Pre-proline 0 C--N 1.317 -0.808 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.24 142.76 98.97 Favored 'Trans proline' 0 C--O 1.248 1.019 0 C-N-CA 122.851 2.367 . . . . 0.0 111.839 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.442 ' CE1' ' HB3' ' A' ' 64' ' ' ASN . 59.4 t80 -73.48 124.19 25.37 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 122.031 0.92 . . . . 0.0 111.456 -176.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.403 ' H ' ' HB2' ' A' ' 90' ' ' HIS . 91.0 t -109.76 117.67 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 CA-C-N 114.428 -1.26 . . . . 0.0 107.929 178.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.442 ' HB3' ' CE1' ' A' ' 62' ' ' PHE . 4.9 p-10 -122.38 11.31 9.99 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -69.31 145.55 52.94 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 111.664 -2.516 . . . . 0.0 112.631 -173.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 m -53.81 -7.58 0.13 Allowed 'General case' 0 CA--C 1.564 1.496 0 C-N-CA 128.353 2.661 . . . . 0.0 114.816 -175.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.7 154.36 40.85 Favored 'General case' 0 C--N 1.316 -0.887 0 O-C-N 122.173 -0.329 . . . . 0.0 110.692 -176.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -79.48 -28.4 41.51 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.741 -0.209 . . . . 0.0 111.206 -175.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -110.54 144.75 38.93 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.395 177.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -106.24 151.44 40.2 Favored Pre-proline 0 C--N 1.307 -1.273 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 171.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -78.62 137.3 14.37 Favored 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 122.238 1.958 . . . . 0.0 111.974 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -132.92 132.78 42.4 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.461 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 87.2 m95 -116.67 134.88 54.28 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.78 -0.575 . . . . 0.0 111.366 -174.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.466 ' HD1' ' SG ' ' A' ' 111' ' ' CYS . 29.0 m-85 -116.07 142.3 46.99 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.617 178.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.2 mt -125.89 142.69 51.4 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -176.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.531 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 81.4 m-85 -134.38 142.55 47.23 Favored 'General case' 0 C--O 1.245 0.82 0 O-C-N 123.719 0.637 . . . . 0.0 110.174 -176.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.457 ' C ' ' HB2' ' A' ' 106' ' ' SER . 0.8 OUTLIER -80.95 -9.95 59.77 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.58 -179.051 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -127.54 162.31 26.75 Favored 'General case' 0 N--CA 1.427 -1.605 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.426 177.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.5 m -73.19 168.75 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 122.804 0.442 . . . . 0.0 110.588 -176.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 57.66 30.35 18.72 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.612 0.72 . . . . 0.0 111.217 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 59.26 40.3 21.56 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.198 176.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 76.6 p -111.5 175.52 5.39 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.517 -0.473 . . . . 0.0 109.742 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.54 -140.62 16.16 Favored Glycine 0 N--CA 1.422 -2.259 0 C-N-CA 120.363 -0.923 . . . . 0.0 111.508 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 32.7 mtt180 -82.93 151.87 25.75 Favored 'General case' 0 C--N 1.287 -2.131 0 C-N-CA 123.487 0.715 . . . . 0.0 109.82 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.3 tt -122.61 137.2 56.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-O 121.198 0.523 . . . . 0.0 110.251 -177.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 95.2 m -131.62 125.82 33.17 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 175.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -115.05 110.09 2.23 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.625 -0.798 . . . . 0.0 114.63 -176.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -101.92 145.51 29.14 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 120.967 0.413 . . . . 0.0 111.279 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -123.32 169.67 15.58 Favored Glycine 0 N--CA 1.419 -2.478 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.866 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.403 ' HB2' ' H ' ' A' ' 63' ' ' VAL . 7.3 p80 -53.36 122.03 8.8 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 124.056 0.943 . . . . 0.0 113.109 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.39 -5.8 80.69 Favored Glycine 0 CA--C 1.5 -0.857 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.873 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.3 m -106.25 146.39 30.4 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-O 121.219 0.533 . . . . 0.0 109.782 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.8 m -134.74 159.11 42.35 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 41.5 mt -93.44 130.43 42.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 175.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -65.8 -47.14 76.08 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.152 0.501 . . . . 0.0 110.066 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.462 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 2.9 m-20 -143.16 99.58 3.47 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 123.719 0.808 . . . . 0.0 108.966 178.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -63.96 -31.85 73.18 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.62 0.724 . . . . 0.0 110.839 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.5 t -63.34 -23.44 67.42 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.735 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.462 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 28.8 mmtp -94.56 -16.1 23.54 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 121.839 -0.538 . . . . 0.0 110.104 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.1 m -63.87 -34.32 77.68 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-O 121.116 0.484 . . . . 0.0 111.283 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 158.67 -67.38 0.28 Allowed Glycine 0 CA--C 1.488 -1.604 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -110.86 149.14 31.02 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.606 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.4 -9.64 13.33 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.26 177.229 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -106.25 108.18 2.88 Favored Glycine 0 N--CA 1.438 -1.189 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.017 -176.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 63.0 mt -92.11 116.04 32.4 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.59 0 CA-C-O 122.22 1.01 . . . . 0.0 109.067 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.457 ' HB2' ' C ' ' A' ' 77' ' ' ASP . 4.0 m -85.35 -29.28 24.61 Favored 'General case' 0 N--CA 1.396 -3.136 0 CA-C-N 112.565 -2.107 . . . . 0.0 114.231 176.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.3 p -154.92 155.15 33.78 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 122.191 -0.318 . . . . 0.0 110.239 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.3 mt -133.14 130.68 58.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -117.71 133.71 55.66 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -99.8 126.77 45.94 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . 0.466 ' SG ' ' HD1' ' A' ' 74' ' ' TYR . 59.1 m -122.95 171.93 8.87 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -178.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 7.8 pt -127.52 143.49 40.51 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.298 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.586 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -117.02 119.45 35.32 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 51.1 p -80.89 178.31 8.49 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 114.228 -1.351 . . . . 0.0 112.363 -172.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -66.51 -23.6 66.27 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 172.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -83.3 -8.17 59.47 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.583 -1.189 . . . . 0.0 109.985 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.96 -11.36 57.51 Favored Glycine 0 N--CA 1.438 -1.186 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.769 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.47 137.05 54.13 Favored 'General case' 0 C--O 1.255 1.364 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 43.3 t -105.58 112.07 37.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -97.77 144.52 27.29 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 94.6 m . . . . . 0 C--N 1.293 -1.871 0 O-C-N 123.062 0.226 . . . . 0.0 110.903 -173.981 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.42 ' CE1' HG12 ' A' ' 63' ' ' VAL . 5.0 m-85 . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 121.631 0.729 . . . . 0.0 110.694 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 20.0 m -128.74 145.6 51.13 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.573 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 54.9 tp -105.68 127.24 52.94 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 177.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 71.6 mt-30 -114.73 124.75 52.58 Favored 'General case' 0 CA--C 1.49 -1.358 0 C-N-CA 119.889 -0.724 . . . . 0.0 109.61 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.5 mp -109.86 123.91 50.4 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.214 176.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -95.12 151.9 18.8 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 123.832 0.707 . . . . 0.0 110.678 -174.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -74.71 -38.64 62.28 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.113 0.483 . . . . 0.0 110.41 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -108.33 178.17 4.58 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.013 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.494 ' O ' ' HB2' ' A' ' 36' ' ' ARG . 3.9 p -80.84 170.95 15.62 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 27.8 p90 46.8 42.27 11.64 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 66.62 21.97 10.57 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.283 1.033 . . . . 0.0 112.24 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.494 ' HB2' ' O ' ' A' ' 33' ' ' THR . 8.6 mmm180 -88.23 159.41 18.15 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.521 0.677 . . . . 0.0 111.785 177.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.14 -165.66 47.34 Favored Glycine 0 N--CA 1.428 -1.885 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.516 178.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.1 m -87.05 171.83 10.43 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -146.78 164.08 33.93 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -176.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 12.7 tt -115.01 152.53 16.61 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.648 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -107.05 124.92 50.35 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.523 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 89.8 t -115.1 132.84 63.16 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.641 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 178.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -114.43 -32.9 5.77 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 121.247 0.546 . . . . 0.0 110.047 -176.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.15 162.73 19.6 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.347 -176.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.6 p -74.74 151.59 39.15 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.147 0.498 . . . . 0.0 111.839 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.1 p -122.81 127.79 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 175.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.92 -14.56 60.69 Favored Glycine 0 C--N 1.301 -1.378 0 C-N-CA 119.368 -1.396 . . . . 0.0 112.906 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.2 p -160.25 125.9 4.04 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 121.086 0.469 . . . . 0.0 112.004 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.7 mt -116.01 118.63 33.44 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.9 m -132.7 111.25 13.54 Favored Pre-proline 0 C--N 1.288 -2.101 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 174.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.9 161.86 92.67 Favored 'Cis proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.012 -1.662 . . . . 0.0 111.433 0.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -63.44 158.18 46.68 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 122.33 2.02 . . . . 0.0 111.05 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 49.5 m0 -89.86 138.91 31.09 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 10.5 p -120.62 76.45 27.2 Favored Pre-proline 0 C--N 1.296 -1.756 0 O-C-N 123.555 0.534 . . . . 0.0 111.477 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.402 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 83.6 Cg_endo -77.54 158.03 32.39 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.779 2.319 . . . . 0.0 113.232 179.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.13 -29.93 13.81 Favored Glycine 0 N--CA 1.429 -1.832 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 175.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.8 p -155.46 158.79 39.13 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.8 t -133.76 143.2 39.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 38.9 t -145.47 148.11 32.91 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.787 175.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.8 t -114.61 117.34 42.65 Favored Pre-proline 0 N--CA 1.428 -1.552 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 175.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -56.57 147.25 70.97 Favored 'Trans proline' 0 C--O 1.247 0.975 0 C-N-CA 122.759 2.306 . . . . 0.0 111.909 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -75.58 112.63 12.12 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.42 HG12 ' CE1' ' A' ' 25' ' ' TYR . 36.8 t -93.85 114.57 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.677 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -109.7 32.79 4.78 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.318 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.526 ' OD1' ' HG2' ' A' ' 67' ' ' LYS . 6.2 t70 -75.33 144.61 42.29 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 113.832 -1.531 . . . . 0.0 108.007 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 m -56.54 -11.58 1.36 Allowed 'General case' 0 CA--C 1.577 1.984 0 C-N-CA 125.264 1.426 . . . . 0.0 114.203 -174.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.526 ' HG2' ' OD1' ' A' ' 65' ' ' ASP . 15.5 mmtp -67.66 145.02 55.21 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 122.984 0.514 . . . . 0.0 109.696 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -81.39 -14.13 57.52 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.826 0.346 . . . . 0.0 111.703 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -104.14 127.86 51.77 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -105.98 150.19 38.97 Favored Pre-proline 0 C--N 1.291 -1.939 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -76.48 140.18 21.29 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 121.771 1.647 . . . . 0.0 112.764 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -133.38 129.29 37.2 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.573 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 82.6 m95 -110.82 139.69 45.9 Favored 'General case' 0 C--N 1.284 -2.26 0 O-C-N 121.897 -0.502 . . . . 0.0 112.162 -172.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.471 ' HD2' ' SG ' ' A' ' 111' ' ' CYS . 35.9 m-85 -117.7 142.51 47.16 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.495 177.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.3 mt -125.59 142.45 51.5 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -176.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.514 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 77.9 m-85 -133.5 141.34 47.73 Favored 'General case' 0 C--N 1.318 -0.765 0 O-C-N 123.64 0.587 . . . . 0.0 109.958 -176.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -81.09 -15.19 56.67 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.426 ' C ' ' HB3' ' A' ' 106' ' ' SER . 5.6 t-20 -125.59 165.16 19.04 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.8 m -68.81 168.51 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 123.146 0.579 . . . . 0.0 111.615 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 56.44 30.25 16.71 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.852 0.861 . . . . 0.0 111.233 178.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.495 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 11.2 m-85 55.66 48.79 17.76 Favored 'General case' 0 C--O 1.25 1.131 0 C-N-CA 124.596 1.158 . . . . 0.0 110.785 178.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 74.6 p -117.43 168.53 10.28 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.862 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.3 -131.19 10.67 Favored Glycine 0 N--CA 1.416 -2.682 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 66.5 mtt85 -87.25 144.14 26.95 Favored 'General case' 0 C--N 1.279 -2.462 0 C-N-CA 124.332 1.053 . . . . 0.0 109.506 -178.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.4 tt -121.87 136.63 58.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-O 121.301 0.572 . . . . 0.0 110.045 -177.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 94.6 m -132.02 123.9 28.22 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.132 175.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -109.02 130.15 9.88 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.945 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -119.61 145.63 46.25 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 123.335 0.654 . . . . 0.0 110.632 178.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -113.22 166.17 12.11 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.91 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -62.47 122.76 16.55 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.256 0.55 . . . . 0.0 111.796 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 92.15 -0.72 72.55 Favored Glycine 0 N--CA 1.433 -1.512 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.47 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.1 m -112.34 146.54 38.11 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 4.5 m -133.56 160.66 36.82 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 49.2 mt -93.63 130.98 41.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 173.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -70.39 -47.42 60.92 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.245 0.545 . . . . 0.0 110.938 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -143.69 98.42 3.24 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -64.66 -30.04 71.05 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.649 0.738 . . . . 0.0 110.518 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.9 t -63.61 -22.8 67.09 Favored 'General case' 0 CA--C 1.555 1.155 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.9 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -95.36 -6.69 40.49 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.101 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.6 m -70.46 -40.55 73.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.118 0.485 . . . . 0.0 111.026 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 156.91 -65.0 0.31 Allowed Glycine 0 CA--C 1.491 -1.462 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -109.17 145.55 35.6 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.26 -9.12 13.47 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.351 177.741 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.39 106.55 2.57 Favored Glycine 0 N--CA 1.43 -1.73 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.614 -177.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 84.7 mt -91.38 115.08 29.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.426 ' HB3' ' C ' ' A' ' 78' ' ' ASN . 5.1 t -86.41 -26.61 24.65 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.847 177.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 90.1 p -150.81 155.73 39.81 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.344 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.7 mt -136.22 130.89 48.47 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -176.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.495 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 35.9 ttmt -117.52 133.67 55.7 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -101.37 121.93 42.81 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . 0.471 ' SG ' ' HD2' ' A' ' 74' ' ' TYR . 50.4 m -119.49 172.18 7.82 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -177.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.5 pt -129.02 144.3 38.6 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -115.21 123.8 49.79 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 45.3 p -77.58 177.14 8.3 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.14 -175.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -66.4 -23.81 66.38 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.657 0.741 . . . . 0.0 109.288 176.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -76.95 -9.42 58.68 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.522 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.22 -1.75 80.31 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 116.219 -0.446 . . . . 0.0 113.261 177.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -83.81 143.87 29.65 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.964 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 17.8 t -103.82 112.23 36.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -100.59 149.95 23.21 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 CA--C 1.48 -1.732 0 C-N-CA 117.972 -1.491 . . . . 0.0 110.002 178.905 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 . . . . . 0 N--CA 1.484 1.233 0 CA-C-O 121.376 0.608 . . . . 0.0 111.905 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 36.4 m -124.58 145.92 49.33 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.568 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 54.7 tp -98.25 119.68 37.33 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 174.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.451 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 64.6 mt-30 -113.68 124.55 52.58 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 3.6 mp -109.59 131.06 55.41 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.038 177.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -90.81 156.29 18.15 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 123.763 0.664 . . . . 0.0 110.64 -176.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -77.06 -41.42 42.49 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.436 -176.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.447 ' C ' ' HA3' ' A' ' 56' ' ' GLY . 45.4 mt-10 -113.14 177.55 4.59 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.554 ' O ' ' HB2' ' A' ' 36' ' ' ARG . 2.0 p -82.58 174.81 10.7 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 23.4 p90 47.35 40.22 10.32 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.398 1.079 . . . . 0.0 113.617 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 65.46 26.66 11.84 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.59 1.156 . . . . 0.0 111.334 176.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.554 ' HB2' ' O ' ' A' ' 33' ' ' THR . 6.5 mmm180 -89.64 147.65 23.78 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.743 0.783 . . . . 0.0 111.939 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.17 -161.0 28.74 Favored Glycine 0 N--CA 1.419 -2.434 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.35 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.2 m -97.43 -177.14 3.72 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 50.4 p90 -142.16 165.97 25.99 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.4 tt -113.6 153.48 15.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -106.3 125.94 51.62 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.494 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 92.4 t -127.18 133.73 67.54 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 175.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -115.99 -31.86 5.59 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-O 121.113 0.482 . . . . 0.0 109.953 -176.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.43 161.85 33.43 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.512 -176.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.5 m -61.02 143.99 54.26 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.703 -175.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.6 p -121.37 136.94 56.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 176.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.31 -18.08 27.37 Favored Glycine 0 N--CA 1.435 -1.387 0 C-N-CA 120.077 -1.058 . . . . 0.0 113.907 -175.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.9 t -156.98 128.61 7.06 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 117.451 0.626 . . . . 0.0 109.57 -178.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 94.5 mt -120.17 119.67 33.93 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.208 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.7 p -131.7 107.96 14.29 Favored Pre-proline 0 C--N 1.298 -1.638 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.268 176.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.73 162.68 89.52 Favored 'Cis proline' 0 C--O 1.242 0.718 0 C-N-CA 123.896 -1.294 . . . . 0.0 111.33 -1.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.45 156.31 42.18 Favored 'Trans proline' 0 C--O 1.243 0.753 0 C-N-CA 122.521 2.147 . . . . 0.0 109.879 176.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -89.65 129.62 36.06 Favored 'General case' 0 C--N 1.288 -2.088 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.13 -177.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.573 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 40.9 p -111.37 80.75 2.71 Favored Pre-proline 0 N--CA 1.424 -1.757 0 O-C-N 123.697 0.623 . . . . 0.0 110.537 176.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -80.25 158.62 23.15 Favored 'Trans proline' 0 N--CA 1.443 -1.458 0 C-N-CA 122.22 1.946 . . . . 0.0 111.776 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.447 ' HA3' ' C ' ' A' ' 32' ' ' GLU . . . -86.73 -39.03 7.78 Favored Glycine 0 N--CA 1.425 -2.076 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 176.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' A' ' 94' ' ' ILE . 72.9 p -147.65 160.96 42.1 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.6 t -137.11 142.23 38.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 36.9 t -145.52 149.1 34.0 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 119.704 -0.799 . . . . 0.0 111.386 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.9 t -116.78 125.2 28.54 Favored Pre-proline 0 N--CA 1.443 -0.78 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.0 143.66 99.38 Favored 'Trans proline' 0 C--O 1.242 0.688 0 C-N-CA 123.222 2.614 . . . . 0.0 112.53 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -70.99 122.0 19.21 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.661 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 93.4 t -96.67 115.39 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 CA-C-O 121.49 0.662 . . . . 0.0 109.57 177.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -101.72 -6.46 23.67 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 113.981 -1.463 . . . . 0.0 110.441 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -58.42 144.74 40.95 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 125.123 1.369 . . . . 0.0 112.034 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.2 m -55.68 -7.52 0.29 Allowed 'General case' 0 CA--C 1.571 1.772 0 C-N-CA 125.708 1.603 . . . . 0.0 113.105 -178.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -64.47 140.92 58.92 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.233 0.54 . . . . 0.0 110.183 178.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.557 ' HB2' ' OE2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -81.19 -28.11 35.08 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.032 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.557 ' OE2' ' HB2' ' A' ' 68' ' ' ARG . 2.4 mp0 -94.35 125.77 39.2 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.3 152.69 42.06 Favored Pre-proline 0 C--N 1.289 -2.058 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.388 174.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.52 134.78 21.04 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 121.505 1.47 . . . . 0.0 110.733 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -129.03 138.33 51.85 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.568 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 87.5 m95 -119.25 133.48 55.73 Favored 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.933 -173.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.503 ' HA ' ' O ' ' A' ' 86' ' ' THR . 24.6 m-85 -113.73 140.0 48.63 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.913 176.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.3 mt -125.31 142.74 51.33 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.576 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 84.8 m-85 -132.35 143.7 50.04 Favored 'General case' 0 C--N 1.32 -0.71 0 O-C-N 123.57 0.543 . . . . 0.0 110.903 -176.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -84.75 0.27 51.2 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.373 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -137.54 163.65 30.65 Favored 'General case' 0 N--CA 1.417 -2.092 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.6 m -75.5 168.95 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 C-N-CA 123.044 0.538 . . . . 0.0 111.151 -176.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 58.06 30.73 19.71 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.894 0.746 . . . . 0.0 111.065 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.576 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 9.6 m-85 59.44 39.14 22.3 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.98 1.312 . . . . 0.0 111.713 177.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 81.0 p -112.28 170.62 8.04 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.548 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.9 -143.67 16.69 Favored Glycine 0 N--CA 1.421 -2.352 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.167 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.576 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 62.6 mtt85 -75.15 140.36 43.31 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 124.17 0.988 . . . . 0.0 108.905 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.2 tt -118.09 137.5 51.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-O 121.016 0.436 . . . . 0.0 109.891 -175.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 87.9 m -130.83 121.47 25.37 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 176.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -109.14 120.65 5.9 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.779 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -115.35 145.36 42.58 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 122.85 0.46 . . . . 0.0 110.757 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -120.2 167.8 13.71 Favored Glycine 0 N--CA 1.429 -1.822 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.284 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -58.25 123.42 15.98 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 123.434 0.694 . . . . 0.0 112.47 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.14 4.65 71.33 Favored Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.247 177.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.5 m -116.93 146.43 42.98 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.7 m -138.23 154.16 49.09 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.515 ' O ' ' HB2' ' A' ' 57' ' ' SER . 41.3 mt -94.58 126.03 47.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 173.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -70.84 -46.24 63.06 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 121.185 0.517 . . . . 0.0 111.391 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.45 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 3.1 m-20 -131.6 96.34 3.95 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -63.87 -36.72 84.84 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.302 0.572 . . . . 0.0 110.665 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.5 t -63.81 -27.84 69.45 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.036 -0.983 . . . . 0.0 112.405 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.45 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 30.3 mmtp -90.53 -9.92 45.45 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -177.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.2 m -84.75 7.61 20.01 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.135 -176.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 132.8 -84.69 0.29 Allowed Glycine 0 N--CA 1.421 -2.326 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.479 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -110.24 150.4 28.75 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.573 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -112.52 -9.79 13.76 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.062 177.9 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -107.7 104.05 2.02 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.907 -176.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 68.0 mt -87.01 115.74 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.808 0 CA-C-O 122.476 1.131 . . . . 0.0 108.839 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 44.3 m -86.44 -29.9 22.47 Favored 'General case' 0 N--CA 1.388 -3.573 0 CA-C-N 112.295 -2.229 . . . . 0.0 114.71 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 81.2 p -154.43 158.64 40.28 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 177.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.1 mt -136.22 132.05 49.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -176.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.576 ' HE2' ' CD2' ' A' ' 81' ' ' TYR . 37.3 ttmt -117.71 127.73 54.21 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -96.94 121.25 38.61 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . 0.491 ' SG ' ' HD2' ' A' ' 74' ' ' TYR . 57.2 m -121.29 172.83 7.73 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 124.047 0.939 . . . . 0.0 108.68 -177.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.5 pt -124.09 140.44 47.48 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 176.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -115.0 127.47 55.69 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 61.7 p -79.21 179.76 7.2 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.766 -172.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -67.21 -29.38 69.02 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.945 177.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.527 ' OD1' ' HG2' ' A' ' 118' ' ' LYS . 1.9 p-10 -84.38 -7.81 59.19 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.92 -177.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.06 3.9 58.84 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.384 -0.912 . . . . 0.0 114.426 175.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.527 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 21.7 ptmt -84.03 145.82 28.29 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 118.067 0.934 . . . . 0.0 109.16 176.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 17.1 t -107.51 116.51 51.23 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -101.68 140.95 35.27 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.293 -1.867 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 121.557 0.694 . . . . 0.0 111.324 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 22.9 m -123.37 148.47 46.01 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.813 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.568 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 55.7 tp -103.28 117.17 33.91 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 174.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.495 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 76.1 mt-30 -109.92 124.22 51.0 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.56 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 3.4 mp -109.98 123.45 49.68 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.613 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -92.0 152.76 19.84 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 123.729 0.643 . . . . 0.0 110.233 -177.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -75.93 -36.45 59.37 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.353 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -107.84 177.95 4.67 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.0 p -82.28 173.13 12.37 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.606 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 26.2 p90 46.46 42.11 10.4 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 114.703 1.372 . . . . 0.0 114.703 176.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 68.05 23.26 8.16 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.889 0.876 . . . . 0.0 111.825 177.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.416 ' HE ' ' HB3' ' A' ' 36' ' ' ARG . 4.2 mtp180 -94.85 164.41 12.93 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 177.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.48 -167.35 50.4 Favored Glycine 0 N--CA 1.426 -2.002 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -175.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.6 m -91.98 177.82 6.06 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 174.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 44.6 p90 -140.39 166.14 25.52 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -178.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.495 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 11.8 tt -114.05 152.65 15.69 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -106.99 125.65 51.28 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.499 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 93.5 t -123.48 133.7 68.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -119.12 -24.16 6.58 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.089 0.471 . . . . 0.0 110.444 -175.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.23 161.93 29.03 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.82 -175.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.7 m -74.43 144.96 44.05 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.119 0.485 . . . . 0.0 110.8 -178.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.0 p -121.75 137.31 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 177.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -97.12 -23.11 15.48 Favored Glycine 0 C--N 1.292 -1.914 0 C-N-CA 120.07 -1.062 . . . . 0.0 113.173 -177.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.9 m -148.84 128.35 13.12 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 122.317 -0.52 . . . . 0.0 110.565 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 83.7 mt -122.02 118.05 27.85 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 176.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.0 m -132.81 112.11 13.57 Favored Pre-proline 0 C--N 1.3 -1.581 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 177.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.91 161.89 92.6 Favored 'Cis proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.076 -1.635 . . . . 0.0 110.841 -0.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -61.52 157.49 41.23 Favored 'Trans proline' 0 C--O 1.243 0.741 0 C-N-CA 122.508 2.138 . . . . 0.0 110.73 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.433 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 48.6 m0 -89.54 139.22 30.75 Favored 'General case' 0 CA--C 1.484 -1.587 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -178.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.528 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 30.1 p -118.47 78.61 14.83 Favored Pre-proline 0 C--N 1.304 -1.371 0 C-N-CA 120.544 -0.462 . . . . 0.0 111.888 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.433 ' HD2' ' O ' ' A' ' 103' ' ' LYS . 85.0 Cg_endo -78.4 157.45 29.19 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.565 2.177 . . . . 0.0 112.996 177.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -93.18 -29.63 10.12 Favored Glycine 0 N--CA 1.431 -1.635 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 177.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.4 p -153.68 151.16 29.34 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.4 t -128.84 142.83 42.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 37.2 t -145.82 149.47 34.38 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.442 176.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 49.0 t -118.81 122.55 29.71 Favored Pre-proline 0 N--CA 1.435 -1.213 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 176.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.3 143.41 83.06 Favored 'Trans proline' 0 C--O 1.244 0.791 0 C-N-CA 122.86 2.373 . . . . 0.0 112.0 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -66.55 125.89 27.18 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 121.465 0.65 . . . . 0.0 110.473 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.4 HG11 ' OD2' ' A' ' 65' ' ' ASP . 59.8 t -101.01 124.2 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.758 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.337 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -120.34 20.63 11.9 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.988 0.899 . . . . 0.0 108.922 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.4 ' OD2' HG11 ' A' ' 63' ' ' VAL . 1.2 m-20 -58.24 145.74 36.44 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 113.982 -1.463 . . . . 0.0 113.187 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.9 m -60.14 -27.11 66.8 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 175.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -56.04 124.67 18.55 Favored 'General case' 0 C--O 1.251 1.156 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.343 173.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -77.54 -27.77 51.71 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.278 -177.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -83.02 125.67 31.7 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-O 122.001 0.905 . . . . 0.0 108.62 178.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 28.4 mmt85 -108.09 153.03 42.02 Favored Pre-proline 0 C--N 1.281 -2.377 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.424 -177.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -85.74 134.76 4.72 Favored 'Trans proline' 0 N--CA 1.441 -1.602 0 C-N-CA 121.281 1.321 . . . . 0.0 112.008 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -129.54 131.0 46.47 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.568 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 86.6 m95 -112.84 132.82 55.11 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.81 -173.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.537 ' HA ' ' O ' ' A' ' 86' ' ' THR . 37.6 m-85 -112.89 142.17 45.87 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.911 176.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.4 mt -125.58 142.65 51.39 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -176.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.519 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 82.5 m-85 -133.13 142.54 48.73 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 123.701 0.626 . . . . 0.0 109.895 -177.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.491 ' HB3' ' CD1' ' A' ' 102' ' ' PHE . 1.7 p-10 -87.89 0.35 55.96 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.566 -178.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -136.48 157.29 47.14 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 174.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.6 m -69.68 164.7 2.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 122.403 0.281 . . . . 0.0 111.674 -174.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 59.83 31.22 20.66 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 123.575 0.75 . . . . 0.0 111.566 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.59 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 12.0 m-85 61.12 39.93 15.48 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.853 1.261 . . . . 0.0 111.735 177.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 72.4 p -112.16 171.48 7.48 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.116 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.59 -133.31 11.67 Favored Glycine 0 N--CA 1.428 -1.859 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.307 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.519 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 54.2 mtt180 -89.26 149.4 23.09 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 124.246 1.019 . . . . 0.0 109.058 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.6 tt -125.52 137.02 59.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 121.273 0.559 . . . . 0.0 110.59 -175.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 95.7 m -131.94 125.99 32.97 Favored 'General case' 0 C--N 1.287 -2.112 0 O-C-N 122.1 -0.375 . . . . 0.0 110.415 176.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -111.38 124.46 6.88 Favored Glycine 0 C--N 1.312 -0.784 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.553 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -116.8 144.79 44.06 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 122.967 0.507 . . . . 0.0 110.315 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -114.05 168.07 12.48 Favored Glycine 0 N--CA 1.435 -1.416 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.612 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 33.5 p80 -64.86 128.81 37.34 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 121.218 0.532 . . . . 0.0 111.899 -177.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.31 6.85 65.99 Favored Glycine 0 N--CA 1.426 -1.998 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.604 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.7 m -118.5 146.45 44.51 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 4.3 m -136.36 155.78 49.57 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 52.4 mt -94.01 128.29 45.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -70.81 -48.28 55.0 Favored 'General case' 0 C--N 1.313 -1.009 0 O-C-N 123.536 0.523 . . . . 0.0 110.5 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -135.37 92.69 2.88 Favored 'General case' 0 CA--C 1.486 -1.488 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.917 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -64.97 -32.26 73.89 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.265 0.555 . . . . 0.0 109.763 177.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.1 t -63.56 -26.62 68.78 Favored 'General case' 0 CA--C 1.552 1.019 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.66 -178.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -95.23 -6.61 41.14 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.527 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.6 m -84.4 39.44 0.73 Allowed 'General case' 0 C--O 1.244 0.778 0 CA-C-O 121.87 0.843 . . . . 0.0 111.488 -176.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.73 -78.77 1.69 Allowed Glycine 0 N--CA 1.424 -2.116 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.491 ' CD1' ' HB3' ' A' ' 77' ' ' ASP . 26.8 p90 -108.19 145.68 33.87 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -177.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.528 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -113.66 -10.46 13.09 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 177.421 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -104.19 110.22 3.55 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.308 -177.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 70.2 mt -95.01 115.7 34.52 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.658 0 CA-C-O 122.387 1.089 . . . . 0.0 108.868 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 57.8 m -86.04 -29.16 23.66 Favored 'General case' 0 N--CA 1.392 -3.357 0 CA-C-N 112.238 -2.255 . . . . 0.0 114.262 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 77.6 p -153.98 155.81 36.28 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.6 mt -134.73 131.15 53.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -176.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.59 ' HE2' ' CD2' ' A' ' 81' ' ' TYR . 34.4 ttmt -117.86 126.34 52.2 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -96.16 130.1 43.29 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 176.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 76.0 m -123.19 170.76 9.91 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 7.5 pt -125.06 142.35 42.24 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 176.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 53.6 tt0 -115.76 128.71 56.06 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.4 p -87.15 178.77 6.8 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.847 -174.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -63.16 -27.05 69.1 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.44 0.696 . . . . 0.0 109.186 174.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -81.05 -8.53 59.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.577 0.704 . . . . 0.0 110.739 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.37 -1.96 77.29 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.432 -0.889 . . . . 0.0 113.792 175.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 113' ' ' GLN . 8.8 ptpt -79.28 147.74 32.4 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.2 t -111.27 115.9 51.1 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -101.78 141.4 34.69 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 75.4 m . . . . . 0 C--N 1.308 -1.202 0 CA-C-O 121.108 0.48 . . . . 0.0 111.993 -175.036 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.41 ' CD1' ' HB3' ' A' ' 71' ' ' PRO . 1.4 m-85 . . . . . 0 CA--C 1.505 -0.764 0 CA-C-O 121.816 0.817 . . . . 0.0 110.398 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.3 m -139.05 154.5 48.22 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -176.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.587 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 53.4 tp -110.06 125.62 53.14 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 176.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.469 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 74.2 mt-30 -112.68 123.71 50.91 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 121.461 0.648 . . . . 0.0 109.572 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.4 mp -110.8 124.82 52.75 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.681 177.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -94.07 153.34 18.19 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 123.418 0.449 . . . . 0.0 111.183 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.46 -36.01 58.14 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.064 -176.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -107.44 178.26 4.59 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.541 ' O ' ' HB2' ' A' ' 36' ' ' ARG . 2.6 p -80.67 169.36 17.72 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 119.674 -0.203 . . . . 0.0 110.556 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 35.4 p90 46.65 42.73 11.82 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.17 1.388 . . . . 0.0 114.47 176.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 61.7 33.42 18.01 Favored 'General case' 0 C--O 1.246 0.904 0 C-N-CA 123.979 0.912 . . . . 0.0 112.502 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.541 ' HB2' ' O ' ' A' ' 33' ' ' THR . 5.4 mmm180 -96.23 154.55 17.19 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.807 174.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.53 -165.74 39.12 Favored Glycine 0 N--CA 1.427 -1.964 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.8 m -88.7 171.84 9.69 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 175.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -137.44 166.59 23.47 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -176.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.5 tt -114.61 150.79 16.48 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.45 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 176.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -107.21 125.63 51.36 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.509 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 74.6 t -117.99 133.54 64.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -117.48 -30.05 5.64 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.335 0.588 . . . . 0.0 110.86 -174.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -113.54 163.58 14.75 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.782 -174.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.4 m -79.05 145.19 33.97 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 173.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.2 p -120.88 128.7 76.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.424 ' C ' ' HG ' ' A' ' 48' ' ' SER . . . -89.79 -20.26 44.37 Favored Glycine 0 N--CA 1.427 -1.952 0 C-N-CA 119.543 -1.313 . . . . 0.0 113.342 -176.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.424 ' HG ' ' C ' ' A' ' 47' ' ' GLY . 50.5 m -157.78 114.52 2.91 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.509 0.671 . . . . 0.0 111.471 -178.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 85.5 mt -102.2 119.4 38.74 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.094 177.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 55.7 p -131.28 110.62 15.24 Favored Pre-proline 0 N--CA 1.425 -1.702 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 174.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 3.1 Cg_exo -77.65 162.37 90.24 Favored 'Cis proline' 0 CA--C 1.539 0.75 0 C-N-CA 124.008 -1.247 . . . . 0.0 111.207 -1.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.12 154.97 67.61 Favored 'Trans proline' 0 C--O 1.246 0.888 0 C-N-CA 122.205 1.937 . . . . 0.0 110.89 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.413 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 49.7 m0 -90.26 137.05 32.66 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.352 -177.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 11.4 p -120.16 78.17 25.46 Favored Pre-proline 0 C--N 1.295 -1.787 0 O-C-N 123.672 0.607 . . . . 0.0 110.368 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.26 157.4 29.69 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.379 2.053 . . . . 0.0 113.33 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -85.89 -34.91 12.06 Favored Glycine 0 N--CA 1.434 -1.477 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.3 p -150.9 156.26 40.83 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.6 t -130.61 141.84 45.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 37.7 t -146.14 150.4 35.82 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-O 121.248 0.546 . . . . 0.0 110.223 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.6 t -113.85 123.1 33.49 Favored Pre-proline 0 C--N 1.299 -1.607 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 176.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -57.47 136.79 78.11 Favored 'Trans proline' 0 C--O 1.247 0.941 0 C-N-CA 122.735 2.29 . . . . 0.0 111.554 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.456 ' CE2' ' HB3' ' A' ' 64' ' ' ASN . 72.8 t80 -72.71 112.58 8.88 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.286 -177.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 44.7 t -93.84 115.15 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.825 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 175.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.456 ' HB3' ' CE2' ' A' ' 62' ' ' PHE . 27.3 p-10 -109.75 15.46 22.74 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-O 122.305 1.05 . . . . 0.0 108.67 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -75.69 147.31 39.52 Favored 'General case' 0 C--N 1.284 -2.279 0 CA-C-N 113.739 -1.573 . . . . 0.0 112.106 -174.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.0 m -52.33 -21.7 3.81 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 126.999 2.12 . . . . 0.0 114.022 -172.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -58.53 137.04 57.67 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.531 0.681 . . . . 0.0 111.803 -176.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -68.31 -23.3 64.72 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 124.892 1.277 . . . . 0.0 113.002 -171.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -109.76 128.48 55.32 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.9 148.81 37.18 Favored Pre-proline 0 C--N 1.298 -1.668 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 174.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.41 ' HB3' ' CD1' ' A' ' 25' ' ' TYR . 92.8 Cg_endo -77.44 137.95 17.07 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 C-N-CA 121.657 1.571 . . . . 0.0 112.564 -177.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -131.73 127.79 37.55 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.587 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 77.5 m95 -110.99 138.05 47.87 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -171.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.476 ' HA ' ' O ' ' A' ' 86' ' ' THR . 34.3 m-85 -116.09 142.9 46.19 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.339 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.4 mt -125.68 142.42 51.52 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 -176.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -133.65 139.96 46.78 Favored 'General case' 0 CA--C 1.503 -0.852 0 O-C-N 123.734 0.647 . . . . 0.0 109.498 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.521 ' HB3' ' CG ' ' A' ' 102' ' ' PHE . 3.6 p-10 -77.82 -15.78 58.81 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -177.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.49 ' C ' ' HB3' ' A' ' 106' ' ' SER . 6.0 t-20 -121.43 166.74 13.67 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.1 m -71.71 165.62 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 C-N-CA 122.905 0.482 . . . . 0.0 111.915 -176.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 57.13 31.2 19.59 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.888 0.875 . . . . 0.0 112.322 176.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.427 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 6.5 m-85 59.9 48.82 8.45 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 125.098 1.359 . . . . 0.0 110.895 177.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 81.6 p -120.68 168.46 11.38 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 116.229 -0.442 . . . . 0.0 109.901 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.59 -138.44 14.28 Favored Glycine 0 N--CA 1.421 -2.327 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -81.77 157.04 24.65 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 123.85 0.86 . . . . 0.0 109.616 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.8 tt -129.75 137.1 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 CA-C-O 121.494 0.664 . . . . 0.0 110.805 -175.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 96.9 m -131.99 128.37 38.25 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -114.78 130.28 9.12 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.815 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -121.3 147.56 45.5 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 123.076 0.55 . . . . 0.0 111.161 178.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.89 168.5 12.81 Favored Glycine 0 N--CA 1.433 -1.517 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.833 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -62.97 122.39 15.89 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.315 0.579 . . . . 0.0 111.769 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.51 -2.63 77.89 Favored Glycine 0 N--CA 1.433 -1.54 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.23 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.0 m -107.07 146.18 31.52 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.1 m -140.88 157.83 44.82 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 52.1 mt -94.01 132.72 37.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 175.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -71.26 -48.66 49.63 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 121.579 0.704 . . . . 0.0 109.852 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.478 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 13.3 m-20 -132.24 96.48 3.89 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.847 178.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -65.57 -37.32 86.35 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.466 0.65 . . . . 0.0 110.01 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.4 t -63.91 -27.93 69.49 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.174 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.478 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 29.1 mmtp -89.19 -7.71 55.04 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 122.044 -0.41 . . . . 0.0 110.341 -178.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.8 m -80.34 -174.37 4.55 Favored 'General case' 0 C--O 1.257 1.493 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -50.26 -66.48 2.34 Favored Glycine 0 CA--C 1.507 -0.447 0 O-C-N 123.38 0.425 . . . . 0.0 113.62 -177.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.521 ' CG ' ' HB3' ' A' ' 77' ' ' ASP . 34.0 p90 -110.83 149.74 30.14 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 119.732 -0.175 . . . . 0.0 110.659 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.03 -12.16 13.25 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.542 177.646 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -112.17 116.19 4.03 Favored Glycine 0 N--CA 1.428 -1.841 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -177.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 70.0 mt -95.46 114.96 33.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.49 ' HB3' ' C ' ' A' ' 78' ' ' ASN . 1.8 t -86.77 -25.08 24.83 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.024 177.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 89.1 p -153.08 155.18 36.33 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 122.325 -0.234 . . . . 0.0 110.474 177.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.2 mt -133.02 132.57 58.94 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -175.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.427 ' HE2' ' CD2' ' A' ' 81' ' ' TYR . 37.9 ttmt -116.53 127.53 54.62 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.255 -1.016 . . . . 0.0 108.255 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -95.61 129.16 42.89 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 69.7 m -125.38 172.11 9.89 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 8.0 pt -128.07 143.11 41.93 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 59.7 tt0 -117.09 119.48 35.38 Favored 'General case' 0 C--N 1.277 -2.548 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 32.0 p -81.9 179.97 7.62 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.255 -171.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -65.36 -25.12 67.44 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.764 174.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -80.78 -7.81 59.5 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.852 0.834 . . . . 0.0 110.097 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.24 -9.78 76.63 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.803 175.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 113' ' ' GLN . 19.6 ptmt -73.49 140.03 46.13 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 21.6 t -103.36 112.3 36.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.404 ' HG2' ' HE2' ' A' ' 118' ' ' LYS . 24.7 mt-10 -98.01 138.03 35.93 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 80.1 m . . . . . 0 C--N 1.305 -1.327 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -174.06 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 121.358 0.599 . . . . 0.0 111.584 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.9 m -123.88 158.96 30.72 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.624 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 57.2 tp -107.24 118.97 38.12 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 171.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -111.23 124.14 51.61 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.619 -0.832 . . . . 0.0 108.951 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.8 mp -110.24 126.71 54.44 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.115 177.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -96.38 151.31 19.66 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 123.572 0.545 . . . . 0.0 109.598 -177.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -74.07 -37.75 64.14 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.139 0.495 . . . . 0.0 111.107 -177.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -108.32 177.44 4.79 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.457 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.442 HG23 ' HA ' ' A' ' 96' ' ' ASP . 2.2 p -81.16 172.54 13.54 Favored 'General case' 0 N--CA 1.413 -2.309 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 11.7 p90 47.6 35.4 4.36 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.852 0.861 . . . . 0.0 113.24 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 61.85 38.65 14.52 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.851 1.26 . . . . 0.0 113.591 177.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -103.46 178.17 4.63 Favored 'General case' 0 C--O 1.248 0.981 0 C-N-CA 120.126 -0.629 . . . . 0.0 112.007 175.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.7 -154.79 40.33 Favored Glycine 0 N--CA 1.425 -2.09 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -176.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.4 m -100.57 174.61 6.0 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 172.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -136.87 165.66 25.44 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 16.6 tt -116.21 152.45 17.92 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.483 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -106.8 125.15 50.63 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.505 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 98.0 t -120.78 133.94 65.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -121.72 -27.73 4.65 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.46 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 10.5 mmpt? -109.72 162.68 14.21 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.655 -173.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.8 m -82.75 141.82 32.09 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 175.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.1 p -120.79 130.54 74.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -89.51 -17.85 53.84 Favored Glycine 0 N--CA 1.43 -1.722 0 C-N-CA 119.722 -1.227 . . . . 0.0 113.308 -176.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.8 p -156.54 130.78 8.61 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 85.5 mt -124.11 117.46 24.71 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 175.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.0 m -133.45 113.49 13.18 Favored Pre-proline 0 C--N 1.293 -1.859 0 CA-C-O 120.407 0.146 . . . . 0.0 110.947 175.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -75.07 162.22 93.25 Favored 'Cis proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.179 -1.592 . . . . 0.0 111.336 -0.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.58 159.29 24.48 Favored 'Trans proline' 0 C--O 1.245 0.842 0 C-N-CA 122.705 2.27 . . . . 0.0 111.615 177.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.497 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 43.9 m0 -88.93 138.91 30.98 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 21.8 p -116.66 78.52 8.93 Favored Pre-proline 0 C--N 1.3 -1.584 0 O-C-N 123.579 0.55 . . . . 0.0 110.747 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.79 153.17 22.7 Favored 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 122.001 1.8 . . . . 0.0 112.589 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.67 -27.11 18.14 Favored Glycine 0 N--CA 1.425 -2.094 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.4 p -155.1 151.73 28.66 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.7 t -132.17 142.65 42.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 35.8 t -145.53 146.78 31.56 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 119.577 -0.849 . . . . 0.0 111.647 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.0 t -113.61 124.66 30.81 Favored Pre-proline 0 N--CA 1.435 -1.209 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 176.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -59.58 145.61 97.56 Favored 'Trans proline' 0 C--O 1.244 0.798 0 C-N-CA 123.115 2.543 . . . . 0.0 112.587 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -74.06 114.75 12.73 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.172 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 91.9 t -95.66 115.73 35.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -110.26 8.16 23.44 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 122.423 1.106 . . . . 0.0 108.713 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.76 145.02 56.55 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.884 -178.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.8 m -67.85 -7.09 25.06 Favored 'General case' 0 CA--C 1.566 1.587 0 C-N-CA 124.995 1.318 . . . . 0.0 110.882 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -51.96 133.47 32.51 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 124.884 1.274 . . . . 0.0 110.311 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.3 tpp180 -70.59 -26.6 63.59 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.179 -172.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -111.33 134.16 53.12 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 122.707 0.403 . . . . 0.0 110.154 176.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.8 153.82 37.95 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 170.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.11 135.12 12.04 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 C-N-CA 121.958 1.772 . . . . 0.0 111.367 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -130.06 136.3 49.21 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.624 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 85.2 m95 -119.21 133.55 55.7 Favored 'General case' 0 C--N 1.291 -1.953 0 C-N-CA 120.134 -0.626 . . . . 0.0 112.241 -173.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 86' ' ' THR . 33.7 m-85 -114.9 140.16 49.21 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.143 177.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.6 mt -125.28 142.74 51.32 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -175.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 78.7 m-85 -133.35 142.28 48.34 Favored 'General case' 0 C--N 1.317 -0.833 0 O-C-N 123.576 0.548 . . . . 0.0 110.423 -175.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -85.27 0.01 53.3 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 120.767 0.317 . . . . 0.0 111.049 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -137.47 158.87 43.47 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.4 m -71.59 166.6 2.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 C-N-CA 122.99 0.516 . . . . 0.0 111.577 -175.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 57.87 30.13 18.6 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.008 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.419 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 9.3 m-85 58.74 47.11 13.3 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 125.019 1.327 . . . . 0.0 111.235 177.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 73.2 p -118.37 173.5 6.78 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.18 -133.34 11.72 Favored Glycine 0 N--CA 1.433 -1.512 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.933 176.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.45 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 56.0 mtt85 -80.83 148.67 29.87 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 123.143 0.577 . . . . 0.0 109.618 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.4 tt -127.27 137.58 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 -177.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 98.2 m -131.24 126.08 34.54 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 176.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -115.16 115.29 3.4 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.491 -0.861 . . . . 0.0 113.745 -177.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -108.32 144.81 35.35 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 122.466 0.306 . . . . 0.0 110.771 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.17 170.76 13.46 Favored Glycine 0 N--CA 1.429 -1.772 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.003 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -64.33 130.75 45.01 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.315 0.578 . . . . 0.0 111.918 -176.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.71 8.23 80.3 Favored Glycine 0 N--CA 1.428 -1.84 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.794 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.3 m -121.32 146.25 47.04 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.9 m -136.33 156.93 47.94 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 50.5 mt -93.59 127.84 45.39 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 172.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -69.07 -46.91 66.64 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.579 0.704 . . . . 0.0 109.447 -177.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.486 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 3.9 m-20 -139.73 98.98 3.59 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.205 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -65.08 -37.75 88.53 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.337 0.589 . . . . 0.0 110.672 178.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.7 t -69.53 -17.93 63.62 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.461 -177.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.486 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 28.9 mmtp -89.95 -6.19 55.94 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.638 -0.664 . . . . 0.0 109.386 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.0 t -85.02 -163.78 0.89 Allowed 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.41 -68.19 1.78 Allowed Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 116.798 -0.183 . . . . 0.0 113.151 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -110.61 147.61 33.91 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 122.488 -0.419 . . . . 0.0 109.917 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -112.43 -0.52 15.28 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.103 177.331 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.497 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -119.19 113.95 2.66 Favored Glycine 0 N--CA 1.436 -1.35 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.812 -176.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 69.2 mt -95.8 116.3 37.17 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.593 0 CA-C-O 122.312 1.053 . . . . 0.0 109.614 -178.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.4 m -85.62 -28.6 24.68 Favored 'General case' 0 N--CA 1.395 -3.193 0 CA-C-N 112.206 -2.27 . . . . 0.0 114.13 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 84.1 p -156.45 156.37 33.67 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 177.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.4 mt -135.18 130.81 51.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -176.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.419 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 37.3 ttmt -117.14 128.19 54.88 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -95.49 129.49 42.64 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 121.631 0.729 . . . . 0.0 109.213 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 82.2 m -125.55 172.68 9.52 Favored 'General case' 0 C--N 1.273 -2.739 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.875 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 7.6 pt -129.03 142.47 43.96 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.477 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -110.91 122.63 48.35 Favored 'General case' 0 C--N 1.278 -2.508 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 82.4 p -77.88 176.54 8.99 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.61 -174.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -66.96 -20.11 65.84 Favored 'General case' 0 C--N 1.316 -0.885 0 O-C-N 122.141 -0.35 . . . . 0.0 111.153 174.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.481 ' OD1' ' HG2' ' A' ' 118' ' ' LYS . 2.1 p30 -86.88 -7.61 58.05 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.264 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 94.17 -0.97 66.87 Favored Glycine 0 N--CA 1.441 -1.003 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.662 175.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.481 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 52.6 pttt -77.87 149.01 34.37 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 119.093 -1.043 . . . . 0.0 109.566 176.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.2 t -109.04 112.04 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.503 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -93.82 144.8 25.1 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 76.9 m . . . . . 0 C--N 1.289 -2.053 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.287 -175.912 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.403 ' CD1' ' HB3' ' A' ' 71' ' ' PRO . 2.3 m-85 . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 121.444 0.64 . . . . 0.0 111.764 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 36.7 m -123.82 154.68 39.24 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.548 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 44.0 tp -105.02 121.92 44.78 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 176.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 41.0 mt-30 -111.86 124.07 51.59 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.8 mp -110.26 123.88 50.6 Favored 'General case' 0 N--CA 1.42 -1.927 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.15 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -88.85 149.07 23.55 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -74.04 -38.42 64.01 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 120.983 0.42 . . . . 0.0 111.059 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -107.84 177.35 4.84 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.223 -176.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.454 HG22 ' HA ' ' A' ' 96' ' ' ASP . 1.0 OUTLIER -81.72 172.72 13.06 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.936 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.268 21.9 p90 47.49 37.8 6.87 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.793 1.237 . . . . 0.0 113.501 177.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 65.26 27.97 12.05 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 125.109 1.364 . . . . 0.0 113.717 178.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -97.55 172.67 7.58 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.426 0.631 . . . . 0.0 110.656 177.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.41 -166.17 37.92 Favored Glycine 0 N--CA 1.424 -2.158 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.3 m -100.68 176.76 5.2 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 173.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -143.89 165.34 28.01 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 120.469 -0.493 . . . . 0.0 110.843 -174.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.493 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 18.2 tt -114.31 152.72 15.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -107.21 125.62 51.35 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 98.7 t -119.71 136.71 55.96 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.384 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 177.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -117.43 -28.01 6.21 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.883 -176.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -107.47 163.04 13.4 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 -173.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.5 p -89.6 141.69 28.37 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 172.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.3 p -120.55 132.91 68.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -174.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.96 -1.7 57.19 Favored Glycine 0 C--N 1.313 -0.746 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.456 -176.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.0 t -166.7 129.58 1.86 Allowed 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.067 0.46 . . . . 0.0 109.906 176.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 85.1 mt -122.41 117.78 26.82 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.0 m -133.25 112.8 13.22 Favored Pre-proline 0 C--N 1.288 -2.09 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 174.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.62 161.86 93.58 Favored 'Cis proline' 0 CA--C 1.549 1.249 0 C-N-CA 123.333 -1.528 . . . . 0.0 111.326 -1.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.81 158.33 43.14 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.948 2.432 . . . . 0.0 110.87 177.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.512 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 48.2 m0 -90.23 143.81 26.43 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -178.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 18.3 p -121.48 76.82 35.38 Favored Pre-proline 0 C--N 1.308 -1.203 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -81.18 157.64 20.09 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.806 2.337 . . . . 0.0 112.624 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.0 -28.38 11.04 Favored Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.3 p -157.33 154.93 29.78 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.7 t -131.61 145.42 35.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -176.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 39.3 t -145.59 147.36 31.99 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.927 176.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.9 t -112.71 126.79 27.74 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 176.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -60.61 150.48 81.73 Favored 'Trans proline' 0 C--O 1.248 1.0 0 C-N-CA 122.983 2.455 . . . . 0.0 112.304 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.537 ' CE1' ' HB2' ' A' ' 64' ' ' ASN . 45.1 t80 -74.36 132.32 41.91 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.956 0.884 . . . . 0.0 111.555 -177.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 99.0 t -123.22 117.78 52.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.537 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 61.7 t30 -118.6 8.25 11.93 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 123.373 1.559 . . . . 0.0 106.842 178.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -60.21 145.03 48.68 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 112.413 -2.176 . . . . 0.0 113.539 -174.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 m -60.73 -7.12 2.06 Favored 'General case' 0 CA--C 1.564 1.509 0 C-N-CA 126.248 1.819 . . . . 0.0 112.568 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -58.54 142.84 47.89 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -74.33 -25.4 59.53 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.866 -174.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -110.71 133.8 53.02 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.87 0.367 . . . . 0.0 111.74 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.32 150.33 37.0 Favored Pre-proline 0 C--N 1.307 -1.242 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 168.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.403 ' HB3' ' CD1' ' A' ' 25' ' ' TYR . 93.9 Cg_endo -80.28 137.0 11.67 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.025 1.816 . . . . 0.0 111.813 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -132.17 137.72 47.75 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.548 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 89.9 m95 -122.07 132.43 54.49 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.16 0.505 . . . . 0.0 111.981 -174.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 86' ' ' THR . 24.2 m-85 -112.74 142.77 44.98 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.434 177.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.5 mt -125.62 142.25 51.61 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -175.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.493 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 93.2 m-85 -132.85 141.47 48.45 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.403 0.62 . . . . 0.0 111.158 -175.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.766 ' HB2' ' CD2' ' A' ' 102' ' ' PHE . 9.0 t70 -85.99 -6.53 59.03 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.544 -177.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -140.06 156.87 46.4 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.727 173.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.736 ' HA ' ' OG ' ' A' ' 107' ' ' SER . 23.6 m -64.46 162.24 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.945 0 C-N-CA 123.655 0.782 . . . . 0.0 112.214 -175.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.44 29.86 17.19 Favored 'General case' 0 CA--C 1.511 -0.551 0 O-C-N 123.859 0.724 . . . . 0.0 109.305 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.426 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 16.1 m-85 56.49 50.93 12.08 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 114.433 -1.258 . . . . 0.0 111.415 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 60.5 p -123.52 177.59 5.58 Favored 'General case' 0 C--O 1.249 1.047 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.762 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.95 -107.96 3.53 Favored Glycine 0 N--CA 1.437 -1.267 0 N-CA-C 111.822 -0.511 . . . . 0.0 111.822 176.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 58.6 mtt85 -114.08 151.86 31.91 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.7 tt -128.65 140.04 50.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 O-C-N 123.712 0.632 . . . . 0.0 111.08 -174.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 24.4 m -132.49 125.42 30.61 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.429 174.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -115.17 107.25 1.73 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.83 -0.7 . . . . 0.0 114.321 -178.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -106.32 145.69 31.34 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 123.045 0.538 . . . . 0.0 111.468 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -123.33 172.64 16.17 Favored Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.678 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -50.23 127.86 18.06 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 124.262 1.025 . . . . 0.0 112.757 -177.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.97 -0.19 88.8 Favored Glycine 0 C--N 1.309 -0.925 0 CA-C-N 115.546 -0.752 . . . . 0.0 113.251 174.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.3 m -110.82 145.9 37.37 Favored 'General case' 0 N--CA 1.421 -1.92 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.543 -177.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.6 m -136.21 156.7 48.3 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 55.2 mt -92.81 135.81 26.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 176.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -70.53 -48.52 55.08 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.506 0.67 . . . . 0.0 110.421 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.454 ' HA ' HG22 ' A' ' 33' ' ' THR . 3.2 m-20 -143.23 99.12 3.38 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -178.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -64.85 -38.37 90.76 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 121.263 0.554 . . . . 0.0 110.817 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.5 t -65.96 -21.01 66.39 Favored 'General case' 0 CA--C 1.558 1.257 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.903 -175.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.452 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 30.0 mmtp -92.83 -7.82 45.26 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.8 t -83.49 7.29 17.46 Favored 'General case' 0 C--O 1.25 1.123 0 CA-C-O 121.065 0.46 . . . . 0.0 111.492 -176.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 115.56 -62.51 0.35 Allowed Glycine 0 N--CA 1.436 -1.362 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 177.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.766 ' CD2' ' HB2' ' A' ' 77' ' ' ASP . 22.7 p90 -110.89 142.59 42.74 Favored 'General case' 0 N--CA 1.427 -1.59 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.144 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -114.01 -8.31 13.07 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -112.55 112.93 3.11 Favored Glycine 0 N--CA 1.422 -2.267 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.954 -174.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 70.1 mt -95.22 115.55 34.42 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 52.3 m -85.43 -26.69 26.22 Favored 'General case' 0 C--N 1.252 -3.652 0 CA-C-N 112.228 -2.26 . . . . 0.0 113.339 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.736 ' OG ' ' HA ' ' A' ' 79' ' ' VAL . 66.6 m -156.29 152.35 27.58 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.215 -0.303 . . . . 0.0 110.794 -177.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.3 mt -135.3 130.19 50.74 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.539 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -176.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.426 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 33.9 ttmt -117.53 131.18 56.75 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -101.42 123.37 45.38 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -177.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 36.1 m -119.71 171.15 8.59 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.4 pt -129.35 146.2 34.57 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 56.4 tt0 -117.79 118.21 31.42 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 17.2 p -78.8 179.67 7.08 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.253 -173.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -58.97 -28.21 66.1 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.635 0.731 . . . . 0.0 110.548 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -77.02 -7.99 56.63 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.9 -176.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.53 6.84 87.04 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.483 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 113' ' ' GLN . 26.2 pttm -87.84 139.28 30.69 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.0 t -103.22 112.44 36.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -102.78 146.01 28.89 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.298 -1.649 0 C-N-CA 119.307 -0.957 . . . . 0.0 109.663 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 N--CA 1.473 0.707 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.4 m -123.32 146.66 47.73 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.606 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 53.8 tp -92.52 121.32 33.85 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 172.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 65.0 mt-30 -114.17 123.7 50.24 Favored 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.635 -177.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 2.8 mp -110.34 119.08 38.06 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.339 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -82.04 145.01 30.44 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 123.521 0.513 . . . . 0.0 110.21 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -69.27 -39.79 78.17 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.598 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -108.37 177.39 4.81 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.428 HG23 ' HA ' ' A' ' 96' ' ' ASP . 1.1 p -83.1 177.18 8.7 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 122.601 0.36 . . . . 0.0 110.602 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.262 16.6 p90 47.39 42.2 13.76 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.886 1.275 . . . . 0.0 113.881 176.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 63.56 27.97 15.1 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.241 176.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.518 ' HA ' ' NE ' ' A' ' 36' ' ' ARG . 3.7 mmp_? -108.5 166.32 10.86 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.317 0.58 . . . . 0.0 110.969 178.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.38 173.74 47.29 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -177.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.3 p -86.28 154.78 21.01 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 40.8 p90 -117.6 165.84 13.09 Favored 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.218 -176.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.488 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.8 tt -114.23 153.26 15.77 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 178.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -105.96 126.03 51.7 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.504 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 92.8 t -123.33 133.4 69.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -118.08 -21.7 8.14 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.055 0.455 . . . . 0.0 110.668 -175.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -129.24 162.18 28.46 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.317 -175.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.2 p -79.02 146.25 33.43 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.839 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.9 p -121.46 137.28 55.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.3 -18.43 39.17 Favored Glycine 0 C--N 1.316 -0.543 0 C-N-CA 119.903 -1.141 . . . . 0.0 113.864 -176.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.3 t -161.18 132.14 5.34 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.1 mt -121.31 118.94 30.77 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.313 178.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.5 m -132.61 110.42 13.5 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 175.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -76.71 160.24 95.28 Favored 'Cis proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.171 -1.595 . . . . 0.0 111.38 0.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.02 158.24 48.73 Favored 'Trans proline' 0 C--O 1.24 0.616 0 C-N-CA 122.31 2.006 . . . . 0.0 110.84 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 52.7 m0 -89.73 136.65 32.91 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 120.351 -0.54 . . . . 0.0 109.881 -177.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 20.2 p -118.73 77.07 14.35 Favored Pre-proline 0 N--CA 1.435 -1.207 0 O-C-N 123.493 0.495 . . . . 0.0 111.757 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -76.4 158.52 36.68 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.387 2.058 . . . . 0.0 111.972 177.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -92.84 -31.58 8.56 Favored Glycine 0 N--CA 1.431 -1.685 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 175.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 94' ' ' ILE . 34.8 p -152.01 153.14 33.44 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 36.7 t -128.91 142.77 43.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -177.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 37.2 t -145.75 147.29 31.75 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.124 177.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 68.2 t -114.13 121.16 37.14 Favored Pre-proline 0 C--N 1.306 -1.296 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 175.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.03 148.17 78.55 Favored 'Trans proline' 0 C--O 1.246 0.905 0 C-N-CA 122.997 2.465 . . . . 0.0 112.315 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.412 ' CE2' ' HB3' ' A' ' 64' ' ' ASN . 76.4 t80 -71.63 111.56 7.03 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.36 0.6 . . . . 0.0 110.594 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.7 t -94.51 115.29 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.98 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.585 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.412 ' HB3' ' CE2' ' A' ' 62' ' ' PHE . 23.7 p-10 -114.73 25.05 11.28 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 125.673 1.589 . . . . 0.0 108.14 178.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.53 ' HB3' ' NH2' ' A' ' 70' ' ' ARG . 16.6 t70 -66.92 146.22 54.63 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 112.867 -1.969 . . . . 0.0 112.396 -176.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.7 m -53.53 -18.49 2.85 Favored 'General case' 0 CA--C 1.57 1.745 0 C-N-CA 125.203 1.401 . . . . 0.0 113.747 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.502 ' HG2' ' OD2' ' A' ' 65' ' ' ASP . 33.4 mmtp -66.52 167.66 10.45 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.773 -0.579 . . . . 0.0 110.132 174.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -106.07 -15.91 14.76 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 175.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.3 mp0 -92.39 128.31 38.2 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.788 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.53 ' NH2' ' HB3' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -106.1 154.18 39.76 Favored Pre-proline 0 C--N 1.291 -1.966 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.306 178.625 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -81.9 135.1 8.64 Favored 'Trans proline' 0 N--CA 1.44 -1.629 0 C-N-CA 121.632 1.555 . . . . 0.0 111.002 178.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -129.12 120.91 26.7 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.606 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 87.0 m95 -106.66 133.93 50.59 Favored 'General case' 0 C--N 1.278 -2.543 0 CA-C-O 121.034 0.445 . . . . 0.0 111.953 -171.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.491 ' HA ' ' O ' ' A' ' 86' ' ' THR . 29.5 m-85 -112.39 140.56 47.01 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.499 177.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.4 mt -125.6 142.37 51.54 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -177.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.507 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 80.5 m-85 -134.48 140.84 46.5 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 123.892 0.745 . . . . 0.0 109.599 -176.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.37 -12.19 59.06 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.51 -177.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.502 ' C ' ' HB3' ' A' ' 106' ' ' SER . 5.1 t-20 -123.25 172.51 8.57 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.8 m -76.23 168.83 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 C-N-CA 123.415 0.686 . . . . 0.0 111.591 -176.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 53.83 30.53 11.53 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.121 0.969 . . . . 0.0 112.431 176.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.52 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 8.2 m-85 63.0 39.44 10.19 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.577 176.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 81.4 p -111.91 170.65 8.0 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.67 -145.31 17.56 Favored Glycine 0 N--CA 1.429 -1.781 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.609 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.507 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 98.0 mtt180 -75.59 147.84 39.29 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 123.128 0.571 . . . . 0.0 109.636 178.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.5 tt -125.38 136.5 60.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 121.705 0.764 . . . . 0.0 110.442 -175.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 93.5 m -131.39 125.16 31.9 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.615 176.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -115.01 118.01 4.19 Favored Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.309 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -112.53 146.0 39.29 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 123.3 0.64 . . . . 0.0 111.146 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -117.94 172.89 14.57 Favored Glycine 0 N--CA 1.434 -1.474 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.127 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.419 ' CD2' ' HG2' ' A' ' 70' ' ' ARG . 2.6 p80 -62.46 132.43 52.47 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 121.272 0.558 . . . . 0.0 111.906 -176.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.8 15.17 79.84 Favored Glycine 0 N--CA 1.43 -1.7 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.766 176.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.8 m -127.22 146.2 50.5 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.7 m -137.55 156.34 48.21 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.413 ' O ' ' HB2' ' A' ' 57' ' ' SER . 46.0 mt -95.31 127.03 47.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 170.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -71.77 -46.34 58.71 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.354 0.597 . . . . 0.0 111.926 177.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.487 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 1.7 m-20 -129.4 96.11 4.2 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.144 178.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -64.69 -35.03 79.73 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.56 0.695 . . . . 0.0 110.34 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.4 t -67.66 -29.32 68.58 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.159 -175.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.487 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 29.4 mmtp -88.39 -6.68 57.54 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -178.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.1 m -80.64 -13.29 59.16 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.882 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 139.02 -70.47 0.46 Allowed Glycine 0 N--CA 1.431 -1.678 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -110.32 146.46 35.7 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.533 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -112.4 -9.96 13.8 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.715 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -109.48 115.54 4.27 Favored Glycine 0 N--CA 1.427 -1.932 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.747 -176.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 79.1 mt -98.77 116.27 41.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.502 ' HB3' ' C ' ' A' ' 78' ' ' ASN . 7.6 t -85.82 -29.9 23.4 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.52 177.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 93.6 p -148.57 155.4 41.06 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 121.872 -0.517 . . . . 0.0 111.273 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.1 mt -133.27 133.71 57.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -176.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.52 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 38.9 ttmt -116.13 132.97 56.51 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 -102.77 118.25 36.42 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 64.6 m -120.14 170.23 9.5 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.2 pt -128.63 141.7 45.88 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.536 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -113.02 122.62 48.15 Favored 'General case' 0 C--N 1.268 -2.967 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.463 ' OG1' ' HG2' ' A' ' 118' ' ' LYS . 30.8 p -76.4 -179.19 5.0 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -177.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -59.07 -29.72 67.54 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.31 0.576 . . . . 0.0 110.38 177.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -76.96 -9.1 58.46 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.782 -175.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.66 8.71 84.24 Favored Glycine 0 N--CA 1.421 -2.307 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.14 -176.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.463 ' HG2' ' OG1' ' A' ' 114' ' ' THR . 9.4 ptpp? -84.02 138.38 33.12 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 26.1 t -107.07 112.09 38.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.584 0.707 . . . . 0.0 111.356 -174.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -101.02 153.04 19.88 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 177.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 85.6 m . . . . . 0 C--N 1.294 -1.821 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.331 -175.775 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.468 ' CD2' ' HB3' ' A' ' 71' ' ' PRO . 4.7 m-85 . . . . . 0 CA--C 1.508 -0.641 0 CA-C-O 121.955 0.883 . . . . 0.0 110.289 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.1 m -126.98 153.54 45.75 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.196 -1.366 . . . . 0.0 107.976 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.586 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 53.0 tp -111.58 130.1 55.85 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 107.024 -1.472 . . . . 0.0 107.024 175.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.503 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 73.3 mt-30 -117.42 124.01 47.8 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.701 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 3.0 mp -110.47 121.93 46.5 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.163 178.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -87.8 151.92 22.51 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 123.577 0.548 . . . . 0.0 110.45 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -74.77 -39.98 61.47 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.091 -178.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -108.46 178.37 4.51 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.416 HG22 ' HA ' ' A' ' 96' ' ' ASP . 2.2 p -80.71 173.38 12.66 Favored 'General case' 0 N--CA 1.413 -2.31 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.594 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.276 21.6 p90 47.11 43.23 14.05 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 124.731 1.212 . . . . 0.0 114.231 177.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 65.97 23.11 11.23 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 124.379 1.072 . . . . 0.0 112.044 175.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.428 ' NE ' ' HA ' ' A' ' 36' ' ' ARG . 5.6 mmp_? -100.48 167.85 10.11 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.385 0.612 . . . . 0.0 112.279 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.02 -166.26 48.3 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -175.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.7 m -90.88 175.37 7.01 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 37.6 p90 -137.17 165.08 26.95 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 16.7 tt -114.6 152.61 16.21 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 176.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -107.05 124.95 50.39 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 175.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.515 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 94.2 t -114.03 133.64 59.4 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.555 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 177.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -115.06 -33.54 5.36 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.468 0.651 . . . . 0.0 110.028 -174.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.92 161.44 25.38 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.692 -177.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 p -75.72 149.25 38.09 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.465 0.65 . . . . 0.0 112.102 -176.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.6 p -121.18 137.38 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.98 -18.9 35.51 Favored Glycine 0 C--N 1.299 -1.478 0 C-N-CA 120.13 -1.033 . . . . 0.0 112.617 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.1 t -159.52 131.38 6.33 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 121.032 0.444 . . . . 0.0 110.159 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 91.1 mt -119.65 118.02 29.84 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.653 177.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.2 t -132.77 114.07 14.09 Favored Pre-proline 0 N--CA 1.419 -2.017 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 174.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.81 161.87 93.88 Favored 'Cis proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.997 -1.668 . . . . 0.0 110.417 -2.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -63.18 156.08 57.54 Favored 'Trans proline' 0 C--O 1.257 1.441 0 C-N-CA 121.85 1.7 . . . . 0.0 110.636 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.475 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 45.5 m0 -89.1 135.4 33.58 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -177.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.559 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 15.3 p -116.18 76.58 6.73 Favored Pre-proline 0 C--N 1.292 -1.918 0 O-C-N 123.362 0.413 . . . . 0.0 111.318 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.12 157.6 33.94 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 122.5 2.133 . . . . 0.0 112.903 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.69 -33.4 10.09 Favored Glycine 0 N--CA 1.431 -1.665 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.7 p -154.27 144.95 22.4 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.2 t -119.95 142.8 33.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -178.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 33.6 t -145.4 147.5 32.32 Favored 'General case' 0 N--CA 1.422 -1.84 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.228 177.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 80.5 t -111.35 122.3 37.97 Favored Pre-proline 0 C--N 1.296 -1.743 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 176.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -58.78 149.23 78.99 Favored 'Trans proline' 0 C--O 1.243 0.764 0 C-N-CA 122.892 2.395 . . . . 0.0 112.246 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -79.02 135.3 36.85 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 82.3 t -113.48 114.06 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 CA-C-O 120.981 0.42 . . . . 0.0 110.348 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -109.35 84.33 1.91 Allowed 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 173.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.688 ' OD1' ' HG2' ' A' ' 67' ' ' LYS . 12.0 t70 -128.27 145.97 50.89 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.633 -172.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.2 m -53.84 -19.52 4.52 Favored 'General case' 0 CA--C 1.59 2.513 0 C-N-CA 125.121 1.368 . . . . 0.0 113.298 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.688 ' HG2' ' OD1' ' A' ' 65' ' ' ASP . 23.5 mmtp -64.13 176.63 0.96 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.724 -0.61 . . . . 0.0 112.272 178.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 66.8 mtm180 -102.68 -29.13 11.71 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.94 0.876 . . . . 0.0 109.642 -176.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.0 134.55 50.75 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.783 -173.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.657 ' NH2' ' HB2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -104.38 153.93 38.71 Favored Pre-proline 0 C--N 1.297 -1.696 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.185 -179.231 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.468 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 93.3 Cg_endo -77.4 140.73 19.58 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.615 1.543 . . . . 0.0 112.122 178.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -133.49 133.78 42.66 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 -178.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.586 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 83.2 m95 -117.3 135.45 53.82 Favored 'General case' 0 C--N 1.288 -2.092 0 O-C-N 121.731 -0.605 . . . . 0.0 112.39 -172.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.424 ' HA ' ' O ' ' A' ' 86' ' ' THR . 33.4 m-85 -113.05 141.93 46.3 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.91 177.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.2 mt -126.11 142.53 51.48 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.514 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 86.3 m-85 -133.59 141.92 47.89 Favored 'General case' 0 C--N 1.316 -0.884 0 O-C-N 123.72 0.638 . . . . 0.0 110.055 -177.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.428 ' HB3' ' CG ' ' A' ' 102' ' ' PHE . 0.8 OUTLIER -85.45 0.09 53.31 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -178.984 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -137.73 159.7 41.26 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 174.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.7 m -70.96 166.32 2.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 C-N-CA 122.626 0.37 . . . . 0.0 111.656 -174.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 58.07 30.8 19.82 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.798 0.839 . . . . 0.0 111.769 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.424 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 12.6 m-85 60.13 44.66 12.68 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.421 176.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 74.9 p -115.57 168.28 10.15 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.26 -141.4 17.49 Favored Glycine 0 N--CA 1.426 -2.021 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.807 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 57.1 mtt180 -77.33 135.85 38.41 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 123.083 0.553 . . . . 0.0 109.771 -177.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.8 tt -115.24 136.75 50.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.348 -175.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 96.9 m -131.9 123.2 26.98 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.172 176.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -110.06 123.89 6.9 Favored Glycine 0 N--CA 1.438 -1.183 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.362 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -115.77 145.66 42.61 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 123.159 0.584 . . . . 0.0 110.511 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.54 167.46 12.53 Favored Glycine 0 N--CA 1.423 -2.218 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.711 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -55.75 125.42 21.15 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 123.815 0.846 . . . . 0.0 112.429 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.16 3.82 84.63 Favored Glycine 0 N--CA 1.431 -1.675 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.336 176.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.9 m -113.57 146.53 39.55 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.4 m -136.75 158.0 45.45 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 56.1 mt -93.4 132.44 37.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 173.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -70.02 -47.42 62.17 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.605 0.717 . . . . 0.0 110.14 -176.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.416 ' HA ' HG22 ' A' ' 33' ' ' THR . 5.6 m-20 -138.89 102.65 4.61 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 176.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.43 ' HZ ' ' CE2' ' A' ' 102' ' ' PHE . 59.3 t80 -64.66 -32.68 74.46 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.402 0.62 . . . . 0.0 110.399 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.9 t -63.54 -24.94 68.02 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.721 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -93.67 -5.81 47.76 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 121.308 0.575 . . . . 0.0 109.572 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.8 t -84.71 31.17 0.54 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.302 0.641 . . . . 0.0 110.439 -177.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.7 -71.91 1.73 Allowed Glycine 0 N--CA 1.437 -1.288 0 C-N-CA 121.263 -0.494 . . . . 0.0 111.972 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.43 ' CE2' ' HZ ' ' A' ' 97' ' ' PHE . 35.0 p90 -109.96 148.37 31.75 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.559 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.43 -6.99 13.47 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.738 179.668 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -116.95 116.59 3.59 Favored Glycine 0 N--CA 1.429 -1.831 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.377 -176.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 64.9 mt -94.78 115.83 34.6 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.675 0 CA-C-O 122.342 1.068 . . . . 0.0 108.888 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.4 m -85.45 -25.07 27.16 Favored 'General case' 0 N--CA 1.39 -3.436 0 CA-C-N 112.425 -2.171 . . . . 0.0 114.252 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.5 p -158.0 152.88 25.22 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 122.076 -0.39 . . . . 0.0 110.014 176.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.8 mt -130.97 131.04 64.32 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -176.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.424 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 36.1 ttmt -116.53 132.82 56.58 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -100.19 129.95 46.27 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 66.7 m -131.0 172.15 12.4 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.7 pt -127.51 140.7 48.39 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -109.16 119.7 40.32 Favored 'General case' 0 C--N 1.276 -2.61 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 71.3 p -74.0 173.6 9.78 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.808 -175.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -66.92 -19.04 65.65 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 121.842 0.83 . . . . 0.0 109.652 175.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -84.68 -8.14 58.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.801 0.81 . . . . 0.0 110.354 177.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.99 -11.53 71.87 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 120.843 -0.694 . . . . 0.0 113.08 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -71.93 134.69 46.15 Favored 'General case' 0 C--O 1.254 1.342 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.7 t -99.51 111.85 30.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -95.29 134.93 37.51 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 48.8 m . . . . . 0 C--N 1.288 -2.103 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 178.782 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 . . . . . 0 CA--C 1.493 -1.246 0 CA-C-O 122.315 1.055 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.518 ' SG ' ' HG3' ' A' ' 61' ' ' PRO . 3.9 p -144.74 160.16 41.68 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 113.681 -1.599 . . . . 0.0 109.82 -178.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.618 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 54.3 tp -111.93 118.53 35.75 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 173.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.45 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 66.7 mt-30 -109.33 123.65 49.64 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.251 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 2.9 mp -110.35 121.73 46.0 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.672 177.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.437 ' CD1' ' HB3' ' A' ' 39' ' ' TYR . 90.4 m-85 -93.12 157.26 16.38 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 123.609 0.568 . . . . 0.0 111.781 -175.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -81.14 -35.13 31.91 Favored 'General case' 0 CA--C 1.494 -1.175 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.865 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -108.23 178.09 4.61 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.3 p -81.39 172.07 14.0 Favored 'General case' 0 N--CA 1.401 -2.899 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.35 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 21.2 p90 47.26 38.93 7.75 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.892 1.277 . . . . 0.0 114.205 176.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 65.41 22.41 11.94 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.551 1.541 . . . . 0.0 114.506 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.18 173.62 7.63 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.255 0.55 . . . . 0.0 111.485 175.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.18 -152.75 34.87 Favored Glycine 0 N--CA 1.426 -2.021 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 -174.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.7 m -108.78 178.51 4.46 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 173.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.437 ' HB3' ' CD1' ' A' ' 30' ' ' TYR . 29.9 p90 -143.53 166.79 23.82 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.095 0.474 . . . . 0.0 110.157 -177.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.0 tt -114.53 152.81 16.13 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.545 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 176.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -106.84 125.54 51.14 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 176.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.461 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 99.4 t -122.6 134.55 65.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -126.09 -2.85 7.02 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.771 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -139.44 162.54 34.8 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -173.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 p -84.42 144.86 28.5 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-O 120.991 0.424 . . . . 0.0 111.599 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.7 p -119.78 137.72 52.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.68 -21.63 30.81 Favored Glycine 0 N--CA 1.433 -1.526 0 C-N-CA 120.072 -1.061 . . . . 0.0 112.389 -177.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.0 p -157.79 129.04 6.66 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-O 121.07 0.462 . . . . 0.0 112.014 -178.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.1 mt -118.5 118.47 31.8 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 175.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.5 m -132.27 114.61 14.84 Favored Pre-proline 0 C--N 1.299 -1.6 0 O-C-N 123.393 0.433 . . . . 0.0 110.08 175.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -76.91 159.41 95.99 Favored 'Cis proline' 0 C--O 1.246 0.899 0 C-N-CA 122.944 -1.69 . . . . 0.0 110.371 -1.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -62.34 157.66 44.45 Favored 'Trans proline' 0 C--O 1.252 1.209 0 C-N-CA 122.482 2.121 . . . . 0.0 111.349 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.425 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 48.8 m0 -89.47 140.27 29.69 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -177.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 35.5 p -123.8 73.78 54.68 Favored Pre-proline 0 C--N 1.305 -1.364 0 O-C-N 123.46 0.475 . . . . 0.0 110.561 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -74.2 156.5 46.63 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 122.354 2.036 . . . . 0.0 113.653 -178.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -83.77 -34.28 19.29 Favored Glycine 0 N--CA 1.431 -1.633 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 177.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.0 p -153.83 154.97 34.92 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.3 t -130.45 142.31 44.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 35.5 t -146.07 152.32 39.14 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.696 176.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 95.4 t -117.2 125.21 28.38 Favored Pre-proline 0 C--N 1.313 -0.991 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 176.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.518 ' HG3' ' SG ' ' A' ' 26' ' ' CYS . 5.9 Cg_exo -49.68 141.31 27.49 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 123.471 2.78 . . . . 0.0 113.288 178.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -75.24 113.47 12.64 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 121.676 0.75 . . . . 0.0 109.868 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.422 ' H ' ' HB2' ' A' ' 90' ' ' HIS . 78.4 t -94.54 125.31 47.18 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.513 -179.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -127.88 12.16 6.71 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 124.428 1.08 . . . . 0.0 108.696 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -57.93 147.04 30.18 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.464 1.506 . . . . 0.0 113.28 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.3 m -53.59 -12.9 0.54 Allowed 'General case' 0 CA--C 1.579 2.071 0 C-N-CA 125.568 1.547 . . . . 0.0 112.179 178.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -58.42 161.39 4.48 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.669 1.188 . . . . 0.0 111.182 175.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.78 -28.25 16.69 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -178.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.67 140.77 43.12 Favored 'General case' 0 N--CA 1.417 -2.098 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.631 -174.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -105.99 154.22 39.65 Favored Pre-proline 0 C--N 1.289 -2.027 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -81.71 135.18 8.9 Favored 'Trans proline' 0 N--CA 1.44 -1.644 0 C-N-CA 121.309 1.34 . . . . 0.0 110.888 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -128.76 123.54 33.22 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 -177.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.618 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 83.4 m95 -109.33 135.35 50.54 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-O 120.759 0.314 . . . . 0.0 111.843 -172.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.449 ' HA ' ' O ' ' A' ' 86' ' ' THR . 39.8 m-85 -113.59 141.85 46.68 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.023 177.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.6 mt -125.37 142.2 51.64 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 -176.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.434 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 80.8 m-85 -131.3 141.49 49.96 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 123.468 0.48 . . . . 0.0 110.49 -176.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.58 -21.76 51.96 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.525 -177.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.486 ' C ' ' HB3' ' A' ' 106' ' ' SER . 8.6 t-20 -118.76 168.33 10.84 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.6 m -73.94 168.96 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 C-N-CA 122.575 0.35 . . . . 0.0 110.298 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 55.48 30.42 15.07 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.447 0.699 . . . . 0.0 112.605 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.409 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 9.3 m-85 58.96 45.85 14.43 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 124.755 1.222 . . . . 0.0 111.316 176.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.7 p -117.33 167.45 11.23 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.186 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.93 -134.19 12.32 Favored Glycine 0 N--CA 1.424 -2.13 0 N-CA-C 111.344 -0.703 . . . . 0.0 111.344 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 64.1 mtm180 -81.17 151.39 28.24 Favored 'General case' 0 C--N 1.287 -2.124 0 C-N-CA 123.611 0.764 . . . . 0.0 110.977 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.4 tt -130.5 137.18 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-O 121.275 0.559 . . . . 0.0 110.303 -176.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 98.4 m -132.38 120.51 22.13 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.906 175.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -108.01 127.8 8.85 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.211 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -118.21 145.5 44.93 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 123.074 0.55 . . . . 0.0 110.793 178.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.75 172.93 14.45 Favored Glycine 0 N--CA 1.433 -1.563 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.455 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.422 ' HB2' ' H ' ' A' ' 63' ' ' VAL . 3.0 p80 -61.65 122.32 15.0 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 123.293 0.637 . . . . 0.0 112.287 -175.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.2 2.13 80.73 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.821 176.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.1 m -110.36 146.13 36.33 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.4 m -140.37 154.5 46.74 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 52.2 mt -93.21 128.79 44.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 173.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -70.26 -47.37 61.59 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 123.539 0.525 . . . . 0.0 110.111 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.499 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 1.6 m-20 -132.97 91.83 2.94 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.761 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -65.46 -33.13 75.22 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.483 0.658 . . . . 0.0 109.429 176.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.7 t -64.31 -28.79 69.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.358 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.499 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 32.2 mmtp -89.57 -6.79 55.97 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 120.61 0.243 . . . . 0.0 110.499 -176.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.3 m -82.21 -175.12 5.5 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.064 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -52.86 -64.11 4.41 Favored Glycine 0 C--N 1.334 0.422 0 O-C-N 123.136 0.272 . . . . 0.0 113.215 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -110.94 143.14 42.07 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 122.505 -0.409 . . . . 0.0 110.462 176.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.601 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -108.93 -9.93 15.1 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.201 -1.036 . . . . 0.0 108.201 175.092 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -108.68 114.01 3.95 Favored Glycine 0 N--CA 1.433 -1.535 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.188 -177.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 71.6 mt -96.92 115.57 36.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.486 ' HB3' ' C ' ' A' ' 78' ' ' ASN . 1.1 t -86.67 -26.48 24.3 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.497 178.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.3 p -150.95 156.68 41.67 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 122.158 -0.339 . . . . 0.0 110.324 178.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.2 mt -135.13 132.28 52.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -176.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.409 ' HE2' ' CD2' ' A' ' 81' ' ' TYR . 32.3 ttmt -117.65 133.92 55.44 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 24.6 ttp180 -102.77 127.73 49.81 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 66.2 m -127.16 171.98 10.95 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.0 pt -129.66 144.87 36.76 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.146 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 177.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.472 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 61.8 tt0 -119.18 122.48 42.1 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 63.4 p -75.35 174.06 10.06 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.404 -175.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -66.36 -28.18 68.46 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.664 0.745 . . . . 0.0 109.525 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -77.12 -7.11 55.2 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.307 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.04 -1.74 61.15 Favored Glycine 0 N--CA 1.438 -1.192 0 N-CA-C 115.534 0.974 . . . . 0.0 115.534 171.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 113' ' ' GLN . 18.5 ptpt -83.73 140.65 31.98 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 118.78 1.29 . . . . 0.0 110.9 -177.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.4 t -101.81 112.06 33.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -99.4 144.79 28.11 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 124.27 1.028 . . . . 0.0 108.241 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 72.8 m . . . . . 0 C--N 1.303 -1.424 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.597 -174.776 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.425 ' CZ ' ' HD3' ' A' ' 71' ' ' PRO . 9.1 m-85 . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 121.137 0.494 . . . . 0.0 112.006 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 63.5 m -123.32 149.63 44.61 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.58 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 49.1 tp -95.62 112.76 24.41 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 174.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.495 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 17.7 mt-30 -111.46 123.17 49.67 Favored 'General case' 0 N--CA 1.422 -1.852 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.745 -177.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.419 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 2.7 mp -110.97 124.71 52.67 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.87 -178.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.425 ' CE1' ' HG2' ' A' ' 35' ' ' GLU . 96.4 m-85 -90.45 155.38 18.96 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 122.623 0.369 . . . . 0.0 110.577 -178.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -75.18 -40.94 58.98 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.897 0.856 . . . . 0.0 109.943 -176.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -108.46 179.01 4.32 Favored 'General case' 0 N--CA 1.421 -1.918 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.403 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.453 HG21 ' HA ' ' A' ' 96' ' ' ASP . 0.8 OUTLIER -81.11 174.94 11.09 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.504 -177.093 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 47.07 34.03 2.64 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 174.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.425 ' HG2' ' CE1' ' A' ' 30' ' ' TYR . 36.1 mt-10 65.35 22.78 12.03 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 124.485 1.114 . . . . 0.0 113.919 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' A' ' 33' ' ' THR . 35.7 ptt180 -97.71 157.52 16.01 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 118.694 -1.202 . . . . 0.0 108.87 174.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.4 -178.65 41.62 Favored Glycine 0 N--CA 1.424 -2.105 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -175.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.0 m -89.59 169.13 11.59 Favored 'General case' 0 C--N 1.286 -2.163 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.553 177.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 21.8 p90 -131.78 165.88 22.8 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.466 -177.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.495 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 15.0 tt -113.87 150.55 15.88 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -106.59 125.15 50.64 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.489 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 88.4 t -123.97 133.88 68.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -117.46 -31.57 5.2 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -176.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.49 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 11.2 mmpt? -103.56 161.98 13.43 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.914 -173.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.9 p -88.99 143.03 27.14 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 172.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.5 p -121.31 131.05 73.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -177.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.77 -15.25 56.89 Favored Glycine 0 C--N 1.298 -1.53 0 C-N-CA 119.851 -1.166 . . . . 0.0 113.03 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.5 p -154.38 123.98 6.59 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.439 0.637 . . . . 0.0 112.415 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 88.4 mt -116.45 118.71 33.42 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.202 177.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.0 p -131.88 107.51 14.0 Favored Pre-proline 0 C--N 1.3 -1.549 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.64 175.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.93 162.22 89.86 Favored 'Cis proline' 0 C--O 1.249 1.068 0 C-N-CA 123.861 -1.308 . . . . 0.0 111.801 0.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.52 154.58 73.07 Favored 'Trans proline' 0 C--O 1.25 1.123 0 C-N-CA 122.125 1.883 . . . . 0.0 110.586 176.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 49.3 m0 -90.23 137.6 32.21 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 20.5 p -121.22 79.41 35.34 Favored Pre-proline 0 N--CA 1.425 -1.688 0 O-C-N 123.258 0.349 . . . . 0.0 111.027 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.409 ' HD2' ' O ' ' A' ' 103' ' ' LYS . 85.4 Cg_endo -77.16 158.49 33.74 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.884 2.389 . . . . 0.0 112.789 178.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.32 -29.82 9.21 Favored Glycine 0 N--CA 1.43 -1.701 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.1 p -150.96 152.61 33.81 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.5 t -126.71 142.99 41.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 17.3 t -145.46 138.48 26.19 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 118.525 0.602 . . . . 0.0 110.109 -176.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.7 t -118.33 125.38 27.9 Favored Pre-proline 0 C--O 1.249 1.056 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -62.1 147.16 95.62 Favored 'Trans proline' 0 C--O 1.249 1.061 0 C-N-CA 122.775 2.317 . . . . 0.0 111.031 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.602 ' CE2' ' HB3' ' A' ' 64' ' ' ASN . 34.7 t80 -74.49 136.31 42.24 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-O 121.95 0.881 . . . . 0.0 111.111 -176.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 98.4 t -118.61 115.08 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.166 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.602 ' HB3' ' CE2' ' A' ' 62' ' ' PHE . 24.5 p-10 -121.67 13.44 10.82 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 123.045 1.402 . . . . 0.0 107.332 178.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.74 146.44 41.47 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 111.737 -2.483 . . . . 0.0 111.483 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.4 m -57.46 -8.22 0.77 Allowed 'General case' 0 CA--C 1.579 2.073 0 C-N-CA 124.69 1.196 . . . . 0.0 112.004 177.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -62.49 136.65 58.0 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.104 0.961 . . . . 0.0 108.731 177.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.525 ' HB2' ' OE1' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -84.24 -28.82 26.98 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -177.894 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.525 ' OE1' ' HB2' ' A' ' 68' ' ' ARG . 3.0 mp0 -97.25 125.08 41.58 Favored 'General case' 0 N--CA 1.415 -2.184 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.47 ' HG2' ' CE1' ' A' ' 90' ' ' HIS . 0.6 OUTLIER -106.75 152.09 40.71 Favored Pre-proline 0 C--N 1.291 -1.955 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.593 179.111 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.425 ' HD3' ' CZ ' ' A' ' 25' ' ' TYR . 74.1 Cg_endo -76.98 134.09 14.3 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 121.089 1.193 . . . . 0.0 110.542 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -133.5 132.82 41.45 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.58 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 89.5 m95 -119.48 133.15 55.82 Favored 'General case' 0 C--N 1.284 -2.275 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.915 -172.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.523 ' HA ' ' O ' ' A' ' 86' ' ' THR . 35.7 m-85 -112.98 141.39 46.87 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.368 177.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.8 mt -125.92 142.16 51.64 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -176.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.54 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 80.2 m-85 -134.45 142.68 47.18 Favored 'General case' 0 CA--C 1.502 -0.874 0 O-C-N 123.796 0.685 . . . . 0.0 110.117 -176.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.403 ' HB3' ' CD1' ' A' ' 102' ' ' PHE . 2.9 p-10 -84.38 -5.82 59.32 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.476 ' C ' ' HB3' ' A' ' 106' ' ' SER . 4.4 t-20 -127.28 167.77 15.67 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 174.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.4 m -73.52 167.37 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 C-N-CA 122.581 0.352 . . . . 0.0 111.627 -176.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 55.92 31.53 18.03 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.237 -0.892 . . . . 0.0 113.226 176.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 62.82 42.83 7.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.857 175.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 69.3 p -118.38 161.7 19.53 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.093 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.98 -144.06 17.12 Favored Glycine 0 N--CA 1.425 -2.065 0 N-CA-C 111.668 -0.573 . . . . 0.0 111.668 177.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 54.9 mtt180 -72.41 142.84 48.69 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.3 tt -125.4 136.43 60.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-O 121.487 0.66 . . . . 0.0 111.241 -173.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.523 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 86.7 m -131.57 123.04 27.1 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.34 176.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -113.69 120.06 5.0 Favored Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.531 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -110.35 147.76 33.29 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 123.673 0.789 . . . . 0.0 111.0 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -121.36 168.41 14.31 Favored Glycine 0 N--CA 1.425 -2.047 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.204 -178.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.47 ' CE1' ' HG2' ' A' ' 70' ' ' ARG . 2.9 p80 -55.12 121.89 9.78 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 124.066 0.946 . . . . 0.0 112.139 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.18 12.37 73.76 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.064 176.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.0 m -125.48 145.9 49.88 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 177.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 22.5 m -144.2 155.84 44.05 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -178.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.7 mt -93.45 125.61 46.0 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.45 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -70.22 -46.76 63.86 Favored 'General case' 0 C--N 1.288 -2.071 0 O-C-N 123.812 0.695 . . . . 0.0 110.353 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.453 ' HA ' HG21 ' A' ' 33' ' ' THR . 3.3 m-20 -132.88 93.55 3.22 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.231 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -64.94 -31.66 73.0 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.431 0.634 . . . . 0.0 110.508 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.7 t -63.49 -23.2 67.29 Favored 'General case' 0 CA--C 1.561 1.375 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.631 -178.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.451 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 30.4 mmtp -92.78 -6.31 49.24 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.925 -0.485 . . . . 0.0 109.765 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.8 m -84.85 13.46 5.86 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.379 0.609 . . . . 0.0 111.786 -177.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 104.72 -79.07 0.28 Allowed Glycine 0 N--CA 1.425 -2.05 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.68 178.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.403 ' CD1' ' HB3' ' A' ' 77' ' ' ASP . 27.5 p90 -100.11 147.13 26.0 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -178.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.3 -14.22 12.84 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.18 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -103.02 110.4 3.71 Favored Glycine 0 N--CA 1.422 -2.271 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.489 -175.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 80.5 mt -93.32 115.65 32.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.476 ' HB3' ' C ' ' A' ' 78' ' ' ASN . 5.3 t -85.99 -29.01 23.85 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.502 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 90.1 p -150.34 156.33 41.31 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.752 -0.203 . . . . 0.0 110.818 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.7 mt -134.01 132.41 56.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -176.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -116.38 131.58 56.91 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -99.5 129.6 45.69 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . 0.417 ' SG ' ' HD2' ' A' ' 74' ' ' TYR . 62.6 m -128.51 172.38 11.21 Favored 'General case' 0 N--CA 1.413 -2.3 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.329 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 70' ' ' ARG . 7.1 pt -131.48 141.98 44.43 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 C-N-CA 123.172 0.589 . . . . 0.0 110.039 177.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -113.69 119.11 36.3 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 33.8 p -80.19 -178.37 6.54 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.45 -172.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -66.1 -28.85 69.13 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.769 0.795 . . . . 0.0 109.636 177.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -80.1 -6.46 57.73 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.422 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.97 6.17 82.55 Favored Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 115.969 -0.56 . . . . 0.0 113.77 175.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 66.0 pttt -82.16 145.08 30.3 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.829 178.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 25.5 t -104.12 111.52 34.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -97.12 144.24 27.16 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 96.8 m . . . . . 0 C--N 1.289 -2.055 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.297 -173.953 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 . . . . . 0 N--CA 1.468 0.463 0 CA-C-O 121.246 0.546 . . . . 0.0 111.718 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.6 m -122.73 145.07 48.73 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.508 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 51.5 tp -96.24 116.24 28.69 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 174.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.437 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 37.3 mt-30 -108.98 124.21 50.34 Favored 'General case' 0 N--CA 1.428 -1.572 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.315 -177.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.7 mp -109.66 118.91 37.8 Favored 'General case' 0 N--CA 1.408 -2.526 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.46 177.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.426 ' CD2' ' HB3' ' A' ' 39' ' ' TYR . 95.4 m-85 -87.51 150.3 23.82 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.508 -176.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -72.09 -44.1 63.76 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.835 -175.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -109.8 178.05 4.54 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.902 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.43 HG23 ' HA ' ' A' ' 96' ' ' ASP . 1.9 p -76.74 170.57 16.22 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-O 119.785 -0.15 . . . . 0.0 111.002 -177.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 14.9 p90 47.41 37.05 5.58 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.899 1.28 . . . . 0.0 114.086 177.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 67.72 26.21 7.89 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.615 1.166 . . . . 0.0 112.853 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 36' ' ' ARG . 8.5 mtp-105 -90.89 162.49 14.76 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 176.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.22 -158.94 36.71 Favored Glycine 0 N--CA 1.424 -2.134 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.3 p -96.44 177.41 5.69 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 174.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.426 ' HB3' ' CD2' ' A' ' 30' ' ' TYR . 38.1 p90 -138.55 166.83 23.32 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.8 tt -113.42 151.56 15.26 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 177.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -106.13 124.87 50.26 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.424 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 92.4 t -123.52 133.55 68.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -122.09 -6.01 8.94 Favored 'General case' 0 C--N 1.31 -1.118 0 O-C-N 123.616 0.573 . . . . 0.0 110.85 -174.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -137.1 162.34 33.66 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.161 -173.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.9 p -86.77 140.2 29.97 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 175.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.2 p -119.53 134.37 63.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -175.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.76 -15.73 48.23 Favored Glycine 0 C--N 1.301 -1.394 0 C-N-CA 120.417 -0.897 . . . . 0.0 113.195 -176.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.7 t -156.61 127.54 6.83 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.442 0.639 . . . . 0.0 111.182 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.5 mt -121.34 117.93 28.19 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.073 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.0 m -132.55 115.41 14.73 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 174.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -75.12 161.92 93.81 Favored 'Cis proline' 0 C--O 1.25 1.089 0 C-N-CA 123.033 -1.653 . . . . 0.0 110.788 -2.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -61.98 156.7 47.8 Favored 'Trans proline' 0 C--O 1.256 1.403 0 C-N-CA 122.129 1.886 . . . . 0.0 110.417 178.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.421 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 45.8 m0 -89.33 135.97 33.29 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -176.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 34.1 p -115.65 81.41 9.15 Favored Pre-proline 0 C--N 1.301 -1.5 0 O-C-N 123.369 0.418 . . . . 0.0 111.165 178.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.417 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 81.3 Cg_endo -81.5 157.7 19.28 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 122.239 1.959 . . . . 0.0 112.583 176.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.06 -30.24 11.42 Favored Glycine 0 N--CA 1.43 -1.747 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 177.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.8 p -155.13 153.52 30.93 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.6 t -130.28 142.7 43.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 49.1 t -145.8 148.12 32.58 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.373 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.413 ' HB ' ' O ' ' A' ' 89' ' ' GLY . 58.7 t -117.39 122.65 30.75 Favored Pre-proline 0 C--N 1.31 -1.133 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 175.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.44 156.39 63.73 Favored 'Trans proline' 0 C--O 1.25 1.075 0 C-N-CA 122.726 2.284 . . . . 0.0 112.577 -177.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -72.84 135.3 45.16 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.386 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 98.4 t -112.19 115.58 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.265 0 CA-C-O 121.743 0.782 . . . . 0.0 111.763 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -112.51 74.54 0.87 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 173.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.437 ' HB3' ' NH2' ' A' ' 70' ' ' ARG . 14.6 t70 -126.99 145.95 50.52 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.191 -170.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -54.37 -18.53 4.21 Favored 'General case' 0 CA--C 1.578 2.044 0 C-N-CA 125.803 1.641 . . . . 0.0 114.429 -178.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.565 ' HB2' ' NH2' ' A' ' 70' ' ' ARG . 75.8 mmtt -65.56 173.79 2.56 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.561 -0.712 . . . . 0.0 111.261 175.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -102.7 -26.82 13.04 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 176.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -92.73 132.31 37.05 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.542 -176.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.565 ' NH2' ' HB2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -104.92 149.77 37.93 Favored Pre-proline 0 C--N 1.3 -1.545 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.626 176.379 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.17 136.18 17.81 Favored 'Trans proline' 0 C--N 1.321 -0.909 0 C-N-CA 121.907 1.738 . . . . 0.0 112.314 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -133.09 130.55 39.46 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.508 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 84.4 m95 -116.2 136.91 52.59 Favored 'General case' 0 C--N 1.286 -2.158 0 O-C-N 121.631 -0.668 . . . . 0.0 111.904 -172.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.481 ' HA ' ' O ' ' A' ' 86' ' ' THR . 41.4 m-85 -115.04 142.3 46.83 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 123.051 0.54 . . . . 0.0 110.426 177.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.8 mt -125.71 142.96 51.25 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -175.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 84.3 m-85 -133.23 145.18 50.31 Favored 'General case' 0 C--O 1.241 0.616 0 O-C-N 123.578 0.549 . . . . 0.0 110.666 -176.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.54 -3.56 58.9 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.794 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -133.26 157.06 46.38 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 119.851 -0.739 . . . . 0.0 109.283 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.422 ' HA ' ' HB2' ' A' ' 107' ' ' SER . 33.9 m -70.81 168.31 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.455 -178.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 59.66 30.23 19.83 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.251 0.621 . . . . 0.0 110.966 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.563 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 16.5 m-85 55.21 44.03 28.33 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 124.781 1.232 . . . . 0.0 112.233 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 59.1 p -117.07 172.85 7.0 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.932 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.68 -136.17 13.5 Favored Glycine 0 N--CA 1.429 -1.767 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.357 178.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 77.6 mtt180 -79.76 153.23 29.35 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.8 tt -133.12 136.82 54.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-O 121.384 0.612 . . . . 0.0 110.785 -175.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 95.5 m -132.39 121.11 22.94 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.999 177.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -108.47 119.76 5.75 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.868 -0.682 . . . . 0.0 114.443 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -110.1 145.53 36.97 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 123.103 0.561 . . . . 0.0 110.596 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.413 ' O ' ' HB ' ' A' ' 60' ' ' VAL . . . -119.61 175.67 15.89 Favored Glycine 0 N--CA 1.429 -1.793 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.946 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -60.17 132.81 55.09 Favored 'General case' 0 C--O 1.247 0.95 0 C-N-CA 123.088 0.555 . . . . 0.0 111.86 -178.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.75 16.34 79.25 Favored Glycine 0 N--CA 1.437 -1.266 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.744 177.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.0 m -121.06 145.48 47.73 Favored 'General case' 0 N--CA 1.42 -1.972 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -178.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.9 m -141.98 155.43 45.45 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 47.7 mt -93.33 130.94 41.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 175.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -70.85 -48.42 54.06 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 123.586 0.554 . . . . 0.0 110.3 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.43 ' HA ' HG23 ' A' ' 33' ' ' THR . 8.2 m-20 -141.57 98.88 3.44 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -63.84 -31.86 73.18 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.481 0.658 . . . . 0.0 110.469 -178.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.9 t -63.4 -22.13 66.7 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.393 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -93.14 -11.04 33.81 Favored 'General case' 0 C--O 1.22 -0.499 0 O-C-N 121.742 -0.599 . . . . 0.0 110.416 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.1 m -78.77 -7.14 57.52 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.42 0.629 . . . . 0.0 110.579 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 123.8 -86.34 0.37 Allowed Glycine 0 N--CA 1.419 -2.478 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -85.73 139.2 31.54 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.574 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -109.43 -6.91 15.28 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.157 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -110.97 113.28 3.41 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.348 -176.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 75.0 mt -97.3 115.31 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.548 0 CA-C-O 122.687 1.232 . . . . 0.0 109.066 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.3 m -85.66 -25.31 26.64 Favored 'General case' 0 N--CA 1.393 -3.296 0 CA-C-N 111.811 -2.45 . . . . 0.0 113.935 178.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.422 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 8.5 t -159.39 153.3 23.21 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -176.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.1 mt -136.3 129.27 46.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -176.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.563 ' HE2' ' CD2' ' A' ' 81' ' ' TYR . 35.3 ttmt -117.23 133.28 56.18 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -100.49 129.85 46.49 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -178.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 71.0 m -126.34 172.0 10.5 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.4 pt -132.23 140.68 47.22 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -109.09 123.91 49.93 Favored 'General case' 0 C--N 1.266 -3.049 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 69.1 p -74.08 166.58 23.15 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.364 -175.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -67.58 -19.23 65.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 122.169 0.985 . . . . 0.0 109.075 175.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -76.93 -7.57 55.8 Favored 'General case' 0 CA--C 1.561 1.369 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.104 175.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.53 3.96 74.06 Favored Glycine 0 CA--C 1.504 -0.645 0 N-CA-C 114.828 0.691 . . . . 0.0 114.828 172.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.419 ' HE2' ' OE2' ' A' ' 120' ' ' GLU . 21.9 ptmt -94.44 139.73 30.75 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 119.138 -1.025 . . . . 0.0 109.421 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 24.2 t -95.27 111.9 26.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.394 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.419 ' OE2' ' HE2' ' A' ' 118' ' ' LYS . 6.3 mm-40 -94.96 142.69 27.19 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 72.4 m . . . . . 0 C--N 1.278 -2.525 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -177.48 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 121.045 0.45 . . . . 0.0 112.021 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.7 m -123.57 144.65 49.45 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.585 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 56.1 tp -88.73 128.28 35.62 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 48.1 mt-30 -117.23 123.42 46.58 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.222 -177.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 3.9 mp -110.82 120.05 41.12 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.893 177.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -89.82 150.41 22.26 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 123.735 0.647 . . . . 0.0 110.461 -176.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -75.34 -36.45 61.03 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.003 0.43 . . . . 0.0 111.17 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -107.99 177.27 4.86 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.422 HG21 ' HA ' ' A' ' 96' ' ' ASP . 1.7 p -82.43 170.45 15.26 Favored 'General case' 0 N--CA 1.407 -2.624 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 29.6 p90 46.83 44.46 14.3 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.803 1.241 . . . . 0.0 114.057 177.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 67.75 22.67 8.82 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.803 0.841 . . . . 0.0 112.615 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 37.4 mtp85 -95.17 161.02 14.29 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 177.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.31 -167.51 41.36 Favored Glycine 0 N--CA 1.423 -2.167 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.775 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 79.4 p -87.9 163.1 16.55 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 176.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 11.4 p90 -129.28 164.95 22.4 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.6 tt -114.95 153.39 16.45 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.038 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -106.75 125.47 51.05 Favored 'General case' 0 N--CA 1.422 -1.856 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 175.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.507 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 97.1 t -118.89 133.41 65.85 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 177.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -116.97 -29.83 5.88 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 123.472 0.482 . . . . 0.0 110.687 -174.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -121.59 163.27 19.2 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.031 -174.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.9 m -75.7 144.01 41.81 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 176.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.6 p -120.95 137.11 55.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.66 -18.71 31.72 Favored Glycine 0 C--N 1.307 -1.044 0 C-N-CA 119.791 -1.195 . . . . 0.0 113.02 -178.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.4 t -153.21 131.6 12.09 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-O 121.053 0.454 . . . . 0.0 110.305 -177.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.2 mt -123.25 117.68 25.86 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.58 177.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.0 m -132.61 111.21 13.64 Favored Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -78.08 160.45 92.13 Favored 'Cis proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.109 -1.621 . . . . 0.0 110.527 -0.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.68 157.75 40.72 Favored 'Trans proline' 0 C--O 1.253 1.254 0 C-N-CA 122.126 1.884 . . . . 0.0 111.007 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.451 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 49.8 m0 -90.16 135.7 33.5 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -177.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 34.9 p -117.52 75.09 8.98 Favored Pre-proline 0 C--N 1.296 -1.751 0 O-C-N 123.387 0.429 . . . . 0.0 110.209 178.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -74.73 157.81 43.63 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 122.151 1.901 . . . . 0.0 113.036 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.97 -31.75 11.75 Favored Glycine 0 N--CA 1.427 -1.921 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.1 p -156.46 153.74 29.3 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.4 t -129.37 143.0 42.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 32.2 t -145.59 152.94 40.48 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.331 177.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.3 t -120.92 128.89 25.55 Favored Pre-proline 0 N--CA 1.443 -0.778 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 176.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.0 140.69 85.9 Favored 'Trans proline' 0 C--O 1.244 0.798 0 C-N-CA 123.18 2.587 . . . . 0.0 112.387 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.469 ' CE1' ' HB3' ' A' ' 64' ' ' ASN . 76.0 t80 -74.75 112.44 10.96 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-O 121.413 0.625 . . . . 0.0 110.462 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.3 t -94.16 115.57 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.148 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.485 178.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.469 ' HB3' ' CE1' ' A' ' 62' ' ' PHE . 6.4 p30 -118.88 15.69 13.43 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.194 -1.409 . . . . 0.0 107.194 177.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.641 ' OD1' ' HG2' ' A' ' 67' ' ' LYS . 8.9 t70 -66.51 147.54 53.14 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 112.358 -2.201 . . . . 0.0 109.476 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.2 m -53.13 -23.37 7.96 Favored 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 123.809 0.843 . . . . 0.0 111.812 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.641 ' HG2' ' OD1' ' A' ' 65' ' ' ASP . 42.5 mmtm -54.49 121.23 7.94 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 176.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -73.75 -25.64 60.27 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.976 -174.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -91.7 127.59 37.21 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -99.72 153.57 37.7 Favored Pre-proline 0 C--N 1.286 -2.193 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -83.22 135.18 7.19 Favored 'Trans proline' 0 N--CA 1.442 -1.503 0 C-N-CA 121.503 1.469 . . . . 0.0 111.078 176.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -130.24 132.2 45.86 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.585 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 82.2 m95 -118.78 134.14 55.35 Favored 'General case' 0 C--N 1.286 -2.185 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.831 -173.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.427 ' HA ' ' O ' ' A' ' 86' ' ' THR . 27.4 m-85 -114.47 140.8 48.42 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.327 178.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.5 mt -125.71 142.34 51.56 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -176.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.497 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 80.5 m-85 -132.84 143.04 49.27 Favored 'General case' 0 C--O 1.247 0.941 0 O-C-N 123.782 0.677 . . . . 0.0 109.791 -176.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 106' ' ' SER . 0.9 OUTLIER -81.2 -14.75 57.23 Favored 'General case' 0 CA--C 1.491 -1.32 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.262 -178.904 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -122.17 166.09 15.12 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.5 m -76.29 167.78 2.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 122.747 0.419 . . . . 0.0 110.92 -175.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 56.32 30.43 16.77 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 124.136 0.974 . . . . 0.0 112.82 178.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.406 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 7.0 m-85 63.01 39.34 10.25 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 124.795 1.238 . . . . 0.0 111.198 177.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 78.8 p -112.06 165.07 12.45 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.63 -139.43 14.57 Favored Glycine 0 N--CA 1.435 -1.427 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.441 178.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 55.5 mtt180 -81.88 147.14 29.47 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 123.322 0.649 . . . . 0.0 109.81 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.8 tt -123.19 136.61 59.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-O 121.155 0.502 . . . . 0.0 110.759 -176.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 90.7 m -131.69 121.17 23.83 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.887 177.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -109.44 121.05 5.96 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.444 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.86 145.19 37.21 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 120.769 0.318 . . . . 0.0 110.677 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -117.76 171.26 13.88 Favored Glycine 0 N--CA 1.42 -2.395 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.073 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -60.88 123.01 16.3 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.722 0.772 . . . . 0.0 112.406 -177.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.31 1.78 71.59 Favored Glycine 0 N--CA 1.429 -1.798 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.961 177.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.3 m -112.43 145.95 39.25 Favored 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -178.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 4.6 m -134.3 158.45 43.73 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 55.0 mt -94.16 129.39 44.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 170.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -70.36 -46.98 63.03 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 123.597 0.561 . . . . 0.0 110.444 -178.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.465 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 2.0 m-20 -138.48 101.16 4.29 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.38 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -65.24 -38.02 89.05 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-O 120.736 0.303 . . . . 0.0 110.983 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.6 t -65.44 -28.01 68.92 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.855 -177.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.465 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 27.1 mmtp -83.64 -5.98 59.32 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.424 0.631 . . . . 0.0 109.738 -177.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 18.6 m -82.67 -168.89 2.21 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.39 -61.11 7.45 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.136 -178.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -111.26 149.54 30.89 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 122.39 0.276 . . . . 0.0 110.68 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -111.65 -7.72 14.25 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.838 177.26 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -114.93 121.4 5.31 Favored Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.374 -176.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 67.6 mt -100.95 115.99 43.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-O 122.107 0.956 . . . . 0.0 109.083 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 77' ' ' ASP . 1.5 m -85.94 -28.81 24.04 Favored 'General case' 0 N--CA 1.406 -2.638 0 CA-C-N 112.716 -2.038 . . . . 0.0 114.257 176.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.9 p -154.22 154.94 34.35 Favored 'General case' 0 C--O 1.237 0.433 0 O-C-N 122.063 -0.398 . . . . 0.0 110.024 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.8 mt -134.12 133.25 55.89 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.608 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -176.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.406 ' HE2' ' CD2' ' A' ' 81' ' ' TYR . 36.2 ttmt -117.11 126.07 52.26 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -95.92 127.96 42.4 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.45 0.643 . . . . 0.0 109.487 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . 0.422 ' SG ' ' HD1' ' A' ' 74' ' ' TYR . 59.7 m -121.94 168.62 11.69 Favored 'General case' 0 N--CA 1.402 -2.868 0 CA-C-N 114.869 -1.059 . . . . 0.0 108.676 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.7 pt -128.37 143.11 42.01 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 176.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -111.21 118.45 35.96 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 63.8 p -77.34 -178.66 5.27 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.485 -171.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -62.6 -36.63 83.36 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.943 174.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.499 ' OD2' ' HG2' ' A' ' 118' ' ' LYS . 2.5 p30 -78.46 -7.06 57.01 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.867 -176.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.0 -5.6 63.62 Favored Glycine 0 CA--C 1.496 -1.123 0 CA-C-N 115.776 -0.647 . . . . 0.0 113.859 173.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.499 ' HG2' ' OD2' ' A' ' 116' ' ' ASP . 6.4 ptpp? -77.66 146.9 35.81 Favored 'General case' 0 CA--C 1.493 -1.24 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.706 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 38.2 t -103.37 111.46 33.21 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -96.99 142.16 29.28 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 73.2 m . . . . . 0 C--N 1.297 -1.692 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.139 -175.773 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.437 ' CD1' ' HB3' ' A' ' 71' ' ' PRO . 5.5 m-85 . . . . . 0 N--CA 1.473 0.685 0 CA-C-O 121.218 0.532 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 7.7 m -124.35 145.34 49.49 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.632 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 61.3 tp -100.12 128.68 46.16 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 176.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.542 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 39.8 mt-30 -118.87 123.95 45.94 Favored 'General case' 0 CA--C 1.492 -1.266 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.534 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.412 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.0 mp -110.76 122.85 48.84 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.881 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -92.0 149.59 21.45 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 123.327 0.392 . . . . 0.0 110.304 -178.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.54 -35.24 63.12 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.095 0.474 . . . . 0.0 111.803 -177.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -108.41 178.05 4.61 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.424 HG21 ' HA ' ' A' ' 96' ' ' ASP . 2.3 p -82.26 170.68 15.11 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.26 21.5 p90 46.85 46.71 15.45 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.289 1.036 . . . . 0.0 113.394 178.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 59.55 23.34 12.02 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.954 1.302 . . . . 0.0 114.129 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -92.01 167.37 12.14 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.623 0.725 . . . . 0.0 111.847 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.16 -164.82 46.36 Favored Glycine 0 N--CA 1.426 -1.995 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.7 m -92.71 173.66 7.65 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 175.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -140.76 161.79 36.95 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.237 0.541 . . . . 0.0 110.129 -178.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.542 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 17.4 tt -114.64 149.53 16.87 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -107.6 125.5 51.4 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 175.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 95.0 t -117.87 134.06 62.68 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -118.17 -20.97 8.41 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.442 0.639 . . . . 0.0 110.485 -174.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -136.42 162.56 32.7 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.226 -174.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.4 p -72.66 147.38 45.8 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.33 0.586 . . . . 0.0 112.209 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.8 p -122.43 132.14 71.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 176.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.72 -15.3 46.69 Favored Glycine 0 C--N 1.303 -1.297 0 C-N-CA 119.566 -1.302 . . . . 0.0 112.861 -177.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.9 p -155.71 123.35 5.6 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.416 0.627 . . . . 0.0 112.377 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.4 mt -114.34 118.88 35.13 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.348 177.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.3 m -132.48 110.61 13.7 Favored Pre-proline 0 C--N 1.303 -1.432 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.837 175.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -77.4 161.94 91.56 Favored 'Cis proline' 0 C--O 1.244 0.797 0 C-N-CA 123.229 -1.571 . . . . 0.0 110.927 0.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.07 158.38 30.25 Favored 'Trans proline' 0 C--O 1.25 1.092 0 C-N-CA 122.526 2.15 . . . . 0.0 110.988 177.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 46.9 m0 -89.67 139.13 30.86 Favored 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.089 -177.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 15.4 p -119.34 78.85 19.61 Favored Pre-proline 0 C--N 1.29 -1.993 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.15 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.443 ' HG2' ' CD2' ' A' ' 97' ' ' PHE . 93.0 Cg_endo -79.18 157.59 26.39 Favored 'Trans proline' 0 N--CA 1.44 -1.648 0 C-N-CA 121.782 1.655 . . . . 0.0 112.257 176.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -93.73 -27.98 11.93 Favored Glycine 0 N--CA 1.428 -1.878 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 176.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.4 p -153.57 150.94 29.2 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.5 t -123.11 142.84 38.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 15.5 t -142.98 137.71 29.54 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -177.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.9 t -121.43 119.02 29.58 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -65.2 137.41 51.78 Favored 'Trans proline' 0 C--O 1.241 0.673 0 C-N-CA 123.036 2.491 . . . . 0.0 113.136 -178.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -71.78 121.75 19.47 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.25 178.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 86.7 t -95.01 115.0 32.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 176.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -103.12 70.17 1.06 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -126.22 145.3 50.45 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -172.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.4 m -58.66 -24.83 62.0 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.436 -1.257 . . . . 0.0 109.807 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 4.3 mptp? -53.09 134.31 38.51 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.563 -177.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 50.9 mtp180 -68.51 -27.99 66.61 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -172.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -106.49 128.03 53.77 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.928 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -104.89 147.01 33.76 Favored Pre-proline 0 C--N 1.284 -2.24 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 171.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.437 ' HB3' ' CD1' ' A' ' 25' ' ' TYR . 93.3 Cg_endo -77.52 135.24 14.53 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.748 1.632 . . . . 0.0 112.522 -177.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -129.35 141.27 51.12 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.632 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 90.0 m95 -122.81 132.11 54.06 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -173.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.489 ' HD2' ' SG ' ' A' ' 111' ' ' CYS . 28.0 m-85 -114.37 142.76 45.92 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.108 176.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.7 mt -125.5 142.37 51.54 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 -175.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.403 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 92.0 m-85 -130.54 139.79 50.47 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.575 0.703 . . . . 0.0 111.21 -176.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.598 ' HB2' ' CD1' ' A' ' 102' ' ' PHE . 0.8 OUTLIER -81.89 -10.59 59.25 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.314 -178.876 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -135.69 156.92 48.08 Favored 'General case' 0 N--CA 1.416 -2.136 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.823 174.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.47 ' HA ' ' HB2' ' A' ' 107' ' ' SER . 21.5 m -65.3 161.45 3.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.967 -176.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 61.52 30.57 18.81 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.199 0.523 . . . . 0.0 111.278 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 57.57 41.85 25.1 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 124.335 1.054 . . . . 0.0 111.333 176.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 77.9 p -112.35 176.35 5.05 Favored 'General case' 0 C--O 1.252 1.203 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.674 178.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.93 -137.79 18.42 Favored Glycine 0 N--CA 1.424 -2.152 0 N-CA-C 111.761 -0.535 . . . . 0.0 111.761 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.41 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . 53.3 mtt180 -82.72 150.21 26.85 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -177.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.0 tt -128.44 137.31 57.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 O-C-N 123.622 0.576 . . . . 0.0 110.594 -174.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 57.1 m -132.43 124.07 27.91 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 122.231 -0.293 . . . . 0.0 110.319 174.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -115.0 113.43 2.95 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.622 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -106.48 145.63 31.56 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 122.994 0.518 . . . . 0.0 111.285 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -110.33 164.61 12.25 Favored Glycine 0 N--CA 1.427 -1.966 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.625 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -64.03 122.15 15.86 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 123.29 0.636 . . . . 0.0 110.994 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.56 16.94 51.17 Favored Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.525 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.4 m -135.69 146.03 47.34 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 175.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 21.7 m -143.96 157.08 44.57 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 61.7 mt -94.45 135.21 29.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -70.81 -47.43 59.48 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.525 0.678 . . . . 0.0 110.483 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.424 ' HA ' HG21 ' A' ' 33' ' ' THR . 5.7 m-20 -136.51 100.77 4.45 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.995 -177.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.443 ' CD2' ' HG2' ' A' ' 55' ' ' PRO . 62.6 t80 -64.2 -29.53 70.63 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.259 0.552 . . . . 0.0 110.796 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.9 t -62.91 -18.78 63.49 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.694 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -94.75 -8.96 36.11 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 122.152 -0.343 . . . . 0.0 110.416 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 26.9 t -85.24 28.82 0.7 Allowed 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.772 0.829 . . . . 0.0 110.798 -177.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.88 -70.84 1.78 Allowed Glycine 0 N--CA 1.432 -1.626 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.054 177.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.598 ' CD1' ' HB2' ' A' ' 77' ' ' ASP . 27.0 p90 -110.41 149.42 30.29 Favored 'General case' 0 C--N 1.29 -1.991 0 O-C-N 122.784 -0.245 . . . . 0.0 110.356 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -114.24 -10.09 12.77 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.681 177.0 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -109.18 99.7 1.28 Allowed Glycine 0 N--CA 1.433 -1.552 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.897 -175.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 69.2 mt -87.05 115.17 27.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-O 122.551 1.167 . . . . 0.0 107.964 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 27.8 m -85.94 -23.97 26.75 Favored 'General case' 0 C--N 1.249 -3.763 0 CA-C-N 112.337 -2.21 . . . . 0.0 113.764 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.47 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 9.3 t -158.48 153.45 25.17 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -176.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.2 mt -137.29 130.32 43.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -178.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.555 ' HD2' ' SG ' ' A' ' 121' ' ' CYS . 24.7 ttmt -117.64 133.48 55.9 Favored 'General case' 0 C--N 1.3 -1.543 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -100.47 127.81 46.71 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -177.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . 0.489 ' SG ' ' HD2' ' A' ' 74' ' ' TYR . 29.6 m -119.38 168.3 11.08 Favored 'General case' 0 N--CA 1.417 -2.117 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -176.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.7 pt -127.38 140.29 49.52 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.525 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -112.79 119.08 36.79 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 63.3 p -79.17 177.37 8.87 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.254 -175.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.1 ttpp -66.32 -20.19 66.02 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.572 0.701 . . . . 0.0 109.421 176.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -78.77 -8.34 58.66 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.813 0.816 . . . . 0.0 109.953 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.68 -11.57 68.16 Favored Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.386 176.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -71.82 139.01 48.75 Favored 'General case' 0 C--O 1.253 1.25 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.65 112.27 37.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -104.6 152.7 22.12 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . 0.555 ' SG ' ' HD2' ' A' ' 109' ' ' LYS . 0.9 OUTLIER . . . . . 0 C--N 1.287 -2.119 0 C-N-CA 118.626 -1.23 . . . . 0.0 110.575 -175.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.412 ' CD2' ' HB3' ' A' ' 71' ' ' PRO . 1.9 m-85 . . . . . 0 C--O 1.243 0.719 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.0 m -125.54 154.79 41.62 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.594 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 54.4 tp -112.26 122.69 48.43 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 171.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.508 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 78.7 mt-30 -116.04 124.88 51.57 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.759 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.419 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 3.6 mp -109.51 126.01 53.09 Favored 'General case' 0 N--CA 1.415 -2.204 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.129 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.401 ' CD1' ' HB3' ' A' ' 39' ' ' TYR . 98.1 m-85 -94.55 147.94 22.76 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 123.783 0.677 . . . . 0.0 110.914 -176.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -72.5 -38.58 68.09 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.979 -177.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -109.74 178.12 4.52 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.0 p -79.09 172.63 13.54 Favored 'General case' 0 N--CA 1.422 -1.872 0 C-N-CA 121.507 -0.077 . . . . 0.0 111.026 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.529 ' CE1' ' HG3' ' A' ' 36' ' ' ARG 0.261 31.6 p90 46.56 42.25 10.88 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 176.777 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 67.94 28.89 6.75 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.984 0.914 . . . . 0.0 112.788 176.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.529 ' HG3' ' CE1' ' A' ' 34' ' ' TYR . 23.7 mmt180 -107.06 172.13 6.99 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-O 121.501 0.667 . . . . 0.0 112.249 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.4 -159.88 39.32 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -177.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.0 m -89.66 179.57 5.99 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 172.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 21.8 p90 -149.42 162.92 39.14 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.508 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 15.6 tt -118.09 151.97 20.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.232 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -107.34 125.92 51.8 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 175.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.521 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 93.0 t -117.67 133.96 62.77 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 176.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -117.59 -29.47 5.76 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 120.994 0.426 . . . . 0.0 110.313 -176.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.09 154.91 47.77 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.838 -177.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.2 m -60.31 145.8 46.32 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 123.527 0.731 . . . . 0.0 111.935 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.5 p -120.84 139.04 49.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 176.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.12 -20.31 30.88 Favored Glycine 0 C--N 1.299 -1.484 0 C-N-CA 119.604 -1.284 . . . . 0.0 112.804 -176.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.3 p -157.72 131.14 7.76 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 120.961 0.41 . . . . 0.0 111.789 -176.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.58 117.22 23.82 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 175.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.9 t -133.6 113.0 12.9 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.403 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -75.56 161.23 94.86 Favored 'Cis proline' 0 C--O 1.246 0.924 0 C-N-CA 123.191 -1.587 . . . . 0.0 111.206 -0.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -61.71 158.87 35.29 Favored 'Trans proline' 0 C--O 1.245 0.859 0 C-N-CA 122.986 2.457 . . . . 0.0 111.312 178.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 48.0 m0 -88.56 137.5 32.27 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 5.4 p -117.59 75.53 9.51 Favored Pre-proline 0 C--N 1.292 -1.905 0 O-C-N 123.31 0.381 . . . . 0.0 111.601 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.424 ' HG2' ' CD2' ' A' ' 97' ' ' PHE . 69.8 Cg_endo -74.35 157.94 45.07 Favored 'Trans proline' 0 C--N 1.359 1.12 0 C-N-CA 122.859 2.373 . . . . 0.0 112.875 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.25 -28.67 14.22 Favored Glycine 0 N--CA 1.436 -1.307 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.3 p -156.1 151.67 27.03 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.5 t -128.45 142.4 43.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 35.8 t -145.84 150.06 35.45 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.515 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.6 t -113.58 123.28 33.41 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 175.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -57.27 140.6 93.42 Favored 'Trans proline' 0 C--O 1.247 0.935 0 C-N-CA 122.552 2.168 . . . . 0.0 111.505 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.421 ' CE1' ' HB2' ' A' ' 64' ' ' ASN . 82.1 t80 -74.09 109.54 7.66 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-O 121.385 0.612 . . . . 0.0 110.681 -177.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.406 ' H ' ' HB2' ' A' ' 90' ' ' HIS . 49.1 t -94.19 114.17 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.566 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.421 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 27.0 t-20 -112.75 88.92 2.94 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 172.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.443 ' OD1' ' HG2' ' A' ' 67' ' ' LYS . 3.8 t70 -127.31 145.81 50.66 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.62 -171.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.9 m -62.93 -6.93 4.3 Favored 'General case' 0 CA--C 1.569 1.71 0 C-N-CA 124.444 1.098 . . . . 0.0 111.157 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.443 ' HG2' ' OD1' ' A' ' 65' ' ' ASP . 75.8 mmtt -61.28 153.95 25.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 171.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.523 ' HB2' ' OE2' ' A' ' 69' ' ' GLU . 45.5 mtm180 -89.17 -28.65 19.87 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.733 -177.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.523 ' OE2' ' HB2' ' A' ' 68' ' ' ARG . 9.7 mp0 -105.37 128.9 53.74 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.435 -177.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -102.52 153.96 37.78 Favored Pre-proline 0 C--N 1.291 -1.968 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 176.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.412 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 93.5 Cg_endo -80.58 141.39 13.85 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.467 1.445 . . . . 0.0 112.476 -177.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -133.22 138.15 46.4 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.594 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 84.3 m95 -120.27 136.91 54.51 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.755 -0.59 . . . . 0.0 112.301 -173.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 86' ' ' THR . 37.1 m-85 -116.74 143.29 45.84 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.678 177.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.8 mt -125.96 142.78 51.36 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 -176.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -133.62 141.71 47.77 Favored 'General case' 0 C--O 1.244 0.794 0 O-C-N 123.625 0.578 . . . . 0.0 109.974 -177.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.65 -5.46 59.31 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.918 -177.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -131.76 162.25 30.94 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 175.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 25.2 m -73.15 167.38 2.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 C-N-CA 122.395 0.278 . . . . 0.0 110.794 -176.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 57.54 30.2 18.34 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.646 0.778 . . . . 0.0 111.968 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.546 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 11.5 m-85 60.1 40.22 18.7 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.401 1.08 . . . . 0.0 111.523 176.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.0 p -111.98 171.28 7.59 Favored 'General case' 0 C--O 1.25 1.095 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.95 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.69 -135.77 13.25 Favored Glycine 0 N--CA 1.427 -1.913 0 C-N-CA 120.881 -0.675 . . . . 0.0 112.105 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -83.48 155.53 23.33 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 123.025 0.53 . . . . 0.0 109.605 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.4 tt -131.66 136.69 56.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 121.318 0.58 . . . . 0.0 110.066 -175.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 76.1 m -132.09 127.62 36.45 Favored 'General case' 0 C--N 1.288 -2.103 0 O-C-N 122.021 -0.424 . . . . 0.0 110.359 175.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -111.1 124.82 7.08 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.81 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -117.76 145.39 44.52 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 123.576 0.751 . . . . 0.0 110.618 177.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -117.3 169.26 13.09 Favored Glycine 0 N--CA 1.433 -1.523 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.92 -178.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.406 ' HB2' ' H ' ' A' ' 63' ' ' VAL . 7.4 p80 -61.13 122.13 14.24 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.449 0.642 . . . . 0.0 112.323 -177.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.56 -1.63 76.05 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.568 177.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.5 m -107.42 146.12 32.1 Favored 'General case' 0 N--CA 1.424 -1.73 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.7 m -137.68 154.51 49.67 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 50.7 mt -93.49 128.11 45.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 173.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -70.92 -47.54 58.54 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.108 0.48 . . . . 0.0 110.984 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.515 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 3.4 m-20 -132.72 88.87 2.56 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.927 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.424 ' CD2' ' HG2' ' A' ' 55' ' ' PRO . 50.7 t80 -65.47 -30.25 71.01 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.778 0.799 . . . . 0.0 109.666 176.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.2 t -66.91 -24.45 66.1 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.463 -178.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.515 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 30.0 mmtp -93.99 -6.78 44.57 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -178.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 26.6 m -79.73 -171.85 3.04 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.46 -64.89 3.97 Favored Glycine 0 CA--C 1.503 -0.702 0 N-CA-C 112.094 -0.403 . . . . 0.0 112.094 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -110.94 146.74 36.05 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.193 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.42 -6.54 13.49 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 175.867 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -112.55 119.18 4.86 Favored Glycine 0 N--CA 1.431 -1.648 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.457 -177.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 64.9 mt -103.06 115.41 44.99 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.763 0 CA-C-O 122.426 1.107 . . . . 0.0 109.476 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 37.8 m -85.73 -29.6 23.78 Favored 'General case' 0 N--CA 1.394 -3.248 0 CA-C-N 112.148 -2.297 . . . . 0.0 113.999 177.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.6 p -153.88 154.61 34.2 Favored 'General case' 0 C--O 1.237 0.42 0 O-C-N 121.862 -0.524 . . . . 0.0 109.965 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.8 mt -133.22 131.45 58.24 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -176.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.546 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 38.2 ttmt -117.51 128.33 54.87 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -95.67 129.58 42.83 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 68.4 m -122.56 171.72 8.91 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.357 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.1 pt -129.41 139.3 52.08 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 176.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -110.56 118.87 37.38 Favored 'General case' 0 C--N 1.274 -2.714 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 72.9 p -69.15 170.23 10.48 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.462 -176.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.2 ttpp -67.06 -19.54 65.69 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.635 0.731 . . . . 0.0 109.276 176.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -84.92 -8.17 58.87 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.744 -177.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.21 -10.62 65.54 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.78 -0.646 . . . . 0.0 114.133 175.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -78.32 138.38 38.54 Favored 'General case' 0 C--O 1.249 1.031 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.902 179.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.3 t -102.31 113.35 38.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -95.49 133.86 39.0 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.75 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 63.6 m . . . . . 0 C--N 1.287 -2.118 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -177.777 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.461 ' CZ ' ' HD3' ' A' ' 71' ' ' PRO . 14.5 m-85 . . . . . 0 CA--C 1.509 -0.603 0 CA-C-O 121.5 0.666 . . . . 0.0 110.694 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 18.5 m -123.12 145.32 48.68 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.582 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 49.7 tp -94.56 124.93 38.88 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 176.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.467 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 16.3 mt-30 -117.42 124.19 48.24 Favored 'General case' 0 N--CA 1.42 -1.929 0 CA-C-O 121.368 0.604 . . . . 0.0 109.469 -177.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 3.6 mp -109.68 125.65 52.85 Favored 'General case' 0 N--CA 1.421 -1.904 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.73 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.496 ' HA ' ' O ' ' A' ' 38' ' ' SER . 85.6 m-85 -95.24 152.31 18.48 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 123.393 0.433 . . . . 0.0 111.464 -176.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.89 -47.56 65.53 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.378 -177.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -108.17 178.4 4.51 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.781 -176.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.434 HG23 ' HA ' ' A' ' 96' ' ' ASP . 2.4 p -77.02 166.29 23.5 Favored 'General case' 0 N--CA 1.403 -2.799 0 O-C-N 123.28 0.362 . . . . 0.0 110.295 -176.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.262 20.9 p90 47.21 47.59 16.41 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 177.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 65.51 22.19 11.82 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.391 1.076 . . . . 0.0 112.19 176.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 33' ' ' THR . 55.1 mtp180 -91.29 160.17 15.65 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.509 0.671 . . . . 0.0 112.63 178.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.35 -148.0 20.42 Favored Glycine 0 N--CA 1.433 -1.542 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -176.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 17.2 m -111.77 -176.65 2.99 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 177.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.483 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 23.4 p90 -143.31 163.15 33.81 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.23 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 15.3 tt -114.35 152.18 16.04 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 177.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -106.84 125.54 51.14 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.51 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 87.5 t -120.1 133.18 67.68 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -115.68 -31.72 5.74 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.487 0.66 . . . . 0.0 109.518 -174.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.47 161.89 29.37 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.321 -176.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.4 p -69.01 146.38 52.75 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 123.623 0.769 . . . . 0.0 112.67 -176.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.0 p -121.82 135.65 61.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.9 -18.11 41.58 Favored Glycine 0 N--CA 1.431 -1.687 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.955 -178.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.5 p -158.92 116.66 2.84 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.405 0.621 . . . . 0.0 112.593 -178.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.9 mt -105.19 116.91 32.74 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.431 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.2 m -133.58 114.75 13.37 Favored Pre-proline 0 N--CA 1.42 -1.962 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 172.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -73.99 162.12 92.91 Favored 'Cis proline' 0 C--O 1.248 0.995 0 C-N-CA 123.315 -1.536 . . . . 0.0 110.946 -0.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.54 155.36 66.92 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.914 1.743 . . . . 0.0 109.931 177.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -89.61 133.43 34.62 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.575 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 22.6 p -116.85 77.22 8.41 Favored Pre-proline 0 C--N 1.298 -1.643 0 O-C-N 123.523 0.514 . . . . 0.0 111.759 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -80.29 158.2 22.93 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.66 2.24 . . . . 0.0 113.012 178.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -89.28 -29.57 16.69 Favored Glycine 0 N--CA 1.437 -1.247 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 177.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.0 p -155.25 154.46 32.2 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.0 t -129.16 143.22 41.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 38.6 t -145.58 149.88 35.37 Favored 'General case' 0 N--CA 1.428 -1.558 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.732 176.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.6 t -116.55 123.81 30.14 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 175.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -60.81 149.04 90.11 Favored 'Trans proline' 0 C--O 1.252 1.18 0 C-N-CA 122.798 2.332 . . . . 0.0 112.321 -177.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.531 ' CE2' ' HB3' ' A' ' 64' ' ' ASN . 79.5 t80 -76.14 110.12 10.36 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 121.825 0.821 . . . . 0.0 111.058 -177.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 66.3 t -94.54 116.31 35.52 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.778 177.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.531 ' HB3' ' CE2' ' A' ' 62' ' ' PHE . 3.7 p-10 -119.28 24.58 10.65 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 122.35 1.071 . . . . 0.0 108.62 178.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -67.93 146.58 53.47 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 113.363 -1.744 . . . . 0.0 111.93 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.2 m -58.71 -8.64 1.37 Allowed 'General case' 0 CA--C 1.57 1.749 0 C-N-CA 125.141 1.377 . . . . 0.0 112.768 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -62.62 138.57 58.52 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -69.21 -29.41 67.37 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.468 0.48 . . . . 0.0 111.509 -173.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -112.02 135.65 52.38 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-O 121.63 0.729 . . . . 0.0 111.612 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.86 148.35 36.36 Favored Pre-proline 0 C--N 1.285 -2.204 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.394 176.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.461 ' HD3' ' CZ ' ' A' ' 25' ' ' TYR . 71.2 Cg_endo -71.59 137.87 31.14 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 121.995 1.797 . . . . 0.0 112.928 -175.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -131.29 123.38 28.22 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.582 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 83.6 m95 -108.55 135.76 49.28 Favored 'General case' 0 C--N 1.281 -2.388 0 O-C-N 122.098 -0.376 . . . . 0.0 111.996 -172.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.455 ' HA ' ' O ' ' A' ' 86' ' ' THR . 41.6 m-85 -113.89 141.91 46.76 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.554 177.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.6 mt -125.35 142.59 51.41 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 -176.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 84.7 m-85 -131.49 139.72 49.38 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 121.197 0.522 . . . . 0.0 111.178 -175.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.13 -12.85 59.14 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.891 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -123.76 165.76 16.74 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 175.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.7 m -77.14 167.47 2.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 118.036 0.38 . . . . 0.0 110.822 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.51 30.96 20.16 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.667 0.787 . . . . 0.0 111.942 177.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 61.92 40.37 12.56 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.799 175.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.8 p -117.49 176.07 5.34 Favored 'General case' 0 C--O 1.25 1.086 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.629 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.57 -134.03 12.26 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 178.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.444 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 52.2 mtm180 -84.38 147.78 26.96 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 122.45 0.3 . . . . 0.0 110.431 176.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.9 tt -124.77 139.24 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 O-C-N 123.654 0.596 . . . . 0.0 110.108 -176.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 67.6 m -131.84 126.44 34.29 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 175.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -111.55 122.12 5.97 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.776 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -112.69 145.07 41.13 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 120.835 0.35 . . . . 0.0 111.041 178.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -117.06 168.32 12.8 Favored Glycine 0 N--CA 1.424 -2.121 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.705 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -59.72 123.87 18.32 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.335 0.588 . . . . 0.0 111.83 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.08 2.78 77.17 Favored Glycine 0 N--CA 1.43 -1.758 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.387 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.1 m -113.19 145.66 40.61 Favored 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 4.6 m -134.8 158.84 43.14 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 46.3 mt -93.65 131.94 39.21 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 173.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -70.21 -47.67 60.44 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.276 0.56 . . . . 0.0 109.903 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.455 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 3.2 m-20 -138.25 100.95 4.26 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -64.77 -36.5 84.53 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.404 0.621 . . . . 0.0 110.422 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.3 t -64.45 -23.76 67.39 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.965 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.455 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 28.2 mmtp -91.99 -7.64 48.35 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 122.147 -0.346 . . . . 0.0 110.413 -178.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.2 m -78.12 -13.93 59.67 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.687 0.756 . . . . 0.0 109.872 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 132.14 -85.16 0.29 Allowed Glycine 0 N--CA 1.42 -2.385 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -86.89 141.9 28.42 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 120.542 -0.463 . . . . 0.0 109.924 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.575 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.52 -8.39 13.35 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.853 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -108.15 109.15 2.84 Favored Glycine 0 N--CA 1.432 -1.614 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.989 -176.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 66.5 mt -91.64 116.06 32.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 122.336 1.065 . . . . 0.0 109.053 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.9 m -85.85 -28.63 24.3 Favored 'General case' 0 N--CA 1.401 -2.923 0 CA-C-N 112.445 -2.161 . . . . 0.0 114.816 177.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.4 p -156.13 157.36 35.86 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.7 mt -137.48 131.47 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -175.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -117.66 133.64 55.74 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -101.27 121.88 42.67 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 120.615 -0.434 . . . . 0.0 109.932 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 65.9 m -119.85 172.14 7.92 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 8.4 pt -127.61 143.22 41.4 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -115.12 120.49 39.97 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 177.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 82.8 p -79.6 176.49 9.66 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.424 -173.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -65.16 -26.85 68.35 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.119 172.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -76.91 -8.71 57.86 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 122.051 0.929 . . . . 0.0 110.211 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.07 -11.54 70.48 Favored Glycine 0 CA--C 1.498 -1.016 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.772 175.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -73.31 141.03 47.14 Favored 'General case' 0 C--O 1.257 1.448 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.889 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 22.6 t -102.13 118.71 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.814 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 177.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -104.3 140.4 37.92 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 69.9 m . . . . . 0 C--N 1.297 -1.704 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.384 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 . . . . . 0 N--CA 1.482 1.175 0 CA-C-O 121.437 0.637 . . . . 0.0 111.543 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.0 m -123.68 145.92 48.62 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.199 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.562 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 57.8 tp -100.03 114.13 27.22 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 175.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 41.2 mt-30 -108.26 124.49 50.38 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.704 -0.798 . . . . 0.0 108.848 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.4 mp -109.41 127.38 54.34 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.032 177.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -94.06 150.37 20.4 Favored 'General case' 0 C--N 1.29 -1.989 0 O-C-N 123.509 0.506 . . . . 0.0 110.148 -176.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -69.88 -43.27 72.17 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 124.055 0.847 . . . . 0.0 109.651 -175.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -114.08 178.88 4.12 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.033 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.424 HG23 ' HA ' ' A' ' 96' ' ' ASP . 2.6 p -74.91 169.72 17.39 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.119 -176.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.444 ' CE2' ' HG3' ' A' ' 36' ' ' ARG 0.258 13.8 p90 47.17 40.16 9.55 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.959 1.304 . . . . 0.0 114.01 177.771 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 62.2 40.43 11.65 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.147 0.979 . . . . 0.0 111.947 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.533 ' NE ' ' HA ' ' A' ' 36' ' ' ARG . 4.3 mmp_? -108.61 162.23 14.34 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.223 0.535 . . . . 0.0 112.162 178.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.26 -163.05 42.72 Favored Glycine 0 N--CA 1.426 -1.967 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -177.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.0 p -89.34 173.84 8.15 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 176.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -140.77 166.01 25.94 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -177.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.8 tt -116.9 152.08 18.69 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 177.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -106.75 125.57 51.18 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 175.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.458 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 97.8 t -122.41 133.04 69.86 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -119.32 -24.49 6.37 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.709 -177.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -115.46 163.14 16.17 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.98 -172.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.9 m -83.1 142.43 31.27 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 176.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.9 p -120.97 129.67 75.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.68 -12.13 59.76 Favored Glycine 0 N--CA 1.432 -1.567 0 C-N-CA 119.672 -1.252 . . . . 0.0 113.795 -178.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 24.4 p -157.7 122.27 4.31 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.279 0.562 . . . . 0.0 112.409 -178.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 72.8 mt -117.82 117.87 30.47 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 175.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.3 p -132.46 109.45 13.52 Favored Pre-proline 0 C--N 1.29 -1.991 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.959 176.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.34 162.06 93.38 Favored 'Cis proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.704 -1.373 . . . . 0.0 111.408 -1.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.76 156.77 59.8 Favored 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 121.975 1.784 . . . . 0.0 111.152 178.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 48.0 m0 -89.27 131.89 35.16 Favored 'General case' 0 CA--C 1.482 -1.668 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.607 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 38.8 p -114.46 78.53 4.86 Favored Pre-proline 0 N--CA 1.43 -1.425 0 O-C-N 123.56 0.537 . . . . 0.0 110.712 178.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -78.21 157.63 29.92 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 122.523 2.149 . . . . 0.0 112.566 179.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -89.59 -30.85 12.39 Favored Glycine 0 N--CA 1.431 -1.651 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 177.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.2 p -153.25 158.25 41.39 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.9 t -136.87 142.67 37.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -177.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 49.4 t -145.95 147.82 32.12 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.691 176.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.1 t -118.73 124.27 28.52 Favored Pre-proline 0 N--CA 1.441 -0.923 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 175.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -63.03 148.66 93.19 Favored 'Trans proline' 0 C--O 1.247 0.971 0 C-N-CA 122.399 2.066 . . . . 0.0 112.062 -178.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -70.96 119.88 15.73 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-O 121.85 0.833 . . . . 0.0 110.249 -178.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 93.1 t -95.83 123.35 47.99 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.349 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -116.09 14.96 16.09 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 122.143 0.973 . . . . 0.0 108.617 -178.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -64.13 145.54 55.77 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 113.519 -1.673 . . . . 0.0 113.717 -175.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.7 m -64.19 -12.42 40.32 Favored 'General case' 0 C--O 1.255 1.372 0 C-N-CA 125.285 1.434 . . . . 0.0 110.981 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.67 141.33 55.29 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -78.02 -29.86 49.68 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.629 0.728 . . . . 0.0 109.803 -177.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.37 129.85 54.87 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.686 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.76 154.14 39.52 Favored Pre-proline 0 C--N 1.286 -2.159 0 CA-C-N 114.616 -1.174 . . . . 0.0 109.237 -178.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -74.08 134.41 19.46 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 121.578 1.519 . . . . 0.0 111.066 -178.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -129.42 128.51 43.12 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 106.309 -1.738 . . . . 0.0 106.309 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.562 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 87.1 m95 -110.38 130.43 55.55 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-O 121.175 0.512 . . . . 0.0 111.565 -173.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.479 ' HA ' ' O ' ' A' ' 86' ' ' THR . 25.3 m-85 -111.19 142.26 43.62 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.359 176.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.3 mt -125.36 142.14 51.67 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 -176.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.42 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 87.2 m-85 -131.42 139.31 49.38 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.112 0.482 . . . . 0.0 110.814 -175.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.679 ' HB2' ' CD1' ' A' ' 102' ' ' PHE . 5.7 t70 -77.68 -18.06 57.03 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.295 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.443 ' C ' ' HB3' ' A' ' 106' ' ' SER . 9.0 t-20 -126.03 162.38 25.42 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 176.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.3 m -67.78 168.12 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.58 0 C-N-CA 123.076 0.551 . . . . 0.0 111.434 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 55.26 30.22 14.28 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.827 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.502 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 13.3 m-85 60.03 45.9 11.49 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.799 1.239 . . . . 0.0 111.749 175.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.8 p -118.94 176.35 5.33 Favored 'General case' 0 C--O 1.249 1.041 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.462 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.87 -133.77 12.16 Favored Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 121.218 -0.515 . . . . 0.0 111.973 177.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 63.9 mtt85 -81.67 148.07 29.2 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.9 tt -129.16 137.2 57.71 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 O-C-N 123.62 0.575 . . . . 0.0 110.424 -175.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 95.7 m -130.97 122.71 27.35 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -111.19 109.68 2.6 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.713 -0.756 . . . . 0.0 114.629 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -103.07 145.07 30.45 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 122.816 0.446 . . . . 0.0 110.95 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.13 175.9 16.1 Favored Glycine 0 N--CA 1.425 -2.063 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.473 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -66.08 122.13 16.72 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.532 0.682 . . . . 0.0 112.194 -176.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.72 0.95 71.51 Favored Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.623 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.0 m -106.59 146.31 30.84 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 5.6 m -136.07 151.37 49.77 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.8 mt -93.51 127.22 45.71 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 174.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -70.51 -47.27 61.26 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.387 0.613 . . . . 0.0 110.48 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.479 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 2.1 m-20 -135.33 93.63 3.01 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.071 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -65.14 -33.69 76.61 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.202 0.525 . . . . 0.0 110.391 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.8 t -65.26 -23.91 67.17 Favored 'General case' 0 CA--C 1.559 1.318 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.136 -176.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.479 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 30.2 mmtp -92.75 -6.4 49.15 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.941 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.2 m -84.9 38.69 0.72 Allowed 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.344 0.592 . . . . 0.0 111.535 -175.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.88 -73.98 2.25 Favored Glycine 0 N--CA 1.426 -2.028 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.679 ' CD1' ' HB2' ' A' ' 77' ' ' ASP . 16.1 p90 -109.81 148.28 31.77 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -179.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.607 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -113.54 -8.03 13.36 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 120.114 -0.635 . . . . 0.0 109.647 179.196 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -113.31 112.65 2.96 Favored Glycine 0 N--CA 1.432 -1.604 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.351 -174.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 76.1 mt -94.26 115.41 33.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.443 ' HB3' ' C ' ' A' ' 78' ' ' ASN . 3.7 t -86.06 -26.42 25.35 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.947 178.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.5 p -152.08 157.22 41.31 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 122.089 -0.382 . . . . 0.0 110.935 177.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.3 mt -135.9 133.2 50.95 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -175.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.502 ' HE2' ' CD2' ' A' ' 81' ' ' TYR . 33.5 ttmt -122.02 128.34 51.32 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -96.3 121.39 38.04 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 60.6 m -119.16 172.09 7.82 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.9 pt -126.17 139.51 51.36 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 CA-C-O 121.127 0.489 . . . . 0.0 110.147 177.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -112.2 119.06 37.08 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 76.6 p -72.35 -178.55 2.57 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 114.636 -1.166 . . . . 0.0 112.059 -174.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -65.72 -31.05 71.83 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.785 0.803 . . . . 0.0 109.173 175.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -79.46 -8.95 59.48 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.652 -178.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.58 -9.32 77.98 Favored Glycine 0 N--CA 1.427 -1.928 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.787 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -70.01 139.32 52.72 Favored 'General case' 0 C--O 1.255 1.36 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.2 t -102.82 112.91 37.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 121.174 0.512 . . . . 0.0 109.761 -176.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -97.17 135.17 39.5 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.483 -1.634 0 C-N-CA 118.505 -1.278 . . . . 0.0 111.221 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.392 0 N-CA-C 111.746 -0.542 . . . . 0.0 111.746 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.77 41.16 1.13 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 122.086 0.946 . . . . 0.0 109.199 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -77.86 -19.49 54.75 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.452 -1.249 . . . . 0.0 113.37 -174.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.7 m -118.6 146.66 44.45 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 122.104 -0.372 . . . . 0.0 111.598 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 30.0 p -123.0 155.71 36.27 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 174.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -100.43 125.55 46.72 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -175.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 64.76 71.51 0.46 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.019 0.927 . . . . 0.0 112.217 -177.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.7 m -144.76 167.76 21.82 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.617 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 59.6 tp -111.96 124.63 52.8 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 169.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.453 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 70.5 mt-30 -113.72 124.37 52.13 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.555 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 3.2 mp -109.84 129.08 55.68 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.015 176.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.432 ' HB3' ' O ' ' A' ' 36' ' ' ARG . 94.9 m-85 -99.59 148.88 23.84 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 123.832 0.708 . . . . 0.0 110.852 -174.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -70.37 -38.1 74.69 Favored 'General case' 0 C--N 1.307 -1.249 0 O-C-N 123.663 0.602 . . . . 0.0 111.275 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -107.98 177.66 4.74 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -177.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.6 p -84.28 175.53 9.34 Favored 'General case' 0 N--CA 1.407 -2.612 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.274 15.5 p90 47.29 42.3 13.47 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 177.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 66.82 23.06 10.12 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.757 -1.111 . . . . 0.0 112.887 175.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.432 ' O ' ' HB3' ' A' ' 30' ' ' TYR . 18.1 mtm180 -102.24 173.38 6.39 Favored 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 119.653 -0.819 . . . . 0.0 112.106 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.69 179.8 51.32 Favored Glycine 0 N--CA 1.419 -2.45 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.52 -178.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.2 m -78.4 167.78 20.8 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 174.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 11.0 p90 -140.54 163.53 32.59 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -176.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.3 tt -114.59 152.98 16.16 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -107.23 125.54 51.26 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 176.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.516 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 84.3 t -117.91 133.38 64.89 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.369 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 176.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -114.81 -31.84 6.0 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 123.337 0.398 . . . . 0.0 110.159 -176.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.99 160.59 33.17 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -177.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.9 m -69.43 139.62 54.05 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 123.645 0.778 . . . . 0.0 112.186 -173.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.1 p -113.71 131.19 66.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 176.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.33 -15.41 51.06 Favored Glycine 0 N--CA 1.433 -1.549 0 C-N-CA 119.546 -1.312 . . . . 0.0 113.154 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.7 p -154.88 124.13 6.35 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.309 0.576 . . . . 0.0 112.474 -178.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 82.8 mt -118.77 117.99 30.37 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.615 175.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.0 p -132.84 110.13 13.16 Favored Pre-proline 0 N--CA 1.428 -1.548 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.636 174.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.5 162.11 92.48 Favored 'Cis proline' 0 C--O 1.252 1.204 0 C-N-CA 123.729 -1.363 . . . . 0.0 111.236 -2.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.76 158.47 37.47 Favored 'Trans proline' 0 C--O 1.244 0.785 0 C-N-CA 122.783 2.322 . . . . 0.0 110.751 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.458 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 47.8 m0 -89.22 138.25 31.59 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 11.0 p -116.74 76.94 8.01 Favored Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 123.576 0.547 . . . . 0.0 111.874 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.456 ' HD2' ' O ' ' A' ' 103' ' ' LYS . 92.8 Cg_endo -76.4 158.57 36.66 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.584 2.189 . . . . 0.0 112.849 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.69 -36.92 8.97 Favored Glycine 0 N--CA 1.435 -1.37 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 175.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.2 p -151.1 159.8 44.27 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.5 t -134.77 143.11 38.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 38.4 t -145.48 148.74 33.58 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.784 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 67.3 t -113.0 121.01 39.31 Favored Pre-proline 0 C--N 1.309 -1.153 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 176.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -57.79 138.4 85.88 Favored 'Trans proline' 0 C--O 1.244 0.799 0 C-N-CA 122.877 2.385 . . . . 0.0 111.498 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.456 ' CE2' ' HB3' ' A' ' 64' ' ' ASN . 40.5 t80 -67.67 136.64 54.67 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-O 121.699 0.761 . . . . 0.0 111.071 -177.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 70.2 t -131.61 114.87 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.456 ' HB3' ' CE2' ' A' ' 62' ' ' PHE . 9.4 p30 -111.95 5.01 18.57 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 175.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.19 145.13 32.52 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 112.615 -2.084 . . . . 0.0 112.931 -172.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.48 -5.64 0.06 Allowed 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 128.991 2.916 . . . . 0.0 115.162 -173.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -59.62 171.55 0.84 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.295 1.038 . . . . 0.0 109.614 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 28.3 mtm180 -90.7 -28.09 18.56 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 118.093 -1.443 . . . . 0.0 107.955 173.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.5 mp0 -103.61 132.26 50.02 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.582 -174.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -106.38 153.78 40.24 Favored Pre-proline 0 C--N 1.289 -2.033 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 169.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.61 135.71 10.52 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 121.648 1.566 . . . . 0.0 113.012 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -133.88 118.58 18.11 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 177.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.617 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 82.9 m95 -107.55 136.77 46.76 Favored 'General case' 0 C--N 1.278 -2.525 0 O-C-N 122.052 -0.405 . . . . 0.0 111.977 -172.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.508 ' HD2' ' SG ' ' A' ' 111' ' ' CYS . 29.3 m-85 -113.52 141.21 47.42 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.765 177.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.5 mt -126.01 142.33 51.57 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 -176.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.404 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 88.0 m-85 -131.75 139.63 49.01 Favored 'General case' 0 C--N 1.31 -1.119 0 O-C-N 123.499 0.5 . . . . 0.0 110.993 -176.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.668 ' HB2' ' CD2' ' A' ' 102' ' ' PHE . 11.8 t70 -85.44 0.9 50.88 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 123.673 0.789 . . . . 0.0 111.224 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -136.58 158.49 44.32 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 172.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.1 m -72.0 169.26 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 C-N-CA 122.316 0.246 . . . . 0.0 110.405 -178.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.48 29.87 19.34 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.168 0.587 . . . . 0.0 110.575 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.413 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 18.9 m-85 56.37 46.82 20.23 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.973 0.909 . . . . 0.0 110.95 177.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 72.9 p -123.32 176.63 6.02 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.475 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.6 -140.8 18.38 Favored Glycine 0 N--CA 1.429 -1.821 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.79 177.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 61.8 mtt180 -73.61 143.46 46.34 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.1 tt -125.33 137.63 57.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 O-C-N 123.572 0.545 . . . . 0.0 110.269 -174.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 52.0 m -131.79 125.11 31.09 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 121.984 -0.448 . . . . 0.0 110.658 175.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -112.22 124.82 6.89 Favored Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.829 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -119.13 146.0 45.5 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 123.251 0.62 . . . . 0.0 110.251 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.29 166.95 12.39 Favored Glycine 0 N--CA 1.431 -1.664 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.362 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -53.3 124.79 15.6 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 124.337 1.055 . . . . 0.0 112.357 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.34 -6.47 82.39 Favored Glycine 0 N--CA 1.435 -1.424 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.612 175.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.9 m -106.44 146.42 30.55 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -178.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.9 m -139.8 152.3 46.44 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 50.8 mt -93.48 133.76 33.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 176.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -71.1 -47.9 55.43 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.205 0.526 . . . . 0.0 110.36 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.435 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 1.9 m-20 -135.0 100.15 4.49 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.25 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -64.4 -38.93 92.75 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.359 0.6 . . . . 0.0 110.375 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.4 t -65.62 -29.76 70.38 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.641 -1.163 . . . . 0.0 112.192 -175.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.435 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 27.5 mmtp -86.31 -14.88 42.34 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 121.988 -0.445 . . . . 0.0 109.963 -176.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.1 m -77.88 -8.08 57.59 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 144.0 -77.26 0.28 Allowed Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.668 ' CD2' ' HB2' ' A' ' 77' ' ' ASP . 37.8 p90 -110.05 147.89 32.73 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.03 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.94 -9.9 12.98 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -109.67 115.71 4.29 Favored Glycine 0 N--CA 1.428 -1.874 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.596 -175.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 64.0 mt -101.17 116.07 44.05 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.7 m -85.28 -26.4 26.65 Favored 'General case' 0 N--CA 1.391 -3.414 0 CA-C-N 112.432 -2.167 . . . . 0.0 114.067 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 77.8 p -156.75 156.35 33.18 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.3 mt -134.24 133.94 55.32 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.768 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -176.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.413 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 31.9 ttmt -122.52 131.42 53.84 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -96.08 122.23 38.7 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.379 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . 0.508 ' SG ' ' HD2' ' A' ' 74' ' ' TYR . 56.3 m -118.86 167.74 11.43 Favored 'General case' 0 N--CA 1.405 -2.7 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 9.2 pt -127.74 145.82 34.43 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 61.5 tt0 -122.6 118.93 29.35 Favored 'General case' 0 C--N 1.274 -2.712 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 27.1 p -79.78 179.16 7.69 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -175.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -66.25 -19.53 65.85 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.727 0.775 . . . . 0.0 110.203 177.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -83.34 -1.67 53.87 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.84 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.55 -5.63 82.89 Favored Glycine 0 CA--C 1.506 -0.483 0 CA-C-N 116.208 -0.451 . . . . 0.0 113.618 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 113' ' ' GLN . 19.0 ptpt -75.96 134.91 40.07 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 39.4 t -104.71 110.57 31.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -100.3 154.49 18.44 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 1.1 t -143.55 154.89 44.07 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 118.642 -1.223 . . . . 0.0 110.376 -177.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 7.8 tp -111.05 118.98 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.692 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.021 176.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -85.83 104.52 15.58 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 . . . . . 0 C--N 1.287 -2.118 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -178.685 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.683 0 N-CA-C 111.114 -0.795 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.43 9.27 4.07 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.967 0.889 . . . . 0.0 111.423 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -77.38 -10.15 59.28 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.264 174.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.2 p -118.84 146.43 44.87 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 173.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 26.2 p -102.58 151.83 21.87 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.4 tptt -87.57 143.19 27.32 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 67.59 39.51 2.78 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 123.862 0.726 . . . . 0.0 111.349 177.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.8 m -124.33 155.09 39.32 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.267 -0.878 . . . . 0.0 108.925 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.597 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 55.2 tp -110.18 117.58 34.06 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 172.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.51 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 77.7 mt-30 -110.22 124.2 51.15 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.579 -0.849 . . . . 0.0 109.618 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 3.2 mp -110.06 125.6 53.12 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.945 178.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -92.91 152.89 19.11 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 123.574 0.546 . . . . 0.0 110.1 -177.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -77.83 -37.9 47.51 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.868 -176.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -108.56 178.31 4.52 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.439 HG21 ' HA ' ' A' ' 96' ' ' ASP . 1.4 p -78.17 169.04 18.92 Favored 'General case' 0 N--CA 1.413 -2.292 0 C-N-CA 122.404 0.282 . . . . 0.0 110.4 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 25.3 p90 46.87 42.51 12.2 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.914 1.286 . . . . 0.0 114.232 176.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 67.65 23.46 8.73 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.414 1.086 . . . . 0.0 112.995 177.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.517 ' NE ' ' HA ' ' A' ' 36' ' ' ARG . 4.4 mmp_? -98.22 165.2 11.99 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.41 -157.8 33.47 Favored Glycine 0 N--CA 1.434 -1.436 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.5 p -85.99 176.64 7.93 Favored 'General case' 0 N--CA 1.421 -1.892 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 174.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 11.7 p90 -149.36 165.79 30.98 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.51 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 13.4 tt -123.03 150.81 27.07 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.747 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -106.88 125.21 50.71 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 174.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.439 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 94.8 t -118.13 133.69 64.13 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -117.86 -26.4 6.5 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.282 0.563 . . . . 0.0 110.569 -176.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -115.73 163.14 16.27 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.334 -174.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.2 p -84.06 143.53 29.67 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 175.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.5 p -120.75 132.38 70.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.56 -16.96 54.12 Favored Glycine 0 N--CA 1.433 -1.536 0 C-N-CA 119.77 -1.205 . . . . 0.0 113.457 -177.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.4 p -157.4 124.29 5.06 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 81.8 mt -117.73 118.65 32.64 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.9 m -133.09 116.85 14.56 Favored Pre-proline 0 N--CA 1.42 -1.942 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.154 175.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -75.62 160.08 96.49 Favored 'Cis proline' 0 C--O 1.251 1.14 0 C-N-CA 122.779 -1.759 . . . . 0.0 110.438 -4.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.0 157.33 29.61 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 122.69 2.26 . . . . 0.0 111.483 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 48.4 m0 -89.66 132.34 35.19 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -178.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.602 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 41.6 p -113.28 78.67 3.45 Favored Pre-proline 0 C--N 1.304 -1.375 0 O-C-N 123.252 0.345 . . . . 0.0 111.144 177.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.468 ' HG2' ' CD2' ' A' ' 97' ' ' PHE . 73.7 Cg_endo -76.37 153.44 35.43 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 122.198 1.932 . . . . 0.0 112.691 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -87.44 -28.53 24.46 Favored Glycine 0 N--CA 1.431 -1.638 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 178.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.7 p -155.08 154.96 33.21 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.6 t -134.01 142.25 41.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -178.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 31.6 t -146.11 149.64 34.42 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 119.637 -0.825 . . . . 0.0 111.52 176.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.7 t -118.03 124.11 28.99 Favored Pre-proline 0 N--CA 1.437 -1.117 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 175.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.89 143.52 79.87 Favored 'Trans proline' 0 C--O 1.246 0.877 0 C-N-CA 122.604 2.203 . . . . 0.0 112.281 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -66.89 136.37 55.29 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.172 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 84.5 t -120.61 129.76 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.9 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -121.48 27.59 8.19 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 124.125 0.97 . . . . 0.0 108.818 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -59.73 144.99 46.67 Favored 'General case' 0 C--O 1.248 1.014 0 C-N-CA 125.887 1.675 . . . . 0.0 111.054 -177.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.3 m -63.74 -14.88 56.33 Favored 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 124.325 1.05 . . . . 0.0 111.315 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -63.68 166.68 6.66 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.977 0.418 . . . . 0.0 110.763 175.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 57.3 mtm180 -90.97 -28.53 17.97 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.293 1.044 . . . . 0.0 109.152 -173.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -109.76 131.16 55.32 Favored 'General case' 0 N--CA 1.409 -2.501 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.661 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -106.18 153.96 39.97 Favored Pre-proline 0 C--N 1.301 -1.522 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.485 177.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -71.94 141.94 37.82 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.26 1.974 . . . . 0.0 113.464 -176.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -133.84 144.35 48.89 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.597 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 88.0 m95 -123.76 137.26 54.72 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.5 -0.75 . . . . 0.0 111.968 -175.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.427 ' HA ' ' O ' ' A' ' 86' ' ' THR . 29.6 m-85 -117.81 141.52 48.32 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.38 177.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.8 mt -125.73 143.07 51.2 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 74.8 m-85 -134.08 143.18 47.86 Favored 'General case' 0 C--O 1.242 0.688 0 O-C-N 123.518 0.512 . . . . 0.0 110.24 -176.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.494 ' HB3' ' CG ' ' A' ' 102' ' ' PHE . 4.3 p-10 -89.17 -0.63 57.6 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -131.21 157.4 43.31 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 174.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.415 HG21 HD21 ' A' ' 80' ' ' ASN . 35.3 m -67.98 169.19 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 120.732 0.301 . . . . 0.0 110.947 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.415 HD21 HG21 ' A' ' 79' ' ' VAL . 64.6 m-80 58.67 30.31 19.73 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 123.825 0.85 . . . . 0.0 111.335 178.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.459 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 13.4 m-85 57.51 38.7 28.13 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 124.659 1.184 . . . . 0.0 111.439 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 72.6 p -111.93 171.27 7.6 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.592 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.32 -138.65 14.78 Favored Glycine 0 N--CA 1.429 -1.833 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 59.1 mtt180 -79.21 153.34 30.06 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.5 tt -128.35 138.71 53.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -177.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 75.2 m -131.52 127.47 37.33 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 175.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -112.38 125.7 7.25 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.149 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -118.2 145.99 44.56 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 123.061 0.544 . . . . 0.0 110.749 178.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -117.45 168.74 12.98 Favored Glycine 0 N--CA 1.428 -1.899 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.95 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 23.5 p80 -62.71 122.17 15.22 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 123.6 0.76 . . . . 0.0 111.895 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.38 17.8 58.21 Favored Glycine 0 N--CA 1.431 -1.669 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.656 177.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.2 m -129.67 146.71 51.43 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.5 m -139.53 152.93 47.32 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 52.1 mt -93.63 122.15 44.87 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.448 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 171.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -70.57 -46.81 62.78 Favored 'General case' 0 C--N 1.289 -2.063 0 O-C-N 123.67 0.606 . . . . 0.0 110.809 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.524 ' HB3' ' CG ' ' A' ' 99' ' ' LYS . 5.4 m-20 -127.06 86.95 2.57 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.159 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.468 ' CD2' ' HG2' ' A' ' 55' ' ' PRO . 69.5 t80 -65.59 -36.17 82.95 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.359 0.599 . . . . 0.0 110.592 177.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.0 t -75.67 -15.85 60.26 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.976 -173.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.524 ' CG ' ' HB3' ' A' ' 96' ' ' ASP . 30.7 mmtp -94.35 -8.91 37.48 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.1 m -82.29 -168.16 1.86 Allowed 'General case' 0 C--O 1.248 0.982 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.961 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.47 -69.42 1.25 Allowed Glycine 0 C--O 1.242 0.64 0 O-C-N 123.109 0.256 . . . . 0.0 113.112 -177.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.494 ' CG ' ' HB3' ' A' ' 77' ' ' ASP . 42.3 p90 -110.39 146.17 36.28 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.343 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.602 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.66 -11.65 12.94 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 176.41 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.34 104.27 2.2 Favored Glycine 0 N--CA 1.44 -1.068 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.462 -176.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 70.4 mt -88.95 115.37 28.67 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.586 0 CA-C-O 122.533 1.159 . . . . 0.0 109.115 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 52.7 m -85.83 -27.44 25.1 Favored 'General case' 0 N--CA 1.395 -3.222 0 CA-C-N 112.108 -2.315 . . . . 0.0 113.934 177.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 81.0 p -157.4 155.58 30.76 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.1 mt -135.09 131.2 52.41 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -175.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.459 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 38.2 ttmt -117.45 133.51 55.89 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -100.43 130.02 46.46 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 61.3 m -130.06 172.88 11.27 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.571 -178.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.5 pt -131.77 143.55 39.98 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -113.79 121.1 43.03 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-O 121.382 0.61 . . . . 0.0 109.801 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.494 ' OG1' ' HG2' ' A' ' 118' ' ' LYS . 70.6 p -76.91 -179.97 5.8 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 114.316 -1.311 . . . . 0.0 112.155 -174.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -66.4 -30.97 71.45 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.81 172.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -76.76 -8.89 58.15 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.982 0.896 . . . . 0.0 110.199 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.89 -4.48 83.33 Favored Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.253 176.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.494 ' HG2' ' OG1' ' A' ' 114' ' ' THR . 10.7 ptmm? -76.13 135.13 39.83 Favored 'General case' 0 C--O 1.258 1.511 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.0 t -100.39 111.09 29.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 -177.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -96.69 149.44 21.81 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 -177.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 84.0 m -129.88 169.53 15.07 Favored 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.755 -175.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 5.1 tp -73.37 136.67 24.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -69.6 109.03 4.09 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 122.39 1.091 . . . . 0.0 109.561 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.49 HE21 ' HA ' ' A' ' 124' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.283 -2.287 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.004 -178.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.111 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.36 -9.21 58.36 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 122.07 0.938 . . . . 0.0 110.257 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -83.02 -16.89 45.32 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.73 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.0 m -83.02 138.59 33.69 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.2 p -116.38 157.62 24.78 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.07 135.59 43.01 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.4 ' CE1' HG13 ' A' ' 63' ' ' VAL . 9.7 m-85 68.15 39.14 2.46 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.081 0.552 . . . . 0.0 112.207 177.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 34.7 m -124.41 145.73 49.31 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.605 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 57.3 tp -99.87 116.18 31.33 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 172.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.439 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 38.0 mt-30 -110.62 124.28 51.58 Favored 'General case' 0 CA--C 1.485 -1.529 0 C-N-CA 119.329 -0.948 . . . . 0.0 109.288 -177.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.3 mp -109.71 131.21 55.27 Favored 'General case' 0 N--CA 1.409 -2.521 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.238 176.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.527 ' CE2' ' HG3' ' A' ' 35' ' ' GLU . 97.8 m-85 -98.14 154.86 17.45 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 123.354 0.409 . . . . 0.0 110.568 -176.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -77.79 -43.61 30.09 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.481 0.657 . . . . 0.0 109.501 -176.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -108.43 178.45 4.49 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.302 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.595 ' HA ' ' OG ' ' A' ' 57' ' ' SER . 0.5 OUTLIER -83.43 179.94 7.53 Favored 'General case' 0 N--CA 1.401 -2.915 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.582 -177.546 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 48.47 40.42 14.97 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.867 0.867 . . . . 0.0 113.258 176.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.527 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 1.0 OUTLIER 57.9 23.7 10.08 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 115.232 1.568 . . . . 0.0 115.232 178.912 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -105.51 173.27 6.38 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 118.012 -1.475 . . . . 0.0 111.016 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.23 -177.39 45.84 Favored Glycine 0 N--CA 1.428 -1.873 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 -178.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 44.4 m -84.41 143.67 29.28 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.393 176.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -116.13 165.92 12.6 Favored 'General case' 0 C--N 1.272 -2.781 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -174.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.0 tt -114.9 152.08 16.56 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.543 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -106.8 125.55 51.14 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 175.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 94.4 t -122.84 133.46 68.88 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -122.61 -14.2 7.81 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp -110.1 162.24 14.76 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.646 -171.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.3 p -97.98 133.19 42.8 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 171.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.8 p -116.74 137.48 50.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -174.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.35 -18.49 35.95 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 119.755 -1.212 . . . . 0.0 113.321 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.5 p -155.81 121.34 4.91 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 86.0 mt -113.06 118.45 34.82 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.043 -0.981 . . . . 0.0 108.741 176.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.0 m -133.15 112.72 13.3 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 174.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.03 161.84 93.53 Favored 'Cis proline' 0 C--O 1.248 0.997 0 C-N-CA 123.313 -1.536 . . . . 0.0 111.255 -0.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -63.12 158.24 45.0 Favored 'Trans proline' 0 C--O 1.246 0.882 0 C-N-CA 122.387 2.058 . . . . 0.0 110.509 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -89.24 133.58 34.39 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 8.0 p -115.64 77.68 6.33 Favored Pre-proline 0 C--N 1.295 -1.799 0 O-C-N 123.628 0.58 . . . . 0.0 111.031 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.415 ' HG2' ' CD1' ' A' ' 97' ' ' PHE . 95.7 Cg_endo -77.65 158.09 32.0 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.286 1.991 . . . . 0.0 112.961 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.89 -39.45 11.77 Favored Glycine 0 N--CA 1.433 -1.55 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 176.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.595 ' OG ' ' HA ' ' A' ' 33' ' ' THR . 55.7 m -149.58 161.21 42.6 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.477 1.111 . . . . 0.0 108.26 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.9 t -135.35 142.33 40.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 48.8 t -146.1 147.99 32.16 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.435 176.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.7 t -116.29 122.34 32.23 Favored Pre-proline 0 N--CA 1.438 -1.066 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.68 147.41 89.9 Favored 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 122.57 2.18 . . . . 0.0 111.108 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -70.1 134.61 48.37 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.4 HG13 ' CE1' ' A' ' 25' ' ' TYR . 57.9 t -121.08 123.51 70.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -120.72 26.27 9.21 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -58.4 144.85 40.46 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.319 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.5 m -60.22 -20.57 59.37 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 123.3 0.64 . . . . 0.0 111.616 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -58.79 139.5 56.25 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -68.63 -24.14 64.52 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.77 -175.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.41 130.52 55.67 Favored 'General case' 0 N--CA 1.418 -2.032 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.95 154.97 40.68 Favored Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.951 175.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.47 134.91 14.32 Favored 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 121.779 1.653 . . . . 0.0 110.662 177.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -129.26 143.7 50.95 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.605 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 88.9 m95 -125.47 132.76 52.62 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 120.204 -0.598 . . . . 0.0 112.131 -173.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.438 ' HD2' ' SG ' ' A' ' 111' ' ' CYS . 27.2 m-85 -114.98 141.61 47.75 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.893 176.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.8 mt -125.72 142.72 51.37 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -175.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.415 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 77.5 m-85 -133.82 143.03 48.11 Favored 'General case' 0 C--N 1.317 -0.813 0 O-C-N 123.634 0.584 . . . . 0.0 109.923 -177.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.554 ' HB3' ' CG ' ' A' ' 102' ' ' PHE . 2.8 p-10 -88.39 0.87 55.75 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.652 -178.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -134.49 160.12 39.01 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.8 m -73.18 167.14 2.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-O 120.61 0.243 . . . . 0.0 111.427 -176.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 57.96 31.1 20.15 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 123.771 0.829 . . . . 0.0 111.421 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.548 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 10.9 m-85 59.64 39.37 21.32 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.893 1.277 . . . . 0.0 111.465 177.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 74.3 p -111.58 176.19 5.12 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.12 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.91 -137.43 15.16 Favored Glycine 0 N--CA 1.429 -1.825 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.835 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 56.2 mtt180 -83.81 150.86 25.49 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 123.547 0.739 . . . . 0.0 109.471 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.9 tt -124.84 139.39 51.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 121.179 0.514 . . . . 0.0 110.667 -176.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 90.7 m -131.47 128.2 38.93 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 174.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -115.06 117.43 4.01 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.541 -0.838 . . . . 0.0 113.194 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -109.9 145.55 36.65 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.017 0.437 . . . . 0.0 110.964 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -122.58 170.9 15.34 Favored Glycine 0 N--CA 1.419 -2.495 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.467 -177.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -63.6 121.5 14.06 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.299 0.571 . . . . 0.0 111.734 -176.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.6 14.72 61.05 Favored Glycine 0 N--CA 1.434 -1.479 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.908 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.6 m -125.09 146.14 49.6 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.9 m -139.15 160.06 40.69 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 50.0 mt -94.06 132.18 38.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 173.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -69.93 -48.41 58.57 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.033 0.444 . . . . 0.0 110.563 -177.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -142.82 93.18 2.48 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.573 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.415 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 49.1 t80 -64.63 -30.06 71.07 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.573 0.701 . . . . 0.0 109.391 178.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.0 t -63.65 -25.07 68.05 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.537 177.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -94.88 -5.59 44.61 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.936 -0.477 . . . . 0.0 110.837 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.9 m -79.61 -176.84 5.54 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -56.37 -63.8 4.98 Favored Glycine 0 C--O 1.249 1.052 0 CA-C-O 121.017 0.232 . . . . 0.0 112.781 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.554 ' CG ' ' HB3' ' A' ' 77' ' ' ASP . 39.9 p90 -110.92 147.23 35.07 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 177.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.94 -9.89 12.98 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.586 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -107.45 113.62 4.02 Favored Glycine 0 N--CA 1.431 -1.66 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.474 -177.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 62.6 mt -96.94 115.18 35.81 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.641 0 CA-C-O 122.336 1.065 . . . . 0.0 108.919 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.7 m -85.61 -29.68 23.89 Favored 'General case' 0 N--CA 1.392 -3.335 0 CA-C-N 112.242 -2.253 . . . . 0.0 113.685 177.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 89.2 p -153.11 155.52 36.93 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.0 mt -135.29 130.17 50.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -176.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.548 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 35.8 ttmt -117.32 131.15 56.86 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -101.76 123.14 45.23 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -177.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . 0.438 ' SG ' ' HD2' ' A' ' 74' ' ' TYR . 60.0 m -119.69 172.5 7.64 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -177.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.6 pt -128.12 141.95 45.1 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -115.68 120.29 38.89 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 108.39 -0.966 . . . . 0.0 108.39 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 44.1 p -76.93 175.53 9.44 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.799 -174.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -67.51 -20.68 65.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.628 0.727 . . . . 0.0 109.043 176.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -77.43 -9.59 58.97 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.512 177.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.28 -9.7 76.81 Favored Glycine 0 N--CA 1.439 -1.163 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.187 176.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -74.56 141.47 44.77 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 117.345 0.573 . . . . 0.0 110.225 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.7 t -106.68 111.28 34.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -105.85 148.09 27.96 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.51 153.21 49.06 Favored 'General case' 0 C--N 1.285 -2.207 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.464 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 7.3 tp -125.53 124.6 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.16 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.371 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.421 HD21 ' C ' ' A' ' 123' ' ' ASN . 0.2 OUTLIER -91.57 108.46 19.92 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 176.269 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 . . . . . 0 C--N 1.287 -2.13 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.459 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.276 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.69 76.64 9.48 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 172.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -80.34 -24.85 39.57 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.142 -174.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.0 m -76.34 125.04 28.47 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 171.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 22.1 p -102.13 149.8 23.91 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.256 -0.978 . . . . 0.0 111.536 -173.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.8 tptt -73.89 139.83 45.26 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.716 -176.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 59.25 37.9 23.55 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.638 0.775 . . . . 0.0 112.935 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 34.5 m -123.08 145.56 48.44 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.471 ' HB3' ' HB ' ' A' ' 42' ' ' VAL . 49.6 tp -93.68 116.8 29.31 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 174.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 37.0 mt-30 -111.69 124.78 53.05 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -177.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 3.9 mp -109.6 129.06 55.61 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.24 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.545 ' CE1' ' HG3' ' A' ' 35' ' ' GLU . 94.6 m-85 -97.16 153.66 17.84 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 123.907 0.754 . . . . 0.0 111.644 -174.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -74.48 -41.64 60.4 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.058 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -107.83 177.65 4.76 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.453 HG21 ' O ' ' A' ' 56' ' ' GLY . 3.4 p -82.11 173.01 12.55 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 19.2 p90 47.46 38.76 8.19 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.545 ' HG3' ' CE1' ' A' ' 30' ' ' TYR . 0.7 OUTLIER 67.43 25.76 8.49 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 124.805 1.242 . . . . 0.0 113.637 177.229 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.7 mtp85 -90.74 159.22 16.44 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 177.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.99 -136.89 13.74 Favored Glycine 0 N--CA 1.422 -2.242 0 CA-C-N 114.365 -1.288 . . . . 0.0 109.911 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.2 m -116.68 -179.49 3.7 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 175.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.462 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 33.8 p90 -141.36 165.29 27.91 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -178.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 17.3 tt -114.63 152.65 16.24 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 177.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -106.71 126.11 51.87 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.471 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 88.2 t -123.43 133.15 69.98 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 176.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -115.53 -35.7 4.49 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-O 121.604 0.716 . . . . 0.0 109.397 -175.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.25 161.03 24.02 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.113 -177.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.9 p -69.03 147.83 50.98 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 123.579 0.549 . . . . 0.0 111.517 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.4 p -121.4 131.19 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.06 -15.86 55.24 Favored Glycine 0 N--CA 1.432 -1.633 0 C-N-CA 119.749 -1.215 . . . . 0.0 113.08 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.5 p -156.74 127.54 6.74 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 83.3 mt -122.57 118.36 28.02 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.474 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.5 m -133.5 113.46 13.12 Favored Pre-proline 0 C--N 1.306 -1.302 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.103 174.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.22 162.1 93.38 Favored 'Cis proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.27 -1.554 . . . . 0.0 111.168 -0.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -63.6 156.84 54.62 Favored 'Trans proline' 0 C--O 1.238 0.505 0 C-N-CA 121.928 1.752 . . . . 0.0 110.695 177.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.4 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 49.2 m0 -89.46 134.83 33.92 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -177.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.606 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 58.0 p -113.87 81.0 5.59 Favored Pre-proline 0 N--CA 1.434 -1.236 0 O-C-N 123.431 0.457 . . . . 0.0 111.199 176.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -79.47 158.42 25.63 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.699 2.266 . . . . 0.0 112.447 177.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.453 ' O ' HG21 ' A' ' 33' ' ' THR . . . -87.93 -35.85 8.8 Favored Glycine 0 N--CA 1.429 -1.814 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 176.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.4 p -150.3 158.15 43.85 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.2 t -132.09 142.57 42.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 38.4 t -145.43 149.55 34.92 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.614 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.1 t -117.28 126.63 27.27 Favored Pre-proline 0 C--N 1.317 -0.808 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.24 142.76 98.97 Favored 'Trans proline' 0 C--O 1.248 1.019 0 C-N-CA 122.851 2.367 . . . . 0.0 111.839 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.442 ' CE1' ' HB3' ' A' ' 64' ' ' ASN . 59.4 t80 -73.48 124.19 25.37 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 122.031 0.92 . . . . 0.0 111.456 -176.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.403 ' H ' ' HB2' ' A' ' 90' ' ' HIS . 91.0 t -109.76 117.67 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 CA-C-N 114.428 -1.26 . . . . 0.0 107.929 178.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.442 ' HB3' ' CE1' ' A' ' 62' ' ' PHE . 4.9 p-10 -122.38 11.31 9.99 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -69.31 145.55 52.94 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 111.664 -2.516 . . . . 0.0 112.631 -173.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 m -53.81 -7.58 0.13 Allowed 'General case' 0 CA--C 1.564 1.496 0 C-N-CA 128.353 2.661 . . . . 0.0 114.816 -175.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.7 154.36 40.85 Favored 'General case' 0 C--N 1.316 -0.887 0 O-C-N 122.173 -0.329 . . . . 0.0 110.692 -176.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -79.48 -28.4 41.51 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.741 -0.209 . . . . 0.0 111.206 -175.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.8 mp0 -110.54 144.75 38.93 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.395 177.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -106.24 151.44 40.2 Favored Pre-proline 0 C--N 1.307 -1.273 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 171.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -78.62 137.3 14.37 Favored 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 122.238 1.958 . . . . 0.0 111.974 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -132.92 132.78 42.4 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.461 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 87.2 m95 -116.67 134.88 54.28 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.78 -0.575 . . . . 0.0 111.366 -174.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.466 ' HD1' ' SG ' ' A' ' 111' ' ' CYS . 29.0 m-85 -116.07 142.3 46.99 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.617 178.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.2 mt -125.89 142.69 51.4 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -176.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.531 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 81.4 m-85 -134.38 142.55 47.23 Favored 'General case' 0 C--O 1.245 0.82 0 O-C-N 123.719 0.637 . . . . 0.0 110.174 -176.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.457 ' C ' ' HB2' ' A' ' 106' ' ' SER . 0.8 OUTLIER -80.95 -9.95 59.77 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.58 -179.051 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -127.54 162.31 26.75 Favored 'General case' 0 N--CA 1.427 -1.605 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.426 177.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.5 m -73.19 168.75 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 122.804 0.442 . . . . 0.0 110.588 -176.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 57.66 30.35 18.72 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.612 0.72 . . . . 0.0 111.217 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 59.26 40.3 21.56 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.198 176.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 76.6 p -111.5 175.52 5.39 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.517 -0.473 . . . . 0.0 109.742 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.54 -140.62 16.16 Favored Glycine 0 N--CA 1.422 -2.259 0 C-N-CA 120.363 -0.923 . . . . 0.0 111.508 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.531 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 32.7 mtt180 -82.93 151.87 25.75 Favored 'General case' 0 C--N 1.287 -2.131 0 C-N-CA 123.487 0.715 . . . . 0.0 109.82 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.3 tt -122.61 137.2 56.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-O 121.198 0.523 . . . . 0.0 110.251 -177.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 95.2 m -131.62 125.82 33.17 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 175.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -115.05 110.09 2.23 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.625 -0.798 . . . . 0.0 114.63 -176.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -101.92 145.51 29.14 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 120.967 0.413 . . . . 0.0 111.279 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -123.32 169.67 15.58 Favored Glycine 0 N--CA 1.419 -2.478 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.866 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.403 ' HB2' ' H ' ' A' ' 63' ' ' VAL . 7.3 p80 -53.36 122.03 8.8 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 124.056 0.943 . . . . 0.0 113.109 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.39 -5.8 80.69 Favored Glycine 0 CA--C 1.5 -0.857 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.873 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.3 m -106.25 146.39 30.4 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-O 121.219 0.533 . . . . 0.0 109.782 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.8 m -134.74 159.11 42.35 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 41.5 mt -93.44 130.43 42.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 175.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -65.8 -47.14 76.08 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.152 0.501 . . . . 0.0 110.066 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.462 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 2.9 m-20 -143.16 99.58 3.47 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 123.719 0.808 . . . . 0.0 108.966 178.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -63.96 -31.85 73.18 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.62 0.724 . . . . 0.0 110.839 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.5 t -63.34 -23.44 67.42 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.735 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.462 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 28.8 mmtp -94.56 -16.1 23.54 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 121.839 -0.538 . . . . 0.0 110.104 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.1 m -63.87 -34.32 77.68 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-O 121.116 0.484 . . . . 0.0 111.283 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 158.67 -67.38 0.28 Allowed Glycine 0 CA--C 1.488 -1.604 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -110.86 149.14 31.02 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.606 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.4 -9.64 13.33 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.26 177.229 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -106.25 108.18 2.88 Favored Glycine 0 N--CA 1.438 -1.189 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.017 -176.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 63.0 mt -92.11 116.04 32.4 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.59 0 CA-C-O 122.22 1.01 . . . . 0.0 109.067 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.457 ' HB2' ' C ' ' A' ' 77' ' ' ASP . 4.0 m -85.35 -29.28 24.61 Favored 'General case' 0 N--CA 1.396 -3.136 0 CA-C-N 112.565 -2.107 . . . . 0.0 114.231 176.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.3 p -154.92 155.15 33.78 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 122.191 -0.318 . . . . 0.0 110.239 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.3 mt -133.14 130.68 58.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -117.71 133.71 55.66 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -99.8 126.77 45.94 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . 0.466 ' SG ' ' HD1' ' A' ' 74' ' ' TYR . 59.1 m -122.95 171.93 8.87 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -178.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 7.8 pt -127.52 143.49 40.51 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.298 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.586 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -117.02 119.45 35.32 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 51.1 p -80.89 178.31 8.49 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 114.228 -1.351 . . . . 0.0 112.363 -172.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -66.51 -23.6 66.27 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 172.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -83.3 -8.17 59.47 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.583 -1.189 . . . . 0.0 109.985 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.96 -11.36 57.51 Favored Glycine 0 N--CA 1.438 -1.186 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.769 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.47 137.05 54.13 Favored 'General case' 0 C--O 1.255 1.364 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 43.3 t -105.58 112.07 37.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -97.77 144.52 27.29 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 94.6 m -130.29 148.56 52.13 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 123.062 0.226 . . . . 0.0 110.903 -173.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 8.8 tp -80.38 121.52 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 CA-C-O 121.983 0.897 . . . . 0.0 110.864 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -90.24 110.31 21.36 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.74 177.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 . . . . . 0 C--N 1.294 -1.813 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.175 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.239 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.05 -5.79 29.08 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.47 0.652 . . . . 0.0 111.776 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -78.62 -24.18 45.48 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.718 177.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.7 m -108.81 134.23 51.78 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.167 -176.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.9 t -146.07 135.8 23.31 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.14 108.66 8.03 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -177.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.42 ' CE1' HG12 ' A' ' 63' ' ' VAL . 5.0 m-85 68.78 49.66 0.68 Allowed 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.631 0.729 . . . . 0.0 110.694 176.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 20.0 m -128.74 145.6 51.13 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.573 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 54.9 tp -105.68 127.24 52.94 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 177.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 71.6 mt-30 -114.73 124.75 52.58 Favored 'General case' 0 CA--C 1.49 -1.358 0 C-N-CA 119.889 -0.724 . . . . 0.0 109.61 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.5 mp -109.86 123.91 50.4 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.214 176.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -95.12 151.9 18.8 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 123.832 0.707 . . . . 0.0 110.678 -174.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -74.71 -38.64 62.28 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.113 0.483 . . . . 0.0 110.41 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -108.33 178.17 4.58 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.013 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.494 ' O ' ' HB2' ' A' ' 36' ' ' ARG . 3.9 p -80.84 170.95 15.62 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 27.8 p90 46.8 42.27 11.64 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 66.62 21.97 10.57 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.283 1.033 . . . . 0.0 112.24 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.494 ' HB2' ' O ' ' A' ' 33' ' ' THR . 8.6 mmm180 -88.23 159.41 18.15 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.521 0.677 . . . . 0.0 111.785 177.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.14 -165.66 47.34 Favored Glycine 0 N--CA 1.428 -1.885 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.516 178.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.1 m -87.05 171.83 10.43 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -146.78 164.08 33.93 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -176.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 12.7 tt -115.01 152.53 16.61 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.648 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -107.05 124.92 50.35 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.523 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 89.8 t -115.1 132.84 63.16 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.641 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 178.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -114.43 -32.9 5.77 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 121.247 0.546 . . . . 0.0 110.047 -176.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.15 162.73 19.6 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.347 -176.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.6 p -74.74 151.59 39.15 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.147 0.498 . . . . 0.0 111.839 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.1 p -122.81 127.79 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 175.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.92 -14.56 60.69 Favored Glycine 0 C--N 1.301 -1.378 0 C-N-CA 119.368 -1.396 . . . . 0.0 112.906 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.2 p -160.25 125.9 4.04 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 121.086 0.469 . . . . 0.0 112.004 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.7 mt -116.01 118.63 33.44 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 18.9 m -132.7 111.25 13.54 Favored Pre-proline 0 C--N 1.288 -2.101 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 174.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.9 161.86 92.67 Favored 'Cis proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.012 -1.662 . . . . 0.0 111.433 0.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -63.44 158.18 46.68 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 122.33 2.02 . . . . 0.0 111.05 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 49.5 m0 -89.86 138.91 31.09 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 10.5 p -120.62 76.45 27.2 Favored Pre-proline 0 C--N 1.296 -1.756 0 O-C-N 123.555 0.534 . . . . 0.0 111.477 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.402 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 83.6 Cg_endo -77.54 158.03 32.39 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.779 2.319 . . . . 0.0 113.232 179.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.13 -29.93 13.81 Favored Glycine 0 N--CA 1.429 -1.832 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 175.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.8 p -155.46 158.79 39.13 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.8 t -133.76 143.2 39.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 38.9 t -145.47 148.11 32.91 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.787 175.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.8 t -114.61 117.34 42.65 Favored Pre-proline 0 N--CA 1.428 -1.552 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 175.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -56.57 147.25 70.97 Favored 'Trans proline' 0 C--O 1.247 0.975 0 C-N-CA 122.759 2.306 . . . . 0.0 111.909 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -75.58 112.63 12.12 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.42 HG12 ' CE1' ' A' ' 25' ' ' TYR . 36.8 t -93.85 114.57 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.677 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -109.7 32.79 4.78 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.318 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.526 ' OD1' ' HG2' ' A' ' 67' ' ' LYS . 6.2 t70 -75.33 144.61 42.29 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 113.832 -1.531 . . . . 0.0 108.007 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 m -56.54 -11.58 1.36 Allowed 'General case' 0 CA--C 1.577 1.984 0 C-N-CA 125.264 1.426 . . . . 0.0 114.203 -174.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.526 ' HG2' ' OD1' ' A' ' 65' ' ' ASP . 15.5 mmtp -67.66 145.02 55.21 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 122.984 0.514 . . . . 0.0 109.696 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -81.39 -14.13 57.52 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.826 0.346 . . . . 0.0 111.703 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -104.14 127.86 51.77 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -105.98 150.19 38.97 Favored Pre-proline 0 C--N 1.291 -1.939 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -76.48 140.18 21.29 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 121.771 1.647 . . . . 0.0 112.764 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -133.38 129.29 37.2 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.573 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 82.6 m95 -110.82 139.69 45.9 Favored 'General case' 0 C--N 1.284 -2.26 0 O-C-N 121.897 -0.502 . . . . 0.0 112.162 -172.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.471 ' HD2' ' SG ' ' A' ' 111' ' ' CYS . 35.9 m-85 -117.7 142.51 47.16 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.495 177.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.3 mt -125.59 142.45 51.5 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -176.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.514 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 77.9 m-85 -133.5 141.34 47.73 Favored 'General case' 0 C--N 1.318 -0.765 0 O-C-N 123.64 0.587 . . . . 0.0 109.958 -176.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -81.09 -15.19 56.67 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.426 ' C ' ' HB3' ' A' ' 106' ' ' SER . 5.6 t-20 -125.59 165.16 19.04 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.8 m -68.81 168.51 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 123.146 0.579 . . . . 0.0 111.615 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 56.44 30.25 16.71 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.852 0.861 . . . . 0.0 111.233 178.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.495 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 11.2 m-85 55.66 48.79 17.76 Favored 'General case' 0 C--O 1.25 1.131 0 C-N-CA 124.596 1.158 . . . . 0.0 110.785 178.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 74.6 p -117.43 168.53 10.28 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.862 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.3 -131.19 10.67 Favored Glycine 0 N--CA 1.416 -2.682 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 66.5 mtt85 -87.25 144.14 26.95 Favored 'General case' 0 C--N 1.279 -2.462 0 C-N-CA 124.332 1.053 . . . . 0.0 109.506 -178.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.4 tt -121.87 136.63 58.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-O 121.301 0.572 . . . . 0.0 110.045 -177.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 94.6 m -132.02 123.9 28.22 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.132 175.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -109.02 130.15 9.88 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.945 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -119.61 145.63 46.25 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 123.335 0.654 . . . . 0.0 110.632 178.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -113.22 166.17 12.11 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.91 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -62.47 122.76 16.55 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.256 0.55 . . . . 0.0 111.796 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 92.15 -0.72 72.55 Favored Glycine 0 N--CA 1.433 -1.512 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.47 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.1 m -112.34 146.54 38.11 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 4.5 m -133.56 160.66 36.82 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 49.2 mt -93.63 130.98 41.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 173.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -70.39 -47.42 60.92 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.245 0.545 . . . . 0.0 110.938 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -143.69 98.42 3.24 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -64.66 -30.04 71.05 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.649 0.738 . . . . 0.0 110.518 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.9 t -63.61 -22.8 67.09 Favored 'General case' 0 CA--C 1.555 1.155 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.9 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -95.36 -6.69 40.49 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.101 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.6 m -70.46 -40.55 73.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.118 0.485 . . . . 0.0 111.026 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 156.91 -65.0 0.31 Allowed Glycine 0 CA--C 1.491 -1.462 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -109.17 145.55 35.6 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.26 -9.12 13.47 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.351 177.741 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.39 106.55 2.57 Favored Glycine 0 N--CA 1.43 -1.73 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.614 -177.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 84.7 mt -91.38 115.08 29.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.426 ' HB3' ' C ' ' A' ' 78' ' ' ASN . 5.1 t -86.41 -26.61 24.65 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.847 177.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 90.1 p -150.81 155.73 39.81 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.344 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.7 mt -136.22 130.89 48.47 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -176.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.495 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 35.9 ttmt -117.52 133.67 55.7 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -101.37 121.93 42.81 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . 0.471 ' SG ' ' HD2' ' A' ' 74' ' ' TYR . 50.4 m -119.49 172.18 7.82 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -177.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.5 pt -129.02 144.3 38.6 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -115.21 123.8 49.79 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 45.3 p -77.58 177.14 8.3 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.14 -175.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -66.4 -23.81 66.38 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.657 0.741 . . . . 0.0 109.288 176.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -76.95 -9.42 58.68 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.522 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.22 -1.75 80.31 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 116.219 -0.446 . . . . 0.0 113.261 177.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -83.81 143.87 29.65 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.964 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 17.8 t -103.82 112.23 36.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -100.59 149.95 23.21 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 1.7 t -141.78 146.19 35.64 Favored 'General case' 0 CA--C 1.48 -1.732 0 C-N-CA 117.972 -1.491 . . . . 0.0 110.002 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 8.9 tp -128.15 122.95 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.172 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.644 175.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -89.65 122.52 32.86 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 119.168 -1.013 . . . . 0.0 108.732 176.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 . . . . . 0 C--N 1.291 -1.95 0 CA-C-O 118.085 -0.96 . . . . 0.0 110.054 -177.713 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.703 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.68 -38.87 73.78 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.122 0.487 . . . . 0.0 110.576 -177.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -94.97 1.59 55.25 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.536 0.684 . . . . 0.0 110.916 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.5 m -89.2 124.41 34.34 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 175.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 21.5 p -113.8 140.71 48.08 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.64 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -71.07 143.04 50.82 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.898 176.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 69.08 33.4 3.4 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 121.376 0.608 . . . . 0.0 111.905 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 36.4 m -124.58 145.92 49.33 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.568 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 54.7 tp -98.25 119.68 37.33 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 174.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.451 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 64.6 mt-30 -113.68 124.55 52.58 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 3.6 mp -109.59 131.06 55.41 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.038 177.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -90.81 156.29 18.15 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 123.763 0.664 . . . . 0.0 110.64 -176.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -77.06 -41.42 42.49 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.436 -176.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.447 ' C ' ' HA3' ' A' ' 56' ' ' GLY . 45.4 mt-10 -113.14 177.55 4.59 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.554 ' O ' ' HB2' ' A' ' 36' ' ' ARG . 2.0 p -82.58 174.81 10.7 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 23.4 p90 47.35 40.22 10.32 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.398 1.079 . . . . 0.0 113.617 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 65.46 26.66 11.84 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.59 1.156 . . . . 0.0 111.334 176.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.554 ' HB2' ' O ' ' A' ' 33' ' ' THR . 6.5 mmm180 -89.64 147.65 23.78 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.743 0.783 . . . . 0.0 111.939 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.17 -161.0 28.74 Favored Glycine 0 N--CA 1.419 -2.434 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.35 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.2 m -97.43 -177.14 3.72 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 50.4 p90 -142.16 165.97 25.99 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.4 tt -113.6 153.48 15.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -106.3 125.94 51.62 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.494 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 92.4 t -127.18 133.73 67.54 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 175.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -115.99 -31.86 5.59 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-O 121.113 0.482 . . . . 0.0 109.953 -176.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.43 161.85 33.43 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.512 -176.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.5 m -61.02 143.99 54.26 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.703 -175.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.6 p -121.37 136.94 56.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 176.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.31 -18.08 27.37 Favored Glycine 0 N--CA 1.435 -1.387 0 C-N-CA 120.077 -1.058 . . . . 0.0 113.907 -175.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.9 t -156.98 128.61 7.06 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 117.451 0.626 . . . . 0.0 109.57 -178.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 94.5 mt -120.17 119.67 33.93 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.208 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.7 p -131.7 107.96 14.29 Favored Pre-proline 0 C--N 1.298 -1.638 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.268 176.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.73 162.68 89.52 Favored 'Cis proline' 0 C--O 1.242 0.718 0 C-N-CA 123.896 -1.294 . . . . 0.0 111.33 -1.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.45 156.31 42.18 Favored 'Trans proline' 0 C--O 1.243 0.753 0 C-N-CA 122.521 2.147 . . . . 0.0 109.879 176.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -89.65 129.62 36.06 Favored 'General case' 0 C--N 1.288 -2.088 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.13 -177.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.573 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 40.9 p -111.37 80.75 2.71 Favored Pre-proline 0 N--CA 1.424 -1.757 0 O-C-N 123.697 0.623 . . . . 0.0 110.537 176.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -80.25 158.62 23.15 Favored 'Trans proline' 0 N--CA 1.443 -1.458 0 C-N-CA 122.22 1.946 . . . . 0.0 111.776 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.447 ' HA3' ' C ' ' A' ' 32' ' ' GLU . . . -86.73 -39.03 7.78 Favored Glycine 0 N--CA 1.425 -2.076 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 176.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' A' ' 94' ' ' ILE . 72.9 p -147.65 160.96 42.1 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.6 t -137.11 142.23 38.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 36.9 t -145.52 149.1 34.0 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 119.704 -0.799 . . . . 0.0 111.386 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.9 t -116.78 125.2 28.54 Favored Pre-proline 0 N--CA 1.443 -0.78 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.0 143.66 99.38 Favored 'Trans proline' 0 C--O 1.242 0.688 0 C-N-CA 123.222 2.614 . . . . 0.0 112.53 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -70.99 122.0 19.21 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.661 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 93.4 t -96.67 115.39 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 CA-C-O 121.49 0.662 . . . . 0.0 109.57 177.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -101.72 -6.46 23.67 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 113.981 -1.463 . . . . 0.0 110.441 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -58.42 144.74 40.95 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 125.123 1.369 . . . . 0.0 112.034 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.2 m -55.68 -7.52 0.29 Allowed 'General case' 0 CA--C 1.571 1.772 0 C-N-CA 125.708 1.603 . . . . 0.0 113.105 -178.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -64.47 140.92 58.92 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.233 0.54 . . . . 0.0 110.183 178.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.557 ' HB2' ' OE2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -81.19 -28.11 35.08 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.032 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.557 ' OE2' ' HB2' ' A' ' 68' ' ' ARG . 2.4 mp0 -94.35 125.77 39.2 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.3 152.69 42.06 Favored Pre-proline 0 C--N 1.289 -2.058 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.388 174.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.52 134.78 21.04 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 121.505 1.47 . . . . 0.0 110.733 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -129.03 138.33 51.85 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.568 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 87.5 m95 -119.25 133.48 55.73 Favored 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.933 -173.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.503 ' HA ' ' O ' ' A' ' 86' ' ' THR . 24.6 m-85 -113.73 140.0 48.63 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.913 176.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.3 mt -125.31 142.74 51.33 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.576 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 84.8 m-85 -132.35 143.7 50.04 Favored 'General case' 0 C--N 1.32 -0.71 0 O-C-N 123.57 0.543 . . . . 0.0 110.903 -176.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -84.75 0.27 51.2 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.373 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -137.54 163.65 30.65 Favored 'General case' 0 N--CA 1.417 -2.092 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.6 m -75.5 168.95 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 C-N-CA 123.044 0.538 . . . . 0.0 111.151 -176.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 58.06 30.73 19.71 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.894 0.746 . . . . 0.0 111.065 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.576 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 9.6 m-85 59.44 39.14 22.3 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.98 1.312 . . . . 0.0 111.713 177.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 81.0 p -112.28 170.62 8.04 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.548 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.9 -143.67 16.69 Favored Glycine 0 N--CA 1.421 -2.352 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.167 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.576 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 62.6 mtt85 -75.15 140.36 43.31 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 124.17 0.988 . . . . 0.0 108.905 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.2 tt -118.09 137.5 51.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-O 121.016 0.436 . . . . 0.0 109.891 -175.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 87.9 m -130.83 121.47 25.37 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 176.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -109.14 120.65 5.9 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.779 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -115.35 145.36 42.58 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 122.85 0.46 . . . . 0.0 110.757 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -120.2 167.8 13.71 Favored Glycine 0 N--CA 1.429 -1.822 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.284 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -58.25 123.42 15.98 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 123.434 0.694 . . . . 0.0 112.47 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.14 4.65 71.33 Favored Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.247 177.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.5 m -116.93 146.43 42.98 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.7 m -138.23 154.16 49.09 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.515 ' O ' ' HB2' ' A' ' 57' ' ' SER . 41.3 mt -94.58 126.03 47.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 173.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -70.84 -46.24 63.06 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 121.185 0.517 . . . . 0.0 111.391 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.45 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 3.1 m-20 -131.6 96.34 3.95 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -63.87 -36.72 84.84 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.302 0.572 . . . . 0.0 110.665 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.5 t -63.81 -27.84 69.45 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.036 -0.983 . . . . 0.0 112.405 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.45 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 30.3 mmtp -90.53 -9.92 45.45 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -177.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.2 m -84.75 7.61 20.01 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.135 -176.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 132.8 -84.69 0.29 Allowed Glycine 0 N--CA 1.421 -2.326 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.479 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -110.24 150.4 28.75 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.573 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -112.52 -9.79 13.76 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.062 177.9 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -107.7 104.05 2.02 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.907 -176.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 68.0 mt -87.01 115.74 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.808 0 CA-C-O 122.476 1.131 . . . . 0.0 108.839 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 44.3 m -86.44 -29.9 22.47 Favored 'General case' 0 N--CA 1.388 -3.573 0 CA-C-N 112.295 -2.229 . . . . 0.0 114.71 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 81.2 p -154.43 158.64 40.28 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 177.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.1 mt -136.22 132.05 49.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -176.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.576 ' HE2' ' CD2' ' A' ' 81' ' ' TYR . 37.3 ttmt -117.71 127.73 54.21 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -96.94 121.25 38.61 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . 0.491 ' SG ' ' HD2' ' A' ' 74' ' ' TYR . 57.2 m -121.29 172.83 7.73 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 124.047 0.939 . . . . 0.0 108.68 -177.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.5 pt -124.09 140.44 47.48 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 176.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -115.0 127.47 55.69 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 61.7 p -79.21 179.76 7.2 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.766 -172.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -67.21 -29.38 69.02 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.945 177.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.527 ' OD1' ' HG2' ' A' ' 118' ' ' LYS . 1.9 p-10 -84.38 -7.81 59.19 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.92 -177.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.06 3.9 58.84 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.384 -0.912 . . . . 0.0 114.426 175.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.527 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 21.7 ptmt -84.03 145.82 28.29 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 118.067 0.934 . . . . 0.0 109.16 176.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 17.1 t -107.51 116.51 51.23 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -101.68 140.95 35.27 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -147.26 160.05 42.94 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 7.8 tp -120.96 119.98 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.335 0 CA-C-O 121.5 0.667 . . . . 0.0 110.21 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -84.05 106.91 16.07 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 . . . . . 0 C--N 1.287 -2.134 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -178.445 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.854 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.39 41.82 0.96 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.664 0.745 . . . . 0.0 109.637 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -76.91 -24.48 52.47 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -178.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.511 ' HA ' HE22 ' A' ' 28' ' ' GLN . 14.3 m -106.63 123.61 48.37 Favored 'General case' 0 N--CA 1.404 -2.727 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.931 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.3 p -105.64 153.78 21.33 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 174.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -83.59 126.61 33.01 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.996 -174.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 74.37 41.25 0.38 Allowed 'General case' 0 N--CA 1.476 0.872 0 O-C-N 124.674 1.234 . . . . 0.0 111.324 177.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 22.9 m -123.37 148.47 46.01 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.813 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.568 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 55.7 tp -103.28 117.17 33.91 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 174.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.511 HE22 ' HA ' ' A' ' 22' ' ' SER . 76.1 mt-30 -109.92 124.22 51.0 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.56 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 3.4 mp -109.98 123.45 49.68 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.613 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -92.0 152.76 19.84 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 123.729 0.643 . . . . 0.0 110.233 -177.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -75.93 -36.45 59.37 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.353 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -107.84 177.95 4.67 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.0 p -82.28 173.13 12.37 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.606 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 26.2 p90 46.46 42.11 10.4 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 114.703 1.372 . . . . 0.0 114.703 176.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 68.05 23.26 8.16 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.889 0.876 . . . . 0.0 111.825 177.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.416 ' HE ' ' HB3' ' A' ' 36' ' ' ARG . 4.2 mtp180 -94.85 164.41 12.93 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 177.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.48 -167.35 50.4 Favored Glycine 0 N--CA 1.426 -2.002 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -175.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.6 m -91.98 177.82 6.06 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 174.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 44.6 p90 -140.39 166.14 25.52 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -178.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.495 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 11.8 tt -114.05 152.65 15.69 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -106.99 125.65 51.28 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.499 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 93.5 t -123.48 133.7 68.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -119.12 -24.16 6.58 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.089 0.471 . . . . 0.0 110.444 -175.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.23 161.93 29.03 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.82 -175.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.7 m -74.43 144.96 44.05 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.119 0.485 . . . . 0.0 110.8 -178.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.0 p -121.75 137.31 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 177.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -97.12 -23.11 15.48 Favored Glycine 0 C--N 1.292 -1.914 0 C-N-CA 120.07 -1.062 . . . . 0.0 113.173 -177.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.9 m -148.84 128.35 13.12 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 122.317 -0.52 . . . . 0.0 110.565 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 83.7 mt -122.02 118.05 27.85 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 176.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.0 m -132.81 112.11 13.57 Favored Pre-proline 0 C--N 1.3 -1.581 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 177.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.91 161.89 92.6 Favored 'Cis proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.076 -1.635 . . . . 0.0 110.841 -0.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -61.52 157.49 41.23 Favored 'Trans proline' 0 C--O 1.243 0.741 0 C-N-CA 122.508 2.138 . . . . 0.0 110.73 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.433 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 48.6 m0 -89.54 139.22 30.75 Favored 'General case' 0 CA--C 1.484 -1.587 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -178.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.528 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 30.1 p -118.47 78.61 14.83 Favored Pre-proline 0 C--N 1.304 -1.371 0 C-N-CA 120.544 -0.462 . . . . 0.0 111.888 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.433 ' HD2' ' O ' ' A' ' 103' ' ' LYS . 85.0 Cg_endo -78.4 157.45 29.19 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.565 2.177 . . . . 0.0 112.996 177.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -93.18 -29.63 10.12 Favored Glycine 0 N--CA 1.431 -1.635 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 177.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.4 p -153.68 151.16 29.34 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.4 t -128.84 142.83 42.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 37.2 t -145.82 149.47 34.38 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.442 176.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 49.0 t -118.81 122.55 29.71 Favored Pre-proline 0 N--CA 1.435 -1.213 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 176.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.3 143.41 83.06 Favored 'Trans proline' 0 C--O 1.244 0.791 0 C-N-CA 122.86 2.373 . . . . 0.0 112.0 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -66.55 125.89 27.18 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 121.465 0.65 . . . . 0.0 110.473 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.4 HG11 ' OD2' ' A' ' 65' ' ' ASP . 59.8 t -101.01 124.2 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.758 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.337 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -120.34 20.63 11.9 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.988 0.899 . . . . 0.0 108.922 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.4 ' OD2' HG11 ' A' ' 63' ' ' VAL . 1.2 m-20 -58.24 145.74 36.44 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 113.982 -1.463 . . . . 0.0 113.187 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.9 m -60.14 -27.11 66.8 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 175.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -56.04 124.67 18.55 Favored 'General case' 0 C--O 1.251 1.156 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.343 173.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -77.54 -27.77 51.71 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.278 -177.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -83.02 125.67 31.7 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-O 122.001 0.905 . . . . 0.0 108.62 178.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 28.4 mmt85 -108.09 153.03 42.02 Favored Pre-proline 0 C--N 1.281 -2.377 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.424 -177.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -85.74 134.76 4.72 Favored 'Trans proline' 0 N--CA 1.441 -1.602 0 C-N-CA 121.281 1.321 . . . . 0.0 112.008 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -129.54 131.0 46.47 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.568 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 86.6 m95 -112.84 132.82 55.11 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.81 -173.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.537 ' HA ' ' O ' ' A' ' 86' ' ' THR . 37.6 m-85 -112.89 142.17 45.87 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.911 176.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.4 mt -125.58 142.65 51.39 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -176.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.519 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 82.5 m-85 -133.13 142.54 48.73 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 123.701 0.626 . . . . 0.0 109.895 -177.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.491 ' HB3' ' CD1' ' A' ' 102' ' ' PHE . 1.7 p-10 -87.89 0.35 55.96 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.566 -178.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -136.48 157.29 47.14 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 174.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.6 m -69.68 164.7 2.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 122.403 0.281 . . . . 0.0 111.674 -174.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 59.83 31.22 20.66 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 123.575 0.75 . . . . 0.0 111.566 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.59 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 12.0 m-85 61.12 39.93 15.48 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.853 1.261 . . . . 0.0 111.735 177.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 72.4 p -112.16 171.48 7.48 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.116 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.59 -133.31 11.67 Favored Glycine 0 N--CA 1.428 -1.859 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.307 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.519 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 54.2 mtt180 -89.26 149.4 23.09 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 124.246 1.019 . . . . 0.0 109.058 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.6 tt -125.52 137.02 59.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 121.273 0.559 . . . . 0.0 110.59 -175.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 95.7 m -131.94 125.99 32.97 Favored 'General case' 0 C--N 1.287 -2.112 0 O-C-N 122.1 -0.375 . . . . 0.0 110.415 176.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -111.38 124.46 6.88 Favored Glycine 0 C--N 1.312 -0.784 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.553 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -116.8 144.79 44.06 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 122.967 0.507 . . . . 0.0 110.315 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -114.05 168.07 12.48 Favored Glycine 0 N--CA 1.435 -1.416 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.612 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 33.5 p80 -64.86 128.81 37.34 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 121.218 0.532 . . . . 0.0 111.899 -177.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.31 6.85 65.99 Favored Glycine 0 N--CA 1.426 -1.998 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.604 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.7 m -118.5 146.45 44.51 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 4.3 m -136.36 155.78 49.57 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 52.4 mt -94.01 128.29 45.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -70.81 -48.28 55.0 Favored 'General case' 0 C--N 1.313 -1.009 0 O-C-N 123.536 0.523 . . . . 0.0 110.5 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -135.37 92.69 2.88 Favored 'General case' 0 CA--C 1.486 -1.488 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.917 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -64.97 -32.26 73.89 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.265 0.555 . . . . 0.0 109.763 177.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.1 t -63.56 -26.62 68.78 Favored 'General case' 0 CA--C 1.552 1.019 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.66 -178.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -95.23 -6.61 41.14 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.527 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.6 m -84.4 39.44 0.73 Allowed 'General case' 0 C--O 1.244 0.778 0 CA-C-O 121.87 0.843 . . . . 0.0 111.488 -176.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.73 -78.77 1.69 Allowed Glycine 0 N--CA 1.424 -2.116 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.491 ' CD1' ' HB3' ' A' ' 77' ' ' ASP . 26.8 p90 -108.19 145.68 33.87 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -177.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.528 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -113.66 -10.46 13.09 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 177.421 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -104.19 110.22 3.55 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.308 -177.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 70.2 mt -95.01 115.7 34.52 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.658 0 CA-C-O 122.387 1.089 . . . . 0.0 108.868 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 57.8 m -86.04 -29.16 23.66 Favored 'General case' 0 N--CA 1.392 -3.357 0 CA-C-N 112.238 -2.255 . . . . 0.0 114.262 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 77.6 p -153.98 155.81 36.28 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.6 mt -134.73 131.15 53.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -176.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.59 ' HE2' ' CD2' ' A' ' 81' ' ' TYR . 34.4 ttmt -117.86 126.34 52.2 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -96.16 130.1 43.29 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 176.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 76.0 m -123.19 170.76 9.91 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 7.5 pt -125.06 142.35 42.24 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 176.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 53.6 tt0 -115.76 128.71 56.06 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.4 p -87.15 178.77 6.8 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.847 -174.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -63.16 -27.05 69.1 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.44 0.696 . . . . 0.0 109.186 174.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -81.05 -8.53 59.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.577 0.704 . . . . 0.0 110.739 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.37 -1.96 77.29 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.432 -0.889 . . . . 0.0 113.792 175.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 113' ' ' GLN . 8.8 ptpt -79.28 147.74 32.4 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.2 t -111.27 115.9 51.1 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -101.78 141.4 34.69 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 75.4 m -130.54 152.19 50.19 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.108 0.48 . . . . 0.0 111.993 -175.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 8.2 tp -125.16 132.7 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 CA-C-O 121.368 0.604 . . . . 0.0 110.264 177.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -91.74 111.61 23.2 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 . . . . . 0 C--N 1.305 -1.353 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -176.234 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.588 0 N-CA-C 112.211 -0.356 . . . . 0.0 112.211 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.16 -11.98 61.28 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.173 0.589 . . . . 0.0 111.825 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -77.31 -23.97 50.97 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.188 -0.914 . . . . 0.0 108.975 177.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.6 m -94.97 146.04 24.52 Favored 'General case' 0 N--CA 1.408 -2.57 0 CA-C-O 121.629 0.728 . . . . 0.0 110.548 -175.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 47.3 t -139.0 138.61 37.4 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 104.784 -2.302 . . . . 0.0 104.784 177.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -81.94 97.77 8.24 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.826 -0.749 . . . . 0.0 110.367 -173.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.41 ' CD1' ' HB3' ' A' ' 71' ' ' PRO . 1.4 m-85 69.41 67.17 0.26 Allowed 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.398 177.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.3 m -139.05 154.5 48.22 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -176.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.587 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 53.4 tp -110.06 125.62 53.14 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 176.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.469 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 74.2 mt-30 -112.68 123.71 50.91 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 121.461 0.648 . . . . 0.0 109.572 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.4 mp -110.8 124.82 52.75 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.681 177.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -94.07 153.34 18.19 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 123.418 0.449 . . . . 0.0 111.183 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.46 -36.01 58.14 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.064 -176.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -107.44 178.26 4.59 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.541 ' O ' ' HB2' ' A' ' 36' ' ' ARG . 2.6 p -80.67 169.36 17.72 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 119.674 -0.203 . . . . 0.0 110.556 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 35.4 p90 46.65 42.73 11.82 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.17 1.388 . . . . 0.0 114.47 176.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 61.7 33.42 18.01 Favored 'General case' 0 C--O 1.246 0.904 0 C-N-CA 123.979 0.912 . . . . 0.0 112.502 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.541 ' HB2' ' O ' ' A' ' 33' ' ' THR . 5.4 mmm180 -96.23 154.55 17.19 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.807 174.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.53 -165.74 39.12 Favored Glycine 0 N--CA 1.427 -1.964 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.8 m -88.7 171.84 9.69 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 175.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -137.44 166.59 23.47 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -176.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.5 tt -114.61 150.79 16.48 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.45 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 176.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -107.21 125.63 51.36 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.509 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 74.6 t -117.99 133.54 64.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -117.48 -30.05 5.64 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.335 0.588 . . . . 0.0 110.86 -174.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -113.54 163.58 14.75 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.782 -174.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.4 m -79.05 145.19 33.97 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 173.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.2 p -120.88 128.7 76.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.424 ' C ' ' HG ' ' A' ' 48' ' ' SER . . . -89.79 -20.26 44.37 Favored Glycine 0 N--CA 1.427 -1.952 0 C-N-CA 119.543 -1.313 . . . . 0.0 113.342 -176.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.424 ' HG ' ' C ' ' A' ' 47' ' ' GLY . 50.5 m -157.78 114.52 2.91 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.509 0.671 . . . . 0.0 111.471 -178.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 85.5 mt -102.2 119.4 38.74 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.094 177.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 55.7 p -131.28 110.62 15.24 Favored Pre-proline 0 N--CA 1.425 -1.702 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 174.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 3.1 Cg_exo -77.65 162.37 90.24 Favored 'Cis proline' 0 CA--C 1.539 0.75 0 C-N-CA 124.008 -1.247 . . . . 0.0 111.207 -1.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.12 154.97 67.61 Favored 'Trans proline' 0 C--O 1.246 0.888 0 C-N-CA 122.205 1.937 . . . . 0.0 110.89 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.413 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 49.7 m0 -90.26 137.05 32.66 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.352 -177.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 11.4 p -120.16 78.17 25.46 Favored Pre-proline 0 C--N 1.295 -1.787 0 O-C-N 123.672 0.607 . . . . 0.0 110.368 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.26 157.4 29.69 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.379 2.053 . . . . 0.0 113.33 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -85.89 -34.91 12.06 Favored Glycine 0 N--CA 1.434 -1.477 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.3 p -150.9 156.26 40.83 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.6 t -130.61 141.84 45.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 37.7 t -146.14 150.4 35.82 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-O 121.248 0.546 . . . . 0.0 110.223 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.6 t -113.85 123.1 33.49 Favored Pre-proline 0 C--N 1.299 -1.607 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 176.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -57.47 136.79 78.11 Favored 'Trans proline' 0 C--O 1.247 0.941 0 C-N-CA 122.735 2.29 . . . . 0.0 111.554 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.456 ' CE2' ' HB3' ' A' ' 64' ' ' ASN . 72.8 t80 -72.71 112.58 8.88 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.286 -177.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 44.7 t -93.84 115.15 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.825 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 175.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.456 ' HB3' ' CE2' ' A' ' 62' ' ' PHE . 27.3 p-10 -109.75 15.46 22.74 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-O 122.305 1.05 . . . . 0.0 108.67 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -75.69 147.31 39.52 Favored 'General case' 0 C--N 1.284 -2.279 0 CA-C-N 113.739 -1.573 . . . . 0.0 112.106 -174.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.0 m -52.33 -21.7 3.81 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 126.999 2.12 . . . . 0.0 114.022 -172.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -58.53 137.04 57.67 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.531 0.681 . . . . 0.0 111.803 -176.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -68.31 -23.3 64.72 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 124.892 1.277 . . . . 0.0 113.002 -171.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -109.76 128.48 55.32 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.9 148.81 37.18 Favored Pre-proline 0 C--N 1.298 -1.668 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 174.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.41 ' HB3' ' CD1' ' A' ' 25' ' ' TYR . 92.8 Cg_endo -77.44 137.95 17.07 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 C-N-CA 121.657 1.571 . . . . 0.0 112.564 -177.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -131.73 127.79 37.55 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.587 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 77.5 m95 -110.99 138.05 47.87 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -171.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.476 ' HA ' ' O ' ' A' ' 86' ' ' THR . 34.3 m-85 -116.09 142.9 46.19 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.339 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.4 mt -125.68 142.42 51.52 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 -176.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -133.65 139.96 46.78 Favored 'General case' 0 CA--C 1.503 -0.852 0 O-C-N 123.734 0.647 . . . . 0.0 109.498 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.521 ' HB3' ' CG ' ' A' ' 102' ' ' PHE . 3.6 p-10 -77.82 -15.78 58.81 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -177.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.49 ' C ' ' HB3' ' A' ' 106' ' ' SER . 6.0 t-20 -121.43 166.74 13.67 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.1 m -71.71 165.62 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 C-N-CA 122.905 0.482 . . . . 0.0 111.915 -176.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 57.13 31.2 19.59 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.888 0.875 . . . . 0.0 112.322 176.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.427 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 6.5 m-85 59.9 48.82 8.45 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 125.098 1.359 . . . . 0.0 110.895 177.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 81.6 p -120.68 168.46 11.38 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 116.229 -0.442 . . . . 0.0 109.901 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.59 -138.44 14.28 Favored Glycine 0 N--CA 1.421 -2.327 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -81.77 157.04 24.65 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 123.85 0.86 . . . . 0.0 109.616 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.8 tt -129.75 137.1 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 CA-C-O 121.494 0.664 . . . . 0.0 110.805 -175.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 96.9 m -131.99 128.37 38.25 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -114.78 130.28 9.12 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.815 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -121.3 147.56 45.5 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 123.076 0.55 . . . . 0.0 111.161 178.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.89 168.5 12.81 Favored Glycine 0 N--CA 1.433 -1.517 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.833 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -62.97 122.39 15.89 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.315 0.579 . . . . 0.0 111.769 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.51 -2.63 77.89 Favored Glycine 0 N--CA 1.433 -1.54 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.23 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.0 m -107.07 146.18 31.52 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.1 m -140.88 157.83 44.82 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 52.1 mt -94.01 132.72 37.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 175.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -71.26 -48.66 49.63 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 121.579 0.704 . . . . 0.0 109.852 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.478 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 13.3 m-20 -132.24 96.48 3.89 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.847 178.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -65.57 -37.32 86.35 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.466 0.65 . . . . 0.0 110.01 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.4 t -63.91 -27.93 69.49 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.174 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.478 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 29.1 mmtp -89.19 -7.71 55.04 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 122.044 -0.41 . . . . 0.0 110.341 -178.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.8 m -80.34 -174.37 4.55 Favored 'General case' 0 C--O 1.257 1.493 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -50.26 -66.48 2.34 Favored Glycine 0 CA--C 1.507 -0.447 0 O-C-N 123.38 0.425 . . . . 0.0 113.62 -177.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.521 ' CG ' ' HB3' ' A' ' 77' ' ' ASP . 34.0 p90 -110.83 149.74 30.14 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 119.732 -0.175 . . . . 0.0 110.659 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.03 -12.16 13.25 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.542 177.646 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -112.17 116.19 4.03 Favored Glycine 0 N--CA 1.428 -1.841 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -177.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 70.0 mt -95.46 114.96 33.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.49 ' HB3' ' C ' ' A' ' 78' ' ' ASN . 1.8 t -86.77 -25.08 24.83 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.024 177.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 89.1 p -153.08 155.18 36.33 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 122.325 -0.234 . . . . 0.0 110.474 177.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.2 mt -133.02 132.57 58.94 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -175.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.427 ' HE2' ' CD2' ' A' ' 81' ' ' TYR . 37.9 ttmt -116.53 127.53 54.62 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.255 -1.016 . . . . 0.0 108.255 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -95.61 129.16 42.89 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 69.7 m -125.38 172.11 9.89 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 8.0 pt -128.07 143.11 41.93 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 59.7 tt0 -117.09 119.48 35.38 Favored 'General case' 0 C--N 1.277 -2.548 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 32.0 p -81.9 179.97 7.62 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.255 -171.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -65.36 -25.12 67.44 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.764 174.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -80.78 -7.81 59.5 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.852 0.834 . . . . 0.0 110.097 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.24 -9.78 76.63 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.803 175.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 113' ' ' GLN . 19.6 ptmt -73.49 140.03 46.13 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 21.6 t -103.36 112.3 36.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.404 ' HG2' ' HE2' ' A' ' 118' ' ' LYS . 24.7 mt-10 -98.01 138.03 35.93 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 80.1 m -130.59 152.14 50.28 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -174.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 8.1 tp -79.01 122.59 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.822 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -85.81 108.33 18.06 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 . . . . . 0 C--N 1.298 -1.672 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.229 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.04 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -164.04 158.08 19.07 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -78.45 -23.98 46.26 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.248 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.6 m -118.64 132.96 56.18 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 20.1 p -102.56 166.34 10.58 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -100.5 130.88 46.64 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 -172.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 70.96 39.91 0.96 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.327 0.651 . . . . 0.0 111.584 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.9 m -123.88 158.96 30.72 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.624 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 57.2 tp -107.24 118.97 38.12 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 171.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -111.23 124.14 51.61 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.619 -0.832 . . . . 0.0 108.951 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.8 mp -110.24 126.71 54.44 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.115 177.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -96.38 151.31 19.66 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 123.572 0.545 . . . . 0.0 109.598 -177.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -74.07 -37.75 64.14 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.139 0.495 . . . . 0.0 111.107 -177.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -108.32 177.44 4.79 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.457 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.442 HG23 ' HA ' ' A' ' 96' ' ' ASP . 2.2 p -81.16 172.54 13.54 Favored 'General case' 0 N--CA 1.413 -2.309 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 11.7 p90 47.6 35.4 4.36 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.852 0.861 . . . . 0.0 113.24 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 61.85 38.65 14.52 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.851 1.26 . . . . 0.0 113.591 177.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -103.46 178.17 4.63 Favored 'General case' 0 C--O 1.248 0.981 0 C-N-CA 120.126 -0.629 . . . . 0.0 112.007 175.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.7 -154.79 40.33 Favored Glycine 0 N--CA 1.425 -2.09 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -176.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.4 m -100.57 174.61 6.0 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 172.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -136.87 165.66 25.44 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 16.6 tt -116.21 152.45 17.92 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.483 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -106.8 125.15 50.63 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.505 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 98.0 t -120.78 133.94 65.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -121.72 -27.73 4.65 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.46 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 10.5 mmpt? -109.72 162.68 14.21 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.655 -173.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.8 m -82.75 141.82 32.09 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 175.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.1 p -120.79 130.54 74.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -89.51 -17.85 53.84 Favored Glycine 0 N--CA 1.43 -1.722 0 C-N-CA 119.722 -1.227 . . . . 0.0 113.308 -176.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.8 p -156.54 130.78 8.61 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 85.5 mt -124.11 117.46 24.71 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 175.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.0 m -133.45 113.49 13.18 Favored Pre-proline 0 C--N 1.293 -1.859 0 CA-C-O 120.407 0.146 . . . . 0.0 110.947 175.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -75.07 162.22 93.25 Favored 'Cis proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.179 -1.592 . . . . 0.0 111.336 -0.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.58 159.29 24.48 Favored 'Trans proline' 0 C--O 1.245 0.842 0 C-N-CA 122.705 2.27 . . . . 0.0 111.615 177.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.497 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 43.9 m0 -88.93 138.91 30.98 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 21.8 p -116.66 78.52 8.93 Favored Pre-proline 0 C--N 1.3 -1.584 0 O-C-N 123.579 0.55 . . . . 0.0 110.747 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.79 153.17 22.7 Favored 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 122.001 1.8 . . . . 0.0 112.589 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.67 -27.11 18.14 Favored Glycine 0 N--CA 1.425 -2.094 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.4 p -155.1 151.73 28.66 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.7 t -132.17 142.65 42.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 35.8 t -145.53 146.78 31.56 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 119.577 -0.849 . . . . 0.0 111.647 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.0 t -113.61 124.66 30.81 Favored Pre-proline 0 N--CA 1.435 -1.209 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 176.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -59.58 145.61 97.56 Favored 'Trans proline' 0 C--O 1.244 0.798 0 C-N-CA 123.115 2.543 . . . . 0.0 112.587 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -74.06 114.75 12.73 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.172 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 91.9 t -95.66 115.73 35.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -110.26 8.16 23.44 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 122.423 1.106 . . . . 0.0 108.713 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.76 145.02 56.55 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.884 -178.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.8 m -67.85 -7.09 25.06 Favored 'General case' 0 CA--C 1.566 1.587 0 C-N-CA 124.995 1.318 . . . . 0.0 110.882 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -51.96 133.47 32.51 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 124.884 1.274 . . . . 0.0 110.311 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.3 tpp180 -70.59 -26.6 63.59 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.179 -172.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -111.33 134.16 53.12 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 122.707 0.403 . . . . 0.0 110.154 176.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.8 153.82 37.95 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 170.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.11 135.12 12.04 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 C-N-CA 121.958 1.772 . . . . 0.0 111.367 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -130.06 136.3 49.21 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.624 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 85.2 m95 -119.21 133.55 55.7 Favored 'General case' 0 C--N 1.291 -1.953 0 C-N-CA 120.134 -0.626 . . . . 0.0 112.241 -173.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 86' ' ' THR . 33.7 m-85 -114.9 140.16 49.21 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.143 177.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.6 mt -125.28 142.74 51.32 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -175.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 78.7 m-85 -133.35 142.28 48.34 Favored 'General case' 0 C--N 1.317 -0.833 0 O-C-N 123.576 0.548 . . . . 0.0 110.423 -175.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -85.27 0.01 53.3 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 120.767 0.317 . . . . 0.0 111.049 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -137.47 158.87 43.47 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.4 m -71.59 166.6 2.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 C-N-CA 122.99 0.516 . . . . 0.0 111.577 -175.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 57.87 30.13 18.6 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.008 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.419 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 9.3 m-85 58.74 47.11 13.3 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 125.019 1.327 . . . . 0.0 111.235 177.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 73.2 p -118.37 173.5 6.78 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.18 -133.34 11.72 Favored Glycine 0 N--CA 1.433 -1.512 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.933 176.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.45 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 56.0 mtt85 -80.83 148.67 29.87 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 123.143 0.577 . . . . 0.0 109.618 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.4 tt -127.27 137.58 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 -177.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 98.2 m -131.24 126.08 34.54 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 176.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -115.16 115.29 3.4 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.491 -0.861 . . . . 0.0 113.745 -177.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -108.32 144.81 35.35 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 122.466 0.306 . . . . 0.0 110.771 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.17 170.76 13.46 Favored Glycine 0 N--CA 1.429 -1.772 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.003 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -64.33 130.75 45.01 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.315 0.578 . . . . 0.0 111.918 -176.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.71 8.23 80.3 Favored Glycine 0 N--CA 1.428 -1.84 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.794 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.3 m -121.32 146.25 47.04 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.9 m -136.33 156.93 47.94 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 50.5 mt -93.59 127.84 45.39 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 172.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -69.07 -46.91 66.64 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.579 0.704 . . . . 0.0 109.447 -177.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.486 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 3.9 m-20 -139.73 98.98 3.59 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.205 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -65.08 -37.75 88.53 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.337 0.589 . . . . 0.0 110.672 178.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.7 t -69.53 -17.93 63.62 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.461 -177.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.486 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 28.9 mmtp -89.95 -6.19 55.94 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.638 -0.664 . . . . 0.0 109.386 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.0 t -85.02 -163.78 0.89 Allowed 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.41 -68.19 1.78 Allowed Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 116.798 -0.183 . . . . 0.0 113.151 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -110.61 147.61 33.91 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 122.488 -0.419 . . . . 0.0 109.917 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -112.43 -0.52 15.28 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.103 177.331 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.497 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -119.19 113.95 2.66 Favored Glycine 0 N--CA 1.436 -1.35 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.812 -176.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 69.2 mt -95.8 116.3 37.17 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.593 0 CA-C-O 122.312 1.053 . . . . 0.0 109.614 -178.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.4 m -85.62 -28.6 24.68 Favored 'General case' 0 N--CA 1.395 -3.193 0 CA-C-N 112.206 -2.27 . . . . 0.0 114.13 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 84.1 p -156.45 156.37 33.67 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 177.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.4 mt -135.18 130.81 51.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -176.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.419 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 37.3 ttmt -117.14 128.19 54.88 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -95.49 129.49 42.64 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 121.631 0.729 . . . . 0.0 109.213 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 82.2 m -125.55 172.68 9.52 Favored 'General case' 0 C--N 1.273 -2.739 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.875 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 7.6 pt -129.03 142.47 43.96 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.477 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -110.91 122.63 48.35 Favored 'General case' 0 C--N 1.278 -2.508 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 82.4 p -77.88 176.54 8.99 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.61 -174.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -66.96 -20.11 65.84 Favored 'General case' 0 C--N 1.316 -0.885 0 O-C-N 122.141 -0.35 . . . . 0.0 111.153 174.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.481 ' OD1' ' HG2' ' A' ' 118' ' ' LYS . 2.1 p30 -86.88 -7.61 58.05 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.264 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 94.17 -0.97 66.87 Favored Glycine 0 N--CA 1.441 -1.003 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.662 175.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.481 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 52.6 pttt -77.87 149.01 34.37 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 119.093 -1.043 . . . . 0.0 109.566 176.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.2 t -109.04 112.04 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.503 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -93.82 144.8 25.1 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 76.9 m -130.43 162.63 28.72 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.287 -175.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 7.5 tp -75.37 132.13 33.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -75.34 105.17 6.23 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-O 121.175 0.512 . . . . 0.0 110.378 -177.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 . . . . . 0 C--N 1.3 -1.551 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -177.393 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.901 0 N-CA-C 112.019 -0.433 . . . . 0.0 112.019 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.96 -22.34 64.12 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.639 0.733 . . . . 0.0 110.844 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -76.97 -12.74 59.98 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.432 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 43.7 m -110.68 147.91 33.36 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.7 p -102.32 146.86 27.42 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.236 177.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -69.19 127.97 34.99 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.423 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.403 ' CD1' ' HB3' ' A' ' 71' ' ' PRO . 2.3 m-85 74.0 39.04 0.54 Allowed 'General case' 0 N--CA 1.483 1.211 0 O-C-N 123.958 0.786 . . . . 0.0 111.764 176.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 36.7 m -123.82 154.68 39.24 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.548 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 44.0 tp -105.02 121.92 44.78 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 176.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 41.0 mt-30 -111.86 124.07 51.59 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.8 mp -110.26 123.88 50.6 Favored 'General case' 0 N--CA 1.42 -1.927 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.15 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -88.85 149.07 23.55 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -74.04 -38.42 64.01 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 120.983 0.42 . . . . 0.0 111.059 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -107.84 177.35 4.84 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.223 -176.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.454 HG22 ' HA ' ' A' ' 96' ' ' ASP . 1.0 OUTLIER -81.72 172.72 13.06 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.936 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.268 21.9 p90 47.49 37.8 6.87 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.793 1.237 . . . . 0.0 113.501 177.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 65.26 27.97 12.05 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 125.109 1.364 . . . . 0.0 113.717 178.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -97.55 172.67 7.58 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.426 0.631 . . . . 0.0 110.656 177.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.41 -166.17 37.92 Favored Glycine 0 N--CA 1.424 -2.158 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.3 m -100.68 176.76 5.2 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 173.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -143.89 165.34 28.01 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 120.469 -0.493 . . . . 0.0 110.843 -174.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.493 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 18.2 tt -114.31 152.72 15.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -107.21 125.62 51.35 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 98.7 t -119.71 136.71 55.96 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.384 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 177.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -117.43 -28.01 6.21 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.883 -176.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -107.47 163.04 13.4 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 -173.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.5 p -89.6 141.69 28.37 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 172.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.3 p -120.55 132.91 68.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -174.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.96 -1.7 57.19 Favored Glycine 0 C--N 1.313 -0.746 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.456 -176.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.0 t -166.7 129.58 1.86 Allowed 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.067 0.46 . . . . 0.0 109.906 176.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 85.1 mt -122.41 117.78 26.82 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.0 m -133.25 112.8 13.22 Favored Pre-proline 0 C--N 1.288 -2.09 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 174.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.62 161.86 93.58 Favored 'Cis proline' 0 CA--C 1.549 1.249 0 C-N-CA 123.333 -1.528 . . . . 0.0 111.326 -1.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.81 158.33 43.14 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.948 2.432 . . . . 0.0 110.87 177.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.512 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 48.2 m0 -90.23 143.81 26.43 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -178.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 18.3 p -121.48 76.82 35.38 Favored Pre-proline 0 C--N 1.308 -1.203 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -81.18 157.64 20.09 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.806 2.337 . . . . 0.0 112.624 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.0 -28.38 11.04 Favored Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.3 p -157.33 154.93 29.78 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.7 t -131.61 145.42 35.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -176.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 39.3 t -145.59 147.36 31.99 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.927 176.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.9 t -112.71 126.79 27.74 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 176.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -60.61 150.48 81.73 Favored 'Trans proline' 0 C--O 1.248 1.0 0 C-N-CA 122.983 2.455 . . . . 0.0 112.304 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.537 ' CE1' ' HB2' ' A' ' 64' ' ' ASN . 45.1 t80 -74.36 132.32 41.91 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.956 0.884 . . . . 0.0 111.555 -177.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 99.0 t -123.22 117.78 52.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.537 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 61.7 t30 -118.6 8.25 11.93 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 123.373 1.559 . . . . 0.0 106.842 178.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -60.21 145.03 48.68 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 112.413 -2.176 . . . . 0.0 113.539 -174.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 m -60.73 -7.12 2.06 Favored 'General case' 0 CA--C 1.564 1.509 0 C-N-CA 126.248 1.819 . . . . 0.0 112.568 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -58.54 142.84 47.89 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -74.33 -25.4 59.53 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.866 -174.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -110.71 133.8 53.02 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.87 0.367 . . . . 0.0 111.74 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.32 150.33 37.0 Favored Pre-proline 0 C--N 1.307 -1.242 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 168.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.403 ' HB3' ' CD1' ' A' ' 25' ' ' TYR . 93.9 Cg_endo -80.28 137.0 11.67 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.025 1.816 . . . . 0.0 111.813 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -132.17 137.72 47.75 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.548 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 89.9 m95 -122.07 132.43 54.49 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.16 0.505 . . . . 0.0 111.981 -174.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 86' ' ' THR . 24.2 m-85 -112.74 142.77 44.98 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.434 177.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.5 mt -125.62 142.25 51.61 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -175.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.493 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 93.2 m-85 -132.85 141.47 48.45 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.403 0.62 . . . . 0.0 111.158 -175.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.766 ' HB2' ' CD2' ' A' ' 102' ' ' PHE . 9.0 t70 -85.99 -6.53 59.03 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.544 -177.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -140.06 156.87 46.4 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.727 173.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.736 ' HA ' ' OG ' ' A' ' 107' ' ' SER . 23.6 m -64.46 162.24 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.945 0 C-N-CA 123.655 0.782 . . . . 0.0 112.214 -175.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.44 29.86 17.19 Favored 'General case' 0 CA--C 1.511 -0.551 0 O-C-N 123.859 0.724 . . . . 0.0 109.305 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.426 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 16.1 m-85 56.49 50.93 12.08 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 114.433 -1.258 . . . . 0.0 111.415 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 60.5 p -123.52 177.59 5.58 Favored 'General case' 0 C--O 1.249 1.047 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.762 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.95 -107.96 3.53 Favored Glycine 0 N--CA 1.437 -1.267 0 N-CA-C 111.822 -0.511 . . . . 0.0 111.822 176.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 58.6 mtt85 -114.08 151.86 31.91 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.7 tt -128.65 140.04 50.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 O-C-N 123.712 0.632 . . . . 0.0 111.08 -174.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 24.4 m -132.49 125.42 30.61 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.429 174.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -115.17 107.25 1.73 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.83 -0.7 . . . . 0.0 114.321 -178.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -106.32 145.69 31.34 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 123.045 0.538 . . . . 0.0 111.468 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -123.33 172.64 16.17 Favored Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.678 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -50.23 127.86 18.06 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 124.262 1.025 . . . . 0.0 112.757 -177.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.97 -0.19 88.8 Favored Glycine 0 C--N 1.309 -0.925 0 CA-C-N 115.546 -0.752 . . . . 0.0 113.251 174.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.3 m -110.82 145.9 37.37 Favored 'General case' 0 N--CA 1.421 -1.92 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.543 -177.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.6 m -136.21 156.7 48.3 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 55.2 mt -92.81 135.81 26.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 176.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -70.53 -48.52 55.08 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.506 0.67 . . . . 0.0 110.421 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.454 ' HA ' HG22 ' A' ' 33' ' ' THR . 3.2 m-20 -143.23 99.12 3.38 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -178.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -64.85 -38.37 90.76 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 121.263 0.554 . . . . 0.0 110.817 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.5 t -65.96 -21.01 66.39 Favored 'General case' 0 CA--C 1.558 1.257 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.903 -175.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.452 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 30.0 mmtp -92.83 -7.82 45.26 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.8 t -83.49 7.29 17.46 Favored 'General case' 0 C--O 1.25 1.123 0 CA-C-O 121.065 0.46 . . . . 0.0 111.492 -176.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 115.56 -62.51 0.35 Allowed Glycine 0 N--CA 1.436 -1.362 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 177.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.766 ' CD2' ' HB2' ' A' ' 77' ' ' ASP . 22.7 p90 -110.89 142.59 42.74 Favored 'General case' 0 N--CA 1.427 -1.59 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.144 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -114.01 -8.31 13.07 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -112.55 112.93 3.11 Favored Glycine 0 N--CA 1.422 -2.267 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.954 -174.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 70.1 mt -95.22 115.55 34.42 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 52.3 m -85.43 -26.69 26.22 Favored 'General case' 0 C--N 1.252 -3.652 0 CA-C-N 112.228 -2.26 . . . . 0.0 113.339 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.736 ' OG ' ' HA ' ' A' ' 79' ' ' VAL . 66.6 m -156.29 152.35 27.58 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.215 -0.303 . . . . 0.0 110.794 -177.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.3 mt -135.3 130.19 50.74 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.539 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -176.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.426 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 33.9 ttmt -117.53 131.18 56.75 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -101.42 123.37 45.38 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -177.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 36.1 m -119.71 171.15 8.59 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.4 pt -129.35 146.2 34.57 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 56.4 tt0 -117.79 118.21 31.42 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 17.2 p -78.8 179.67 7.08 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.253 -173.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -58.97 -28.21 66.1 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.635 0.731 . . . . 0.0 110.548 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -77.02 -7.99 56.63 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.9 -176.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.53 6.84 87.04 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.483 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 113' ' ' GLN . 26.2 pttm -87.84 139.28 30.69 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.0 t -103.22 112.44 36.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -102.78 146.01 28.89 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -138.88 149.08 44.46 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.307 -0.957 . . . . 0.0 109.663 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 6.2 tp -126.32 127.56 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.416 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.424 ' OD1' ' HE1' ' A' ' 81' ' ' TYR . 7.2 t30 -84.45 104.78 14.75 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 173.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 . . . . . 0 C--N 1.295 -1.792 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.28 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.741 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.84 49.2 1.57 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.984 0.897 . . . . 0.0 109.36 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -81.32 -16.24 53.02 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.777 -1.102 . . . . 0.0 110.706 -177.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.9 m -55.6 125.09 19.59 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.2 p -102.52 157.25 17.06 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.13 0.49 . . . . 0.0 112.129 -173.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -70.19 126.22 29.05 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.498 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 64.51 43.71 4.35 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 175.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.4 m -123.32 146.66 47.73 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.606 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 53.8 tp -92.52 121.32 33.85 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 172.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 65.0 mt-30 -114.17 123.7 50.24 Favored 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.635 -177.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 2.8 mp -110.34 119.08 38.06 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.339 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -82.04 145.01 30.44 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 123.521 0.513 . . . . 0.0 110.21 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -69.27 -39.79 78.17 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.598 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -108.37 177.39 4.81 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.428 HG23 ' HA ' ' A' ' 96' ' ' ASP . 1.1 p -83.1 177.18 8.7 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 122.601 0.36 . . . . 0.0 110.602 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.262 16.6 p90 47.39 42.2 13.76 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.886 1.275 . . . . 0.0 113.881 176.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 63.56 27.97 15.1 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.241 176.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.518 ' HA ' ' NE ' ' A' ' 36' ' ' ARG . 3.7 mmp_? -108.5 166.32 10.86 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.317 0.58 . . . . 0.0 110.969 178.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.38 173.74 47.29 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -177.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.3 p -86.28 154.78 21.01 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 40.8 p90 -117.6 165.84 13.09 Favored 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.218 -176.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.488 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.8 tt -114.23 153.26 15.77 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 178.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -105.96 126.03 51.7 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.504 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 92.8 t -123.33 133.4 69.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -118.08 -21.7 8.14 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.055 0.455 . . . . 0.0 110.668 -175.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -129.24 162.18 28.46 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.317 -175.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.2 p -79.02 146.25 33.43 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.839 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.9 p -121.46 137.28 55.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.3 -18.43 39.17 Favored Glycine 0 C--N 1.316 -0.543 0 C-N-CA 119.903 -1.141 . . . . 0.0 113.864 -176.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.3 t -161.18 132.14 5.34 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.1 mt -121.31 118.94 30.77 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.313 178.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.5 m -132.61 110.42 13.5 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 175.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -76.71 160.24 95.28 Favored 'Cis proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.171 -1.595 . . . . 0.0 111.38 0.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.02 158.24 48.73 Favored 'Trans proline' 0 C--O 1.24 0.616 0 C-N-CA 122.31 2.006 . . . . 0.0 110.84 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 52.7 m0 -89.73 136.65 32.91 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 120.351 -0.54 . . . . 0.0 109.881 -177.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 20.2 p -118.73 77.07 14.35 Favored Pre-proline 0 N--CA 1.435 -1.207 0 O-C-N 123.493 0.495 . . . . 0.0 111.757 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -76.4 158.52 36.68 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.387 2.058 . . . . 0.0 111.972 177.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -92.84 -31.58 8.56 Favored Glycine 0 N--CA 1.431 -1.685 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 175.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 94' ' ' ILE . 34.8 p -152.01 153.14 33.44 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 36.7 t -128.91 142.77 43.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -177.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 37.2 t -145.75 147.29 31.75 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.124 177.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 68.2 t -114.13 121.16 37.14 Favored Pre-proline 0 C--N 1.306 -1.296 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 175.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.03 148.17 78.55 Favored 'Trans proline' 0 C--O 1.246 0.905 0 C-N-CA 122.997 2.465 . . . . 0.0 112.315 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.412 ' CE2' ' HB3' ' A' ' 64' ' ' ASN . 76.4 t80 -71.63 111.56 7.03 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.36 0.6 . . . . 0.0 110.594 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.7 t -94.51 115.29 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.98 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.585 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.412 ' HB3' ' CE2' ' A' ' 62' ' ' PHE . 23.7 p-10 -114.73 25.05 11.28 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 125.673 1.589 . . . . 0.0 108.14 178.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.53 ' HB3' ' NH2' ' A' ' 70' ' ' ARG . 16.6 t70 -66.92 146.22 54.63 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 112.867 -1.969 . . . . 0.0 112.396 -176.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.7 m -53.53 -18.49 2.85 Favored 'General case' 0 CA--C 1.57 1.745 0 C-N-CA 125.203 1.401 . . . . 0.0 113.747 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.502 ' HG2' ' OD2' ' A' ' 65' ' ' ASP . 33.4 mmtp -66.52 167.66 10.45 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.773 -0.579 . . . . 0.0 110.132 174.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -106.07 -15.91 14.76 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 175.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.3 mp0 -92.39 128.31 38.2 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.788 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.53 ' NH2' ' HB3' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -106.1 154.18 39.76 Favored Pre-proline 0 C--N 1.291 -1.966 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.306 178.625 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -81.9 135.1 8.64 Favored 'Trans proline' 0 N--CA 1.44 -1.629 0 C-N-CA 121.632 1.555 . . . . 0.0 111.002 178.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -129.12 120.91 26.7 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.606 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 87.0 m95 -106.66 133.93 50.59 Favored 'General case' 0 C--N 1.278 -2.543 0 CA-C-O 121.034 0.445 . . . . 0.0 111.953 -171.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.491 ' HA ' ' O ' ' A' ' 86' ' ' THR . 29.5 m-85 -112.39 140.56 47.01 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.499 177.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.4 mt -125.6 142.37 51.54 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -177.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.507 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 80.5 m-85 -134.48 140.84 46.5 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 123.892 0.745 . . . . 0.0 109.599 -176.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.37 -12.19 59.06 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.51 -177.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.502 ' C ' ' HB3' ' A' ' 106' ' ' SER . 5.1 t-20 -123.25 172.51 8.57 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.8 m -76.23 168.83 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 C-N-CA 123.415 0.686 . . . . 0.0 111.591 -176.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 53.83 30.53 11.53 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.121 0.969 . . . . 0.0 112.431 176.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.52 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 8.2 m-85 63.0 39.44 10.19 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.577 176.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 81.4 p -111.91 170.65 8.0 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.67 -145.31 17.56 Favored Glycine 0 N--CA 1.429 -1.781 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.609 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.507 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 98.0 mtt180 -75.59 147.84 39.29 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 123.128 0.571 . . . . 0.0 109.636 178.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.5 tt -125.38 136.5 60.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 121.705 0.764 . . . . 0.0 110.442 -175.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 93.5 m -131.39 125.16 31.9 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.615 176.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -115.01 118.01 4.19 Favored Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.309 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -112.53 146.0 39.29 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 123.3 0.64 . . . . 0.0 111.146 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -117.94 172.89 14.57 Favored Glycine 0 N--CA 1.434 -1.474 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.127 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.419 ' CD2' ' HG2' ' A' ' 70' ' ' ARG . 2.6 p80 -62.46 132.43 52.47 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 121.272 0.558 . . . . 0.0 111.906 -176.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.8 15.17 79.84 Favored Glycine 0 N--CA 1.43 -1.7 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.766 176.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.8 m -127.22 146.2 50.5 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.7 m -137.55 156.34 48.21 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.413 ' O ' ' HB2' ' A' ' 57' ' ' SER . 46.0 mt -95.31 127.03 47.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 170.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -71.77 -46.34 58.71 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.354 0.597 . . . . 0.0 111.926 177.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.487 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 1.7 m-20 -129.4 96.11 4.2 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.144 178.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -64.69 -35.03 79.73 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.56 0.695 . . . . 0.0 110.34 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.4 t -67.66 -29.32 68.58 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.159 -175.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.487 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 29.4 mmtp -88.39 -6.68 57.54 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -178.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.1 m -80.64 -13.29 59.16 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.882 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 139.02 -70.47 0.46 Allowed Glycine 0 N--CA 1.431 -1.678 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -110.32 146.46 35.7 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.533 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -112.4 -9.96 13.8 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.715 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -109.48 115.54 4.27 Favored Glycine 0 N--CA 1.427 -1.932 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.747 -176.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 79.1 mt -98.77 116.27 41.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.502 ' HB3' ' C ' ' A' ' 78' ' ' ASN . 7.6 t -85.82 -29.9 23.4 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.52 177.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 93.6 p -148.57 155.4 41.06 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 121.872 -0.517 . . . . 0.0 111.273 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.1 mt -133.27 133.71 57.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -176.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.52 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 38.9 ttmt -116.13 132.97 56.51 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 -102.77 118.25 36.42 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 64.6 m -120.14 170.23 9.5 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.2 pt -128.63 141.7 45.88 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.536 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -113.02 122.62 48.15 Favored 'General case' 0 C--N 1.268 -2.967 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.463 ' OG1' ' HG2' ' A' ' 118' ' ' LYS . 30.8 p -76.4 -179.19 5.0 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -177.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -59.07 -29.72 67.54 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.31 0.576 . . . . 0.0 110.38 177.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -76.96 -9.1 58.46 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.782 -175.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.66 8.71 84.24 Favored Glycine 0 N--CA 1.421 -2.307 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.14 -176.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.463 ' HG2' ' OG1' ' A' ' 114' ' ' THR . 9.4 ptpp? -84.02 138.38 33.12 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 26.1 t -107.07 112.09 38.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.584 0.707 . . . . 0.0 111.356 -174.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -101.02 153.04 19.88 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 177.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 85.6 m -130.02 149.19 51.85 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.331 -175.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 10.3 tp -83.74 128.01 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -177.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -83.13 105.09 13.82 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -178.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 . . . . . 0 C--N 1.286 -2.186 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.404 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.099 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.32 -70.85 0.25 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 117.791 0.796 . . . . 0.0 109.944 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -113.55 -24.46 9.23 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 174.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.0 m -86.09 146.77 26.47 Favored 'General case' 0 N--CA 1.417 -2.088 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.618 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 47.9 t -143.13 137.58 29.2 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -77.26 102.25 6.6 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -177.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.468 ' CD2' ' HB3' ' A' ' 71' ' ' PRO . 4.7 m-85 70.5 50.65 0.38 Allowed 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.289 172.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.1 m -126.98 153.54 45.75 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.196 -1.366 . . . . 0.0 107.976 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.586 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 53.0 tp -111.58 130.1 55.85 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 107.024 -1.472 . . . . 0.0 107.024 175.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.503 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 73.3 mt-30 -117.42 124.01 47.8 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.701 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 3.0 mp -110.47 121.93 46.5 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.163 178.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -87.8 151.92 22.51 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 123.577 0.548 . . . . 0.0 110.45 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -74.77 -39.98 61.47 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.091 -178.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -108.46 178.37 4.51 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.416 HG22 ' HA ' ' A' ' 96' ' ' ASP . 2.2 p -80.71 173.38 12.66 Favored 'General case' 0 N--CA 1.413 -2.31 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.594 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.276 21.6 p90 47.11 43.23 14.05 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 124.731 1.212 . . . . 0.0 114.231 177.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 65.97 23.11 11.23 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 124.379 1.072 . . . . 0.0 112.044 175.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.428 ' NE ' ' HA ' ' A' ' 36' ' ' ARG . 5.6 mmp_? -100.48 167.85 10.11 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.385 0.612 . . . . 0.0 112.279 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.02 -166.26 48.3 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -175.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.7 m -90.88 175.37 7.01 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 37.6 p90 -137.17 165.08 26.95 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 16.7 tt -114.6 152.61 16.21 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 176.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -107.05 124.95 50.39 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 175.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.515 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 94.2 t -114.03 133.64 59.4 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.555 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 177.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -115.06 -33.54 5.36 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.468 0.651 . . . . 0.0 110.028 -174.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.92 161.44 25.38 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.692 -177.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 p -75.72 149.25 38.09 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.465 0.65 . . . . 0.0 112.102 -176.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.6 p -121.18 137.38 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.98 -18.9 35.51 Favored Glycine 0 C--N 1.299 -1.478 0 C-N-CA 120.13 -1.033 . . . . 0.0 112.617 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.1 t -159.52 131.38 6.33 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 121.032 0.444 . . . . 0.0 110.159 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 91.1 mt -119.65 118.02 29.84 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.653 177.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.2 t -132.77 114.07 14.09 Favored Pre-proline 0 N--CA 1.419 -2.017 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 174.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.81 161.87 93.88 Favored 'Cis proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.997 -1.668 . . . . 0.0 110.417 -2.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -63.18 156.08 57.54 Favored 'Trans proline' 0 C--O 1.257 1.441 0 C-N-CA 121.85 1.7 . . . . 0.0 110.636 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.475 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 45.5 m0 -89.1 135.4 33.58 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -177.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.559 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 15.3 p -116.18 76.58 6.73 Favored Pre-proline 0 C--N 1.292 -1.918 0 O-C-N 123.362 0.413 . . . . 0.0 111.318 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.12 157.6 33.94 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 122.5 2.133 . . . . 0.0 112.903 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.69 -33.4 10.09 Favored Glycine 0 N--CA 1.431 -1.665 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.7 p -154.27 144.95 22.4 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.2 t -119.95 142.8 33.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -178.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 33.6 t -145.4 147.5 32.32 Favored 'General case' 0 N--CA 1.422 -1.84 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.228 177.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 80.5 t -111.35 122.3 37.97 Favored Pre-proline 0 C--N 1.296 -1.743 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 176.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -58.78 149.23 78.99 Favored 'Trans proline' 0 C--O 1.243 0.764 0 C-N-CA 122.892 2.395 . . . . 0.0 112.246 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -79.02 135.3 36.85 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 82.3 t -113.48 114.06 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 CA-C-O 120.981 0.42 . . . . 0.0 110.348 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -109.35 84.33 1.91 Allowed 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 173.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.688 ' OD1' ' HG2' ' A' ' 67' ' ' LYS . 12.0 t70 -128.27 145.97 50.89 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.633 -172.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.2 m -53.84 -19.52 4.52 Favored 'General case' 0 CA--C 1.59 2.513 0 C-N-CA 125.121 1.368 . . . . 0.0 113.298 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.688 ' HG2' ' OD1' ' A' ' 65' ' ' ASP . 23.5 mmtp -64.13 176.63 0.96 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.724 -0.61 . . . . 0.0 112.272 178.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 66.8 mtm180 -102.68 -29.13 11.71 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.94 0.876 . . . . 0.0 109.642 -176.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.0 134.55 50.75 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.783 -173.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.657 ' NH2' ' HB2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -104.38 153.93 38.71 Favored Pre-proline 0 C--N 1.297 -1.696 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.185 -179.231 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.468 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 93.3 Cg_endo -77.4 140.73 19.58 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.615 1.543 . . . . 0.0 112.122 178.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -133.49 133.78 42.66 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 -178.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.586 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 83.2 m95 -117.3 135.45 53.82 Favored 'General case' 0 C--N 1.288 -2.092 0 O-C-N 121.731 -0.605 . . . . 0.0 112.39 -172.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.424 ' HA ' ' O ' ' A' ' 86' ' ' THR . 33.4 m-85 -113.05 141.93 46.3 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.91 177.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.2 mt -126.11 142.53 51.48 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.514 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 86.3 m-85 -133.59 141.92 47.89 Favored 'General case' 0 C--N 1.316 -0.884 0 O-C-N 123.72 0.638 . . . . 0.0 110.055 -177.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.428 ' HB3' ' CG ' ' A' ' 102' ' ' PHE . 0.8 OUTLIER -85.45 0.09 53.31 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -178.984 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -137.73 159.7 41.26 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 174.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.7 m -70.96 166.32 2.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 C-N-CA 122.626 0.37 . . . . 0.0 111.656 -174.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 58.07 30.8 19.82 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.798 0.839 . . . . 0.0 111.769 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.424 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 12.6 m-85 60.13 44.66 12.68 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.421 176.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 74.9 p -115.57 168.28 10.15 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.26 -141.4 17.49 Favored Glycine 0 N--CA 1.426 -2.021 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.807 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 57.1 mtt180 -77.33 135.85 38.41 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 123.083 0.553 . . . . 0.0 109.771 -177.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.8 tt -115.24 136.75 50.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.348 -175.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 96.9 m -131.9 123.2 26.98 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.172 176.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -110.06 123.89 6.9 Favored Glycine 0 N--CA 1.438 -1.183 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.362 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -115.77 145.66 42.61 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 123.159 0.584 . . . . 0.0 110.511 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.54 167.46 12.53 Favored Glycine 0 N--CA 1.423 -2.218 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.711 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -55.75 125.42 21.15 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 123.815 0.846 . . . . 0.0 112.429 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.16 3.82 84.63 Favored Glycine 0 N--CA 1.431 -1.675 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.336 176.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.9 m -113.57 146.53 39.55 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.4 m -136.75 158.0 45.45 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 56.1 mt -93.4 132.44 37.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 173.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -70.02 -47.42 62.17 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.605 0.717 . . . . 0.0 110.14 -176.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.416 ' HA ' HG22 ' A' ' 33' ' ' THR . 5.6 m-20 -138.89 102.65 4.61 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 176.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.43 ' HZ ' ' CE2' ' A' ' 102' ' ' PHE . 59.3 t80 -64.66 -32.68 74.46 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.402 0.62 . . . . 0.0 110.399 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.9 t -63.54 -24.94 68.02 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.721 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -93.67 -5.81 47.76 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 121.308 0.575 . . . . 0.0 109.572 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.8 t -84.71 31.17 0.54 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.302 0.641 . . . . 0.0 110.439 -177.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.7 -71.91 1.73 Allowed Glycine 0 N--CA 1.437 -1.288 0 C-N-CA 121.263 -0.494 . . . . 0.0 111.972 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.43 ' CE2' ' HZ ' ' A' ' 97' ' ' PHE . 35.0 p90 -109.96 148.37 31.75 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.559 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.43 -6.99 13.47 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.738 179.668 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -116.95 116.59 3.59 Favored Glycine 0 N--CA 1.429 -1.831 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.377 -176.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 64.9 mt -94.78 115.83 34.6 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.675 0 CA-C-O 122.342 1.068 . . . . 0.0 108.888 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.4 m -85.45 -25.07 27.16 Favored 'General case' 0 N--CA 1.39 -3.436 0 CA-C-N 112.425 -2.171 . . . . 0.0 114.252 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.5 p -158.0 152.88 25.22 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 122.076 -0.39 . . . . 0.0 110.014 176.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.8 mt -130.97 131.04 64.32 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -176.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.424 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 36.1 ttmt -116.53 132.82 56.58 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -100.19 129.95 46.27 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 66.7 m -131.0 172.15 12.4 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.7 pt -127.51 140.7 48.39 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -109.16 119.7 40.32 Favored 'General case' 0 C--N 1.276 -2.61 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 71.3 p -74.0 173.6 9.78 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.808 -175.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -66.92 -19.04 65.65 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 121.842 0.83 . . . . 0.0 109.652 175.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -84.68 -8.14 58.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.801 0.81 . . . . 0.0 110.354 177.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.99 -11.53 71.87 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 120.843 -0.694 . . . . 0.0 113.08 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -71.93 134.69 46.15 Favored 'General case' 0 C--O 1.254 1.342 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.7 t -99.51 111.85 30.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -95.29 134.93 37.51 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 48.8 m -131.01 156.37 45.24 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 8.9 tp -103.7 120.11 53.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 C-N-CA 119.879 -0.728 . . . . 0.0 110.319 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -72.97 114.13 10.77 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.497 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 . . . . . 0 C--N 1.292 -1.897 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.584 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.13 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.92 -17.94 62.45 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -175.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -77.75 5.25 9.77 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -177.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 57.7 m -52.28 128.93 26.73 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-O 121.963 0.887 . . . . 0.0 113.092 -177.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.0 p -102.56 166.44 10.52 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.863 -178.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.8 mmmm -107.92 -32.28 7.65 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-O 121.766 0.793 . . . . 0.0 111.549 -177.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -121.06 68.58 0.88 Allowed 'General case' 0 C--N 1.279 -2.464 0 CA-C-O 122.315 1.055 . . . . 0.0 110.111 -175.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.518 ' SG ' ' HG3' ' A' ' 61' ' ' PRO . 3.9 p -144.74 160.16 41.68 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 113.681 -1.599 . . . . 0.0 109.82 -178.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.618 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 54.3 tp -111.93 118.53 35.75 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 173.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.45 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 66.7 mt-30 -109.33 123.65 49.64 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.251 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 2.9 mp -110.35 121.73 46.0 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.672 177.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.437 ' CD1' ' HB3' ' A' ' 39' ' ' TYR . 90.4 m-85 -93.12 157.26 16.38 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 123.609 0.568 . . . . 0.0 111.781 -175.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -81.14 -35.13 31.91 Favored 'General case' 0 CA--C 1.494 -1.175 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.865 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -108.23 178.09 4.61 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.3 p -81.39 172.07 14.0 Favored 'General case' 0 N--CA 1.401 -2.899 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.35 178.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 21.2 p90 47.26 38.93 7.75 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.892 1.277 . . . . 0.0 114.205 176.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 65.41 22.41 11.94 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.551 1.541 . . . . 0.0 114.506 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.18 173.62 7.63 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.255 0.55 . . . . 0.0 111.485 175.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.18 -152.75 34.87 Favored Glycine 0 N--CA 1.426 -2.021 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 -174.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.7 m -108.78 178.51 4.46 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 173.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.437 ' HB3' ' CD1' ' A' ' 30' ' ' TYR . 29.9 p90 -143.53 166.79 23.82 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.095 0.474 . . . . 0.0 110.157 -177.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.0 tt -114.53 152.81 16.13 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.545 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 176.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -106.84 125.54 51.14 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 176.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.461 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 99.4 t -122.6 134.55 65.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -126.09 -2.85 7.02 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.771 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -139.44 162.54 34.8 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -173.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 p -84.42 144.86 28.5 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-O 120.991 0.424 . . . . 0.0 111.599 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.7 p -119.78 137.72 52.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.68 -21.63 30.81 Favored Glycine 0 N--CA 1.433 -1.526 0 C-N-CA 120.072 -1.061 . . . . 0.0 112.389 -177.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.0 p -157.79 129.04 6.66 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-O 121.07 0.462 . . . . 0.0 112.014 -178.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.1 mt -118.5 118.47 31.8 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 175.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.5 m -132.27 114.61 14.84 Favored Pre-proline 0 C--N 1.299 -1.6 0 O-C-N 123.393 0.433 . . . . 0.0 110.08 175.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -76.91 159.41 95.99 Favored 'Cis proline' 0 C--O 1.246 0.899 0 C-N-CA 122.944 -1.69 . . . . 0.0 110.371 -1.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -62.34 157.66 44.45 Favored 'Trans proline' 0 C--O 1.252 1.209 0 C-N-CA 122.482 2.121 . . . . 0.0 111.349 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.425 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 48.8 m0 -89.47 140.27 29.69 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -177.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 35.5 p -123.8 73.78 54.68 Favored Pre-proline 0 C--N 1.305 -1.364 0 O-C-N 123.46 0.475 . . . . 0.0 110.561 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -74.2 156.5 46.63 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 122.354 2.036 . . . . 0.0 113.653 -178.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -83.77 -34.28 19.29 Favored Glycine 0 N--CA 1.431 -1.633 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 177.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.0 p -153.83 154.97 34.92 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.3 t -130.45 142.31 44.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 35.5 t -146.07 152.32 39.14 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.696 176.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 95.4 t -117.2 125.21 28.38 Favored Pre-proline 0 C--N 1.313 -0.991 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 176.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.518 ' HG3' ' SG ' ' A' ' 26' ' ' CYS . 5.9 Cg_exo -49.68 141.31 27.49 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 123.471 2.78 . . . . 0.0 113.288 178.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -75.24 113.47 12.64 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 121.676 0.75 . . . . 0.0 109.868 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.422 ' H ' ' HB2' ' A' ' 90' ' ' HIS . 78.4 t -94.54 125.31 47.18 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.513 -179.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -127.88 12.16 6.71 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 124.428 1.08 . . . . 0.0 108.696 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -57.93 147.04 30.18 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.464 1.506 . . . . 0.0 113.28 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.3 m -53.59 -12.9 0.54 Allowed 'General case' 0 CA--C 1.579 2.071 0 C-N-CA 125.568 1.547 . . . . 0.0 112.179 178.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -58.42 161.39 4.48 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.669 1.188 . . . . 0.0 111.182 175.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.78 -28.25 16.69 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -178.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.67 140.77 43.12 Favored 'General case' 0 N--CA 1.417 -2.098 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.631 -174.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -105.99 154.22 39.65 Favored Pre-proline 0 C--N 1.289 -2.027 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -81.71 135.18 8.9 Favored 'Trans proline' 0 N--CA 1.44 -1.644 0 C-N-CA 121.309 1.34 . . . . 0.0 110.888 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -128.76 123.54 33.22 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 -177.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.618 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 83.4 m95 -109.33 135.35 50.54 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-O 120.759 0.314 . . . . 0.0 111.843 -172.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.449 ' HA ' ' O ' ' A' ' 86' ' ' THR . 39.8 m-85 -113.59 141.85 46.68 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.023 177.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.6 mt -125.37 142.2 51.64 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 -176.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.434 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 80.8 m-85 -131.3 141.49 49.96 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 123.468 0.48 . . . . 0.0 110.49 -176.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.58 -21.76 51.96 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.525 -177.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.486 ' C ' ' HB3' ' A' ' 106' ' ' SER . 8.6 t-20 -118.76 168.33 10.84 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.6 m -73.94 168.96 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 C-N-CA 122.575 0.35 . . . . 0.0 110.298 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 55.48 30.42 15.07 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.447 0.699 . . . . 0.0 112.605 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.409 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 9.3 m-85 58.96 45.85 14.43 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 124.755 1.222 . . . . 0.0 111.316 176.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.7 p -117.33 167.45 11.23 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.186 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.93 -134.19 12.32 Favored Glycine 0 N--CA 1.424 -2.13 0 N-CA-C 111.344 -0.703 . . . . 0.0 111.344 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 64.1 mtm180 -81.17 151.39 28.24 Favored 'General case' 0 C--N 1.287 -2.124 0 C-N-CA 123.611 0.764 . . . . 0.0 110.977 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.4 tt -130.5 137.18 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-O 121.275 0.559 . . . . 0.0 110.303 -176.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 98.4 m -132.38 120.51 22.13 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.906 175.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -108.01 127.8 8.85 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.211 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -118.21 145.5 44.93 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 123.074 0.55 . . . . 0.0 110.793 178.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.75 172.93 14.45 Favored Glycine 0 N--CA 1.433 -1.563 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.455 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.422 ' HB2' ' H ' ' A' ' 63' ' ' VAL . 3.0 p80 -61.65 122.32 15.0 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 123.293 0.637 . . . . 0.0 112.287 -175.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.2 2.13 80.73 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.821 176.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.1 m -110.36 146.13 36.33 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.4 m -140.37 154.5 46.74 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 52.2 mt -93.21 128.79 44.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 173.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -70.26 -47.37 61.59 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 123.539 0.525 . . . . 0.0 110.111 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.499 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 1.6 m-20 -132.97 91.83 2.94 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.761 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -65.46 -33.13 75.22 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.483 0.658 . . . . 0.0 109.429 176.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.7 t -64.31 -28.79 69.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.358 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.499 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 32.2 mmtp -89.57 -6.79 55.97 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 120.61 0.243 . . . . 0.0 110.499 -176.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.3 m -82.21 -175.12 5.5 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.064 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -52.86 -64.11 4.41 Favored Glycine 0 C--N 1.334 0.422 0 O-C-N 123.136 0.272 . . . . 0.0 113.215 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -110.94 143.14 42.07 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 122.505 -0.409 . . . . 0.0 110.462 176.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.601 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -108.93 -9.93 15.1 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.201 -1.036 . . . . 0.0 108.201 175.092 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -108.68 114.01 3.95 Favored Glycine 0 N--CA 1.433 -1.535 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.188 -177.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 71.6 mt -96.92 115.57 36.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.486 ' HB3' ' C ' ' A' ' 78' ' ' ASN . 1.1 t -86.67 -26.48 24.3 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.497 178.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.3 p -150.95 156.68 41.67 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 122.158 -0.339 . . . . 0.0 110.324 178.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.2 mt -135.13 132.28 52.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -176.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.409 ' HE2' ' CD2' ' A' ' 81' ' ' TYR . 32.3 ttmt -117.65 133.92 55.44 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 24.6 ttp180 -102.77 127.73 49.81 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 66.2 m -127.16 171.98 10.95 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.0 pt -129.66 144.87 36.76 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.146 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 177.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.472 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 61.8 tt0 -119.18 122.48 42.1 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 63.4 p -75.35 174.06 10.06 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.404 -175.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -66.36 -28.18 68.46 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.664 0.745 . . . . 0.0 109.525 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -77.12 -7.11 55.2 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.307 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.04 -1.74 61.15 Favored Glycine 0 N--CA 1.438 -1.192 0 N-CA-C 115.534 0.974 . . . . 0.0 115.534 171.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 113' ' ' GLN . 18.5 ptpt -83.73 140.65 31.98 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 118.78 1.29 . . . . 0.0 110.9 -177.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.4 t -101.81 112.06 33.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -99.4 144.79 28.11 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 124.27 1.028 . . . . 0.0 108.241 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 72.8 m -129.64 151.77 49.88 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.597 -174.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 6.0 tp -72.97 139.71 19.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.148 178.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -70.86 105.6 3.3 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 . . . . . 0 C--N 1.29 -1.983 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 179.976 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.47 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.88 31.31 20.67 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.923 0.889 . . . . 0.0 111.526 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -83.86 -25.39 30.31 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.756 0.788 . . . . 0.0 109.295 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.8 m -91.51 146.93 23.39 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 175.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 19.6 p -103.04 151.67 22.25 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.925 0.869 . . . . 0.0 112.349 -175.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -76.02 135.61 39.96 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.537 -1.21 . . . . 0.0 108.895 -178.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.425 ' CZ ' ' HD3' ' A' ' 71' ' ' PRO . 9.1 m-85 64.87 39.71 5.85 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.137 0.494 . . . . 0.0 112.006 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 63.5 m -123.32 149.63 44.61 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.58 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 49.1 tp -95.62 112.76 24.41 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 174.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.495 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 17.7 mt-30 -111.46 123.17 49.67 Favored 'General case' 0 N--CA 1.422 -1.852 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.745 -177.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.419 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 2.7 mp -110.97 124.71 52.67 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.87 -178.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.425 ' CE1' ' HG2' ' A' ' 35' ' ' GLU . 96.4 m-85 -90.45 155.38 18.96 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 122.623 0.369 . . . . 0.0 110.577 -178.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -75.18 -40.94 58.98 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.897 0.856 . . . . 0.0 109.943 -176.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -108.46 179.01 4.32 Favored 'General case' 0 N--CA 1.421 -1.918 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.403 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.453 HG21 ' HA ' ' A' ' 96' ' ' ASP . 0.8 OUTLIER -81.11 174.94 11.09 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.504 -177.093 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 47.07 34.03 2.64 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 174.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.425 ' HG2' ' CE1' ' A' ' 30' ' ' TYR . 36.1 mt-10 65.35 22.78 12.03 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 124.485 1.114 . . . . 0.0 113.919 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' A' ' 33' ' ' THR . 35.7 ptt180 -97.71 157.52 16.01 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 118.694 -1.202 . . . . 0.0 108.87 174.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.4 -178.65 41.62 Favored Glycine 0 N--CA 1.424 -2.105 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -175.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.0 m -89.59 169.13 11.59 Favored 'General case' 0 C--N 1.286 -2.163 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.553 177.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 21.8 p90 -131.78 165.88 22.8 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.466 -177.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.495 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 15.0 tt -113.87 150.55 15.88 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -106.59 125.15 50.64 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.489 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 88.4 t -123.97 133.88 68.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -117.46 -31.57 5.2 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -176.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.49 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 11.2 mmpt? -103.56 161.98 13.43 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.914 -173.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.9 p -88.99 143.03 27.14 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 172.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.5 p -121.31 131.05 73.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -177.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.77 -15.25 56.89 Favored Glycine 0 C--N 1.298 -1.53 0 C-N-CA 119.851 -1.166 . . . . 0.0 113.03 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.5 p -154.38 123.98 6.59 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.439 0.637 . . . . 0.0 112.415 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 88.4 mt -116.45 118.71 33.42 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.202 177.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.0 p -131.88 107.51 14.0 Favored Pre-proline 0 C--N 1.3 -1.549 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.64 175.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.93 162.22 89.86 Favored 'Cis proline' 0 C--O 1.249 1.068 0 C-N-CA 123.861 -1.308 . . . . 0.0 111.801 0.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.52 154.58 73.07 Favored 'Trans proline' 0 C--O 1.25 1.123 0 C-N-CA 122.125 1.883 . . . . 0.0 110.586 176.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 49.3 m0 -90.23 137.6 32.21 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 20.5 p -121.22 79.41 35.34 Favored Pre-proline 0 N--CA 1.425 -1.688 0 O-C-N 123.258 0.349 . . . . 0.0 111.027 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.409 ' HD2' ' O ' ' A' ' 103' ' ' LYS . 85.4 Cg_endo -77.16 158.49 33.74 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.884 2.389 . . . . 0.0 112.789 178.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.32 -29.82 9.21 Favored Glycine 0 N--CA 1.43 -1.701 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.1 p -150.96 152.61 33.81 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.5 t -126.71 142.99 41.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 17.3 t -145.46 138.48 26.19 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 118.525 0.602 . . . . 0.0 110.109 -176.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.7 t -118.33 125.38 27.9 Favored Pre-proline 0 C--O 1.249 1.056 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -62.1 147.16 95.62 Favored 'Trans proline' 0 C--O 1.249 1.061 0 C-N-CA 122.775 2.317 . . . . 0.0 111.031 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.602 ' CE2' ' HB3' ' A' ' 64' ' ' ASN . 34.7 t80 -74.49 136.31 42.24 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-O 121.95 0.881 . . . . 0.0 111.111 -176.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 98.4 t -118.61 115.08 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.166 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.602 ' HB3' ' CE2' ' A' ' 62' ' ' PHE . 24.5 p-10 -121.67 13.44 10.82 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 123.045 1.402 . . . . 0.0 107.332 178.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.74 146.44 41.47 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 111.737 -2.483 . . . . 0.0 111.483 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.4 m -57.46 -8.22 0.77 Allowed 'General case' 0 CA--C 1.579 2.073 0 C-N-CA 124.69 1.196 . . . . 0.0 112.004 177.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -62.49 136.65 58.0 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.104 0.961 . . . . 0.0 108.731 177.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.525 ' HB2' ' OE1' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -84.24 -28.82 26.98 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -177.894 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.525 ' OE1' ' HB2' ' A' ' 68' ' ' ARG . 3.0 mp0 -97.25 125.08 41.58 Favored 'General case' 0 N--CA 1.415 -2.184 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.47 ' HG2' ' CE1' ' A' ' 90' ' ' HIS . 0.6 OUTLIER -106.75 152.09 40.71 Favored Pre-proline 0 C--N 1.291 -1.955 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.593 179.111 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.425 ' HD3' ' CZ ' ' A' ' 25' ' ' TYR . 74.1 Cg_endo -76.98 134.09 14.3 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 121.089 1.193 . . . . 0.0 110.542 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -133.5 132.82 41.45 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.58 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 89.5 m95 -119.48 133.15 55.82 Favored 'General case' 0 C--N 1.284 -2.275 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.915 -172.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.523 ' HA ' ' O ' ' A' ' 86' ' ' THR . 35.7 m-85 -112.98 141.39 46.87 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.368 177.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.8 mt -125.92 142.16 51.64 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -176.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.54 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 80.2 m-85 -134.45 142.68 47.18 Favored 'General case' 0 CA--C 1.502 -0.874 0 O-C-N 123.796 0.685 . . . . 0.0 110.117 -176.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.403 ' HB3' ' CD1' ' A' ' 102' ' ' PHE . 2.9 p-10 -84.38 -5.82 59.32 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.476 ' C ' ' HB3' ' A' ' 106' ' ' SER . 4.4 t-20 -127.28 167.77 15.67 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 174.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.4 m -73.52 167.37 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 C-N-CA 122.581 0.352 . . . . 0.0 111.627 -176.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 55.92 31.53 18.03 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.237 -0.892 . . . . 0.0 113.226 176.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 62.82 42.83 7.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.857 175.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 69.3 p -118.38 161.7 19.53 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.093 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.98 -144.06 17.12 Favored Glycine 0 N--CA 1.425 -2.065 0 N-CA-C 111.668 -0.573 . . . . 0.0 111.668 177.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 54.9 mtt180 -72.41 142.84 48.69 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.3 tt -125.4 136.43 60.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-O 121.487 0.66 . . . . 0.0 111.241 -173.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.523 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 86.7 m -131.57 123.04 27.1 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.34 176.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -113.69 120.06 5.0 Favored Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.531 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -110.35 147.76 33.29 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 123.673 0.789 . . . . 0.0 111.0 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -121.36 168.41 14.31 Favored Glycine 0 N--CA 1.425 -2.047 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.204 -178.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.47 ' CE1' ' HG2' ' A' ' 70' ' ' ARG . 2.9 p80 -55.12 121.89 9.78 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 124.066 0.946 . . . . 0.0 112.139 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.18 12.37 73.76 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.064 176.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.0 m -125.48 145.9 49.88 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 177.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 22.5 m -144.2 155.84 44.05 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -178.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.7 mt -93.45 125.61 46.0 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.45 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -70.22 -46.76 63.86 Favored 'General case' 0 C--N 1.288 -2.071 0 O-C-N 123.812 0.695 . . . . 0.0 110.353 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.453 ' HA ' HG21 ' A' ' 33' ' ' THR . 3.3 m-20 -132.88 93.55 3.22 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.231 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -64.94 -31.66 73.0 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.431 0.634 . . . . 0.0 110.508 179.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.7 t -63.49 -23.2 67.29 Favored 'General case' 0 CA--C 1.561 1.375 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.631 -178.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.451 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 30.4 mmtp -92.78 -6.31 49.24 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.925 -0.485 . . . . 0.0 109.765 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.8 m -84.85 13.46 5.86 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.379 0.609 . . . . 0.0 111.786 -177.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 104.72 -79.07 0.28 Allowed Glycine 0 N--CA 1.425 -2.05 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.68 178.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.403 ' CD1' ' HB3' ' A' ' 77' ' ' ASP . 27.5 p90 -100.11 147.13 26.0 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -178.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.3 -14.22 12.84 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.18 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -103.02 110.4 3.71 Favored Glycine 0 N--CA 1.422 -2.271 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.489 -175.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 80.5 mt -93.32 115.65 32.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.476 ' HB3' ' C ' ' A' ' 78' ' ' ASN . 5.3 t -85.99 -29.01 23.85 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.502 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 90.1 p -150.34 156.33 41.31 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.752 -0.203 . . . . 0.0 110.818 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.7 mt -134.01 132.41 56.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -176.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -116.38 131.58 56.91 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -99.5 129.6 45.69 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . 0.417 ' SG ' ' HD2' ' A' ' 74' ' ' TYR . 62.6 m -128.51 172.38 11.21 Favored 'General case' 0 N--CA 1.413 -2.3 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.329 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 70' ' ' ARG . 7.1 pt -131.48 141.98 44.43 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 C-N-CA 123.172 0.589 . . . . 0.0 110.039 177.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -113.69 119.11 36.3 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 33.8 p -80.19 -178.37 6.54 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.45 -172.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -66.1 -28.85 69.13 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.769 0.795 . . . . 0.0 109.636 177.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -80.1 -6.46 57.73 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.422 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.97 6.17 82.55 Favored Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 115.969 -0.56 . . . . 0.0 113.77 175.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 66.0 pttt -82.16 145.08 30.3 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.829 178.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 25.5 t -104.12 111.52 34.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -97.12 144.24 27.16 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 96.8 m -129.84 153.43 48.28 Favored 'General case' 0 C--N 1.289 -2.055 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.297 -173.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 10.5 tp -125.26 127.95 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.449 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -92.26 128.64 38.18 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 . . . . . 0 C--N 1.293 -1.888 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -176.742 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.97 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.59 76.67 8.11 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 173.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.498 ' HB3' ' OH ' ' A' ' 39' ' ' TYR . 12.5 m-20 -87.85 -24.52 23.67 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.191 -171.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.0 m -74.56 123.81 25.48 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 15.5 p -104.37 151.85 22.99 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.371 -176.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.6 tptt -68.32 131.41 45.29 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.655 -178.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 65.47 38.91 5.38 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 124.104 0.877 . . . . 0.0 111.718 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.6 m -122.73 145.07 48.73 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.508 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 51.5 tp -96.24 116.24 28.69 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 174.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.437 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 37.3 mt-30 -108.98 124.21 50.34 Favored 'General case' 0 N--CA 1.428 -1.572 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.315 -177.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.7 mp -109.66 118.91 37.8 Favored 'General case' 0 N--CA 1.408 -2.526 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.46 177.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.426 ' CD2' ' HB3' ' A' ' 39' ' ' TYR . 95.4 m-85 -87.51 150.3 23.82 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.508 -176.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -72.09 -44.1 63.76 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.835 -175.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -109.8 178.05 4.54 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.902 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.43 HG23 ' HA ' ' A' ' 96' ' ' ASP . 1.9 p -76.74 170.57 16.22 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-O 119.785 -0.15 . . . . 0.0 111.002 -177.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 14.9 p90 47.41 37.05 5.58 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.899 1.28 . . . . 0.0 114.086 177.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 67.72 26.21 7.89 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.615 1.166 . . . . 0.0 112.853 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.471 ' CZ ' ' HB3' ' A' ' 36' ' ' ARG . 8.5 mtp-105 -90.89 162.49 14.76 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 176.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.22 -158.94 36.71 Favored Glycine 0 N--CA 1.424 -2.134 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.3 p -96.44 177.41 5.69 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 174.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.498 ' OH ' ' HB3' ' A' ' 21' ' ' ASP . 38.1 p90 -138.55 166.83 23.32 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.8 tt -113.42 151.56 15.26 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 177.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -106.13 124.87 50.26 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.424 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 92.4 t -123.52 133.55 68.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -122.09 -6.01 8.94 Favored 'General case' 0 C--N 1.31 -1.118 0 O-C-N 123.616 0.573 . . . . 0.0 110.85 -174.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -137.1 162.34 33.66 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.161 -173.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.9 p -86.77 140.2 29.97 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 175.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.2 p -119.53 134.37 63.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -175.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.76 -15.73 48.23 Favored Glycine 0 C--N 1.301 -1.394 0 C-N-CA 120.417 -0.897 . . . . 0.0 113.195 -176.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.7 t -156.61 127.54 6.83 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.442 0.639 . . . . 0.0 111.182 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.5 mt -121.34 117.93 28.19 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.073 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.0 m -132.55 115.41 14.73 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 174.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -75.12 161.92 93.81 Favored 'Cis proline' 0 C--O 1.25 1.089 0 C-N-CA 123.033 -1.653 . . . . 0.0 110.788 -2.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -61.98 156.7 47.8 Favored 'Trans proline' 0 C--O 1.256 1.403 0 C-N-CA 122.129 1.886 . . . . 0.0 110.417 178.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.421 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 45.8 m0 -89.33 135.97 33.29 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -176.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 34.1 p -115.65 81.41 9.15 Favored Pre-proline 0 C--N 1.301 -1.5 0 O-C-N 123.369 0.418 . . . . 0.0 111.165 178.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.417 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 81.3 Cg_endo -81.5 157.7 19.28 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 122.239 1.959 . . . . 0.0 112.583 176.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.06 -30.24 11.42 Favored Glycine 0 N--CA 1.43 -1.747 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 177.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.8 p -155.13 153.52 30.93 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.6 t -130.28 142.7 43.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 49.1 t -145.8 148.12 32.58 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.373 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.413 ' HB ' ' O ' ' A' ' 89' ' ' GLY . 58.7 t -117.39 122.65 30.75 Favored Pre-proline 0 C--N 1.31 -1.133 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 175.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.44 156.39 63.73 Favored 'Trans proline' 0 C--O 1.25 1.075 0 C-N-CA 122.726 2.284 . . . . 0.0 112.577 -177.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -72.84 135.3 45.16 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.386 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 98.4 t -112.19 115.58 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.265 0 CA-C-O 121.743 0.782 . . . . 0.0 111.763 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -112.51 74.54 0.87 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 173.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.437 ' HB3' ' NH2' ' A' ' 70' ' ' ARG . 14.6 t70 -126.99 145.95 50.52 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.191 -170.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -54.37 -18.53 4.21 Favored 'General case' 0 CA--C 1.578 2.044 0 C-N-CA 125.803 1.641 . . . . 0.0 114.429 -178.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.565 ' HB2' ' NH2' ' A' ' 70' ' ' ARG . 75.8 mmtt -65.56 173.79 2.56 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.561 -0.712 . . . . 0.0 111.261 175.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -102.7 -26.82 13.04 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 176.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -92.73 132.31 37.05 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.542 -176.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.565 ' NH2' ' HB2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -104.92 149.77 37.93 Favored Pre-proline 0 C--N 1.3 -1.545 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.626 176.379 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.17 136.18 17.81 Favored 'Trans proline' 0 C--N 1.321 -0.909 0 C-N-CA 121.907 1.738 . . . . 0.0 112.314 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -133.09 130.55 39.46 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.508 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 84.4 m95 -116.2 136.91 52.59 Favored 'General case' 0 C--N 1.286 -2.158 0 O-C-N 121.631 -0.668 . . . . 0.0 111.904 -172.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.481 ' HA ' ' O ' ' A' ' 86' ' ' THR . 41.4 m-85 -115.04 142.3 46.83 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 123.051 0.54 . . . . 0.0 110.426 177.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.8 mt -125.71 142.96 51.25 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -175.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 84.3 m-85 -133.23 145.18 50.31 Favored 'General case' 0 C--O 1.241 0.616 0 O-C-N 123.578 0.549 . . . . 0.0 110.666 -176.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.54 -3.56 58.9 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.794 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -133.26 157.06 46.38 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 119.851 -0.739 . . . . 0.0 109.283 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.422 ' HA ' ' HB2' ' A' ' 107' ' ' SER . 33.9 m -70.81 168.31 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.455 -178.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 59.66 30.23 19.83 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.251 0.621 . . . . 0.0 110.966 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.563 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 16.5 m-85 55.21 44.03 28.33 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 124.781 1.232 . . . . 0.0 112.233 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 59.1 p -117.07 172.85 7.0 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.932 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.68 -136.17 13.5 Favored Glycine 0 N--CA 1.429 -1.767 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.357 178.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 77.6 mtt180 -79.76 153.23 29.35 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.8 tt -133.12 136.82 54.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-O 121.384 0.612 . . . . 0.0 110.785 -175.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 95.5 m -132.39 121.11 22.94 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.999 177.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -108.47 119.76 5.75 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.868 -0.682 . . . . 0.0 114.443 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -110.1 145.53 36.97 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 123.103 0.561 . . . . 0.0 110.596 178.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.413 ' O ' ' HB ' ' A' ' 60' ' ' VAL . . . -119.61 175.67 15.89 Favored Glycine 0 N--CA 1.429 -1.793 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.946 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -60.17 132.81 55.09 Favored 'General case' 0 C--O 1.247 0.95 0 C-N-CA 123.088 0.555 . . . . 0.0 111.86 -178.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.75 16.34 79.25 Favored Glycine 0 N--CA 1.437 -1.266 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.744 177.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.0 m -121.06 145.48 47.73 Favored 'General case' 0 N--CA 1.42 -1.972 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -178.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.9 m -141.98 155.43 45.45 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 47.7 mt -93.33 130.94 41.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 175.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -70.85 -48.42 54.06 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 123.586 0.554 . . . . 0.0 110.3 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.43 ' HA ' HG23 ' A' ' 33' ' ' THR . 8.2 m-20 -141.57 98.88 3.44 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -63.84 -31.86 73.18 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.481 0.658 . . . . 0.0 110.469 -178.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.9 t -63.4 -22.13 66.7 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.393 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -93.14 -11.04 33.81 Favored 'General case' 0 C--O 1.22 -0.499 0 O-C-N 121.742 -0.599 . . . . 0.0 110.416 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.1 m -78.77 -7.14 57.52 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.42 0.629 . . . . 0.0 110.579 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 123.8 -86.34 0.37 Allowed Glycine 0 N--CA 1.419 -2.478 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -85.73 139.2 31.54 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.574 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -109.43 -6.91 15.28 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.157 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -110.97 113.28 3.41 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.348 -176.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 75.0 mt -97.3 115.31 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.548 0 CA-C-O 122.687 1.232 . . . . 0.0 109.066 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.3 m -85.66 -25.31 26.64 Favored 'General case' 0 N--CA 1.393 -3.296 0 CA-C-N 111.811 -2.45 . . . . 0.0 113.935 178.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.422 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 8.5 t -159.39 153.3 23.21 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -176.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.1 mt -136.3 129.27 46.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -176.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.563 ' HE2' ' CD2' ' A' ' 81' ' ' TYR . 35.3 ttmt -117.23 133.28 56.18 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -100.49 129.85 46.49 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -178.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 71.0 m -126.34 172.0 10.5 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.4 pt -132.23 140.68 47.22 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -109.09 123.91 49.93 Favored 'General case' 0 C--N 1.266 -3.049 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 69.1 p -74.08 166.58 23.15 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.364 -175.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -67.58 -19.23 65.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 122.169 0.985 . . . . 0.0 109.075 175.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -76.93 -7.57 55.8 Favored 'General case' 0 CA--C 1.561 1.369 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.104 175.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.53 3.96 74.06 Favored Glycine 0 CA--C 1.504 -0.645 0 N-CA-C 114.828 0.691 . . . . 0.0 114.828 172.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.419 ' HE2' ' OE2' ' A' ' 120' ' ' GLU . 21.9 ptmt -94.44 139.73 30.75 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 119.138 -1.025 . . . . 0.0 109.421 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 24.2 t -95.27 111.9 26.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.394 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.419 ' OE2' ' HE2' ' A' ' 118' ' ' LYS . 6.3 mm-40 -94.96 142.69 27.19 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 72.4 m -130.19 162.63 28.47 Favored 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -177.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 7.4 tp -73.58 128.02 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 172.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -68.45 104.37 1.89 Allowed 'General case' 0 CA--C 1.49 -1.351 0 CA-C-O 121.827 0.822 . . . . 0.0 110.519 -178.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 . . . . . 0 C--N 1.293 -1.864 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 -179.727 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.213 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -131.22 110.07 10.87 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -80.73 -24.21 38.92 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.503 0.668 . . . . 0.0 110.097 -177.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.8 m -102.87 129.16 49.48 Favored 'General case' 0 N--CA 1.416 -2.14 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 174.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.522 ' O ' ' HG3' ' A' ' 61' ' ' PRO . 54.0 t -102.73 134.69 45.7 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -73.65 112.04 9.36 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 123.28 0.632 . . . . 0.0 110.556 -173.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 70.17 33.86 2.54 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 123.817 0.698 . . . . 0.0 112.021 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.421 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 6.7 m -123.57 144.65 49.45 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.585 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 56.1 tp -88.73 128.28 35.62 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.445 ' NE2' ' H ' ' A' ' 23' ' ' CYS . 48.1 mt-30 -117.23 123.42 46.58 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.222 -177.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 3.9 mp -110.82 120.05 41.12 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.893 177.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -89.82 150.41 22.26 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 123.735 0.647 . . . . 0.0 110.461 -176.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -75.34 -36.45 61.03 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.003 0.43 . . . . 0.0 111.17 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -107.99 177.27 4.86 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.422 HG21 ' HA ' ' A' ' 96' ' ' ASP . 1.7 p -82.43 170.45 15.26 Favored 'General case' 0 N--CA 1.407 -2.624 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 29.6 p90 46.83 44.46 14.3 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.803 1.241 . . . . 0.0 114.057 177.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 67.75 22.67 8.82 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.803 0.841 . . . . 0.0 112.615 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 37.4 mtp85 -95.17 161.02 14.29 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 177.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.31 -167.51 41.36 Favored Glycine 0 N--CA 1.423 -2.167 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.775 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 79.4 p -87.9 163.1 16.55 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 176.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 11.4 p90 -129.28 164.95 22.4 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.6 tt -114.95 153.39 16.45 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.038 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -106.75 125.47 51.05 Favored 'General case' 0 N--CA 1.422 -1.856 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 175.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.507 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 97.1 t -118.89 133.41 65.85 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 177.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -116.97 -29.83 5.88 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 123.472 0.482 . . . . 0.0 110.687 -174.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -121.59 163.27 19.2 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.031 -174.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.9 m -75.7 144.01 41.81 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 176.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.6 p -120.95 137.11 55.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.66 -18.71 31.72 Favored Glycine 0 C--N 1.307 -1.044 0 C-N-CA 119.791 -1.195 . . . . 0.0 113.02 -178.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.4 t -153.21 131.6 12.09 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-O 121.053 0.454 . . . . 0.0 110.305 -177.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.2 mt -123.25 117.68 25.86 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.58 177.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.0 m -132.61 111.21 13.64 Favored Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -78.08 160.45 92.13 Favored 'Cis proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.109 -1.621 . . . . 0.0 110.527 -0.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.68 157.75 40.72 Favored 'Trans proline' 0 C--O 1.253 1.254 0 C-N-CA 122.126 1.884 . . . . 0.0 111.007 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.451 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 49.8 m0 -90.16 135.7 33.5 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -177.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 34.9 p -117.52 75.09 8.98 Favored Pre-proline 0 C--N 1.296 -1.751 0 O-C-N 123.387 0.429 . . . . 0.0 110.209 178.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -74.73 157.81 43.63 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 122.151 1.901 . . . . 0.0 113.036 -178.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.97 -31.75 11.75 Favored Glycine 0 N--CA 1.427 -1.921 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.1 p -156.46 153.74 29.3 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.4 t -129.37 143.0 42.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 32.2 t -145.59 152.94 40.48 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.331 177.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.3 t -120.92 128.89 25.55 Favored Pre-proline 0 N--CA 1.443 -0.778 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 176.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.522 ' HG3' ' O ' ' A' ' 23' ' ' CYS . 30.9 Cg_endo -62.0 140.69 85.9 Favored 'Trans proline' 0 C--O 1.244 0.798 0 C-N-CA 123.18 2.587 . . . . 0.0 112.387 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.469 ' CE1' ' HB3' ' A' ' 64' ' ' ASN . 76.0 t80 -74.75 112.44 10.96 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-O 121.413 0.625 . . . . 0.0 110.462 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.3 t -94.16 115.57 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.148 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.485 178.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.469 ' HB3' ' CE1' ' A' ' 62' ' ' PHE . 6.4 p30 -118.88 15.69 13.43 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.194 -1.409 . . . . 0.0 107.194 177.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.641 ' OD1' ' HG2' ' A' ' 67' ' ' LYS . 8.9 t70 -66.51 147.54 53.14 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 112.358 -2.201 . . . . 0.0 109.476 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.2 m -53.13 -23.37 7.96 Favored 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 123.809 0.843 . . . . 0.0 111.812 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.641 ' HG2' ' OD1' ' A' ' 65' ' ' ASP . 42.5 mmtm -54.49 121.23 7.94 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 176.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -73.75 -25.64 60.27 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.976 -174.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -91.7 127.59 37.21 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -99.72 153.57 37.7 Favored Pre-proline 0 C--N 1.286 -2.193 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -83.22 135.18 7.19 Favored 'Trans proline' 0 N--CA 1.442 -1.503 0 C-N-CA 121.503 1.469 . . . . 0.0 111.078 176.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -130.24 132.2 45.86 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.585 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 82.2 m95 -118.78 134.14 55.35 Favored 'General case' 0 C--N 1.286 -2.185 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.831 -173.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.427 ' HA ' ' O ' ' A' ' 86' ' ' THR . 27.4 m-85 -114.47 140.8 48.42 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.327 178.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.5 mt -125.71 142.34 51.56 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -176.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.497 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 80.5 m-85 -132.84 143.04 49.27 Favored 'General case' 0 C--O 1.247 0.941 0 O-C-N 123.782 0.677 . . . . 0.0 109.791 -176.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 106' ' ' SER . 0.9 OUTLIER -81.2 -14.75 57.23 Favored 'General case' 0 CA--C 1.491 -1.32 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.262 -178.904 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -122.17 166.09 15.12 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.5 m -76.29 167.78 2.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 122.747 0.419 . . . . 0.0 110.92 -175.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 56.32 30.43 16.77 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 124.136 0.974 . . . . 0.0 112.82 178.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.406 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 7.0 m-85 63.01 39.34 10.25 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 124.795 1.238 . . . . 0.0 111.198 177.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 78.8 p -112.06 165.07 12.45 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.63 -139.43 14.57 Favored Glycine 0 N--CA 1.435 -1.427 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.441 178.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 55.5 mtt180 -81.88 147.14 29.47 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 123.322 0.649 . . . . 0.0 109.81 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.8 tt -123.19 136.61 59.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-O 121.155 0.502 . . . . 0.0 110.759 -176.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 90.7 m -131.69 121.17 23.83 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.887 177.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -109.44 121.05 5.96 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.444 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.86 145.19 37.21 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 120.769 0.318 . . . . 0.0 110.677 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -117.76 171.26 13.88 Favored Glycine 0 N--CA 1.42 -2.395 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.073 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -60.88 123.01 16.3 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.722 0.772 . . . . 0.0 112.406 -177.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.31 1.78 71.59 Favored Glycine 0 N--CA 1.429 -1.798 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.961 177.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.3 m -112.43 145.95 39.25 Favored 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -178.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 4.6 m -134.3 158.45 43.73 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 55.0 mt -94.16 129.39 44.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 170.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -70.36 -46.98 63.03 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 123.597 0.561 . . . . 0.0 110.444 -178.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.465 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 2.0 m-20 -138.48 101.16 4.29 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.38 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -65.24 -38.02 89.05 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-O 120.736 0.303 . . . . 0.0 110.983 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.6 t -65.44 -28.01 68.92 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.855 -177.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.465 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 27.1 mmtp -83.64 -5.98 59.32 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.424 0.631 . . . . 0.0 109.738 -177.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 18.6 m -82.67 -168.89 2.21 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.39 -61.11 7.45 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.136 -178.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -111.26 149.54 30.89 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 122.39 0.276 . . . . 0.0 110.68 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -111.65 -7.72 14.25 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.838 177.26 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -114.93 121.4 5.31 Favored Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.374 -176.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 67.6 mt -100.95 115.99 43.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-O 122.107 0.956 . . . . 0.0 109.083 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 77' ' ' ASP . 1.5 m -85.94 -28.81 24.04 Favored 'General case' 0 N--CA 1.406 -2.638 0 CA-C-N 112.716 -2.038 . . . . 0.0 114.257 176.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.9 p -154.22 154.94 34.35 Favored 'General case' 0 C--O 1.237 0.433 0 O-C-N 122.063 -0.398 . . . . 0.0 110.024 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.8 mt -134.12 133.25 55.89 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.608 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -176.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.406 ' HE2' ' CD2' ' A' ' 81' ' ' TYR . 36.2 ttmt -117.11 126.07 52.26 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -95.92 127.96 42.4 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.45 0.643 . . . . 0.0 109.487 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . 0.422 ' SG ' ' HD1' ' A' ' 74' ' ' TYR . 59.7 m -121.94 168.62 11.69 Favored 'General case' 0 N--CA 1.402 -2.868 0 CA-C-N 114.869 -1.059 . . . . 0.0 108.676 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.7 pt -128.37 143.11 42.01 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 176.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -111.21 118.45 35.96 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 63.8 p -77.34 -178.66 5.27 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.485 -171.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -62.6 -36.63 83.36 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.943 174.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.499 ' OD2' ' HG2' ' A' ' 118' ' ' LYS . 2.5 p30 -78.46 -7.06 57.01 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.867 -176.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.0 -5.6 63.62 Favored Glycine 0 CA--C 1.496 -1.123 0 CA-C-N 115.776 -0.647 . . . . 0.0 113.859 173.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.499 ' HG2' ' OD2' ' A' ' 116' ' ' ASP . 6.4 ptpp? -77.66 146.9 35.81 Favored 'General case' 0 CA--C 1.493 -1.24 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.706 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 38.2 t -103.37 111.46 33.21 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -96.99 142.16 29.28 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 73.2 m -130.36 171.62 12.74 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.139 -175.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 6.3 tp -107.67 121.9 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 175.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -91.68 116.05 28.56 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 . . . . . 0 C--N 1.302 -1.481 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.192 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.75 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 63.25 18.19 10.8 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.136 1.374 . . . . 0.0 111.381 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.09 -16.7 16.99 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.627 -176.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.5 p -118.71 142.41 47.71 Favored 'General case' 0 N--CA 1.418 -2.039 0 CA-C-O 121.19 0.519 . . . . 0.0 111.649 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.417 ' HB3' ' HB2' ' A' ' 26' ' ' CYS . 54.0 t -146.06 135.97 23.49 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -73.09 106.77 5.1 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.743 -174.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.437 ' CD1' ' HB3' ' A' ' 71' ' ' PRO . 5.5 m-85 71.62 41.33 0.72 Allowed 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.843 177.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.417 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 7.7 m -124.35 145.34 49.49 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.632 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 61.3 tp -100.12 128.68 46.16 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 176.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.542 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 39.8 mt-30 -118.87 123.95 45.94 Favored 'General case' 0 CA--C 1.492 -1.266 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.534 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.412 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.0 mp -110.76 122.85 48.84 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.881 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -92.0 149.59 21.45 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 123.327 0.392 . . . . 0.0 110.304 -178.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.54 -35.24 63.12 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.095 0.474 . . . . 0.0 111.803 -177.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -108.41 178.05 4.61 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.424 HG21 ' HA ' ' A' ' 96' ' ' ASP . 2.3 p -82.26 170.68 15.11 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.26 21.5 p90 46.85 46.71 15.45 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.289 1.036 . . . . 0.0 113.394 178.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 59.55 23.34 12.02 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.954 1.302 . . . . 0.0 114.129 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -92.01 167.37 12.14 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.623 0.725 . . . . 0.0 111.847 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.16 -164.82 46.36 Favored Glycine 0 N--CA 1.426 -1.995 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.7 m -92.71 173.66 7.65 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 175.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -140.76 161.79 36.95 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.237 0.541 . . . . 0.0 110.129 -178.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.542 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 17.4 tt -114.64 149.53 16.87 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -107.6 125.5 51.4 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 175.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 95.0 t -117.87 134.06 62.68 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -118.17 -20.97 8.41 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.442 0.639 . . . . 0.0 110.485 -174.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -136.42 162.56 32.7 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.226 -174.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.4 p -72.66 147.38 45.8 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.33 0.586 . . . . 0.0 112.209 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.8 p -122.43 132.14 71.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 176.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.72 -15.3 46.69 Favored Glycine 0 C--N 1.303 -1.297 0 C-N-CA 119.566 -1.302 . . . . 0.0 112.861 -177.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.9 p -155.71 123.35 5.6 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.416 0.627 . . . . 0.0 112.377 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.4 mt -114.34 118.88 35.13 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.348 177.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.3 m -132.48 110.61 13.7 Favored Pre-proline 0 C--N 1.303 -1.432 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.837 175.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -77.4 161.94 91.56 Favored 'Cis proline' 0 C--O 1.244 0.797 0 C-N-CA 123.229 -1.571 . . . . 0.0 110.927 0.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.07 158.38 30.25 Favored 'Trans proline' 0 C--O 1.25 1.092 0 C-N-CA 122.526 2.15 . . . . 0.0 110.988 177.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 46.9 m0 -89.67 139.13 30.86 Favored 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.089 -177.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 15.4 p -119.34 78.85 19.61 Favored Pre-proline 0 C--N 1.29 -1.993 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.15 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.443 ' HG2' ' CD2' ' A' ' 97' ' ' PHE . 93.0 Cg_endo -79.18 157.59 26.39 Favored 'Trans proline' 0 N--CA 1.44 -1.648 0 C-N-CA 121.782 1.655 . . . . 0.0 112.257 176.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -93.73 -27.98 11.93 Favored Glycine 0 N--CA 1.428 -1.878 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 176.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.4 p -153.57 150.94 29.2 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.5 t -123.11 142.84 38.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 15.5 t -142.98 137.71 29.54 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -177.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.9 t -121.43 119.02 29.58 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -65.2 137.41 51.78 Favored 'Trans proline' 0 C--O 1.241 0.673 0 C-N-CA 123.036 2.491 . . . . 0.0 113.136 -178.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -71.78 121.75 19.47 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.25 178.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 86.7 t -95.01 115.0 32.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 176.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -103.12 70.17 1.06 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -126.22 145.3 50.45 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -172.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.4 m -58.66 -24.83 62.0 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.436 -1.257 . . . . 0.0 109.807 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 4.3 mptp? -53.09 134.31 38.51 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.563 -177.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 50.9 mtp180 -68.51 -27.99 66.61 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -172.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -106.49 128.03 53.77 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.928 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -104.89 147.01 33.76 Favored Pre-proline 0 C--N 1.284 -2.24 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 171.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.437 ' HB3' ' CD1' ' A' ' 25' ' ' TYR . 93.3 Cg_endo -77.52 135.24 14.53 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.748 1.632 . . . . 0.0 112.522 -177.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -129.35 141.27 51.12 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.632 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 90.0 m95 -122.81 132.11 54.06 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -173.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.489 ' HD2' ' SG ' ' A' ' 111' ' ' CYS . 28.0 m-85 -114.37 142.76 45.92 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.108 176.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.7 mt -125.5 142.37 51.54 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 -175.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.403 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 92.0 m-85 -130.54 139.79 50.47 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.575 0.703 . . . . 0.0 111.21 -176.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.598 ' HB2' ' CD1' ' A' ' 102' ' ' PHE . 0.8 OUTLIER -81.89 -10.59 59.25 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.314 -178.876 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -135.69 156.92 48.08 Favored 'General case' 0 N--CA 1.416 -2.136 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.823 174.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.47 ' HA ' ' HB2' ' A' ' 107' ' ' SER . 21.5 m -65.3 161.45 3.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.967 -176.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 61.52 30.57 18.81 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.199 0.523 . . . . 0.0 111.278 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 57.57 41.85 25.1 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 124.335 1.054 . . . . 0.0 111.333 176.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 77.9 p -112.35 176.35 5.05 Favored 'General case' 0 C--O 1.252 1.203 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.674 178.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.93 -137.79 18.42 Favored Glycine 0 N--CA 1.424 -2.152 0 N-CA-C 111.761 -0.535 . . . . 0.0 111.761 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.41 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . 53.3 mtt180 -82.72 150.21 26.85 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -177.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.0 tt -128.44 137.31 57.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 O-C-N 123.622 0.576 . . . . 0.0 110.594 -174.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 57.1 m -132.43 124.07 27.91 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 122.231 -0.293 . . . . 0.0 110.319 174.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -115.0 113.43 2.95 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.622 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -106.48 145.63 31.56 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 122.994 0.518 . . . . 0.0 111.285 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -110.33 164.61 12.25 Favored Glycine 0 N--CA 1.427 -1.966 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.625 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -64.03 122.15 15.86 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 123.29 0.636 . . . . 0.0 110.994 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.56 16.94 51.17 Favored Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.525 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.4 m -135.69 146.03 47.34 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 175.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 21.7 m -143.96 157.08 44.57 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 61.7 mt -94.45 135.21 29.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -70.81 -47.43 59.48 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.525 0.678 . . . . 0.0 110.483 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.424 ' HA ' HG21 ' A' ' 33' ' ' THR . 5.7 m-20 -136.51 100.77 4.45 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.995 -177.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.443 ' CD2' ' HG2' ' A' ' 55' ' ' PRO . 62.6 t80 -64.2 -29.53 70.63 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.259 0.552 . . . . 0.0 110.796 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.9 t -62.91 -18.78 63.49 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.694 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -94.75 -8.96 36.11 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 122.152 -0.343 . . . . 0.0 110.416 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 26.9 t -85.24 28.82 0.7 Allowed 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.772 0.829 . . . . 0.0 110.798 -177.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.88 -70.84 1.78 Allowed Glycine 0 N--CA 1.432 -1.626 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.054 177.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.598 ' CD1' ' HB2' ' A' ' 77' ' ' ASP . 27.0 p90 -110.41 149.42 30.29 Favored 'General case' 0 C--N 1.29 -1.991 0 O-C-N 122.784 -0.245 . . . . 0.0 110.356 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -114.24 -10.09 12.77 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.681 177.0 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -109.18 99.7 1.28 Allowed Glycine 0 N--CA 1.433 -1.552 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.897 -175.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 69.2 mt -87.05 115.17 27.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-O 122.551 1.167 . . . . 0.0 107.964 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 27.8 m -85.94 -23.97 26.75 Favored 'General case' 0 C--N 1.249 -3.763 0 CA-C-N 112.337 -2.21 . . . . 0.0 113.764 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.47 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 9.3 t -158.48 153.45 25.17 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -176.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.2 mt -137.29 130.32 43.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -178.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.555 ' HD2' ' SG ' ' A' ' 121' ' ' CYS . 24.7 ttmt -117.64 133.48 55.9 Favored 'General case' 0 C--N 1.3 -1.543 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -100.47 127.81 46.71 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -177.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . 0.489 ' SG ' ' HD2' ' A' ' 74' ' ' TYR . 29.6 m -119.38 168.3 11.08 Favored 'General case' 0 N--CA 1.417 -2.117 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -176.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.7 pt -127.38 140.29 49.52 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.525 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -112.79 119.08 36.79 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 63.3 p -79.17 177.37 8.87 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.254 -175.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.1 ttpp -66.32 -20.19 66.02 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.572 0.701 . . . . 0.0 109.421 176.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -78.77 -8.34 58.66 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.813 0.816 . . . . 0.0 109.953 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.68 -11.57 68.16 Favored Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.386 176.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -71.82 139.01 48.75 Favored 'General case' 0 C--O 1.253 1.25 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.65 112.27 37.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -104.6 152.7 22.12 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . 0.555 ' SG ' ' HD2' ' A' ' 109' ' ' LYS . 0.9 OUTLIER -135.41 156.4 48.98 Favored 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 118.626 -1.23 . . . . 0.0 110.575 -175.586 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 9.4 tp -125.48 134.74 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.549 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -92.61 104.9 17.15 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 . . . . . 0 C--N 1.303 -1.417 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.024 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.339 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.3 -11.3 60.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.777 0.798 . . . . 0.0 110.79 -178.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -80.08 -8.24 59.29 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.166 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.5 m -112.6 124.61 52.93 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 176.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.5 p -138.71 156.92 46.99 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.319 0.581 . . . . 0.0 111.113 -176.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -75.99 118.34 18.65 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.114 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.412 ' CD2' ' HB3' ' A' ' 71' ' ' PRO . 1.9 m-85 69.97 53.22 0.37 Allowed 'General case' 0 C--O 1.243 0.719 0 CA-C-N 114.979 -1.01 . . . . 0.0 112.697 171.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.0 m -125.54 154.79 41.62 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.594 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 54.4 tp -112.26 122.69 48.43 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 171.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.508 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 78.7 mt-30 -116.04 124.88 51.57 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.759 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.419 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 3.6 mp -109.51 126.01 53.09 Favored 'General case' 0 N--CA 1.415 -2.204 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.129 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.401 ' CD1' ' HB3' ' A' ' 39' ' ' TYR . 98.1 m-85 -94.55 147.94 22.76 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 123.783 0.677 . . . . 0.0 110.914 -176.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -72.5 -38.58 68.09 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.979 -177.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -109.74 178.12 4.52 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.0 p -79.09 172.63 13.54 Favored 'General case' 0 N--CA 1.422 -1.872 0 C-N-CA 121.507 -0.077 . . . . 0.0 111.026 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.529 ' CE1' ' HG3' ' A' ' 36' ' ' ARG 0.261 31.6 p90 46.56 42.25 10.88 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 176.777 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 67.94 28.89 6.75 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.984 0.914 . . . . 0.0 112.788 176.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.529 ' HG3' ' CE1' ' A' ' 34' ' ' TYR . 23.7 mmt180 -107.06 172.13 6.99 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-O 121.501 0.667 . . . . 0.0 112.249 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.4 -159.88 39.32 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -177.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.0 m -89.66 179.57 5.99 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 172.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 21.8 p90 -149.42 162.92 39.14 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.508 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 15.6 tt -118.09 151.97 20.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.232 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -107.34 125.92 51.8 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 175.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.521 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 93.0 t -117.67 133.96 62.77 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 176.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -117.59 -29.47 5.76 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 120.994 0.426 . . . . 0.0 110.313 -176.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.09 154.91 47.77 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.838 -177.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.2 m -60.31 145.8 46.32 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 123.527 0.731 . . . . 0.0 111.935 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.5 p -120.84 139.04 49.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 176.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.12 -20.31 30.88 Favored Glycine 0 C--N 1.299 -1.484 0 C-N-CA 119.604 -1.284 . . . . 0.0 112.804 -176.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.3 p -157.72 131.14 7.76 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 120.961 0.41 . . . . 0.0 111.789 -176.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.58 117.22 23.82 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 175.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.9 t -133.6 113.0 12.9 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.403 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -75.56 161.23 94.86 Favored 'Cis proline' 0 C--O 1.246 0.924 0 C-N-CA 123.191 -1.587 . . . . 0.0 111.206 -0.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -61.71 158.87 35.29 Favored 'Trans proline' 0 C--O 1.245 0.859 0 C-N-CA 122.986 2.457 . . . . 0.0 111.312 178.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 48.0 m0 -88.56 137.5 32.27 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 5.4 p -117.59 75.53 9.51 Favored Pre-proline 0 C--N 1.292 -1.905 0 O-C-N 123.31 0.381 . . . . 0.0 111.601 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.424 ' HG2' ' CD2' ' A' ' 97' ' ' PHE . 69.8 Cg_endo -74.35 157.94 45.07 Favored 'Trans proline' 0 C--N 1.359 1.12 0 C-N-CA 122.859 2.373 . . . . 0.0 112.875 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.25 -28.67 14.22 Favored Glycine 0 N--CA 1.436 -1.307 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.3 p -156.1 151.67 27.03 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.5 t -128.45 142.4 43.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 35.8 t -145.84 150.06 35.45 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.515 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.6 t -113.58 123.28 33.41 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 175.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -57.27 140.6 93.42 Favored 'Trans proline' 0 C--O 1.247 0.935 0 C-N-CA 122.552 2.168 . . . . 0.0 111.505 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.421 ' CE1' ' HB2' ' A' ' 64' ' ' ASN . 82.1 t80 -74.09 109.54 7.66 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-O 121.385 0.612 . . . . 0.0 110.681 -177.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.406 ' H ' ' HB2' ' A' ' 90' ' ' HIS . 49.1 t -94.19 114.17 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.566 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.421 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 27.0 t-20 -112.75 88.92 2.94 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 172.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.443 ' OD1' ' HG2' ' A' ' 67' ' ' LYS . 3.8 t70 -127.31 145.81 50.66 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.62 -171.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.9 m -62.93 -6.93 4.3 Favored 'General case' 0 CA--C 1.569 1.71 0 C-N-CA 124.444 1.098 . . . . 0.0 111.157 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.443 ' HG2' ' OD1' ' A' ' 65' ' ' ASP . 75.8 mmtt -61.28 153.95 25.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 171.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.523 ' HB2' ' OE2' ' A' ' 69' ' ' GLU . 45.5 mtm180 -89.17 -28.65 19.87 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.733 -177.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.523 ' OE2' ' HB2' ' A' ' 68' ' ' ARG . 9.7 mp0 -105.37 128.9 53.74 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.435 -177.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -102.52 153.96 37.78 Favored Pre-proline 0 C--N 1.291 -1.968 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 176.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.412 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 93.5 Cg_endo -80.58 141.39 13.85 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.467 1.445 . . . . 0.0 112.476 -177.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -133.22 138.15 46.4 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.594 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 84.3 m95 -120.27 136.91 54.51 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.755 -0.59 . . . . 0.0 112.301 -173.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 86' ' ' THR . 37.1 m-85 -116.74 143.29 45.84 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.678 177.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.8 mt -125.96 142.78 51.36 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 -176.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -133.62 141.71 47.77 Favored 'General case' 0 C--O 1.244 0.794 0 O-C-N 123.625 0.578 . . . . 0.0 109.974 -177.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.65 -5.46 59.31 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.918 -177.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -131.76 162.25 30.94 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 175.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 25.2 m -73.15 167.38 2.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 C-N-CA 122.395 0.278 . . . . 0.0 110.794 -176.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 57.54 30.2 18.34 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.646 0.778 . . . . 0.0 111.968 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.546 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 11.5 m-85 60.1 40.22 18.7 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.401 1.08 . . . . 0.0 111.523 176.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.0 p -111.98 171.28 7.59 Favored 'General case' 0 C--O 1.25 1.095 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.95 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.69 -135.77 13.25 Favored Glycine 0 N--CA 1.427 -1.913 0 C-N-CA 120.881 -0.675 . . . . 0.0 112.105 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -83.48 155.53 23.33 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 123.025 0.53 . . . . 0.0 109.605 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.4 tt -131.66 136.69 56.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 121.318 0.58 . . . . 0.0 110.066 -175.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 76.1 m -132.09 127.62 36.45 Favored 'General case' 0 C--N 1.288 -2.103 0 O-C-N 122.021 -0.424 . . . . 0.0 110.359 175.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -111.1 124.82 7.08 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.81 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -117.76 145.39 44.52 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 123.576 0.751 . . . . 0.0 110.618 177.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -117.3 169.26 13.09 Favored Glycine 0 N--CA 1.433 -1.523 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.92 -178.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.406 ' HB2' ' H ' ' A' ' 63' ' ' VAL . 7.4 p80 -61.13 122.13 14.24 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.449 0.642 . . . . 0.0 112.323 -177.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.56 -1.63 76.05 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.568 177.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.5 m -107.42 146.12 32.1 Favored 'General case' 0 N--CA 1.424 -1.73 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.7 m -137.68 154.51 49.67 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 50.7 mt -93.49 128.11 45.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 173.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -70.92 -47.54 58.54 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.108 0.48 . . . . 0.0 110.984 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.515 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 3.4 m-20 -132.72 88.87 2.56 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.927 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.424 ' CD2' ' HG2' ' A' ' 55' ' ' PRO . 50.7 t80 -65.47 -30.25 71.01 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.778 0.799 . . . . 0.0 109.666 176.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.2 t -66.91 -24.45 66.1 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.463 -178.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.515 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 30.0 mmtp -93.99 -6.78 44.57 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -178.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 26.6 m -79.73 -171.85 3.04 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.46 -64.89 3.97 Favored Glycine 0 CA--C 1.503 -0.702 0 N-CA-C 112.094 -0.403 . . . . 0.0 112.094 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -110.94 146.74 36.05 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.193 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.42 -6.54 13.49 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 175.867 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -112.55 119.18 4.86 Favored Glycine 0 N--CA 1.431 -1.648 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.457 -177.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 64.9 mt -103.06 115.41 44.99 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.763 0 CA-C-O 122.426 1.107 . . . . 0.0 109.476 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 37.8 m -85.73 -29.6 23.78 Favored 'General case' 0 N--CA 1.394 -3.248 0 CA-C-N 112.148 -2.297 . . . . 0.0 113.999 177.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.6 p -153.88 154.61 34.2 Favored 'General case' 0 C--O 1.237 0.42 0 O-C-N 121.862 -0.524 . . . . 0.0 109.965 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.8 mt -133.22 131.45 58.24 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -176.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.546 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 38.2 ttmt -117.51 128.33 54.87 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -95.67 129.58 42.83 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 68.4 m -122.56 171.72 8.91 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.357 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.1 pt -129.41 139.3 52.08 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 176.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -110.56 118.87 37.38 Favored 'General case' 0 C--N 1.274 -2.714 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 72.9 p -69.15 170.23 10.48 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.462 -176.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.2 ttpp -67.06 -19.54 65.69 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.635 0.731 . . . . 0.0 109.276 176.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -84.92 -8.17 58.87 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.744 -177.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.21 -10.62 65.54 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.78 -0.646 . . . . 0.0 114.133 175.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -78.32 138.38 38.54 Favored 'General case' 0 C--O 1.249 1.031 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.902 179.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.3 t -102.31 113.35 38.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -95.49 133.86 39.0 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.75 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 63.6 m -136.91 158.45 44.42 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 7.4 tp -73.76 118.99 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.894 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 171.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -81.11 104.77 11.82 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.466 -175.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 . . . . . 0 N--CA 1.429 -1.499 0 N-CA-C 104.003 -2.592 . . . . 0.0 104.003 178.82 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.461 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 70.75 4.44 5.01 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.788 1.235 . . . . 0.0 113.534 176.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -88.03 -23.75 23.69 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 122.089 0.947 . . . . 0.0 109.269 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.6 p -102.91 139.73 38.1 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.015 174.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 61' ' ' PRO . 44.4 t -102.1 134.09 45.91 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 -177.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.5 mmtm -77.03 120.51 22.24 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -176.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.461 ' CZ ' ' HD3' ' A' ' 71' ' ' PRO . 14.5 m-85 66.52 35.82 5.31 Favored 'General case' 0 CA--C 1.509 -0.603 0 O-C-N 124.563 1.165 . . . . 0.0 110.694 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.428 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 18.5 m -123.12 145.32 48.68 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.582 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 49.7 tp -94.56 124.93 38.88 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 176.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.467 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 16.3 mt-30 -117.42 124.19 48.24 Favored 'General case' 0 N--CA 1.42 -1.929 0 CA-C-O 121.368 0.604 . . . . 0.0 109.469 -177.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 3.6 mp -109.68 125.65 52.85 Favored 'General case' 0 N--CA 1.421 -1.904 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.73 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.496 ' HA ' ' O ' ' A' ' 38' ' ' SER . 85.6 m-85 -95.24 152.31 18.48 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 123.393 0.433 . . . . 0.0 111.464 -176.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.89 -47.56 65.53 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.378 -177.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -108.17 178.4 4.51 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.781 -176.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.434 HG23 ' HA ' ' A' ' 96' ' ' ASP . 2.4 p -77.02 166.29 23.5 Favored 'General case' 0 N--CA 1.403 -2.799 0 O-C-N 123.28 0.362 . . . . 0.0 110.295 -176.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.262 20.9 p90 47.21 47.59 16.41 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 177.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 65.51 22.19 11.82 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.391 1.076 . . . . 0.0 112.19 176.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 33' ' ' THR . 55.1 mtp180 -91.29 160.17 15.65 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.509 0.671 . . . . 0.0 112.63 178.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.35 -148.0 20.42 Favored Glycine 0 N--CA 1.433 -1.542 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -176.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 17.2 m -111.77 -176.65 2.99 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 177.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.483 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 23.4 p90 -143.31 163.15 33.81 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.23 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 15.3 tt -114.35 152.18 16.04 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 177.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -106.84 125.54 51.14 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.51 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 87.5 t -120.1 133.18 67.68 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -115.68 -31.72 5.74 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.487 0.66 . . . . 0.0 109.518 -174.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.47 161.89 29.37 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.321 -176.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.4 p -69.01 146.38 52.75 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 123.623 0.769 . . . . 0.0 112.67 -176.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.0 p -121.82 135.65 61.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.9 -18.11 41.58 Favored Glycine 0 N--CA 1.431 -1.687 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.955 -178.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.5 p -158.92 116.66 2.84 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.405 0.621 . . . . 0.0 112.593 -178.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.9 mt -105.19 116.91 32.74 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.431 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.2 m -133.58 114.75 13.37 Favored Pre-proline 0 N--CA 1.42 -1.962 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 172.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -73.99 162.12 92.91 Favored 'Cis proline' 0 C--O 1.248 0.995 0 C-N-CA 123.315 -1.536 . . . . 0.0 110.946 -0.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.54 155.36 66.92 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.914 1.743 . . . . 0.0 109.931 177.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -89.61 133.43 34.62 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.575 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 22.6 p -116.85 77.22 8.41 Favored Pre-proline 0 C--N 1.298 -1.643 0 O-C-N 123.523 0.514 . . . . 0.0 111.759 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -80.29 158.2 22.93 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.66 2.24 . . . . 0.0 113.012 178.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -89.28 -29.57 16.69 Favored Glycine 0 N--CA 1.437 -1.247 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 177.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.0 p -155.25 154.46 32.2 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.0 t -129.16 143.22 41.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 38.6 t -145.58 149.88 35.37 Favored 'General case' 0 N--CA 1.428 -1.558 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.732 176.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.6 t -116.55 123.81 30.14 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 175.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.48 ' HG3' ' O ' ' A' ' 23' ' ' CYS . 26.2 Cg_endo -60.81 149.04 90.11 Favored 'Trans proline' 0 C--O 1.252 1.18 0 C-N-CA 122.798 2.332 . . . . 0.0 112.321 -177.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.531 ' CE2' ' HB3' ' A' ' 64' ' ' ASN . 79.5 t80 -76.14 110.12 10.36 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 121.825 0.821 . . . . 0.0 111.058 -177.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 66.3 t -94.54 116.31 35.52 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.778 177.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.531 ' HB3' ' CE2' ' A' ' 62' ' ' PHE . 3.7 p-10 -119.28 24.58 10.65 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 122.35 1.071 . . . . 0.0 108.62 178.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -67.93 146.58 53.47 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 113.363 -1.744 . . . . 0.0 111.93 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.2 m -58.71 -8.64 1.37 Allowed 'General case' 0 CA--C 1.57 1.749 0 C-N-CA 125.141 1.377 . . . . 0.0 112.768 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -62.62 138.57 58.52 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -69.21 -29.41 67.37 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.468 0.48 . . . . 0.0 111.509 -173.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -112.02 135.65 52.38 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-O 121.63 0.729 . . . . 0.0 111.612 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.86 148.35 36.36 Favored Pre-proline 0 C--N 1.285 -2.204 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.394 176.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.461 ' HD3' ' CZ ' ' A' ' 25' ' ' TYR . 71.2 Cg_endo -71.59 137.87 31.14 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 121.995 1.797 . . . . 0.0 112.928 -175.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -131.29 123.38 28.22 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.582 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 83.6 m95 -108.55 135.76 49.28 Favored 'General case' 0 C--N 1.281 -2.388 0 O-C-N 122.098 -0.376 . . . . 0.0 111.996 -172.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.455 ' HA ' ' O ' ' A' ' 86' ' ' THR . 41.6 m-85 -113.89 141.91 46.76 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.554 177.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.6 mt -125.35 142.59 51.41 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 -176.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 84.7 m-85 -131.49 139.72 49.38 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 121.197 0.522 . . . . 0.0 111.178 -175.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.13 -12.85 59.14 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.891 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -123.76 165.76 16.74 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 175.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.7 m -77.14 167.47 2.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 118.036 0.38 . . . . 0.0 110.822 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.51 30.96 20.16 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.667 0.787 . . . . 0.0 111.942 177.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 61.92 40.37 12.56 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.799 175.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.8 p -117.49 176.07 5.34 Favored 'General case' 0 C--O 1.25 1.086 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.629 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.57 -134.03 12.26 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 178.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.444 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 52.2 mtm180 -84.38 147.78 26.96 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 122.45 0.3 . . . . 0.0 110.431 176.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.9 tt -124.77 139.24 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 O-C-N 123.654 0.596 . . . . 0.0 110.108 -176.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 67.6 m -131.84 126.44 34.29 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 175.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -111.55 122.12 5.97 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.776 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -112.69 145.07 41.13 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 120.835 0.35 . . . . 0.0 111.041 178.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -117.06 168.32 12.8 Favored Glycine 0 N--CA 1.424 -2.121 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.705 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -59.72 123.87 18.32 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.335 0.588 . . . . 0.0 111.83 -178.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.08 2.78 77.17 Favored Glycine 0 N--CA 1.43 -1.758 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.387 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.1 m -113.19 145.66 40.61 Favored 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 4.6 m -134.8 158.84 43.14 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 46.3 mt -93.65 131.94 39.21 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 173.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -70.21 -47.67 60.44 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.276 0.56 . . . . 0.0 109.903 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.455 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 3.2 m-20 -138.25 100.95 4.26 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -64.77 -36.5 84.53 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.404 0.621 . . . . 0.0 110.422 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.3 t -64.45 -23.76 67.39 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.965 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.455 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 28.2 mmtp -91.99 -7.64 48.35 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 122.147 -0.346 . . . . 0.0 110.413 -178.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.2 m -78.12 -13.93 59.67 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.687 0.756 . . . . 0.0 109.872 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 132.14 -85.16 0.29 Allowed Glycine 0 N--CA 1.42 -2.385 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -86.89 141.9 28.42 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 120.542 -0.463 . . . . 0.0 109.924 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.575 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.52 -8.39 13.35 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.853 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -108.15 109.15 2.84 Favored Glycine 0 N--CA 1.432 -1.614 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.989 -176.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 66.5 mt -91.64 116.06 32.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 122.336 1.065 . . . . 0.0 109.053 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.9 m -85.85 -28.63 24.3 Favored 'General case' 0 N--CA 1.401 -2.923 0 CA-C-N 112.445 -2.161 . . . . 0.0 114.816 177.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.4 p -156.13 157.36 35.86 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.7 mt -137.48 131.47 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -175.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -117.66 133.64 55.74 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -101.27 121.88 42.67 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 120.615 -0.434 . . . . 0.0 109.932 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 65.9 m -119.85 172.14 7.92 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 8.4 pt -127.61 143.22 41.4 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -115.12 120.49 39.97 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 177.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 82.8 p -79.6 176.49 9.66 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.424 -173.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -65.16 -26.85 68.35 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.119 172.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -76.91 -8.71 57.86 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 122.051 0.929 . . . . 0.0 110.211 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.07 -11.54 70.48 Favored Glycine 0 CA--C 1.498 -1.016 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.772 175.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -73.31 141.03 47.14 Favored 'General case' 0 C--O 1.257 1.448 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.889 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 22.6 t -102.13 118.71 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.814 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 177.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -104.3 140.4 37.92 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 69.9 m -130.74 147.82 52.44 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 8.2 tp -126.6 135.98 62.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 175.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -86.34 104.2 15.64 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.939 0.876 . . . . 0.0 110.112 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 . . . . . 0 C--N 1.292 -1.923 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.909 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.53 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.87 32.91 2.23 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -76.95 -5.16 47.47 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.834 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.0 p -106.48 124.12 49.11 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 165.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.9 p -125.95 153.36 44.4 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 119.446 -0.901 . . . . 0.0 111.839 -174.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.2 mmmm -89.36 143.39 26.86 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 69.17 36.95 2.24 Favored 'General case' 0 N--CA 1.482 1.175 0 O-C-N 123.822 0.701 . . . . 0.0 111.543 177.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.0 m -123.68 145.92 48.62 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.199 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.562 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 57.8 tp -100.03 114.13 27.22 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 175.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 41.2 mt-30 -108.26 124.49 50.38 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.704 -0.798 . . . . 0.0 108.848 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.4 mp -109.41 127.38 54.34 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.032 177.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -94.06 150.37 20.4 Favored 'General case' 0 C--N 1.29 -1.989 0 O-C-N 123.509 0.506 . . . . 0.0 110.148 -176.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -69.88 -43.27 72.17 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 124.055 0.847 . . . . 0.0 109.651 -175.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -114.08 178.88 4.12 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.033 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.424 HG23 ' HA ' ' A' ' 96' ' ' ASP . 2.6 p -74.91 169.72 17.39 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.119 -176.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.444 ' CE2' ' HG3' ' A' ' 36' ' ' ARG 0.258 13.8 p90 47.17 40.16 9.55 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.959 1.304 . . . . 0.0 114.01 177.771 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 62.2 40.43 11.65 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.147 0.979 . . . . 0.0 111.947 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.533 ' NE ' ' HA ' ' A' ' 36' ' ' ARG . 4.3 mmp_? -108.61 162.23 14.34 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.223 0.535 . . . . 0.0 112.162 178.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.26 -163.05 42.72 Favored Glycine 0 N--CA 1.426 -1.967 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -177.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.0 p -89.34 173.84 8.15 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 176.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -140.77 166.01 25.94 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -177.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.8 tt -116.9 152.08 18.69 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 177.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -106.75 125.57 51.18 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 175.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.458 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 97.8 t -122.41 133.04 69.86 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -119.32 -24.49 6.37 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.709 -177.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -115.46 163.14 16.17 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.98 -172.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.9 m -83.1 142.43 31.27 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 176.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.9 p -120.97 129.67 75.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.68 -12.13 59.76 Favored Glycine 0 N--CA 1.432 -1.567 0 C-N-CA 119.672 -1.252 . . . . 0.0 113.795 -178.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 24.4 p -157.7 122.27 4.31 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.279 0.562 . . . . 0.0 112.409 -178.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 72.8 mt -117.82 117.87 30.47 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 175.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.3 p -132.46 109.45 13.52 Favored Pre-proline 0 C--N 1.29 -1.991 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.959 176.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.34 162.06 93.38 Favored 'Cis proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.704 -1.373 . . . . 0.0 111.408 -1.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.76 156.77 59.8 Favored 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 121.975 1.784 . . . . 0.0 111.152 178.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 48.0 m0 -89.27 131.89 35.16 Favored 'General case' 0 CA--C 1.482 -1.668 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.607 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 38.8 p -114.46 78.53 4.86 Favored Pre-proline 0 N--CA 1.43 -1.425 0 O-C-N 123.56 0.537 . . . . 0.0 110.712 178.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -78.21 157.63 29.92 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 122.523 2.149 . . . . 0.0 112.566 179.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -89.59 -30.85 12.39 Favored Glycine 0 N--CA 1.431 -1.651 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 177.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.2 p -153.25 158.25 41.39 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.9 t -136.87 142.67 37.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -177.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 49.4 t -145.95 147.82 32.12 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.691 176.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.1 t -118.73 124.27 28.52 Favored Pre-proline 0 N--CA 1.441 -0.923 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 175.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -63.03 148.66 93.19 Favored 'Trans proline' 0 C--O 1.247 0.971 0 C-N-CA 122.399 2.066 . . . . 0.0 112.062 -178.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -70.96 119.88 15.73 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-O 121.85 0.833 . . . . 0.0 110.249 -178.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 93.1 t -95.83 123.35 47.99 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.349 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -116.09 14.96 16.09 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 122.143 0.973 . . . . 0.0 108.617 -178.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -64.13 145.54 55.77 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 113.519 -1.673 . . . . 0.0 113.717 -175.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.7 m -64.19 -12.42 40.32 Favored 'General case' 0 C--O 1.255 1.372 0 C-N-CA 125.285 1.434 . . . . 0.0 110.981 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -59.67 141.33 55.29 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -78.02 -29.86 49.68 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.629 0.728 . . . . 0.0 109.803 -177.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.37 129.85 54.87 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.686 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.76 154.14 39.52 Favored Pre-proline 0 C--N 1.286 -2.159 0 CA-C-N 114.616 -1.174 . . . . 0.0 109.237 -178.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -74.08 134.41 19.46 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 121.578 1.519 . . . . 0.0 111.066 -178.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -129.42 128.51 43.12 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 106.309 -1.738 . . . . 0.0 106.309 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.562 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 87.1 m95 -110.38 130.43 55.55 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-O 121.175 0.512 . . . . 0.0 111.565 -173.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.479 ' HA ' ' O ' ' A' ' 86' ' ' THR . 25.3 m-85 -111.19 142.26 43.62 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.359 176.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.3 mt -125.36 142.14 51.67 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 -176.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.42 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 87.2 m-85 -131.42 139.31 49.38 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.112 0.482 . . . . 0.0 110.814 -175.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.679 ' HB2' ' CD1' ' A' ' 102' ' ' PHE . 5.7 t70 -77.68 -18.06 57.03 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.295 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.443 ' C ' ' HB3' ' A' ' 106' ' ' SER . 9.0 t-20 -126.03 162.38 25.42 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 176.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.3 m -67.78 168.12 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.58 0 C-N-CA 123.076 0.551 . . . . 0.0 111.434 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 55.26 30.22 14.28 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.827 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.502 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 13.3 m-85 60.03 45.9 11.49 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.799 1.239 . . . . 0.0 111.749 175.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.8 p -118.94 176.35 5.33 Favored 'General case' 0 C--O 1.249 1.041 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.462 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.87 -133.77 12.16 Favored Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 121.218 -0.515 . . . . 0.0 111.973 177.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 63.9 mtt85 -81.67 148.07 29.2 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.9 tt -129.16 137.2 57.71 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 O-C-N 123.62 0.575 . . . . 0.0 110.424 -175.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 95.7 m -130.97 122.71 27.35 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -111.19 109.68 2.6 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.713 -0.756 . . . . 0.0 114.629 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -103.07 145.07 30.45 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 122.816 0.446 . . . . 0.0 110.95 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.13 175.9 16.1 Favored Glycine 0 N--CA 1.425 -2.063 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.473 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -66.08 122.13 16.72 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.532 0.682 . . . . 0.0 112.194 -176.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.72 0.95 71.51 Favored Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.623 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.0 m -106.59 146.31 30.84 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 5.6 m -136.07 151.37 49.77 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.8 mt -93.51 127.22 45.71 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 174.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -70.51 -47.27 61.26 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.387 0.613 . . . . 0.0 110.48 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.479 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 2.1 m-20 -135.33 93.63 3.01 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.071 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -65.14 -33.69 76.61 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.202 0.525 . . . . 0.0 110.391 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.8 t -65.26 -23.91 67.17 Favored 'General case' 0 CA--C 1.559 1.318 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.136 -176.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.479 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 30.2 mmtp -92.75 -6.4 49.15 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.941 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.2 m -84.9 38.69 0.72 Allowed 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.344 0.592 . . . . 0.0 111.535 -175.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.88 -73.98 2.25 Favored Glycine 0 N--CA 1.426 -2.028 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.679 ' CD1' ' HB2' ' A' ' 77' ' ' ASP . 16.1 p90 -109.81 148.28 31.77 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -179.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.607 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -113.54 -8.03 13.36 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 120.114 -0.635 . . . . 0.0 109.647 179.196 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -113.31 112.65 2.96 Favored Glycine 0 N--CA 1.432 -1.604 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.351 -174.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 76.1 mt -94.26 115.41 33.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.443 ' HB3' ' C ' ' A' ' 78' ' ' ASN . 3.7 t -86.06 -26.42 25.35 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.947 178.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.5 p -152.08 157.22 41.31 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 122.089 -0.382 . . . . 0.0 110.935 177.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.3 mt -135.9 133.2 50.95 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -175.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.502 ' HE2' ' CD2' ' A' ' 81' ' ' TYR . 33.5 ttmt -122.02 128.34 51.32 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -96.3 121.39 38.04 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 60.6 m -119.16 172.09 7.82 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.9 pt -126.17 139.51 51.36 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 CA-C-O 121.127 0.489 . . . . 0.0 110.147 177.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -112.2 119.06 37.08 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 76.6 p -72.35 -178.55 2.57 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 114.636 -1.166 . . . . 0.0 112.059 -174.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -65.72 -31.05 71.83 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.785 0.803 . . . . 0.0 109.173 175.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -79.46 -8.95 59.48 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.652 -178.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.58 -9.32 77.98 Favored Glycine 0 N--CA 1.427 -1.928 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.787 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -70.01 139.32 52.72 Favored 'General case' 0 C--O 1.255 1.36 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.2 t -102.82 112.91 37.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 121.174 0.512 . . . . 0.0 109.761 -176.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -97.17 135.17 39.5 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -138.01 157.11 47.03 Favored 'General case' 0 CA--C 1.483 -1.634 0 C-N-CA 118.505 -1.278 . . . . 0.0 111.221 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 5.5 tp -125.43 123.14 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.782 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.063 176.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -73.79 106.15 5.39 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.629 0.728 . . . . 0.0 109.359 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 . . . . . 0 C--N 1.284 -2.243 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.384 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 . . . . . 0 N--CA 1.476 0.834 0 CA-C-O 121.254 0.549 . . . . 0.0 112.217 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.7 m -144.76 167.76 21.82 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.626 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 59.6 tp -111.96 124.63 52.8 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 169.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 70.5 mt-30 -113.72 124.37 52.13 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.555 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.443 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 3.2 mp -109.84 129.08 55.68 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.015 176.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.444 ' HB3' ' O ' ' A' ' 36' ' ' ARG . 94.9 m-85 -99.59 148.88 23.84 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 123.832 0.708 . . . . 0.0 110.852 -174.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -70.37 -38.1 74.69 Favored 'General case' 0 C--N 1.307 -1.249 0 O-C-N 123.663 0.602 . . . . 0.0 111.275 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -107.98 177.66 4.74 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -177.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.427 HG22 ' HA ' ' A' ' 96' ' ' ASP . 2.6 p -84.28 175.53 9.34 Favored 'General case' 0 N--CA 1.407 -2.612 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.274 15.5 p90 47.29 42.3 13.47 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 177.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 66.82 23.06 10.12 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.757 -1.111 . . . . 0.0 112.887 175.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.444 ' O ' ' HB3' ' A' ' 30' ' ' TYR . 18.1 mtm180 -102.24 173.38 6.39 Favored 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 119.653 -0.819 . . . . 0.0 112.106 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.69 179.8 51.32 Favored Glycine 0 N--CA 1.419 -2.45 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.52 -178.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.2 m -78.4 167.78 20.8 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 174.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 11.0 p90 -140.54 163.53 32.59 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -176.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.3 tt -114.59 152.98 16.16 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -107.23 125.54 51.26 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 176.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.549 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 84.3 t -117.91 133.38 64.89 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.369 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 176.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -114.81 -31.84 6.0 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 123.337 0.398 . . . . 0.0 110.159 -176.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.99 160.59 33.17 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -177.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.9 m -69.43 139.62 54.05 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 123.645 0.778 . . . . 0.0 112.186 -173.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.1 p -113.71 131.19 66.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 176.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.33 -15.41 51.06 Favored Glycine 0 N--CA 1.433 -1.549 0 C-N-CA 119.546 -1.312 . . . . 0.0 113.154 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.7 p -154.88 124.13 6.35 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.309 0.576 . . . . 0.0 112.474 -178.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 82.8 mt -118.77 117.99 30.37 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.615 175.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 15.0 p -132.84 110.13 13.16 Favored Pre-proline 0 N--CA 1.428 -1.548 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.636 174.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 74.2 Cg_endo -76.5 162.11 92.48 Favored 'Cis proline' 0 C--O 1.252 1.204 0 C-N-CA 123.729 -1.363 . . . . 0.0 111.236 -2.083 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.76 158.47 37.47 Favored 'Trans proline' 0 C--O 1.244 0.785 0 C-N-CA 122.783 2.322 . . . . 0.0 110.751 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.46 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 47.8 m0 -89.22 138.25 31.59 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 11.0 p -116.74 76.94 8.01 Favored Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 123.576 0.547 . . . . 0.0 111.874 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.466 ' HD2' ' O ' ' A' ' 103' ' ' LYS . 92.8 Cg_endo -76.4 158.57 36.66 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.584 2.189 . . . . 0.0 112.849 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.69 -36.92 8.97 Favored Glycine 0 N--CA 1.435 -1.37 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 175.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.2 p -151.1 159.8 44.27 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.5 t -134.77 143.11 38.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 38.4 t -145.48 148.74 33.58 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.784 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 67.3 t -113.0 121.01 39.31 Favored Pre-proline 0 C--N 1.309 -1.153 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 176.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -57.79 138.4 85.88 Favored 'Trans proline' 0 C--O 1.244 0.799 0 C-N-CA 122.877 2.385 . . . . 0.0 111.498 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.465 ' CE2' ' HB3' ' A' ' 64' ' ' ASN . 40.5 t80 -67.67 136.64 54.67 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-O 121.699 0.761 . . . . 0.0 111.071 -177.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 70.2 t -131.61 114.87 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.465 ' HB3' ' CE2' ' A' ' 62' ' ' PHE . 9.4 p30 -111.95 5.01 18.57 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 175.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.19 145.13 32.52 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 112.615 -2.084 . . . . 0.0 112.931 -172.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.48 -5.64 0.06 Allowed 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 128.991 2.916 . . . . 0.0 115.162 -173.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -59.62 171.55 0.84 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.295 1.038 . . . . 0.0 109.614 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 114' ' ' THR . 28.3 mtm180 -90.7 -28.09 18.56 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 118.093 -1.443 . . . . 0.0 107.955 173.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.449 ' HG2' HD12 ' A' ' 112' ' ' ILE . 18.5 mp0 -103.61 132.26 50.02 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.582 -174.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -106.38 153.78 40.24 Favored Pre-proline 0 C--N 1.289 -2.033 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 169.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.61 135.71 10.52 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 121.648 1.566 . . . . 0.0 113.012 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -133.88 118.58 18.11 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 177.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.626 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 82.9 m95 -107.55 136.77 46.76 Favored 'General case' 0 C--N 1.278 -2.525 0 O-C-N 122.052 -0.405 . . . . 0.0 111.977 -172.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.513 ' HD2' ' SG ' ' A' ' 111' ' ' CYS . 29.3 m-85 -113.52 141.21 47.42 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.765 177.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.415 HD21 HD21 ' A' ' 27' ' ' LEU . 22.5 mt -126.01 142.33 51.57 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 -176.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 88.0 m-85 -131.75 139.63 49.01 Favored 'General case' 0 C--N 1.31 -1.119 0 O-C-N 123.499 0.5 . . . . 0.0 110.993 -176.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.673 ' HB2' ' CD2' ' A' ' 102' ' ' PHE . 11.8 t70 -85.44 0.9 50.88 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 123.673 0.789 . . . . 0.0 111.224 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -136.58 158.49 44.32 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 172.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.1 m -72.0 169.26 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 C-N-CA 122.316 0.246 . . . . 0.0 110.405 -178.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 60.48 29.87 19.34 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.168 0.587 . . . . 0.0 110.575 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.436 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 18.9 m-85 56.37 46.82 20.23 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.973 0.909 . . . . 0.0 110.95 177.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 72.9 p -123.32 176.63 6.02 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.475 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.6 -140.8 18.38 Favored Glycine 0 N--CA 1.429 -1.821 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.79 177.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 61.8 mtt180 -73.61 143.46 46.34 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.1 tt -125.33 137.63 57.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 O-C-N 123.572 0.545 . . . . 0.0 110.269 -174.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 52.0 m -131.79 125.11 31.09 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 121.984 -0.448 . . . . 0.0 110.658 175.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -112.22 124.82 6.89 Favored Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.829 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -119.13 146.0 45.5 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 123.251 0.62 . . . . 0.0 110.251 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.29 166.95 12.39 Favored Glycine 0 N--CA 1.431 -1.664 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.362 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -53.3 124.79 15.6 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 124.337 1.055 . . . . 0.0 112.357 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.34 -6.47 82.39 Favored Glycine 0 N--CA 1.435 -1.424 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.612 175.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.9 m -106.44 146.42 30.55 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -178.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.9 m -139.8 152.3 46.44 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 50.8 mt -93.48 133.76 33.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 176.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -71.1 -47.9 55.43 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.205 0.526 . . . . 0.0 110.36 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.554 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 1.9 m-20 -135.0 100.15 4.49 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.25 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -64.4 -38.93 92.75 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.359 0.6 . . . . 0.0 110.375 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.4 t -65.62 -29.76 70.38 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.641 -1.163 . . . . 0.0 112.192 -175.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.554 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 27.5 mmtp -86.31 -14.88 42.34 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 121.988 -0.445 . . . . 0.0 109.963 -176.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.1 m -77.88 -8.08 57.59 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 144.0 -77.26 0.28 Allowed Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.673 ' CD2' ' HB2' ' A' ' 77' ' ' ASP . 37.8 p90 -110.05 147.89 32.73 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.03 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.539 ' H ' ' HD3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -113.94 -9.9 12.98 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.958 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -109.67 115.71 4.29 Favored Glycine 0 N--CA 1.428 -1.874 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.596 -175.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 64.0 mt -101.17 116.07 44.05 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.7 m -85.28 -26.4 26.65 Favored 'General case' 0 N--CA 1.391 -3.414 0 CA-C-N 112.432 -2.167 . . . . 0.0 114.067 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 77.8 p -156.75 156.35 33.18 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.3 mt -134.24 133.94 55.32 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.768 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -176.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.436 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 31.9 ttmt -122.52 131.42 53.84 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -96.08 122.23 38.7 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.379 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' CYS . . . . . 0.513 ' SG ' ' HD2' ' A' ' 74' ' ' TYR . 56.3 m -118.86 167.74 11.43 Favored 'General case' 0 N--CA 1.405 -2.7 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.449 HD12 ' HG2' ' A' ' 69' ' ' GLU . 9.2 pt -127.74 145.82 34.43 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.414 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 61.5 tt0 -122.6 118.93 29.35 Favored 'General case' 0 C--N 1.274 -2.712 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 68' ' ' ARG . 27.1 p -79.78 179.16 7.69 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -175.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -66.25 -19.53 65.85 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.727 0.775 . . . . 0.0 110.203 177.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -83.34 -1.67 53.87 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.84 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.55 -5.63 82.89 Favored Glycine 0 CA--C 1.506 -0.483 0 CA-C-N 116.208 -0.451 . . . . 0.0 113.618 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 113' ' ' GLN . 19.0 ptpt -75.96 134.91 40.07 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 39.4 t -104.71 110.57 31.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -100.3 154.49 18.44 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.288 -2.097 0 C-N-CA 118.642 -1.223 . . . . 0.0 110.376 -177.206 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 121.565 0.698 . . . . 0.0 111.349 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.8 m -124.33 155.09 39.32 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.267 -0.878 . . . . 0.0 108.925 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.606 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 55.2 tp -110.18 117.58 34.06 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 172.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.523 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 77.7 mt-30 -110.22 124.2 51.15 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.579 -0.849 . . . . 0.0 109.618 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 3.2 mp -110.06 125.6 53.12 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.945 178.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -92.91 152.89 19.11 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 123.574 0.546 . . . . 0.0 110.1 -177.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -77.83 -37.9 47.51 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.868 -176.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -108.56 178.31 4.52 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.462 HG22 ' HA ' ' A' ' 96' ' ' ASP . 1.4 p -78.17 169.04 18.92 Favored 'General case' 0 N--CA 1.413 -2.292 0 C-N-CA 122.404 0.282 . . . . 0.0 110.4 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 25.3 p90 46.87 42.51 12.2 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.914 1.286 . . . . 0.0 114.232 176.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 67.65 23.46 8.73 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.414 1.086 . . . . 0.0 112.995 177.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.518 ' HA ' ' NE ' ' A' ' 36' ' ' ARG . 4.4 mmp_? -98.22 165.2 11.99 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.41 -157.8 33.47 Favored Glycine 0 N--CA 1.434 -1.436 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.5 p -85.99 176.64 7.93 Favored 'General case' 0 N--CA 1.421 -1.892 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 174.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.435 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 11.7 p90 -149.36 165.79 30.98 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 13.4 tt -123.03 150.81 27.07 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.747 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -106.88 125.21 50.71 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 174.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.472 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 94.8 t -118.13 133.69 64.13 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -117.86 -26.4 6.5 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.282 0.563 . . . . 0.0 110.569 -176.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -115.73 163.14 16.27 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.334 -174.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.4 ' HB3' ' H ' ' A' ' 110' ' ' ARG . 6.2 p -84.06 143.53 29.67 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 175.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.5 p -120.75 132.38 70.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.56 -16.96 54.12 Favored Glycine 0 N--CA 1.433 -1.536 0 C-N-CA 119.77 -1.205 . . . . 0.0 113.457 -177.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.4 p -157.4 124.29 5.06 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 81.8 mt -117.73 118.65 32.64 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 18.9 m -133.09 116.85 14.56 Favored Pre-proline 0 N--CA 1.42 -1.942 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.154 175.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 58.5 Cg_endo -75.62 160.08 96.49 Favored 'Cis proline' 0 C--O 1.251 1.14 0 C-N-CA 122.779 -1.759 . . . . 0.0 110.438 -4.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.0 157.33 29.61 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 122.69 2.26 . . . . 0.0 111.483 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 48.4 m0 -89.66 132.34 35.19 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -178.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.614 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 41.6 p -113.28 78.67 3.45 Favored Pre-proline 0 C--N 1.304 -1.375 0 O-C-N 123.252 0.345 . . . . 0.0 111.144 177.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.48 ' HG2' ' CD2' ' A' ' 97' ' ' PHE . 73.7 Cg_endo -76.37 153.44 35.43 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 122.198 1.932 . . . . 0.0 112.691 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -87.44 -28.53 24.46 Favored Glycine 0 N--CA 1.431 -1.638 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 178.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.7 p -155.08 154.96 33.21 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.6 t -134.01 142.25 41.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -178.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 31.6 t -146.11 149.64 34.42 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 119.637 -0.825 . . . . 0.0 111.52 176.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.7 t -118.03 124.11 28.99 Favored Pre-proline 0 N--CA 1.437 -1.117 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 175.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.89 143.52 79.87 Favored 'Trans proline' 0 C--O 1.246 0.877 0 C-N-CA 122.604 2.203 . . . . 0.0 112.281 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -66.89 136.37 55.29 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.172 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.469 HG12 ' H ' ' A' ' 65' ' ' ASP . 84.5 t -120.61 129.76 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.9 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -121.48 27.59 8.19 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 124.125 0.97 . . . . 0.0 108.818 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.469 ' H ' HG12 ' A' ' 63' ' ' VAL . 7.0 t0 -59.73 144.99 46.67 Favored 'General case' 0 C--O 1.248 1.014 0 C-N-CA 125.887 1.675 . . . . 0.0 111.054 -177.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.3 m -63.74 -14.88 56.33 Favored 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 124.325 1.05 . . . . 0.0 111.315 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.4 ' HG2' ' OD1' ' A' ' 65' ' ' ASP . 33.7 mmtp -63.68 166.68 6.66 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.977 0.418 . . . . 0.0 110.763 175.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 57.3 mtm180 -90.97 -28.53 17.97 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.293 1.044 . . . . 0.0 109.152 -173.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -109.76 131.16 55.32 Favored 'General case' 0 N--CA 1.409 -2.501 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.661 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -106.18 153.96 39.97 Favored Pre-proline 0 C--N 1.301 -1.522 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.485 177.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -71.94 141.94 37.82 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.26 1.974 . . . . 0.0 113.464 -176.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -133.84 144.35 48.89 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.606 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 88.0 m95 -123.76 137.26 54.72 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.5 -0.75 . . . . 0.0 111.968 -175.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.434 ' HA ' ' O ' ' A' ' 86' ' ' THR . 29.6 m-85 -117.81 141.52 48.32 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.38 177.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.8 mt -125.73 143.07 51.2 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.416 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 74.8 m-85 -134.08 143.18 47.86 Favored 'General case' 0 C--O 1.242 0.688 0 O-C-N 123.518 0.512 . . . . 0.0 110.24 -176.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.507 ' HB3' ' CG ' ' A' ' 102' ' ' PHE . 4.3 p-10 -89.17 -0.63 57.6 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -131.21 157.4 43.31 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 174.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.3 m -67.98 169.19 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 120.732 0.301 . . . . 0.0 110.947 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 31.0 m120 58.67 30.31 19.73 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 123.825 0.85 . . . . 0.0 111.335 178.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.499 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 13.4 m-85 57.51 38.7 28.13 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 124.659 1.184 . . . . 0.0 111.439 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 72.6 p -111.93 171.27 7.6 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.592 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.32 -138.65 14.78 Favored Glycine 0 N--CA 1.429 -1.833 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 59.1 mtt180 -79.21 153.34 30.06 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.5 tt -128.35 138.71 53.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -177.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 75.2 m -131.52 127.47 37.33 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 175.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -112.38 125.7 7.25 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.149 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.524 HD21 HD11 ' A' ' 94' ' ' ILE . 3.2 mm? -118.2 145.99 44.56 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 123.061 0.544 . . . . 0.0 110.749 178.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -117.45 168.74 12.98 Favored Glycine 0 N--CA 1.428 -1.899 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.95 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 23.5 p80 -62.71 122.17 15.22 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 123.6 0.76 . . . . 0.0 111.895 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.38 17.8 58.21 Favored Glycine 0 N--CA 1.431 -1.669 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.656 177.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.2 m -129.67 146.71 51.43 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.5 m -139.53 152.93 47.32 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.524 HD11 HD21 ' A' ' 88' ' ' LEU . 52.1 mt -93.63 122.15 44.87 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.448 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 171.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -70.57 -46.81 62.78 Favored 'General case' 0 C--N 1.289 -2.063 0 O-C-N 123.67 0.606 . . . . 0.0 110.809 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.647 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 5.4 m-20 -127.06 86.95 2.57 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.159 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.48 ' CD2' ' HG2' ' A' ' 55' ' ' PRO . 69.5 t80 -65.59 -36.17 82.95 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.359 0.599 . . . . 0.0 110.592 177.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.0 t -75.67 -15.85 60.26 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.976 -173.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.647 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 30.7 mmtp -94.35 -8.91 37.48 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.1 m -82.29 -168.16 1.86 Allowed 'General case' 0 C--O 1.248 0.982 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.961 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.47 -69.42 1.25 Allowed Glycine 0 C--O 1.242 0.64 0 O-C-N 123.109 0.256 . . . . 0.0 113.112 -177.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.507 ' CG ' ' HB3' ' A' ' 77' ' ' ASP . 42.3 p90 -110.39 146.17 36.28 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.343 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.614 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.66 -11.65 12.94 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 176.41 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.34 104.27 2.2 Favored Glycine 0 N--CA 1.44 -1.068 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.462 -176.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 70.4 mt -88.95 115.37 28.67 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.586 0 CA-C-O 122.533 1.159 . . . . 0.0 109.115 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 52.7 m -85.83 -27.44 25.1 Favored 'General case' 0 N--CA 1.395 -3.222 0 CA-C-N 112.108 -2.315 . . . . 0.0 113.934 177.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 81.0 p -157.4 155.58 30.76 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.1 mt -135.09 131.2 52.41 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -175.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.499 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 38.2 ttmt -117.45 133.51 55.89 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.4 ' H ' ' HB3' ' A' ' 45' ' ' SER . 54.3 ttp180 -100.43 130.02 46.46 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 61.3 m -130.06 172.88 11.27 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.571 -178.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.5 pt -131.77 143.55 39.98 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -113.79 121.1 43.03 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-O 121.382 0.61 . . . . 0.0 109.801 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.512 ' OG1' ' HG2' ' A' ' 118' ' ' LYS . 70.6 p -76.91 -179.97 5.8 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 114.316 -1.311 . . . . 0.0 112.155 -174.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -66.4 -30.97 71.45 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.81 172.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -76.76 -8.89 58.15 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.982 0.896 . . . . 0.0 110.199 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.89 -4.48 83.33 Favored Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.253 176.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.512 ' HG2' ' OG1' ' A' ' 114' ' ' THR . 10.7 ptmm? -76.13 135.13 39.83 Favored 'General case' 0 C--O 1.258 1.511 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.0 t -100.39 111.09 29.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 -177.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -96.69 149.44 21.81 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 -177.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 84.0 m . . . . . 0 C--N 1.287 -2.147 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.755 -175.85 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 121.069 0.461 . . . . 0.0 112.207 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 34.7 m -124.41 145.73 49.31 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.616 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 57.3 tp -99.87 116.18 31.33 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 172.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.45 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 43.9 mt-30 -110.62 124.28 51.58 Favored 'General case' 0 CA--C 1.485 -1.529 0 C-N-CA 119.329 -0.948 . . . . 0.0 109.288 -177.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.444 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.3 mp -109.71 131.21 55.27 Favored 'General case' 0 N--CA 1.409 -2.521 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.238 176.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.536 ' CE2' ' HG3' ' A' ' 35' ' ' GLU . 97.8 m-85 -98.14 154.86 17.45 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 123.354 0.409 . . . . 0.0 110.568 -176.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -77.79 -43.61 30.09 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.481 0.657 . . . . 0.0 109.501 -176.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -108.43 178.45 4.49 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.302 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.625 ' HA ' ' OG ' ' A' ' 57' ' ' SER . 0.5 OUTLIER -83.43 179.94 7.53 Favored 'General case' 0 N--CA 1.401 -2.915 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.582 -177.546 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 48.47 40.42 14.97 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.867 0.867 . . . . 0.0 113.258 176.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.536 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 1.0 OUTLIER 57.9 23.7 10.08 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 115.232 1.568 . . . . 0.0 115.232 178.912 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -105.51 173.27 6.38 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 118.012 -1.475 . . . . 0.0 111.016 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.23 -177.39 45.84 Favored Glycine 0 N--CA 1.428 -1.873 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 -178.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 44.4 m -84.41 143.67 29.28 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.393 176.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 12.4 p90 -116.13 165.92 12.6 Favored 'General case' 0 C--N 1.272 -2.781 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -174.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.0 tt -114.9 152.08 16.56 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.543 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -106.8 125.55 51.14 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 175.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 94.4 t -122.84 133.46 68.88 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -122.61 -14.2 7.81 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp -110.1 162.24 14.76 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.646 -171.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.442 ' HB3' ' H ' ' A' ' 110' ' ' ARG . 2.3 p -97.98 133.19 42.8 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 171.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.8 p -116.74 137.48 50.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -174.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.35 -18.49 35.95 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 119.755 -1.212 . . . . 0.0 113.321 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.5 p -155.81 121.34 4.91 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 86.0 mt -113.06 118.45 34.82 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.043 -0.981 . . . . 0.0 108.741 176.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.0 m -133.15 112.72 13.3 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 174.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.03 161.84 93.53 Favored 'Cis proline' 0 C--O 1.248 0.997 0 C-N-CA 123.313 -1.536 . . . . 0.0 111.255 -0.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -63.12 158.24 45.0 Favored 'Trans proline' 0 C--O 1.246 0.882 0 C-N-CA 122.387 2.058 . . . . 0.0 110.509 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -89.24 133.58 34.39 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 8.0 p -115.64 77.68 6.33 Favored Pre-proline 0 C--N 1.295 -1.799 0 O-C-N 123.628 0.58 . . . . 0.0 111.031 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.444 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 95.7 Cg_endo -77.65 158.09 32.0 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.286 1.991 . . . . 0.0 112.961 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.89 -39.45 11.77 Favored Glycine 0 N--CA 1.433 -1.55 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 176.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.625 ' OG ' ' HA ' ' A' ' 33' ' ' THR . 55.7 m -149.58 161.21 42.6 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.477 1.111 . . . . 0.0 108.26 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.402 HG22 HD23 ' A' ' 29' ' ' LEU . 38.9 t -135.35 142.33 40.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 48.8 t -146.1 147.99 32.16 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.435 176.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.7 t -116.29 122.34 32.23 Favored Pre-proline 0 N--CA 1.438 -1.066 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.68 147.41 89.9 Favored 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 122.57 2.18 . . . . 0.0 111.108 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -70.1 134.61 48.37 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.427 HG12 ' H ' ' A' ' 65' ' ' ASP . 57.9 t -121.08 123.51 70.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -120.72 26.27 9.21 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.427 ' H ' HG12 ' A' ' 63' ' ' VAL . 9.8 t70 -58.4 144.85 40.46 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.319 -178.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.5 m -60.22 -20.57 59.37 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 123.3 0.64 . . . . 0.0 111.616 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -58.79 139.5 56.25 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -68.63 -24.14 64.52 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.77 -175.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.41 130.52 55.67 Favored 'General case' 0 N--CA 1.418 -2.032 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.95 154.97 40.68 Favored Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.951 175.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.47 134.91 14.32 Favored 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 121.779 1.653 . . . . 0.0 110.662 177.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -129.26 143.7 50.95 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.616 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 88.9 m95 -125.47 132.76 52.62 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 120.204 -0.598 . . . . 0.0 112.131 -173.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 86' ' ' THR . 27.2 m-85 -114.98 141.61 47.75 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.893 176.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.8 mt -125.72 142.72 51.37 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -175.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.42 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 77.5 m-85 -133.82 143.03 48.11 Favored 'General case' 0 C--N 1.317 -0.813 0 O-C-N 123.634 0.584 . . . . 0.0 109.923 -177.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.562 ' HB3' ' CG ' ' A' ' 102' ' ' PHE . 2.8 p-10 -88.39 0.87 55.75 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.652 -178.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -134.49 160.12 39.01 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.8 m -73.18 167.14 2.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-O 120.61 0.243 . . . . 0.0 111.427 -176.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.8 m120 57.96 31.1 20.15 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 123.771 0.829 . . . . 0.0 111.421 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.566 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 10.9 m-85 59.64 39.37 21.32 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.893 1.277 . . . . 0.0 111.465 177.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 74.3 p -111.58 176.19 5.12 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.12 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.91 -137.43 15.16 Favored Glycine 0 N--CA 1.429 -1.825 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.835 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 56.2 mtt180 -83.81 150.86 25.49 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 123.547 0.739 . . . . 0.0 109.471 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.9 tt -124.84 139.39 51.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 121.179 0.514 . . . . 0.0 110.667 -176.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 90.7 m -131.47 128.2 38.93 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 174.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -115.06 117.43 4.01 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.541 -0.838 . . . . 0.0 113.194 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.434 HD21 HD11 ' A' ' 94' ' ' ILE . 4.0 mm? -109.9 145.55 36.65 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.017 0.437 . . . . 0.0 110.964 178.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -122.58 170.9 15.34 Favored Glycine 0 N--CA 1.419 -2.495 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.467 -177.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -63.6 121.5 14.06 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.299 0.571 . . . . 0.0 111.734 -176.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.6 14.72 61.05 Favored Glycine 0 N--CA 1.434 -1.479 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.908 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.6 m -125.09 146.14 49.6 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.9 m -139.15 160.06 40.69 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.434 HD11 HD21 ' A' ' 88' ' ' LEU . 50.0 mt -94.06 132.18 38.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 173.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -69.93 -48.41 58.57 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.033 0.444 . . . . 0.0 110.563 -177.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.477 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 11.1 m-20 -142.82 93.18 2.48 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.573 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.433 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 49.1 t80 -64.63 -30.06 71.07 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.573 0.701 . . . . 0.0 109.391 178.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.0 t -63.65 -25.07 68.05 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.537 177.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.477 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 34.4 mmtp -94.88 -5.59 44.61 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.936 -0.477 . . . . 0.0 110.837 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.9 m -79.61 -176.84 5.54 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -56.37 -63.8 4.98 Favored Glycine 0 C--O 1.249 1.052 0 CA-C-O 121.017 0.232 . . . . 0.0 112.781 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.562 ' CG ' ' HB3' ' A' ' 77' ' ' ASP . 39.9 p90 -110.92 147.23 35.07 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 177.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.94 -9.89 12.98 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.586 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -107.45 113.62 4.02 Favored Glycine 0 N--CA 1.431 -1.66 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.474 -177.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 62.6 mt -96.94 115.18 35.81 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.641 0 CA-C-O 122.336 1.065 . . . . 0.0 108.919 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.7 m -85.61 -29.68 23.89 Favored 'General case' 0 N--CA 1.392 -3.335 0 CA-C-N 112.242 -2.253 . . . . 0.0 113.685 177.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 89.2 p -153.11 155.52 36.93 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.0 mt -135.29 130.17 50.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -176.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.566 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 35.8 ttmt -117.32 131.15 56.86 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.442 ' H ' ' HB3' ' A' ' 45' ' ' SER . 25.7 ttp180 -101.76 123.14 45.23 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' CYS . . . . . 0.439 ' SG ' ' HD2' ' A' ' 74' ' ' TYR . 60.0 m -119.69 172.5 7.64 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -177.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.6 pt -128.12 141.95 45.1 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -115.68 120.29 38.89 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 108.39 -0.966 . . . . 0.0 108.39 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 44.1 p -76.93 175.53 9.44 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.799 -174.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -67.51 -20.68 65.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.628 0.727 . . . . 0.0 109.043 176.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -77.43 -9.59 58.97 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.512 177.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.28 -9.7 76.81 Favored Glycine 0 N--CA 1.439 -1.163 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.187 176.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -74.56 141.47 44.77 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 117.345 0.573 . . . . 0.0 110.225 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.7 t -106.68 111.28 34.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -105.85 148.09 27.96 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.285 -2.207 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.464 -178.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 34.5 m -123.08 145.56 48.44 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.499 ' HB3' ' HB ' ' A' ' 42' ' ' VAL . 49.6 tp -93.68 116.8 29.31 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 174.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.498 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 41.6 mt-30 -111.69 124.78 53.05 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -177.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 3.9 mp -109.6 129.06 55.61 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.24 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.556 ' CE1' ' HG3' ' A' ' 35' ' ' GLU . 94.6 m-85 -97.16 153.66 17.84 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 123.907 0.754 . . . . 0.0 111.644 -174.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -74.48 -41.64 60.4 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.058 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -107.83 177.65 4.76 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 56' ' ' GLY . 3.4 p -82.11 173.01 12.55 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 19.2 p90 47.46 38.76 8.19 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.556 ' HG3' ' CE1' ' A' ' 30' ' ' TYR . 0.7 OUTLIER 67.43 25.76 8.49 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 124.805 1.242 . . . . 0.0 113.637 177.229 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.7 mtp85 -90.74 159.22 16.44 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 177.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.99 -136.89 13.74 Favored Glycine 0 N--CA 1.422 -2.242 0 CA-C-N 114.365 -1.288 . . . . 0.0 109.911 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.2 m -116.68 -179.49 3.7 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 175.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 33.8 p90 -141.36 165.29 27.91 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -178.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 17.3 tt -114.63 152.65 16.24 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 177.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -106.71 126.11 51.87 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.499 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 88.2 t -123.43 133.15 69.98 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 176.049 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -115.53 -35.7 4.49 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-O 121.604 0.716 . . . . 0.0 109.397 -175.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.25 161.03 24.02 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.113 -177.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.429 ' HB3' ' H ' ' A' ' 110' ' ' ARG . 4.9 p -69.03 147.83 50.98 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 123.579 0.549 . . . . 0.0 111.517 -178.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.4 p -121.4 131.19 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.06 -15.86 55.24 Favored Glycine 0 N--CA 1.432 -1.633 0 C-N-CA 119.749 -1.215 . . . . 0.0 113.08 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.5 p -156.74 127.54 6.74 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 83.3 mt -122.57 118.36 28.02 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.474 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 14.5 m -133.5 113.46 13.12 Favored Pre-proline 0 C--N 1.306 -1.302 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.103 174.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 73.2 Cg_endo -75.22 162.1 93.38 Favored 'Cis proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.27 -1.554 . . . . 0.0 111.168 -0.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -63.6 156.84 54.62 Favored 'Trans proline' 0 C--O 1.238 0.505 0 C-N-CA 121.928 1.752 . . . . 0.0 110.695 177.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.401 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 49.2 m0 -89.46 134.83 33.92 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -177.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.62 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 58.0 p -113.87 81.0 5.59 Favored Pre-proline 0 N--CA 1.434 -1.236 0 O-C-N 123.431 0.457 . . . . 0.0 111.199 176.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.42 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 95.7 Cg_endo -79.47 158.42 25.63 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.699 2.266 . . . . 0.0 112.447 177.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.427 ' O ' HG22 ' A' ' 33' ' ' THR . . . -87.93 -35.85 8.8 Favored Glycine 0 N--CA 1.429 -1.814 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 176.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 94' ' ' ILE . 89.4 p -150.3 158.15 43.85 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.451 HG22 HD23 ' A' ' 29' ' ' LEU . 43.2 t -132.09 142.57 42.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 93' ' ' CYS . 38.4 t -145.43 149.55 34.92 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.614 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.1 t -117.28 126.63 27.27 Favored Pre-proline 0 C--N 1.317 -0.808 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.24 142.76 98.97 Favored 'Trans proline' 0 C--O 1.248 1.019 0 C-N-CA 122.851 2.367 . . . . 0.0 111.839 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.452 ' CE1' ' HB3' ' A' ' 64' ' ' ASN . 59.4 t80 -73.48 124.19 25.37 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 122.031 0.92 . . . . 0.0 111.456 -176.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.456 ' H ' ' HB2' ' A' ' 90' ' ' HIS . 91.0 t -109.76 117.67 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 CA-C-N 114.428 -1.26 . . . . 0.0 107.929 178.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.452 ' HB3' ' CE1' ' A' ' 62' ' ' PHE . 4.9 p-10 -122.38 11.31 9.99 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -69.31 145.55 52.94 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 111.664 -2.516 . . . . 0.0 112.631 -173.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 m -53.81 -7.58 0.13 Allowed 'General case' 0 CA--C 1.564 1.496 0 C-N-CA 128.353 2.661 . . . . 0.0 114.816 -175.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.482 ' H ' ' HD2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -66.7 154.36 40.85 Favored 'General case' 0 C--N 1.316 -0.887 0 O-C-N 122.173 -0.329 . . . . 0.0 110.692 -176.902 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -79.48 -28.4 41.51 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.741 -0.209 . . . . 0.0 111.206 -175.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.424 ' HG2' HD12 ' A' ' 112' ' ' ILE . 9.8 mp0 -110.54 144.75 38.93 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.395 177.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -106.24 151.44 40.2 Favored Pre-proline 0 C--N 1.307 -1.273 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 171.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -78.62 137.3 14.37 Favored 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 122.238 1.958 . . . . 0.0 111.974 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -132.92 132.78 42.4 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.487 ' CE3' HD22 ' A' ' 27' ' ' LEU . 87.2 m95 -116.67 134.88 54.28 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.78 -0.575 . . . . 0.0 111.366 -174.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.469 ' HD1' ' SG ' ' A' ' 111' ' ' CYS . 29.0 m-85 -116.07 142.3 46.99 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.617 178.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.2 mt -125.89 142.69 51.4 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -176.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.539 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 81.4 m-85 -134.38 142.55 47.23 Favored 'General case' 0 C--O 1.245 0.82 0 O-C-N 123.719 0.637 . . . . 0.0 110.174 -176.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.45 ' C ' ' HB2' ' A' ' 106' ' ' SER . 0.8 OUTLIER -80.95 -9.95 59.77 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.58 -179.051 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -127.54 162.31 26.75 Favored 'General case' 0 N--CA 1.427 -1.605 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.426 177.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.5 m -73.19 168.75 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 122.804 0.442 . . . . 0.0 110.588 -176.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.5 m120 57.66 30.35 18.72 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.612 0.72 . . . . 0.0 111.217 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.401 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 16.2 m-85 59.26 40.3 21.56 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.198 176.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 76.6 p -111.5 175.52 5.39 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.517 -0.473 . . . . 0.0 109.742 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.54 -140.62 16.16 Favored Glycine 0 N--CA 1.422 -2.259 0 C-N-CA 120.363 -0.923 . . . . 0.0 111.508 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.539 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 32.7 mtt180 -82.93 151.87 25.75 Favored 'General case' 0 C--N 1.287 -2.131 0 C-N-CA 123.487 0.715 . . . . 0.0 109.82 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.3 tt -122.61 137.2 56.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-O 121.198 0.523 . . . . 0.0 110.251 -177.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 95.2 m -131.62 125.82 33.17 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 175.007 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -115.05 110.09 2.23 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.625 -0.798 . . . . 0.0 114.63 -176.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.45 HD21 HD11 ' A' ' 94' ' ' ILE . 3.9 mm? -101.92 145.51 29.14 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 120.967 0.413 . . . . 0.0 111.279 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -123.32 169.67 15.58 Favored Glycine 0 N--CA 1.419 -2.478 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.866 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.456 ' HB2' ' H ' ' A' ' 63' ' ' VAL . 7.3 p80 -53.36 122.03 8.8 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 124.056 0.943 . . . . 0.0 113.109 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.39 -5.8 80.69 Favored Glycine 0 CA--C 1.5 -0.857 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.873 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.3 m -106.25 146.39 30.4 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-O 121.219 0.533 . . . . 0.0 109.782 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 59' ' ' CYS . 3.8 m -134.74 159.11 42.35 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.45 HD11 HD21 ' A' ' 88' ' ' LEU . 41.5 mt -93.44 130.43 42.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 175.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -65.8 -47.14 76.08 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.152 0.501 . . . . 0.0 110.066 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.579 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 2.9 m-20 -143.16 99.58 3.47 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 123.719 0.808 . . . . 0.0 108.966 178.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -63.96 -31.85 73.18 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.62 0.724 . . . . 0.0 110.839 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.5 t -63.34 -23.44 67.42 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.735 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.579 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 28.8 mmtp -94.56 -16.1 23.54 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 121.839 -0.538 . . . . 0.0 110.104 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.1 m -63.87 -34.32 77.68 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-O 121.116 0.484 . . . . 0.0 111.283 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 158.67 -67.38 0.28 Allowed Glycine 0 CA--C 1.488 -1.604 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -110.86 149.14 31.02 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.4 -9.64 13.33 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.26 177.229 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -106.25 108.18 2.88 Favored Glycine 0 N--CA 1.438 -1.189 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.017 -176.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 63.0 mt -92.11 116.04 32.4 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.59 0 CA-C-O 122.22 1.01 . . . . 0.0 109.067 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.45 ' HB2' ' C ' ' A' ' 77' ' ' ASP . 4.0 m -85.35 -29.28 24.61 Favored 'General case' 0 N--CA 1.396 -3.136 0 CA-C-N 112.565 -2.107 . . . . 0.0 114.231 176.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.3 p -154.92 155.15 33.78 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 122.191 -0.318 . . . . 0.0 110.239 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.3 mt -133.14 130.68 58.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.401 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 33.1 ttmt -117.71 133.71 55.66 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.429 ' H ' ' HB3' ' A' ' 45' ' ' SER . 58.6 ttt180 -99.8 126.77 45.94 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' CYS . . . . . 0.469 ' SG ' ' HD1' ' A' ' 74' ' ' TYR . 59.1 m -122.95 171.93 8.87 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -178.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 7.8 pt -127.52 143.49 40.51 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.298 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.586 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -117.02 119.45 35.32 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 51.1 p -80.89 178.31 8.49 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 114.228 -1.351 . . . . 0.0 112.363 -172.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -66.51 -23.6 66.27 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 172.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -83.3 -8.17 59.47 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.583 -1.189 . . . . 0.0 109.985 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.96 -11.36 57.51 Favored Glycine 0 N--CA 1.438 -1.186 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.769 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.47 137.05 54.13 Favored 'General case' 0 C--O 1.255 1.364 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 43.3 t -105.58 112.07 37.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -97.77 144.52 27.29 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 94.6 m . . . . . 0 C--N 1.293 -1.871 0 O-C-N 123.062 0.226 . . . . 0.0 110.903 -173.981 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.434 ' CE1' HG11 ' A' ' 63' ' ' VAL . 5.0 m-85 . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 121.631 0.729 . . . . 0.0 110.694 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 20.0 m -128.74 145.6 51.13 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.582 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 54.9 tp -105.68 127.24 52.94 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 177.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.486 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 71.6 mt-30 -114.73 124.75 52.58 Favored 'General case' 0 CA--C 1.49 -1.358 0 C-N-CA 119.889 -0.724 . . . . 0.0 109.61 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.5 mp -109.86 123.91 50.4 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.214 176.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.411 ' CD1' ' HB3' ' A' ' 39' ' ' TYR . 89.6 m-85 -95.12 151.9 18.8 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 123.832 0.707 . . . . 0.0 110.678 -174.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -74.71 -38.64 62.28 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.113 0.483 . . . . 0.0 110.41 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -108.33 178.17 4.58 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.013 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.496 ' O ' ' HB2' ' A' ' 36' ' ' ARG . 3.9 p -80.84 170.95 15.62 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 27.8 p90 46.8 42.27 11.64 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 66.62 21.97 10.57 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.283 1.033 . . . . 0.0 112.24 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 33' ' ' THR . 8.6 mmm180 -88.23 159.41 18.15 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.521 0.677 . . . . 0.0 111.785 177.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.14 -165.66 47.34 Favored Glycine 0 N--CA 1.428 -1.885 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.516 178.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.1 m -87.05 171.83 10.43 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.411 ' HB3' ' CD1' ' A' ' 30' ' ' TYR . 12.4 p90 -146.78 164.08 33.93 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -176.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 12.7 tt -115.01 152.53 16.61 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.648 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -107.05 124.92 50.35 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.559 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 89.8 t -115.1 132.84 63.16 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.641 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 178.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -114.43 -32.9 5.77 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 121.247 0.546 . . . . 0.0 110.047 -176.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.15 162.73 19.6 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.347 -176.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.6 p -74.74 151.59 39.15 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.147 0.498 . . . . 0.0 111.839 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.1 p -122.81 127.79 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 175.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.92 -14.56 60.69 Favored Glycine 0 C--N 1.301 -1.378 0 C-N-CA 119.368 -1.396 . . . . 0.0 112.906 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.2 p -160.25 125.9 4.04 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 121.086 0.469 . . . . 0.0 112.004 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.7 mt -116.01 118.63 33.44 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 18.9 m -132.7 111.25 13.54 Favored Pre-proline 0 C--N 1.288 -2.101 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 174.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 71.8 Cg_endo -76.9 161.86 92.67 Favored 'Cis proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.012 -1.662 . . . . 0.0 111.433 0.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -63.44 158.18 46.68 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 122.33 2.02 . . . . 0.0 111.05 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 49.5 m0 -89.86 138.91 31.09 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 10.5 p -120.62 76.45 27.2 Favored Pre-proline 0 C--N 1.296 -1.756 0 O-C-N 123.555 0.534 . . . . 0.0 111.477 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.479 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 83.6 Cg_endo -77.54 158.03 32.39 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.779 2.319 . . . . 0.0 113.232 179.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.13 -29.93 13.81 Favored Glycine 0 N--CA 1.429 -1.832 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 175.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.8 p -155.46 158.79 39.13 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.8 t -133.76 143.2 39.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 38.9 t -145.47 148.11 32.91 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.787 175.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.8 t -114.61 117.34 42.65 Favored Pre-proline 0 N--CA 1.428 -1.552 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 175.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -56.57 147.25 70.97 Favored 'Trans proline' 0 C--O 1.247 0.975 0 C-N-CA 122.759 2.306 . . . . 0.0 111.909 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -75.58 112.63 12.12 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.447 HG12 ' H ' ' A' ' 65' ' ' ASP . 36.8 t -93.85 114.57 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.677 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -109.7 32.79 4.78 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.318 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.547 ' OD1' ' HG2' ' A' ' 67' ' ' LYS . 6.2 t70 -75.33 144.61 42.29 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 113.832 -1.531 . . . . 0.0 108.007 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 m -56.54 -11.58 1.36 Allowed 'General case' 0 CA--C 1.577 1.984 0 C-N-CA 125.264 1.426 . . . . 0.0 114.203 -174.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.547 ' HG2' ' OD1' ' A' ' 65' ' ' ASP . 15.5 mmtp -67.66 145.02 55.21 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 122.984 0.514 . . . . 0.0 109.696 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -81.39 -14.13 57.52 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.826 0.346 . . . . 0.0 111.703 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -104.14 127.86 51.77 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -105.98 150.19 38.97 Favored Pre-proline 0 C--N 1.291 -1.939 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -76.48 140.18 21.29 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 121.771 1.647 . . . . 0.0 112.764 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -133.38 129.29 37.2 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.582 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 82.6 m95 -110.82 139.69 45.9 Favored 'General case' 0 C--N 1.284 -2.26 0 O-C-N 121.897 -0.502 . . . . 0.0 112.162 -172.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.473 ' HD2' ' SG ' ' A' ' 111' ' ' CYS . 35.9 m-85 -117.7 142.51 47.16 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.495 177.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.3 mt -125.59 142.45 51.5 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -176.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.522 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 77.9 m-85 -133.5 141.34 47.73 Favored 'General case' 0 C--N 1.318 -0.765 0 O-C-N 123.64 0.587 . . . . 0.0 109.958 -176.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.422 ' HB3' ' CD2' ' A' ' 102' ' ' PHE . 10.3 p-10 -81.09 -15.19 56.67 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -177.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.43 ' C ' ' HB3' ' A' ' 106' ' ' SER . 5.6 t-20 -125.59 165.16 19.04 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.8 m -68.81 168.51 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 123.146 0.579 . . . . 0.0 111.615 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.0 m120 56.44 30.25 16.71 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.852 0.861 . . . . 0.0 111.233 178.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.513 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 11.2 m-85 55.66 48.79 17.76 Favored 'General case' 0 C--O 1.25 1.131 0 C-N-CA 124.596 1.158 . . . . 0.0 110.785 178.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 74.6 p -117.43 168.53 10.28 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.862 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.3 -131.19 10.67 Favored Glycine 0 N--CA 1.416 -2.682 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 66.5 mtt85 -87.25 144.14 26.95 Favored 'General case' 0 C--N 1.279 -2.462 0 C-N-CA 124.332 1.053 . . . . 0.0 109.506 -178.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.4 tt -121.87 136.63 58.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-O 121.301 0.572 . . . . 0.0 110.045 -177.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 94.6 m -132.02 123.9 28.22 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.132 175.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -109.02 130.15 9.88 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.945 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.41 HD21 HD11 ' A' ' 94' ' ' ILE . 3.1 mm? -119.61 145.63 46.25 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 123.335 0.654 . . . . 0.0 110.632 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -113.22 166.17 12.11 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.91 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.401 ' HB2' ' H ' ' A' ' 63' ' ' VAL . 41.3 p-80 -62.47 122.76 16.55 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.256 0.55 . . . . 0.0 111.796 -178.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 92.15 -0.72 72.55 Favored Glycine 0 N--CA 1.433 -1.512 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.47 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.1 m -112.34 146.54 38.11 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 4.5 m -133.56 160.66 36.82 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.41 HD11 HD21 ' A' ' 88' ' ' LEU . 49.2 mt -93.63 130.98 41.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 173.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -70.39 -47.42 60.92 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.245 0.545 . . . . 0.0 110.938 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.444 ' HA ' HG22 ' A' ' 33' ' ' THR . 5.2 m-20 -143.69 98.42 3.24 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -64.66 -30.04 71.05 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.649 0.738 . . . . 0.0 110.518 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.9 t -63.61 -22.8 67.09 Favored 'General case' 0 CA--C 1.555 1.155 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.9 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -95.36 -6.69 40.49 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.101 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.6 m -70.46 -40.55 73.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.118 0.485 . . . . 0.0 111.026 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 156.91 -65.0 0.31 Allowed Glycine 0 CA--C 1.491 -1.462 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.422 ' CD2' ' HB3' ' A' ' 77' ' ' ASP . 39.7 p90 -109.17 145.55 35.6 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.26 -9.12 13.47 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.351 177.741 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.39 106.55 2.57 Favored Glycine 0 N--CA 1.43 -1.73 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.614 -177.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 84.7 mt -91.38 115.08 29.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.43 ' HB3' ' C ' ' A' ' 78' ' ' ASN . 5.1 t -86.41 -26.61 24.65 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.847 177.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 90.1 p -150.81 155.73 39.81 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.344 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.7 mt -136.22 130.89 48.47 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -176.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.513 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 35.9 ttmt -117.52 133.67 55.7 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -101.37 121.93 42.81 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' CYS . . . . . 0.473 ' SG ' ' HD2' ' A' ' 74' ' ' TYR . 50.4 m -119.49 172.18 7.82 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -177.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.5 pt -129.02 144.3 38.6 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 57.3 tt0 -115.21 123.8 49.79 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 45.3 p -77.58 177.14 8.3 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.14 -175.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -66.4 -23.81 66.38 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.657 0.741 . . . . 0.0 109.288 176.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -76.95 -9.42 58.68 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.522 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.22 -1.75 80.31 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 116.219 -0.446 . . . . 0.0 113.261 177.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 113' ' ' GLN . 7.2 ptpp? -83.81 143.87 29.65 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.964 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 17.8 t -103.82 112.23 36.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -100.59 149.95 23.21 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 CA--C 1.48 -1.732 0 C-N-CA 117.972 -1.491 . . . . 0.0 110.002 178.905 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 . . . . . 0 N--CA 1.484 1.233 0 CA-C-O 121.376 0.608 . . . . 0.0 111.905 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 36.4 m -124.58 145.92 49.33 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.575 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 54.7 tp -98.25 119.68 37.33 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 174.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.468 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 64.6 mt-30 -113.68 124.55 52.58 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 3.6 mp -109.59 131.06 55.41 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.038 177.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -90.81 156.29 18.15 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 123.763 0.664 . . . . 0.0 110.64 -176.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -77.06 -41.42 42.49 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.436 -176.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.445 ' C ' ' HA3' ' A' ' 56' ' ' GLY . 45.4 mt-10 -113.14 177.55 4.59 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.567 ' O ' ' HB2' ' A' ' 36' ' ' ARG . 2.0 p -82.58 174.81 10.7 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 23.4 p90 47.35 40.22 10.32 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.398 1.079 . . . . 0.0 113.617 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 65.46 26.66 11.84 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.59 1.156 . . . . 0.0 111.334 176.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.567 ' HB2' ' O ' ' A' ' 33' ' ' THR . 6.5 mmm180 -89.64 147.65 23.78 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.743 0.783 . . . . 0.0 111.939 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.17 -161.0 28.74 Favored Glycine 0 N--CA 1.419 -2.434 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.35 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.2 m -97.43 -177.14 3.72 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.438 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 50.4 p90 -142.16 165.97 25.99 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.4 tt -113.6 153.48 15.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -106.3 125.94 51.62 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.524 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 92.4 t -127.18 133.73 67.54 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 175.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -115.99 -31.86 5.59 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-O 121.113 0.482 . . . . 0.0 109.953 -176.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.43 161.85 33.43 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.512 -176.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.5 m -61.02 143.99 54.26 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.703 -175.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.6 p -121.37 136.94 56.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 176.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.31 -18.08 27.37 Favored Glycine 0 N--CA 1.435 -1.387 0 C-N-CA 120.077 -1.058 . . . . 0.0 113.907 -175.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.9 t -156.98 128.61 7.06 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 117.451 0.626 . . . . 0.0 109.57 -178.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 94.5 mt -120.17 119.67 33.93 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.208 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 20.7 p -131.7 107.96 14.29 Favored Pre-proline 0 C--N 1.298 -1.638 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.268 176.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 90.3 Cg_endo -77.73 162.68 89.52 Favored 'Cis proline' 0 C--O 1.242 0.718 0 C-N-CA 123.896 -1.294 . . . . 0.0 111.33 -1.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.45 156.31 42.18 Favored 'Trans proline' 0 C--O 1.243 0.753 0 C-N-CA 122.521 2.147 . . . . 0.0 109.879 176.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -89.65 129.62 36.06 Favored 'General case' 0 C--N 1.288 -2.088 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.13 -177.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.586 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 40.9 p -111.37 80.75 2.71 Favored Pre-proline 0 N--CA 1.424 -1.757 0 O-C-N 123.697 0.623 . . . . 0.0 110.537 176.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.412 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 91.8 Cg_endo -80.25 158.62 23.15 Favored 'Trans proline' 0 N--CA 1.443 -1.458 0 C-N-CA 122.22 1.946 . . . . 0.0 111.776 177.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.445 ' HA3' ' C ' ' A' ' 32' ' ' GLU . . . -86.73 -39.03 7.78 Favored Glycine 0 N--CA 1.425 -2.076 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 176.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.542 ' HB2' ' O ' ' A' ' 94' ' ' ILE . 72.9 p -147.65 160.96 42.1 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.417 HG22 HD23 ' A' ' 29' ' ' LEU . 42.6 t -137.11 142.23 38.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -177.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 36.9 t -145.52 149.1 34.0 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 119.704 -0.799 . . . . 0.0 111.386 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.9 t -116.78 125.2 28.54 Favored Pre-proline 0 N--CA 1.443 -0.78 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.0 143.66 99.38 Favored 'Trans proline' 0 C--O 1.242 0.688 0 C-N-CA 123.222 2.614 . . . . 0.0 112.53 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -70.99 122.0 19.21 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.661 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 93.4 t -96.67 115.39 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 CA-C-O 121.49 0.662 . . . . 0.0 109.57 177.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -101.72 -6.46 23.67 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 113.981 -1.463 . . . . 0.0 110.441 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -58.42 144.74 40.95 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 125.123 1.369 . . . . 0.0 112.034 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.2 m -55.68 -7.52 0.29 Allowed 'General case' 0 CA--C 1.571 1.772 0 C-N-CA 125.708 1.603 . . . . 0.0 113.105 -178.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -64.47 140.92 58.92 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.233 0.54 . . . . 0.0 110.183 178.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.562 ' HB2' ' OE2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -81.19 -28.11 35.08 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.032 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.562 ' OE2' ' HB2' ' A' ' 68' ' ' ARG . 2.4 mp0 -94.35 125.77 39.2 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.3 152.69 42.06 Favored Pre-proline 0 C--N 1.289 -2.058 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.388 174.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.52 134.78 21.04 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 121.505 1.47 . . . . 0.0 110.733 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -129.03 138.33 51.85 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.575 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 87.5 m95 -119.25 133.48 55.73 Favored 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.933 -173.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.507 ' HA ' ' O ' ' A' ' 86' ' ' THR . 24.6 m-85 -113.73 140.0 48.63 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.913 176.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.3 mt -125.31 142.74 51.33 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.583 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 84.8 m-85 -132.35 143.7 50.04 Favored 'General case' 0 C--N 1.32 -0.71 0 O-C-N 123.57 0.543 . . . . 0.0 110.903 -176.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -84.75 0.27 51.2 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.373 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -137.54 163.65 30.65 Favored 'General case' 0 N--CA 1.417 -2.092 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.6 m -75.5 168.95 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 C-N-CA 123.044 0.538 . . . . 0.0 111.151 -176.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.9 m120 58.06 30.73 19.71 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.894 0.746 . . . . 0.0 111.065 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.592 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 9.6 m-85 59.44 39.14 22.3 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.98 1.312 . . . . 0.0 111.713 177.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 81.0 p -112.28 170.62 8.04 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.548 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.9 -143.67 16.69 Favored Glycine 0 N--CA 1.421 -2.352 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.167 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.583 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 62.6 mtt85 -75.15 140.36 43.31 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 124.17 0.988 . . . . 0.0 108.905 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.2 tt -118.09 137.5 51.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-O 121.016 0.436 . . . . 0.0 109.891 -175.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 87.9 m -130.83 121.47 25.37 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 176.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -109.14 120.65 5.9 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.779 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.415 HD21 HD11 ' A' ' 94' ' ' ILE . 2.7 mm? -115.35 145.36 42.58 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 122.85 0.46 . . . . 0.0 110.757 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -120.2 167.8 13.71 Favored Glycine 0 N--CA 1.429 -1.822 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.284 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -58.25 123.42 15.98 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 123.434 0.694 . . . . 0.0 112.47 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.14 4.65 71.33 Favored Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.247 177.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.5 m -116.93 146.43 42.98 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.7 m -138.23 154.16 49.09 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.542 ' O ' ' HB2' ' A' ' 57' ' ' SER . 41.3 mt -94.58 126.03 47.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 173.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -70.84 -46.24 63.06 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 121.185 0.517 . . . . 0.0 111.391 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.587 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 3.1 m-20 -131.6 96.34 3.95 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.413 ' HA ' HG21 ' A' ' 94' ' ' ILE . 64.6 t80 -63.87 -36.72 84.84 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.302 0.572 . . . . 0.0 110.665 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.5 t -63.81 -27.84 69.45 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.036 -0.983 . . . . 0.0 112.405 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.587 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 30.3 mmtp -90.53 -9.92 45.45 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -177.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.2 m -84.75 7.61 20.01 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.135 -176.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 132.8 -84.69 0.29 Allowed Glycine 0 N--CA 1.421 -2.326 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.479 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -110.24 150.4 28.75 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.586 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -112.52 -9.79 13.76 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.062 177.9 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -107.7 104.05 2.02 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.907 -176.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 68.0 mt -87.01 115.74 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.808 0 CA-C-O 122.476 1.131 . . . . 0.0 108.839 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 44.3 m -86.44 -29.9 22.47 Favored 'General case' 0 N--CA 1.388 -3.573 0 CA-C-N 112.295 -2.229 . . . . 0.0 114.71 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 81.2 p -154.43 158.64 40.28 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 177.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.1 mt -136.22 132.05 49.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -176.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.592 ' HE2' ' CD2' ' A' ' 81' ' ' TYR . 37.3 ttmt -117.71 127.73 54.21 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -96.94 121.25 38.61 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' CYS . . . . . 0.495 ' SG ' ' HD2' ' A' ' 74' ' ' TYR . 57.2 m -121.29 172.83 7.73 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 124.047 0.939 . . . . 0.0 108.68 -177.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.5 pt -124.09 140.44 47.48 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 176.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -115.0 127.47 55.69 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 61.7 p -79.21 179.76 7.2 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.766 -172.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -67.21 -29.38 69.02 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.945 177.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.544 ' OD1' ' HG2' ' A' ' 118' ' ' LYS . 1.9 p-10 -84.38 -7.81 59.19 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.92 -177.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.06 3.9 58.84 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.384 -0.912 . . . . 0.0 114.426 175.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.544 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 21.7 ptmt -84.03 145.82 28.29 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 118.067 0.934 . . . . 0.0 109.16 176.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 17.1 t -107.51 116.51 51.23 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -101.68 140.95 35.27 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.293 -1.867 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 121.557 0.694 . . . . 0.0 111.324 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 22.9 m -123.37 148.47 46.01 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.813 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.577 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 55.7 tp -103.28 117.17 33.91 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 174.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.51 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 76.1 mt-30 -109.92 124.22 51.0 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.56 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.476 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.4 mp -109.98 123.45 49.68 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.613 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -92.0 152.76 19.84 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 123.729 0.643 . . . . 0.0 110.233 -177.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -75.93 -36.45 59.37 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.353 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -107.84 177.95 4.67 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 96' ' ' ASP . 7.0 p -82.28 173.13 12.37 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.606 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 26.2 p90 46.46 42.11 10.4 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 114.703 1.372 . . . . 0.0 114.703 176.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 68.05 23.26 8.16 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.889 0.876 . . . . 0.0 111.825 177.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.423 ' HE ' ' HB3' ' A' ' 36' ' ' ARG . 4.2 mtp180 -94.85 164.41 12.93 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 177.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.48 -167.35 50.4 Favored Glycine 0 N--CA 1.426 -2.002 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -175.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.6 m -91.98 177.82 6.06 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 174.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 44.6 p90 -140.39 166.14 25.52 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -178.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.51 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 11.8 tt -114.05 152.65 15.69 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -106.99 125.65 51.28 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 93.5 t -123.48 133.7 68.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -119.12 -24.16 6.58 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.089 0.471 . . . . 0.0 110.444 -175.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.23 161.93 29.03 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.82 -175.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.7 m -74.43 144.96 44.05 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.119 0.485 . . . . 0.0 110.8 -178.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.0 p -121.75 137.31 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 177.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -97.12 -23.11 15.48 Favored Glycine 0 C--N 1.292 -1.914 0 C-N-CA 120.07 -1.062 . . . . 0.0 113.173 -177.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.9 m -148.84 128.35 13.12 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 122.317 -0.52 . . . . 0.0 110.565 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 83.7 mt -122.02 118.05 27.85 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 176.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 5.0 m -132.81 112.11 13.57 Favored Pre-proline 0 C--N 1.3 -1.581 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 177.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 71.7 Cg_endo -76.91 161.89 92.6 Favored 'Cis proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.076 -1.635 . . . . 0.0 110.841 -0.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -61.52 157.49 41.23 Favored 'Trans proline' 0 C--O 1.243 0.741 0 C-N-CA 122.508 2.138 . . . . 0.0 110.73 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.432 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 48.6 m0 -89.54 139.22 30.75 Favored 'General case' 0 CA--C 1.484 -1.587 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -178.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 30.1 p -118.47 78.61 14.83 Favored Pre-proline 0 C--N 1.304 -1.371 0 C-N-CA 120.544 -0.462 . . . . 0.0 111.888 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.476 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 85.0 Cg_endo -78.4 157.45 29.19 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.565 2.177 . . . . 0.0 112.996 177.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -93.18 -29.63 10.12 Favored Glycine 0 N--CA 1.431 -1.635 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 177.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.4 p -153.68 151.16 29.34 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.4 t -128.84 142.83 42.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 37.2 t -145.82 149.47 34.38 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.442 176.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 49.0 t -118.81 122.55 29.71 Favored Pre-proline 0 N--CA 1.435 -1.213 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 176.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.3 143.41 83.06 Favored 'Trans proline' 0 C--O 1.244 0.791 0 C-N-CA 122.86 2.373 . . . . 0.0 112.0 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -66.55 125.89 27.18 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 121.465 0.65 . . . . 0.0 110.473 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.401 HG13 ' OD2' ' A' ' 65' ' ' ASP . 59.8 t -101.01 124.2 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.758 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.337 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -120.34 20.63 11.9 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.988 0.899 . . . . 0.0 108.922 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.401 ' OD2' HG13 ' A' ' 63' ' ' VAL . 1.2 m-20 -58.24 145.74 36.44 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 113.982 -1.463 . . . . 0.0 113.187 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.9 m -60.14 -27.11 66.8 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 175.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -56.04 124.67 18.55 Favored 'General case' 0 C--O 1.251 1.156 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.343 173.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -77.54 -27.77 51.71 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.278 -177.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -83.02 125.67 31.7 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-O 122.001 0.905 . . . . 0.0 108.62 178.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 28.4 mmt85 -108.09 153.03 42.02 Favored Pre-proline 0 C--N 1.281 -2.377 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.424 -177.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -85.74 134.76 4.72 Favored 'Trans proline' 0 N--CA 1.441 -1.602 0 C-N-CA 121.281 1.321 . . . . 0.0 112.008 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -129.54 131.0 46.47 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.577 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 86.6 m95 -112.84 132.82 55.11 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.81 -173.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.534 ' HA ' ' O ' ' A' ' 86' ' ' THR . 37.6 m-85 -112.89 142.17 45.87 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.911 176.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.4 mt -125.58 142.65 51.39 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -176.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.524 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 82.5 m-85 -133.13 142.54 48.73 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 123.701 0.626 . . . . 0.0 109.895 -177.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.5 ' HB3' ' CD1' ' A' ' 102' ' ' PHE . 1.7 p-10 -87.89 0.35 55.96 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.566 -178.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -136.48 157.29 47.14 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 174.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.6 m -69.68 164.7 2.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 122.403 0.281 . . . . 0.0 111.674 -174.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.8 m120 59.83 31.22 20.66 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 123.575 0.75 . . . . 0.0 111.566 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.615 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 12.0 m-85 61.12 39.93 15.48 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.853 1.261 . . . . 0.0 111.735 177.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 72.4 p -112.16 171.48 7.48 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.116 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.59 -133.31 11.67 Favored Glycine 0 N--CA 1.428 -1.859 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.307 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.524 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 54.2 mtt180 -89.26 149.4 23.09 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 124.246 1.019 . . . . 0.0 109.058 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.6 tt -125.52 137.02 59.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 121.273 0.559 . . . . 0.0 110.59 -175.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 95.7 m -131.94 125.99 32.97 Favored 'General case' 0 C--N 1.287 -2.112 0 O-C-N 122.1 -0.375 . . . . 0.0 110.415 176.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -111.38 124.46 6.88 Favored Glycine 0 C--N 1.312 -0.784 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.553 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -116.8 144.79 44.06 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 122.967 0.507 . . . . 0.0 110.315 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -114.05 168.07 12.48 Favored Glycine 0 N--CA 1.435 -1.416 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.612 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 33.5 p80 -64.86 128.81 37.34 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 121.218 0.532 . . . . 0.0 111.899 -177.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.31 6.85 65.99 Favored Glycine 0 N--CA 1.426 -1.998 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.604 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.7 m -118.5 146.45 44.51 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 4.3 m -136.36 155.78 49.57 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 52.4 mt -94.01 128.29 45.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -70.81 -48.28 55.0 Favored 'General case' 0 C--N 1.313 -1.009 0 O-C-N 123.536 0.523 . . . . 0.0 110.5 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.46 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 10.6 m-20 -135.37 92.69 2.88 Favored 'General case' 0 CA--C 1.486 -1.488 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.917 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.41 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 65.6 t80 -64.97 -32.26 73.89 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.265 0.555 . . . . 0.0 109.763 177.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.1 t -63.56 -26.62 68.78 Favored 'General case' 0 CA--C 1.552 1.019 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.66 -178.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.46 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 73.7 mmtt -95.23 -6.61 41.14 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.527 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.6 m -84.4 39.44 0.73 Allowed 'General case' 0 C--O 1.244 0.778 0 CA-C-O 121.87 0.843 . . . . 0.0 111.488 -176.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.73 -78.77 1.69 Allowed Glycine 0 N--CA 1.424 -2.116 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.5 ' CD1' ' HB3' ' A' ' 77' ' ' ASP . 26.8 p90 -108.19 145.68 33.87 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -177.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -113.66 -10.46 13.09 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 177.421 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -104.19 110.22 3.55 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.308 -177.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 70.2 mt -95.01 115.7 34.52 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.658 0 CA-C-O 122.387 1.089 . . . . 0.0 108.868 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 57.8 m -86.04 -29.16 23.66 Favored 'General case' 0 N--CA 1.392 -3.357 0 CA-C-N 112.238 -2.255 . . . . 0.0 114.262 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 77.6 p -153.98 155.81 36.28 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.6 mt -134.73 131.15 53.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -176.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.615 ' HE2' ' CD2' ' A' ' 81' ' ' TYR . 34.4 ttmt -117.86 126.34 52.2 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -96.16 130.1 43.29 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 176.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 76.0 m -123.19 170.76 9.91 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 7.5 pt -125.06 142.35 42.24 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 176.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 53.6 tt0 -115.76 128.71 56.06 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.4 p -87.15 178.77 6.8 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.847 -174.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -63.16 -27.05 69.1 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.44 0.696 . . . . 0.0 109.186 174.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -81.05 -8.53 59.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.577 0.704 . . . . 0.0 110.739 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.37 -1.96 77.29 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.432 -0.889 . . . . 0.0 113.792 175.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 113' ' ' GLN . 8.8 ptpt -79.28 147.74 32.4 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.2 t -111.27 115.9 51.1 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -101.78 141.4 34.69 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 75.4 m . . . . . 0 C--N 1.308 -1.202 0 CA-C-O 121.108 0.48 . . . . 0.0 111.993 -175.036 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 . . . . . 0 CA--C 1.505 -0.764 0 CA-C-O 121.816 0.817 . . . . 0.0 110.398 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.3 m -139.05 154.5 48.22 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -176.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.597 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 53.4 tp -110.06 125.62 53.14 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 176.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 74.2 mt-30 -112.68 123.71 50.91 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 121.461 0.648 . . . . 0.0 109.572 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.454 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.4 mp -110.8 124.82 52.75 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.681 177.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -94.07 153.34 18.19 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 123.418 0.449 . . . . 0.0 111.183 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.46 -36.01 58.14 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.064 -176.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -107.44 178.26 4.59 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.548 ' O ' ' HB2' ' A' ' 36' ' ' ARG . 2.6 p -80.67 169.36 17.72 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 119.674 -0.203 . . . . 0.0 110.556 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 35.4 p90 46.65 42.73 11.82 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.17 1.388 . . . . 0.0 114.47 176.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 61.7 33.42 18.01 Favored 'General case' 0 C--O 1.246 0.904 0 C-N-CA 123.979 0.912 . . . . 0.0 112.502 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.548 ' HB2' ' O ' ' A' ' 33' ' ' THR . 5.4 mmm180 -96.23 154.55 17.19 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.807 174.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.53 -165.74 39.12 Favored Glycine 0 N--CA 1.427 -1.964 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.8 m -88.7 171.84 9.69 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 175.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -137.44 166.59 23.47 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -176.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.5 tt -114.61 150.79 16.48 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.45 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 176.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -107.21 125.63 51.36 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.545 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 74.6 t -117.99 133.54 64.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.115 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -117.48 -30.05 5.64 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.335 0.588 . . . . 0.0 110.86 -174.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -113.54 163.58 14.75 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.782 -174.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.4 m -79.05 145.19 33.97 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 173.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.426 HG12 ' HB ' ' A' ' 108' ' ' ILE . 12.2 p -120.88 128.7 76.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -89.79 -20.26 44.37 Favored Glycine 0 N--CA 1.427 -1.952 0 C-N-CA 119.543 -1.313 . . . . 0.0 113.342 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.5 m -157.78 114.52 2.91 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.509 0.671 . . . . 0.0 111.471 -178.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 85.5 mt -102.2 119.4 38.74 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.094 177.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 55.7 p -131.28 110.62 15.24 Favored Pre-proline 0 N--CA 1.425 -1.702 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 174.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 3.1 Cg_exo -77.65 162.37 90.24 Favored 'Cis proline' 0 CA--C 1.539 0.75 0 C-N-CA 124.008 -1.247 . . . . 0.0 111.207 -1.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.12 154.97 67.61 Favored 'Trans proline' 0 C--O 1.246 0.888 0 C-N-CA 122.205 1.937 . . . . 0.0 110.89 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.415 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 49.7 m0 -90.26 137.05 32.66 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.352 -177.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 11.4 p -120.16 78.17 25.46 Favored Pre-proline 0 C--N 1.295 -1.787 0 O-C-N 123.672 0.607 . . . . 0.0 110.368 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.454 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 84.8 Cg_endo -78.26 157.4 29.69 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.379 2.053 . . . . 0.0 113.33 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -85.89 -34.91 12.06 Favored Glycine 0 N--CA 1.434 -1.477 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.3 p -150.9 156.26 40.83 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.408 HG22 HD23 ' A' ' 29' ' ' LEU . 38.6 t -130.61 141.84 45.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 37.7 t -146.14 150.4 35.82 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-O 121.248 0.546 . . . . 0.0 110.223 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.6 t -113.85 123.1 33.49 Favored Pre-proline 0 C--N 1.299 -1.607 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 176.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -57.47 136.79 78.11 Favored 'Trans proline' 0 C--O 1.247 0.941 0 C-N-CA 122.735 2.29 . . . . 0.0 111.554 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.472 ' CE2' ' HB3' ' A' ' 64' ' ' ASN . 72.8 t80 -72.71 112.58 8.88 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.286 -177.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 44.7 t -93.84 115.15 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.825 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 175.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.472 ' HB3' ' CE2' ' A' ' 62' ' ' PHE . 27.3 p-10 -109.75 15.46 22.74 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-O 122.305 1.05 . . . . 0.0 108.67 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -75.69 147.31 39.52 Favored 'General case' 0 C--N 1.284 -2.279 0 CA-C-N 113.739 -1.573 . . . . 0.0 112.106 -174.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.0 m -52.33 -21.7 3.81 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 126.999 2.12 . . . . 0.0 114.022 -172.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -58.53 137.04 57.67 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.531 0.681 . . . . 0.0 111.803 -176.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -68.31 -23.3 64.72 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 124.892 1.277 . . . . 0.0 113.002 -171.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.452 ' HG3' HG22 ' A' ' 114' ' ' THR . 19.9 mp0 -109.76 128.48 55.32 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.9 148.81 37.18 Favored Pre-proline 0 C--N 1.298 -1.668 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 174.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -77.44 137.95 17.07 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 C-N-CA 121.657 1.571 . . . . 0.0 112.564 -177.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -131.73 127.79 37.55 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.597 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 77.5 m95 -110.99 138.05 47.87 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -171.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.482 ' HA ' ' O ' ' A' ' 86' ' ' THR . 34.3 m-85 -116.09 142.9 46.19 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.339 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.436 HD21 HD21 ' A' ' 27' ' ' LEU . 19.4 mt -125.68 142.42 51.52 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 -176.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -133.65 139.96 46.78 Favored 'General case' 0 CA--C 1.503 -0.852 0 O-C-N 123.734 0.647 . . . . 0.0 109.498 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.536 ' HB3' ' CG ' ' A' ' 102' ' ' PHE . 3.6 p-10 -77.82 -15.78 58.81 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -177.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.498 ' C ' ' HB3' ' A' ' 106' ' ' SER . 6.0 t-20 -121.43 166.74 13.67 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.1 m -71.71 165.62 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 C-N-CA 122.905 0.482 . . . . 0.0 111.915 -176.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.5 m120 57.13 31.2 19.59 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.888 0.875 . . . . 0.0 112.322 176.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.467 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 6.5 m-85 59.9 48.82 8.45 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 125.098 1.359 . . . . 0.0 110.895 177.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 81.6 p -120.68 168.46 11.38 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 116.229 -0.442 . . . . 0.0 109.901 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.59 -138.44 14.28 Favored Glycine 0 N--CA 1.421 -2.327 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -81.77 157.04 24.65 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 123.85 0.86 . . . . 0.0 109.616 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.8 tt -129.75 137.1 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 CA-C-O 121.494 0.664 . . . . 0.0 110.805 -175.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 96.9 m -131.99 128.37 38.25 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -114.78 130.28 9.12 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.815 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.505 HD21 HD11 ' A' ' 94' ' ' ILE . 3.7 mm? -121.3 147.56 45.5 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 123.076 0.55 . . . . 0.0 111.161 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.89 168.5 12.81 Favored Glycine 0 N--CA 1.433 -1.517 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.833 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -62.97 122.39 15.89 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.315 0.579 . . . . 0.0 111.769 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.51 -2.63 77.89 Favored Glycine 0 N--CA 1.433 -1.54 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.23 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.0 m -107.07 146.18 31.52 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.1 m -140.88 157.83 44.82 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.505 HD11 HD21 ' A' ' 88' ' ' LEU . 52.1 mt -94.01 132.72 37.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 175.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -71.26 -48.66 49.63 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 121.579 0.704 . . . . 0.0 109.852 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.596 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 13.3 m-20 -132.24 96.48 3.89 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.847 178.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.415 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 61.5 t80 -65.57 -37.32 86.35 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.466 0.65 . . . . 0.0 110.01 175.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.4 t -63.91 -27.93 69.49 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.174 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.596 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 29.1 mmtp -89.19 -7.71 55.04 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 122.044 -0.41 . . . . 0.0 110.341 -178.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.8 m -80.34 -174.37 4.55 Favored 'General case' 0 C--O 1.257 1.493 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -50.26 -66.48 2.34 Favored Glycine 0 CA--C 1.507 -0.447 0 O-C-N 123.38 0.425 . . . . 0.0 113.62 -177.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.536 ' CG ' ' HB3' ' A' ' 77' ' ' ASP . 34.0 p90 -110.83 149.74 30.14 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 119.732 -0.175 . . . . 0.0 110.659 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.03 -12.16 13.25 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.542 177.646 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -112.17 116.19 4.03 Favored Glycine 0 N--CA 1.428 -1.841 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -177.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 70.0 mt -95.46 114.96 33.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.498 ' HB3' ' C ' ' A' ' 78' ' ' ASN . 1.8 t -86.77 -25.08 24.83 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.024 177.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 89.1 p -153.08 155.18 36.33 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 122.325 -0.234 . . . . 0.0 110.474 177.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.426 ' HB ' HG12 ' A' ' 46' ' ' VAL . 47.2 mt -133.02 132.57 58.94 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -175.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.467 ' HE2' ' CD2' ' A' ' 81' ' ' TYR . 37.9 ttmt -116.53 127.53 54.62 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.255 -1.016 . . . . 0.0 108.255 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -95.61 129.16 42.89 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 69.7 m -125.38 172.11 9.89 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 8.0 pt -128.07 143.11 41.93 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 59.7 tt0 -117.09 119.48 35.38 Favored 'General case' 0 C--N 1.277 -2.548 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.452 HG22 ' HG3' ' A' ' 69' ' ' GLU . 32.0 p -81.9 179.97 7.62 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.255 -171.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -65.36 -25.12 67.44 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.764 174.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -80.78 -7.81 59.5 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.852 0.834 . . . . 0.0 110.097 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.24 -9.78 76.63 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.803 175.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.449 ' HE2' ' HG2' ' A' ' 120' ' ' GLU . 19.6 ptmt -73.49 140.03 46.13 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 21.6 t -103.36 112.3 36.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.449 ' HG2' ' HE2' ' A' ' 118' ' ' LYS . 24.7 mt-10 -98.01 138.03 35.93 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 80.1 m . . . . . 0 C--N 1.305 -1.327 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -174.06 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 121.358 0.599 . . . . 0.0 111.584 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.404 ' HG ' ' HE1' ' A' ' 43' ' ' TYR . 14.9 m -123.88 158.96 30.72 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.634 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 57.2 tp -107.24 118.97 38.12 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 171.063 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 46.3 mt-30 -111.23 124.14 51.61 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.619 -0.832 . . . . 0.0 108.951 -178.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.8 mp -110.24 126.71 54.44 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.115 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -96.38 151.31 19.66 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 123.572 0.545 . . . . 0.0 109.598 -177.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -74.07 -37.75 64.14 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.139 0.495 . . . . 0.0 111.107 -177.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -108.32 177.44 4.79 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.457 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.457 HG22 ' HA ' ' A' ' 96' ' ' ASP . 2.2 p -81.16 172.54 13.54 Favored 'General case' 0 N--CA 1.413 -2.309 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 11.7 p90 47.6 35.4 4.36 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.852 0.861 . . . . 0.0 113.24 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 61.85 38.65 14.52 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.851 1.26 . . . . 0.0 113.591 177.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -103.46 178.17 4.63 Favored 'General case' 0 C--O 1.248 0.981 0 C-N-CA 120.126 -0.629 . . . . 0.0 112.007 175.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.7 -154.79 40.33 Favored Glycine 0 N--CA 1.425 -2.09 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -176.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.4 m -100.57 174.61 6.0 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 172.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -136.87 165.66 25.44 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 16.6 tt -116.21 152.45 17.92 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.483 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -106.8 125.15 50.63 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 98.0 t -120.78 133.94 65.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TYR . . . . . 0.404 ' HE1' ' HG ' ' A' ' 26' ' ' CYS . 30.2 m-85 -121.72 -27.73 4.65 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.506 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 10.5 mmpt? -109.72 162.68 14.21 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.655 -173.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.8 m -82.75 141.82 32.09 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 175.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.1 p -120.79 130.54 74.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -89.51 -17.85 53.84 Favored Glycine 0 N--CA 1.43 -1.722 0 C-N-CA 119.722 -1.227 . . . . 0.0 113.308 -176.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.8 p -156.54 130.78 8.61 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 85.5 mt -124.11 117.46 24.71 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 175.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 40.0 m -133.45 113.49 13.18 Favored Pre-proline 0 C--N 1.293 -1.859 0 CA-C-O 120.407 0.146 . . . . 0.0 110.947 175.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 7.3 Cg_exo -75.07 162.22 93.25 Favored 'Cis proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.179 -1.592 . . . . 0.0 111.336 -0.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.58 159.29 24.48 Favored 'Trans proline' 0 C--O 1.245 0.842 0 C-N-CA 122.705 2.27 . . . . 0.0 111.615 177.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.505 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 43.9 m0 -88.93 138.91 30.98 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 21.8 p -116.66 78.52 8.93 Favored Pre-proline 0 C--N 1.3 -1.584 0 O-C-N 123.579 0.55 . . . . 0.0 110.747 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.481 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 92.3 Cg_endo -79.79 153.17 22.7 Favored 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 122.001 1.8 . . . . 0.0 112.589 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.67 -27.11 18.14 Favored Glycine 0 N--CA 1.425 -2.094 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.4 p -155.1 151.73 28.66 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.7 t -132.17 142.65 42.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 35.8 t -145.53 146.78 31.56 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 119.577 -0.849 . . . . 0.0 111.647 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.0 t -113.61 124.66 30.81 Favored Pre-proline 0 N--CA 1.435 -1.209 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 176.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -59.58 145.61 97.56 Favored 'Trans proline' 0 C--O 1.244 0.798 0 C-N-CA 123.115 2.543 . . . . 0.0 112.587 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -74.06 114.75 12.73 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.172 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 91.9 t -95.66 115.73 35.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -110.26 8.16 23.44 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 122.423 1.106 . . . . 0.0 108.713 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.76 145.02 56.55 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.884 -178.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.8 m -67.85 -7.09 25.06 Favored 'General case' 0 CA--C 1.566 1.587 0 C-N-CA 124.995 1.318 . . . . 0.0 110.882 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -51.96 133.47 32.51 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 124.884 1.274 . . . . 0.0 110.311 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.3 tpp180 -70.59 -26.6 63.59 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.179 -172.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -111.33 134.16 53.12 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 122.707 0.403 . . . . 0.0 110.154 176.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.8 153.82 37.95 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 170.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.11 135.12 12.04 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 C-N-CA 121.958 1.772 . . . . 0.0 111.367 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -130.06 136.3 49.21 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.634 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 85.2 m95 -119.21 133.55 55.7 Favored 'General case' 0 C--N 1.291 -1.953 0 C-N-CA 120.134 -0.626 . . . . 0.0 112.241 -173.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.456 ' HA ' ' O ' ' A' ' 86' ' ' THR . 33.7 m-85 -114.9 140.16 49.21 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.143 177.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.6 mt -125.28 142.74 51.32 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -175.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.454 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 78.7 m-85 -133.35 142.28 48.34 Favored 'General case' 0 C--N 1.317 -0.833 0 O-C-N 123.576 0.548 . . . . 0.0 110.423 -175.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -85.27 0.01 53.3 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 120.767 0.317 . . . . 0.0 111.049 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -137.47 158.87 43.47 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.4 m -71.59 166.6 2.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 C-N-CA 122.99 0.516 . . . . 0.0 111.577 -175.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 30.5 m120 57.87 30.13 18.6 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.008 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.467 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 9.3 m-85 58.74 47.11 13.3 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 125.019 1.327 . . . . 0.0 111.235 177.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 73.2 p -118.37 173.5 6.78 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.18 -133.34 11.72 Favored Glycine 0 N--CA 1.433 -1.512 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.933 176.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.454 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 56.0 mtt85 -80.83 148.67 29.87 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 123.143 0.577 . . . . 0.0 109.618 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.4 tt -127.27 137.58 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 -177.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 98.2 m -131.24 126.08 34.54 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 176.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -115.16 115.29 3.4 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.491 -0.861 . . . . 0.0 113.745 -177.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -108.32 144.81 35.35 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 122.466 0.306 . . . . 0.0 110.771 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.17 170.76 13.46 Favored Glycine 0 N--CA 1.429 -1.772 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.003 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -64.33 130.75 45.01 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.315 0.578 . . . . 0.0 111.918 -176.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.71 8.23 80.3 Favored Glycine 0 N--CA 1.428 -1.84 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.794 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.3 m -121.32 146.25 47.04 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.9 m -136.33 156.93 47.94 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 50.5 mt -93.59 127.84 45.39 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 172.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -69.07 -46.91 66.64 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.579 0.704 . . . . 0.0 109.447 -177.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.645 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 3.9 m-20 -139.73 98.98 3.59 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.205 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -65.08 -37.75 88.53 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.337 0.589 . . . . 0.0 110.672 178.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.7 t -69.53 -17.93 63.62 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.461 -177.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.645 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 28.9 mmtp -89.95 -6.19 55.94 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.638 -0.664 . . . . 0.0 109.386 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.0 t -85.02 -163.78 0.89 Allowed 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.41 -68.19 1.78 Allowed Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 116.798 -0.183 . . . . 0.0 113.151 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -110.61 147.61 33.91 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 122.488 -0.419 . . . . 0.0 109.917 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -112.43 -0.52 15.28 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.103 177.331 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.505 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -119.19 113.95 2.66 Favored Glycine 0 N--CA 1.436 -1.35 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.812 -176.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 69.2 mt -95.8 116.3 37.17 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.593 0 CA-C-O 122.312 1.053 . . . . 0.0 109.614 -178.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.4 m -85.62 -28.6 24.68 Favored 'General case' 0 N--CA 1.395 -3.193 0 CA-C-N 112.206 -2.27 . . . . 0.0 114.13 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 84.1 p -156.45 156.37 33.67 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 177.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.4 mt -135.18 130.81 51.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -176.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.467 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 37.3 ttmt -117.14 128.19 54.88 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -95.49 129.49 42.64 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 121.631 0.729 . . . . 0.0 109.213 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 82.2 m -125.55 172.68 9.52 Favored 'General case' 0 C--N 1.273 -2.739 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.875 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.404 HG13 ' HB2' ' A' ' 120' ' ' GLU . 7.6 pt -129.03 142.47 43.96 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.477 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -110.91 122.63 48.35 Favored 'General case' 0 C--N 1.278 -2.508 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 82.4 p -77.88 176.54 8.99 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.61 -174.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -66.96 -20.11 65.84 Favored 'General case' 0 C--N 1.316 -0.885 0 O-C-N 122.141 -0.35 . . . . 0.0 111.153 174.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.507 ' OD1' ' HG2' ' A' ' 118' ' ' LYS . 2.1 p30 -86.88 -7.61 58.05 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.264 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 94.17 -0.97 66.87 Favored Glycine 0 N--CA 1.441 -1.003 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.662 175.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.507 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 52.6 pttt -77.87 149.01 34.37 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 119.093 -1.043 . . . . 0.0 109.566 176.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.2 t -109.04 112.04 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.503 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.404 ' HB2' HG13 ' A' ' 112' ' ' ILE . 6.6 mm-40 -93.82 144.8 25.1 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 76.9 m . . . . . 0 C--N 1.289 -2.053 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.287 -175.912 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 121.444 0.64 . . . . 0.0 111.764 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 36.7 m -123.82 154.68 39.24 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.554 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 44.0 tp -105.02 121.92 44.78 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 176.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.5 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 45.3 mt-30 -111.86 124.07 51.59 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.454 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.8 mp -110.26 123.88 50.6 Favored 'General case' 0 N--CA 1.42 -1.927 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.15 177.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -88.85 149.07 23.55 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -74.04 -38.42 64.01 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 120.983 0.42 . . . . 0.0 111.059 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -107.84 177.35 4.84 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.223 -176.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.43 HG22 ' HA ' ' A' ' 96' ' ' ASP . 1.0 OUTLIER -81.72 172.72 13.06 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.936 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.268 21.9 p90 47.49 37.8 6.87 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.793 1.237 . . . . 0.0 113.501 177.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 65.26 27.97 12.05 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 125.109 1.364 . . . . 0.0 113.717 178.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -97.55 172.67 7.58 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.426 0.631 . . . . 0.0 110.656 177.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.41 -166.17 37.92 Favored Glycine 0 N--CA 1.424 -2.158 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.3 m -100.68 176.76 5.2 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 173.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -143.89 165.34 28.01 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 120.469 -0.493 . . . . 0.0 110.843 -174.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 18.2 tt -114.31 152.72 15.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -107.21 125.62 51.35 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 98.7 t -119.71 136.71 55.96 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.384 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 177.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -117.43 -28.01 6.21 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.883 -176.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -107.47 163.04 13.4 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 -173.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.435 ' HB3' ' H ' ' A' ' 110' ' ' ARG . 4.5 p -89.6 141.69 28.37 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 172.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.418 HG12 ' HB ' ' A' ' 108' ' ' ILE . 8.3 p -120.55 132.91 68.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -174.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.96 -1.7 57.19 Favored Glycine 0 C--N 1.313 -0.746 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.456 -176.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.0 t -166.7 129.58 1.86 Allowed 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.067 0.46 . . . . 0.0 109.906 176.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 85.1 mt -122.41 117.78 26.82 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.0 m -133.25 112.8 13.22 Favored Pre-proline 0 C--N 1.288 -2.09 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 174.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.62 161.86 93.58 Favored 'Cis proline' 0 CA--C 1.549 1.249 0 C-N-CA 123.333 -1.528 . . . . 0.0 111.326 -1.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.81 158.33 43.14 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.948 2.432 . . . . 0.0 110.87 177.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.515 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 48.2 m0 -90.23 143.81 26.43 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -178.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 18.3 p -121.48 76.82 35.38 Favored Pre-proline 0 C--N 1.308 -1.203 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.454 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 92.3 Cg_endo -81.18 157.64 20.09 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.806 2.337 . . . . 0.0 112.624 177.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.0 -28.38 11.04 Favored Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.3 p -157.33 154.93 29.78 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.7 t -131.61 145.42 35.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -176.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 39.3 t -145.59 147.36 31.99 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.927 176.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.9 t -112.71 126.79 27.74 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 176.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -60.61 150.48 81.73 Favored 'Trans proline' 0 C--O 1.248 1.0 0 C-N-CA 122.983 2.455 . . . . 0.0 112.304 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.548 ' CE1' ' HB2' ' A' ' 64' ' ' ASN . 45.1 t80 -74.36 132.32 41.91 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.956 0.884 . . . . 0.0 111.555 -177.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 99.0 t -123.22 117.78 52.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.548 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 61.7 t30 -118.6 8.25 11.93 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 123.373 1.559 . . . . 0.0 106.842 178.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -60.21 145.03 48.68 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 112.413 -2.176 . . . . 0.0 113.539 -174.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 m -60.73 -7.12 2.06 Favored 'General case' 0 CA--C 1.564 1.509 0 C-N-CA 126.248 1.819 . . . . 0.0 112.568 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -58.54 142.84 47.89 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -74.33 -25.4 59.53 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.866 -174.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.459 ' HG2' HD12 ' A' ' 112' ' ' ILE . 4.5 mp0 -110.71 133.8 53.02 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.87 0.367 . . . . 0.0 111.74 177.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.32 150.33 37.0 Favored Pre-proline 0 C--N 1.307 -1.242 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 168.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -80.28 137.0 11.67 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.025 1.816 . . . . 0.0 111.813 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -132.17 137.72 47.75 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.554 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 89.9 m95 -122.07 132.43 54.49 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.16 0.505 . . . . 0.0 111.981 -174.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' A' ' 86' ' ' THR . 24.2 m-85 -112.74 142.77 44.98 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.434 177.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.5 mt -125.62 142.25 51.61 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -175.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.498 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 93.2 m-85 -132.85 141.47 48.45 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.403 0.62 . . . . 0.0 111.158 -175.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.758 ' HB2' ' CD2' ' A' ' 102' ' ' PHE . 9.0 t70 -85.99 -6.53 59.03 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.544 -177.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -140.06 156.87 46.4 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.727 173.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.738 ' HA ' ' OG ' ' A' ' 107' ' ' SER . 23.6 m -64.46 162.24 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.945 0 C-N-CA 123.655 0.782 . . . . 0.0 112.214 -175.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 62.44 29.86 17.19 Favored 'General case' 0 CA--C 1.511 -0.551 0 O-C-N 123.859 0.724 . . . . 0.0 109.305 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.455 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 16.1 m-85 56.49 50.93 12.08 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 114.433 -1.258 . . . . 0.0 111.415 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 60.5 p -123.52 177.59 5.58 Favored 'General case' 0 C--O 1.249 1.047 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.762 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.95 -107.96 3.53 Favored Glycine 0 N--CA 1.437 -1.267 0 N-CA-C 111.822 -0.511 . . . . 0.0 111.822 176.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 58.6 mtt85 -114.08 151.86 31.91 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.7 tt -128.65 140.04 50.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 O-C-N 123.712 0.632 . . . . 0.0 111.08 -174.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 24.4 m -132.49 125.42 30.61 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.429 174.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -115.17 107.25 1.73 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.83 -0.7 . . . . 0.0 114.321 -178.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -106.32 145.69 31.34 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 123.045 0.538 . . . . 0.0 111.468 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -123.33 172.64 16.17 Favored Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.678 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -50.23 127.86 18.06 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 124.262 1.025 . . . . 0.0 112.757 -177.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.97 -0.19 88.8 Favored Glycine 0 C--N 1.309 -0.925 0 CA-C-N 115.546 -0.752 . . . . 0.0 113.251 174.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.3 m -110.82 145.9 37.37 Favored 'General case' 0 N--CA 1.421 -1.92 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.543 -177.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.6 m -136.21 156.7 48.3 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 55.2 mt -92.81 135.81 26.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 176.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -70.53 -48.52 55.08 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.506 0.67 . . . . 0.0 110.421 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.579 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 3.2 m-20 -143.23 99.12 3.38 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -178.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -64.85 -38.37 90.76 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 121.263 0.554 . . . . 0.0 110.817 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.5 t -65.96 -21.01 66.39 Favored 'General case' 0 CA--C 1.558 1.257 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.903 -175.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.579 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 30.0 mmtp -92.83 -7.82 45.26 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.8 t -83.49 7.29 17.46 Favored 'General case' 0 C--O 1.25 1.123 0 CA-C-O 121.065 0.46 . . . . 0.0 111.492 -176.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 115.56 -62.51 0.35 Allowed Glycine 0 N--CA 1.436 -1.362 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 177.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.758 ' CD2' ' HB2' ' A' ' 77' ' ' ASP . 22.7 p90 -110.89 142.59 42.74 Favored 'General case' 0 N--CA 1.427 -1.59 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.144 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -114.01 -8.31 13.07 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.842 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.515 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -112.55 112.93 3.11 Favored Glycine 0 N--CA 1.422 -2.267 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.954 -174.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 70.1 mt -95.22 115.55 34.42 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 52.3 m -85.43 -26.69 26.22 Favored 'General case' 0 C--N 1.252 -3.652 0 CA-C-N 112.228 -2.26 . . . . 0.0 113.339 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.738 ' OG ' ' HA ' ' A' ' 79' ' ' VAL . 66.6 m -156.29 152.35 27.58 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.215 -0.303 . . . . 0.0 110.794 -177.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.418 ' HB ' HG12 ' A' ' 46' ' ' VAL . 40.3 mt -135.3 130.19 50.74 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.539 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -176.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.455 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 33.9 ttmt -117.53 131.18 56.75 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.435 ' H ' ' HB3' ' A' ' 45' ' ' SER . 55.9 ttp180 -101.42 123.37 45.38 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -177.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 36.1 m -119.71 171.15 8.59 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.459 HD12 ' HG2' ' A' ' 69' ' ' GLU . 8.4 pt -129.35 146.2 34.57 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.427 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 56.4 tt0 -117.79 118.21 31.42 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 17.2 p -78.8 179.67 7.08 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.253 -173.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -58.97 -28.21 66.1 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.635 0.731 . . . . 0.0 110.548 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -77.02 -7.99 56.63 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.9 -176.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.53 6.84 87.04 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.483 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 113' ' ' GLN . 26.2 pttm -87.84 139.28 30.69 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.0 t -103.22 112.44 36.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -102.78 146.01 28.89 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.298 -1.649 0 C-N-CA 119.307 -0.957 . . . . 0.0 109.663 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 N--CA 1.473 0.707 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.4 m -123.32 146.66 47.73 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.614 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 53.8 tp -92.52 121.32 33.85 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 172.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.501 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 65.0 mt-30 -114.17 123.7 50.24 Favored 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.635 -177.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 2.8 mp -110.34 119.08 38.06 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.339 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -82.04 145.01 30.44 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 123.521 0.513 . . . . 0.0 110.21 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -69.27 -39.79 78.17 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.598 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -108.37 177.39 4.81 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.435 HG22 ' HA ' ' A' ' 96' ' ' ASP . 1.1 p -83.1 177.18 8.7 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 122.601 0.36 . . . . 0.0 110.602 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.262 16.6 p90 47.39 42.2 13.76 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.886 1.275 . . . . 0.0 113.881 176.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 63.56 27.97 15.1 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.241 176.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.543 ' HA ' ' NE ' ' A' ' 36' ' ' ARG . 3.7 mmp_? -108.5 166.32 10.86 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.317 0.58 . . . . 0.0 110.969 178.076 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.38 173.74 47.29 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -177.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.3 p -86.28 154.78 21.01 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 40.8 p90 -117.6 165.84 13.09 Favored 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.218 -176.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.8 tt -114.23 153.26 15.77 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 178.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -105.96 126.03 51.7 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.535 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 92.8 t -123.33 133.4 69.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -118.08 -21.7 8.14 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.055 0.455 . . . . 0.0 110.668 -175.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -129.24 162.18 28.46 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.317 -175.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.454 ' HB3' ' H ' ' A' ' 110' ' ' ARG . 4.2 p -79.02 146.25 33.43 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.839 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.9 p -121.46 137.28 55.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.3 -18.43 39.17 Favored Glycine 0 C--N 1.316 -0.543 0 C-N-CA 119.903 -1.141 . . . . 0.0 113.864 -176.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.3 t -161.18 132.14 5.34 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.1 mt -121.31 118.94 30.77 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.313 178.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.5 m -132.61 110.42 13.5 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 175.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -76.71 160.24 95.28 Favored 'Cis proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.171 -1.595 . . . . 0.0 111.38 0.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.02 158.24 48.73 Favored 'Trans proline' 0 C--O 1.24 0.616 0 C-N-CA 122.31 2.006 . . . . 0.0 110.84 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 52.7 m0 -89.73 136.65 32.91 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 120.351 -0.54 . . . . 0.0 109.881 -177.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 20.2 p -118.73 77.07 14.35 Favored Pre-proline 0 N--CA 1.435 -1.207 0 O-C-N 123.493 0.495 . . . . 0.0 111.757 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.469 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 96.0 Cg_endo -76.4 158.52 36.68 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.387 2.058 . . . . 0.0 111.972 177.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -92.84 -31.58 8.56 Favored Glycine 0 N--CA 1.431 -1.685 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 175.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 94' ' ' ILE . 34.8 p -152.01 153.14 33.44 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.418 HG22 HD23 ' A' ' 29' ' ' LEU . 36.7 t -128.91 142.77 43.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -177.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 37.2 t -145.75 147.29 31.75 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.124 177.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 68.2 t -114.13 121.16 37.14 Favored Pre-proline 0 C--N 1.306 -1.296 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 175.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.03 148.17 78.55 Favored 'Trans proline' 0 C--O 1.246 0.905 0 C-N-CA 122.997 2.465 . . . . 0.0 112.315 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.424 ' CE2' ' HB3' ' A' ' 64' ' ' ASN . 76.4 t80 -71.63 111.56 7.03 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.36 0.6 . . . . 0.0 110.594 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.411 ' H ' ' HB2' ' A' ' 90' ' ' HIS . 48.7 t -94.51 115.29 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.98 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.585 178.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.424 ' HB3' ' CE2' ' A' ' 62' ' ' PHE . 23.7 p-10 -114.73 25.05 11.28 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 125.673 1.589 . . . . 0.0 108.14 178.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.53 ' HB3' ' NH2' ' A' ' 70' ' ' ARG . 16.6 t70 -66.92 146.22 54.63 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 112.867 -1.969 . . . . 0.0 112.396 -176.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.7 m -53.53 -18.49 2.85 Favored 'General case' 0 CA--C 1.57 1.745 0 C-N-CA 125.203 1.401 . . . . 0.0 113.747 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.518 ' HG2' ' OD2' ' A' ' 65' ' ' ASP . 33.4 mmtp -66.52 167.66 10.45 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.773 -0.579 . . . . 0.0 110.132 174.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -106.07 -15.91 14.76 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 175.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.3 mp0 -92.39 128.31 38.2 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.788 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.53 ' NH2' ' HB3' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -106.1 154.18 39.76 Favored Pre-proline 0 C--N 1.291 -1.966 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.306 178.625 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -81.9 135.1 8.64 Favored 'Trans proline' 0 N--CA 1.44 -1.629 0 C-N-CA 121.632 1.555 . . . . 0.0 111.002 178.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -129.12 120.91 26.7 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.614 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 87.0 m95 -106.66 133.93 50.59 Favored 'General case' 0 C--N 1.278 -2.543 0 CA-C-O 121.034 0.445 . . . . 0.0 111.953 -171.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 86' ' ' THR . 29.5 m-85 -112.39 140.56 47.01 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.499 177.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.4 mt -125.6 142.37 51.54 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -177.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 80.5 m-85 -134.48 140.84 46.5 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 123.892 0.745 . . . . 0.0 109.599 -176.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.37 -12.19 59.06 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.51 -177.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.504 ' C ' ' HB3' ' A' ' 106' ' ' SER . 5.1 t-20 -123.25 172.51 8.57 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.8 m -76.23 168.83 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 C-N-CA 123.415 0.686 . . . . 0.0 111.591 -176.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.3 m120 53.83 30.53 11.53 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.121 0.969 . . . . 0.0 112.431 176.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.555 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 8.2 m-85 63.0 39.44 10.19 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.577 176.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 81.4 p -111.91 170.65 8.0 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.67 -145.31 17.56 Favored Glycine 0 N--CA 1.429 -1.781 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.609 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.515 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 98.0 mtt180 -75.59 147.84 39.29 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 123.128 0.571 . . . . 0.0 109.636 178.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.5 tt -125.38 136.5 60.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 121.705 0.764 . . . . 0.0 110.442 -175.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 93.5 m -131.39 125.16 31.9 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.615 176.017 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -115.01 118.01 4.19 Favored Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.309 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -112.53 146.0 39.29 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 123.3 0.64 . . . . 0.0 111.146 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -117.94 172.89 14.57 Favored Glycine 0 N--CA 1.434 -1.474 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.127 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.439 ' CD2' ' HG2' ' A' ' 70' ' ' ARG . 2.6 p80 -62.46 132.43 52.47 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 121.272 0.558 . . . . 0.0 111.906 -176.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.8 15.17 79.84 Favored Glycine 0 N--CA 1.43 -1.7 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.766 176.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.8 m -127.22 146.2 50.5 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.7 m -137.55 156.34 48.21 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.436 ' O ' ' HB2' ' A' ' 57' ' ' SER . 46.0 mt -95.31 127.03 47.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 170.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -71.77 -46.34 58.71 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.354 0.597 . . . . 0.0 111.926 177.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.617 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 1.7 m-20 -129.4 96.11 4.2 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.144 178.126 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -64.69 -35.03 79.73 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.56 0.695 . . . . 0.0 110.34 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.4 t -67.66 -29.32 68.58 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.159 -175.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.617 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 29.4 mmtp -88.39 -6.68 57.54 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -178.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.1 m -80.64 -13.29 59.16 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.882 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 139.02 -70.47 0.46 Allowed Glycine 0 N--CA 1.431 -1.678 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -110.32 146.46 35.7 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -112.4 -9.96 13.8 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.715 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -109.48 115.54 4.27 Favored Glycine 0 N--CA 1.427 -1.932 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.747 -176.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 79.1 mt -98.77 116.27 41.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.504 ' HB3' ' C ' ' A' ' 78' ' ' ASN . 7.6 t -85.82 -29.9 23.4 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.52 177.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 93.6 p -148.57 155.4 41.06 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 121.872 -0.517 . . . . 0.0 111.273 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.1 mt -133.27 133.71 57.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -176.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.555 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 38.9 ttmt -116.13 132.97 56.51 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.454 ' H ' ' HB3' ' A' ' 45' ' ' SER . 46.3 ttp180 -102.77 118.25 36.42 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 64.6 m -120.14 170.23 9.5 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.2 pt -128.63 141.7 45.88 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.536 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 37.1 tt0 -113.02 122.62 48.15 Favored 'General case' 0 C--N 1.268 -2.967 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.483 ' OG1' ' HG2' ' A' ' 118' ' ' LYS . 30.8 p -76.4 -179.19 5.0 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -177.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -59.07 -29.72 67.54 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.31 0.576 . . . . 0.0 110.38 177.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -76.96 -9.1 58.46 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.782 -175.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.66 8.71 84.24 Favored Glycine 0 N--CA 1.421 -2.307 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.14 -176.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.483 ' HG2' ' OG1' ' A' ' 114' ' ' THR . 9.4 ptpp? -84.02 138.38 33.12 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 26.1 t -107.07 112.09 38.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.584 0.707 . . . . 0.0 111.356 -174.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -101.02 153.04 19.88 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 177.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 85.6 m . . . . . 0 C--N 1.294 -1.821 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.331 -175.775 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.458 ' CD2' ' HB3' ' A' ' 71' ' ' PRO . 4.7 m-85 . . . . . 0 CA--C 1.508 -0.641 0 CA-C-O 121.955 0.883 . . . . 0.0 110.289 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.1 m -126.98 153.54 45.75 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.196 -1.366 . . . . 0.0 107.976 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.596 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 53.0 tp -111.58 130.1 55.85 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 107.024 -1.472 . . . . 0.0 107.024 175.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.517 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 73.3 mt-30 -117.42 124.01 47.8 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.701 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.0 mp -110.47 121.93 46.5 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.163 178.124 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -87.8 151.92 22.51 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 123.577 0.548 . . . . 0.0 110.45 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -74.77 -39.98 61.47 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.091 -178.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -108.46 178.37 4.51 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.46 HG22 ' HA ' ' A' ' 96' ' ' ASP . 2.2 p -80.71 173.38 12.66 Favored 'General case' 0 N--CA 1.413 -2.31 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.594 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.276 21.6 p90 47.11 43.23 14.05 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 124.731 1.212 . . . . 0.0 114.231 177.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 65.97 23.11 11.23 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 124.379 1.072 . . . . 0.0 112.044 175.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.435 ' HA ' ' NE ' ' A' ' 36' ' ' ARG . 5.6 mmp_? -100.48 167.85 10.11 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.385 0.612 . . . . 0.0 112.279 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.02 -166.26 48.3 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -175.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.7 m -90.88 175.37 7.01 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.425 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 37.6 p90 -137.17 165.08 26.95 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 16.7 tt -114.6 152.61 16.21 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 176.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -107.05 124.95 50.39 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 175.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.55 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 94.2 t -114.03 133.64 59.4 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.555 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 177.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -115.06 -33.54 5.36 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.468 0.651 . . . . 0.0 110.028 -174.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.92 161.44 25.38 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.692 -177.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 p -75.72 149.25 38.09 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.465 0.65 . . . . 0.0 112.102 -176.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.409 HG12 ' HB ' ' A' ' 108' ' ' ILE . 10.6 p -121.18 137.38 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.98 -18.9 35.51 Favored Glycine 0 C--N 1.299 -1.478 0 C-N-CA 120.13 -1.033 . . . . 0.0 112.617 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.1 t -159.52 131.38 6.33 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 121.032 0.444 . . . . 0.0 110.159 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 91.1 mt -119.65 118.02 29.84 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.653 177.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 29.2 t -132.77 114.07 14.09 Favored Pre-proline 0 N--CA 1.419 -2.017 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 174.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 60.0 Cg_endo -74.81 161.87 93.88 Favored 'Cis proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.997 -1.668 . . . . 0.0 110.417 -2.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -63.18 156.08 57.54 Favored 'Trans proline' 0 C--O 1.257 1.441 0 C-N-CA 121.85 1.7 . . . . 0.0 110.636 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.481 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 45.5 m0 -89.1 135.4 33.58 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -177.049 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 15.3 p -116.18 76.58 6.73 Favored Pre-proline 0 C--N 1.292 -1.918 0 O-C-N 123.362 0.413 . . . . 0.0 111.318 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.434 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 85.6 Cg_endo -77.12 157.6 33.94 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 122.5 2.133 . . . . 0.0 112.903 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.69 -33.4 10.09 Favored Glycine 0 N--CA 1.431 -1.665 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.7 p -154.27 144.95 22.4 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.418 HG11 HD11 ' A' ' 75' ' ' LEU . 32.2 t -119.95 142.8 33.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 33.6 t -145.4 147.5 32.32 Favored 'General case' 0 N--CA 1.422 -1.84 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.228 177.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 80.5 t -111.35 122.3 37.97 Favored Pre-proline 0 C--N 1.296 -1.743 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 176.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -58.78 149.23 78.99 Favored 'Trans proline' 0 C--O 1.243 0.764 0 C-N-CA 122.892 2.395 . . . . 0.0 112.246 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -79.02 135.3 36.85 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 82.3 t -113.48 114.06 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 CA-C-O 120.981 0.42 . . . . 0.0 110.348 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -109.35 84.33 1.91 Allowed 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 173.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.7 ' OD1' ' HG2' ' A' ' 67' ' ' LYS . 12.0 t70 -128.27 145.97 50.89 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.633 -172.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.2 m -53.84 -19.52 4.52 Favored 'General case' 0 CA--C 1.59 2.513 0 C-N-CA 125.121 1.368 . . . . 0.0 113.298 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.7 ' HG2' ' OD1' ' A' ' 65' ' ' ASP . 23.5 mmtp -64.13 176.63 0.96 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.724 -0.61 . . . . 0.0 112.272 178.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 66.8 mtm180 -102.68 -29.13 11.71 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.94 0.876 . . . . 0.0 109.642 -176.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.0 134.55 50.75 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.783 -173.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.661 ' NH2' ' HB2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -104.38 153.93 38.71 Favored Pre-proline 0 C--N 1.297 -1.696 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.185 -179.231 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.458 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 93.3 Cg_endo -77.4 140.73 19.58 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.615 1.543 . . . . 0.0 112.122 178.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -133.49 133.78 42.66 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 -178.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.596 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 83.2 m95 -117.3 135.45 53.82 Favored 'General case' 0 C--N 1.288 -2.092 0 O-C-N 121.731 -0.605 . . . . 0.0 112.39 -172.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.424 ' HA ' ' O ' ' A' ' 86' ' ' THR . 33.4 m-85 -113.05 141.93 46.3 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.91 177.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.418 HD11 HG11 ' A' ' 58' ' ' VAL . 19.2 mt -126.11 142.53 51.48 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -177.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.521 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 86.3 m-85 -133.59 141.92 47.89 Favored 'General case' 0 C--N 1.316 -0.884 0 O-C-N 123.72 0.638 . . . . 0.0 110.055 -177.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.438 ' HB3' ' CG ' ' A' ' 102' ' ' PHE . 0.8 OUTLIER -85.45 0.09 53.31 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -178.984 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -137.73 159.7 41.26 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 174.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.7 m -70.96 166.32 2.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 C-N-CA 122.626 0.37 . . . . 0.0 111.656 -174.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.6 m120 58.07 30.8 19.82 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.798 0.839 . . . . 0.0 111.769 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.464 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 12.6 m-85 60.13 44.66 12.68 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.421 176.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 74.9 p -115.57 168.28 10.15 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.26 -141.4 17.49 Favored Glycine 0 N--CA 1.426 -2.021 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.807 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.521 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 57.1 mtt180 -77.33 135.85 38.41 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 123.083 0.553 . . . . 0.0 109.771 -177.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.8 tt -115.24 136.75 50.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.348 -175.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 96.9 m -131.9 123.2 26.98 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.172 176.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -110.06 123.89 6.9 Favored Glycine 0 N--CA 1.438 -1.183 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.362 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.417 HD21 HD11 ' A' ' 94' ' ' ILE . 3.3 mm? -115.77 145.66 42.61 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 123.159 0.584 . . . . 0.0 110.511 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.54 167.46 12.53 Favored Glycine 0 N--CA 1.423 -2.218 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.711 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -55.75 125.42 21.15 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 123.815 0.846 . . . . 0.0 112.429 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.16 3.82 84.63 Favored Glycine 0 N--CA 1.431 -1.675 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.336 176.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.9 m -113.57 146.53 39.55 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.4 m -136.75 158.0 45.45 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.417 HD11 HD21 ' A' ' 88' ' ' LEU . 56.1 mt -93.4 132.44 37.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 173.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -70.02 -47.42 62.17 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.605 0.717 . . . . 0.0 110.14 -176.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.46 ' HA ' HG22 ' A' ' 33' ' ' THR . 5.6 m-20 -138.89 102.65 4.61 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 176.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.432 ' HZ ' ' CE2' ' A' ' 102' ' ' PHE . 59.3 t80 -64.66 -32.68 74.46 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.402 0.62 . . . . 0.0 110.399 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.9 t -63.54 -24.94 68.02 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.721 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.454 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 31.8 mmtp -93.67 -5.81 47.76 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 121.308 0.575 . . . . 0.0 109.572 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.8 t -84.71 31.17 0.54 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.302 0.641 . . . . 0.0 110.439 -177.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.7 -71.91 1.73 Allowed Glycine 0 N--CA 1.437 -1.288 0 C-N-CA 121.263 -0.494 . . . . 0.0 111.972 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.438 ' CG ' ' HB3' ' A' ' 77' ' ' ASP . 35.0 p90 -109.96 148.37 31.75 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.577 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.43 -6.99 13.47 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.738 179.668 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -116.95 116.59 3.59 Favored Glycine 0 N--CA 1.429 -1.831 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.377 -176.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 64.9 mt -94.78 115.83 34.6 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.675 0 CA-C-O 122.342 1.068 . . . . 0.0 108.888 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.4 m -85.45 -25.07 27.16 Favored 'General case' 0 N--CA 1.39 -3.436 0 CA-C-N 112.425 -2.171 . . . . 0.0 114.252 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.5 p -158.0 152.88 25.22 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 122.076 -0.39 . . . . 0.0 110.014 176.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.409 ' HB ' HG12 ' A' ' 46' ' ' VAL . 44.8 mt -130.97 131.04 64.32 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -176.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.464 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 36.1 ttmt -116.53 132.82 56.58 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -100.19 129.95 46.27 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 66.7 m -131.0 172.15 12.4 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.7 pt -127.51 140.7 48.39 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -109.16 119.7 40.32 Favored 'General case' 0 C--N 1.276 -2.61 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 71.3 p -74.0 173.6 9.78 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.808 -175.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -66.92 -19.04 65.65 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 121.842 0.83 . . . . 0.0 109.652 175.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -84.68 -8.14 58.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.801 0.81 . . . . 0.0 110.354 177.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.99 -11.53 71.87 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 120.843 -0.694 . . . . 0.0 113.08 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -71.93 134.69 46.15 Favored 'General case' 0 C--O 1.254 1.342 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.7 t -99.51 111.85 30.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -95.29 134.93 37.51 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 48.8 m . . . . . 0 C--N 1.288 -2.103 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 178.782 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 . . . . . 0 CA--C 1.493 -1.246 0 CA-C-O 122.315 1.055 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.545 ' SG ' ' HG3' ' A' ' 61' ' ' PRO . 3.9 p -144.74 160.16 41.68 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 113.681 -1.599 . . . . 0.0 109.82 -178.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.631 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 54.3 tp -111.93 118.53 35.75 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 173.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 66.7 mt-30 -109.33 123.65 49.64 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.251 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.454 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 2.9 mp -110.35 121.73 46.0 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.672 177.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.443 ' CD1' ' HB3' ' A' ' 39' ' ' TYR . 90.4 m-85 -93.12 157.26 16.38 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 123.609 0.568 . . . . 0.0 111.781 -175.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -81.14 -35.13 31.91 Favored 'General case' 0 CA--C 1.494 -1.175 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.865 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -108.23 178.09 4.61 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.469 HG22 ' HA ' ' A' ' 96' ' ' ASP . 3.3 p -81.39 172.07 14.0 Favored 'General case' 0 N--CA 1.401 -2.899 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.35 178.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 21.2 p90 47.26 38.93 7.75 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.892 1.277 . . . . 0.0 114.205 176.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 65.41 22.41 11.94 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.551 1.541 . . . . 0.0 114.506 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.18 173.62 7.63 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.255 0.55 . . . . 0.0 111.485 175.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.18 -152.75 34.87 Favored Glycine 0 N--CA 1.426 -2.021 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 -174.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.7 m -108.78 178.51 4.46 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 173.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.443 ' HB3' ' CD1' ' A' ' 30' ' ' TYR . 29.9 p90 -143.53 166.79 23.82 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.095 0.474 . . . . 0.0 110.157 -177.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.0 tt -114.53 152.81 16.13 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.545 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 176.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -106.84 125.54 51.14 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 176.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.494 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 99.4 t -122.6 134.55 65.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -126.09 -2.85 7.02 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.771 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -139.44 162.54 34.8 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -173.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.45 ' HB3' ' H ' ' A' ' 110' ' ' ARG . 2.8 p -84.42 144.86 28.5 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-O 120.991 0.424 . . . . 0.0 111.599 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.7 p -119.78 137.72 52.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.68 -21.63 30.81 Favored Glycine 0 N--CA 1.433 -1.526 0 C-N-CA 120.072 -1.061 . . . . 0.0 112.389 -177.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.0 p -157.79 129.04 6.66 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-O 121.07 0.462 . . . . 0.0 112.014 -178.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.1 mt -118.5 118.47 31.8 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 175.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 38.5 m -132.27 114.61 14.84 Favored Pre-proline 0 C--N 1.299 -1.6 0 O-C-N 123.393 0.433 . . . . 0.0 110.08 175.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 6.2 Cg_exo -76.91 159.41 95.99 Favored 'Cis proline' 0 C--O 1.246 0.899 0 C-N-CA 122.944 -1.69 . . . . 0.0 110.371 -1.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -62.34 157.66 44.45 Favored 'Trans proline' 0 C--O 1.252 1.209 0 C-N-CA 122.482 2.121 . . . . 0.0 111.349 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.428 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 48.8 m0 -89.47 140.27 29.69 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -177.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.613 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 35.5 p -123.8 73.78 54.68 Favored Pre-proline 0 C--N 1.305 -1.364 0 O-C-N 123.46 0.475 . . . . 0.0 110.561 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.454 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 81.6 Cg_endo -74.2 156.5 46.63 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 122.354 2.036 . . . . 0.0 113.653 -178.261 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -83.77 -34.28 19.29 Favored Glycine 0 N--CA 1.431 -1.633 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 177.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.0 p -153.83 154.97 34.92 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.3 t -130.45 142.31 44.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 35.5 t -146.07 152.32 39.14 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.696 176.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 95.4 t -117.2 125.21 28.38 Favored Pre-proline 0 C--N 1.313 -0.991 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 176.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.545 ' HG3' ' SG ' ' A' ' 26' ' ' CYS . 5.9 Cg_exo -49.68 141.31 27.49 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 123.471 2.78 . . . . 0.0 113.288 178.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -75.24 113.47 12.64 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 121.676 0.75 . . . . 0.0 109.868 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.468 ' H ' ' HB2' ' A' ' 90' ' ' HIS . 78.4 t -94.54 125.31 47.18 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.513 -179.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -127.88 12.16 6.71 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 124.428 1.08 . . . . 0.0 108.696 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -57.93 147.04 30.18 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.464 1.506 . . . . 0.0 113.28 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.3 m -53.59 -12.9 0.54 Allowed 'General case' 0 CA--C 1.579 2.071 0 C-N-CA 125.568 1.547 . . . . 0.0 112.179 178.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -58.42 161.39 4.48 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.669 1.188 . . . . 0.0 111.182 175.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.78 -28.25 16.69 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -178.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.67 140.77 43.12 Favored 'General case' 0 N--CA 1.417 -2.098 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.631 -174.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -105.99 154.22 39.65 Favored Pre-proline 0 C--N 1.289 -2.027 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.406 ' CD ' HG21 ' A' ' 63' ' ' VAL . 85.0 Cg_endo -81.71 135.18 8.9 Favored 'Trans proline' 0 N--CA 1.44 -1.644 0 C-N-CA 121.309 1.34 . . . . 0.0 110.888 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -128.76 123.54 33.22 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 -177.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.631 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 83.4 m95 -109.33 135.35 50.54 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-O 120.759 0.314 . . . . 0.0 111.843 -172.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 86' ' ' THR . 39.8 m-85 -113.59 141.85 46.68 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.023 177.011 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.6 mt -125.37 142.2 51.64 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 -176.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.44 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 80.8 m-85 -131.3 141.49 49.96 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 123.468 0.48 . . . . 0.0 110.49 -176.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.58 -21.76 51.96 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.525 -177.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.498 ' C ' ' HB3' ' A' ' 106' ' ' SER . 8.6 t-20 -118.76 168.33 10.84 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.6 m -73.94 168.96 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 C-N-CA 122.575 0.35 . . . . 0.0 110.298 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.6 m120 55.48 30.42 15.07 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.447 0.699 . . . . 0.0 112.605 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.445 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 9.3 m-85 58.96 45.85 14.43 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 124.755 1.222 . . . . 0.0 111.316 176.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.7 p -117.33 167.45 11.23 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.186 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.93 -134.19 12.32 Favored Glycine 0 N--CA 1.424 -2.13 0 N-CA-C 111.344 -0.703 . . . . 0.0 111.344 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.44 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 64.1 mtm180 -81.17 151.39 28.24 Favored 'General case' 0 C--N 1.287 -2.124 0 C-N-CA 123.611 0.764 . . . . 0.0 110.977 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.4 tt -130.5 137.18 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-O 121.275 0.559 . . . . 0.0 110.303 -176.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 98.4 m -132.38 120.51 22.13 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.906 175.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -108.01 127.8 8.85 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.211 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.49 HD21 HD11 ' A' ' 94' ' ' ILE . 3.3 mm? -118.21 145.5 44.93 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 123.074 0.55 . . . . 0.0 110.793 178.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.75 172.93 14.45 Favored Glycine 0 N--CA 1.433 -1.563 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.455 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.468 ' HB2' ' H ' ' A' ' 63' ' ' VAL . 3.0 p80 -61.65 122.32 15.0 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 123.293 0.637 . . . . 0.0 112.287 -175.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.2 2.13 80.73 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.821 176.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.1 m -110.36 146.13 36.33 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.4 m -140.37 154.5 46.74 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.49 HD11 HD21 ' A' ' 88' ' ' LEU . 52.2 mt -93.21 128.79 44.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 173.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -70.26 -47.37 61.59 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 123.539 0.525 . . . . 0.0 110.111 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.616 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 1.6 m-20 -132.97 91.83 2.94 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.761 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -65.46 -33.13 75.22 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.483 0.658 . . . . 0.0 109.429 176.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.7 t -64.31 -28.79 69.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.358 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.616 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 32.2 mmtp -89.57 -6.79 55.97 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 120.61 0.243 . . . . 0.0 110.499 -176.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.3 m -82.21 -175.12 5.5 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.064 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -52.86 -64.11 4.41 Favored Glycine 0 C--N 1.334 0.422 0 O-C-N 123.136 0.272 . . . . 0.0 113.215 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -110.94 143.14 42.07 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 122.505 -0.409 . . . . 0.0 110.462 176.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.613 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -108.93 -9.93 15.1 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.201 -1.036 . . . . 0.0 108.201 175.092 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -108.68 114.01 3.95 Favored Glycine 0 N--CA 1.433 -1.535 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.188 -177.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 71.6 mt -96.92 115.57 36.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.498 ' HB3' ' C ' ' A' ' 78' ' ' ASN . 1.1 t -86.67 -26.48 24.3 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.497 178.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.3 p -150.95 156.68 41.67 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 122.158 -0.339 . . . . 0.0 110.324 178.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.2 mt -135.13 132.28 52.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -176.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.445 ' HE2' ' CD2' ' A' ' 81' ' ' TYR . 32.3 ttmt -117.65 133.92 55.44 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.45 ' H ' ' HB3' ' A' ' 45' ' ' SER . 24.6 ttp180 -102.77 127.73 49.81 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 66.2 m -127.16 171.98 10.95 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.0 pt -129.66 144.87 36.76 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.146 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 177.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.481 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 61.8 tt0 -119.18 122.48 42.1 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 63.4 p -75.35 174.06 10.06 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.404 -175.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -66.36 -28.18 68.46 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.664 0.745 . . . . 0.0 109.525 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -77.12 -7.11 55.2 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.307 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.04 -1.74 61.15 Favored Glycine 0 N--CA 1.438 -1.192 0 N-CA-C 115.534 0.974 . . . . 0.0 115.534 171.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 113' ' ' GLN . 18.5 ptpt -83.73 140.65 31.98 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 118.78 1.29 . . . . 0.0 110.9 -177.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.4 t -101.81 112.06 33.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -99.4 144.79 28.11 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 124.27 1.028 . . . . 0.0 108.241 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 72.8 m . . . . . 0 C--N 1.303 -1.424 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.597 -174.776 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.43 ' CZ ' ' HD3' ' A' ' 71' ' ' PRO . 9.1 m-85 . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 121.137 0.494 . . . . 0.0 112.006 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 63.5 m -123.32 149.63 44.61 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.591 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 49.1 tp -95.62 112.76 24.41 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 174.073 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.526 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 91.3 mt-30 -111.46 123.17 49.67 Favored 'General case' 0 N--CA 1.422 -1.852 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.745 -177.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.451 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 2.7 mp -110.97 124.71 52.67 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.87 -178.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.416 ' CE1' ' HG2' ' A' ' 35' ' ' GLU . 96.4 m-85 -90.45 155.38 18.96 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 122.623 0.369 . . . . 0.0 110.577 -178.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -75.18 -40.94 58.98 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.897 0.856 . . . . 0.0 109.943 -176.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.483 ' HB2' ' HG3' ' A' ' 36' ' ' ARG . 24.8 mm-40 -108.46 179.01 4.32 Favored 'General case' 0 N--CA 1.421 -1.918 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.403 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.513 HG22 ' HA ' ' A' ' 96' ' ' ASP . 0.8 OUTLIER -81.11 174.94 11.09 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.504 -177.093 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 47.07 34.03 2.64 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 174.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.416 ' HG2' ' CE1' ' A' ' 30' ' ' TYR . 36.1 mt-10 65.35 22.78 12.03 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 124.485 1.114 . . . . 0.0 113.919 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.483 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 35.7 ptt180 -97.71 157.52 16.01 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 118.694 -1.202 . . . . 0.0 108.87 174.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.4 -178.65 41.62 Favored Glycine 0 N--CA 1.424 -2.105 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -175.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.0 m -89.59 169.13 11.59 Favored 'General case' 0 C--N 1.286 -2.163 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.553 177.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.435 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 21.8 p90 -131.78 165.88 22.8 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.466 -177.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 15.0 tt -113.87 150.55 15.88 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -106.59 125.15 50.64 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.503 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 88.4 t -123.97 133.88 68.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -117.46 -31.57 5.2 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -176.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.542 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 11.2 mmpt? -103.56 161.98 13.43 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.914 -173.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.9 p -88.99 143.03 27.14 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 172.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.5 p -121.31 131.05 73.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -177.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.77 -15.25 56.89 Favored Glycine 0 C--N 1.298 -1.53 0 C-N-CA 119.851 -1.166 . . . . 0.0 113.03 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.5 p -154.38 123.98 6.59 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.439 0.637 . . . . 0.0 112.415 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 88.4 mt -116.45 118.71 33.42 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.202 177.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 25.0 p -131.88 107.51 14.0 Favored Pre-proline 0 C--N 1.3 -1.549 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.64 175.05 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 72.8 Cg_endo -77.93 162.22 89.86 Favored 'Cis proline' 0 C--O 1.249 1.068 0 C-N-CA 123.861 -1.308 . . . . 0.0 111.801 0.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.52 154.58 73.07 Favored 'Trans proline' 0 C--O 1.25 1.123 0 C-N-CA 122.125 1.883 . . . . 0.0 110.586 176.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 49.3 m0 -90.23 137.6 32.21 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 20.5 p -121.22 79.41 35.34 Favored Pre-proline 0 N--CA 1.425 -1.688 0 O-C-N 123.258 0.349 . . . . 0.0 111.027 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.451 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 85.4 Cg_endo -77.16 158.49 33.74 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.884 2.389 . . . . 0.0 112.789 178.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.32 -29.82 9.21 Favored Glycine 0 N--CA 1.43 -1.701 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.1 p -150.96 152.61 33.81 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.411 HG22 HD23 ' A' ' 29' ' ' LEU . 40.5 t -126.71 142.99 41.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -178.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 17.3 t -145.46 138.48 26.19 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 118.525 0.602 . . . . 0.0 110.109 -176.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.7 t -118.33 125.38 27.9 Favored Pre-proline 0 C--O 1.249 1.056 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -62.1 147.16 95.62 Favored 'Trans proline' 0 C--O 1.249 1.061 0 C-N-CA 122.775 2.317 . . . . 0.0 111.031 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.612 ' CE2' ' HB3' ' A' ' 64' ' ' ASN . 34.7 t80 -74.49 136.31 42.24 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-O 121.95 0.881 . . . . 0.0 111.111 -176.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 98.4 t -118.61 115.08 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.166 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.612 ' HB3' ' CE2' ' A' ' 62' ' ' PHE . 24.5 p-10 -121.67 13.44 10.82 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 123.045 1.402 . . . . 0.0 107.332 178.093 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.74 146.44 41.47 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 111.737 -2.483 . . . . 0.0 111.483 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.4 m -57.46 -8.22 0.77 Allowed 'General case' 0 CA--C 1.579 2.073 0 C-N-CA 124.69 1.196 . . . . 0.0 112.004 177.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -62.49 136.65 58.0 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.104 0.961 . . . . 0.0 108.731 177.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.539 ' HB2' ' OE1' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -84.24 -28.82 26.98 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -177.894 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.539 ' OE1' ' HB2' ' A' ' 68' ' ' ARG . 3.0 mp0 -97.25 125.08 41.58 Favored 'General case' 0 N--CA 1.415 -2.184 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.484 ' HG2' ' CE1' ' A' ' 90' ' ' HIS . 0.6 OUTLIER -106.75 152.09 40.71 Favored Pre-proline 0 C--N 1.291 -1.955 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.593 179.111 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.43 ' HD3' ' CZ ' ' A' ' 25' ' ' TYR . 74.1 Cg_endo -76.98 134.09 14.3 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 121.089 1.193 . . . . 0.0 110.542 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -133.5 132.82 41.45 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.591 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 89.5 m95 -119.48 133.15 55.82 Favored 'General case' 0 C--N 1.284 -2.275 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.915 -172.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.525 ' HA ' ' O ' ' A' ' 86' ' ' THR . 35.7 m-85 -112.98 141.39 46.87 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.368 177.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.8 mt -125.92 142.16 51.64 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -176.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.544 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 80.2 m-85 -134.45 142.68 47.18 Favored 'General case' 0 CA--C 1.502 -0.874 0 O-C-N 123.796 0.685 . . . . 0.0 110.117 -176.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.409 ' HB3' ' CD1' ' A' ' 102' ' ' PHE . 2.9 p-10 -84.38 -5.82 59.32 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.476 ' C ' ' HB3' ' A' ' 106' ' ' SER . 4.4 t-20 -127.28 167.77 15.67 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 174.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.4 m -73.52 167.37 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 C-N-CA 122.581 0.352 . . . . 0.0 111.627 -176.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.4 m120 55.92 31.53 18.03 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.237 -0.892 . . . . 0.0 113.226 176.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 62.82 42.83 7.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.857 175.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 69.3 p -118.38 161.7 19.53 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.093 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.98 -144.06 17.12 Favored Glycine 0 N--CA 1.425 -2.065 0 N-CA-C 111.668 -0.573 . . . . 0.0 111.668 177.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.544 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 54.9 mtt180 -72.41 142.84 48.69 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.3 tt -125.4 136.43 60.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-O 121.487 0.66 . . . . 0.0 111.241 -173.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 86.7 m -131.57 123.04 27.1 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.34 176.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -113.69 120.06 5.0 Favored Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.531 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.465 HD21 HD11 ' A' ' 94' ' ' ILE . 3.3 mm? -110.35 147.76 33.29 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 123.673 0.789 . . . . 0.0 111.0 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -121.36 168.41 14.31 Favored Glycine 0 N--CA 1.425 -2.047 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.204 -178.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.484 ' CE1' ' HG2' ' A' ' 70' ' ' ARG . 2.9 p80 -55.12 121.89 9.78 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 124.066 0.946 . . . . 0.0 112.139 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.18 12.37 73.76 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.064 176.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.0 m -125.48 145.9 49.88 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 177.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 22.5 m -144.2 155.84 44.05 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -178.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.465 HD11 HD21 ' A' ' 88' ' ' LEU . 48.7 mt -93.45 125.61 46.0 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.45 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -70.22 -46.76 63.86 Favored 'General case' 0 C--N 1.288 -2.071 0 O-C-N 123.812 0.695 . . . . 0.0 110.353 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.587 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 3.3 m-20 -132.88 93.55 3.22 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.231 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.407 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 54.3 t80 -64.94 -31.66 73.0 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.431 0.634 . . . . 0.0 110.508 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.7 t -63.49 -23.2 67.29 Favored 'General case' 0 CA--C 1.561 1.375 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.631 -178.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.587 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 30.4 mmtp -92.78 -6.31 49.24 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.925 -0.485 . . . . 0.0 109.765 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.8 m -84.85 13.46 5.86 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.379 0.609 . . . . 0.0 111.786 -177.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 104.72 -79.07 0.28 Allowed Glycine 0 N--CA 1.425 -2.05 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.68 178.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.409 ' CD1' ' HB3' ' A' ' 77' ' ' ASP . 27.5 p90 -100.11 147.13 26.0 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -178.437 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.548 ' H ' ' HD3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -113.3 -14.22 12.84 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.18 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -103.02 110.4 3.71 Favored Glycine 0 N--CA 1.422 -2.271 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.489 -175.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 80.5 mt -93.32 115.65 32.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.476 ' HB3' ' C ' ' A' ' 78' ' ' ASN . 5.3 t -85.99 -29.01 23.85 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.502 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 90.1 p -150.34 156.33 41.31 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.752 -0.203 . . . . 0.0 110.818 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.7 mt -134.01 132.41 56.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -176.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -116.38 131.58 56.91 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -99.5 129.6 45.69 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' CYS . . . . . 0.422 ' SG ' ' HD2' ' A' ' 74' ' ' TYR . 62.6 m -128.51 172.38 11.21 Favored 'General case' 0 N--CA 1.413 -2.3 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.329 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 70' ' ' ARG . 7.1 pt -131.48 141.98 44.43 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 C-N-CA 123.172 0.589 . . . . 0.0 110.039 177.188 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.42 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 52.6 tt0 -113.69 119.11 36.3 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 33.8 p -80.19 -178.37 6.54 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.45 -172.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -66.1 -28.85 69.13 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.769 0.795 . . . . 0.0 109.636 177.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -80.1 -6.46 57.73 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.422 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.97 6.17 82.55 Favored Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 115.969 -0.56 . . . . 0.0 113.77 175.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 113' ' ' GLN . 66.0 pttt -82.16 145.08 30.3 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.829 178.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 25.5 t -104.12 111.52 34.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -97.12 144.24 27.16 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 96.8 m . . . . . 0 C--N 1.289 -2.055 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.297 -173.953 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 . . . . . 0 N--CA 1.468 0.463 0 CA-C-O 121.246 0.546 . . . . 0.0 111.718 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.6 m -122.73 145.07 48.73 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.517 HD22 ' CE3' ' A' ' 73' ' ' TRP . 51.5 tp -96.24 116.24 28.69 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 174.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 42.9 mt-30 -108.98 124.21 50.34 Favored 'General case' 0 N--CA 1.428 -1.572 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.315 -177.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.496 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.7 mp -109.66 118.91 37.8 Favored 'General case' 0 N--CA 1.408 -2.526 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.46 177.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.438 ' CD2' ' HB3' ' A' ' 39' ' ' TYR . 95.4 m-85 -87.51 150.3 23.82 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.508 -176.152 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -72.09 -44.1 63.76 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.835 -175.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -109.8 178.05 4.54 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.902 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.455 HG22 ' HA ' ' A' ' 96' ' ' ASP . 1.9 p -76.74 170.57 16.22 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-O 119.785 -0.15 . . . . 0.0 111.002 -177.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 14.9 p90 47.41 37.05 5.58 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.899 1.28 . . . . 0.0 114.086 177.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 67.72 26.21 7.89 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.615 1.166 . . . . 0.0 112.853 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.471 ' CZ ' ' HB3' ' A' ' 36' ' ' ARG . 8.5 mtp-105 -90.89 162.49 14.76 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 176.035 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.22 -158.94 36.71 Favored Glycine 0 N--CA 1.424 -2.134 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.3 p -96.44 177.41 5.69 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 174.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.438 ' HB3' ' CD2' ' A' ' 30' ' ' TYR . 38.1 p90 -138.55 166.83 23.32 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.035 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.8 tt -113.42 151.56 15.26 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 177.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -106.13 124.87 50.26 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.449 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 92.4 t -123.52 133.55 68.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -122.09 -6.01 8.94 Favored 'General case' 0 C--N 1.31 -1.118 0 O-C-N 123.616 0.573 . . . . 0.0 110.85 -174.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -137.1 162.34 33.66 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.161 -173.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.44 ' HB3' ' H ' ' A' ' 110' ' ' ARG . 3.9 p -86.77 140.2 29.97 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 175.095 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.2 p -119.53 134.37 63.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -175.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.76 -15.73 48.23 Favored Glycine 0 C--N 1.301 -1.394 0 C-N-CA 120.417 -0.897 . . . . 0.0 113.195 -176.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.7 t -156.61 127.54 6.83 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.442 0.639 . . . . 0.0 111.182 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.5 mt -121.34 117.93 28.19 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.073 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.0 m -132.55 115.41 14.73 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 174.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -75.12 161.92 93.81 Favored 'Cis proline' 0 C--O 1.25 1.089 0 C-N-CA 123.033 -1.653 . . . . 0.0 110.788 -2.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -61.98 156.7 47.8 Favored 'Trans proline' 0 C--O 1.256 1.403 0 C-N-CA 122.129 1.886 . . . . 0.0 110.417 178.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.426 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 45.8 m0 -89.33 135.97 33.29 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -176.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 34.1 p -115.65 81.41 9.15 Favored Pre-proline 0 C--N 1.301 -1.5 0 O-C-N 123.369 0.418 . . . . 0.0 111.165 178.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.496 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 81.3 Cg_endo -81.5 157.7 19.28 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 122.239 1.959 . . . . 0.0 112.583 176.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.06 -30.24 11.42 Favored Glycine 0 N--CA 1.43 -1.747 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 177.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.8 p -155.13 153.52 30.93 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.6 t -130.28 142.7 43.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 49.1 t -145.8 148.12 32.58 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.373 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.422 ' HB ' ' O ' ' A' ' 89' ' ' GLY . 58.7 t -117.39 122.65 30.75 Favored Pre-proline 0 C--N 1.31 -1.133 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 175.329 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.44 156.39 63.73 Favored 'Trans proline' 0 C--O 1.25 1.075 0 C-N-CA 122.726 2.284 . . . . 0.0 112.577 -177.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -72.84 135.3 45.16 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.386 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 98.4 t -112.19 115.58 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.265 0 CA-C-O 121.743 0.782 . . . . 0.0 111.763 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -112.51 74.54 0.87 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 173.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.432 ' HB3' ' NH2' ' A' ' 70' ' ' ARG . 14.6 t70 -126.99 145.95 50.52 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.191 -170.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -54.37 -18.53 4.21 Favored 'General case' 0 CA--C 1.578 2.044 0 C-N-CA 125.803 1.641 . . . . 0.0 114.429 -178.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.57 ' HB2' ' NH2' ' A' ' 70' ' ' ARG . 75.8 mmtt -65.56 173.79 2.56 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.561 -0.712 . . . . 0.0 111.261 175.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -102.7 -26.82 13.04 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 176.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -92.73 132.31 37.05 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.542 -176.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.57 ' NH2' ' HB2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -104.92 149.77 37.93 Favored Pre-proline 0 C--N 1.3 -1.545 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.626 176.379 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.17 136.18 17.81 Favored 'Trans proline' 0 C--N 1.321 -0.909 0 C-N-CA 121.907 1.738 . . . . 0.0 112.314 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -133.09 130.55 39.46 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.517 ' CE3' HD22 ' A' ' 27' ' ' LEU . 84.4 m95 -116.2 136.91 52.59 Favored 'General case' 0 C--N 1.286 -2.158 0 O-C-N 121.631 -0.668 . . . . 0.0 111.904 -172.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 86' ' ' THR . 41.4 m-85 -115.04 142.3 46.83 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 123.051 0.54 . . . . 0.0 110.426 177.147 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.8 mt -125.71 142.96 51.25 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -175.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 84.3 m-85 -133.23 145.18 50.31 Favored 'General case' 0 C--O 1.241 0.616 0 O-C-N 123.578 0.549 . . . . 0.0 110.666 -176.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.54 -3.56 58.9 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.794 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -133.26 157.06 46.38 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 119.851 -0.739 . . . . 0.0 109.283 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.454 ' HA ' ' HB2' ' A' ' 107' ' ' SER . 33.9 m -70.81 168.31 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.455 -178.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.6 m120 59.66 30.23 19.83 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.251 0.621 . . . . 0.0 110.966 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.602 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 16.5 m-85 55.21 44.03 28.33 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 124.781 1.232 . . . . 0.0 112.233 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 59.1 p -117.07 172.85 7.0 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.932 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.68 -136.17 13.5 Favored Glycine 0 N--CA 1.429 -1.767 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.357 178.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 77.6 mtt180 -79.76 153.23 29.35 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.8 tt -133.12 136.82 54.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-O 121.384 0.612 . . . . 0.0 110.785 -175.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 95.5 m -132.39 121.11 22.94 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.999 177.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -108.47 119.76 5.75 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.868 -0.682 . . . . 0.0 114.443 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.4 HD21 HD11 ' A' ' 94' ' ' ILE . 3.4 mm? -110.1 145.53 36.97 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 123.103 0.561 . . . . 0.0 110.596 178.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.422 ' O ' ' HB ' ' A' ' 60' ' ' VAL . . . -119.61 175.67 15.89 Favored Glycine 0 N--CA 1.429 -1.793 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.946 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -60.17 132.81 55.09 Favored 'General case' 0 C--O 1.247 0.95 0 C-N-CA 123.088 0.555 . . . . 0.0 111.86 -178.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.75 16.34 79.25 Favored Glycine 0 N--CA 1.437 -1.266 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.744 177.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.0 m -121.06 145.48 47.73 Favored 'General case' 0 N--CA 1.42 -1.972 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -178.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.9 m -141.98 155.43 45.45 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.4 HD11 HD21 ' A' ' 88' ' ' LEU . 47.7 mt -93.33 130.94 41.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 175.082 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -70.85 -48.42 54.06 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 123.586 0.554 . . . . 0.0 110.3 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.455 ' HA ' HG22 ' A' ' 33' ' ' THR . 8.2 m-20 -141.57 98.88 3.44 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -63.84 -31.86 73.18 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.481 0.658 . . . . 0.0 110.469 -178.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.9 t -63.4 -22.13 66.7 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.393 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -93.14 -11.04 33.81 Favored 'General case' 0 C--O 1.22 -0.499 0 O-C-N 121.742 -0.599 . . . . 0.0 110.416 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.1 m -78.77 -7.14 57.52 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.42 0.629 . . . . 0.0 110.579 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 123.8 -86.34 0.37 Allowed Glycine 0 N--CA 1.419 -2.478 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -85.73 139.2 31.54 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.584 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -109.43 -6.91 15.28 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.157 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -110.97 113.28 3.41 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.348 -176.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 75.0 mt -97.3 115.31 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.548 0 CA-C-O 122.687 1.232 . . . . 0.0 109.066 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.3 m -85.66 -25.31 26.64 Favored 'General case' 0 N--CA 1.393 -3.296 0 CA-C-N 111.811 -2.45 . . . . 0.0 113.935 178.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.454 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 8.5 t -159.39 153.3 23.21 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -176.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.1 mt -136.3 129.27 46.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -176.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.602 ' HE2' ' CD2' ' A' ' 81' ' ' TYR . 35.3 ttmt -117.23 133.28 56.18 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.44 ' H ' ' HB3' ' A' ' 45' ' ' SER . 55.5 ttp180 -100.49 129.85 46.49 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -178.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 71.0 m -126.34 172.0 10.5 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.4 pt -132.23 140.68 47.22 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -109.09 123.91 49.93 Favored 'General case' 0 C--N 1.266 -3.049 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 69.1 p -74.08 166.58 23.15 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.364 -175.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -67.58 -19.23 65.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 122.169 0.985 . . . . 0.0 109.075 175.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -76.93 -7.57 55.8 Favored 'General case' 0 CA--C 1.561 1.369 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.104 175.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.53 3.96 74.06 Favored Glycine 0 CA--C 1.504 -0.645 0 N-CA-C 114.828 0.691 . . . . 0.0 114.828 172.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.425 ' HE2' ' OE2' ' A' ' 120' ' ' GLU . 21.9 ptmt -94.44 139.73 30.75 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 119.138 -1.025 . . . . 0.0 109.421 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 24.2 t -95.27 111.9 26.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.394 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.425 ' OE2' ' HE2' ' A' ' 118' ' ' LYS . 6.3 mm-40 -94.96 142.69 27.19 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 72.4 m . . . . . 0 C--N 1.278 -2.525 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -177.48 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 121.045 0.45 . . . . 0.0 112.021 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.7 m -123.57 144.65 49.45 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.593 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 56.1 tp -88.73 128.28 35.62 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.439 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 48.1 mt-30 -117.23 123.42 46.58 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.222 -177.249 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.9 mp -110.82 120.05 41.12 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.893 177.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -89.82 150.41 22.26 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 123.735 0.647 . . . . 0.0 110.461 -176.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -75.34 -36.45 61.03 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.003 0.43 . . . . 0.0 111.17 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -107.99 177.27 4.86 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.452 HG22 ' HA ' ' A' ' 96' ' ' ASP . 1.7 p -82.43 170.45 15.26 Favored 'General case' 0 N--CA 1.407 -2.624 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 29.6 p90 46.83 44.46 14.3 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.803 1.241 . . . . 0.0 114.057 177.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 67.75 22.67 8.82 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.803 0.841 . . . . 0.0 112.615 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 37.4 mtp85 -95.17 161.02 14.29 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 177.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.31 -167.51 41.36 Favored Glycine 0 N--CA 1.423 -2.167 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.775 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 79.4 p -87.9 163.1 16.55 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 176.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 11.4 p90 -129.28 164.95 22.4 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.6 tt -114.95 153.39 16.45 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.038 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -106.75 125.47 51.05 Favored 'General case' 0 N--CA 1.422 -1.856 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 175.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.54 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 97.1 t -118.89 133.41 65.85 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 177.168 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -116.97 -29.83 5.88 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 123.472 0.482 . . . . 0.0 110.687 -174.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -121.59 163.27 19.2 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.031 -174.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.9 m -75.7 144.01 41.81 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 176.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.6 p -120.95 137.11 55.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.66 -18.71 31.72 Favored Glycine 0 C--N 1.307 -1.044 0 C-N-CA 119.791 -1.195 . . . . 0.0 113.02 -178.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.4 t -153.21 131.6 12.09 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-O 121.053 0.454 . . . . 0.0 110.305 -177.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.2 mt -123.25 117.68 25.86 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.58 177.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 11.0 m -132.61 111.21 13.64 Favored Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 177.492 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 5.1 Cg_exo -78.08 160.45 92.13 Favored 'Cis proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.109 -1.621 . . . . 0.0 110.527 -0.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.68 157.75 40.72 Favored 'Trans proline' 0 C--O 1.253 1.254 0 C-N-CA 122.126 1.884 . . . . 0.0 111.007 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.451 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 49.8 m0 -90.16 135.7 33.5 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -177.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 34.9 p -117.52 75.09 8.98 Favored Pre-proline 0 C--N 1.296 -1.751 0 O-C-N 123.387 0.429 . . . . 0.0 110.209 178.096 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.467 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 96.4 Cg_endo -74.73 157.81 43.63 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 122.151 1.901 . . . . 0.0 113.036 -178.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.97 -31.75 11.75 Favored Glycine 0 N--CA 1.427 -1.921 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.1 p -156.46 153.74 29.3 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.4 t -129.37 143.0 42.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 32.2 t -145.59 152.94 40.48 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.331 177.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.3 t -120.92 128.89 25.55 Favored Pre-proline 0 N--CA 1.443 -0.778 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 176.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.0 140.69 85.9 Favored 'Trans proline' 0 C--O 1.244 0.798 0 C-N-CA 123.18 2.587 . . . . 0.0 112.387 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.475 ' CE1' ' HB3' ' A' ' 64' ' ' ASN . 76.0 t80 -74.75 112.44 10.96 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-O 121.413 0.625 . . . . 0.0 110.462 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.3 t -94.16 115.57 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.148 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.485 178.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.475 ' HB3' ' CE1' ' A' ' 62' ' ' PHE . 6.4 p30 -118.88 15.69 13.43 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.194 -1.409 . . . . 0.0 107.194 177.304 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.652 ' OD1' ' HG2' ' A' ' 67' ' ' LYS . 8.9 t70 -66.51 147.54 53.14 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 112.358 -2.201 . . . . 0.0 109.476 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.2 m -53.13 -23.37 7.96 Favored 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 123.809 0.843 . . . . 0.0 111.812 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.652 ' HG2' ' OD1' ' A' ' 65' ' ' ASP . 42.5 mmtm -54.49 121.23 7.94 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 176.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -73.75 -25.64 60.27 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.976 -174.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -91.7 127.59 37.21 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -99.72 153.57 37.7 Favored Pre-proline 0 C--N 1.286 -2.193 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -83.22 135.18 7.19 Favored 'Trans proline' 0 N--CA 1.442 -1.503 0 C-N-CA 121.503 1.469 . . . . 0.0 111.078 176.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -130.24 132.2 45.86 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.593 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 82.2 m95 -118.78 134.14 55.35 Favored 'General case' 0 C--N 1.286 -2.185 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.831 -173.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 86' ' ' THR . 27.4 m-85 -114.47 140.8 48.42 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.327 178.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.5 mt -125.71 142.34 51.56 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -176.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.504 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 80.5 m-85 -132.84 143.04 49.27 Favored 'General case' 0 C--O 1.247 0.941 0 O-C-N 123.782 0.677 . . . . 0.0 109.791 -176.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.2 -14.75 57.23 Favored 'General case' 0 CA--C 1.491 -1.32 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.262 -178.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -122.17 166.09 15.12 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.5 m -76.29 167.78 2.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 122.747 0.419 . . . . 0.0 110.92 -175.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.3 m120 56.32 30.43 16.77 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 124.136 0.974 . . . . 0.0 112.82 178.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.441 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 7.0 m-85 63.01 39.34 10.25 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 124.795 1.238 . . . . 0.0 111.198 177.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 78.8 p -112.06 165.07 12.45 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.63 -139.43 14.57 Favored Glycine 0 N--CA 1.435 -1.427 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.441 178.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 55.5 mtt180 -81.88 147.14 29.47 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 123.322 0.649 . . . . 0.0 109.81 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.8 tt -123.19 136.61 59.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-O 121.155 0.502 . . . . 0.0 110.759 -176.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 90.7 m -131.69 121.17 23.83 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.887 177.055 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -109.44 121.05 5.96 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.444 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.409 HD21 HD11 ' A' ' 94' ' ' ILE . 3.3 mm? -109.86 145.19 37.21 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 120.769 0.318 . . . . 0.0 110.677 178.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -117.76 171.26 13.88 Favored Glycine 0 N--CA 1.42 -2.395 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.073 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -60.88 123.01 16.3 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.722 0.772 . . . . 0.0 112.406 -177.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.31 1.78 71.59 Favored Glycine 0 N--CA 1.429 -1.798 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.961 177.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.3 m -112.43 145.95 39.25 Favored 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -178.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 4.6 m -134.3 158.45 43.73 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.409 HD11 HD21 ' A' ' 88' ' ' LEU . 55.0 mt -94.16 129.39 44.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 170.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -70.36 -46.98 63.03 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 123.597 0.561 . . . . 0.0 110.444 -178.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.618 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 2.0 m-20 -138.48 101.16 4.29 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.38 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -65.24 -38.02 89.05 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-O 120.736 0.303 . . . . 0.0 110.983 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.6 t -65.44 -28.01 68.92 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.855 -177.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.618 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 27.1 mmtp -83.64 -5.98 59.32 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.424 0.631 . . . . 0.0 109.738 -177.276 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 18.6 m -82.67 -168.89 2.21 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.39 -61.11 7.45 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.136 -178.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -111.26 149.54 30.89 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 122.39 0.276 . . . . 0.0 110.68 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -111.65 -7.72 14.25 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.838 177.26 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -114.93 121.4 5.31 Favored Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.374 -176.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 67.6 mt -100.95 115.99 43.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-O 122.107 0.956 . . . . 0.0 109.083 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.5 m -85.94 -28.81 24.04 Favored 'General case' 0 N--CA 1.406 -2.638 0 CA-C-N 112.716 -2.038 . . . . 0.0 114.257 176.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.9 p -154.22 154.94 34.35 Favored 'General case' 0 C--O 1.237 0.433 0 O-C-N 122.063 -0.398 . . . . 0.0 110.024 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.8 mt -134.12 133.25 55.89 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.608 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -176.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.483 ' HD3' ' HB3' ' A' ' 121' ' ' CYS . 36.2 ttmt -117.11 126.07 52.26 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -95.92 127.96 42.4 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.45 0.643 . . . . 0.0 109.487 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' CYS . . . . . 0.425 ' SG ' ' HD1' ' A' ' 74' ' ' TYR . 59.7 m -121.94 168.62 11.69 Favored 'General case' 0 N--CA 1.402 -2.868 0 CA-C-N 114.869 -1.059 . . . . 0.0 108.676 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.7 pt -128.37 143.11 42.01 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 176.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -111.21 118.45 35.96 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 63.8 p -77.34 -178.66 5.27 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.485 -171.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -62.6 -36.63 83.36 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.943 174.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.477 ' OD2' ' HG2' ' A' ' 118' ' ' LYS . 2.5 p30 -78.46 -7.06 57.01 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.867 -176.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.0 -5.6 63.62 Favored Glycine 0 CA--C 1.496 -1.123 0 CA-C-N 115.776 -0.647 . . . . 0.0 113.859 173.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.477 ' HG2' ' OD2' ' A' ' 116' ' ' ASP . 6.4 ptpp? -77.66 146.9 35.81 Favored 'General case' 0 CA--C 1.493 -1.24 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.706 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 38.2 t -103.37 111.46 33.21 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -96.99 142.16 29.28 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' CYS . . . . . 0.483 ' HB3' ' HD3' ' A' ' 109' ' ' LYS . 73.2 m . . . . . 0 C--N 1.297 -1.692 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.139 -175.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.416 ' CD1' ' HB3' ' A' ' 71' ' ' PRO . 5.5 m-85 . . . . . 0 N--CA 1.473 0.685 0 CA-C-O 121.218 0.532 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 7.7 m -124.35 145.34 49.49 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.646 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 61.3 tp -100.12 128.68 46.16 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 176.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.556 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 47.8 mt-30 -118.87 123.95 45.94 Favored 'General case' 0 CA--C 1.492 -1.266 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.534 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.488 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.0 mp -110.76 122.85 48.84 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.881 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.411 ' CD2' ' HB3' ' A' ' 39' ' ' TYR . 93.3 m-85 -92.0 149.59 21.45 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 123.327 0.392 . . . . 0.0 110.304 -178.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.54 -35.24 63.12 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.095 0.474 . . . . 0.0 111.803 -177.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -108.41 178.05 4.61 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.462 HG22 ' HA ' ' A' ' 96' ' ' ASP . 2.3 p -82.26 170.68 15.11 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.26 21.5 p90 46.85 46.71 15.45 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.289 1.036 . . . . 0.0 113.394 178.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 59.55 23.34 12.02 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.954 1.302 . . . . 0.0 114.129 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -92.01 167.37 12.14 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.623 0.725 . . . . 0.0 111.847 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.16 -164.82 46.36 Favored Glycine 0 N--CA 1.426 -1.995 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.7 m -92.71 173.66 7.65 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 175.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.411 ' HB3' ' CD2' ' A' ' 30' ' ' TYR . 18.0 p90 -140.76 161.79 36.95 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.237 0.541 . . . . 0.0 110.129 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.556 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 17.4 tt -114.64 149.53 16.87 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -107.6 125.5 51.4 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 175.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.571 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 95.0 t -117.87 134.06 62.68 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -118.17 -20.97 8.41 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.442 0.639 . . . . 0.0 110.485 -174.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -136.42 162.56 32.7 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.226 -174.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.4 p -72.66 147.38 45.8 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.33 0.586 . . . . 0.0 112.209 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.8 p -122.43 132.14 71.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 176.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.72 -15.3 46.69 Favored Glycine 0 C--N 1.303 -1.297 0 C-N-CA 119.566 -1.302 . . . . 0.0 112.861 -177.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.9 p -155.71 123.35 5.6 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.416 0.627 . . . . 0.0 112.377 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.4 mt -114.34 118.88 35.13 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.348 177.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 19.3 m -132.48 110.61 13.7 Favored Pre-proline 0 C--N 1.303 -1.432 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.837 175.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 5.1 Cg_exo -77.4 161.94 91.56 Favored 'Cis proline' 0 C--O 1.244 0.797 0 C-N-CA 123.229 -1.571 . . . . 0.0 110.927 0.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.07 158.38 30.25 Favored 'Trans proline' 0 C--O 1.25 1.092 0 C-N-CA 122.526 2.15 . . . . 0.0 110.988 177.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 46.9 m0 -89.67 139.13 30.86 Favored 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.089 -177.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 15.4 p -119.34 78.85 19.61 Favored Pre-proline 0 C--N 1.29 -1.993 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.15 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.488 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 93.0 Cg_endo -79.18 157.59 26.39 Favored 'Trans proline' 0 N--CA 1.44 -1.648 0 C-N-CA 121.782 1.655 . . . . 0.0 112.257 176.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -93.73 -27.98 11.93 Favored Glycine 0 N--CA 1.428 -1.878 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 176.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.4 p -153.57 150.94 29.2 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.5 t -123.11 142.84 38.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 15.5 t -142.98 137.71 29.54 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -177.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.9 t -121.43 119.02 29.58 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -65.2 137.41 51.78 Favored 'Trans proline' 0 C--O 1.241 0.673 0 C-N-CA 123.036 2.491 . . . . 0.0 113.136 -178.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -71.78 121.75 19.47 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.25 178.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 86.7 t -95.01 115.0 32.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 176.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -103.12 70.17 1.06 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -126.22 145.3 50.45 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -172.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.4 m -58.66 -24.83 62.0 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.436 -1.257 . . . . 0.0 109.807 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.461 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 4.3 mptp? -53.09 134.31 38.51 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.563 -177.07 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 50.9 mtp180 -68.51 -27.99 66.61 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -172.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -106.49 128.03 53.77 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.928 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -104.89 147.01 33.76 Favored Pre-proline 0 C--N 1.284 -2.24 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 171.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.416 ' HB3' ' CD1' ' A' ' 25' ' ' TYR . 93.3 Cg_endo -77.52 135.24 14.53 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.748 1.632 . . . . 0.0 112.522 -177.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -129.35 141.27 51.12 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.646 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 90.0 m95 -122.81 132.11 54.06 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -173.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.489 ' HD2' ' SG ' ' A' ' 111' ' ' CYS . 28.0 m-85 -114.37 142.76 45.92 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.108 176.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.7 mt -125.5 142.37 51.54 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 -175.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 92.0 m-85 -130.54 139.79 50.47 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.575 0.703 . . . . 0.0 111.21 -176.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.599 ' HB2' ' CD1' ' A' ' 102' ' ' PHE . 0.8 OUTLIER -81.89 -10.59 59.25 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.314 -178.876 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -135.69 156.92 48.08 Favored 'General case' 0 N--CA 1.416 -2.136 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.823 174.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.506 ' HA ' ' HB2' ' A' ' 107' ' ' SER . 21.5 m -65.3 161.45 3.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.967 -176.372 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.9 m120 61.52 30.57 18.81 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.199 0.523 . . . . 0.0 111.278 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 57.57 41.85 25.1 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 124.335 1.054 . . . . 0.0 111.333 176.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 77.9 p -112.35 176.35 5.05 Favored 'General case' 0 C--O 1.252 1.203 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.674 178.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.93 -137.79 18.42 Favored Glycine 0 N--CA 1.424 -2.152 0 N-CA-C 111.761 -0.535 . . . . 0.0 111.761 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.438 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . 53.3 mtt180 -82.72 150.21 26.85 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -177.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.0 tt -128.44 137.31 57.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 O-C-N 123.622 0.576 . . . . 0.0 110.594 -174.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 57.1 m -132.43 124.07 27.91 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 122.231 -0.293 . . . . 0.0 110.319 174.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -115.0 113.43 2.95 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.622 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.42 HD21 HD11 ' A' ' 94' ' ' ILE . 2.4 mm? -106.48 145.63 31.56 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 122.994 0.518 . . . . 0.0 111.285 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -110.33 164.61 12.25 Favored Glycine 0 N--CA 1.427 -1.966 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.625 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -64.03 122.15 15.86 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 123.29 0.636 . . . . 0.0 110.994 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.56 16.94 51.17 Favored Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.525 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.4 m -135.69 146.03 47.34 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 175.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 21.7 m -143.96 157.08 44.57 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.42 HD11 HD21 ' A' ' 88' ' ' LEU . 61.7 mt -94.45 135.21 29.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -70.81 -47.43 59.48 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.525 0.678 . . . . 0.0 110.483 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.462 ' HA ' HG22 ' A' ' 33' ' ' THR . 5.7 m-20 -136.51 100.77 4.45 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.995 -177.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.456 ' CD2' ' HG2' ' A' ' 55' ' ' PRO . 62.6 t80 -64.2 -29.53 70.63 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.259 0.552 . . . . 0.0 110.796 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.9 t -62.91 -18.78 63.49 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.694 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -94.75 -8.96 36.11 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 122.152 -0.343 . . . . 0.0 110.416 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 26.9 t -85.24 28.82 0.7 Allowed 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.772 0.829 . . . . 0.0 110.798 -177.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.88 -70.84 1.78 Allowed Glycine 0 N--CA 1.432 -1.626 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.054 177.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.599 ' CD1' ' HB2' ' A' ' 77' ' ' ASP . 27.0 p90 -110.41 149.42 30.29 Favored 'General case' 0 C--N 1.29 -1.991 0 O-C-N 122.784 -0.245 . . . . 0.0 110.356 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -114.24 -10.09 12.77 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.681 177.0 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -109.18 99.7 1.28 Allowed Glycine 0 N--CA 1.433 -1.552 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.897 -175.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 69.2 mt -87.05 115.17 27.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-O 122.551 1.167 . . . . 0.0 107.964 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 27.8 m -85.94 -23.97 26.75 Favored 'General case' 0 C--N 1.249 -3.763 0 CA-C-N 112.337 -2.21 . . . . 0.0 113.764 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.506 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 9.3 t -158.48 153.45 25.17 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -176.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.2 mt -137.29 130.32 43.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -178.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.559 ' HD2' ' SG ' ' A' ' 121' ' ' CYS . 24.7 ttmt -117.64 133.48 55.9 Favored 'General case' 0 C--N 1.3 -1.543 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -100.47 127.81 46.71 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -177.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' CYS . . . . . 0.489 ' SG ' ' HD2' ' A' ' 74' ' ' TYR . 29.6 m -119.38 168.3 11.08 Favored 'General case' 0 N--CA 1.417 -2.117 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -176.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.7 pt -127.38 140.29 49.52 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.525 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -112.79 119.08 36.79 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 63.3 p -79.17 177.37 8.87 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.254 -175.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.1 ttpp -66.32 -20.19 66.02 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.572 0.701 . . . . 0.0 109.421 176.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -78.77 -8.34 58.66 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.813 0.816 . . . . 0.0 109.953 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.68 -11.57 68.16 Favored Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.386 176.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -71.82 139.01 48.75 Favored 'General case' 0 C--O 1.253 1.25 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.65 112.27 37.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -104.6 152.7 22.12 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' CYS . . . . . 0.559 ' SG ' ' HD2' ' A' ' 109' ' ' LYS . 0.9 OUTLIER . . . . . 0 C--N 1.287 -2.119 0 C-N-CA 118.626 -1.23 . . . . 0.0 110.575 -175.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 . . . . . 0 C--O 1.243 0.719 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.411 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 12.0 m -125.54 154.79 41.62 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.604 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 54.4 tp -112.26 122.69 48.43 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 171.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.525 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 78.7 mt-30 -116.04 124.88 51.57 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.759 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 3.6 mp -109.51 126.01 53.09 Favored 'General case' 0 N--CA 1.415 -2.204 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.129 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.417 ' CD1' ' HB3' ' A' ' 39' ' ' TYR . 98.1 m-85 -94.55 147.94 22.76 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 123.783 0.677 . . . . 0.0 110.914 -176.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -72.5 -38.58 68.09 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.979 -177.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -109.74 178.12 4.52 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.407 HG22 ' HA ' ' A' ' 96' ' ' ASP . 6.0 p -79.09 172.63 13.54 Favored 'General case' 0 N--CA 1.422 -1.872 0 C-N-CA 121.507 -0.077 . . . . 0.0 111.026 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.544 ' CE1' ' HG3' ' A' ' 36' ' ' ARG 0.261 31.6 p90 46.56 42.25 10.88 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 176.777 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 67.94 28.89 6.75 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.984 0.914 . . . . 0.0 112.788 176.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.544 ' HG3' ' CE1' ' A' ' 34' ' ' TYR . 23.7 mmt180 -107.06 172.13 6.99 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-O 121.501 0.667 . . . . 0.0 112.249 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.4 -159.88 39.32 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -177.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.0 m -89.66 179.57 5.99 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 172.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 21.8 p90 -149.42 162.92 39.14 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.525 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 15.6 tt -118.09 151.97 20.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.232 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -107.34 125.92 51.8 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 175.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.551 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 93.0 t -117.67 133.96 62.77 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 176.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -117.59 -29.47 5.76 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 120.994 0.426 . . . . 0.0 110.313 -176.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.09 154.91 47.77 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.838 -177.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.2 m -60.31 145.8 46.32 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 123.527 0.731 . . . . 0.0 111.935 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.5 p -120.84 139.04 49.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 176.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.12 -20.31 30.88 Favored Glycine 0 C--N 1.299 -1.484 0 C-N-CA 119.604 -1.284 . . . . 0.0 112.804 -176.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.3 p -157.72 131.14 7.76 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 120.961 0.41 . . . . 0.0 111.789 -176.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.58 117.22 23.82 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 175.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 13.9 t -133.6 113.0 12.9 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.403 176.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 8.1 Cg_exo -75.56 161.23 94.86 Favored 'Cis proline' 0 C--O 1.246 0.924 0 C-N-CA 123.191 -1.587 . . . . 0.0 111.206 -0.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -61.71 158.87 35.29 Favored 'Trans proline' 0 C--O 1.245 0.859 0 C-N-CA 122.986 2.457 . . . . 0.0 111.312 178.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 48.0 m0 -88.56 137.5 32.27 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 5.4 p -117.59 75.53 9.51 Favored Pre-proline 0 C--N 1.292 -1.905 0 O-C-N 123.31 0.381 . . . . 0.0 111.601 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.437 ' HG2' ' CD2' ' A' ' 97' ' ' PHE . 69.8 Cg_endo -74.35 157.94 45.07 Favored 'Trans proline' 0 C--N 1.359 1.12 0 C-N-CA 122.859 2.373 . . . . 0.0 112.875 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.25 -28.67 14.22 Favored Glycine 0 N--CA 1.436 -1.307 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.3 p -156.1 151.67 27.03 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.5 t -128.45 142.4 43.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 35.8 t -145.84 150.06 35.45 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.515 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.6 t -113.58 123.28 33.41 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 175.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.411 ' HD2' ' O ' ' A' ' 26' ' ' CYS . 10.3 Cg_endo -57.27 140.6 93.42 Favored 'Trans proline' 0 C--O 1.247 0.935 0 C-N-CA 122.552 2.168 . . . . 0.0 111.505 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.431 ' CE1' ' HB2' ' A' ' 64' ' ' ASN . 82.1 t80 -74.09 109.54 7.66 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-O 121.385 0.612 . . . . 0.0 110.681 -177.419 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.442 ' H ' ' HB2' ' A' ' 90' ' ' HIS . 49.1 t -94.19 114.17 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.566 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.431 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 27.0 t-20 -112.75 88.92 2.94 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 172.254 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.466 ' OD1' ' HG2' ' A' ' 67' ' ' LYS . 3.8 t70 -127.31 145.81 50.66 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.62 -171.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.9 m -62.93 -6.93 4.3 Favored 'General case' 0 CA--C 1.569 1.71 0 C-N-CA 124.444 1.098 . . . . 0.0 111.157 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.466 ' HG2' ' OD1' ' A' ' 65' ' ' ASP . 75.8 mmtt -61.28 153.95 25.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 171.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.543 ' HB2' ' OE2' ' A' ' 69' ' ' GLU . 45.5 mtm180 -89.17 -28.65 19.87 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.733 -177.033 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.543 ' OE2' ' HB2' ' A' ' 68' ' ' ARG . 9.7 mp0 -105.37 128.9 53.74 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.435 -177.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -102.52 153.96 37.78 Favored Pre-proline 0 C--N 1.291 -1.968 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 176.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -80.58 141.39 13.85 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.467 1.445 . . . . 0.0 112.476 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -133.22 138.15 46.4 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.604 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 84.3 m95 -120.27 136.91 54.51 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.755 -0.59 . . . . 0.0 112.301 -173.114 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 86' ' ' THR . 37.1 m-85 -116.74 143.29 45.84 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.678 177.309 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.8 mt -125.96 142.78 51.36 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 -176.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -133.62 141.71 47.77 Favored 'General case' 0 C--O 1.244 0.794 0 O-C-N 123.625 0.578 . . . . 0.0 109.974 -177.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.65 -5.46 59.31 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.918 -177.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -131.76 162.25 30.94 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 175.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 25.2 m -73.15 167.38 2.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 C-N-CA 122.395 0.278 . . . . 0.0 110.794 -176.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.9 m120 57.54 30.2 18.34 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.646 0.778 . . . . 0.0 111.968 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.564 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 11.5 m-85 60.1 40.22 18.7 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.401 1.08 . . . . 0.0 111.523 176.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.0 p -111.98 171.28 7.59 Favored 'General case' 0 C--O 1.25 1.095 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.95 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.69 -135.77 13.25 Favored Glycine 0 N--CA 1.427 -1.913 0 C-N-CA 120.881 -0.675 . . . . 0.0 112.105 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -83.48 155.53 23.33 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 123.025 0.53 . . . . 0.0 109.605 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.4 tt -131.66 136.69 56.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 121.318 0.58 . . . . 0.0 110.066 -175.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 76.1 m -132.09 127.62 36.45 Favored 'General case' 0 C--N 1.288 -2.103 0 O-C-N 122.021 -0.424 . . . . 0.0 110.359 175.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -111.1 124.82 7.08 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.81 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.45 HD21 HD11 ' A' ' 94' ' ' ILE . 2.9 mm? -117.76 145.39 44.52 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 123.576 0.751 . . . . 0.0 110.618 177.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -117.3 169.26 13.09 Favored Glycine 0 N--CA 1.433 -1.523 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.92 -178.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.442 ' HB2' ' H ' ' A' ' 63' ' ' VAL . 35.9 p-80 -61.13 122.13 14.24 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.449 0.642 . . . . 0.0 112.323 -177.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.56 -1.63 76.05 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.568 177.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.5 m -107.42 146.12 32.1 Favored 'General case' 0 N--CA 1.424 -1.73 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.7 m -137.68 154.51 49.67 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.45 HD11 HD21 ' A' ' 88' ' ' LEU . 50.7 mt -93.49 128.11 45.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 173.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -70.92 -47.54 58.54 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.108 0.48 . . . . 0.0 110.984 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.667 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 3.4 m-20 -132.72 88.87 2.56 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.927 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.437 ' CD2' ' HG2' ' A' ' 55' ' ' PRO . 50.7 t80 -65.47 -30.25 71.01 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.778 0.799 . . . . 0.0 109.666 176.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.2 t -66.91 -24.45 66.1 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.463 -178.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.667 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 30.0 mmtp -93.99 -6.78 44.57 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -178.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 26.6 m -79.73 -171.85 3.04 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.46 -64.89 3.97 Favored Glycine 0 CA--C 1.503 -0.702 0 N-CA-C 112.094 -0.403 . . . . 0.0 112.094 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -110.94 146.74 36.05 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.193 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.558 ' H ' ' HD3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -113.42 -6.54 13.49 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 175.867 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -112.55 119.18 4.86 Favored Glycine 0 N--CA 1.431 -1.648 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.457 -177.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 64.9 mt -103.06 115.41 44.99 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.763 0 CA-C-O 122.426 1.107 . . . . 0.0 109.476 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 37.8 m -85.73 -29.6 23.78 Favored 'General case' 0 N--CA 1.394 -3.248 0 CA-C-N 112.148 -2.297 . . . . 0.0 113.999 177.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.6 p -153.88 154.61 34.2 Favored 'General case' 0 C--O 1.237 0.42 0 O-C-N 121.862 -0.524 . . . . 0.0 109.965 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.8 mt -133.22 131.45 58.24 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -176.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.564 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 38.2 ttmt -117.51 128.33 54.87 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -95.67 129.58 42.83 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 68.4 m -122.56 171.72 8.91 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.357 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.1 pt -129.41 139.3 52.08 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 176.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -110.56 118.87 37.38 Favored 'General case' 0 C--N 1.274 -2.714 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 72.9 p -69.15 170.23 10.48 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.462 -176.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.2 ttpp -67.06 -19.54 65.69 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.635 0.731 . . . . 0.0 109.276 176.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -84.92 -8.17 58.87 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.744 -177.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.21 -10.62 65.54 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.78 -0.646 . . . . 0.0 114.133 175.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -78.32 138.38 38.54 Favored 'General case' 0 C--O 1.249 1.031 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.902 179.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.3 t -102.31 113.35 38.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -95.49 133.86 39.0 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.75 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 63.6 m . . . . . 0 C--N 1.287 -2.118 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -177.777 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.463 ' CZ ' ' HD3' ' A' ' 71' ' ' PRO . 14.5 m-85 . . . . . 0 CA--C 1.509 -0.603 0 CA-C-O 121.5 0.666 . . . . 0.0 110.694 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 18.5 m -123.12 145.32 48.68 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.591 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 49.7 tp -94.56 124.93 38.88 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 176.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.479 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 88.5 mt-30 -117.42 124.19 48.24 Favored 'General case' 0 N--CA 1.42 -1.929 0 CA-C-O 121.368 0.604 . . . . 0.0 109.469 -177.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.498 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 3.6 mp -109.68 125.65 52.85 Favored 'General case' 0 N--CA 1.421 -1.904 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.73 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.504 ' HA ' ' O ' ' A' ' 38' ' ' SER . 85.6 m-85 -95.24 152.31 18.48 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 123.393 0.433 . . . . 0.0 111.464 -176.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.89 -47.56 65.53 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.378 -177.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -108.17 178.4 4.51 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.781 -176.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.455 HG22 ' HA ' ' A' ' 96' ' ' ASP . 2.4 p -77.02 166.29 23.5 Favored 'General case' 0 N--CA 1.403 -2.799 0 O-C-N 123.28 0.362 . . . . 0.0 110.295 -176.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.408 ' CE2' ' HD3' ' A' ' 36' ' ' ARG 0.262 20.9 p90 47.21 47.59 16.41 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 177.704 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 65.51 22.19 11.82 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.391 1.076 . . . . 0.0 112.19 176.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.408 ' HD3' ' CE2' ' A' ' 34' ' ' TYR . 55.1 mtp180 -91.29 160.17 15.65 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.509 0.671 . . . . 0.0 112.63 178.521 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.35 -148.0 20.42 Favored Glycine 0 N--CA 1.433 -1.542 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -176.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 17.2 m -111.77 -176.65 2.99 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 177.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 23.4 p90 -143.31 163.15 33.81 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.23 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 15.3 tt -114.35 152.18 16.04 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 177.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -106.84 125.54 51.14 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 87.5 t -120.1 133.18 67.68 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -115.68 -31.72 5.74 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.487 0.66 . . . . 0.0 109.518 -174.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.47 161.89 29.37 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.321 -176.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.4 p -69.01 146.38 52.75 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 123.623 0.769 . . . . 0.0 112.67 -176.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.0 p -121.82 135.65 61.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.9 -18.11 41.58 Favored Glycine 0 N--CA 1.431 -1.687 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.955 -178.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.5 p -158.92 116.66 2.84 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.405 0.621 . . . . 0.0 112.593 -178.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.9 mt -105.19 116.91 32.74 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.431 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.2 m -133.58 114.75 13.37 Favored Pre-proline 0 N--CA 1.42 -1.962 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 172.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -73.99 162.12 92.91 Favored 'Cis proline' 0 C--O 1.248 0.995 0 C-N-CA 123.315 -1.536 . . . . 0.0 110.946 -0.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.54 155.36 66.92 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.914 1.743 . . . . 0.0 109.931 177.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -89.61 133.43 34.62 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.588 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 22.6 p -116.85 77.22 8.41 Favored Pre-proline 0 C--N 1.298 -1.643 0 O-C-N 123.523 0.514 . . . . 0.0 111.759 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.408 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 97.2 Cg_endo -80.29 158.2 22.93 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.66 2.24 . . . . 0.0 113.012 178.023 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -89.28 -29.57 16.69 Favored Glycine 0 N--CA 1.437 -1.247 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 177.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.0 p -155.25 154.46 32.2 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.0 t -129.16 143.22 41.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 38.6 t -145.58 149.88 35.37 Favored 'General case' 0 N--CA 1.428 -1.558 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.732 176.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.6 t -116.55 123.81 30.14 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 175.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -60.81 149.04 90.11 Favored 'Trans proline' 0 C--O 1.252 1.18 0 C-N-CA 122.798 2.332 . . . . 0.0 112.321 -177.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.547 ' CE2' ' HB3' ' A' ' 64' ' ' ASN . 79.5 t80 -76.14 110.12 10.36 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 121.825 0.821 . . . . 0.0 111.058 -177.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.442 ' H ' ' HB2' ' A' ' 90' ' ' HIS . 66.3 t -94.54 116.31 35.52 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.778 177.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.547 ' HB3' ' CE2' ' A' ' 62' ' ' PHE . 3.7 p-10 -119.28 24.58 10.65 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 122.35 1.071 . . . . 0.0 108.62 178.097 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -67.93 146.58 53.47 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 113.363 -1.744 . . . . 0.0 111.93 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.2 m -58.71 -8.64 1.37 Allowed 'General case' 0 CA--C 1.57 1.749 0 C-N-CA 125.141 1.377 . . . . 0.0 112.768 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -62.62 138.57 58.52 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -69.21 -29.41 67.37 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.468 0.48 . . . . 0.0 111.509 -173.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -112.02 135.65 52.38 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-O 121.63 0.729 . . . . 0.0 111.612 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.86 148.35 36.36 Favored Pre-proline 0 C--N 1.285 -2.204 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.394 176.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.463 ' HD3' ' CZ ' ' A' ' 25' ' ' TYR . 71.2 Cg_endo -71.59 137.87 31.14 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 121.995 1.797 . . . . 0.0 112.928 -175.207 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -131.29 123.38 28.22 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.591 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 83.6 m95 -108.55 135.76 49.28 Favored 'General case' 0 C--N 1.281 -2.388 0 O-C-N 122.098 -0.376 . . . . 0.0 111.996 -172.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' A' ' 86' ' ' THR . 41.6 m-85 -113.89 141.91 46.76 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.554 177.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.403 HD21 HD21 ' A' ' 27' ' ' LEU . 22.6 mt -125.35 142.59 51.41 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 -176.021 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.448 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 84.7 m-85 -131.49 139.72 49.38 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 121.197 0.522 . . . . 0.0 111.178 -175.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.13 -12.85 59.14 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.891 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -123.76 165.76 16.74 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 175.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.7 m -77.14 167.47 2.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 118.036 0.38 . . . . 0.0 110.822 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 60.51 30.96 20.16 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.667 0.787 . . . . 0.0 111.942 177.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.431 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 5.8 m-85 61.92 40.37 12.56 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.799 175.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.8 p -117.49 176.07 5.34 Favored 'General case' 0 C--O 1.25 1.086 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.629 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.57 -134.03 12.26 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 178.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 52.2 mtm180 -84.38 147.78 26.96 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 122.45 0.3 . . . . 0.0 110.431 176.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.9 tt -124.77 139.24 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 O-C-N 123.654 0.596 . . . . 0.0 110.108 -176.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 67.6 m -131.84 126.44 34.29 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 175.031 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -111.55 122.12 5.97 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.776 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.466 HD21 HD11 ' A' ' 94' ' ' ILE . 3.7 mm? -112.69 145.07 41.13 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 120.835 0.35 . . . . 0.0 111.041 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -117.06 168.32 12.8 Favored Glycine 0 N--CA 1.424 -2.121 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.705 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.442 ' HB2' ' H ' ' A' ' 63' ' ' VAL . 7.2 p80 -59.72 123.87 18.32 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.335 0.588 . . . . 0.0 111.83 -178.204 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.08 2.78 77.17 Favored Glycine 0 N--CA 1.43 -1.758 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.387 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.1 m -113.19 145.66 40.61 Favored 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 4.6 m -134.8 158.84 43.14 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.466 HD11 HD21 ' A' ' 88' ' ' LEU . 46.3 mt -93.65 131.94 39.21 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 173.022 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -70.21 -47.67 60.44 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.276 0.56 . . . . 0.0 109.903 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.59 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 3.2 m-20 -138.25 100.95 4.26 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -64.77 -36.5 84.53 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.404 0.621 . . . . 0.0 110.422 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.3 t -64.45 -23.76 67.39 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.965 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.59 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 28.2 mmtp -91.99 -7.64 48.35 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 122.147 -0.346 . . . . 0.0 110.413 -178.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.2 m -78.12 -13.93 59.67 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.687 0.756 . . . . 0.0 109.872 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 132.14 -85.16 0.29 Allowed Glycine 0 N--CA 1.42 -2.385 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -86.89 141.9 28.42 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 120.542 -0.463 . . . . 0.0 109.924 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.588 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.52 -8.39 13.35 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.853 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -108.15 109.15 2.84 Favored Glycine 0 N--CA 1.432 -1.614 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.989 -176.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 66.5 mt -91.64 116.06 32.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 122.336 1.065 . . . . 0.0 109.053 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.9 m -85.85 -28.63 24.3 Favored 'General case' 0 N--CA 1.401 -2.923 0 CA-C-N 112.445 -2.161 . . . . 0.0 114.816 177.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.4 p -156.13 157.36 35.86 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.7 mt -137.48 131.47 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -175.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.431 ' HE2' ' CD2' ' A' ' 81' ' ' TYR . 37.6 ttmt -117.66 133.64 55.74 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -101.27 121.88 42.67 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 120.615 -0.434 . . . . 0.0 109.932 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 65.9 m -119.85 172.14 7.92 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 8.4 pt -127.61 143.22 41.4 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.031 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -115.12 120.49 39.97 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 177.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 82.8 p -79.6 176.49 9.66 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.424 -173.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -65.16 -26.85 68.35 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.119 172.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -76.91 -8.71 57.86 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 122.051 0.929 . . . . 0.0 110.211 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.07 -11.54 70.48 Favored Glycine 0 CA--C 1.498 -1.016 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.772 175.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -73.31 141.03 47.14 Favored 'General case' 0 C--O 1.257 1.448 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.889 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 22.6 t -102.13 118.71 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.814 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 177.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -104.3 140.4 37.92 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 69.9 m . . . . . 0 C--N 1.297 -1.704 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.384 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 . . . . . 0 N--CA 1.482 1.175 0 CA-C-O 121.437 0.637 . . . . 0.0 111.543 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.0 m -123.68 145.92 48.62 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.199 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.571 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 57.8 tp -100.03 114.13 27.22 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 175.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 44.8 mt-30 -108.26 124.49 50.38 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.704 -0.798 . . . . 0.0 108.848 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.4 mp -109.41 127.38 54.34 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.032 177.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -94.06 150.37 20.4 Favored 'General case' 0 C--N 1.29 -1.989 0 O-C-N 123.509 0.506 . . . . 0.0 110.148 -176.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -69.88 -43.27 72.17 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 124.055 0.847 . . . . 0.0 109.651 -175.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -114.08 178.88 4.12 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.033 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.441 HG22 ' HA ' ' A' ' 96' ' ' ASP . 2.6 p -74.91 169.72 17.39 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.119 -176.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.456 ' CE2' ' HG3' ' A' ' 36' ' ' ARG 0.258 13.8 p90 47.17 40.16 9.55 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.959 1.304 . . . . 0.0 114.01 177.771 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 62.2 40.43 11.65 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.147 0.979 . . . . 0.0 111.947 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.539 ' HA ' ' NE ' ' A' ' 36' ' ' ARG . 4.3 mmp_? -108.61 162.23 14.34 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.223 0.535 . . . . 0.0 112.162 178.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.26 -163.05 42.72 Favored Glycine 0 N--CA 1.426 -1.967 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -177.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.0 p -89.34 173.84 8.15 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 176.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -140.77 166.01 25.94 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -177.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.8 tt -116.9 152.08 18.69 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 177.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -106.75 125.57 51.18 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 175.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.494 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 97.8 t -122.41 133.04 69.86 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.489 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -119.32 -24.49 6.37 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.709 -177.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -115.46 163.14 16.17 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.98 -172.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.9 m -83.1 142.43 31.27 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 176.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.9 p -120.97 129.67 75.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.68 -12.13 59.76 Favored Glycine 0 N--CA 1.432 -1.567 0 C-N-CA 119.672 -1.252 . . . . 0.0 113.795 -178.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 24.4 p -157.7 122.27 4.31 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.279 0.562 . . . . 0.0 112.409 -178.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 72.8 mt -117.82 117.87 30.47 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 175.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 12.3 p -132.46 109.45 13.52 Favored Pre-proline 0 C--N 1.29 -1.991 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.959 176.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 72.4 Cg_endo -75.34 162.06 93.38 Favored 'Cis proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.704 -1.373 . . . . 0.0 111.408 -1.315 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.76 156.77 59.8 Favored 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 121.975 1.784 . . . . 0.0 111.152 178.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 48.0 m0 -89.27 131.89 35.16 Favored 'General case' 0 CA--C 1.482 -1.668 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.623 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 38.8 p -114.46 78.53 4.86 Favored Pre-proline 0 N--CA 1.43 -1.425 0 O-C-N 123.56 0.537 . . . . 0.0 110.712 178.018 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.417 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 88.4 Cg_endo -78.21 157.63 29.92 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 122.523 2.149 . . . . 0.0 112.566 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -89.59 -30.85 12.39 Favored Glycine 0 N--CA 1.431 -1.651 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 177.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.2 p -153.25 158.25 41.39 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.9 t -136.87 142.67 37.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -177.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 49.4 t -145.95 147.82 32.12 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.691 176.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.1 t -118.73 124.27 28.52 Favored Pre-proline 0 N--CA 1.441 -0.923 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 175.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -63.03 148.66 93.19 Favored 'Trans proline' 0 C--O 1.247 0.971 0 C-N-CA 122.399 2.066 . . . . 0.0 112.062 -178.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -70.96 119.88 15.73 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-O 121.85 0.833 . . . . 0.0 110.249 -178.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.451 ' H ' ' HB2' ' A' ' 90' ' ' HIS . 93.1 t -95.83 123.35 47.99 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.349 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -116.09 14.96 16.09 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 122.143 0.973 . . . . 0.0 108.617 -178.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.4 ' HB3' ' HG2' ' A' ' 67' ' ' LYS . 1.9 m-20 -64.13 145.54 55.77 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 113.519 -1.673 . . . . 0.0 113.717 -175.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.7 m -64.19 -12.42 40.32 Favored 'General case' 0 C--O 1.255 1.372 0 C-N-CA 125.285 1.434 . . . . 0.0 110.981 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.4 ' HG2' ' HB3' ' A' ' 65' ' ' ASP . 73.3 mmtt -59.67 141.33 55.29 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.41 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -78.02 -29.86 49.68 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.629 0.728 . . . . 0.0 109.803 -177.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.411 ' HB2' ' HB ' ' A' ' 112' ' ' ILE . 0.4 OUTLIER -107.37 129.85 54.87 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.686 -179.873 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.76 154.14 39.52 Favored Pre-proline 0 C--N 1.286 -2.159 0 CA-C-N 114.616 -1.174 . . . . 0.0 109.237 -178.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -74.08 134.41 19.46 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 121.578 1.519 . . . . 0.0 111.066 -178.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -129.42 128.51 43.12 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 106.309 -1.738 . . . . 0.0 106.309 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.571 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 87.1 m95 -110.38 130.43 55.55 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-O 121.175 0.512 . . . . 0.0 111.565 -173.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.48 ' HA ' ' O ' ' A' ' 86' ' ' THR . 25.3 m-85 -111.19 142.26 43.62 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.359 176.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.3 mt -125.36 142.14 51.67 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 -176.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.427 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 87.2 m-85 -131.42 139.31 49.38 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.112 0.482 . . . . 0.0 110.814 -175.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.678 ' HB2' ' CD1' ' A' ' 102' ' ' PHE . 5.7 t70 -77.68 -18.06 57.03 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.295 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.454 ' C ' ' HB3' ' A' ' 106' ' ' SER . 9.0 t-20 -126.03 162.38 25.42 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 176.013 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.3 m -67.78 168.12 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.58 0 C-N-CA 123.076 0.551 . . . . 0.0 111.434 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.7 m120 55.26 30.22 14.28 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.827 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.53 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 13.3 m-85 60.03 45.9 11.49 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.799 1.239 . . . . 0.0 111.749 175.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.8 p -118.94 176.35 5.33 Favored 'General case' 0 C--O 1.249 1.041 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.462 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.87 -133.77 12.16 Favored Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 121.218 -0.515 . . . . 0.0 111.973 177.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 63.9 mtt85 -81.67 148.07 29.2 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.157 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.9 tt -129.16 137.2 57.71 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 O-C-N 123.62 0.575 . . . . 0.0 110.424 -175.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 95.7 m -130.97 122.71 27.35 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -111.19 109.68 2.6 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.713 -0.756 . . . . 0.0 114.629 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -103.07 145.07 30.45 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 122.816 0.446 . . . . 0.0 110.95 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.13 175.9 16.1 Favored Glycine 0 N--CA 1.425 -2.063 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.473 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.451 ' HB2' ' H ' ' A' ' 63' ' ' VAL . 10.0 p80 -66.08 122.13 16.72 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.532 0.682 . . . . 0.0 112.194 -176.333 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.72 0.95 71.51 Favored Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.623 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.0 m -106.59 146.31 30.84 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 5.6 m -136.07 151.37 49.77 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.8 mt -93.51 127.22 45.71 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 174.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -70.51 -47.27 61.26 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.387 0.613 . . . . 0.0 110.48 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.622 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 2.1 m-20 -135.33 93.63 3.01 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.071 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -65.14 -33.69 76.61 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.202 0.525 . . . . 0.0 110.391 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.8 t -65.26 -23.91 67.17 Favored 'General case' 0 CA--C 1.559 1.318 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.136 -176.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.622 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 30.2 mmtp -92.75 -6.4 49.15 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.941 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.2 m -84.9 38.69 0.72 Allowed 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.344 0.592 . . . . 0.0 111.535 -175.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.88 -73.98 2.25 Favored Glycine 0 N--CA 1.426 -2.028 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.678 ' CD1' ' HB2' ' A' ' 77' ' ' ASP . 16.1 p90 -109.81 148.28 31.77 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -179.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.623 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -113.54 -8.03 13.36 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 120.114 -0.635 . . . . 0.0 109.647 179.196 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -113.31 112.65 2.96 Favored Glycine 0 N--CA 1.432 -1.604 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.351 -174.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 76.1 mt -94.26 115.41 33.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.454 ' HB3' ' C ' ' A' ' 78' ' ' ASN . 3.7 t -86.06 -26.42 25.35 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.947 178.109 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.5 p -152.08 157.22 41.31 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 122.089 -0.382 . . . . 0.0 110.935 177.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.3 mt -135.9 133.2 50.95 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -175.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.53 ' HE2' ' CD2' ' A' ' 81' ' ' TYR . 33.5 ttmt -122.02 128.34 51.32 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -96.3 121.39 38.04 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 60.6 m -119.16 172.09 7.82 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.411 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 6.9 pt -126.17 139.51 51.36 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 CA-C-O 121.127 0.489 . . . . 0.0 110.147 177.66 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -112.2 119.06 37.08 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 76.6 p -72.35 -178.55 2.57 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 114.636 -1.166 . . . . 0.0 112.059 -174.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -65.72 -31.05 71.83 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.785 0.803 . . . . 0.0 109.173 175.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -79.46 -8.95 59.48 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.652 -178.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.58 -9.32 77.98 Favored Glycine 0 N--CA 1.427 -1.928 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.787 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -70.01 139.32 52.72 Favored 'General case' 0 C--O 1.255 1.36 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.2 t -102.82 112.91 37.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 121.174 0.512 . . . . 0.0 109.761 -176.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -97.17 135.17 39.5 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.483 -1.634 0 C-N-CA 118.505 -1.278 . . . . 0.0 111.221 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.392 0 N-CA-C 111.746 -0.542 . . . . 0.0 111.746 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.77 41.16 1.13 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 122.086 0.946 . . . . 0.0 109.199 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -77.86 -19.49 54.75 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.452 -1.249 . . . . 0.0 113.37 -174.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.7 m -118.6 146.66 44.45 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 122.104 -0.372 . . . . 0.0 111.598 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 30.0 p -123.0 155.71 36.27 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 174.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -100.43 125.55 46.72 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -175.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 64.76 71.51 0.46 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.019 0.927 . . . . 0.0 112.217 -177.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.7 m -144.76 167.76 21.82 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.626 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 59.6 tp -111.96 124.63 52.8 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 169.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 70.5 mt-30 -113.72 124.37 52.13 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.555 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.443 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 3.2 mp -109.84 129.08 55.68 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.015 176.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.444 ' HB3' ' O ' ' A' ' 36' ' ' ARG . 94.9 m-85 -99.59 148.88 23.84 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 123.832 0.708 . . . . 0.0 110.852 -174.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -70.37 -38.1 74.69 Favored 'General case' 0 C--N 1.307 -1.249 0 O-C-N 123.663 0.602 . . . . 0.0 111.275 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -107.98 177.66 4.74 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -177.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.427 HG22 ' HA ' ' A' ' 96' ' ' ASP . 2.6 p -84.28 175.53 9.34 Favored 'General case' 0 N--CA 1.407 -2.612 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.274 15.5 p90 47.29 42.3 13.47 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 177.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 66.82 23.06 10.12 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.757 -1.111 . . . . 0.0 112.887 175.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.444 ' O ' ' HB3' ' A' ' 30' ' ' TYR . 18.1 mtm180 -102.24 173.38 6.39 Favored 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 119.653 -0.819 . . . . 0.0 112.106 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.69 179.8 51.32 Favored Glycine 0 N--CA 1.419 -2.45 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.52 -178.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.2 m -78.4 167.78 20.8 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 174.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 11.0 p90 -140.54 163.53 32.59 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -176.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.3 tt -114.59 152.98 16.16 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -107.23 125.54 51.26 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 176.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.549 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 84.3 t -117.91 133.38 64.89 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.369 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 176.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -114.81 -31.84 6.0 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 123.337 0.398 . . . . 0.0 110.159 -176.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.99 160.59 33.17 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -177.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.9 m -69.43 139.62 54.05 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 123.645 0.778 . . . . 0.0 112.186 -173.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.1 p -113.71 131.19 66.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 176.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.33 -15.41 51.06 Favored Glycine 0 N--CA 1.433 -1.549 0 C-N-CA 119.546 -1.312 . . . . 0.0 113.154 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.7 p -154.88 124.13 6.35 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.309 0.576 . . . . 0.0 112.474 -178.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 82.8 mt -118.77 117.99 30.37 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.615 175.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 15.0 p -132.84 110.13 13.16 Favored Pre-proline 0 N--CA 1.428 -1.548 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.636 174.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 74.2 Cg_endo -76.5 162.11 92.48 Favored 'Cis proline' 0 C--O 1.252 1.204 0 C-N-CA 123.729 -1.363 . . . . 0.0 111.236 -2.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.76 158.47 37.47 Favored 'Trans proline' 0 C--O 1.244 0.785 0 C-N-CA 122.783 2.322 . . . . 0.0 110.751 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.46 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 47.8 m0 -89.22 138.25 31.59 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 11.0 p -116.74 76.94 8.01 Favored Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 123.576 0.547 . . . . 0.0 111.874 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.466 ' HD2' ' O ' ' A' ' 103' ' ' LYS . 92.8 Cg_endo -76.4 158.57 36.66 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.584 2.189 . . . . 0.0 112.849 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.69 -36.92 8.97 Favored Glycine 0 N--CA 1.435 -1.37 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 175.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.2 p -151.1 159.8 44.27 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.5 t -134.77 143.11 38.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 38.4 t -145.48 148.74 33.58 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.784 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 67.3 t -113.0 121.01 39.31 Favored Pre-proline 0 C--N 1.309 -1.153 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 176.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -57.79 138.4 85.88 Favored 'Trans proline' 0 C--O 1.244 0.799 0 C-N-CA 122.877 2.385 . . . . 0.0 111.498 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.465 ' CE2' ' HB3' ' A' ' 64' ' ' ASN . 40.5 t80 -67.67 136.64 54.67 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-O 121.699 0.761 . . . . 0.0 111.071 -177.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 70.2 t -131.61 114.87 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.465 ' HB3' ' CE2' ' A' ' 62' ' ' PHE . 9.4 p30 -111.95 5.01 18.57 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 175.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.19 145.13 32.52 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 112.615 -2.084 . . . . 0.0 112.931 -172.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.48 -5.64 0.06 Allowed 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 128.991 2.916 . . . . 0.0 115.162 -173.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -59.62 171.55 0.84 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.295 1.038 . . . . 0.0 109.614 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 114' ' ' THR . 28.3 mtm180 -90.7 -28.09 18.56 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 118.093 -1.443 . . . . 0.0 107.955 173.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.449 ' HG2' HD12 ' A' ' 112' ' ' ILE . 18.5 mp0 -103.61 132.26 50.02 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.582 -174.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -106.38 153.78 40.24 Favored Pre-proline 0 C--N 1.289 -2.033 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 169.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.61 135.71 10.52 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 121.648 1.566 . . . . 0.0 113.012 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -133.88 118.58 18.11 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 177.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.626 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 82.9 m95 -107.55 136.77 46.76 Favored 'General case' 0 C--N 1.278 -2.525 0 O-C-N 122.052 -0.405 . . . . 0.0 111.977 -172.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.513 ' HD2' ' SG ' ' A' ' 111' ' ' CYS . 29.3 m-85 -113.52 141.21 47.42 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.765 177.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.415 HD21 HD21 ' A' ' 27' ' ' LEU . 22.5 mt -126.01 142.33 51.57 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 -176.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 88.0 m-85 -131.75 139.63 49.01 Favored 'General case' 0 C--N 1.31 -1.119 0 O-C-N 123.499 0.5 . . . . 0.0 110.993 -176.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.673 ' HB2' ' CD2' ' A' ' 102' ' ' PHE . 11.8 t70 -85.44 0.9 50.88 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 123.673 0.789 . . . . 0.0 111.224 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -136.58 158.49 44.32 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 172.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.1 m -72.0 169.26 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 C-N-CA 122.316 0.246 . . . . 0.0 110.405 -178.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 60.48 29.87 19.34 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.168 0.587 . . . . 0.0 110.575 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.436 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 18.9 m-85 56.37 46.82 20.23 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.973 0.909 . . . . 0.0 110.95 177.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 72.9 p -123.32 176.63 6.02 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.475 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.6 -140.8 18.38 Favored Glycine 0 N--CA 1.429 -1.821 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.79 177.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 61.8 mtt180 -73.61 143.46 46.34 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.1 tt -125.33 137.63 57.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 O-C-N 123.572 0.545 . . . . 0.0 110.269 -174.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 52.0 m -131.79 125.11 31.09 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 121.984 -0.448 . . . . 0.0 110.658 175.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -112.22 124.82 6.89 Favored Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.829 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -119.13 146.0 45.5 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 123.251 0.62 . . . . 0.0 110.251 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.29 166.95 12.39 Favored Glycine 0 N--CA 1.431 -1.664 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.362 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -53.3 124.79 15.6 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 124.337 1.055 . . . . 0.0 112.357 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.34 -6.47 82.39 Favored Glycine 0 N--CA 1.435 -1.424 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.612 175.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.9 m -106.44 146.42 30.55 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -178.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.9 m -139.8 152.3 46.44 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 50.8 mt -93.48 133.76 33.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 176.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -71.1 -47.9 55.43 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.205 0.526 . . . . 0.0 110.36 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.554 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 1.9 m-20 -135.0 100.15 4.49 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.25 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -64.4 -38.93 92.75 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.359 0.6 . . . . 0.0 110.375 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.4 t -65.62 -29.76 70.38 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.641 -1.163 . . . . 0.0 112.192 -175.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.554 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 27.5 mmtp -86.31 -14.88 42.34 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 121.988 -0.445 . . . . 0.0 109.963 -176.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.1 m -77.88 -8.08 57.59 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 144.0 -77.26 0.28 Allowed Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.673 ' CD2' ' HB2' ' A' ' 77' ' ' ASP . 37.8 p90 -110.05 147.89 32.73 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.03 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.539 ' H ' ' HD3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -113.94 -9.9 12.98 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -109.67 115.71 4.29 Favored Glycine 0 N--CA 1.428 -1.874 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.596 -175.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 64.0 mt -101.17 116.07 44.05 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.7 m -85.28 -26.4 26.65 Favored 'General case' 0 N--CA 1.391 -3.414 0 CA-C-N 112.432 -2.167 . . . . 0.0 114.067 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 77.8 p -156.75 156.35 33.18 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.3 mt -134.24 133.94 55.32 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.768 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -176.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.436 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 31.9 ttmt -122.52 131.42 53.84 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -96.08 122.23 38.7 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.379 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' CYS . . . . . 0.513 ' SG ' ' HD2' ' A' ' 74' ' ' TYR . 56.3 m -118.86 167.74 11.43 Favored 'General case' 0 N--CA 1.405 -2.7 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.449 HD12 ' HG2' ' A' ' 69' ' ' GLU . 9.2 pt -127.74 145.82 34.43 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.414 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 61.5 tt0 -122.6 118.93 29.35 Favored 'General case' 0 C--N 1.274 -2.712 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 68' ' ' ARG . 27.1 p -79.78 179.16 7.69 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -175.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -66.25 -19.53 65.85 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.727 0.775 . . . . 0.0 110.203 177.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -83.34 -1.67 53.87 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.84 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.55 -5.63 82.89 Favored Glycine 0 CA--C 1.506 -0.483 0 CA-C-N 116.208 -0.451 . . . . 0.0 113.618 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 113' ' ' GLN . 19.0 ptpt -75.96 134.91 40.07 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 39.4 t -104.71 110.57 31.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -100.3 154.49 18.44 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 1.1 t -143.55 154.89 44.07 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 118.642 -1.223 . . . . 0.0 110.376 -177.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 7.8 tp -111.05 118.98 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.692 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.021 176.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -85.83 104.52 15.58 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 . . . . . 0 C--N 1.287 -2.118 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -178.685 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.683 0 N-CA-C 111.114 -0.795 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.43 9.27 4.07 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.967 0.889 . . . . 0.0 111.423 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -77.38 -10.15 59.28 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.264 174.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.2 p -118.84 146.43 44.87 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 173.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 26.2 p -102.58 151.83 21.87 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.4 tptt -87.57 143.19 27.32 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 67.59 39.51 2.78 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 123.862 0.726 . . . . 0.0 111.349 177.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.8 m -124.33 155.09 39.32 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.267 -0.878 . . . . 0.0 108.925 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.606 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 55.2 tp -110.18 117.58 34.06 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 172.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.523 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 77.7 mt-30 -110.22 124.2 51.15 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.579 -0.849 . . . . 0.0 109.618 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 3.2 mp -110.06 125.6 53.12 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.945 178.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -92.91 152.89 19.11 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 123.574 0.546 . . . . 0.0 110.1 -177.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -77.83 -37.9 47.51 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.868 -176.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -108.56 178.31 4.52 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.462 HG22 ' HA ' ' A' ' 96' ' ' ASP . 1.4 p -78.17 169.04 18.92 Favored 'General case' 0 N--CA 1.413 -2.292 0 C-N-CA 122.404 0.282 . . . . 0.0 110.4 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 25.3 p90 46.87 42.51 12.2 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.914 1.286 . . . . 0.0 114.232 176.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 67.65 23.46 8.73 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.414 1.086 . . . . 0.0 112.995 177.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.518 ' HA ' ' NE ' ' A' ' 36' ' ' ARG . 4.4 mmp_? -98.22 165.2 11.99 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.41 -157.8 33.47 Favored Glycine 0 N--CA 1.434 -1.436 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.5 p -85.99 176.64 7.93 Favored 'General case' 0 N--CA 1.421 -1.892 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 174.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.435 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 11.7 p90 -149.36 165.79 30.98 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 13.4 tt -123.03 150.81 27.07 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.747 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -106.88 125.21 50.71 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 174.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.472 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 94.8 t -118.13 133.69 64.13 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -117.86 -26.4 6.5 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.282 0.563 . . . . 0.0 110.569 -176.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -115.73 163.14 16.27 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.334 -174.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.4 ' HB3' ' H ' ' A' ' 110' ' ' ARG . 6.2 p -84.06 143.53 29.67 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 175.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.5 p -120.75 132.38 70.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.56 -16.96 54.12 Favored Glycine 0 N--CA 1.433 -1.536 0 C-N-CA 119.77 -1.205 . . . . 0.0 113.457 -177.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.4 p -157.4 124.29 5.06 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 81.8 mt -117.73 118.65 32.64 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 18.9 m -133.09 116.85 14.56 Favored Pre-proline 0 N--CA 1.42 -1.942 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.154 175.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 58.5 Cg_endo -75.62 160.08 96.49 Favored 'Cis proline' 0 C--O 1.251 1.14 0 C-N-CA 122.779 -1.759 . . . . 0.0 110.438 -4.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.0 157.33 29.61 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 122.69 2.26 . . . . 0.0 111.483 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 48.4 m0 -89.66 132.34 35.19 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -178.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.614 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 41.6 p -113.28 78.67 3.45 Favored Pre-proline 0 C--N 1.304 -1.375 0 O-C-N 123.252 0.345 . . . . 0.0 111.144 177.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.48 ' HG2' ' CD2' ' A' ' 97' ' ' PHE . 73.7 Cg_endo -76.37 153.44 35.43 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 122.198 1.932 . . . . 0.0 112.691 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -87.44 -28.53 24.46 Favored Glycine 0 N--CA 1.431 -1.638 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 178.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.7 p -155.08 154.96 33.21 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.6 t -134.01 142.25 41.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -178.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 31.6 t -146.11 149.64 34.42 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 119.637 -0.825 . . . . 0.0 111.52 176.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.7 t -118.03 124.11 28.99 Favored Pre-proline 0 N--CA 1.437 -1.117 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 175.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.89 143.52 79.87 Favored 'Trans proline' 0 C--O 1.246 0.877 0 C-N-CA 122.604 2.203 . . . . 0.0 112.281 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -66.89 136.37 55.29 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.172 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.469 HG12 ' H ' ' A' ' 65' ' ' ASP . 84.5 t -120.61 129.76 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.9 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -121.48 27.59 8.19 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 124.125 0.97 . . . . 0.0 108.818 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.469 ' H ' HG12 ' A' ' 63' ' ' VAL . 7.0 t0 -59.73 144.99 46.67 Favored 'General case' 0 C--O 1.248 1.014 0 C-N-CA 125.887 1.675 . . . . 0.0 111.054 -177.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.3 m -63.74 -14.88 56.33 Favored 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 124.325 1.05 . . . . 0.0 111.315 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.4 ' HG2' ' OD1' ' A' ' 65' ' ' ASP . 33.7 mmtp -63.68 166.68 6.66 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.977 0.418 . . . . 0.0 110.763 175.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 57.3 mtm180 -90.97 -28.53 17.97 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.293 1.044 . . . . 0.0 109.152 -173.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -109.76 131.16 55.32 Favored 'General case' 0 N--CA 1.409 -2.501 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.661 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -106.18 153.96 39.97 Favored Pre-proline 0 C--N 1.301 -1.522 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.485 177.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -71.94 141.94 37.82 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.26 1.974 . . . . 0.0 113.464 -176.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -133.84 144.35 48.89 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.606 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 88.0 m95 -123.76 137.26 54.72 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.5 -0.75 . . . . 0.0 111.968 -175.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.434 ' HA ' ' O ' ' A' ' 86' ' ' THR . 29.6 m-85 -117.81 141.52 48.32 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.38 177.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.8 mt -125.73 143.07 51.2 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.416 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 74.8 m-85 -134.08 143.18 47.86 Favored 'General case' 0 C--O 1.242 0.688 0 O-C-N 123.518 0.512 . . . . 0.0 110.24 -176.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.507 ' HB3' ' CG ' ' A' ' 102' ' ' PHE . 4.3 p-10 -89.17 -0.63 57.6 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -131.21 157.4 43.31 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 174.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.3 m -67.98 169.19 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 120.732 0.301 . . . . 0.0 110.947 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 31.0 m120 58.67 30.31 19.73 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 123.825 0.85 . . . . 0.0 111.335 178.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.499 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 13.4 m-85 57.51 38.7 28.13 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 124.659 1.184 . . . . 0.0 111.439 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 72.6 p -111.93 171.27 7.6 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.592 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.32 -138.65 14.78 Favored Glycine 0 N--CA 1.429 -1.833 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 59.1 mtt180 -79.21 153.34 30.06 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.5 tt -128.35 138.71 53.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -177.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 75.2 m -131.52 127.47 37.33 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 175.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -112.38 125.7 7.25 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.149 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.524 HD21 HD11 ' A' ' 94' ' ' ILE . 3.2 mm? -118.2 145.99 44.56 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 123.061 0.544 . . . . 0.0 110.749 178.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -117.45 168.74 12.98 Favored Glycine 0 N--CA 1.428 -1.899 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.95 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 23.5 p80 -62.71 122.17 15.22 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 123.6 0.76 . . . . 0.0 111.895 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.38 17.8 58.21 Favored Glycine 0 N--CA 1.431 -1.669 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.656 177.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.2 m -129.67 146.71 51.43 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.5 m -139.53 152.93 47.32 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.524 HD11 HD21 ' A' ' 88' ' ' LEU . 52.1 mt -93.63 122.15 44.87 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.448 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 171.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -70.57 -46.81 62.78 Favored 'General case' 0 C--N 1.289 -2.063 0 O-C-N 123.67 0.606 . . . . 0.0 110.809 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.647 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 5.4 m-20 -127.06 86.95 2.57 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.159 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.48 ' CD2' ' HG2' ' A' ' 55' ' ' PRO . 69.5 t80 -65.59 -36.17 82.95 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.359 0.599 . . . . 0.0 110.592 177.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.0 t -75.67 -15.85 60.26 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.976 -173.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.647 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 30.7 mmtp -94.35 -8.91 37.48 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.1 m -82.29 -168.16 1.86 Allowed 'General case' 0 C--O 1.248 0.982 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.961 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.47 -69.42 1.25 Allowed Glycine 0 C--O 1.242 0.64 0 O-C-N 123.109 0.256 . . . . 0.0 113.112 -177.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.507 ' CG ' ' HB3' ' A' ' 77' ' ' ASP . 42.3 p90 -110.39 146.17 36.28 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.343 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.614 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.66 -11.65 12.94 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 176.41 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.34 104.27 2.2 Favored Glycine 0 N--CA 1.44 -1.068 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.462 -176.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 70.4 mt -88.95 115.37 28.67 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.586 0 CA-C-O 122.533 1.159 . . . . 0.0 109.115 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 52.7 m -85.83 -27.44 25.1 Favored 'General case' 0 N--CA 1.395 -3.222 0 CA-C-N 112.108 -2.315 . . . . 0.0 113.934 177.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 81.0 p -157.4 155.58 30.76 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.1 mt -135.09 131.2 52.41 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -175.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.499 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 38.2 ttmt -117.45 133.51 55.89 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.4 ' H ' ' HB3' ' A' ' 45' ' ' SER . 54.3 ttp180 -100.43 130.02 46.46 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 61.3 m -130.06 172.88 11.27 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.571 -178.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.5 pt -131.77 143.55 39.98 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -113.79 121.1 43.03 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-O 121.382 0.61 . . . . 0.0 109.801 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.512 ' OG1' ' HG2' ' A' ' 118' ' ' LYS . 70.6 p -76.91 -179.97 5.8 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 114.316 -1.311 . . . . 0.0 112.155 -174.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -66.4 -30.97 71.45 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.81 172.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -76.76 -8.89 58.15 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.982 0.896 . . . . 0.0 110.199 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.89 -4.48 83.33 Favored Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.253 176.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.512 ' HG2' ' OG1' ' A' ' 114' ' ' THR . 10.7 ptmm? -76.13 135.13 39.83 Favored 'General case' 0 C--O 1.258 1.511 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.0 t -100.39 111.09 29.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 -177.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -96.69 149.44 21.81 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 -177.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 84.0 m -129.88 169.53 15.07 Favored 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.755 -175.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 5.1 tp -73.37 136.67 24.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -69.6 109.03 4.09 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 122.39 1.091 . . . . 0.0 109.561 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.564 ' HA ' HE21 ' A' ' 124' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.283 -2.287 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.004 -178.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.506 ' N ' ' HG ' ' A' ' 22' ' ' SER . . . . . . . . 0 N--CA 1.473 1.111 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.36 -9.21 58.36 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 122.07 0.938 . . . . 0.0 110.257 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -83.02 -16.89 45.32 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.73 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.508 ' HA ' ' NE2' ' A' ' 28' ' ' GLN . 15.0 m -83.02 138.59 33.69 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.2 p -116.38 157.62 24.78 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.07 135.59 43.01 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 68.15 39.14 2.46 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.081 0.552 . . . . 0.0 112.207 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 34.7 m -124.41 145.73 49.31 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.616 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 57.3 tp -99.87 116.18 31.33 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 172.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.508 ' NE2' ' HA ' ' A' ' 22' ' ' SER . 43.9 mt-30 -110.62 124.28 51.58 Favored 'General case' 0 CA--C 1.485 -1.529 0 C-N-CA 119.329 -0.948 . . . . 0.0 109.288 -177.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.444 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.3 mp -109.71 131.21 55.27 Favored 'General case' 0 N--CA 1.409 -2.521 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.238 176.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.536 ' CE2' ' HG3' ' A' ' 35' ' ' GLU . 97.8 m-85 -98.14 154.86 17.45 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 123.354 0.409 . . . . 0.0 110.568 -176.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -77.79 -43.61 30.09 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.481 0.657 . . . . 0.0 109.501 -176.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -108.43 178.45 4.49 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.302 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.625 ' HA ' ' OG ' ' A' ' 57' ' ' SER . 0.5 OUTLIER -83.43 179.94 7.53 Favored 'General case' 0 N--CA 1.401 -2.915 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.582 -177.546 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 48.47 40.42 14.97 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.867 0.867 . . . . 0.0 113.258 176.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.536 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 1.0 OUTLIER 57.9 23.7 10.08 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 115.232 1.568 . . . . 0.0 115.232 178.912 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -105.51 173.27 6.38 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 118.012 -1.475 . . . . 0.0 111.016 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.23 -177.39 45.84 Favored Glycine 0 N--CA 1.428 -1.873 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 -178.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 44.4 m -84.41 143.67 29.28 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.393 176.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 12.4 p90 -116.13 165.92 12.6 Favored 'General case' 0 C--N 1.272 -2.781 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -174.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.0 tt -114.9 152.08 16.56 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.543 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -106.8 125.55 51.14 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 175.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 94.4 t -122.84 133.46 68.88 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -122.61 -14.2 7.81 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp -110.1 162.24 14.76 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.646 -171.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.442 ' HB3' ' H ' ' A' ' 110' ' ' ARG . 2.3 p -97.98 133.19 42.8 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 171.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.8 p -116.74 137.48 50.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -174.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.35 -18.49 35.95 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 119.755 -1.212 . . . . 0.0 113.321 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.5 p -155.81 121.34 4.91 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 86.0 mt -113.06 118.45 34.82 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.043 -0.981 . . . . 0.0 108.741 176.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.0 m -133.15 112.72 13.3 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 174.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.03 161.84 93.53 Favored 'Cis proline' 0 C--O 1.248 0.997 0 C-N-CA 123.313 -1.536 . . . . 0.0 111.255 -0.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -63.12 158.24 45.0 Favored 'Trans proline' 0 C--O 1.246 0.882 0 C-N-CA 122.387 2.058 . . . . 0.0 110.509 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -89.24 133.58 34.39 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 8.0 p -115.64 77.68 6.33 Favored Pre-proline 0 C--N 1.295 -1.799 0 O-C-N 123.628 0.58 . . . . 0.0 111.031 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.444 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 95.7 Cg_endo -77.65 158.09 32.0 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.286 1.991 . . . . 0.0 112.961 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.89 -39.45 11.77 Favored Glycine 0 N--CA 1.433 -1.55 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 176.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.625 ' OG ' ' HA ' ' A' ' 33' ' ' THR . 55.7 m -149.58 161.21 42.6 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.477 1.111 . . . . 0.0 108.26 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.402 HG22 HD23 ' A' ' 29' ' ' LEU . 38.9 t -135.35 142.33 40.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 48.8 t -146.1 147.99 32.16 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.435 176.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.7 t -116.29 122.34 32.23 Favored Pre-proline 0 N--CA 1.438 -1.066 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.68 147.41 89.9 Favored 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 122.57 2.18 . . . . 0.0 111.108 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -70.1 134.61 48.37 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.427 HG12 ' H ' ' A' ' 65' ' ' ASP . 57.9 t -121.08 123.51 70.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -120.72 26.27 9.21 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.427 ' H ' HG12 ' A' ' 63' ' ' VAL . 9.8 t70 -58.4 144.85 40.46 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.319 -178.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.5 m -60.22 -20.57 59.37 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 123.3 0.64 . . . . 0.0 111.616 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -58.79 139.5 56.25 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -68.63 -24.14 64.52 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.77 -175.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.41 130.52 55.67 Favored 'General case' 0 N--CA 1.418 -2.032 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.95 154.97 40.68 Favored Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.951 175.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.47 134.91 14.32 Favored 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 121.779 1.653 . . . . 0.0 110.662 177.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -129.26 143.7 50.95 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.616 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 88.9 m95 -125.47 132.76 52.62 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 120.204 -0.598 . . . . 0.0 112.131 -173.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 86' ' ' THR . 27.2 m-85 -114.98 141.61 47.75 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.893 176.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.8 mt -125.72 142.72 51.37 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -175.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.42 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 77.5 m-85 -133.82 143.03 48.11 Favored 'General case' 0 C--N 1.317 -0.813 0 O-C-N 123.634 0.584 . . . . 0.0 109.923 -177.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.562 ' HB3' ' CG ' ' A' ' 102' ' ' PHE . 2.8 p-10 -88.39 0.87 55.75 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.652 -178.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -134.49 160.12 39.01 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.8 m -73.18 167.14 2.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-O 120.61 0.243 . . . . 0.0 111.427 -176.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.8 m120 57.96 31.1 20.15 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 123.771 0.829 . . . . 0.0 111.421 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.566 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 10.9 m-85 59.64 39.37 21.32 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.893 1.277 . . . . 0.0 111.465 177.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 74.3 p -111.58 176.19 5.12 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.12 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.91 -137.43 15.16 Favored Glycine 0 N--CA 1.429 -1.825 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.835 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 56.2 mtt180 -83.81 150.86 25.49 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 123.547 0.739 . . . . 0.0 109.471 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.9 tt -124.84 139.39 51.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 121.179 0.514 . . . . 0.0 110.667 -176.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 90.7 m -131.47 128.2 38.93 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 174.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -115.06 117.43 4.01 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.541 -0.838 . . . . 0.0 113.194 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.434 HD21 HD11 ' A' ' 94' ' ' ILE . 4.0 mm? -109.9 145.55 36.65 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.017 0.437 . . . . 0.0 110.964 178.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -122.58 170.9 15.34 Favored Glycine 0 N--CA 1.419 -2.495 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.467 -177.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -63.6 121.5 14.06 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.299 0.571 . . . . 0.0 111.734 -176.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.6 14.72 61.05 Favored Glycine 0 N--CA 1.434 -1.479 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.908 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.6 m -125.09 146.14 49.6 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.9 m -139.15 160.06 40.69 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.434 HD11 HD21 ' A' ' 88' ' ' LEU . 50.0 mt -94.06 132.18 38.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 173.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -69.93 -48.41 58.57 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.033 0.444 . . . . 0.0 110.563 -177.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.477 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 11.1 m-20 -142.82 93.18 2.48 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.573 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.433 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 49.1 t80 -64.63 -30.06 71.07 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.573 0.701 . . . . 0.0 109.391 178.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.0 t -63.65 -25.07 68.05 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.537 177.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.477 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 34.4 mmtp -94.88 -5.59 44.61 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.936 -0.477 . . . . 0.0 110.837 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.9 m -79.61 -176.84 5.54 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -56.37 -63.8 4.98 Favored Glycine 0 C--O 1.249 1.052 0 CA-C-O 121.017 0.232 . . . . 0.0 112.781 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.562 ' CG ' ' HB3' ' A' ' 77' ' ' ASP . 39.9 p90 -110.92 147.23 35.07 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 177.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.94 -9.89 12.98 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.586 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -107.45 113.62 4.02 Favored Glycine 0 N--CA 1.431 -1.66 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.474 -177.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 62.6 mt -96.94 115.18 35.81 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.641 0 CA-C-O 122.336 1.065 . . . . 0.0 108.919 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.7 m -85.61 -29.68 23.89 Favored 'General case' 0 N--CA 1.392 -3.335 0 CA-C-N 112.242 -2.253 . . . . 0.0 113.685 177.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 89.2 p -153.11 155.52 36.93 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.0 mt -135.29 130.17 50.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -176.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.566 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 35.8 ttmt -117.32 131.15 56.86 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.442 ' H ' ' HB3' ' A' ' 45' ' ' SER . 25.7 ttp180 -101.76 123.14 45.23 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' CYS . . . . . 0.439 ' SG ' ' HD2' ' A' ' 74' ' ' TYR . 60.0 m -119.69 172.5 7.64 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -177.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.6 pt -128.12 141.95 45.1 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -115.68 120.29 38.89 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 108.39 -0.966 . . . . 0.0 108.39 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 44.1 p -76.93 175.53 9.44 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.799 -174.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -67.51 -20.68 65.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.628 0.727 . . . . 0.0 109.043 176.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -77.43 -9.59 58.97 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.512 177.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.28 -9.7 76.81 Favored Glycine 0 N--CA 1.439 -1.163 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.187 176.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -74.56 141.47 44.77 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 117.345 0.573 . . . . 0.0 110.225 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.7 t -106.68 111.28 34.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -105.85 148.09 27.96 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.51 153.21 49.06 Favored 'General case' 0 C--N 1.285 -2.207 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.464 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 7.3 tp -125.53 124.6 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.16 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.371 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -91.57 108.46 19.92 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 176.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 . . . . . 0 C--N 1.287 -2.13 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.459 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.276 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.69 76.64 9.48 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 172.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -80.34 -24.85 39.57 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.142 -174.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.0 m -76.34 125.04 28.47 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 171.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 22.1 p -102.13 149.8 23.91 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.256 -0.978 . . . . 0.0 111.536 -173.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.8 tptt -73.89 139.83 45.26 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.716 -176.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 59.25 37.9 23.55 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.638 0.775 . . . . 0.0 112.935 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 34.5 m -123.08 145.56 48.44 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.499 ' HB3' ' HB ' ' A' ' 42' ' ' VAL . 49.6 tp -93.68 116.8 29.31 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 174.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.498 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 41.6 mt-30 -111.69 124.78 53.05 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -177.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 3.9 mp -109.6 129.06 55.61 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.24 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.556 ' CE1' ' HG3' ' A' ' 35' ' ' GLU . 94.6 m-85 -97.16 153.66 17.84 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 123.907 0.754 . . . . 0.0 111.644 -174.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -74.48 -41.64 60.4 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.058 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -107.83 177.65 4.76 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 56' ' ' GLY . 3.4 p -82.11 173.01 12.55 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 19.2 p90 47.46 38.76 8.19 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.556 ' HG3' ' CE1' ' A' ' 30' ' ' TYR . 0.7 OUTLIER 67.43 25.76 8.49 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 124.805 1.242 . . . . 0.0 113.637 177.229 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.7 mtp85 -90.74 159.22 16.44 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 177.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.99 -136.89 13.74 Favored Glycine 0 N--CA 1.422 -2.242 0 CA-C-N 114.365 -1.288 . . . . 0.0 109.911 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.2 m -116.68 -179.49 3.7 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 175.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 33.8 p90 -141.36 165.29 27.91 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -178.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 17.3 tt -114.63 152.65 16.24 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 177.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -106.71 126.11 51.87 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.499 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 88.2 t -123.43 133.15 69.98 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 176.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -115.53 -35.7 4.49 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-O 121.604 0.716 . . . . 0.0 109.397 -175.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.25 161.03 24.02 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.113 -177.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.429 ' HB3' ' H ' ' A' ' 110' ' ' ARG . 4.9 p -69.03 147.83 50.98 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 123.579 0.549 . . . . 0.0 111.517 -178.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.4 p -121.4 131.19 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.06 -15.86 55.24 Favored Glycine 0 N--CA 1.432 -1.633 0 C-N-CA 119.749 -1.215 . . . . 0.0 113.08 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.5 p -156.74 127.54 6.74 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 83.3 mt -122.57 118.36 28.02 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.474 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 14.5 m -133.5 113.46 13.12 Favored Pre-proline 0 C--N 1.306 -1.302 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.103 174.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 73.2 Cg_endo -75.22 162.1 93.38 Favored 'Cis proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.27 -1.554 . . . . 0.0 111.168 -0.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -63.6 156.84 54.62 Favored 'Trans proline' 0 C--O 1.238 0.505 0 C-N-CA 121.928 1.752 . . . . 0.0 110.695 177.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.401 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 49.2 m0 -89.46 134.83 33.92 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -177.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.62 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 58.0 p -113.87 81.0 5.59 Favored Pre-proline 0 N--CA 1.434 -1.236 0 O-C-N 123.431 0.457 . . . . 0.0 111.199 176.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.42 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 95.7 Cg_endo -79.47 158.42 25.63 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.699 2.266 . . . . 0.0 112.447 177.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.427 ' O ' HG22 ' A' ' 33' ' ' THR . . . -87.93 -35.85 8.8 Favored Glycine 0 N--CA 1.429 -1.814 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 176.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 94' ' ' ILE . 89.4 p -150.3 158.15 43.85 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.451 HG22 HD23 ' A' ' 29' ' ' LEU . 43.2 t -132.09 142.57 42.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 93' ' ' CYS . 38.4 t -145.43 149.55 34.92 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.614 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.1 t -117.28 126.63 27.27 Favored Pre-proline 0 C--N 1.317 -0.808 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.24 142.76 98.97 Favored 'Trans proline' 0 C--O 1.248 1.019 0 C-N-CA 122.851 2.367 . . . . 0.0 111.839 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.452 ' CE1' ' HB3' ' A' ' 64' ' ' ASN . 59.4 t80 -73.48 124.19 25.37 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 122.031 0.92 . . . . 0.0 111.456 -176.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.456 ' H ' ' HB2' ' A' ' 90' ' ' HIS . 91.0 t -109.76 117.67 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 CA-C-N 114.428 -1.26 . . . . 0.0 107.929 178.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.452 ' HB3' ' CE1' ' A' ' 62' ' ' PHE . 4.9 p-10 -122.38 11.31 9.99 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -69.31 145.55 52.94 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 111.664 -2.516 . . . . 0.0 112.631 -173.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 m -53.81 -7.58 0.13 Allowed 'General case' 0 CA--C 1.564 1.496 0 C-N-CA 128.353 2.661 . . . . 0.0 114.816 -175.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.482 ' H ' ' HD2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -66.7 154.36 40.85 Favored 'General case' 0 C--N 1.316 -0.887 0 O-C-N 122.173 -0.329 . . . . 0.0 110.692 -176.902 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -79.48 -28.4 41.51 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.741 -0.209 . . . . 0.0 111.206 -175.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.424 ' HG2' HD12 ' A' ' 112' ' ' ILE . 9.8 mp0 -110.54 144.75 38.93 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.395 177.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -106.24 151.44 40.2 Favored Pre-proline 0 C--N 1.307 -1.273 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 171.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -78.62 137.3 14.37 Favored 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 122.238 1.958 . . . . 0.0 111.974 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -132.92 132.78 42.4 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.487 ' CE3' HD22 ' A' ' 27' ' ' LEU . 87.2 m95 -116.67 134.88 54.28 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.78 -0.575 . . . . 0.0 111.366 -174.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.469 ' HD1' ' SG ' ' A' ' 111' ' ' CYS . 29.0 m-85 -116.07 142.3 46.99 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.617 178.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.2 mt -125.89 142.69 51.4 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -176.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.539 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 81.4 m-85 -134.38 142.55 47.23 Favored 'General case' 0 C--O 1.245 0.82 0 O-C-N 123.719 0.637 . . . . 0.0 110.174 -176.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.45 ' C ' ' HB2' ' A' ' 106' ' ' SER . 0.8 OUTLIER -80.95 -9.95 59.77 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.58 -179.051 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -127.54 162.31 26.75 Favored 'General case' 0 N--CA 1.427 -1.605 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.426 177.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.5 m -73.19 168.75 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 122.804 0.442 . . . . 0.0 110.588 -176.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.5 m120 57.66 30.35 18.72 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.612 0.72 . . . . 0.0 111.217 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.401 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 16.2 m-85 59.26 40.3 21.56 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.198 176.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 76.6 p -111.5 175.52 5.39 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.517 -0.473 . . . . 0.0 109.742 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.54 -140.62 16.16 Favored Glycine 0 N--CA 1.422 -2.259 0 C-N-CA 120.363 -0.923 . . . . 0.0 111.508 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.539 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 32.7 mtt180 -82.93 151.87 25.75 Favored 'General case' 0 C--N 1.287 -2.131 0 C-N-CA 123.487 0.715 . . . . 0.0 109.82 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.3 tt -122.61 137.2 56.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-O 121.198 0.523 . . . . 0.0 110.251 -177.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 95.2 m -131.62 125.82 33.17 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 175.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -115.05 110.09 2.23 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.625 -0.798 . . . . 0.0 114.63 -176.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.45 HD21 HD11 ' A' ' 94' ' ' ILE . 3.9 mm? -101.92 145.51 29.14 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 120.967 0.413 . . . . 0.0 111.279 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -123.32 169.67 15.58 Favored Glycine 0 N--CA 1.419 -2.478 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.866 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.456 ' HB2' ' H ' ' A' ' 63' ' ' VAL . 7.3 p80 -53.36 122.03 8.8 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 124.056 0.943 . . . . 0.0 113.109 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.39 -5.8 80.69 Favored Glycine 0 CA--C 1.5 -0.857 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.873 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.3 m -106.25 146.39 30.4 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-O 121.219 0.533 . . . . 0.0 109.782 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 59' ' ' CYS . 3.8 m -134.74 159.11 42.35 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.45 HD11 HD21 ' A' ' 88' ' ' LEU . 41.5 mt -93.44 130.43 42.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 175.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -65.8 -47.14 76.08 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.152 0.501 . . . . 0.0 110.066 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.579 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 2.9 m-20 -143.16 99.58 3.47 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 123.719 0.808 . . . . 0.0 108.966 178.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -63.96 -31.85 73.18 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.62 0.724 . . . . 0.0 110.839 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.5 t -63.34 -23.44 67.42 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.735 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.579 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 28.8 mmtp -94.56 -16.1 23.54 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 121.839 -0.538 . . . . 0.0 110.104 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.1 m -63.87 -34.32 77.68 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-O 121.116 0.484 . . . . 0.0 111.283 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 158.67 -67.38 0.28 Allowed Glycine 0 CA--C 1.488 -1.604 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -110.86 149.14 31.02 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.4 -9.64 13.33 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.26 177.229 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -106.25 108.18 2.88 Favored Glycine 0 N--CA 1.438 -1.189 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.017 -176.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 63.0 mt -92.11 116.04 32.4 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.59 0 CA-C-O 122.22 1.01 . . . . 0.0 109.067 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.45 ' HB2' ' C ' ' A' ' 77' ' ' ASP . 4.0 m -85.35 -29.28 24.61 Favored 'General case' 0 N--CA 1.396 -3.136 0 CA-C-N 112.565 -2.107 . . . . 0.0 114.231 176.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.3 p -154.92 155.15 33.78 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 122.191 -0.318 . . . . 0.0 110.239 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.3 mt -133.14 130.68 58.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.401 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 33.1 ttmt -117.71 133.71 55.66 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.429 ' H ' ' HB3' ' A' ' 45' ' ' SER . 58.6 ttt180 -99.8 126.77 45.94 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' CYS . . . . . 0.469 ' SG ' ' HD1' ' A' ' 74' ' ' TYR . 59.1 m -122.95 171.93 8.87 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -178.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 7.8 pt -127.52 143.49 40.51 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.298 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.586 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -117.02 119.45 35.32 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 51.1 p -80.89 178.31 8.49 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 114.228 -1.351 . . . . 0.0 112.363 -172.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -66.51 -23.6 66.27 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 172.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -83.3 -8.17 59.47 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.583 -1.189 . . . . 0.0 109.985 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.96 -11.36 57.51 Favored Glycine 0 N--CA 1.438 -1.186 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.769 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.47 137.05 54.13 Favored 'General case' 0 C--O 1.255 1.364 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 43.3 t -105.58 112.07 37.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -97.77 144.52 27.29 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 94.6 m -130.29 148.56 52.13 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 123.062 0.226 . . . . 0.0 110.903 -173.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 8.8 tp -80.38 121.52 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 CA-C-O 121.983 0.897 . . . . 0.0 110.864 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -90.24 110.31 21.36 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.74 177.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 . . . . . 0 C--N 1.294 -1.813 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.175 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.239 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.05 -5.79 29.08 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.47 0.652 . . . . 0.0 111.776 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -78.62 -24.18 45.48 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.718 177.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.7 m -108.81 134.23 51.78 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.167 -176.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.414 ' HB3' ' HB2' ' A' ' 26' ' ' CYS . 42.9 t -146.07 135.8 23.31 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.14 108.66 8.03 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -177.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.434 ' CE1' HG11 ' A' ' 63' ' ' VAL . 5.0 m-85 68.78 49.66 0.68 Allowed 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.631 0.729 . . . . 0.0 110.694 176.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.414 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 20.0 m -128.74 145.6 51.13 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.582 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 54.9 tp -105.68 127.24 52.94 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 177.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.486 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 71.6 mt-30 -114.73 124.75 52.58 Favored 'General case' 0 CA--C 1.49 -1.358 0 C-N-CA 119.889 -0.724 . . . . 0.0 109.61 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.5 mp -109.86 123.91 50.4 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.214 176.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.411 ' CD1' ' HB3' ' A' ' 39' ' ' TYR . 89.6 m-85 -95.12 151.9 18.8 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 123.832 0.707 . . . . 0.0 110.678 -174.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -74.71 -38.64 62.28 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.113 0.483 . . . . 0.0 110.41 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -108.33 178.17 4.58 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.013 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.496 ' O ' ' HB2' ' A' ' 36' ' ' ARG . 3.9 p -80.84 170.95 15.62 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 27.8 p90 46.8 42.27 11.64 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 66.62 21.97 10.57 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.283 1.033 . . . . 0.0 112.24 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 33' ' ' THR . 8.6 mmm180 -88.23 159.41 18.15 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.521 0.677 . . . . 0.0 111.785 177.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.14 -165.66 47.34 Favored Glycine 0 N--CA 1.428 -1.885 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.516 178.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.1 m -87.05 171.83 10.43 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.411 ' HB3' ' CD1' ' A' ' 30' ' ' TYR . 12.4 p90 -146.78 164.08 33.93 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -176.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 12.7 tt -115.01 152.53 16.61 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.648 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -107.05 124.92 50.35 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.559 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 89.8 t -115.1 132.84 63.16 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.641 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 178.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -114.43 -32.9 5.77 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 121.247 0.546 . . . . 0.0 110.047 -176.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.15 162.73 19.6 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.347 -176.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.6 p -74.74 151.59 39.15 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.147 0.498 . . . . 0.0 111.839 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.1 p -122.81 127.79 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 175.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.92 -14.56 60.69 Favored Glycine 0 C--N 1.301 -1.378 0 C-N-CA 119.368 -1.396 . . . . 0.0 112.906 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.2 p -160.25 125.9 4.04 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 121.086 0.469 . . . . 0.0 112.004 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.7 mt -116.01 118.63 33.44 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 18.9 m -132.7 111.25 13.54 Favored Pre-proline 0 C--N 1.288 -2.101 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 174.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 71.8 Cg_endo -76.9 161.86 92.67 Favored 'Cis proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.012 -1.662 . . . . 0.0 111.433 0.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -63.44 158.18 46.68 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 122.33 2.02 . . . . 0.0 111.05 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 49.5 m0 -89.86 138.91 31.09 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 10.5 p -120.62 76.45 27.2 Favored Pre-proline 0 C--N 1.296 -1.756 0 O-C-N 123.555 0.534 . . . . 0.0 111.477 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.479 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 83.6 Cg_endo -77.54 158.03 32.39 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.779 2.319 . . . . 0.0 113.232 179.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.13 -29.93 13.81 Favored Glycine 0 N--CA 1.429 -1.832 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 175.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.8 p -155.46 158.79 39.13 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.8 t -133.76 143.2 39.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 38.9 t -145.47 148.11 32.91 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.787 175.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.8 t -114.61 117.34 42.65 Favored Pre-proline 0 N--CA 1.428 -1.552 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 175.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -56.57 147.25 70.97 Favored 'Trans proline' 0 C--O 1.247 0.975 0 C-N-CA 122.759 2.306 . . . . 0.0 111.909 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -75.58 112.63 12.12 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.447 HG12 ' H ' ' A' ' 65' ' ' ASP . 36.8 t -93.85 114.57 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.677 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -109.7 32.79 4.78 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.318 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.547 ' OD1' ' HG2' ' A' ' 67' ' ' LYS . 6.2 t70 -75.33 144.61 42.29 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 113.832 -1.531 . . . . 0.0 108.007 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 m -56.54 -11.58 1.36 Allowed 'General case' 0 CA--C 1.577 1.984 0 C-N-CA 125.264 1.426 . . . . 0.0 114.203 -174.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.547 ' HG2' ' OD1' ' A' ' 65' ' ' ASP . 15.5 mmtp -67.66 145.02 55.21 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 122.984 0.514 . . . . 0.0 109.696 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -81.39 -14.13 57.52 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.826 0.346 . . . . 0.0 111.703 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -104.14 127.86 51.77 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -105.98 150.19 38.97 Favored Pre-proline 0 C--N 1.291 -1.939 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -76.48 140.18 21.29 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 121.771 1.647 . . . . 0.0 112.764 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -133.38 129.29 37.2 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.582 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 82.6 m95 -110.82 139.69 45.9 Favored 'General case' 0 C--N 1.284 -2.26 0 O-C-N 121.897 -0.502 . . . . 0.0 112.162 -172.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.473 ' HD2' ' SG ' ' A' ' 111' ' ' CYS . 35.9 m-85 -117.7 142.51 47.16 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.495 177.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.3 mt -125.59 142.45 51.5 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -176.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.522 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 77.9 m-85 -133.5 141.34 47.73 Favored 'General case' 0 C--N 1.318 -0.765 0 O-C-N 123.64 0.587 . . . . 0.0 109.958 -176.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.422 ' HB3' ' CD2' ' A' ' 102' ' ' PHE . 10.3 p-10 -81.09 -15.19 56.67 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -177.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.43 ' C ' ' HB3' ' A' ' 106' ' ' SER . 5.6 t-20 -125.59 165.16 19.04 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.8 m -68.81 168.51 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 123.146 0.579 . . . . 0.0 111.615 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.0 m120 56.44 30.25 16.71 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.852 0.861 . . . . 0.0 111.233 178.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.513 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 11.2 m-85 55.66 48.79 17.76 Favored 'General case' 0 C--O 1.25 1.131 0 C-N-CA 124.596 1.158 . . . . 0.0 110.785 178.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 74.6 p -117.43 168.53 10.28 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.862 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.3 -131.19 10.67 Favored Glycine 0 N--CA 1.416 -2.682 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 66.5 mtt85 -87.25 144.14 26.95 Favored 'General case' 0 C--N 1.279 -2.462 0 C-N-CA 124.332 1.053 . . . . 0.0 109.506 -178.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.4 tt -121.87 136.63 58.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-O 121.301 0.572 . . . . 0.0 110.045 -177.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 94.6 m -132.02 123.9 28.22 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.132 175.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -109.02 130.15 9.88 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.945 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.41 HD21 HD11 ' A' ' 94' ' ' ILE . 3.1 mm? -119.61 145.63 46.25 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 123.335 0.654 . . . . 0.0 110.632 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -113.22 166.17 12.11 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.91 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.401 ' HB2' ' H ' ' A' ' 63' ' ' VAL . 41.3 p-80 -62.47 122.76 16.55 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.256 0.55 . . . . 0.0 111.796 -178.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 92.15 -0.72 72.55 Favored Glycine 0 N--CA 1.433 -1.512 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.47 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.1 m -112.34 146.54 38.11 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 4.5 m -133.56 160.66 36.82 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.41 HD11 HD21 ' A' ' 88' ' ' LEU . 49.2 mt -93.63 130.98 41.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 173.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -70.39 -47.42 60.92 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.245 0.545 . . . . 0.0 110.938 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.444 ' HA ' HG22 ' A' ' 33' ' ' THR . 5.2 m-20 -143.69 98.42 3.24 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -64.66 -30.04 71.05 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.649 0.738 . . . . 0.0 110.518 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.9 t -63.61 -22.8 67.09 Favored 'General case' 0 CA--C 1.555 1.155 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.9 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -95.36 -6.69 40.49 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.101 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.6 m -70.46 -40.55 73.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.118 0.485 . . . . 0.0 111.026 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 156.91 -65.0 0.31 Allowed Glycine 0 CA--C 1.491 -1.462 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.422 ' CD2' ' HB3' ' A' ' 77' ' ' ASP . 39.7 p90 -109.17 145.55 35.6 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.26 -9.12 13.47 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.351 177.741 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.39 106.55 2.57 Favored Glycine 0 N--CA 1.43 -1.73 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.614 -177.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 84.7 mt -91.38 115.08 29.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.43 ' HB3' ' C ' ' A' ' 78' ' ' ASN . 5.1 t -86.41 -26.61 24.65 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.847 177.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 90.1 p -150.81 155.73 39.81 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.344 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.7 mt -136.22 130.89 48.47 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -176.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.513 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 35.9 ttmt -117.52 133.67 55.7 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -101.37 121.93 42.81 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' CYS . . . . . 0.473 ' SG ' ' HD2' ' A' ' 74' ' ' TYR . 50.4 m -119.49 172.18 7.82 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -177.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.5 pt -129.02 144.3 38.6 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 57.3 tt0 -115.21 123.8 49.79 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 45.3 p -77.58 177.14 8.3 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.14 -175.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -66.4 -23.81 66.38 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.657 0.741 . . . . 0.0 109.288 176.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -76.95 -9.42 58.68 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.522 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.22 -1.75 80.31 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 116.219 -0.446 . . . . 0.0 113.261 177.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 113' ' ' GLN . 7.2 ptpp? -83.81 143.87 29.65 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.964 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 17.8 t -103.82 112.23 36.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -100.59 149.95 23.21 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 1.7 t -141.78 146.19 35.64 Favored 'General case' 0 CA--C 1.48 -1.732 0 C-N-CA 117.972 -1.491 . . . . 0.0 110.002 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 8.9 tp -128.15 122.95 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.172 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.644 175.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -89.65 122.52 32.86 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 119.168 -1.013 . . . . 0.0 108.732 176.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 . . . . . 0 C--N 1.291 -1.95 0 CA-C-O 118.085 -0.96 . . . . 0.0 110.054 -177.713 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.703 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.68 -38.87 73.78 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.122 0.487 . . . . 0.0 110.576 -177.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -94.97 1.59 55.25 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.536 0.684 . . . . 0.0 110.916 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.5 m -89.2 124.41 34.34 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 175.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 21.5 p -113.8 140.71 48.08 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.64 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.45 ' HE3' ' HA ' ' A' ' 63' ' ' VAL . 9.7 mmmm -71.07 143.04 50.82 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.898 176.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 69.08 33.4 3.4 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 121.376 0.608 . . . . 0.0 111.905 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 36.4 m -124.58 145.92 49.33 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.575 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 54.7 tp -98.25 119.68 37.33 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 174.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.468 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 64.6 mt-30 -113.68 124.55 52.58 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 3.6 mp -109.59 131.06 55.41 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.038 177.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -90.81 156.29 18.15 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 123.763 0.664 . . . . 0.0 110.64 -176.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -77.06 -41.42 42.49 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.436 -176.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.445 ' C ' ' HA3' ' A' ' 56' ' ' GLY . 45.4 mt-10 -113.14 177.55 4.59 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.567 ' O ' ' HB2' ' A' ' 36' ' ' ARG . 2.0 p -82.58 174.81 10.7 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 23.4 p90 47.35 40.22 10.32 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.398 1.079 . . . . 0.0 113.617 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 65.46 26.66 11.84 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.59 1.156 . . . . 0.0 111.334 176.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.567 ' HB2' ' O ' ' A' ' 33' ' ' THR . 6.5 mmm180 -89.64 147.65 23.78 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.743 0.783 . . . . 0.0 111.939 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.17 -161.0 28.74 Favored Glycine 0 N--CA 1.419 -2.434 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.35 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.2 m -97.43 -177.14 3.72 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.438 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 50.4 p90 -142.16 165.97 25.99 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.4 tt -113.6 153.48 15.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -106.3 125.94 51.62 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.524 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 92.4 t -127.18 133.73 67.54 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 175.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -115.99 -31.86 5.59 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-O 121.113 0.482 . . . . 0.0 109.953 -176.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.43 161.85 33.43 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.512 -176.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.5 m -61.02 143.99 54.26 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.703 -175.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.6 p -121.37 136.94 56.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 176.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.31 -18.08 27.37 Favored Glycine 0 N--CA 1.435 -1.387 0 C-N-CA 120.077 -1.058 . . . . 0.0 113.907 -175.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.9 t -156.98 128.61 7.06 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 117.451 0.626 . . . . 0.0 109.57 -178.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 94.5 mt -120.17 119.67 33.93 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.208 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 20.7 p -131.7 107.96 14.29 Favored Pre-proline 0 C--N 1.298 -1.638 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.268 176.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 90.3 Cg_endo -77.73 162.68 89.52 Favored 'Cis proline' 0 C--O 1.242 0.718 0 C-N-CA 123.896 -1.294 . . . . 0.0 111.33 -1.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.45 156.31 42.18 Favored 'Trans proline' 0 C--O 1.243 0.753 0 C-N-CA 122.521 2.147 . . . . 0.0 109.879 176.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -89.65 129.62 36.06 Favored 'General case' 0 C--N 1.288 -2.088 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.13 -177.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.586 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 40.9 p -111.37 80.75 2.71 Favored Pre-proline 0 N--CA 1.424 -1.757 0 O-C-N 123.697 0.623 . . . . 0.0 110.537 176.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.412 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 91.8 Cg_endo -80.25 158.62 23.15 Favored 'Trans proline' 0 N--CA 1.443 -1.458 0 C-N-CA 122.22 1.946 . . . . 0.0 111.776 177.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.445 ' HA3' ' C ' ' A' ' 32' ' ' GLU . . . -86.73 -39.03 7.78 Favored Glycine 0 N--CA 1.425 -2.076 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 176.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.542 ' HB2' ' O ' ' A' ' 94' ' ' ILE . 72.9 p -147.65 160.96 42.1 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.417 HG22 HD23 ' A' ' 29' ' ' LEU . 42.6 t -137.11 142.23 38.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -177.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 36.9 t -145.52 149.1 34.0 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 119.704 -0.799 . . . . 0.0 111.386 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.9 t -116.78 125.2 28.54 Favored Pre-proline 0 N--CA 1.443 -0.78 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.0 143.66 99.38 Favored 'Trans proline' 0 C--O 1.242 0.688 0 C-N-CA 123.222 2.614 . . . . 0.0 112.53 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -70.99 122.0 19.21 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.661 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.45 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 93.4 t -96.67 115.39 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 CA-C-O 121.49 0.662 . . . . 0.0 109.57 177.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -101.72 -6.46 23.67 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 113.981 -1.463 . . . . 0.0 110.441 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -58.42 144.74 40.95 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 125.123 1.369 . . . . 0.0 112.034 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.2 m -55.68 -7.52 0.29 Allowed 'General case' 0 CA--C 1.571 1.772 0 C-N-CA 125.708 1.603 . . . . 0.0 113.105 -178.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -64.47 140.92 58.92 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.233 0.54 . . . . 0.0 110.183 178.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.562 ' HB2' ' OE2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -81.19 -28.11 35.08 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.032 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.562 ' OE2' ' HB2' ' A' ' 68' ' ' ARG . 2.4 mp0 -94.35 125.77 39.2 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.3 152.69 42.06 Favored Pre-proline 0 C--N 1.289 -2.058 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.388 174.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.52 134.78 21.04 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 121.505 1.47 . . . . 0.0 110.733 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -129.03 138.33 51.85 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.575 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 87.5 m95 -119.25 133.48 55.73 Favored 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.933 -173.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.507 ' HA ' ' O ' ' A' ' 86' ' ' THR . 24.6 m-85 -113.73 140.0 48.63 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.913 176.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.3 mt -125.31 142.74 51.33 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.583 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 84.8 m-85 -132.35 143.7 50.04 Favored 'General case' 0 C--N 1.32 -0.71 0 O-C-N 123.57 0.543 . . . . 0.0 110.903 -176.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -84.75 0.27 51.2 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.373 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -137.54 163.65 30.65 Favored 'General case' 0 N--CA 1.417 -2.092 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.6 m -75.5 168.95 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 C-N-CA 123.044 0.538 . . . . 0.0 111.151 -176.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.9 m120 58.06 30.73 19.71 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.894 0.746 . . . . 0.0 111.065 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.592 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 9.6 m-85 59.44 39.14 22.3 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.98 1.312 . . . . 0.0 111.713 177.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 81.0 p -112.28 170.62 8.04 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.548 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.9 -143.67 16.69 Favored Glycine 0 N--CA 1.421 -2.352 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.167 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.583 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 62.6 mtt85 -75.15 140.36 43.31 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 124.17 0.988 . . . . 0.0 108.905 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.2 tt -118.09 137.5 51.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-O 121.016 0.436 . . . . 0.0 109.891 -175.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 87.9 m -130.83 121.47 25.37 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 176.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -109.14 120.65 5.9 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.779 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.415 HD21 HD11 ' A' ' 94' ' ' ILE . 2.7 mm? -115.35 145.36 42.58 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 122.85 0.46 . . . . 0.0 110.757 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -120.2 167.8 13.71 Favored Glycine 0 N--CA 1.429 -1.822 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.284 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -58.25 123.42 15.98 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 123.434 0.694 . . . . 0.0 112.47 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.14 4.65 71.33 Favored Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.247 177.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.5 m -116.93 146.43 42.98 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.7 m -138.23 154.16 49.09 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.542 ' O ' ' HB2' ' A' ' 57' ' ' SER . 41.3 mt -94.58 126.03 47.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 173.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -70.84 -46.24 63.06 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 121.185 0.517 . . . . 0.0 111.391 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.587 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 3.1 m-20 -131.6 96.34 3.95 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.413 ' HA ' HG21 ' A' ' 94' ' ' ILE . 64.6 t80 -63.87 -36.72 84.84 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.302 0.572 . . . . 0.0 110.665 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.5 t -63.81 -27.84 69.45 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.036 -0.983 . . . . 0.0 112.405 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.587 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 30.3 mmtp -90.53 -9.92 45.45 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -177.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.2 m -84.75 7.61 20.01 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.135 -176.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 132.8 -84.69 0.29 Allowed Glycine 0 N--CA 1.421 -2.326 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.479 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -110.24 150.4 28.75 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.586 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -112.52 -9.79 13.76 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.062 177.9 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -107.7 104.05 2.02 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.907 -176.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 68.0 mt -87.01 115.74 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.808 0 CA-C-O 122.476 1.131 . . . . 0.0 108.839 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 44.3 m -86.44 -29.9 22.47 Favored 'General case' 0 N--CA 1.388 -3.573 0 CA-C-N 112.295 -2.229 . . . . 0.0 114.71 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 81.2 p -154.43 158.64 40.28 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 177.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.1 mt -136.22 132.05 49.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -176.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.592 ' HE2' ' CD2' ' A' ' 81' ' ' TYR . 37.3 ttmt -117.71 127.73 54.21 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -96.94 121.25 38.61 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' CYS . . . . . 0.495 ' SG ' ' HD2' ' A' ' 74' ' ' TYR . 57.2 m -121.29 172.83 7.73 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 124.047 0.939 . . . . 0.0 108.68 -177.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.5 pt -124.09 140.44 47.48 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 176.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -115.0 127.47 55.69 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 61.7 p -79.21 179.76 7.2 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.766 -172.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -67.21 -29.38 69.02 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.945 177.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.544 ' OD1' ' HG2' ' A' ' 118' ' ' LYS . 1.9 p-10 -84.38 -7.81 59.19 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.92 -177.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.06 3.9 58.84 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.384 -0.912 . . . . 0.0 114.426 175.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.544 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 21.7 ptmt -84.03 145.82 28.29 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 118.067 0.934 . . . . 0.0 109.16 176.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 17.1 t -107.51 116.51 51.23 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -101.68 140.95 35.27 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -147.26 160.05 42.94 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 7.8 tp -120.96 119.98 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.335 0 CA-C-O 121.5 0.667 . . . . 0.0 110.21 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -84.05 106.91 16.07 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 . . . . . 0 C--N 1.287 -2.134 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -178.445 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.854 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.39 41.82 0.96 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.664 0.745 . . . . 0.0 109.637 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -76.91 -24.48 52.47 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -178.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.3 m -106.63 123.61 48.37 Favored 'General case' 0 N--CA 1.404 -2.727 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.931 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.3 p -105.64 153.78 21.33 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 174.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -83.59 126.61 33.01 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.996 -174.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 74.37 41.25 0.38 Allowed 'General case' 0 N--CA 1.476 0.872 0 O-C-N 124.674 1.234 . . . . 0.0 111.324 177.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 22.9 m -123.37 148.47 46.01 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.813 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.577 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 55.7 tp -103.28 117.17 33.91 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 174.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.51 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 27.1 mt-30 -109.92 124.22 51.0 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.56 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.476 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.4 mp -109.98 123.45 49.68 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.613 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -92.0 152.76 19.84 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 123.729 0.643 . . . . 0.0 110.233 -177.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -75.93 -36.45 59.37 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.353 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -107.84 177.95 4.67 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 96' ' ' ASP . 7.0 p -82.28 173.13 12.37 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.606 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 26.2 p90 46.46 42.11 10.4 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 114.703 1.372 . . . . 0.0 114.703 176.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 68.05 23.26 8.16 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.889 0.876 . . . . 0.0 111.825 177.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.423 ' HE ' ' HB3' ' A' ' 36' ' ' ARG . 4.2 mtp180 -94.85 164.41 12.93 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 177.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.48 -167.35 50.4 Favored Glycine 0 N--CA 1.426 -2.002 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -175.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.6 m -91.98 177.82 6.06 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 174.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 44.6 p90 -140.39 166.14 25.52 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -178.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.51 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 11.8 tt -114.05 152.65 15.69 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -106.99 125.65 51.28 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 93.5 t -123.48 133.7 68.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -119.12 -24.16 6.58 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.089 0.471 . . . . 0.0 110.444 -175.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.23 161.93 29.03 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.82 -175.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.7 m -74.43 144.96 44.05 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.119 0.485 . . . . 0.0 110.8 -178.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.0 p -121.75 137.31 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 177.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -97.12 -23.11 15.48 Favored Glycine 0 C--N 1.292 -1.914 0 C-N-CA 120.07 -1.062 . . . . 0.0 113.173 -177.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.9 m -148.84 128.35 13.12 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 122.317 -0.52 . . . . 0.0 110.565 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 83.7 mt -122.02 118.05 27.85 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 176.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 5.0 m -132.81 112.11 13.57 Favored Pre-proline 0 C--N 1.3 -1.581 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 177.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 71.7 Cg_endo -76.91 161.89 92.6 Favored 'Cis proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.076 -1.635 . . . . 0.0 110.841 -0.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -61.52 157.49 41.23 Favored 'Trans proline' 0 C--O 1.243 0.741 0 C-N-CA 122.508 2.138 . . . . 0.0 110.73 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.432 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 48.6 m0 -89.54 139.22 30.75 Favored 'General case' 0 CA--C 1.484 -1.587 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -178.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 30.1 p -118.47 78.61 14.83 Favored Pre-proline 0 C--N 1.304 -1.371 0 C-N-CA 120.544 -0.462 . . . . 0.0 111.888 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.476 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 85.0 Cg_endo -78.4 157.45 29.19 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.565 2.177 . . . . 0.0 112.996 177.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -93.18 -29.63 10.12 Favored Glycine 0 N--CA 1.431 -1.635 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 177.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.4 p -153.68 151.16 29.34 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.4 t -128.84 142.83 42.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 37.2 t -145.82 149.47 34.38 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.442 176.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 49.0 t -118.81 122.55 29.71 Favored Pre-proline 0 N--CA 1.435 -1.213 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 176.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.3 143.41 83.06 Favored 'Trans proline' 0 C--O 1.244 0.791 0 C-N-CA 122.86 2.373 . . . . 0.0 112.0 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -66.55 125.89 27.18 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 121.465 0.65 . . . . 0.0 110.473 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.401 HG13 ' OD2' ' A' ' 65' ' ' ASP . 59.8 t -101.01 124.2 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.758 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.337 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -120.34 20.63 11.9 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.988 0.899 . . . . 0.0 108.922 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.401 ' OD2' HG13 ' A' ' 63' ' ' VAL . 1.2 m-20 -58.24 145.74 36.44 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 113.982 -1.463 . . . . 0.0 113.187 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.9 m -60.14 -27.11 66.8 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 175.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -56.04 124.67 18.55 Favored 'General case' 0 C--O 1.251 1.156 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.343 173.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -77.54 -27.77 51.71 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.278 -177.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -83.02 125.67 31.7 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-O 122.001 0.905 . . . . 0.0 108.62 178.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 28.4 mmt85 -108.09 153.03 42.02 Favored Pre-proline 0 C--N 1.281 -2.377 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.424 -177.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -85.74 134.76 4.72 Favored 'Trans proline' 0 N--CA 1.441 -1.602 0 C-N-CA 121.281 1.321 . . . . 0.0 112.008 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -129.54 131.0 46.47 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.577 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 86.6 m95 -112.84 132.82 55.11 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.81 -173.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.534 ' HA ' ' O ' ' A' ' 86' ' ' THR . 37.6 m-85 -112.89 142.17 45.87 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.911 176.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.4 mt -125.58 142.65 51.39 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -176.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.524 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 82.5 m-85 -133.13 142.54 48.73 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 123.701 0.626 . . . . 0.0 109.895 -177.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.5 ' HB3' ' CD1' ' A' ' 102' ' ' PHE . 1.7 p-10 -87.89 0.35 55.96 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.566 -178.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -136.48 157.29 47.14 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 174.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.6 m -69.68 164.7 2.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 122.403 0.281 . . . . 0.0 111.674 -174.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 15.8 m120 59.83 31.22 20.66 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 123.575 0.75 . . . . 0.0 111.566 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.615 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 12.0 m-85 61.12 39.93 15.48 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.853 1.261 . . . . 0.0 111.735 177.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 72.4 p -112.16 171.48 7.48 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.116 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.59 -133.31 11.67 Favored Glycine 0 N--CA 1.428 -1.859 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.307 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.524 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 54.2 mtt180 -89.26 149.4 23.09 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 124.246 1.019 . . . . 0.0 109.058 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.6 tt -125.52 137.02 59.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 121.273 0.559 . . . . 0.0 110.59 -175.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 95.7 m -131.94 125.99 32.97 Favored 'General case' 0 C--N 1.287 -2.112 0 O-C-N 122.1 -0.375 . . . . 0.0 110.415 176.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -111.38 124.46 6.88 Favored Glycine 0 C--N 1.312 -0.784 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.553 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -116.8 144.79 44.06 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 122.967 0.507 . . . . 0.0 110.315 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -114.05 168.07 12.48 Favored Glycine 0 N--CA 1.435 -1.416 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.612 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 33.5 p80 -64.86 128.81 37.34 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 121.218 0.532 . . . . 0.0 111.899 -177.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.31 6.85 65.99 Favored Glycine 0 N--CA 1.426 -1.998 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.604 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.7 m -118.5 146.45 44.51 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 4.3 m -136.36 155.78 49.57 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 52.4 mt -94.01 128.29 45.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -70.81 -48.28 55.0 Favored 'General case' 0 C--N 1.313 -1.009 0 O-C-N 123.536 0.523 . . . . 0.0 110.5 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.46 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 10.6 m-20 -135.37 92.69 2.88 Favored 'General case' 0 CA--C 1.486 -1.488 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.917 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.41 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 65.6 t80 -64.97 -32.26 73.89 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.265 0.555 . . . . 0.0 109.763 177.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.1 t -63.56 -26.62 68.78 Favored 'General case' 0 CA--C 1.552 1.019 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.66 -178.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.46 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 73.7 mmtt -95.23 -6.61 41.14 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.527 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.6 m -84.4 39.44 0.73 Allowed 'General case' 0 C--O 1.244 0.778 0 CA-C-O 121.87 0.843 . . . . 0.0 111.488 -176.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.73 -78.77 1.69 Allowed Glycine 0 N--CA 1.424 -2.116 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.5 ' CD1' ' HB3' ' A' ' 77' ' ' ASP . 26.8 p90 -108.19 145.68 33.87 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -177.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -113.66 -10.46 13.09 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 177.421 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -104.19 110.22 3.55 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.308 -177.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 70.2 mt -95.01 115.7 34.52 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.658 0 CA-C-O 122.387 1.089 . . . . 0.0 108.868 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 57.8 m -86.04 -29.16 23.66 Favored 'General case' 0 N--CA 1.392 -3.357 0 CA-C-N 112.238 -2.255 . . . . 0.0 114.262 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 77.6 p -153.98 155.81 36.28 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.6 mt -134.73 131.15 53.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -176.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.615 ' HE2' ' CD2' ' A' ' 81' ' ' TYR . 34.4 ttmt -117.86 126.34 52.2 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -96.16 130.1 43.29 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 176.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 76.0 m -123.19 170.76 9.91 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 7.5 pt -125.06 142.35 42.24 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 176.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 53.6 tt0 -115.76 128.71 56.06 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.4 p -87.15 178.77 6.8 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.847 -174.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -63.16 -27.05 69.1 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.44 0.696 . . . . 0.0 109.186 174.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -81.05 -8.53 59.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.577 0.704 . . . . 0.0 110.739 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.37 -1.96 77.29 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.432 -0.889 . . . . 0.0 113.792 175.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 113' ' ' GLN . 8.8 ptpt -79.28 147.74 32.4 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.2 t -111.27 115.9 51.1 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -101.78 141.4 34.69 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 75.4 m -130.54 152.19 50.19 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.108 0.48 . . . . 0.0 111.993 -175.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 8.2 tp -125.16 132.7 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 CA-C-O 121.368 0.604 . . . . 0.0 110.264 177.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -91.74 111.61 23.2 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 . . . . . 0 C--N 1.305 -1.353 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -176.234 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.588 0 N-CA-C 112.211 -0.356 . . . . 0.0 112.211 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.16 -11.98 61.28 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.173 0.589 . . . . 0.0 111.825 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -77.31 -23.97 50.97 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.188 -0.914 . . . . 0.0 108.975 177.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.6 m -94.97 146.04 24.52 Favored 'General case' 0 N--CA 1.408 -2.57 0 CA-C-O 121.629 0.728 . . . . 0.0 110.548 -175.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 47.3 t -139.0 138.61 37.4 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 104.784 -2.302 . . . . 0.0 104.784 177.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -81.94 97.77 8.24 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.826 -0.749 . . . . 0.0 110.367 -173.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 69.41 67.17 0.26 Allowed 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.398 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.3 m -139.05 154.5 48.22 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -176.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.597 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 53.4 tp -110.06 125.62 53.14 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 176.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 74.2 mt-30 -112.68 123.71 50.91 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 121.461 0.648 . . . . 0.0 109.572 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.454 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.4 mp -110.8 124.82 52.75 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.681 177.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -94.07 153.34 18.19 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 123.418 0.449 . . . . 0.0 111.183 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.46 -36.01 58.14 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.064 -176.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -107.44 178.26 4.59 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.548 ' O ' ' HB2' ' A' ' 36' ' ' ARG . 2.6 p -80.67 169.36 17.72 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 119.674 -0.203 . . . . 0.0 110.556 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 35.4 p90 46.65 42.73 11.82 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.17 1.388 . . . . 0.0 114.47 176.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 61.7 33.42 18.01 Favored 'General case' 0 C--O 1.246 0.904 0 C-N-CA 123.979 0.912 . . . . 0.0 112.502 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.548 ' HB2' ' O ' ' A' ' 33' ' ' THR . 5.4 mmm180 -96.23 154.55 17.19 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.807 174.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.53 -165.74 39.12 Favored Glycine 0 N--CA 1.427 -1.964 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.8 m -88.7 171.84 9.69 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 175.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -137.44 166.59 23.47 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -176.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.5 tt -114.61 150.79 16.48 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.45 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 176.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -107.21 125.63 51.36 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.545 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 74.6 t -117.99 133.54 64.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -117.48 -30.05 5.64 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.335 0.588 . . . . 0.0 110.86 -174.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -113.54 163.58 14.75 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.782 -174.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.4 m -79.05 145.19 33.97 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 173.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.426 HG12 ' HB ' ' A' ' 108' ' ' ILE . 12.2 p -120.88 128.7 76.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -89.79 -20.26 44.37 Favored Glycine 0 N--CA 1.427 -1.952 0 C-N-CA 119.543 -1.313 . . . . 0.0 113.342 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.5 m -157.78 114.52 2.91 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.509 0.671 . . . . 0.0 111.471 -178.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 85.5 mt -102.2 119.4 38.74 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.094 177.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 55.7 p -131.28 110.62 15.24 Favored Pre-proline 0 N--CA 1.425 -1.702 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 174.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 3.1 Cg_exo -77.65 162.37 90.24 Favored 'Cis proline' 0 CA--C 1.539 0.75 0 C-N-CA 124.008 -1.247 . . . . 0.0 111.207 -1.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.12 154.97 67.61 Favored 'Trans proline' 0 C--O 1.246 0.888 0 C-N-CA 122.205 1.937 . . . . 0.0 110.89 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.415 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 49.7 m0 -90.26 137.05 32.66 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.352 -177.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 11.4 p -120.16 78.17 25.46 Favored Pre-proline 0 C--N 1.295 -1.787 0 O-C-N 123.672 0.607 . . . . 0.0 110.368 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.454 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 84.8 Cg_endo -78.26 157.4 29.69 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.379 2.053 . . . . 0.0 113.33 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -85.89 -34.91 12.06 Favored Glycine 0 N--CA 1.434 -1.477 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.3 p -150.9 156.26 40.83 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.408 HG22 HD23 ' A' ' 29' ' ' LEU . 38.6 t -130.61 141.84 45.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 37.7 t -146.14 150.4 35.82 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-O 121.248 0.546 . . . . 0.0 110.223 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.6 t -113.85 123.1 33.49 Favored Pre-proline 0 C--N 1.299 -1.607 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 176.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -57.47 136.79 78.11 Favored 'Trans proline' 0 C--O 1.247 0.941 0 C-N-CA 122.735 2.29 . . . . 0.0 111.554 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.472 ' CE2' ' HB3' ' A' ' 64' ' ' ASN . 72.8 t80 -72.71 112.58 8.88 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.286 -177.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 44.7 t -93.84 115.15 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.825 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 175.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.472 ' HB3' ' CE2' ' A' ' 62' ' ' PHE . 27.3 p-10 -109.75 15.46 22.74 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-O 122.305 1.05 . . . . 0.0 108.67 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -75.69 147.31 39.52 Favored 'General case' 0 C--N 1.284 -2.279 0 CA-C-N 113.739 -1.573 . . . . 0.0 112.106 -174.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.0 m -52.33 -21.7 3.81 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 126.999 2.12 . . . . 0.0 114.022 -172.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -58.53 137.04 57.67 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.531 0.681 . . . . 0.0 111.803 -176.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -68.31 -23.3 64.72 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 124.892 1.277 . . . . 0.0 113.002 -171.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.452 ' HG3' HG22 ' A' ' 114' ' ' THR . 19.9 mp0 -109.76 128.48 55.32 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.9 148.81 37.18 Favored Pre-proline 0 C--N 1.298 -1.668 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 174.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -77.44 137.95 17.07 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 C-N-CA 121.657 1.571 . . . . 0.0 112.564 -177.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -131.73 127.79 37.55 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.597 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 77.5 m95 -110.99 138.05 47.87 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -171.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.482 ' HA ' ' O ' ' A' ' 86' ' ' THR . 34.3 m-85 -116.09 142.9 46.19 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.339 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.436 HD21 HD21 ' A' ' 27' ' ' LEU . 19.4 mt -125.68 142.42 51.52 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 -176.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -133.65 139.96 46.78 Favored 'General case' 0 CA--C 1.503 -0.852 0 O-C-N 123.734 0.647 . . . . 0.0 109.498 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.536 ' HB3' ' CG ' ' A' ' 102' ' ' PHE . 3.6 p-10 -77.82 -15.78 58.81 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -177.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.498 ' C ' ' HB3' ' A' ' 106' ' ' SER . 6.0 t-20 -121.43 166.74 13.67 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.1 m -71.71 165.62 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 C-N-CA 122.905 0.482 . . . . 0.0 111.915 -176.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 13.5 m120 57.13 31.2 19.59 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.888 0.875 . . . . 0.0 112.322 176.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.467 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 6.5 m-85 59.9 48.82 8.45 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 125.098 1.359 . . . . 0.0 110.895 177.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 81.6 p -120.68 168.46 11.38 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 116.229 -0.442 . . . . 0.0 109.901 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.59 -138.44 14.28 Favored Glycine 0 N--CA 1.421 -2.327 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -81.77 157.04 24.65 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 123.85 0.86 . . . . 0.0 109.616 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.8 tt -129.75 137.1 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 CA-C-O 121.494 0.664 . . . . 0.0 110.805 -175.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 96.9 m -131.99 128.37 38.25 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -114.78 130.28 9.12 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.815 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.505 HD21 HD11 ' A' ' 94' ' ' ILE . 3.7 mm? -121.3 147.56 45.5 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 123.076 0.55 . . . . 0.0 111.161 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.89 168.5 12.81 Favored Glycine 0 N--CA 1.433 -1.517 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.833 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -62.97 122.39 15.89 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.315 0.579 . . . . 0.0 111.769 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.51 -2.63 77.89 Favored Glycine 0 N--CA 1.433 -1.54 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.23 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.0 m -107.07 146.18 31.52 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.1 m -140.88 157.83 44.82 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.505 HD11 HD21 ' A' ' 88' ' ' LEU . 52.1 mt -94.01 132.72 37.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 175.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -71.26 -48.66 49.63 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 121.579 0.704 . . . . 0.0 109.852 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.596 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 13.3 m-20 -132.24 96.48 3.89 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.847 178.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.415 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 61.5 t80 -65.57 -37.32 86.35 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.466 0.65 . . . . 0.0 110.01 175.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.4 t -63.91 -27.93 69.49 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.174 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.596 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 29.1 mmtp -89.19 -7.71 55.04 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 122.044 -0.41 . . . . 0.0 110.341 -178.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.8 m -80.34 -174.37 4.55 Favored 'General case' 0 C--O 1.257 1.493 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -50.26 -66.48 2.34 Favored Glycine 0 CA--C 1.507 -0.447 0 O-C-N 123.38 0.425 . . . . 0.0 113.62 -177.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.536 ' CG ' ' HB3' ' A' ' 77' ' ' ASP . 34.0 p90 -110.83 149.74 30.14 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 119.732 -0.175 . . . . 0.0 110.659 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.03 -12.16 13.25 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.542 177.646 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -112.17 116.19 4.03 Favored Glycine 0 N--CA 1.428 -1.841 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -177.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 70.0 mt -95.46 114.96 33.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.498 ' HB3' ' C ' ' A' ' 78' ' ' ASN . 1.8 t -86.77 -25.08 24.83 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.024 177.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 89.1 p -153.08 155.18 36.33 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 122.325 -0.234 . . . . 0.0 110.474 177.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.426 ' HB ' HG12 ' A' ' 46' ' ' VAL . 47.2 mt -133.02 132.57 58.94 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -175.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.467 ' HE2' ' CD2' ' A' ' 81' ' ' TYR . 37.9 ttmt -116.53 127.53 54.62 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.255 -1.016 . . . . 0.0 108.255 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -95.61 129.16 42.89 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 69.7 m -125.38 172.11 9.89 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 8.0 pt -128.07 143.11 41.93 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 59.7 tt0 -117.09 119.48 35.38 Favored 'General case' 0 C--N 1.277 -2.548 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.452 HG22 ' HG3' ' A' ' 69' ' ' GLU . 32.0 p -81.9 179.97 7.62 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.255 -171.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -65.36 -25.12 67.44 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.764 174.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -80.78 -7.81 59.5 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.852 0.834 . . . . 0.0 110.097 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.24 -9.78 76.63 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.803 175.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.449 ' HE2' ' HG2' ' A' ' 120' ' ' GLU . 19.6 ptmt -73.49 140.03 46.13 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 21.6 t -103.36 112.3 36.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.449 ' HG2' ' HE2' ' A' ' 118' ' ' LYS . 24.7 mt-10 -98.01 138.03 35.93 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 80.1 m -130.59 152.14 50.28 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -174.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 8.1 tp -79.01 122.59 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.822 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -85.81 108.33 18.06 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 . . . . . 0 C--N 1.298 -1.672 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.229 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.04 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -164.04 158.08 19.07 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -78.45 -23.98 46.26 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.248 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.6 m -118.64 132.96 56.18 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 20.1 p -102.56 166.34 10.58 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -100.5 130.88 46.64 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 -172.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 70.96 39.91 0.96 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.327 0.651 . . . . 0.0 111.584 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.9 m -123.88 158.96 30.72 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.634 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 57.2 tp -107.24 118.97 38.12 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 171.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 39.4 mt-30 -111.23 124.14 51.61 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.619 -0.832 . . . . 0.0 108.951 -178.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.8 mp -110.24 126.71 54.44 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.115 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -96.38 151.31 19.66 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 123.572 0.545 . . . . 0.0 109.598 -177.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -74.07 -37.75 64.14 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.139 0.495 . . . . 0.0 111.107 -177.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -108.32 177.44 4.79 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.457 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.457 HG22 ' HA ' ' A' ' 96' ' ' ASP . 2.2 p -81.16 172.54 13.54 Favored 'General case' 0 N--CA 1.413 -2.309 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 11.7 p90 47.6 35.4 4.36 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.852 0.861 . . . . 0.0 113.24 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 61.85 38.65 14.52 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.851 1.26 . . . . 0.0 113.591 177.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -103.46 178.17 4.63 Favored 'General case' 0 C--O 1.248 0.981 0 C-N-CA 120.126 -0.629 . . . . 0.0 112.007 175.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.7 -154.79 40.33 Favored Glycine 0 N--CA 1.425 -2.09 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -176.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.4 m -100.57 174.61 6.0 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 172.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -136.87 165.66 25.44 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 16.6 tt -116.21 152.45 17.92 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.483 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -106.8 125.15 50.63 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 98.0 t -120.78 133.94 65.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -121.72 -27.73 4.65 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.506 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 10.5 mmpt? -109.72 162.68 14.21 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.655 -173.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.8 m -82.75 141.82 32.09 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 175.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.1 p -120.79 130.54 74.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -89.51 -17.85 53.84 Favored Glycine 0 N--CA 1.43 -1.722 0 C-N-CA 119.722 -1.227 . . . . 0.0 113.308 -176.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.8 p -156.54 130.78 8.61 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 85.5 mt -124.11 117.46 24.71 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 175.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 40.0 m -133.45 113.49 13.18 Favored Pre-proline 0 C--N 1.293 -1.859 0 CA-C-O 120.407 0.146 . . . . 0.0 110.947 175.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 7.3 Cg_exo -75.07 162.22 93.25 Favored 'Cis proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.179 -1.592 . . . . 0.0 111.336 -0.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.58 159.29 24.48 Favored 'Trans proline' 0 C--O 1.245 0.842 0 C-N-CA 122.705 2.27 . . . . 0.0 111.615 177.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.505 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 43.9 m0 -88.93 138.91 30.98 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 21.8 p -116.66 78.52 8.93 Favored Pre-proline 0 C--N 1.3 -1.584 0 O-C-N 123.579 0.55 . . . . 0.0 110.747 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.481 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 92.3 Cg_endo -79.79 153.17 22.7 Favored 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 122.001 1.8 . . . . 0.0 112.589 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.67 -27.11 18.14 Favored Glycine 0 N--CA 1.425 -2.094 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.4 p -155.1 151.73 28.66 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.7 t -132.17 142.65 42.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 35.8 t -145.53 146.78 31.56 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 119.577 -0.849 . . . . 0.0 111.647 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.0 t -113.61 124.66 30.81 Favored Pre-proline 0 N--CA 1.435 -1.209 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 176.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -59.58 145.61 97.56 Favored 'Trans proline' 0 C--O 1.244 0.798 0 C-N-CA 123.115 2.543 . . . . 0.0 112.587 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -74.06 114.75 12.73 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.172 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 91.9 t -95.66 115.73 35.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -110.26 8.16 23.44 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 122.423 1.106 . . . . 0.0 108.713 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.76 145.02 56.55 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.884 -178.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.8 m -67.85 -7.09 25.06 Favored 'General case' 0 CA--C 1.566 1.587 0 C-N-CA 124.995 1.318 . . . . 0.0 110.882 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -51.96 133.47 32.51 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 124.884 1.274 . . . . 0.0 110.311 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.3 tpp180 -70.59 -26.6 63.59 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.179 -172.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -111.33 134.16 53.12 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 122.707 0.403 . . . . 0.0 110.154 176.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.8 153.82 37.95 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 170.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.11 135.12 12.04 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 C-N-CA 121.958 1.772 . . . . 0.0 111.367 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -130.06 136.3 49.21 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.634 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 85.2 m95 -119.21 133.55 55.7 Favored 'General case' 0 C--N 1.291 -1.953 0 C-N-CA 120.134 -0.626 . . . . 0.0 112.241 -173.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.456 ' HA ' ' O ' ' A' ' 86' ' ' THR . 33.7 m-85 -114.9 140.16 49.21 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.143 177.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.6 mt -125.28 142.74 51.32 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -175.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.454 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 78.7 m-85 -133.35 142.28 48.34 Favored 'General case' 0 C--N 1.317 -0.833 0 O-C-N 123.576 0.548 . . . . 0.0 110.423 -175.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -85.27 0.01 53.3 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 120.767 0.317 . . . . 0.0 111.049 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -137.47 158.87 43.47 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.4 m -71.59 166.6 2.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 C-N-CA 122.99 0.516 . . . . 0.0 111.577 -175.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 30.5 m120 57.87 30.13 18.6 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.008 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.467 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 9.3 m-85 58.74 47.11 13.3 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 125.019 1.327 . . . . 0.0 111.235 177.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 73.2 p -118.37 173.5 6.78 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.18 -133.34 11.72 Favored Glycine 0 N--CA 1.433 -1.512 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.933 176.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.454 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 56.0 mtt85 -80.83 148.67 29.87 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 123.143 0.577 . . . . 0.0 109.618 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.4 tt -127.27 137.58 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 -177.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 98.2 m -131.24 126.08 34.54 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 176.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -115.16 115.29 3.4 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.491 -0.861 . . . . 0.0 113.745 -177.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -108.32 144.81 35.35 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 122.466 0.306 . . . . 0.0 110.771 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.17 170.76 13.46 Favored Glycine 0 N--CA 1.429 -1.772 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.003 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -64.33 130.75 45.01 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.315 0.578 . . . . 0.0 111.918 -176.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.71 8.23 80.3 Favored Glycine 0 N--CA 1.428 -1.84 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.794 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.3 m -121.32 146.25 47.04 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.9 m -136.33 156.93 47.94 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 50.5 mt -93.59 127.84 45.39 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 172.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -69.07 -46.91 66.64 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.579 0.704 . . . . 0.0 109.447 -177.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.645 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 3.9 m-20 -139.73 98.98 3.59 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.205 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -65.08 -37.75 88.53 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.337 0.589 . . . . 0.0 110.672 178.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.7 t -69.53 -17.93 63.62 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.461 -177.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.645 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 28.9 mmtp -89.95 -6.19 55.94 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.638 -0.664 . . . . 0.0 109.386 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.0 t -85.02 -163.78 0.89 Allowed 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.41 -68.19 1.78 Allowed Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 116.798 -0.183 . . . . 0.0 113.151 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -110.61 147.61 33.91 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 122.488 -0.419 . . . . 0.0 109.917 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -112.43 -0.52 15.28 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.103 177.331 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.505 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -119.19 113.95 2.66 Favored Glycine 0 N--CA 1.436 -1.35 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.812 -176.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 69.2 mt -95.8 116.3 37.17 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.593 0 CA-C-O 122.312 1.053 . . . . 0.0 109.614 -178.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.4 m -85.62 -28.6 24.68 Favored 'General case' 0 N--CA 1.395 -3.193 0 CA-C-N 112.206 -2.27 . . . . 0.0 114.13 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 84.1 p -156.45 156.37 33.67 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 177.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.4 mt -135.18 130.81 51.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -176.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.467 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 37.3 ttmt -117.14 128.19 54.88 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -95.49 129.49 42.64 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 121.631 0.729 . . . . 0.0 109.213 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 82.2 m -125.55 172.68 9.52 Favored 'General case' 0 C--N 1.273 -2.739 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.875 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.404 HG13 ' HB2' ' A' ' 120' ' ' GLU . 7.6 pt -129.03 142.47 43.96 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.477 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -110.91 122.63 48.35 Favored 'General case' 0 C--N 1.278 -2.508 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 82.4 p -77.88 176.54 8.99 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.61 -174.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -66.96 -20.11 65.84 Favored 'General case' 0 C--N 1.316 -0.885 0 O-C-N 122.141 -0.35 . . . . 0.0 111.153 174.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.507 ' OD1' ' HG2' ' A' ' 118' ' ' LYS . 2.1 p30 -86.88 -7.61 58.05 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.264 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 94.17 -0.97 66.87 Favored Glycine 0 N--CA 1.441 -1.003 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.662 175.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.507 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 52.6 pttt -77.87 149.01 34.37 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 119.093 -1.043 . . . . 0.0 109.566 176.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.2 t -109.04 112.04 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.503 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.404 ' HB2' HG13 ' A' ' 112' ' ' ILE . 6.6 mm-40 -93.82 144.8 25.1 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 76.9 m -130.43 162.63 28.72 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.287 -175.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 7.5 tp -75.37 132.13 33.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -75.34 105.17 6.23 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-O 121.175 0.512 . . . . 0.0 110.378 -177.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 . . . . . 0 C--N 1.3 -1.551 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -177.393 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.901 0 N-CA-C 112.019 -0.433 . . . . 0.0 112.019 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.96 -22.34 64.12 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.639 0.733 . . . . 0.0 110.844 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -76.97 -12.74 59.98 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.432 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 43.7 m -110.68 147.91 33.36 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.7 p -102.32 146.86 27.42 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.236 177.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -69.19 127.97 34.99 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.423 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 74.0 39.04 0.54 Allowed 'General case' 0 N--CA 1.483 1.211 0 O-C-N 123.958 0.786 . . . . 0.0 111.764 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 36.7 m -123.82 154.68 39.24 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.554 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 44.0 tp -105.02 121.92 44.78 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 176.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.5 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 45.3 mt-30 -111.86 124.07 51.59 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.454 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.8 mp -110.26 123.88 50.6 Favored 'General case' 0 N--CA 1.42 -1.927 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.15 177.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -88.85 149.07 23.55 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -74.04 -38.42 64.01 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 120.983 0.42 . . . . 0.0 111.059 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -107.84 177.35 4.84 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.223 -176.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.43 HG22 ' HA ' ' A' ' 96' ' ' ASP . 1.0 OUTLIER -81.72 172.72 13.06 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.936 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.268 21.9 p90 47.49 37.8 6.87 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.793 1.237 . . . . 0.0 113.501 177.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 65.26 27.97 12.05 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 125.109 1.364 . . . . 0.0 113.717 178.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -97.55 172.67 7.58 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.426 0.631 . . . . 0.0 110.656 177.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.41 -166.17 37.92 Favored Glycine 0 N--CA 1.424 -2.158 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.3 m -100.68 176.76 5.2 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 173.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -143.89 165.34 28.01 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 120.469 -0.493 . . . . 0.0 110.843 -174.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 18.2 tt -114.31 152.72 15.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -107.21 125.62 51.35 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 98.7 t -119.71 136.71 55.96 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.384 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 177.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -117.43 -28.01 6.21 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.883 -176.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -107.47 163.04 13.4 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 -173.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.435 ' HB3' ' H ' ' A' ' 110' ' ' ARG . 4.5 p -89.6 141.69 28.37 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 172.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.418 HG12 ' HB ' ' A' ' 108' ' ' ILE . 8.3 p -120.55 132.91 68.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -174.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.96 -1.7 57.19 Favored Glycine 0 C--N 1.313 -0.746 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.456 -176.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.0 t -166.7 129.58 1.86 Allowed 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.067 0.46 . . . . 0.0 109.906 176.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 85.1 mt -122.41 117.78 26.82 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.0 m -133.25 112.8 13.22 Favored Pre-proline 0 C--N 1.288 -2.09 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 174.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.62 161.86 93.58 Favored 'Cis proline' 0 CA--C 1.549 1.249 0 C-N-CA 123.333 -1.528 . . . . 0.0 111.326 -1.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.81 158.33 43.14 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.948 2.432 . . . . 0.0 110.87 177.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.515 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 48.2 m0 -90.23 143.81 26.43 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -178.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 18.3 p -121.48 76.82 35.38 Favored Pre-proline 0 C--N 1.308 -1.203 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.454 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 92.3 Cg_endo -81.18 157.64 20.09 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.806 2.337 . . . . 0.0 112.624 177.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.0 -28.38 11.04 Favored Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.3 p -157.33 154.93 29.78 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.7 t -131.61 145.42 35.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -176.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 39.3 t -145.59 147.36 31.99 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.927 176.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.9 t -112.71 126.79 27.74 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 176.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -60.61 150.48 81.73 Favored 'Trans proline' 0 C--O 1.248 1.0 0 C-N-CA 122.983 2.455 . . . . 0.0 112.304 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.548 ' CE1' ' HB2' ' A' ' 64' ' ' ASN . 45.1 t80 -74.36 132.32 41.91 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.956 0.884 . . . . 0.0 111.555 -177.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 99.0 t -123.22 117.78 52.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.548 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 61.7 t30 -118.6 8.25 11.93 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 123.373 1.559 . . . . 0.0 106.842 178.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -60.21 145.03 48.68 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 112.413 -2.176 . . . . 0.0 113.539 -174.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 m -60.73 -7.12 2.06 Favored 'General case' 0 CA--C 1.564 1.509 0 C-N-CA 126.248 1.819 . . . . 0.0 112.568 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -58.54 142.84 47.89 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -74.33 -25.4 59.53 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.866 -174.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.459 ' HG2' HD12 ' A' ' 112' ' ' ILE . 4.5 mp0 -110.71 133.8 53.02 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.87 0.367 . . . . 0.0 111.74 177.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.32 150.33 37.0 Favored Pre-proline 0 C--N 1.307 -1.242 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 168.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -80.28 137.0 11.67 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.025 1.816 . . . . 0.0 111.813 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -132.17 137.72 47.75 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.554 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 89.9 m95 -122.07 132.43 54.49 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.16 0.505 . . . . 0.0 111.981 -174.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' A' ' 86' ' ' THR . 24.2 m-85 -112.74 142.77 44.98 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.434 177.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.5 mt -125.62 142.25 51.61 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -175.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.498 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 93.2 m-85 -132.85 141.47 48.45 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.403 0.62 . . . . 0.0 111.158 -175.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.758 ' HB2' ' CD2' ' A' ' 102' ' ' PHE . 9.0 t70 -85.99 -6.53 59.03 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.544 -177.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -140.06 156.87 46.4 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.727 173.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.738 ' HA ' ' OG ' ' A' ' 107' ' ' SER . 23.6 m -64.46 162.24 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.945 0 C-N-CA 123.655 0.782 . . . . 0.0 112.214 -175.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 62.44 29.86 17.19 Favored 'General case' 0 CA--C 1.511 -0.551 0 O-C-N 123.859 0.724 . . . . 0.0 109.305 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.455 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 16.1 m-85 56.49 50.93 12.08 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 114.433 -1.258 . . . . 0.0 111.415 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 60.5 p -123.52 177.59 5.58 Favored 'General case' 0 C--O 1.249 1.047 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.762 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.95 -107.96 3.53 Favored Glycine 0 N--CA 1.437 -1.267 0 N-CA-C 111.822 -0.511 . . . . 0.0 111.822 176.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 58.6 mtt85 -114.08 151.86 31.91 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.7 tt -128.65 140.04 50.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 O-C-N 123.712 0.632 . . . . 0.0 111.08 -174.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 24.4 m -132.49 125.42 30.61 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.429 174.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -115.17 107.25 1.73 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.83 -0.7 . . . . 0.0 114.321 -178.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -106.32 145.69 31.34 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 123.045 0.538 . . . . 0.0 111.468 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -123.33 172.64 16.17 Favored Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.678 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -50.23 127.86 18.06 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 124.262 1.025 . . . . 0.0 112.757 -177.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.97 -0.19 88.8 Favored Glycine 0 C--N 1.309 -0.925 0 CA-C-N 115.546 -0.752 . . . . 0.0 113.251 174.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.3 m -110.82 145.9 37.37 Favored 'General case' 0 N--CA 1.421 -1.92 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.543 -177.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.6 m -136.21 156.7 48.3 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 55.2 mt -92.81 135.81 26.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 176.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -70.53 -48.52 55.08 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.506 0.67 . . . . 0.0 110.421 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.579 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 3.2 m-20 -143.23 99.12 3.38 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -178.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -64.85 -38.37 90.76 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 121.263 0.554 . . . . 0.0 110.817 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.5 t -65.96 -21.01 66.39 Favored 'General case' 0 CA--C 1.558 1.257 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.903 -175.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.579 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 30.0 mmtp -92.83 -7.82 45.26 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.8 t -83.49 7.29 17.46 Favored 'General case' 0 C--O 1.25 1.123 0 CA-C-O 121.065 0.46 . . . . 0.0 111.492 -176.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 115.56 -62.51 0.35 Allowed Glycine 0 N--CA 1.436 -1.362 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 177.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.758 ' CD2' ' HB2' ' A' ' 77' ' ' ASP . 22.7 p90 -110.89 142.59 42.74 Favored 'General case' 0 N--CA 1.427 -1.59 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.144 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -114.01 -8.31 13.07 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.842 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.515 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -112.55 112.93 3.11 Favored Glycine 0 N--CA 1.422 -2.267 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.954 -174.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 70.1 mt -95.22 115.55 34.42 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 52.3 m -85.43 -26.69 26.22 Favored 'General case' 0 C--N 1.252 -3.652 0 CA-C-N 112.228 -2.26 . . . . 0.0 113.339 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.738 ' OG ' ' HA ' ' A' ' 79' ' ' VAL . 66.6 m -156.29 152.35 27.58 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.215 -0.303 . . . . 0.0 110.794 -177.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.418 ' HB ' HG12 ' A' ' 46' ' ' VAL . 40.3 mt -135.3 130.19 50.74 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.539 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -176.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.455 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 33.9 ttmt -117.53 131.18 56.75 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.435 ' H ' ' HB3' ' A' ' 45' ' ' SER . 55.9 ttp180 -101.42 123.37 45.38 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -177.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 36.1 m -119.71 171.15 8.59 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.459 HD12 ' HG2' ' A' ' 69' ' ' GLU . 8.4 pt -129.35 146.2 34.57 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.427 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 56.4 tt0 -117.79 118.21 31.42 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 17.2 p -78.8 179.67 7.08 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.253 -173.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -58.97 -28.21 66.1 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.635 0.731 . . . . 0.0 110.548 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -77.02 -7.99 56.63 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.9 -176.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.53 6.84 87.04 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.483 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 113' ' ' GLN . 26.2 pttm -87.84 139.28 30.69 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.0 t -103.22 112.44 36.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -102.78 146.01 28.89 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -138.88 149.08 44.46 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.307 -0.957 . . . . 0.0 109.663 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 6.2 tp -126.32 127.56 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.416 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.423 ' OD1' ' HE1' ' A' ' 81' ' ' TYR . 7.2 t30 -84.45 104.78 14.75 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 173.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 . . . . . 0 C--N 1.295 -1.792 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.28 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.741 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.84 49.2 1.57 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.984 0.897 . . . . 0.0 109.36 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -81.32 -16.24 53.02 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.777 -1.102 . . . . 0.0 110.706 -177.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.9 m -55.6 125.09 19.59 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.2 p -102.52 157.25 17.06 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.13 0.49 . . . . 0.0 112.129 -173.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -70.19 126.22 29.05 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.498 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 64.51 43.71 4.35 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 175.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.4 m -123.32 146.66 47.73 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.614 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 53.8 tp -92.52 121.32 33.85 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 172.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.501 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 65.0 mt-30 -114.17 123.7 50.24 Favored 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.635 -177.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 2.8 mp -110.34 119.08 38.06 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.339 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -82.04 145.01 30.44 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 123.521 0.513 . . . . 0.0 110.21 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -69.27 -39.79 78.17 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.598 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -108.37 177.39 4.81 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.435 HG22 ' HA ' ' A' ' 96' ' ' ASP . 1.1 p -83.1 177.18 8.7 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 122.601 0.36 . . . . 0.0 110.602 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.262 16.6 p90 47.39 42.2 13.76 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.886 1.275 . . . . 0.0 113.881 176.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 63.56 27.97 15.1 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.241 176.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.543 ' HA ' ' NE ' ' A' ' 36' ' ' ARG . 3.7 mmp_? -108.5 166.32 10.86 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.317 0.58 . . . . 0.0 110.969 178.076 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.38 173.74 47.29 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -177.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.3 p -86.28 154.78 21.01 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 40.8 p90 -117.6 165.84 13.09 Favored 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.218 -176.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.8 tt -114.23 153.26 15.77 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 178.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -105.96 126.03 51.7 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.535 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 92.8 t -123.33 133.4 69.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -118.08 -21.7 8.14 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.055 0.455 . . . . 0.0 110.668 -175.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -129.24 162.18 28.46 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.317 -175.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.454 ' HB3' ' H ' ' A' ' 110' ' ' ARG . 4.2 p -79.02 146.25 33.43 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.839 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.9 p -121.46 137.28 55.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.3 -18.43 39.17 Favored Glycine 0 C--N 1.316 -0.543 0 C-N-CA 119.903 -1.141 . . . . 0.0 113.864 -176.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.3 t -161.18 132.14 5.34 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.1 mt -121.31 118.94 30.77 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.313 178.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.5 m -132.61 110.42 13.5 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 175.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -76.71 160.24 95.28 Favored 'Cis proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.171 -1.595 . . . . 0.0 111.38 0.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.02 158.24 48.73 Favored 'Trans proline' 0 C--O 1.24 0.616 0 C-N-CA 122.31 2.006 . . . . 0.0 110.84 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 52.7 m0 -89.73 136.65 32.91 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 120.351 -0.54 . . . . 0.0 109.881 -177.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 20.2 p -118.73 77.07 14.35 Favored Pre-proline 0 N--CA 1.435 -1.207 0 O-C-N 123.493 0.495 . . . . 0.0 111.757 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.469 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 96.0 Cg_endo -76.4 158.52 36.68 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.387 2.058 . . . . 0.0 111.972 177.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -92.84 -31.58 8.56 Favored Glycine 0 N--CA 1.431 -1.685 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 175.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 94' ' ' ILE . 34.8 p -152.01 153.14 33.44 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.418 HG22 HD23 ' A' ' 29' ' ' LEU . 36.7 t -128.91 142.77 43.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -177.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 37.2 t -145.75 147.29 31.75 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.124 177.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 68.2 t -114.13 121.16 37.14 Favored Pre-proline 0 C--N 1.306 -1.296 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 175.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.03 148.17 78.55 Favored 'Trans proline' 0 C--O 1.246 0.905 0 C-N-CA 122.997 2.465 . . . . 0.0 112.315 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.424 ' CE2' ' HB3' ' A' ' 64' ' ' ASN . 76.4 t80 -71.63 111.56 7.03 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.36 0.6 . . . . 0.0 110.594 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.411 ' H ' ' HB2' ' A' ' 90' ' ' HIS . 48.7 t -94.51 115.29 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.98 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.585 178.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.424 ' HB3' ' CE2' ' A' ' 62' ' ' PHE . 23.7 p-10 -114.73 25.05 11.28 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 125.673 1.589 . . . . 0.0 108.14 178.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.53 ' HB3' ' NH2' ' A' ' 70' ' ' ARG . 16.6 t70 -66.92 146.22 54.63 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 112.867 -1.969 . . . . 0.0 112.396 -176.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.7 m -53.53 -18.49 2.85 Favored 'General case' 0 CA--C 1.57 1.745 0 C-N-CA 125.203 1.401 . . . . 0.0 113.747 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.518 ' HG2' ' OD2' ' A' ' 65' ' ' ASP . 33.4 mmtp -66.52 167.66 10.45 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.773 -0.579 . . . . 0.0 110.132 174.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -106.07 -15.91 14.76 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 175.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.3 mp0 -92.39 128.31 38.2 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.788 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.53 ' NH2' ' HB3' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -106.1 154.18 39.76 Favored Pre-proline 0 C--N 1.291 -1.966 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.306 178.625 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -81.9 135.1 8.64 Favored 'Trans proline' 0 N--CA 1.44 -1.629 0 C-N-CA 121.632 1.555 . . . . 0.0 111.002 178.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -129.12 120.91 26.7 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.614 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 87.0 m95 -106.66 133.93 50.59 Favored 'General case' 0 C--N 1.278 -2.543 0 CA-C-O 121.034 0.445 . . . . 0.0 111.953 -171.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 86' ' ' THR . 29.5 m-85 -112.39 140.56 47.01 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.499 177.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.4 mt -125.6 142.37 51.54 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -177.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 80.5 m-85 -134.48 140.84 46.5 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 123.892 0.745 . . . . 0.0 109.599 -176.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.37 -12.19 59.06 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.51 -177.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.504 ' C ' ' HB3' ' A' ' 106' ' ' SER . 5.1 t-20 -123.25 172.51 8.57 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.8 m -76.23 168.83 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 C-N-CA 123.415 0.686 . . . . 0.0 111.591 -176.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.3 m120 53.83 30.53 11.53 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.121 0.969 . . . . 0.0 112.431 176.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.555 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 8.2 m-85 63.0 39.44 10.19 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.577 176.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 81.4 p -111.91 170.65 8.0 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.67 -145.31 17.56 Favored Glycine 0 N--CA 1.429 -1.781 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.609 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.515 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 98.0 mtt180 -75.59 147.84 39.29 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 123.128 0.571 . . . . 0.0 109.636 178.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.5 tt -125.38 136.5 60.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 121.705 0.764 . . . . 0.0 110.442 -175.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 93.5 m -131.39 125.16 31.9 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.615 176.017 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -115.01 118.01 4.19 Favored Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.309 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -112.53 146.0 39.29 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 123.3 0.64 . . . . 0.0 111.146 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -117.94 172.89 14.57 Favored Glycine 0 N--CA 1.434 -1.474 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.127 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.439 ' CD2' ' HG2' ' A' ' 70' ' ' ARG . 2.6 p80 -62.46 132.43 52.47 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 121.272 0.558 . . . . 0.0 111.906 -176.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.8 15.17 79.84 Favored Glycine 0 N--CA 1.43 -1.7 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.766 176.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.8 m -127.22 146.2 50.5 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.7 m -137.55 156.34 48.21 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.436 ' O ' ' HB2' ' A' ' 57' ' ' SER . 46.0 mt -95.31 127.03 47.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 170.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -71.77 -46.34 58.71 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.354 0.597 . . . . 0.0 111.926 177.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.617 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 1.7 m-20 -129.4 96.11 4.2 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.144 178.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -64.69 -35.03 79.73 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.56 0.695 . . . . 0.0 110.34 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.4 t -67.66 -29.32 68.58 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.159 -175.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.617 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 29.4 mmtp -88.39 -6.68 57.54 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -178.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.1 m -80.64 -13.29 59.16 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.882 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 139.02 -70.47 0.46 Allowed Glycine 0 N--CA 1.431 -1.678 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -110.32 146.46 35.7 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -112.4 -9.96 13.8 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.715 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -109.48 115.54 4.27 Favored Glycine 0 N--CA 1.427 -1.932 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.747 -176.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 79.1 mt -98.77 116.27 41.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.504 ' HB3' ' C ' ' A' ' 78' ' ' ASN . 7.6 t -85.82 -29.9 23.4 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.52 177.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 93.6 p -148.57 155.4 41.06 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 121.872 -0.517 . . . . 0.0 111.273 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.1 mt -133.27 133.71 57.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -176.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.555 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 38.9 ttmt -116.13 132.97 56.51 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.454 ' H ' ' HB3' ' A' ' 45' ' ' SER . 46.3 ttp180 -102.77 118.25 36.42 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 64.6 m -120.14 170.23 9.5 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.2 pt -128.63 141.7 45.88 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.536 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 37.1 tt0 -113.02 122.62 48.15 Favored 'General case' 0 C--N 1.268 -2.967 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.483 ' OG1' ' HG2' ' A' ' 118' ' ' LYS . 30.8 p -76.4 -179.19 5.0 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -177.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -59.07 -29.72 67.54 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.31 0.576 . . . . 0.0 110.38 177.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -76.96 -9.1 58.46 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.782 -175.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.66 8.71 84.24 Favored Glycine 0 N--CA 1.421 -2.307 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.14 -176.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.483 ' HG2' ' OG1' ' A' ' 114' ' ' THR . 9.4 ptpp? -84.02 138.38 33.12 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 26.1 t -107.07 112.09 38.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.584 0.707 . . . . 0.0 111.356 -174.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -101.02 153.04 19.88 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 177.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 85.6 m -130.02 149.19 51.85 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.331 -175.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 10.3 tp -83.74 128.01 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -177.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -83.13 105.09 13.82 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -178.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 . . . . . 0 C--N 1.286 -2.186 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.404 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.099 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.32 -70.85 0.25 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 117.791 0.796 . . . . 0.0 109.944 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -113.55 -24.46 9.23 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 174.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.0 m -86.09 146.77 26.47 Favored 'General case' 0 N--CA 1.417 -2.088 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.618 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.4 ' HB3' ' HB2' ' A' ' 26' ' ' CYS . 47.9 t -143.13 137.58 29.2 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 178.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -77.26 102.25 6.6 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -177.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.458 ' CD2' ' HB3' ' A' ' 71' ' ' PRO . 4.7 m-85 70.5 50.65 0.38 Allowed 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.289 172.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 14.1 m -126.98 153.54 45.75 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.196 -1.366 . . . . 0.0 107.976 -178.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.596 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 53.0 tp -111.58 130.1 55.85 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 107.024 -1.472 . . . . 0.0 107.024 175.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.517 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 73.3 mt-30 -117.42 124.01 47.8 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.701 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.0 mp -110.47 121.93 46.5 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.163 178.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -87.8 151.92 22.51 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 123.577 0.548 . . . . 0.0 110.45 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -74.77 -39.98 61.47 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.091 -178.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -108.46 178.37 4.51 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.46 HG22 ' HA ' ' A' ' 96' ' ' ASP . 2.2 p -80.71 173.38 12.66 Favored 'General case' 0 N--CA 1.413 -2.31 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.594 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.276 21.6 p90 47.11 43.23 14.05 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 124.731 1.212 . . . . 0.0 114.231 177.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 65.97 23.11 11.23 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 124.379 1.072 . . . . 0.0 112.044 175.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.435 ' HA ' ' NE ' ' A' ' 36' ' ' ARG . 5.6 mmp_? -100.48 167.85 10.11 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.385 0.612 . . . . 0.0 112.279 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.02 -166.26 48.3 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -175.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.7 m -90.88 175.37 7.01 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.425 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 37.6 p90 -137.17 165.08 26.95 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 16.7 tt -114.6 152.61 16.21 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 176.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -107.05 124.95 50.39 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 175.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.55 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 94.2 t -114.03 133.64 59.4 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.555 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 177.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -115.06 -33.54 5.36 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.468 0.651 . . . . 0.0 110.028 -174.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.92 161.44 25.38 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.692 -177.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 p -75.72 149.25 38.09 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.465 0.65 . . . . 0.0 112.102 -176.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.409 HG12 ' HB ' ' A' ' 108' ' ' ILE . 10.6 p -121.18 137.38 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.98 -18.9 35.51 Favored Glycine 0 C--N 1.299 -1.478 0 C-N-CA 120.13 -1.033 . . . . 0.0 112.617 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.1 t -159.52 131.38 6.33 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 121.032 0.444 . . . . 0.0 110.159 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 91.1 mt -119.65 118.02 29.84 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.653 177.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 29.2 t -132.77 114.07 14.09 Favored Pre-proline 0 N--CA 1.419 -2.017 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 174.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 60.0 Cg_endo -74.81 161.87 93.88 Favored 'Cis proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.997 -1.668 . . . . 0.0 110.417 -2.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -63.18 156.08 57.54 Favored 'Trans proline' 0 C--O 1.257 1.441 0 C-N-CA 121.85 1.7 . . . . 0.0 110.636 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.481 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 45.5 m0 -89.1 135.4 33.58 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -177.049 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 15.3 p -116.18 76.58 6.73 Favored Pre-proline 0 C--N 1.292 -1.918 0 O-C-N 123.362 0.413 . . . . 0.0 111.318 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.434 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 85.6 Cg_endo -77.12 157.6 33.94 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 122.5 2.133 . . . . 0.0 112.903 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.69 -33.4 10.09 Favored Glycine 0 N--CA 1.431 -1.665 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.7 p -154.27 144.95 22.4 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.418 HG11 HD11 ' A' ' 75' ' ' LEU . 32.2 t -119.95 142.8 33.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 33.6 t -145.4 147.5 32.32 Favored 'General case' 0 N--CA 1.422 -1.84 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.228 177.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 80.5 t -111.35 122.3 37.97 Favored Pre-proline 0 C--N 1.296 -1.743 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 176.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -58.78 149.23 78.99 Favored 'Trans proline' 0 C--O 1.243 0.764 0 C-N-CA 122.892 2.395 . . . . 0.0 112.246 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -79.02 135.3 36.85 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 82.3 t -113.48 114.06 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 CA-C-O 120.981 0.42 . . . . 0.0 110.348 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -109.35 84.33 1.91 Allowed 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 173.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.7 ' OD1' ' HG2' ' A' ' 67' ' ' LYS . 12.0 t70 -128.27 145.97 50.89 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.633 -172.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.2 m -53.84 -19.52 4.52 Favored 'General case' 0 CA--C 1.59 2.513 0 C-N-CA 125.121 1.368 . . . . 0.0 113.298 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.7 ' HG2' ' OD1' ' A' ' 65' ' ' ASP . 23.5 mmtp -64.13 176.63 0.96 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.724 -0.61 . . . . 0.0 112.272 178.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 66.8 mtm180 -102.68 -29.13 11.71 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.94 0.876 . . . . 0.0 109.642 -176.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.0 134.55 50.75 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.783 -173.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.661 ' NH2' ' HB2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -104.38 153.93 38.71 Favored Pre-proline 0 C--N 1.297 -1.696 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.185 -179.231 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.458 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 93.3 Cg_endo -77.4 140.73 19.58 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.615 1.543 . . . . 0.0 112.122 178.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -133.49 133.78 42.66 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 -178.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.596 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 83.2 m95 -117.3 135.45 53.82 Favored 'General case' 0 C--N 1.288 -2.092 0 O-C-N 121.731 -0.605 . . . . 0.0 112.39 -172.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.424 ' HA ' ' O ' ' A' ' 86' ' ' THR . 33.4 m-85 -113.05 141.93 46.3 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.91 177.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.418 HD11 HG11 ' A' ' 58' ' ' VAL . 19.2 mt -126.11 142.53 51.48 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -177.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.521 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 86.3 m-85 -133.59 141.92 47.89 Favored 'General case' 0 C--N 1.316 -0.884 0 O-C-N 123.72 0.638 . . . . 0.0 110.055 -177.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.438 ' HB3' ' CG ' ' A' ' 102' ' ' PHE . 0.8 OUTLIER -85.45 0.09 53.31 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -178.984 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -137.73 159.7 41.26 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 174.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.7 m -70.96 166.32 2.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 C-N-CA 122.626 0.37 . . . . 0.0 111.656 -174.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 22.6 m120 58.07 30.8 19.82 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.798 0.839 . . . . 0.0 111.769 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.464 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 12.6 m-85 60.13 44.66 12.68 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.421 176.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 74.9 p -115.57 168.28 10.15 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.26 -141.4 17.49 Favored Glycine 0 N--CA 1.426 -2.021 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.807 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.521 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 57.1 mtt180 -77.33 135.85 38.41 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 123.083 0.553 . . . . 0.0 109.771 -177.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.8 tt -115.24 136.75 50.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.348 -175.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 96.9 m -131.9 123.2 26.98 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.172 176.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -110.06 123.89 6.9 Favored Glycine 0 N--CA 1.438 -1.183 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.362 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.417 HD21 HD11 ' A' ' 94' ' ' ILE . 3.3 mm? -115.77 145.66 42.61 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 123.159 0.584 . . . . 0.0 110.511 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.54 167.46 12.53 Favored Glycine 0 N--CA 1.423 -2.218 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.711 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -55.75 125.42 21.15 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 123.815 0.846 . . . . 0.0 112.429 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.16 3.82 84.63 Favored Glycine 0 N--CA 1.431 -1.675 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.336 176.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.9 m -113.57 146.53 39.55 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.4 m -136.75 158.0 45.45 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.417 HD11 HD21 ' A' ' 88' ' ' LEU . 56.1 mt -93.4 132.44 37.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 173.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -70.02 -47.42 62.17 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.605 0.717 . . . . 0.0 110.14 -176.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.46 ' HA ' HG22 ' A' ' 33' ' ' THR . 5.6 m-20 -138.89 102.65 4.61 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 176.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.432 ' HZ ' ' CE2' ' A' ' 102' ' ' PHE . 59.3 t80 -64.66 -32.68 74.46 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.402 0.62 . . . . 0.0 110.399 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.9 t -63.54 -24.94 68.02 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.721 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.454 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 31.8 mmtp -93.67 -5.81 47.76 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 121.308 0.575 . . . . 0.0 109.572 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.8 t -84.71 31.17 0.54 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.302 0.641 . . . . 0.0 110.439 -177.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.7 -71.91 1.73 Allowed Glycine 0 N--CA 1.437 -1.288 0 C-N-CA 121.263 -0.494 . . . . 0.0 111.972 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.438 ' CG ' ' HB3' ' A' ' 77' ' ' ASP . 35.0 p90 -109.96 148.37 31.75 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.577 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.43 -6.99 13.47 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.738 179.668 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -116.95 116.59 3.59 Favored Glycine 0 N--CA 1.429 -1.831 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.377 -176.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 64.9 mt -94.78 115.83 34.6 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.675 0 CA-C-O 122.342 1.068 . . . . 0.0 108.888 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.4 m -85.45 -25.07 27.16 Favored 'General case' 0 N--CA 1.39 -3.436 0 CA-C-N 112.425 -2.171 . . . . 0.0 114.252 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.5 p -158.0 152.88 25.22 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 122.076 -0.39 . . . . 0.0 110.014 176.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.409 ' HB ' HG12 ' A' ' 46' ' ' VAL . 44.8 mt -130.97 131.04 64.32 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -176.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.464 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 36.1 ttmt -116.53 132.82 56.58 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -100.19 129.95 46.27 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 66.7 m -131.0 172.15 12.4 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.7 pt -127.51 140.7 48.39 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -109.16 119.7 40.32 Favored 'General case' 0 C--N 1.276 -2.61 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 71.3 p -74.0 173.6 9.78 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.808 -175.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -66.92 -19.04 65.65 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 121.842 0.83 . . . . 0.0 109.652 175.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -84.68 -8.14 58.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.801 0.81 . . . . 0.0 110.354 177.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.99 -11.53 71.87 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 120.843 -0.694 . . . . 0.0 113.08 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -71.93 134.69 46.15 Favored 'General case' 0 C--O 1.254 1.342 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.7 t -99.51 111.85 30.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -95.29 134.93 37.51 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 48.8 m -131.01 156.37 45.24 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 8.9 tp -103.7 120.11 53.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 C-N-CA 119.879 -0.728 . . . . 0.0 110.319 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -72.97 114.13 10.77 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.497 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 . . . . . 0 C--N 1.292 -1.897 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.584 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.13 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.92 -17.94 62.45 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -175.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -77.75 5.25 9.77 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -177.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 57.7 m -52.28 128.93 26.73 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-O 121.963 0.887 . . . . 0.0 113.092 -177.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.0 p -102.56 166.44 10.52 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.863 -178.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.404 ' HE2' ' HA ' ' A' ' 63' ' ' VAL . 8.8 mmmm -107.92 -32.28 7.65 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-O 121.766 0.793 . . . . 0.0 111.549 -177.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -121.06 68.58 0.88 Allowed 'General case' 0 C--N 1.279 -2.464 0 CA-C-O 122.315 1.055 . . . . 0.0 110.111 -175.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.545 ' SG ' ' HG3' ' A' ' 61' ' ' PRO . 3.9 p -144.74 160.16 41.68 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 113.681 -1.599 . . . . 0.0 109.82 -178.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.631 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 54.3 tp -111.93 118.53 35.75 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 173.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 66.7 mt-30 -109.33 123.65 49.64 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.251 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.454 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 2.9 mp -110.35 121.73 46.0 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.672 177.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.443 ' CD1' ' HB3' ' A' ' 39' ' ' TYR . 90.4 m-85 -93.12 157.26 16.38 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 123.609 0.568 . . . . 0.0 111.781 -175.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -81.14 -35.13 31.91 Favored 'General case' 0 CA--C 1.494 -1.175 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.865 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -108.23 178.09 4.61 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.469 HG22 ' HA ' ' A' ' 96' ' ' ASP . 3.3 p -81.39 172.07 14.0 Favored 'General case' 0 N--CA 1.401 -2.899 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.35 178.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 21.2 p90 47.26 38.93 7.75 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.892 1.277 . . . . 0.0 114.205 176.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 65.41 22.41 11.94 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.551 1.541 . . . . 0.0 114.506 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.18 173.62 7.63 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.255 0.55 . . . . 0.0 111.485 175.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.18 -152.75 34.87 Favored Glycine 0 N--CA 1.426 -2.021 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 -174.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.7 m -108.78 178.51 4.46 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 173.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.443 ' HB3' ' CD1' ' A' ' 30' ' ' TYR . 29.9 p90 -143.53 166.79 23.82 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.095 0.474 . . . . 0.0 110.157 -177.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.0 tt -114.53 152.81 16.13 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.545 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 176.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -106.84 125.54 51.14 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 176.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.494 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 99.4 t -122.6 134.55 65.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -126.09 -2.85 7.02 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.771 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -139.44 162.54 34.8 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -173.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.45 ' HB3' ' H ' ' A' ' 110' ' ' ARG . 2.8 p -84.42 144.86 28.5 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-O 120.991 0.424 . . . . 0.0 111.599 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.7 p -119.78 137.72 52.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.68 -21.63 30.81 Favored Glycine 0 N--CA 1.433 -1.526 0 C-N-CA 120.072 -1.061 . . . . 0.0 112.389 -177.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.0 p -157.79 129.04 6.66 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-O 121.07 0.462 . . . . 0.0 112.014 -178.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.1 mt -118.5 118.47 31.8 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 175.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 38.5 m -132.27 114.61 14.84 Favored Pre-proline 0 C--N 1.299 -1.6 0 O-C-N 123.393 0.433 . . . . 0.0 110.08 175.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 6.2 Cg_exo -76.91 159.41 95.99 Favored 'Cis proline' 0 C--O 1.246 0.899 0 C-N-CA 122.944 -1.69 . . . . 0.0 110.371 -1.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -62.34 157.66 44.45 Favored 'Trans proline' 0 C--O 1.252 1.209 0 C-N-CA 122.482 2.121 . . . . 0.0 111.349 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.428 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 48.8 m0 -89.47 140.27 29.69 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -177.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.613 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 35.5 p -123.8 73.78 54.68 Favored Pre-proline 0 C--N 1.305 -1.364 0 O-C-N 123.46 0.475 . . . . 0.0 110.561 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.454 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 81.6 Cg_endo -74.2 156.5 46.63 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 122.354 2.036 . . . . 0.0 113.653 -178.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -83.77 -34.28 19.29 Favored Glycine 0 N--CA 1.431 -1.633 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 177.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.0 p -153.83 154.97 34.92 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.3 t -130.45 142.31 44.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 35.5 t -146.07 152.32 39.14 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.696 176.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 95.4 t -117.2 125.21 28.38 Favored Pre-proline 0 C--N 1.313 -0.991 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 176.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.545 ' HG3' ' SG ' ' A' ' 26' ' ' CYS . 5.9 Cg_exo -49.68 141.31 27.49 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 123.471 2.78 . . . . 0.0 113.288 178.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -75.24 113.47 12.64 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 121.676 0.75 . . . . 0.0 109.868 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.468 ' H ' ' HB2' ' A' ' 90' ' ' HIS . 78.4 t -94.54 125.31 47.18 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.513 -179.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -127.88 12.16 6.71 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 124.428 1.08 . . . . 0.0 108.696 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -57.93 147.04 30.18 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.464 1.506 . . . . 0.0 113.28 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.3 m -53.59 -12.9 0.54 Allowed 'General case' 0 CA--C 1.579 2.071 0 C-N-CA 125.568 1.547 . . . . 0.0 112.179 178.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -58.42 161.39 4.48 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.669 1.188 . . . . 0.0 111.182 175.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.78 -28.25 16.69 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -178.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.67 140.77 43.12 Favored 'General case' 0 N--CA 1.417 -2.098 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.631 -174.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -105.99 154.22 39.65 Favored Pre-proline 0 C--N 1.289 -2.027 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.406 ' CD ' HG21 ' A' ' 63' ' ' VAL . 85.0 Cg_endo -81.71 135.18 8.9 Favored 'Trans proline' 0 N--CA 1.44 -1.644 0 C-N-CA 121.309 1.34 . . . . 0.0 110.888 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -128.76 123.54 33.22 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 -177.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.631 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 83.4 m95 -109.33 135.35 50.54 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-O 120.759 0.314 . . . . 0.0 111.843 -172.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 86' ' ' THR . 39.8 m-85 -113.59 141.85 46.68 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.023 177.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.6 mt -125.37 142.2 51.64 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 -176.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.44 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 80.8 m-85 -131.3 141.49 49.96 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 123.468 0.48 . . . . 0.0 110.49 -176.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.58 -21.76 51.96 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.525 -177.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.498 ' C ' ' HB3' ' A' ' 106' ' ' SER . 8.6 t-20 -118.76 168.33 10.84 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.6 m -73.94 168.96 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 C-N-CA 122.575 0.35 . . . . 0.0 110.298 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 14.6 m120 55.48 30.42 15.07 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.447 0.699 . . . . 0.0 112.605 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.445 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 9.3 m-85 58.96 45.85 14.43 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 124.755 1.222 . . . . 0.0 111.316 176.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.7 p -117.33 167.45 11.23 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.186 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.93 -134.19 12.32 Favored Glycine 0 N--CA 1.424 -2.13 0 N-CA-C 111.344 -0.703 . . . . 0.0 111.344 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.44 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 64.1 mtm180 -81.17 151.39 28.24 Favored 'General case' 0 C--N 1.287 -2.124 0 C-N-CA 123.611 0.764 . . . . 0.0 110.977 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.4 tt -130.5 137.18 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-O 121.275 0.559 . . . . 0.0 110.303 -176.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 98.4 m -132.38 120.51 22.13 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.906 175.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -108.01 127.8 8.85 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.211 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.49 HD21 HD11 ' A' ' 94' ' ' ILE . 3.3 mm? -118.21 145.5 44.93 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 123.074 0.55 . . . . 0.0 110.793 178.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.75 172.93 14.45 Favored Glycine 0 N--CA 1.433 -1.563 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.455 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.468 ' HB2' ' H ' ' A' ' 63' ' ' VAL . 3.0 p80 -61.65 122.32 15.0 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 123.293 0.637 . . . . 0.0 112.287 -175.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.2 2.13 80.73 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.821 176.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.1 m -110.36 146.13 36.33 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.4 m -140.37 154.5 46.74 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.49 HD11 HD21 ' A' ' 88' ' ' LEU . 52.2 mt -93.21 128.79 44.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 173.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -70.26 -47.37 61.59 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 123.539 0.525 . . . . 0.0 110.111 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.616 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 1.6 m-20 -132.97 91.83 2.94 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.761 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -65.46 -33.13 75.22 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.483 0.658 . . . . 0.0 109.429 176.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.7 t -64.31 -28.79 69.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.358 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.616 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 32.2 mmtp -89.57 -6.79 55.97 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 120.61 0.243 . . . . 0.0 110.499 -176.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.3 m -82.21 -175.12 5.5 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.064 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -52.86 -64.11 4.41 Favored Glycine 0 C--N 1.334 0.422 0 O-C-N 123.136 0.272 . . . . 0.0 113.215 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -110.94 143.14 42.07 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 122.505 -0.409 . . . . 0.0 110.462 176.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.613 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -108.93 -9.93 15.1 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.201 -1.036 . . . . 0.0 108.201 175.092 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -108.68 114.01 3.95 Favored Glycine 0 N--CA 1.433 -1.535 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.188 -177.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 71.6 mt -96.92 115.57 36.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.498 ' HB3' ' C ' ' A' ' 78' ' ' ASN . 1.1 t -86.67 -26.48 24.3 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.497 178.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.3 p -150.95 156.68 41.67 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 122.158 -0.339 . . . . 0.0 110.324 178.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.2 mt -135.13 132.28 52.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -176.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.445 ' HE2' ' CD2' ' A' ' 81' ' ' TYR . 32.3 ttmt -117.65 133.92 55.44 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.45 ' H ' ' HB3' ' A' ' 45' ' ' SER . 24.6 ttp180 -102.77 127.73 49.81 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 66.2 m -127.16 171.98 10.95 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.0 pt -129.66 144.87 36.76 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.146 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 177.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.481 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 61.8 tt0 -119.18 122.48 42.1 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 63.4 p -75.35 174.06 10.06 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.404 -175.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -66.36 -28.18 68.46 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.664 0.745 . . . . 0.0 109.525 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -77.12 -7.11 55.2 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.307 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.04 -1.74 61.15 Favored Glycine 0 N--CA 1.438 -1.192 0 N-CA-C 115.534 0.974 . . . . 0.0 115.534 171.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 113' ' ' GLN . 18.5 ptpt -83.73 140.65 31.98 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 118.78 1.29 . . . . 0.0 110.9 -177.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.4 t -101.81 112.06 33.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -99.4 144.79 28.11 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 124.27 1.028 . . . . 0.0 108.241 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 72.8 m -129.64 151.77 49.88 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.597 -174.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 6.0 tp -72.97 139.71 19.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.148 178.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -70.86 105.6 3.3 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 . . . . . 0 C--N 1.29 -1.983 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 179.976 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.47 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.88 31.31 20.67 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.923 0.889 . . . . 0.0 111.526 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -83.86 -25.39 30.31 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.756 0.788 . . . . 0.0 109.295 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.8 m -91.51 146.93 23.39 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 175.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 19.6 p -103.04 151.67 22.25 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.925 0.869 . . . . 0.0 112.349 -175.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -76.02 135.61 39.96 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.537 -1.21 . . . . 0.0 108.895 -178.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.43 ' CZ ' ' HD3' ' A' ' 71' ' ' PRO . 9.1 m-85 64.87 39.71 5.85 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.137 0.494 . . . . 0.0 112.006 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 63.5 m -123.32 149.63 44.61 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.591 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 49.1 tp -95.62 112.76 24.41 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 174.073 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.526 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 17.7 mt-30 -111.46 123.17 49.67 Favored 'General case' 0 N--CA 1.422 -1.852 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.745 -177.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.451 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 2.7 mp -110.97 124.71 52.67 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.87 -178.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.416 ' CE1' ' HG2' ' A' ' 35' ' ' GLU . 96.4 m-85 -90.45 155.38 18.96 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 122.623 0.369 . . . . 0.0 110.577 -178.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -75.18 -40.94 58.98 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.897 0.856 . . . . 0.0 109.943 -176.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.483 ' HB2' ' HG3' ' A' ' 36' ' ' ARG . 24.8 mm-40 -108.46 179.01 4.32 Favored 'General case' 0 N--CA 1.421 -1.918 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.403 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.513 HG22 ' HA ' ' A' ' 96' ' ' ASP . 0.8 OUTLIER -81.11 174.94 11.09 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.504 -177.093 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 47.07 34.03 2.64 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 174.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.416 ' HG2' ' CE1' ' A' ' 30' ' ' TYR . 36.1 mt-10 65.35 22.78 12.03 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 124.485 1.114 . . . . 0.0 113.919 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.483 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 35.7 ptt180 -97.71 157.52 16.01 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 118.694 -1.202 . . . . 0.0 108.87 174.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.4 -178.65 41.62 Favored Glycine 0 N--CA 1.424 -2.105 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -175.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.0 m -89.59 169.13 11.59 Favored 'General case' 0 C--N 1.286 -2.163 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.553 177.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.435 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 21.8 p90 -131.78 165.88 22.8 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.466 -177.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 15.0 tt -113.87 150.55 15.88 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -106.59 125.15 50.64 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.503 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 88.4 t -123.97 133.88 68.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -117.46 -31.57 5.2 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -176.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.542 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 11.2 mmpt? -103.56 161.98 13.43 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.914 -173.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.9 p -88.99 143.03 27.14 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 172.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.5 p -121.31 131.05 73.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -177.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.77 -15.25 56.89 Favored Glycine 0 C--N 1.298 -1.53 0 C-N-CA 119.851 -1.166 . . . . 0.0 113.03 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.5 p -154.38 123.98 6.59 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.439 0.637 . . . . 0.0 112.415 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 88.4 mt -116.45 118.71 33.42 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.202 177.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 25.0 p -131.88 107.51 14.0 Favored Pre-proline 0 C--N 1.3 -1.549 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.64 175.05 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 72.8 Cg_endo -77.93 162.22 89.86 Favored 'Cis proline' 0 C--O 1.249 1.068 0 C-N-CA 123.861 -1.308 . . . . 0.0 111.801 0.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.52 154.58 73.07 Favored 'Trans proline' 0 C--O 1.25 1.123 0 C-N-CA 122.125 1.883 . . . . 0.0 110.586 176.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 49.3 m0 -90.23 137.6 32.21 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 20.5 p -121.22 79.41 35.34 Favored Pre-proline 0 N--CA 1.425 -1.688 0 O-C-N 123.258 0.349 . . . . 0.0 111.027 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.451 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 85.4 Cg_endo -77.16 158.49 33.74 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.884 2.389 . . . . 0.0 112.789 178.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.32 -29.82 9.21 Favored Glycine 0 N--CA 1.43 -1.701 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.1 p -150.96 152.61 33.81 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.411 HG22 HD23 ' A' ' 29' ' ' LEU . 40.5 t -126.71 142.99 41.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -178.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 17.3 t -145.46 138.48 26.19 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 118.525 0.602 . . . . 0.0 110.109 -176.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.7 t -118.33 125.38 27.9 Favored Pre-proline 0 C--O 1.249 1.056 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -62.1 147.16 95.62 Favored 'Trans proline' 0 C--O 1.249 1.061 0 C-N-CA 122.775 2.317 . . . . 0.0 111.031 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.612 ' CE2' ' HB3' ' A' ' 64' ' ' ASN . 34.7 t80 -74.49 136.31 42.24 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-O 121.95 0.881 . . . . 0.0 111.111 -176.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 98.4 t -118.61 115.08 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.166 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.612 ' HB3' ' CE2' ' A' ' 62' ' ' PHE . 24.5 p-10 -121.67 13.44 10.82 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 123.045 1.402 . . . . 0.0 107.332 178.093 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.74 146.44 41.47 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 111.737 -2.483 . . . . 0.0 111.483 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.4 m -57.46 -8.22 0.77 Allowed 'General case' 0 CA--C 1.579 2.073 0 C-N-CA 124.69 1.196 . . . . 0.0 112.004 177.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -62.49 136.65 58.0 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.104 0.961 . . . . 0.0 108.731 177.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.539 ' HB2' ' OE1' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -84.24 -28.82 26.98 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -177.894 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.539 ' OE1' ' HB2' ' A' ' 68' ' ' ARG . 3.0 mp0 -97.25 125.08 41.58 Favored 'General case' 0 N--CA 1.415 -2.184 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.484 ' HG2' ' CE1' ' A' ' 90' ' ' HIS . 0.6 OUTLIER -106.75 152.09 40.71 Favored Pre-proline 0 C--N 1.291 -1.955 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.593 179.111 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.43 ' HD3' ' CZ ' ' A' ' 25' ' ' TYR . 74.1 Cg_endo -76.98 134.09 14.3 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 121.089 1.193 . . . . 0.0 110.542 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -133.5 132.82 41.45 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.591 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 89.5 m95 -119.48 133.15 55.82 Favored 'General case' 0 C--N 1.284 -2.275 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.915 -172.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.525 ' HA ' ' O ' ' A' ' 86' ' ' THR . 35.7 m-85 -112.98 141.39 46.87 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.368 177.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.8 mt -125.92 142.16 51.64 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -176.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.544 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 80.2 m-85 -134.45 142.68 47.18 Favored 'General case' 0 CA--C 1.502 -0.874 0 O-C-N 123.796 0.685 . . . . 0.0 110.117 -176.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.409 ' HB3' ' CD1' ' A' ' 102' ' ' PHE . 2.9 p-10 -84.38 -5.82 59.32 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.476 ' C ' ' HB3' ' A' ' 106' ' ' SER . 4.4 t-20 -127.28 167.77 15.67 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 174.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.4 m -73.52 167.37 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 C-N-CA 122.581 0.352 . . . . 0.0 111.627 -176.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.4 m120 55.92 31.53 18.03 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.237 -0.892 . . . . 0.0 113.226 176.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 62.82 42.83 7.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.857 175.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 69.3 p -118.38 161.7 19.53 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.093 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.98 -144.06 17.12 Favored Glycine 0 N--CA 1.425 -2.065 0 N-CA-C 111.668 -0.573 . . . . 0.0 111.668 177.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.544 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 54.9 mtt180 -72.41 142.84 48.69 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.3 tt -125.4 136.43 60.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-O 121.487 0.66 . . . . 0.0 111.241 -173.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 86.7 m -131.57 123.04 27.1 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.34 176.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -113.69 120.06 5.0 Favored Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.531 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.465 HD21 HD11 ' A' ' 94' ' ' ILE . 3.3 mm? -110.35 147.76 33.29 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 123.673 0.789 . . . . 0.0 111.0 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -121.36 168.41 14.31 Favored Glycine 0 N--CA 1.425 -2.047 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.204 -178.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.484 ' CE1' ' HG2' ' A' ' 70' ' ' ARG . 2.9 p80 -55.12 121.89 9.78 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 124.066 0.946 . . . . 0.0 112.139 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.18 12.37 73.76 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.064 176.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.0 m -125.48 145.9 49.88 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 177.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 22.5 m -144.2 155.84 44.05 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -178.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.465 HD11 HD21 ' A' ' 88' ' ' LEU . 48.7 mt -93.45 125.61 46.0 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.45 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -70.22 -46.76 63.86 Favored 'General case' 0 C--N 1.288 -2.071 0 O-C-N 123.812 0.695 . . . . 0.0 110.353 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.587 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 3.3 m-20 -132.88 93.55 3.22 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.231 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.407 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 54.3 t80 -64.94 -31.66 73.0 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.431 0.634 . . . . 0.0 110.508 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.7 t -63.49 -23.2 67.29 Favored 'General case' 0 CA--C 1.561 1.375 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.631 -178.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.587 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 30.4 mmtp -92.78 -6.31 49.24 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.925 -0.485 . . . . 0.0 109.765 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.8 m -84.85 13.46 5.86 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.379 0.609 . . . . 0.0 111.786 -177.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 104.72 -79.07 0.28 Allowed Glycine 0 N--CA 1.425 -2.05 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.68 178.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.409 ' CD1' ' HB3' ' A' ' 77' ' ' ASP . 27.5 p90 -100.11 147.13 26.0 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -178.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.548 ' H ' ' HD3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -113.3 -14.22 12.84 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.18 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -103.02 110.4 3.71 Favored Glycine 0 N--CA 1.422 -2.271 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.489 -175.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 80.5 mt -93.32 115.65 32.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.476 ' HB3' ' C ' ' A' ' 78' ' ' ASN . 5.3 t -85.99 -29.01 23.85 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.502 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 90.1 p -150.34 156.33 41.31 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.752 -0.203 . . . . 0.0 110.818 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.7 mt -134.01 132.41 56.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -176.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -116.38 131.58 56.91 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -99.5 129.6 45.69 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' CYS . . . . . 0.422 ' SG ' ' HD2' ' A' ' 74' ' ' TYR . 62.6 m -128.51 172.38 11.21 Favored 'General case' 0 N--CA 1.413 -2.3 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.329 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 70' ' ' ARG . 7.1 pt -131.48 141.98 44.43 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 C-N-CA 123.172 0.589 . . . . 0.0 110.039 177.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.42 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 52.6 tt0 -113.69 119.11 36.3 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 33.8 p -80.19 -178.37 6.54 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.45 -172.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -66.1 -28.85 69.13 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.769 0.795 . . . . 0.0 109.636 177.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -80.1 -6.46 57.73 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.422 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.97 6.17 82.55 Favored Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 115.969 -0.56 . . . . 0.0 113.77 175.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 113' ' ' GLN . 66.0 pttt -82.16 145.08 30.3 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.829 178.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 25.5 t -104.12 111.52 34.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -97.12 144.24 27.16 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 96.8 m -129.84 153.43 48.28 Favored 'General case' 0 C--N 1.289 -2.055 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.297 -173.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 10.5 tp -125.26 127.95 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.449 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -92.26 128.64 38.18 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 . . . . . 0 C--N 1.293 -1.888 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -176.742 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.97 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.59 76.67 8.11 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 173.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.509 ' HB3' ' OH ' ' A' ' 39' ' ' TYR . 12.5 m-20 -87.85 -24.52 23.67 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.191 -171.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.445 ' HA ' HE22 ' A' ' 28' ' ' GLN . 20.0 m -74.56 123.81 25.48 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 175.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.413 ' O ' ' HG3' ' A' ' 61' ' ' PRO . 15.5 p -104.37 151.85 22.99 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.371 -176.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.6 tptt -68.32 131.41 45.29 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.655 -178.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 65.47 38.91 5.38 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 124.104 0.877 . . . . 0.0 111.718 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.6 m -122.73 145.07 48.73 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.517 HD22 ' CE3' ' A' ' 73' ' ' TRP . 51.5 tp -96.24 116.24 28.69 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 174.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 42.9 mt-30 -108.98 124.21 50.34 Favored 'General case' 0 N--CA 1.428 -1.572 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.315 -177.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.496 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.7 mp -109.66 118.91 37.8 Favored 'General case' 0 N--CA 1.408 -2.526 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.46 177.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.438 ' CD2' ' HB3' ' A' ' 39' ' ' TYR . 95.4 m-85 -87.51 150.3 23.82 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.508 -176.152 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -72.09 -44.1 63.76 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.835 -175.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -109.8 178.05 4.54 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.902 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.455 HG22 ' HA ' ' A' ' 96' ' ' ASP . 1.9 p -76.74 170.57 16.22 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-O 119.785 -0.15 . . . . 0.0 111.002 -177.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 14.9 p90 47.41 37.05 5.58 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.899 1.28 . . . . 0.0 114.086 177.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 67.72 26.21 7.89 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.615 1.166 . . . . 0.0 112.853 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.471 ' CZ ' ' HB3' ' A' ' 36' ' ' ARG . 8.5 mtp-105 -90.89 162.49 14.76 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 176.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.22 -158.94 36.71 Favored Glycine 0 N--CA 1.424 -2.134 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.3 p -96.44 177.41 5.69 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 174.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.509 ' OH ' ' HB3' ' A' ' 21' ' ' ASP . 38.1 p90 -138.55 166.83 23.32 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.8 tt -113.42 151.56 15.26 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 177.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -106.13 124.87 50.26 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.449 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 92.4 t -123.52 133.55 68.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -122.09 -6.01 8.94 Favored 'General case' 0 C--N 1.31 -1.118 0 O-C-N 123.616 0.573 . . . . 0.0 110.85 -174.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -137.1 162.34 33.66 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.161 -173.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.44 ' HB3' ' H ' ' A' ' 110' ' ' ARG . 3.9 p -86.77 140.2 29.97 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 175.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.2 p -119.53 134.37 63.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -175.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.76 -15.73 48.23 Favored Glycine 0 C--N 1.301 -1.394 0 C-N-CA 120.417 -0.897 . . . . 0.0 113.195 -176.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.7 t -156.61 127.54 6.83 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.442 0.639 . . . . 0.0 111.182 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.5 mt -121.34 117.93 28.19 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.073 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.0 m -132.55 115.41 14.73 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 174.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -75.12 161.92 93.81 Favored 'Cis proline' 0 C--O 1.25 1.089 0 C-N-CA 123.033 -1.653 . . . . 0.0 110.788 -2.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -61.98 156.7 47.8 Favored 'Trans proline' 0 C--O 1.256 1.403 0 C-N-CA 122.129 1.886 . . . . 0.0 110.417 178.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.426 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 45.8 m0 -89.33 135.97 33.29 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -176.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 34.1 p -115.65 81.41 9.15 Favored Pre-proline 0 C--N 1.301 -1.5 0 O-C-N 123.369 0.418 . . . . 0.0 111.165 178.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.496 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 81.3 Cg_endo -81.5 157.7 19.28 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 122.239 1.959 . . . . 0.0 112.583 176.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.06 -30.24 11.42 Favored Glycine 0 N--CA 1.43 -1.747 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 177.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.8 p -155.13 153.52 30.93 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.6 t -130.28 142.7 43.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 49.1 t -145.8 148.12 32.58 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.373 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.422 ' HB ' ' O ' ' A' ' 89' ' ' GLY . 58.7 t -117.39 122.65 30.75 Favored Pre-proline 0 C--N 1.31 -1.133 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 175.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.413 ' HG3' ' O ' ' A' ' 23' ' ' CYS . 39.7 Cg_endo -65.44 156.39 63.73 Favored 'Trans proline' 0 C--O 1.25 1.075 0 C-N-CA 122.726 2.284 . . . . 0.0 112.577 -177.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -72.84 135.3 45.16 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.386 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 98.4 t -112.19 115.58 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.265 0 CA-C-O 121.743 0.782 . . . . 0.0 111.763 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -112.51 74.54 0.87 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 173.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.432 ' HB3' ' NH2' ' A' ' 70' ' ' ARG . 14.6 t70 -126.99 145.95 50.52 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.191 -170.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -54.37 -18.53 4.21 Favored 'General case' 0 CA--C 1.578 2.044 0 C-N-CA 125.803 1.641 . . . . 0.0 114.429 -178.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.57 ' HB2' ' NH2' ' A' ' 70' ' ' ARG . 75.8 mmtt -65.56 173.79 2.56 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.561 -0.712 . . . . 0.0 111.261 175.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -102.7 -26.82 13.04 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 176.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -92.73 132.31 37.05 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.542 -176.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.57 ' NH2' ' HB2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -104.92 149.77 37.93 Favored Pre-proline 0 C--N 1.3 -1.545 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.626 176.379 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.17 136.18 17.81 Favored 'Trans proline' 0 C--N 1.321 -0.909 0 C-N-CA 121.907 1.738 . . . . 0.0 112.314 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -133.09 130.55 39.46 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.517 ' CE3' HD22 ' A' ' 27' ' ' LEU . 84.4 m95 -116.2 136.91 52.59 Favored 'General case' 0 C--N 1.286 -2.158 0 O-C-N 121.631 -0.668 . . . . 0.0 111.904 -172.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 86' ' ' THR . 41.4 m-85 -115.04 142.3 46.83 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 123.051 0.54 . . . . 0.0 110.426 177.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.8 mt -125.71 142.96 51.25 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -175.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 84.3 m-85 -133.23 145.18 50.31 Favored 'General case' 0 C--O 1.241 0.616 0 O-C-N 123.578 0.549 . . . . 0.0 110.666 -176.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.54 -3.56 58.9 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.794 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -133.26 157.06 46.38 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 119.851 -0.739 . . . . 0.0 109.283 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.454 ' HA ' ' HB2' ' A' ' 107' ' ' SER . 33.9 m -70.81 168.31 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.455 -178.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.6 m120 59.66 30.23 19.83 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.251 0.621 . . . . 0.0 110.966 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.602 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 16.5 m-85 55.21 44.03 28.33 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 124.781 1.232 . . . . 0.0 112.233 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 59.1 p -117.07 172.85 7.0 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.932 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.68 -136.17 13.5 Favored Glycine 0 N--CA 1.429 -1.767 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.357 178.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 77.6 mtt180 -79.76 153.23 29.35 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.8 tt -133.12 136.82 54.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-O 121.384 0.612 . . . . 0.0 110.785 -175.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 95.5 m -132.39 121.11 22.94 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.999 177.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -108.47 119.76 5.75 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.868 -0.682 . . . . 0.0 114.443 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.4 HD21 HD11 ' A' ' 94' ' ' ILE . 3.4 mm? -110.1 145.53 36.97 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 123.103 0.561 . . . . 0.0 110.596 178.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.422 ' O ' ' HB ' ' A' ' 60' ' ' VAL . . . -119.61 175.67 15.89 Favored Glycine 0 N--CA 1.429 -1.793 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.946 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -60.17 132.81 55.09 Favored 'General case' 0 C--O 1.247 0.95 0 C-N-CA 123.088 0.555 . . . . 0.0 111.86 -178.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.75 16.34 79.25 Favored Glycine 0 N--CA 1.437 -1.266 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.744 177.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.0 m -121.06 145.48 47.73 Favored 'General case' 0 N--CA 1.42 -1.972 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -178.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.9 m -141.98 155.43 45.45 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.4 HD11 HD21 ' A' ' 88' ' ' LEU . 47.7 mt -93.33 130.94 41.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 175.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -70.85 -48.42 54.06 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 123.586 0.554 . . . . 0.0 110.3 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.455 ' HA ' HG22 ' A' ' 33' ' ' THR . 8.2 m-20 -141.57 98.88 3.44 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -63.84 -31.86 73.18 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.481 0.658 . . . . 0.0 110.469 -178.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.9 t -63.4 -22.13 66.7 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.393 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -93.14 -11.04 33.81 Favored 'General case' 0 C--O 1.22 -0.499 0 O-C-N 121.742 -0.599 . . . . 0.0 110.416 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.1 m -78.77 -7.14 57.52 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.42 0.629 . . . . 0.0 110.579 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 123.8 -86.34 0.37 Allowed Glycine 0 N--CA 1.419 -2.478 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -85.73 139.2 31.54 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.584 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -109.43 -6.91 15.28 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.157 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -110.97 113.28 3.41 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.348 -176.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 75.0 mt -97.3 115.31 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.548 0 CA-C-O 122.687 1.232 . . . . 0.0 109.066 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.3 m -85.66 -25.31 26.64 Favored 'General case' 0 N--CA 1.393 -3.296 0 CA-C-N 111.811 -2.45 . . . . 0.0 113.935 178.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.454 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 8.5 t -159.39 153.3 23.21 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -176.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.1 mt -136.3 129.27 46.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -176.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.602 ' HE2' ' CD2' ' A' ' 81' ' ' TYR . 35.3 ttmt -117.23 133.28 56.18 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.44 ' H ' ' HB3' ' A' ' 45' ' ' SER . 55.5 ttp180 -100.49 129.85 46.49 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -178.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 71.0 m -126.34 172.0 10.5 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.4 pt -132.23 140.68 47.22 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -109.09 123.91 49.93 Favored 'General case' 0 C--N 1.266 -3.049 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 69.1 p -74.08 166.58 23.15 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.364 -175.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -67.58 -19.23 65.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 122.169 0.985 . . . . 0.0 109.075 175.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -76.93 -7.57 55.8 Favored 'General case' 0 CA--C 1.561 1.369 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.104 175.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.53 3.96 74.06 Favored Glycine 0 CA--C 1.504 -0.645 0 N-CA-C 114.828 0.691 . . . . 0.0 114.828 172.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.425 ' HE2' ' OE2' ' A' ' 120' ' ' GLU . 21.9 ptmt -94.44 139.73 30.75 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 119.138 -1.025 . . . . 0.0 109.421 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 24.2 t -95.27 111.9 26.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.394 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.425 ' OE2' ' HE2' ' A' ' 118' ' ' LYS . 6.3 mm-40 -94.96 142.69 27.19 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 72.4 m -130.19 162.63 28.47 Favored 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -177.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 7.4 tp -73.58 128.02 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 172.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -68.45 104.37 1.89 Allowed 'General case' 0 CA--C 1.49 -1.351 0 CA-C-O 121.827 0.822 . . . . 0.0 110.519 -178.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 . . . . . 0 C--N 1.293 -1.864 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 -179.727 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.213 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -131.22 110.07 10.87 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -80.73 -24.21 38.92 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.503 0.668 . . . . 0.0 110.097 -177.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.8 m -102.87 129.16 49.48 Favored 'General case' 0 N--CA 1.416 -2.14 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 174.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.533 ' O ' ' HG3' ' A' ' 61' ' ' PRO . 54.0 t -102.73 134.69 45.7 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -73.65 112.04 9.36 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 123.28 0.632 . . . . 0.0 110.556 -173.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 70.17 33.86 2.54 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 123.817 0.698 . . . . 0.0 112.021 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 6.7 m -123.57 144.65 49.45 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.593 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 56.1 tp -88.73 128.28 35.62 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.439 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 19.4 mt-30 -117.23 123.42 46.58 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.222 -177.249 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.9 mp -110.82 120.05 41.12 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.893 177.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -89.82 150.41 22.26 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 123.735 0.647 . . . . 0.0 110.461 -176.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -75.34 -36.45 61.03 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.003 0.43 . . . . 0.0 111.17 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -107.99 177.27 4.86 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.452 HG22 ' HA ' ' A' ' 96' ' ' ASP . 1.7 p -82.43 170.45 15.26 Favored 'General case' 0 N--CA 1.407 -2.624 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 29.6 p90 46.83 44.46 14.3 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.803 1.241 . . . . 0.0 114.057 177.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 67.75 22.67 8.82 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.803 0.841 . . . . 0.0 112.615 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 37.4 mtp85 -95.17 161.02 14.29 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 177.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.31 -167.51 41.36 Favored Glycine 0 N--CA 1.423 -2.167 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.775 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 79.4 p -87.9 163.1 16.55 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 176.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 11.4 p90 -129.28 164.95 22.4 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.6 tt -114.95 153.39 16.45 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.038 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -106.75 125.47 51.05 Favored 'General case' 0 N--CA 1.422 -1.856 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 175.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.54 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 97.1 t -118.89 133.41 65.85 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 177.168 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -116.97 -29.83 5.88 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 123.472 0.482 . . . . 0.0 110.687 -174.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -121.59 163.27 19.2 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.031 -174.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.9 m -75.7 144.01 41.81 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 176.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.6 p -120.95 137.11 55.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.66 -18.71 31.72 Favored Glycine 0 C--N 1.307 -1.044 0 C-N-CA 119.791 -1.195 . . . . 0.0 113.02 -178.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.4 t -153.21 131.6 12.09 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-O 121.053 0.454 . . . . 0.0 110.305 -177.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.2 mt -123.25 117.68 25.86 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.58 177.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 11.0 m -132.61 111.21 13.64 Favored Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 177.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 5.1 Cg_exo -78.08 160.45 92.13 Favored 'Cis proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.109 -1.621 . . . . 0.0 110.527 -0.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.68 157.75 40.72 Favored 'Trans proline' 0 C--O 1.253 1.254 0 C-N-CA 122.126 1.884 . . . . 0.0 111.007 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.451 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 49.8 m0 -90.16 135.7 33.5 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -177.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 34.9 p -117.52 75.09 8.98 Favored Pre-proline 0 C--N 1.296 -1.751 0 O-C-N 123.387 0.429 . . . . 0.0 110.209 178.096 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.467 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 96.4 Cg_endo -74.73 157.81 43.63 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 122.151 1.901 . . . . 0.0 113.036 -178.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.97 -31.75 11.75 Favored Glycine 0 N--CA 1.427 -1.921 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.1 p -156.46 153.74 29.3 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.4 t -129.37 143.0 42.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 32.2 t -145.59 152.94 40.48 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.331 177.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.3 t -120.92 128.89 25.55 Favored Pre-proline 0 N--CA 1.443 -0.778 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 176.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.533 ' HG3' ' O ' ' A' ' 23' ' ' CYS . 30.9 Cg_endo -62.0 140.69 85.9 Favored 'Trans proline' 0 C--O 1.244 0.798 0 C-N-CA 123.18 2.587 . . . . 0.0 112.387 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.475 ' CE1' ' HB3' ' A' ' 64' ' ' ASN . 76.0 t80 -74.75 112.44 10.96 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-O 121.413 0.625 . . . . 0.0 110.462 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.3 t -94.16 115.57 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.148 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.485 178.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.475 ' HB3' ' CE1' ' A' ' 62' ' ' PHE . 6.4 p30 -118.88 15.69 13.43 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.194 -1.409 . . . . 0.0 107.194 177.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.652 ' OD1' ' HG2' ' A' ' 67' ' ' LYS . 8.9 t70 -66.51 147.54 53.14 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 112.358 -2.201 . . . . 0.0 109.476 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.2 m -53.13 -23.37 7.96 Favored 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 123.809 0.843 . . . . 0.0 111.812 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.652 ' HG2' ' OD1' ' A' ' 65' ' ' ASP . 42.5 mmtm -54.49 121.23 7.94 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 176.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -73.75 -25.64 60.27 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.976 -174.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -91.7 127.59 37.21 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -99.72 153.57 37.7 Favored Pre-proline 0 C--N 1.286 -2.193 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -83.22 135.18 7.19 Favored 'Trans proline' 0 N--CA 1.442 -1.503 0 C-N-CA 121.503 1.469 . . . . 0.0 111.078 176.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -130.24 132.2 45.86 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.593 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 82.2 m95 -118.78 134.14 55.35 Favored 'General case' 0 C--N 1.286 -2.185 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.831 -173.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 86' ' ' THR . 27.4 m-85 -114.47 140.8 48.42 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.327 178.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.5 mt -125.71 142.34 51.56 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -176.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.504 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 80.5 m-85 -132.84 143.04 49.27 Favored 'General case' 0 C--O 1.247 0.941 0 O-C-N 123.782 0.677 . . . . 0.0 109.791 -176.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.2 -14.75 57.23 Favored 'General case' 0 CA--C 1.491 -1.32 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.262 -178.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -122.17 166.09 15.12 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.5 m -76.29 167.78 2.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 122.747 0.419 . . . . 0.0 110.92 -175.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.3 m120 56.32 30.43 16.77 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 124.136 0.974 . . . . 0.0 112.82 178.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.441 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 7.0 m-85 63.01 39.34 10.25 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 124.795 1.238 . . . . 0.0 111.198 177.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 78.8 p -112.06 165.07 12.45 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.63 -139.43 14.57 Favored Glycine 0 N--CA 1.435 -1.427 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.441 178.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 55.5 mtt180 -81.88 147.14 29.47 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 123.322 0.649 . . . . 0.0 109.81 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.8 tt -123.19 136.61 59.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-O 121.155 0.502 . . . . 0.0 110.759 -176.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 90.7 m -131.69 121.17 23.83 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.887 177.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -109.44 121.05 5.96 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.444 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.409 HD21 HD11 ' A' ' 94' ' ' ILE . 3.3 mm? -109.86 145.19 37.21 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 120.769 0.318 . . . . 0.0 110.677 178.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -117.76 171.26 13.88 Favored Glycine 0 N--CA 1.42 -2.395 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.073 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -60.88 123.01 16.3 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.722 0.772 . . . . 0.0 112.406 -177.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.31 1.78 71.59 Favored Glycine 0 N--CA 1.429 -1.798 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.961 177.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.3 m -112.43 145.95 39.25 Favored 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -178.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 4.6 m -134.3 158.45 43.73 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.409 HD11 HD21 ' A' ' 88' ' ' LEU . 55.0 mt -94.16 129.39 44.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 170.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -70.36 -46.98 63.03 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 123.597 0.561 . . . . 0.0 110.444 -178.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.618 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 2.0 m-20 -138.48 101.16 4.29 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.38 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -65.24 -38.02 89.05 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-O 120.736 0.303 . . . . 0.0 110.983 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.6 t -65.44 -28.01 68.92 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.855 -177.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.618 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 27.1 mmtp -83.64 -5.98 59.32 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.424 0.631 . . . . 0.0 109.738 -177.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 18.6 m -82.67 -168.89 2.21 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.39 -61.11 7.45 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.136 -178.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -111.26 149.54 30.89 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 122.39 0.276 . . . . 0.0 110.68 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -111.65 -7.72 14.25 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.838 177.26 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -114.93 121.4 5.31 Favored Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.374 -176.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 67.6 mt -100.95 115.99 43.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-O 122.107 0.956 . . . . 0.0 109.083 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.5 m -85.94 -28.81 24.04 Favored 'General case' 0 N--CA 1.406 -2.638 0 CA-C-N 112.716 -2.038 . . . . 0.0 114.257 176.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.9 p -154.22 154.94 34.35 Favored 'General case' 0 C--O 1.237 0.433 0 O-C-N 122.063 -0.398 . . . . 0.0 110.024 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.8 mt -134.12 133.25 55.89 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.608 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -176.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.483 ' HD3' ' HB3' ' A' ' 121' ' ' CYS . 36.2 ttmt -117.11 126.07 52.26 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -95.92 127.96 42.4 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.45 0.643 . . . . 0.0 109.487 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' CYS . . . . . 0.425 ' SG ' ' HD1' ' A' ' 74' ' ' TYR . 59.7 m -121.94 168.62 11.69 Favored 'General case' 0 N--CA 1.402 -2.868 0 CA-C-N 114.869 -1.059 . . . . 0.0 108.676 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.7 pt -128.37 143.11 42.01 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 176.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -111.21 118.45 35.96 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 63.8 p -77.34 -178.66 5.27 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.485 -171.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -62.6 -36.63 83.36 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.943 174.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.477 ' OD2' ' HG2' ' A' ' 118' ' ' LYS . 2.5 p30 -78.46 -7.06 57.01 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.867 -176.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.0 -5.6 63.62 Favored Glycine 0 CA--C 1.496 -1.123 0 CA-C-N 115.776 -0.647 . . . . 0.0 113.859 173.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.477 ' HG2' ' OD2' ' A' ' 116' ' ' ASP . 6.4 ptpp? -77.66 146.9 35.81 Favored 'General case' 0 CA--C 1.493 -1.24 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.706 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 38.2 t -103.37 111.46 33.21 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -96.99 142.16 29.28 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' CYS . . . . . 0.483 ' HB3' ' HD3' ' A' ' 109' ' ' LYS . 73.2 m -130.36 171.62 12.74 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.139 -175.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 6.3 tp -107.67 121.9 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 175.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -91.68 116.05 28.56 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 . . . . . 0 C--N 1.302 -1.481 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.192 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.75 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 63.25 18.19 10.8 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.136 1.374 . . . . 0.0 111.381 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.09 -16.7 16.99 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.627 -176.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.412 ' HA ' ' HB3' ' A' ' 61' ' ' PRO . 12.5 p -118.71 142.41 47.71 Favored 'General case' 0 N--CA 1.418 -2.039 0 CA-C-O 121.19 0.519 . . . . 0.0 111.649 178.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.455 ' HB3' ' HB2' ' A' ' 26' ' ' CYS . 54.0 t -146.06 135.97 23.49 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -73.09 106.77 5.1 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.743 -174.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.416 ' CD1' ' HB3' ' A' ' 71' ' ' PRO . 5.5 m-85 71.62 41.33 0.72 Allowed 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.843 177.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.455 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 7.7 m -124.35 145.34 49.49 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.646 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 61.3 tp -100.12 128.68 46.16 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 176.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.556 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 47.8 mt-30 -118.87 123.95 45.94 Favored 'General case' 0 CA--C 1.492 -1.266 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.534 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.488 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.0 mp -110.76 122.85 48.84 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.881 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.411 ' CD2' ' HB3' ' A' ' 39' ' ' TYR . 93.3 m-85 -92.0 149.59 21.45 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 123.327 0.392 . . . . 0.0 110.304 -178.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.54 -35.24 63.12 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.095 0.474 . . . . 0.0 111.803 -177.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -108.41 178.05 4.61 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.462 HG22 ' HA ' ' A' ' 96' ' ' ASP . 2.3 p -82.26 170.68 15.11 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.26 21.5 p90 46.85 46.71 15.45 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.289 1.036 . . . . 0.0 113.394 178.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 59.55 23.34 12.02 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.954 1.302 . . . . 0.0 114.129 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -92.01 167.37 12.14 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.623 0.725 . . . . 0.0 111.847 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.16 -164.82 46.36 Favored Glycine 0 N--CA 1.426 -1.995 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.7 m -92.71 173.66 7.65 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 175.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.411 ' HB3' ' CD2' ' A' ' 30' ' ' TYR . 18.0 p90 -140.76 161.79 36.95 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.237 0.541 . . . . 0.0 110.129 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.556 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 17.4 tt -114.64 149.53 16.87 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -107.6 125.5 51.4 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 175.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.571 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 95.0 t -117.87 134.06 62.68 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -118.17 -20.97 8.41 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.442 0.639 . . . . 0.0 110.485 -174.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -136.42 162.56 32.7 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.226 -174.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.4 p -72.66 147.38 45.8 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.33 0.586 . . . . 0.0 112.209 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.8 p -122.43 132.14 71.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 176.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.72 -15.3 46.69 Favored Glycine 0 C--N 1.303 -1.297 0 C-N-CA 119.566 -1.302 . . . . 0.0 112.861 -177.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.9 p -155.71 123.35 5.6 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.416 0.627 . . . . 0.0 112.377 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.4 mt -114.34 118.88 35.13 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.348 177.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 19.3 m -132.48 110.61 13.7 Favored Pre-proline 0 C--N 1.303 -1.432 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.837 175.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 5.1 Cg_exo -77.4 161.94 91.56 Favored 'Cis proline' 0 C--O 1.244 0.797 0 C-N-CA 123.229 -1.571 . . . . 0.0 110.927 0.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.07 158.38 30.25 Favored 'Trans proline' 0 C--O 1.25 1.092 0 C-N-CA 122.526 2.15 . . . . 0.0 110.988 177.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 46.9 m0 -89.67 139.13 30.86 Favored 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.089 -177.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 15.4 p -119.34 78.85 19.61 Favored Pre-proline 0 C--N 1.29 -1.993 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.15 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.488 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 93.0 Cg_endo -79.18 157.59 26.39 Favored 'Trans proline' 0 N--CA 1.44 -1.648 0 C-N-CA 121.782 1.655 . . . . 0.0 112.257 176.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -93.73 -27.98 11.93 Favored Glycine 0 N--CA 1.428 -1.878 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 176.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.4 p -153.57 150.94 29.2 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.5 t -123.11 142.84 38.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 15.5 t -142.98 137.71 29.54 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -177.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.9 t -121.43 119.02 29.58 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.412 ' HB3' ' HA ' ' A' ' 22' ' ' SER . 23.5 Cg_endo -65.2 137.41 51.78 Favored 'Trans proline' 0 C--O 1.241 0.673 0 C-N-CA 123.036 2.491 . . . . 0.0 113.136 -178.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -71.78 121.75 19.47 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.25 178.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 86.7 t -95.01 115.0 32.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 176.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -103.12 70.17 1.06 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -126.22 145.3 50.45 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -172.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.4 m -58.66 -24.83 62.0 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.436 -1.257 . . . . 0.0 109.807 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.461 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 4.3 mptp? -53.09 134.31 38.51 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.563 -177.07 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 50.9 mtp180 -68.51 -27.99 66.61 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -172.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -106.49 128.03 53.77 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.928 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -104.89 147.01 33.76 Favored Pre-proline 0 C--N 1.284 -2.24 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 171.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.416 ' HB3' ' CD1' ' A' ' 25' ' ' TYR . 93.3 Cg_endo -77.52 135.24 14.53 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.748 1.632 . . . . 0.0 112.522 -177.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -129.35 141.27 51.12 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.646 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 90.0 m95 -122.81 132.11 54.06 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -173.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.489 ' HD2' ' SG ' ' A' ' 111' ' ' CYS . 28.0 m-85 -114.37 142.76 45.92 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.108 176.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.7 mt -125.5 142.37 51.54 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 -175.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 92.0 m-85 -130.54 139.79 50.47 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.575 0.703 . . . . 0.0 111.21 -176.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.599 ' HB2' ' CD1' ' A' ' 102' ' ' PHE . 0.8 OUTLIER -81.89 -10.59 59.25 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.314 -178.876 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -135.69 156.92 48.08 Favored 'General case' 0 N--CA 1.416 -2.136 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.823 174.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.506 ' HA ' ' HB2' ' A' ' 107' ' ' SER . 21.5 m -65.3 161.45 3.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.967 -176.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.9 m120 61.52 30.57 18.81 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.199 0.523 . . . . 0.0 111.278 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 57.57 41.85 25.1 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 124.335 1.054 . . . . 0.0 111.333 176.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 77.9 p -112.35 176.35 5.05 Favored 'General case' 0 C--O 1.252 1.203 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.674 178.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.93 -137.79 18.42 Favored Glycine 0 N--CA 1.424 -2.152 0 N-CA-C 111.761 -0.535 . . . . 0.0 111.761 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.438 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . 53.3 mtt180 -82.72 150.21 26.85 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -177.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.0 tt -128.44 137.31 57.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 O-C-N 123.622 0.576 . . . . 0.0 110.594 -174.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 57.1 m -132.43 124.07 27.91 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 122.231 -0.293 . . . . 0.0 110.319 174.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -115.0 113.43 2.95 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.622 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.42 HD21 HD11 ' A' ' 94' ' ' ILE . 2.4 mm? -106.48 145.63 31.56 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 122.994 0.518 . . . . 0.0 111.285 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -110.33 164.61 12.25 Favored Glycine 0 N--CA 1.427 -1.966 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.625 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -64.03 122.15 15.86 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 123.29 0.636 . . . . 0.0 110.994 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.56 16.94 51.17 Favored Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.525 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.4 m -135.69 146.03 47.34 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 175.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 21.7 m -143.96 157.08 44.57 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.42 HD11 HD21 ' A' ' 88' ' ' LEU . 61.7 mt -94.45 135.21 29.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -70.81 -47.43 59.48 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.525 0.678 . . . . 0.0 110.483 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.462 ' HA ' HG22 ' A' ' 33' ' ' THR . 5.7 m-20 -136.51 100.77 4.45 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.995 -177.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.456 ' CD2' ' HG2' ' A' ' 55' ' ' PRO . 62.6 t80 -64.2 -29.53 70.63 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.259 0.552 . . . . 0.0 110.796 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.9 t -62.91 -18.78 63.49 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.694 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -94.75 -8.96 36.11 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 122.152 -0.343 . . . . 0.0 110.416 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 26.9 t -85.24 28.82 0.7 Allowed 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.772 0.829 . . . . 0.0 110.798 -177.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.88 -70.84 1.78 Allowed Glycine 0 N--CA 1.432 -1.626 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.054 177.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.599 ' CD1' ' HB2' ' A' ' 77' ' ' ASP . 27.0 p90 -110.41 149.42 30.29 Favored 'General case' 0 C--N 1.29 -1.991 0 O-C-N 122.784 -0.245 . . . . 0.0 110.356 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -114.24 -10.09 12.77 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.681 177.0 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -109.18 99.7 1.28 Allowed Glycine 0 N--CA 1.433 -1.552 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.897 -175.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 69.2 mt -87.05 115.17 27.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-O 122.551 1.167 . . . . 0.0 107.964 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 27.8 m -85.94 -23.97 26.75 Favored 'General case' 0 C--N 1.249 -3.763 0 CA-C-N 112.337 -2.21 . . . . 0.0 113.764 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.506 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 9.3 t -158.48 153.45 25.17 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -176.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.2 mt -137.29 130.32 43.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -178.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.559 ' HD2' ' SG ' ' A' ' 121' ' ' CYS . 24.7 ttmt -117.64 133.48 55.9 Favored 'General case' 0 C--N 1.3 -1.543 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -100.47 127.81 46.71 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -177.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' CYS . . . . . 0.489 ' SG ' ' HD2' ' A' ' 74' ' ' TYR . 29.6 m -119.38 168.3 11.08 Favored 'General case' 0 N--CA 1.417 -2.117 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -176.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.7 pt -127.38 140.29 49.52 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.525 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -112.79 119.08 36.79 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 63.3 p -79.17 177.37 8.87 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.254 -175.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.1 ttpp -66.32 -20.19 66.02 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.572 0.701 . . . . 0.0 109.421 176.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -78.77 -8.34 58.66 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.813 0.816 . . . . 0.0 109.953 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.68 -11.57 68.16 Favored Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.386 176.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -71.82 139.01 48.75 Favored 'General case' 0 C--O 1.253 1.25 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.65 112.27 37.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -104.6 152.7 22.12 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' CYS . . . . . 0.559 ' SG ' ' HD2' ' A' ' 109' ' ' LYS . 0.9 OUTLIER -135.41 156.4 48.98 Favored 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 118.626 -1.23 . . . . 0.0 110.575 -175.586 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 9.4 tp -125.48 134.74 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.549 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -92.61 104.9 17.15 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 . . . . . 0 C--N 1.303 -1.417 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.024 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.339 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.3 -11.3 60.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.777 0.798 . . . . 0.0 110.79 -178.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -80.08 -8.24 59.29 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.166 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.5 m -112.6 124.61 52.93 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 176.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.5 p -138.71 156.92 46.99 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.319 0.581 . . . . 0.0 111.113 -176.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -75.99 118.34 18.65 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.114 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 69.97 53.22 0.37 Allowed 'General case' 0 C--O 1.243 0.719 0 CA-C-N 114.979 -1.01 . . . . 0.0 112.697 171.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.411 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 12.0 m -125.54 154.79 41.62 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.604 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 54.4 tp -112.26 122.69 48.43 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 171.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.525 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 78.7 mt-30 -116.04 124.88 51.57 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.759 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 3.6 mp -109.51 126.01 53.09 Favored 'General case' 0 N--CA 1.415 -2.204 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.129 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.417 ' CD1' ' HB3' ' A' ' 39' ' ' TYR . 98.1 m-85 -94.55 147.94 22.76 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 123.783 0.677 . . . . 0.0 110.914 -176.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -72.5 -38.58 68.09 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.979 -177.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -109.74 178.12 4.52 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.407 HG22 ' HA ' ' A' ' 96' ' ' ASP . 6.0 p -79.09 172.63 13.54 Favored 'General case' 0 N--CA 1.422 -1.872 0 C-N-CA 121.507 -0.077 . . . . 0.0 111.026 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.544 ' CE1' ' HG3' ' A' ' 36' ' ' ARG 0.261 31.6 p90 46.56 42.25 10.88 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 176.777 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 67.94 28.89 6.75 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.984 0.914 . . . . 0.0 112.788 176.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.544 ' HG3' ' CE1' ' A' ' 34' ' ' TYR . 23.7 mmt180 -107.06 172.13 6.99 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-O 121.501 0.667 . . . . 0.0 112.249 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.4 -159.88 39.32 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -177.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.0 m -89.66 179.57 5.99 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 172.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 21.8 p90 -149.42 162.92 39.14 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.525 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 15.6 tt -118.09 151.97 20.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.232 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -107.34 125.92 51.8 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 175.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.551 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 93.0 t -117.67 133.96 62.77 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 176.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -117.59 -29.47 5.76 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 120.994 0.426 . . . . 0.0 110.313 -176.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.09 154.91 47.77 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.838 -177.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.2 m -60.31 145.8 46.32 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 123.527 0.731 . . . . 0.0 111.935 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.5 p -120.84 139.04 49.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 176.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.12 -20.31 30.88 Favored Glycine 0 C--N 1.299 -1.484 0 C-N-CA 119.604 -1.284 . . . . 0.0 112.804 -176.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.3 p -157.72 131.14 7.76 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 120.961 0.41 . . . . 0.0 111.789 -176.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.58 117.22 23.82 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 175.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 13.9 t -133.6 113.0 12.9 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.403 176.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 8.1 Cg_exo -75.56 161.23 94.86 Favored 'Cis proline' 0 C--O 1.246 0.924 0 C-N-CA 123.191 -1.587 . . . . 0.0 111.206 -0.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -61.71 158.87 35.29 Favored 'Trans proline' 0 C--O 1.245 0.859 0 C-N-CA 122.986 2.457 . . . . 0.0 111.312 178.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 48.0 m0 -88.56 137.5 32.27 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 5.4 p -117.59 75.53 9.51 Favored Pre-proline 0 C--N 1.292 -1.905 0 O-C-N 123.31 0.381 . . . . 0.0 111.601 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.437 ' HG2' ' CD2' ' A' ' 97' ' ' PHE . 69.8 Cg_endo -74.35 157.94 45.07 Favored 'Trans proline' 0 C--N 1.359 1.12 0 C-N-CA 122.859 2.373 . . . . 0.0 112.875 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.25 -28.67 14.22 Favored Glycine 0 N--CA 1.436 -1.307 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.3 p -156.1 151.67 27.03 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.5 t -128.45 142.4 43.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 35.8 t -145.84 150.06 35.45 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.515 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.6 t -113.58 123.28 33.41 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 175.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.411 ' HD2' ' O ' ' A' ' 26' ' ' CYS . 10.3 Cg_endo -57.27 140.6 93.42 Favored 'Trans proline' 0 C--O 1.247 0.935 0 C-N-CA 122.552 2.168 . . . . 0.0 111.505 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.431 ' CE1' ' HB2' ' A' ' 64' ' ' ASN . 82.1 t80 -74.09 109.54 7.66 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-O 121.385 0.612 . . . . 0.0 110.681 -177.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.442 ' H ' ' HB2' ' A' ' 90' ' ' HIS . 49.1 t -94.19 114.17 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.566 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.431 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 27.0 t-20 -112.75 88.92 2.94 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 172.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.466 ' OD1' ' HG2' ' A' ' 67' ' ' LYS . 3.8 t70 -127.31 145.81 50.66 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.62 -171.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.9 m -62.93 -6.93 4.3 Favored 'General case' 0 CA--C 1.569 1.71 0 C-N-CA 124.444 1.098 . . . . 0.0 111.157 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.466 ' HG2' ' OD1' ' A' ' 65' ' ' ASP . 75.8 mmtt -61.28 153.95 25.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 171.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.543 ' HB2' ' OE2' ' A' ' 69' ' ' GLU . 45.5 mtm180 -89.17 -28.65 19.87 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.733 -177.033 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.543 ' OE2' ' HB2' ' A' ' 68' ' ' ARG . 9.7 mp0 -105.37 128.9 53.74 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.435 -177.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -102.52 153.96 37.78 Favored Pre-proline 0 C--N 1.291 -1.968 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 176.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -80.58 141.39 13.85 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.467 1.445 . . . . 0.0 112.476 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -133.22 138.15 46.4 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.604 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 84.3 m95 -120.27 136.91 54.51 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.755 -0.59 . . . . 0.0 112.301 -173.114 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 86' ' ' THR . 37.1 m-85 -116.74 143.29 45.84 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.678 177.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.8 mt -125.96 142.78 51.36 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 -176.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -133.62 141.71 47.77 Favored 'General case' 0 C--O 1.244 0.794 0 O-C-N 123.625 0.578 . . . . 0.0 109.974 -177.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.65 -5.46 59.31 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.918 -177.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -131.76 162.25 30.94 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 175.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 25.2 m -73.15 167.38 2.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 C-N-CA 122.395 0.278 . . . . 0.0 110.794 -176.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 17.9 m120 57.54 30.2 18.34 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.646 0.778 . . . . 0.0 111.968 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.564 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 11.5 m-85 60.1 40.22 18.7 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.401 1.08 . . . . 0.0 111.523 176.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.0 p -111.98 171.28 7.59 Favored 'General case' 0 C--O 1.25 1.095 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.95 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.69 -135.77 13.25 Favored Glycine 0 N--CA 1.427 -1.913 0 C-N-CA 120.881 -0.675 . . . . 0.0 112.105 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -83.48 155.53 23.33 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 123.025 0.53 . . . . 0.0 109.605 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.4 tt -131.66 136.69 56.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 121.318 0.58 . . . . 0.0 110.066 -175.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 76.1 m -132.09 127.62 36.45 Favored 'General case' 0 C--N 1.288 -2.103 0 O-C-N 122.021 -0.424 . . . . 0.0 110.359 175.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -111.1 124.82 7.08 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.81 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.45 HD21 HD11 ' A' ' 94' ' ' ILE . 2.9 mm? -117.76 145.39 44.52 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 123.576 0.751 . . . . 0.0 110.618 177.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -117.3 169.26 13.09 Favored Glycine 0 N--CA 1.433 -1.523 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.92 -178.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.442 ' HB2' ' H ' ' A' ' 63' ' ' VAL . 35.9 p-80 -61.13 122.13 14.24 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.449 0.642 . . . . 0.0 112.323 -177.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.56 -1.63 76.05 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.568 177.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.5 m -107.42 146.12 32.1 Favored 'General case' 0 N--CA 1.424 -1.73 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.7 m -137.68 154.51 49.67 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.45 HD11 HD21 ' A' ' 88' ' ' LEU . 50.7 mt -93.49 128.11 45.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 173.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -70.92 -47.54 58.54 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.108 0.48 . . . . 0.0 110.984 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.667 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 3.4 m-20 -132.72 88.87 2.56 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.927 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.437 ' CD2' ' HG2' ' A' ' 55' ' ' PRO . 50.7 t80 -65.47 -30.25 71.01 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.778 0.799 . . . . 0.0 109.666 176.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.2 t -66.91 -24.45 66.1 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.463 -178.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.667 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 30.0 mmtp -93.99 -6.78 44.57 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -178.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 26.6 m -79.73 -171.85 3.04 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.46 -64.89 3.97 Favored Glycine 0 CA--C 1.503 -0.702 0 N-CA-C 112.094 -0.403 . . . . 0.0 112.094 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -110.94 146.74 36.05 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.193 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.558 ' H ' ' HD3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -113.42 -6.54 13.49 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 175.867 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -112.55 119.18 4.86 Favored Glycine 0 N--CA 1.431 -1.648 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.457 -177.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 64.9 mt -103.06 115.41 44.99 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.763 0 CA-C-O 122.426 1.107 . . . . 0.0 109.476 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 37.8 m -85.73 -29.6 23.78 Favored 'General case' 0 N--CA 1.394 -3.248 0 CA-C-N 112.148 -2.297 . . . . 0.0 113.999 177.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.6 p -153.88 154.61 34.2 Favored 'General case' 0 C--O 1.237 0.42 0 O-C-N 121.862 -0.524 . . . . 0.0 109.965 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.8 mt -133.22 131.45 58.24 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -176.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.564 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 38.2 ttmt -117.51 128.33 54.87 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -95.67 129.58 42.83 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 68.4 m -122.56 171.72 8.91 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.357 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.1 pt -129.41 139.3 52.08 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 176.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -110.56 118.87 37.38 Favored 'General case' 0 C--N 1.274 -2.714 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 72.9 p -69.15 170.23 10.48 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.462 -176.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.2 ttpp -67.06 -19.54 65.69 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.635 0.731 . . . . 0.0 109.276 176.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -84.92 -8.17 58.87 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.744 -177.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.21 -10.62 65.54 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.78 -0.646 . . . . 0.0 114.133 175.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -78.32 138.38 38.54 Favored 'General case' 0 C--O 1.249 1.031 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.902 179.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.3 t -102.31 113.35 38.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -95.49 133.86 39.0 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.75 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 63.6 m -136.91 158.45 44.42 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 7.4 tp -73.76 118.99 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.894 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 171.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -81.11 104.77 11.82 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.466 -175.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 . . . . . 0 N--CA 1.429 -1.499 0 N-CA-C 104.003 -2.592 . . . . 0.0 104.003 178.82 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.461 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 70.75 4.44 5.01 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.788 1.235 . . . . 0.0 113.534 176.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -88.03 -23.75 23.69 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 122.089 0.947 . . . . 0.0 109.269 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.6 p -102.91 139.73 38.1 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.015 174.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.508 ' O ' ' HG3' ' A' ' 61' ' ' PRO . 44.4 t -102.1 134.09 45.91 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 -177.283 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.5 mmtm -77.03 120.51 22.24 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -176.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.463 ' CZ ' ' HD3' ' A' ' 71' ' ' PRO . 14.5 m-85 66.52 35.82 5.31 Favored 'General case' 0 CA--C 1.509 -0.603 0 O-C-N 124.563 1.165 . . . . 0.0 110.694 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.458 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 18.5 m -123.12 145.32 48.68 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.591 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 49.7 tp -94.56 124.93 38.88 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 176.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.479 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 16.3 mt-30 -117.42 124.19 48.24 Favored 'General case' 0 N--CA 1.42 -1.929 0 CA-C-O 121.368 0.604 . . . . 0.0 109.469 -177.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.498 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 3.6 mp -109.68 125.65 52.85 Favored 'General case' 0 N--CA 1.421 -1.904 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.73 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.504 ' HA ' ' O ' ' A' ' 38' ' ' SER . 85.6 m-85 -95.24 152.31 18.48 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 123.393 0.433 . . . . 0.0 111.464 -176.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.89 -47.56 65.53 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.378 -177.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -108.17 178.4 4.51 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.781 -176.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.455 HG22 ' HA ' ' A' ' 96' ' ' ASP . 2.4 p -77.02 166.29 23.5 Favored 'General case' 0 N--CA 1.403 -2.799 0 O-C-N 123.28 0.362 . . . . 0.0 110.295 -176.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.408 ' CE2' ' HD3' ' A' ' 36' ' ' ARG 0.262 20.9 p90 47.21 47.59 16.41 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 177.704 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 65.51 22.19 11.82 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.391 1.076 . . . . 0.0 112.19 176.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.408 ' HD3' ' CE2' ' A' ' 34' ' ' TYR . 55.1 mtp180 -91.29 160.17 15.65 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.509 0.671 . . . . 0.0 112.63 178.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.35 -148.0 20.42 Favored Glycine 0 N--CA 1.433 -1.542 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -176.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 17.2 m -111.77 -176.65 2.99 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 177.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 23.4 p90 -143.31 163.15 33.81 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.23 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 15.3 tt -114.35 152.18 16.04 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 177.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -106.84 125.54 51.14 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 87.5 t -120.1 133.18 67.68 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -115.68 -31.72 5.74 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.487 0.66 . . . . 0.0 109.518 -174.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.47 161.89 29.37 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.321 -176.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.4 p -69.01 146.38 52.75 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 123.623 0.769 . . . . 0.0 112.67 -176.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.0 p -121.82 135.65 61.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.9 -18.11 41.58 Favored Glycine 0 N--CA 1.431 -1.687 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.955 -178.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.5 p -158.92 116.66 2.84 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.405 0.621 . . . . 0.0 112.593 -178.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.9 mt -105.19 116.91 32.74 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.431 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.2 m -133.58 114.75 13.37 Favored Pre-proline 0 N--CA 1.42 -1.962 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 172.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -73.99 162.12 92.91 Favored 'Cis proline' 0 C--O 1.248 0.995 0 C-N-CA 123.315 -1.536 . . . . 0.0 110.946 -0.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.54 155.36 66.92 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.914 1.743 . . . . 0.0 109.931 177.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -89.61 133.43 34.62 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.588 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 22.6 p -116.85 77.22 8.41 Favored Pre-proline 0 C--N 1.298 -1.643 0 O-C-N 123.523 0.514 . . . . 0.0 111.759 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.408 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 97.2 Cg_endo -80.29 158.2 22.93 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.66 2.24 . . . . 0.0 113.012 178.023 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -89.28 -29.57 16.69 Favored Glycine 0 N--CA 1.437 -1.247 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 177.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.0 p -155.25 154.46 32.2 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.0 t -129.16 143.22 41.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 38.6 t -145.58 149.88 35.37 Favored 'General case' 0 N--CA 1.428 -1.558 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.732 176.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.6 t -116.55 123.81 30.14 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 175.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.508 ' HG3' ' O ' ' A' ' 23' ' ' CYS . 26.2 Cg_endo -60.81 149.04 90.11 Favored 'Trans proline' 0 C--O 1.252 1.18 0 C-N-CA 122.798 2.332 . . . . 0.0 112.321 -177.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.547 ' CE2' ' HB3' ' A' ' 64' ' ' ASN . 79.5 t80 -76.14 110.12 10.36 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 121.825 0.821 . . . . 0.0 111.058 -177.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.442 ' H ' ' HB2' ' A' ' 90' ' ' HIS . 66.3 t -94.54 116.31 35.52 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.778 177.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.547 ' HB3' ' CE2' ' A' ' 62' ' ' PHE . 3.7 p-10 -119.28 24.58 10.65 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 122.35 1.071 . . . . 0.0 108.62 178.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -67.93 146.58 53.47 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 113.363 -1.744 . . . . 0.0 111.93 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.2 m -58.71 -8.64 1.37 Allowed 'General case' 0 CA--C 1.57 1.749 0 C-N-CA 125.141 1.377 . . . . 0.0 112.768 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -62.62 138.57 58.52 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -69.21 -29.41 67.37 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.468 0.48 . . . . 0.0 111.509 -173.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -112.02 135.65 52.38 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-O 121.63 0.729 . . . . 0.0 111.612 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.86 148.35 36.36 Favored Pre-proline 0 C--N 1.285 -2.204 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.394 176.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.463 ' HD3' ' CZ ' ' A' ' 25' ' ' TYR . 71.2 Cg_endo -71.59 137.87 31.14 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 121.995 1.797 . . . . 0.0 112.928 -175.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -131.29 123.38 28.22 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.591 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 83.6 m95 -108.55 135.76 49.28 Favored 'General case' 0 C--N 1.281 -2.388 0 O-C-N 122.098 -0.376 . . . . 0.0 111.996 -172.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' A' ' 86' ' ' THR . 41.6 m-85 -113.89 141.91 46.76 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.554 177.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.403 HD21 HD21 ' A' ' 27' ' ' LEU . 22.6 mt -125.35 142.59 51.41 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 -176.021 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.448 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 84.7 m-85 -131.49 139.72 49.38 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 121.197 0.522 . . . . 0.0 111.178 -175.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.13 -12.85 59.14 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.891 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -123.76 165.76 16.74 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 175.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.7 m -77.14 167.47 2.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 118.036 0.38 . . . . 0.0 110.822 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 60.51 30.96 20.16 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.667 0.787 . . . . 0.0 111.942 177.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.431 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 5.8 m-85 61.92 40.37 12.56 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.799 175.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.8 p -117.49 176.07 5.34 Favored 'General case' 0 C--O 1.25 1.086 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.629 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.57 -134.03 12.26 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 178.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 52.2 mtm180 -84.38 147.78 26.96 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 122.45 0.3 . . . . 0.0 110.431 176.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.9 tt -124.77 139.24 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 O-C-N 123.654 0.596 . . . . 0.0 110.108 -176.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 67.6 m -131.84 126.44 34.29 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 175.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -111.55 122.12 5.97 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.776 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.466 HD21 HD11 ' A' ' 94' ' ' ILE . 3.7 mm? -112.69 145.07 41.13 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 120.835 0.35 . . . . 0.0 111.041 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -117.06 168.32 12.8 Favored Glycine 0 N--CA 1.424 -2.121 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.705 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.442 ' HB2' ' H ' ' A' ' 63' ' ' VAL . 7.2 p80 -59.72 123.87 18.32 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.335 0.588 . . . . 0.0 111.83 -178.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.08 2.78 77.17 Favored Glycine 0 N--CA 1.43 -1.758 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.387 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.1 m -113.19 145.66 40.61 Favored 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 4.6 m -134.8 158.84 43.14 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.466 HD11 HD21 ' A' ' 88' ' ' LEU . 46.3 mt -93.65 131.94 39.21 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 173.022 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -70.21 -47.67 60.44 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.276 0.56 . . . . 0.0 109.903 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.59 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 3.2 m-20 -138.25 100.95 4.26 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -64.77 -36.5 84.53 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.404 0.621 . . . . 0.0 110.422 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.3 t -64.45 -23.76 67.39 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.965 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.59 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 28.2 mmtp -91.99 -7.64 48.35 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 122.147 -0.346 . . . . 0.0 110.413 -178.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.2 m -78.12 -13.93 59.67 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.687 0.756 . . . . 0.0 109.872 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 132.14 -85.16 0.29 Allowed Glycine 0 N--CA 1.42 -2.385 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -86.89 141.9 28.42 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 120.542 -0.463 . . . . 0.0 109.924 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.588 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.52 -8.39 13.35 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.853 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -108.15 109.15 2.84 Favored Glycine 0 N--CA 1.432 -1.614 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.989 -176.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 66.5 mt -91.64 116.06 32.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 122.336 1.065 . . . . 0.0 109.053 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.9 m -85.85 -28.63 24.3 Favored 'General case' 0 N--CA 1.401 -2.923 0 CA-C-N 112.445 -2.161 . . . . 0.0 114.816 177.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.4 p -156.13 157.36 35.86 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.7 mt -137.48 131.47 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -175.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.431 ' HE2' ' CD2' ' A' ' 81' ' ' TYR . 37.6 ttmt -117.66 133.64 55.74 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -101.27 121.88 42.67 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 120.615 -0.434 . . . . 0.0 109.932 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 65.9 m -119.85 172.14 7.92 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 8.4 pt -127.61 143.22 41.4 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -115.12 120.49 39.97 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 177.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 82.8 p -79.6 176.49 9.66 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.424 -173.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -65.16 -26.85 68.35 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.119 172.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -76.91 -8.71 57.86 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 122.051 0.929 . . . . 0.0 110.211 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.07 -11.54 70.48 Favored Glycine 0 CA--C 1.498 -1.016 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.772 175.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -73.31 141.03 47.14 Favored 'General case' 0 C--O 1.257 1.448 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.889 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 22.6 t -102.13 118.71 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.814 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 177.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -104.3 140.4 37.92 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 69.9 m -130.74 147.82 52.44 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 8.2 tp -126.6 135.98 62.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 175.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -86.34 104.2 15.64 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.939 0.876 . . . . 0.0 110.112 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 . . . . . 0 C--N 1.292 -1.923 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.909 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.53 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.87 32.91 2.23 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -76.95 -5.16 47.47 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.834 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.0 p -106.48 124.12 49.11 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 165.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.9 p -125.95 153.36 44.4 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 119.446 -0.901 . . . . 0.0 111.839 -174.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.2 mmmm -89.36 143.39 26.86 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 69.17 36.95 2.24 Favored 'General case' 0 N--CA 1.482 1.175 0 O-C-N 123.822 0.701 . . . . 0.0 111.543 177.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.0 m -123.68 145.92 48.62 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.199 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.571 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 57.8 tp -100.03 114.13 27.22 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 175.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 44.8 mt-30 -108.26 124.49 50.38 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.704 -0.798 . . . . 0.0 108.848 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.4 mp -109.41 127.38 54.34 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.032 177.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -94.06 150.37 20.4 Favored 'General case' 0 C--N 1.29 -1.989 0 O-C-N 123.509 0.506 . . . . 0.0 110.148 -176.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -69.88 -43.27 72.17 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 124.055 0.847 . . . . 0.0 109.651 -175.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -114.08 178.88 4.12 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.033 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.441 HG22 ' HA ' ' A' ' 96' ' ' ASP . 2.6 p -74.91 169.72 17.39 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.119 -176.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.456 ' CE2' ' HG3' ' A' ' 36' ' ' ARG 0.258 13.8 p90 47.17 40.16 9.55 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.959 1.304 . . . . 0.0 114.01 177.771 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 62.2 40.43 11.65 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.147 0.979 . . . . 0.0 111.947 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.539 ' HA ' ' NE ' ' A' ' 36' ' ' ARG . 4.3 mmp_? -108.61 162.23 14.34 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.223 0.535 . . . . 0.0 112.162 178.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.26 -163.05 42.72 Favored Glycine 0 N--CA 1.426 -1.967 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -177.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.0 p -89.34 173.84 8.15 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 176.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -140.77 166.01 25.94 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -177.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.8 tt -116.9 152.08 18.69 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 177.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -106.75 125.57 51.18 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 175.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.494 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 97.8 t -122.41 133.04 69.86 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.489 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -119.32 -24.49 6.37 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.709 -177.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -115.46 163.14 16.17 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.98 -172.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.9 m -83.1 142.43 31.27 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 176.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.9 p -120.97 129.67 75.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.68 -12.13 59.76 Favored Glycine 0 N--CA 1.432 -1.567 0 C-N-CA 119.672 -1.252 . . . . 0.0 113.795 -178.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 24.4 p -157.7 122.27 4.31 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.279 0.562 . . . . 0.0 112.409 -178.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 72.8 mt -117.82 117.87 30.47 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 175.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 12.3 p -132.46 109.45 13.52 Favored Pre-proline 0 C--N 1.29 -1.991 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.959 176.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 72.4 Cg_endo -75.34 162.06 93.38 Favored 'Cis proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.704 -1.373 . . . . 0.0 111.408 -1.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.76 156.77 59.8 Favored 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 121.975 1.784 . . . . 0.0 111.152 178.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 48.0 m0 -89.27 131.89 35.16 Favored 'General case' 0 CA--C 1.482 -1.668 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.623 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 38.8 p -114.46 78.53 4.86 Favored Pre-proline 0 N--CA 1.43 -1.425 0 O-C-N 123.56 0.537 . . . . 0.0 110.712 178.018 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.417 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 88.4 Cg_endo -78.21 157.63 29.92 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 122.523 2.149 . . . . 0.0 112.566 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -89.59 -30.85 12.39 Favored Glycine 0 N--CA 1.431 -1.651 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 177.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.2 p -153.25 158.25 41.39 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.9 t -136.87 142.67 37.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -177.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 49.4 t -145.95 147.82 32.12 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.691 176.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.1 t -118.73 124.27 28.52 Favored Pre-proline 0 N--CA 1.441 -0.923 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 175.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -63.03 148.66 93.19 Favored 'Trans proline' 0 C--O 1.247 0.971 0 C-N-CA 122.399 2.066 . . . . 0.0 112.062 -178.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -70.96 119.88 15.73 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-O 121.85 0.833 . . . . 0.0 110.249 -178.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.451 ' H ' ' HB2' ' A' ' 90' ' ' HIS . 93.1 t -95.83 123.35 47.99 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.349 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -116.09 14.96 16.09 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 122.143 0.973 . . . . 0.0 108.617 -178.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.4 ' HB3' ' HG2' ' A' ' 67' ' ' LYS . 1.9 m-20 -64.13 145.54 55.77 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 113.519 -1.673 . . . . 0.0 113.717 -175.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.7 m -64.19 -12.42 40.32 Favored 'General case' 0 C--O 1.255 1.372 0 C-N-CA 125.285 1.434 . . . . 0.0 110.981 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.4 ' HG2' ' HB3' ' A' ' 65' ' ' ASP . 73.3 mmtt -59.67 141.33 55.29 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.41 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -78.02 -29.86 49.68 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.629 0.728 . . . . 0.0 109.803 -177.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.411 ' HB2' ' HB ' ' A' ' 112' ' ' ILE . 0.4 OUTLIER -107.37 129.85 54.87 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.686 -179.873 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.76 154.14 39.52 Favored Pre-proline 0 C--N 1.286 -2.159 0 CA-C-N 114.616 -1.174 . . . . 0.0 109.237 -178.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -74.08 134.41 19.46 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 121.578 1.519 . . . . 0.0 111.066 -178.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -129.42 128.51 43.12 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 106.309 -1.738 . . . . 0.0 106.309 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.571 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 87.1 m95 -110.38 130.43 55.55 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-O 121.175 0.512 . . . . 0.0 111.565 -173.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.48 ' HA ' ' O ' ' A' ' 86' ' ' THR . 25.3 m-85 -111.19 142.26 43.62 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.359 176.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.3 mt -125.36 142.14 51.67 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 -176.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.427 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 87.2 m-85 -131.42 139.31 49.38 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.112 0.482 . . . . 0.0 110.814 -175.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.678 ' HB2' ' CD1' ' A' ' 102' ' ' PHE . 5.7 t70 -77.68 -18.06 57.03 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.295 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.454 ' C ' ' HB3' ' A' ' 106' ' ' SER . 9.0 t-20 -126.03 162.38 25.42 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 176.013 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.3 m -67.78 168.12 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.58 0 C-N-CA 123.076 0.551 . . . . 0.0 111.434 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.7 m120 55.26 30.22 14.28 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.827 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.53 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 13.3 m-85 60.03 45.9 11.49 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.799 1.239 . . . . 0.0 111.749 175.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.8 p -118.94 176.35 5.33 Favored 'General case' 0 C--O 1.249 1.041 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.462 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.87 -133.77 12.16 Favored Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 121.218 -0.515 . . . . 0.0 111.973 177.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 63.9 mtt85 -81.67 148.07 29.2 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.157 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.9 tt -129.16 137.2 57.71 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 O-C-N 123.62 0.575 . . . . 0.0 110.424 -175.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 95.7 m -130.97 122.71 27.35 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -111.19 109.68 2.6 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.713 -0.756 . . . . 0.0 114.629 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -103.07 145.07 30.45 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 122.816 0.446 . . . . 0.0 110.95 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.13 175.9 16.1 Favored Glycine 0 N--CA 1.425 -2.063 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.473 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.451 ' HB2' ' H ' ' A' ' 63' ' ' VAL . 10.0 p80 -66.08 122.13 16.72 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.532 0.682 . . . . 0.0 112.194 -176.333 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.72 0.95 71.51 Favored Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.623 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.0 m -106.59 146.31 30.84 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 5.6 m -136.07 151.37 49.77 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.8 mt -93.51 127.22 45.71 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 174.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -70.51 -47.27 61.26 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.387 0.613 . . . . 0.0 110.48 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.622 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 2.1 m-20 -135.33 93.63 3.01 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.071 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -65.14 -33.69 76.61 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.202 0.525 . . . . 0.0 110.391 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.8 t -65.26 -23.91 67.17 Favored 'General case' 0 CA--C 1.559 1.318 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.136 -176.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.622 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 30.2 mmtp -92.75 -6.4 49.15 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.941 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.2 m -84.9 38.69 0.72 Allowed 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.344 0.592 . . . . 0.0 111.535 -175.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.88 -73.98 2.25 Favored Glycine 0 N--CA 1.426 -2.028 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.678 ' CD1' ' HB2' ' A' ' 77' ' ' ASP . 16.1 p90 -109.81 148.28 31.77 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -179.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.623 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -113.54 -8.03 13.36 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 120.114 -0.635 . . . . 0.0 109.647 179.196 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -113.31 112.65 2.96 Favored Glycine 0 N--CA 1.432 -1.604 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.351 -174.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 76.1 mt -94.26 115.41 33.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.454 ' HB3' ' C ' ' A' ' 78' ' ' ASN . 3.7 t -86.06 -26.42 25.35 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.947 178.109 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.5 p -152.08 157.22 41.31 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 122.089 -0.382 . . . . 0.0 110.935 177.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.3 mt -135.9 133.2 50.95 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -175.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.53 ' HE2' ' CD2' ' A' ' 81' ' ' TYR . 33.5 ttmt -122.02 128.34 51.32 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -96.3 121.39 38.04 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 60.6 m -119.16 172.09 7.82 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.411 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 6.9 pt -126.17 139.51 51.36 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 CA-C-O 121.127 0.489 . . . . 0.0 110.147 177.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -112.2 119.06 37.08 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 76.6 p -72.35 -178.55 2.57 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 114.636 -1.166 . . . . 0.0 112.059 -174.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -65.72 -31.05 71.83 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.785 0.803 . . . . 0.0 109.173 175.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -79.46 -8.95 59.48 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.652 -178.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.58 -9.32 77.98 Favored Glycine 0 N--CA 1.427 -1.928 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.787 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -70.01 139.32 52.72 Favored 'General case' 0 C--O 1.255 1.36 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.2 t -102.82 112.91 37.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 121.174 0.512 . . . . 0.0 109.761 -176.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -97.17 135.17 39.5 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -138.01 157.11 47.03 Favored 'General case' 0 CA--C 1.483 -1.634 0 C-N-CA 118.505 -1.278 . . . . 0.0 111.221 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 5.5 tp -125.43 123.14 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.782 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.063 176.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -73.79 106.15 5.39 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.629 0.728 . . . . 0.0 109.359 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 . . . . . 0 C--N 1.284 -2.243 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.384 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 . . . . . 0 N--CA 1.476 0.834 0 CA-C-O 121.254 0.549 . . . . 0.0 112.217 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.7 m -144.76 167.76 21.82 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.626 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 59.6 tp -111.96 124.63 52.8 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 169.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 70.5 mt-30 -113.72 124.37 52.13 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.555 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.443 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 3.2 mp -109.84 129.08 55.68 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.015 176.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.444 ' HB3' ' O ' ' A' ' 36' ' ' ARG . 94.9 m-85 -99.59 148.88 23.84 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 123.832 0.708 . . . . 0.0 110.852 -174.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -70.37 -38.1 74.69 Favored 'General case' 0 C--N 1.307 -1.249 0 O-C-N 123.663 0.602 . . . . 0.0 111.275 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -107.98 177.66 4.74 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -177.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.427 HG22 ' HA ' ' A' ' 96' ' ' ASP . 2.6 p -84.28 175.53 9.34 Favored 'General case' 0 N--CA 1.407 -2.612 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.274 15.5 p90 47.29 42.3 13.47 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 177.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 66.82 23.06 10.12 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.757 -1.111 . . . . 0.0 112.887 175.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.444 ' O ' ' HB3' ' A' ' 30' ' ' TYR . 18.1 mtm180 -102.24 173.38 6.39 Favored 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 119.653 -0.819 . . . . 0.0 112.106 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.69 179.8 51.32 Favored Glycine 0 N--CA 1.419 -2.45 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.52 -178.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.2 m -78.4 167.78 20.8 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 174.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 11.0 p90 -140.54 163.53 32.59 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -176.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.3 tt -114.59 152.98 16.16 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -107.23 125.54 51.26 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 176.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.549 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 84.3 t -117.91 133.38 64.89 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.369 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 176.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -114.81 -31.84 6.0 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 123.337 0.398 . . . . 0.0 110.159 -176.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.99 160.59 33.17 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -177.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.9 m -69.43 139.62 54.05 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 123.645 0.778 . . . . 0.0 112.186 -173.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.1 p -113.71 131.19 66.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 176.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.33 -15.41 51.06 Favored Glycine 0 N--CA 1.433 -1.549 0 C-N-CA 119.546 -1.312 . . . . 0.0 113.154 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.7 p -154.88 124.13 6.35 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.309 0.576 . . . . 0.0 112.474 -178.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 82.8 mt -118.77 117.99 30.37 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.615 175.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 15.0 p -132.84 110.13 13.16 Favored Pre-proline 0 N--CA 1.428 -1.548 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.636 174.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 74.2 Cg_endo -76.5 162.11 92.48 Favored 'Cis proline' 0 C--O 1.252 1.204 0 C-N-CA 123.729 -1.363 . . . . 0.0 111.236 -2.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.76 158.47 37.47 Favored 'Trans proline' 0 C--O 1.244 0.785 0 C-N-CA 122.783 2.322 . . . . 0.0 110.751 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.46 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 47.8 m0 -89.22 138.25 31.59 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 11.0 p -116.74 76.94 8.01 Favored Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 123.576 0.547 . . . . 0.0 111.874 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.466 ' HD2' ' O ' ' A' ' 103' ' ' LYS . 92.8 Cg_endo -76.4 158.57 36.66 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.584 2.189 . . . . 0.0 112.849 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.69 -36.92 8.97 Favored Glycine 0 N--CA 1.435 -1.37 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 175.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.2 p -151.1 159.8 44.27 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.5 t -134.77 143.11 38.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 38.4 t -145.48 148.74 33.58 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.784 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 67.3 t -113.0 121.01 39.31 Favored Pre-proline 0 C--N 1.309 -1.153 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 176.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -57.79 138.4 85.88 Favored 'Trans proline' 0 C--O 1.244 0.799 0 C-N-CA 122.877 2.385 . . . . 0.0 111.498 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.465 ' CE2' ' HB3' ' A' ' 64' ' ' ASN . 40.5 t80 -67.67 136.64 54.67 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-O 121.699 0.761 . . . . 0.0 111.071 -177.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 70.2 t -131.61 114.87 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.465 ' HB3' ' CE2' ' A' ' 62' ' ' PHE . 9.4 p30 -111.95 5.01 18.57 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 175.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.19 145.13 32.52 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 112.615 -2.084 . . . . 0.0 112.931 -172.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.48 -5.64 0.06 Allowed 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 128.991 2.916 . . . . 0.0 115.162 -173.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -59.62 171.55 0.84 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.295 1.038 . . . . 0.0 109.614 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 114' ' ' THR . 28.3 mtm180 -90.7 -28.09 18.56 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 118.093 -1.443 . . . . 0.0 107.955 173.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.449 ' HG2' HD12 ' A' ' 112' ' ' ILE . 18.5 mp0 -103.61 132.26 50.02 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.582 -174.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -106.38 153.78 40.24 Favored Pre-proline 0 C--N 1.289 -2.033 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 169.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.61 135.71 10.52 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 121.648 1.566 . . . . 0.0 113.012 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -133.88 118.58 18.11 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 177.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.626 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 82.9 m95 -107.55 136.77 46.76 Favored 'General case' 0 C--N 1.278 -2.525 0 O-C-N 122.052 -0.405 . . . . 0.0 111.977 -172.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.513 ' HD2' ' SG ' ' A' ' 111' ' ' CYS . 29.3 m-85 -113.52 141.21 47.42 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.765 177.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.415 HD21 HD21 ' A' ' 27' ' ' LEU . 22.5 mt -126.01 142.33 51.57 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 -176.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 88.0 m-85 -131.75 139.63 49.01 Favored 'General case' 0 C--N 1.31 -1.119 0 O-C-N 123.499 0.5 . . . . 0.0 110.993 -176.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.673 ' HB2' ' CD2' ' A' ' 102' ' ' PHE . 11.8 t70 -85.44 0.9 50.88 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 123.673 0.789 . . . . 0.0 111.224 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -136.58 158.49 44.32 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 172.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.1 m -72.0 169.26 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 C-N-CA 122.316 0.246 . . . . 0.0 110.405 -178.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.48 29.87 19.34 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.168 0.587 . . . . 0.0 110.575 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.436 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 18.9 m-85 56.37 46.82 20.23 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.973 0.909 . . . . 0.0 110.95 177.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 72.9 p -123.32 176.63 6.02 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.475 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.6 -140.8 18.38 Favored Glycine 0 N--CA 1.429 -1.821 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.79 177.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 61.8 mtt180 -73.61 143.46 46.34 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.1 tt -125.33 137.63 57.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 O-C-N 123.572 0.545 . . . . 0.0 110.269 -174.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 52.0 m -131.79 125.11 31.09 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 121.984 -0.448 . . . . 0.0 110.658 175.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -112.22 124.82 6.89 Favored Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.829 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -119.13 146.0 45.5 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 123.251 0.62 . . . . 0.0 110.251 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.29 166.95 12.39 Favored Glycine 0 N--CA 1.431 -1.664 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.362 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -53.3 124.79 15.6 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 124.337 1.055 . . . . 0.0 112.357 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.34 -6.47 82.39 Favored Glycine 0 N--CA 1.435 -1.424 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.612 175.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.9 m -106.44 146.42 30.55 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -178.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.9 m -139.8 152.3 46.44 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 50.8 mt -93.48 133.76 33.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 176.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -71.1 -47.9 55.43 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.205 0.526 . . . . 0.0 110.36 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.554 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 1.9 m-20 -135.0 100.15 4.49 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.25 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -64.4 -38.93 92.75 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.359 0.6 . . . . 0.0 110.375 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.4 t -65.62 -29.76 70.38 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.641 -1.163 . . . . 0.0 112.192 -175.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.554 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 27.5 mmtp -86.31 -14.88 42.34 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 121.988 -0.445 . . . . 0.0 109.963 -176.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.1 m -77.88 -8.08 57.59 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 144.0 -77.26 0.28 Allowed Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.673 ' CD2' ' HB2' ' A' ' 77' ' ' ASP . 37.8 p90 -110.05 147.89 32.73 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.03 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.539 ' H ' ' HD3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -113.94 -9.9 12.98 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -109.67 115.71 4.29 Favored Glycine 0 N--CA 1.428 -1.874 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.596 -175.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 64.0 mt -101.17 116.07 44.05 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.7 m -85.28 -26.4 26.65 Favored 'General case' 0 N--CA 1.391 -3.414 0 CA-C-N 112.432 -2.167 . . . . 0.0 114.067 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 77.8 p -156.75 156.35 33.18 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.3 mt -134.24 133.94 55.32 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.768 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -176.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.436 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 31.9 ttmt -122.52 131.42 53.84 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -96.08 122.23 38.7 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.379 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . 0.513 ' SG ' ' HD2' ' A' ' 74' ' ' TYR . 56.3 m -118.86 167.74 11.43 Favored 'General case' 0 N--CA 1.405 -2.7 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.449 HD12 ' HG2' ' A' ' 69' ' ' GLU . 9.2 pt -127.74 145.82 34.43 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.414 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 61.5 tt0 -122.6 118.93 29.35 Favored 'General case' 0 C--N 1.274 -2.712 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 68' ' ' ARG . 27.1 p -79.78 179.16 7.69 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -175.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -66.25 -19.53 65.85 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.727 0.775 . . . . 0.0 110.203 177.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -83.34 -1.67 53.87 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.84 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.55 -5.63 82.89 Favored Glycine 0 CA--C 1.506 -0.483 0 CA-C-N 116.208 -0.451 . . . . 0.0 113.618 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 113' ' ' GLN . 19.0 ptpt -75.96 134.91 40.07 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 39.4 t -104.71 110.57 31.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -100.3 154.49 18.44 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.288 -2.097 0 C-N-CA 118.642 -1.223 . . . . 0.0 110.376 -177.206 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 121.565 0.698 . . . . 0.0 111.349 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.8 m -124.33 155.09 39.32 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.267 -0.878 . . . . 0.0 108.925 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.606 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 55.2 tp -110.18 117.58 34.06 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 172.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.523 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 77.7 mt-30 -110.22 124.2 51.15 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.579 -0.849 . . . . 0.0 109.618 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 3.2 mp -110.06 125.6 53.12 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.945 178.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -92.91 152.89 19.11 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 123.574 0.546 . . . . 0.0 110.1 -177.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -77.83 -37.9 47.51 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.868 -176.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -108.56 178.31 4.52 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.462 HG22 ' HA ' ' A' ' 96' ' ' ASP . 1.4 p -78.17 169.04 18.92 Favored 'General case' 0 N--CA 1.413 -2.292 0 C-N-CA 122.404 0.282 . . . . 0.0 110.4 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 25.3 p90 46.87 42.51 12.2 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.914 1.286 . . . . 0.0 114.232 176.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 67.65 23.46 8.73 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.414 1.086 . . . . 0.0 112.995 177.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.518 ' HA ' ' NE ' ' A' ' 36' ' ' ARG . 4.4 mmp_? -98.22 165.2 11.99 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.41 -157.8 33.47 Favored Glycine 0 N--CA 1.434 -1.436 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.5 p -85.99 176.64 7.93 Favored 'General case' 0 N--CA 1.421 -1.892 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 174.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.435 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 11.7 p90 -149.36 165.79 30.98 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 13.4 tt -123.03 150.81 27.07 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.747 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -106.88 125.21 50.71 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 174.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.472 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 94.8 t -118.13 133.69 64.13 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -117.86 -26.4 6.5 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.282 0.563 . . . . 0.0 110.569 -176.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -115.73 163.14 16.27 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.334 -174.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.4 ' HB3' ' H ' ' A' ' 110' ' ' ARG . 6.2 p -84.06 143.53 29.67 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 175.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.5 p -120.75 132.38 70.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.56 -16.96 54.12 Favored Glycine 0 N--CA 1.433 -1.536 0 C-N-CA 119.77 -1.205 . . . . 0.0 113.457 -177.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.4 p -157.4 124.29 5.06 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 81.8 mt -117.73 118.65 32.64 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 18.9 m -133.09 116.85 14.56 Favored Pre-proline 0 N--CA 1.42 -1.942 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.154 175.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 58.5 Cg_endo -75.62 160.08 96.49 Favored 'Cis proline' 0 C--O 1.251 1.14 0 C-N-CA 122.779 -1.759 . . . . 0.0 110.438 -4.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.0 157.33 29.61 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 122.69 2.26 . . . . 0.0 111.483 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 48.4 m0 -89.66 132.34 35.19 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -178.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.614 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 41.6 p -113.28 78.67 3.45 Favored Pre-proline 0 C--N 1.304 -1.375 0 O-C-N 123.252 0.345 . . . . 0.0 111.144 177.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.48 ' HG2' ' CD2' ' A' ' 97' ' ' PHE . 73.7 Cg_endo -76.37 153.44 35.43 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 122.198 1.932 . . . . 0.0 112.691 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -87.44 -28.53 24.46 Favored Glycine 0 N--CA 1.431 -1.638 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 178.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.7 p -155.08 154.96 33.21 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.6 t -134.01 142.25 41.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -178.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 31.6 t -146.11 149.64 34.42 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 119.637 -0.825 . . . . 0.0 111.52 176.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.7 t -118.03 124.11 28.99 Favored Pre-proline 0 N--CA 1.437 -1.117 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 175.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.89 143.52 79.87 Favored 'Trans proline' 0 C--O 1.246 0.877 0 C-N-CA 122.604 2.203 . . . . 0.0 112.281 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -66.89 136.37 55.29 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.172 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.469 HG12 ' H ' ' A' ' 65' ' ' ASP . 84.5 t -120.61 129.76 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.9 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -121.48 27.59 8.19 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 124.125 0.97 . . . . 0.0 108.818 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.469 ' H ' HG12 ' A' ' 63' ' ' VAL . 7.0 t0 -59.73 144.99 46.67 Favored 'General case' 0 C--O 1.248 1.014 0 C-N-CA 125.887 1.675 . . . . 0.0 111.054 -177.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.3 m -63.74 -14.88 56.33 Favored 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 124.325 1.05 . . . . 0.0 111.315 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.4 ' HG2' ' OD1' ' A' ' 65' ' ' ASP . 33.7 mmtp -63.68 166.68 6.66 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.977 0.418 . . . . 0.0 110.763 175.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 57.3 mtm180 -90.97 -28.53 17.97 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.293 1.044 . . . . 0.0 109.152 -173.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -109.76 131.16 55.32 Favored 'General case' 0 N--CA 1.409 -2.501 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.661 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -106.18 153.96 39.97 Favored Pre-proline 0 C--N 1.301 -1.522 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.485 177.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -71.94 141.94 37.82 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.26 1.974 . . . . 0.0 113.464 -176.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -133.84 144.35 48.89 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.606 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 88.0 m95 -123.76 137.26 54.72 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.5 -0.75 . . . . 0.0 111.968 -175.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.434 ' HA ' ' O ' ' A' ' 86' ' ' THR . 29.6 m-85 -117.81 141.52 48.32 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.38 177.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.8 mt -125.73 143.07 51.2 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.416 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 74.8 m-85 -134.08 143.18 47.86 Favored 'General case' 0 C--O 1.242 0.688 0 O-C-N 123.518 0.512 . . . . 0.0 110.24 -176.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.507 ' HB3' ' CG ' ' A' ' 102' ' ' PHE . 4.3 p-10 -89.17 -0.63 57.6 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.416 HD22 ' HA ' ' A' ' 78' ' ' ASN . 2.9 t-20 -131.21 157.4 43.31 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 174.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.587 HG23 HD22 ' A' ' 80' ' ' ASN . 35.3 m -67.98 169.19 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 120.732 0.301 . . . . 0.0 110.947 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.587 HD22 HG23 ' A' ' 79' ' ' VAL . 64.6 m-80 58.67 30.31 19.73 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 123.825 0.85 . . . . 0.0 111.335 178.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.499 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 13.4 m-85 57.51 38.7 28.13 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 124.659 1.184 . . . . 0.0 111.439 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 72.6 p -111.93 171.27 7.6 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.592 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.32 -138.65 14.78 Favored Glycine 0 N--CA 1.429 -1.833 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 59.1 mtt180 -79.21 153.34 30.06 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.5 tt -128.35 138.71 53.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -177.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 75.2 m -131.52 127.47 37.33 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 175.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -112.38 125.7 7.25 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.149 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.524 HD21 HD11 ' A' ' 94' ' ' ILE . 3.2 mm? -118.2 145.99 44.56 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 123.061 0.544 . . . . 0.0 110.749 178.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -117.45 168.74 12.98 Favored Glycine 0 N--CA 1.428 -1.899 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.95 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 23.5 p80 -62.71 122.17 15.22 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 123.6 0.76 . . . . 0.0 111.895 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.38 17.8 58.21 Favored Glycine 0 N--CA 1.431 -1.669 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.656 177.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.2 m -129.67 146.71 51.43 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.5 m -139.53 152.93 47.32 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.524 HD11 HD21 ' A' ' 88' ' ' LEU . 52.1 mt -93.63 122.15 44.87 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.448 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 171.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -70.57 -46.81 62.78 Favored 'General case' 0 C--N 1.289 -2.063 0 O-C-N 123.67 0.606 . . . . 0.0 110.809 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.647 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 5.4 m-20 -127.06 86.95 2.57 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.159 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.48 ' CD2' ' HG2' ' A' ' 55' ' ' PRO . 69.5 t80 -65.59 -36.17 82.95 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.359 0.599 . . . . 0.0 110.592 177.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.0 t -75.67 -15.85 60.26 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.976 -173.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.647 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 30.7 mmtp -94.35 -8.91 37.48 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.1 m -82.29 -168.16 1.86 Allowed 'General case' 0 C--O 1.248 0.982 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.961 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.47 -69.42 1.25 Allowed Glycine 0 C--O 1.242 0.64 0 O-C-N 123.109 0.256 . . . . 0.0 113.112 -177.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.507 ' CG ' ' HB3' ' A' ' 77' ' ' ASP . 42.3 p90 -110.39 146.17 36.28 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.343 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.614 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.66 -11.65 12.94 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 176.41 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.34 104.27 2.2 Favored Glycine 0 N--CA 1.44 -1.068 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.462 -176.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 70.4 mt -88.95 115.37 28.67 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.586 0 CA-C-O 122.533 1.159 . . . . 0.0 109.115 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 52.7 m -85.83 -27.44 25.1 Favored 'General case' 0 N--CA 1.395 -3.222 0 CA-C-N 112.108 -2.315 . . . . 0.0 113.934 177.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 81.0 p -157.4 155.58 30.76 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.1 mt -135.09 131.2 52.41 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -175.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.499 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 38.2 ttmt -117.45 133.51 55.89 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.4 ' H ' ' HB3' ' A' ' 45' ' ' SER . 54.3 ttp180 -100.43 130.02 46.46 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 61.3 m -130.06 172.88 11.27 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.571 -178.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.5 pt -131.77 143.55 39.98 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -113.79 121.1 43.03 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-O 121.382 0.61 . . . . 0.0 109.801 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.512 ' OG1' ' HG2' ' A' ' 118' ' ' LYS . 70.6 p -76.91 -179.97 5.8 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 114.316 -1.311 . . . . 0.0 112.155 -174.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -66.4 -30.97 71.45 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.81 172.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -76.76 -8.89 58.15 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.982 0.896 . . . . 0.0 110.199 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.89 -4.48 83.33 Favored Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.253 176.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.512 ' HG2' ' OG1' ' A' ' 114' ' ' THR . 10.7 ptmm? -76.13 135.13 39.83 Favored 'General case' 0 C--O 1.258 1.511 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.0 t -100.39 111.09 29.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 -177.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -96.69 149.44 21.81 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 -177.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 84.0 m . . . . . 0 C--N 1.287 -2.147 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.755 -175.85 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 121.069 0.461 . . . . 0.0 112.207 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 34.7 m -124.41 145.73 49.31 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.616 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 57.3 tp -99.87 116.18 31.33 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 172.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.45 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 38.0 mt-30 -110.62 124.28 51.58 Favored 'General case' 0 CA--C 1.485 -1.529 0 C-N-CA 119.329 -0.948 . . . . 0.0 109.288 -177.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.444 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.3 mp -109.71 131.21 55.27 Favored 'General case' 0 N--CA 1.409 -2.521 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.238 176.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.536 ' CE2' ' HG3' ' A' ' 35' ' ' GLU . 97.8 m-85 -98.14 154.86 17.45 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 123.354 0.409 . . . . 0.0 110.568 -176.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -77.79 -43.61 30.09 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.481 0.657 . . . . 0.0 109.501 -176.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -108.43 178.45 4.49 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.302 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.625 ' HA ' ' OG ' ' A' ' 57' ' ' SER . 0.5 OUTLIER -83.43 179.94 7.53 Favored 'General case' 0 N--CA 1.401 -2.915 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.582 -177.546 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 48.47 40.42 14.97 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.867 0.867 . . . . 0.0 113.258 176.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.536 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 1.0 OUTLIER 57.9 23.7 10.08 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 115.232 1.568 . . . . 0.0 115.232 178.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -105.51 173.27 6.38 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 118.012 -1.475 . . . . 0.0 111.016 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.23 -177.39 45.84 Favored Glycine 0 N--CA 1.428 -1.873 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 -178.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 44.4 m -84.41 143.67 29.28 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.393 176.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 12.4 p90 -116.13 165.92 12.6 Favored 'General case' 0 C--N 1.272 -2.781 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -174.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.0 tt -114.9 152.08 16.56 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.543 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -106.8 125.55 51.14 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 175.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 94.4 t -122.84 133.46 68.88 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -122.61 -14.2 7.81 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp -110.1 162.24 14.76 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.646 -171.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.442 ' HB3' ' H ' ' A' ' 110' ' ' ARG . 2.3 p -97.98 133.19 42.8 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 171.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.8 p -116.74 137.48 50.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -174.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.35 -18.49 35.95 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 119.755 -1.212 . . . . 0.0 113.321 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.5 p -155.81 121.34 4.91 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 86.0 mt -113.06 118.45 34.82 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.043 -0.981 . . . . 0.0 108.741 176.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.0 m -133.15 112.72 13.3 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 174.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.03 161.84 93.53 Favored 'Cis proline' 0 C--O 1.248 0.997 0 C-N-CA 123.313 -1.536 . . . . 0.0 111.255 -0.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -63.12 158.24 45.0 Favored 'Trans proline' 0 C--O 1.246 0.882 0 C-N-CA 122.387 2.058 . . . . 0.0 110.509 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -89.24 133.58 34.39 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 8.0 p -115.64 77.68 6.33 Favored Pre-proline 0 C--N 1.295 -1.799 0 O-C-N 123.628 0.58 . . . . 0.0 111.031 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.444 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 95.7 Cg_endo -77.65 158.09 32.0 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.286 1.991 . . . . 0.0 112.961 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.89 -39.45 11.77 Favored Glycine 0 N--CA 1.433 -1.55 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 176.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.625 ' OG ' ' HA ' ' A' ' 33' ' ' THR . 55.7 m -149.58 161.21 42.6 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.477 1.111 . . . . 0.0 108.26 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.402 HG22 HD23 ' A' ' 29' ' ' LEU . 38.9 t -135.35 142.33 40.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 48.8 t -146.1 147.99 32.16 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.435 176.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.7 t -116.29 122.34 32.23 Favored Pre-proline 0 N--CA 1.438 -1.066 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.44 ' HD3' HE21 ' A' ' 28' ' ' GLN . 35.5 Cg_endo -64.68 147.41 89.9 Favored 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 122.57 2.18 . . . . 0.0 111.108 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -70.1 134.61 48.37 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.427 HG12 ' H ' ' A' ' 65' ' ' ASP . 57.9 t -121.08 123.51 70.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -120.72 26.27 9.21 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.427 ' H ' HG12 ' A' ' 63' ' ' VAL . 9.8 t70 -58.4 144.85 40.46 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.319 -178.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.5 m -60.22 -20.57 59.37 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 123.3 0.64 . . . . 0.0 111.616 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -58.79 139.5 56.25 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -68.63 -24.14 64.52 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.77 -175.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.41 130.52 55.67 Favored 'General case' 0 N--CA 1.418 -2.032 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.95 154.97 40.68 Favored Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.951 175.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.47 134.91 14.32 Favored 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 121.779 1.653 . . . . 0.0 110.662 177.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -129.26 143.7 50.95 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.616 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 88.9 m95 -125.47 132.76 52.62 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 120.204 -0.598 . . . . 0.0 112.131 -173.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 86' ' ' THR . 27.2 m-85 -114.98 141.61 47.75 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.893 176.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.8 mt -125.72 142.72 51.37 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -175.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.42 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 77.5 m-85 -133.82 143.03 48.11 Favored 'General case' 0 C--N 1.317 -0.813 0 O-C-N 123.634 0.584 . . . . 0.0 109.923 -177.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.562 ' HB3' ' CG ' ' A' ' 102' ' ' PHE . 2.8 p-10 -88.39 0.87 55.75 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.652 -178.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.472 ' HA ' HD22 ' A' ' 78' ' ' ASN . 2.0 t-20 -134.49 160.12 39.01 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 176.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.495 HG23 HD22 ' A' ' 80' ' ' ASN . 33.8 m -73.18 167.14 2.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-O 120.61 0.243 . . . . 0.0 111.427 -176.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.495 HD22 HG23 ' A' ' 79' ' ' VAL . 64.7 m-80 57.96 31.1 20.15 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 123.771 0.829 . . . . 0.0 111.421 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.566 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 10.9 m-85 59.64 39.37 21.32 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.893 1.277 . . . . 0.0 111.465 177.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 74.3 p -111.58 176.19 5.12 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.12 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.91 -137.43 15.16 Favored Glycine 0 N--CA 1.429 -1.825 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.835 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 56.2 mtt180 -83.81 150.86 25.49 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 123.547 0.739 . . . . 0.0 109.471 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.9 tt -124.84 139.39 51.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 121.179 0.514 . . . . 0.0 110.667 -176.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 90.7 m -131.47 128.2 38.93 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 174.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -115.06 117.43 4.01 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.541 -0.838 . . . . 0.0 113.194 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.434 HD21 HD11 ' A' ' 94' ' ' ILE . 4.0 mm? -109.9 145.55 36.65 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.017 0.437 . . . . 0.0 110.964 178.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -122.58 170.9 15.34 Favored Glycine 0 N--CA 1.419 -2.495 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.467 -177.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -63.6 121.5 14.06 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.299 0.571 . . . . 0.0 111.734 -176.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.6 14.72 61.05 Favored Glycine 0 N--CA 1.434 -1.479 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.908 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.6 m -125.09 146.14 49.6 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.9 m -139.15 160.06 40.69 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.434 HD11 HD21 ' A' ' 88' ' ' LEU . 50.0 mt -94.06 132.18 38.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 173.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -69.93 -48.41 58.57 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.033 0.444 . . . . 0.0 110.563 -177.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.477 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 11.1 m-20 -142.82 93.18 2.48 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.573 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.433 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 49.1 t80 -64.63 -30.06 71.07 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.573 0.701 . . . . 0.0 109.391 178.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.0 t -63.65 -25.07 68.05 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.537 177.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.477 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 34.4 mmtp -94.88 -5.59 44.61 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.936 -0.477 . . . . 0.0 110.837 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.9 m -79.61 -176.84 5.54 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -56.37 -63.8 4.98 Favored Glycine 0 C--O 1.249 1.052 0 CA-C-O 121.017 0.232 . . . . 0.0 112.781 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.562 ' CG ' ' HB3' ' A' ' 77' ' ' ASP . 39.9 p90 -110.92 147.23 35.07 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 177.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.94 -9.89 12.98 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.586 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -107.45 113.62 4.02 Favored Glycine 0 N--CA 1.431 -1.66 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.474 -177.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 62.6 mt -96.94 115.18 35.81 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.641 0 CA-C-O 122.336 1.065 . . . . 0.0 108.919 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.7 m -85.61 -29.68 23.89 Favored 'General case' 0 N--CA 1.392 -3.335 0 CA-C-N 112.242 -2.253 . . . . 0.0 113.685 177.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 89.2 p -153.11 155.52 36.93 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.0 mt -135.29 130.17 50.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -176.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.566 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 35.8 ttmt -117.32 131.15 56.86 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.442 ' H ' ' HB3' ' A' ' 45' ' ' SER . 25.7 ttp180 -101.76 123.14 45.23 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . 0.439 ' SG ' ' HD2' ' A' ' 74' ' ' TYR . 60.0 m -119.69 172.5 7.64 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -177.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.6 pt -128.12 141.95 45.1 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -115.68 120.29 38.89 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 108.39 -0.966 . . . . 0.0 108.39 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 44.1 p -76.93 175.53 9.44 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.799 -174.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -67.51 -20.68 65.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.628 0.727 . . . . 0.0 109.043 176.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -77.43 -9.59 58.97 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.512 177.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.28 -9.7 76.81 Favored Glycine 0 N--CA 1.439 -1.163 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.187 176.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -74.56 141.47 44.77 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 117.345 0.573 . . . . 0.0 110.225 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.7 t -106.68 111.28 34.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -105.85 148.09 27.96 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.285 -2.207 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.464 -178.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 34.5 m -123.08 145.56 48.44 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.499 ' HB3' ' HB ' ' A' ' 42' ' ' VAL . 49.6 tp -93.68 116.8 29.31 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 174.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.498 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 37.0 mt-30 -111.69 124.78 53.05 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -177.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 3.9 mp -109.6 129.06 55.61 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.24 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.556 ' CE1' ' HG3' ' A' ' 35' ' ' GLU . 94.6 m-85 -97.16 153.66 17.84 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 123.907 0.754 . . . . 0.0 111.644 -174.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -74.48 -41.64 60.4 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.058 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -107.83 177.65 4.76 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 56' ' ' GLY . 3.4 p -82.11 173.01 12.55 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 19.2 p90 47.46 38.76 8.19 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.556 ' HG3' ' CE1' ' A' ' 30' ' ' TYR . 0.7 OUTLIER 67.43 25.76 8.49 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 124.805 1.242 . . . . 0.0 113.637 177.229 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.7 mtp85 -90.74 159.22 16.44 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 177.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.99 -136.89 13.74 Favored Glycine 0 N--CA 1.422 -2.242 0 CA-C-N 114.365 -1.288 . . . . 0.0 109.911 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.2 m -116.68 -179.49 3.7 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 175.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 33.8 p90 -141.36 165.29 27.91 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -178.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 17.3 tt -114.63 152.65 16.24 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 177.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -106.71 126.11 51.87 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.499 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 88.2 t -123.43 133.15 69.98 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 176.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -115.53 -35.7 4.49 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-O 121.604 0.716 . . . . 0.0 109.397 -175.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.25 161.03 24.02 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.113 -177.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.429 ' HB3' ' H ' ' A' ' 110' ' ' ARG . 4.9 p -69.03 147.83 50.98 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 123.579 0.549 . . . . 0.0 111.517 -178.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.4 p -121.4 131.19 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.06 -15.86 55.24 Favored Glycine 0 N--CA 1.432 -1.633 0 C-N-CA 119.749 -1.215 . . . . 0.0 113.08 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.5 p -156.74 127.54 6.74 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 83.3 mt -122.57 118.36 28.02 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.474 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 14.5 m -133.5 113.46 13.12 Favored Pre-proline 0 C--N 1.306 -1.302 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.103 174.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 73.2 Cg_endo -75.22 162.1 93.38 Favored 'Cis proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.27 -1.554 . . . . 0.0 111.168 -0.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -63.6 156.84 54.62 Favored 'Trans proline' 0 C--O 1.238 0.505 0 C-N-CA 121.928 1.752 . . . . 0.0 110.695 177.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.401 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 49.2 m0 -89.46 134.83 33.92 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -177.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.62 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 58.0 p -113.87 81.0 5.59 Favored Pre-proline 0 N--CA 1.434 -1.236 0 O-C-N 123.431 0.457 . . . . 0.0 111.199 176.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.42 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 95.7 Cg_endo -79.47 158.42 25.63 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.699 2.266 . . . . 0.0 112.447 177.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.427 ' O ' HG22 ' A' ' 33' ' ' THR . . . -87.93 -35.85 8.8 Favored Glycine 0 N--CA 1.429 -1.814 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 176.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 94' ' ' ILE . 89.4 p -150.3 158.15 43.85 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.451 HG22 HD23 ' A' ' 29' ' ' LEU . 43.2 t -132.09 142.57 42.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 93' ' ' CYS . 38.4 t -145.43 149.55 34.92 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.614 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.1 t -117.28 126.63 27.27 Favored Pre-proline 0 C--N 1.317 -0.808 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.24 142.76 98.97 Favored 'Trans proline' 0 C--O 1.248 1.019 0 C-N-CA 122.851 2.367 . . . . 0.0 111.839 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.452 ' CE1' ' HB3' ' A' ' 64' ' ' ASN . 59.4 t80 -73.48 124.19 25.37 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 122.031 0.92 . . . . 0.0 111.456 -176.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.456 ' H ' ' HB2' ' A' ' 90' ' ' HIS . 91.0 t -109.76 117.67 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 CA-C-N 114.428 -1.26 . . . . 0.0 107.929 178.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.452 ' HB3' ' CE1' ' A' ' 62' ' ' PHE . 4.9 p-10 -122.38 11.31 9.99 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -69.31 145.55 52.94 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 111.664 -2.516 . . . . 0.0 112.631 -173.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 m -53.81 -7.58 0.13 Allowed 'General case' 0 CA--C 1.564 1.496 0 C-N-CA 128.353 2.661 . . . . 0.0 114.816 -175.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.482 ' H ' ' HD2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -66.7 154.36 40.85 Favored 'General case' 0 C--N 1.316 -0.887 0 O-C-N 122.173 -0.329 . . . . 0.0 110.692 -176.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -79.48 -28.4 41.51 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.741 -0.209 . . . . 0.0 111.206 -175.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.424 ' HG2' HD12 ' A' ' 112' ' ' ILE . 9.8 mp0 -110.54 144.75 38.93 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.395 177.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -106.24 151.44 40.2 Favored Pre-proline 0 C--N 1.307 -1.273 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 171.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -78.62 137.3 14.37 Favored 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 122.238 1.958 . . . . 0.0 111.974 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -132.92 132.78 42.4 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.487 ' CE3' HD22 ' A' ' 27' ' ' LEU . 87.2 m95 -116.67 134.88 54.28 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.78 -0.575 . . . . 0.0 111.366 -174.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.469 ' HD1' ' SG ' ' A' ' 111' ' ' CYS . 29.0 m-85 -116.07 142.3 46.99 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.617 178.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.2 mt -125.89 142.69 51.4 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -176.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.539 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 81.4 m-85 -134.38 142.55 47.23 Favored 'General case' 0 C--O 1.245 0.82 0 O-C-N 123.719 0.637 . . . . 0.0 110.174 -176.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.45 ' C ' ' HB2' ' A' ' 106' ' ' SER . 0.8 OUTLIER -80.95 -9.95 59.77 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.58 -179.051 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -127.54 162.31 26.75 Favored 'General case' 0 N--CA 1.427 -1.605 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.426 177.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.413 HG23 HD22 ' A' ' 80' ' ' ASN . 24.5 m -73.19 168.75 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 122.804 0.442 . . . . 0.0 110.588 -176.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.413 HD22 HG23 ' A' ' 79' ' ' VAL . 43.6 m-80 57.66 30.35 18.72 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.612 0.72 . . . . 0.0 111.217 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.401 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 16.2 m-85 59.26 40.3 21.56 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.198 176.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 76.6 p -111.5 175.52 5.39 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.517 -0.473 . . . . 0.0 109.742 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.54 -140.62 16.16 Favored Glycine 0 N--CA 1.422 -2.259 0 C-N-CA 120.363 -0.923 . . . . 0.0 111.508 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.539 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 32.7 mtt180 -82.93 151.87 25.75 Favored 'General case' 0 C--N 1.287 -2.131 0 C-N-CA 123.487 0.715 . . . . 0.0 109.82 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.3 tt -122.61 137.2 56.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-O 121.198 0.523 . . . . 0.0 110.251 -177.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 95.2 m -131.62 125.82 33.17 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 175.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -115.05 110.09 2.23 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.625 -0.798 . . . . 0.0 114.63 -176.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.45 HD21 HD11 ' A' ' 94' ' ' ILE . 3.9 mm? -101.92 145.51 29.14 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 120.967 0.413 . . . . 0.0 111.279 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -123.32 169.67 15.58 Favored Glycine 0 N--CA 1.419 -2.478 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.866 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.456 ' HB2' ' H ' ' A' ' 63' ' ' VAL . 7.3 p80 -53.36 122.03 8.8 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 124.056 0.943 . . . . 0.0 113.109 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.39 -5.8 80.69 Favored Glycine 0 CA--C 1.5 -0.857 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.873 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.3 m -106.25 146.39 30.4 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-O 121.219 0.533 . . . . 0.0 109.782 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 59' ' ' CYS . 3.8 m -134.74 159.11 42.35 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.45 HD11 HD21 ' A' ' 88' ' ' LEU . 41.5 mt -93.44 130.43 42.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 175.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -65.8 -47.14 76.08 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.152 0.501 . . . . 0.0 110.066 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.579 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 2.9 m-20 -143.16 99.58 3.47 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 123.719 0.808 . . . . 0.0 108.966 178.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -63.96 -31.85 73.18 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.62 0.724 . . . . 0.0 110.839 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.5 t -63.34 -23.44 67.42 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.735 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.579 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 28.8 mmtp -94.56 -16.1 23.54 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 121.839 -0.538 . . . . 0.0 110.104 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.1 m -63.87 -34.32 77.68 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-O 121.116 0.484 . . . . 0.0 111.283 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 158.67 -67.38 0.28 Allowed Glycine 0 CA--C 1.488 -1.604 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -110.86 149.14 31.02 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.4 -9.64 13.33 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.26 177.229 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -106.25 108.18 2.88 Favored Glycine 0 N--CA 1.438 -1.189 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.017 -176.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 63.0 mt -92.11 116.04 32.4 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.59 0 CA-C-O 122.22 1.01 . . . . 0.0 109.067 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.45 ' HB2' ' C ' ' A' ' 77' ' ' ASP . 4.0 m -85.35 -29.28 24.61 Favored 'General case' 0 N--CA 1.396 -3.136 0 CA-C-N 112.565 -2.107 . . . . 0.0 114.231 176.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.3 p -154.92 155.15 33.78 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 122.191 -0.318 . . . . 0.0 110.239 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.3 mt -133.14 130.68 58.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.401 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 33.1 ttmt -117.71 133.71 55.66 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.429 ' H ' ' HB3' ' A' ' 45' ' ' SER . 58.6 ttt180 -99.8 126.77 45.94 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . 0.469 ' SG ' ' HD1' ' A' ' 74' ' ' TYR . 59.1 m -122.95 171.93 8.87 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -178.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 7.8 pt -127.52 143.49 40.51 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.298 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.586 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -117.02 119.45 35.32 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 51.1 p -80.89 178.31 8.49 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 114.228 -1.351 . . . . 0.0 112.363 -172.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -66.51 -23.6 66.27 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 172.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -83.3 -8.17 59.47 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.583 -1.189 . . . . 0.0 109.985 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.96 -11.36 57.51 Favored Glycine 0 N--CA 1.438 -1.186 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.769 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.47 137.05 54.13 Favored 'General case' 0 C--O 1.255 1.364 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 43.3 t -105.58 112.07 37.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -97.77 144.52 27.29 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 94.6 m . . . . . 0 C--N 1.293 -1.871 0 O-C-N 123.062 0.226 . . . . 0.0 110.903 -173.981 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.434 ' CE1' HG11 ' A' ' 63' ' ' VAL . 5.0 m-85 . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 121.631 0.729 . . . . 0.0 110.694 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 20.0 m -128.74 145.6 51.13 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.582 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 54.9 tp -105.68 127.24 52.94 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 177.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.486 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 71.6 mt-30 -114.73 124.75 52.58 Favored 'General case' 0 CA--C 1.49 -1.358 0 C-N-CA 119.889 -0.724 . . . . 0.0 109.61 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.5 mp -109.86 123.91 50.4 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.214 176.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.411 ' CD1' ' HB3' ' A' ' 39' ' ' TYR . 89.6 m-85 -95.12 151.9 18.8 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 123.832 0.707 . . . . 0.0 110.678 -174.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -74.71 -38.64 62.28 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.113 0.483 . . . . 0.0 110.41 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -108.33 178.17 4.58 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.013 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.496 ' O ' ' HB2' ' A' ' 36' ' ' ARG . 3.9 p -80.84 170.95 15.62 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 27.8 p90 46.8 42.27 11.64 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 66.62 21.97 10.57 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.283 1.033 . . . . 0.0 112.24 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 33' ' ' THR . 8.6 mmm180 -88.23 159.41 18.15 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.521 0.677 . . . . 0.0 111.785 177.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.14 -165.66 47.34 Favored Glycine 0 N--CA 1.428 -1.885 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.516 178.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.1 m -87.05 171.83 10.43 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.411 ' HB3' ' CD1' ' A' ' 30' ' ' TYR . 12.4 p90 -146.78 164.08 33.93 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -176.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 12.7 tt -115.01 152.53 16.61 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.648 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -107.05 124.92 50.35 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.559 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 89.8 t -115.1 132.84 63.16 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.641 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 178.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -114.43 -32.9 5.77 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 121.247 0.546 . . . . 0.0 110.047 -176.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.15 162.73 19.6 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.347 -176.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.6 p -74.74 151.59 39.15 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.147 0.498 . . . . 0.0 111.839 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.1 p -122.81 127.79 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 175.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.92 -14.56 60.69 Favored Glycine 0 C--N 1.301 -1.378 0 C-N-CA 119.368 -1.396 . . . . 0.0 112.906 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.2 p -160.25 125.9 4.04 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 121.086 0.469 . . . . 0.0 112.004 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.7 mt -116.01 118.63 33.44 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 18.9 m -132.7 111.25 13.54 Favored Pre-proline 0 C--N 1.288 -2.101 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 174.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 71.8 Cg_endo -76.9 161.86 92.67 Favored 'Cis proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.012 -1.662 . . . . 0.0 111.433 0.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -63.44 158.18 46.68 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 122.33 2.02 . . . . 0.0 111.05 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 49.5 m0 -89.86 138.91 31.09 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 10.5 p -120.62 76.45 27.2 Favored Pre-proline 0 C--N 1.296 -1.756 0 O-C-N 123.555 0.534 . . . . 0.0 111.477 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.479 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 83.6 Cg_endo -77.54 158.03 32.39 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.779 2.319 . . . . 0.0 113.232 179.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.13 -29.93 13.81 Favored Glycine 0 N--CA 1.429 -1.832 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 175.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.8 p -155.46 158.79 39.13 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.8 t -133.76 143.2 39.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 38.9 t -145.47 148.11 32.91 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.787 175.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.8 t -114.61 117.34 42.65 Favored Pre-proline 0 N--CA 1.428 -1.552 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 175.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -56.57 147.25 70.97 Favored 'Trans proline' 0 C--O 1.247 0.975 0 C-N-CA 122.759 2.306 . . . . 0.0 111.909 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -75.58 112.63 12.12 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.447 HG12 ' H ' ' A' ' 65' ' ' ASP . 36.8 t -93.85 114.57 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.677 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -109.7 32.79 4.78 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.318 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.547 ' OD1' ' HG2' ' A' ' 67' ' ' LYS . 6.2 t70 -75.33 144.61 42.29 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 113.832 -1.531 . . . . 0.0 108.007 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 m -56.54 -11.58 1.36 Allowed 'General case' 0 CA--C 1.577 1.984 0 C-N-CA 125.264 1.426 . . . . 0.0 114.203 -174.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.547 ' HG2' ' OD1' ' A' ' 65' ' ' ASP . 15.5 mmtp -67.66 145.02 55.21 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 122.984 0.514 . . . . 0.0 109.696 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -81.39 -14.13 57.52 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.826 0.346 . . . . 0.0 111.703 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -104.14 127.86 51.77 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -105.98 150.19 38.97 Favored Pre-proline 0 C--N 1.291 -1.939 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -76.48 140.18 21.29 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 121.771 1.647 . . . . 0.0 112.764 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -133.38 129.29 37.2 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.582 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 82.6 m95 -110.82 139.69 45.9 Favored 'General case' 0 C--N 1.284 -2.26 0 O-C-N 121.897 -0.502 . . . . 0.0 112.162 -172.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.473 ' HD2' ' SG ' ' A' ' 111' ' ' CYS . 35.9 m-85 -117.7 142.51 47.16 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.495 177.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.3 mt -125.59 142.45 51.5 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -176.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.522 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 77.9 m-85 -133.5 141.34 47.73 Favored 'General case' 0 C--N 1.318 -0.765 0 O-C-N 123.64 0.587 . . . . 0.0 109.958 -176.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.422 ' HB3' ' CD2' ' A' ' 102' ' ' PHE . 10.3 p-10 -81.09 -15.19 56.67 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -177.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.43 ' C ' ' HB3' ' A' ' 106' ' ' SER . 5.6 t-20 -125.59 165.16 19.04 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.403 HG23 HD22 ' A' ' 80' ' ' ASN . 34.8 m -68.81 168.51 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 123.146 0.579 . . . . 0.0 111.615 -177.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.403 HD22 HG23 ' A' ' 79' ' ' VAL . 46.0 m-80 56.44 30.25 16.71 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.852 0.861 . . . . 0.0 111.233 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.513 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 11.2 m-85 55.66 48.79 17.76 Favored 'General case' 0 C--O 1.25 1.131 0 C-N-CA 124.596 1.158 . . . . 0.0 110.785 178.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 74.6 p -117.43 168.53 10.28 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.862 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.3 -131.19 10.67 Favored Glycine 0 N--CA 1.416 -2.682 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 66.5 mtt85 -87.25 144.14 26.95 Favored 'General case' 0 C--N 1.279 -2.462 0 C-N-CA 124.332 1.053 . . . . 0.0 109.506 -178.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.4 tt -121.87 136.63 58.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-O 121.301 0.572 . . . . 0.0 110.045 -177.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 94.6 m -132.02 123.9 28.22 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.132 175.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -109.02 130.15 9.88 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.945 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.41 HD21 HD11 ' A' ' 94' ' ' ILE . 3.1 mm? -119.61 145.63 46.25 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 123.335 0.654 . . . . 0.0 110.632 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -113.22 166.17 12.11 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.91 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.401 ' HB2' ' H ' ' A' ' 63' ' ' VAL . 8.4 p80 -62.47 122.76 16.55 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.256 0.55 . . . . 0.0 111.796 -178.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 92.15 -0.72 72.55 Favored Glycine 0 N--CA 1.433 -1.512 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.47 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.1 m -112.34 146.54 38.11 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 4.5 m -133.56 160.66 36.82 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.41 HD11 HD21 ' A' ' 88' ' ' LEU . 49.2 mt -93.63 130.98 41.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 173.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -70.39 -47.42 60.92 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.245 0.545 . . . . 0.0 110.938 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.444 ' HA ' HG22 ' A' ' 33' ' ' THR . 5.2 m-20 -143.69 98.42 3.24 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -64.66 -30.04 71.05 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.649 0.738 . . . . 0.0 110.518 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.9 t -63.61 -22.8 67.09 Favored 'General case' 0 CA--C 1.555 1.155 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.9 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -95.36 -6.69 40.49 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.101 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.6 m -70.46 -40.55 73.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.118 0.485 . . . . 0.0 111.026 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 156.91 -65.0 0.31 Allowed Glycine 0 CA--C 1.491 -1.462 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.422 ' CD2' ' HB3' ' A' ' 77' ' ' ASP . 39.7 p90 -109.17 145.55 35.6 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.26 -9.12 13.47 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.351 177.741 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.39 106.55 2.57 Favored Glycine 0 N--CA 1.43 -1.73 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.614 -177.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 84.7 mt -91.38 115.08 29.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.43 ' HB3' ' C ' ' A' ' 78' ' ' ASN . 5.1 t -86.41 -26.61 24.65 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.847 177.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 90.1 p -150.81 155.73 39.81 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.344 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.7 mt -136.22 130.89 48.47 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -176.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.513 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 35.9 ttmt -117.52 133.67 55.7 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -101.37 121.93 42.81 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . 0.473 ' SG ' ' HD2' ' A' ' 74' ' ' TYR . 50.4 m -119.49 172.18 7.82 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -177.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.5 pt -129.02 144.3 38.6 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 57.3 tt0 -115.21 123.8 49.79 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 45.3 p -77.58 177.14 8.3 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.14 -175.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -66.4 -23.81 66.38 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.657 0.741 . . . . 0.0 109.288 176.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -76.95 -9.42 58.68 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.522 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.22 -1.75 80.31 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 116.219 -0.446 . . . . 0.0 113.261 177.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 113' ' ' GLN . 7.2 ptpp? -83.81 143.87 29.65 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.964 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 17.8 t -103.82 112.23 36.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -100.59 149.95 23.21 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 CA--C 1.48 -1.732 0 C-N-CA 117.972 -1.491 . . . . 0.0 110.002 178.905 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 . . . . . 0 N--CA 1.484 1.233 0 CA-C-O 121.376 0.608 . . . . 0.0 111.905 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 36.4 m -124.58 145.92 49.33 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.575 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 54.7 tp -98.25 119.68 37.33 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 174.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.468 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 64.6 mt-30 -113.68 124.55 52.58 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 3.6 mp -109.59 131.06 55.41 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.038 177.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -90.81 156.29 18.15 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 123.763 0.664 . . . . 0.0 110.64 -176.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -77.06 -41.42 42.49 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.436 -176.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.445 ' C ' ' HA3' ' A' ' 56' ' ' GLY . 45.4 mt-10 -113.14 177.55 4.59 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.567 ' O ' ' HB2' ' A' ' 36' ' ' ARG . 2.0 p -82.58 174.81 10.7 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 23.4 p90 47.35 40.22 10.32 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.398 1.079 . . . . 0.0 113.617 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 65.46 26.66 11.84 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.59 1.156 . . . . 0.0 111.334 176.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.567 ' HB2' ' O ' ' A' ' 33' ' ' THR . 6.5 mmm180 -89.64 147.65 23.78 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.743 0.783 . . . . 0.0 111.939 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.17 -161.0 28.74 Favored Glycine 0 N--CA 1.419 -2.434 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.35 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.2 m -97.43 -177.14 3.72 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.438 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 50.4 p90 -142.16 165.97 25.99 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.4 tt -113.6 153.48 15.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -106.3 125.94 51.62 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.524 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 92.4 t -127.18 133.73 67.54 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 175.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -115.99 -31.86 5.59 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-O 121.113 0.482 . . . . 0.0 109.953 -176.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.43 161.85 33.43 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.512 -176.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.5 m -61.02 143.99 54.26 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.703 -175.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.6 p -121.37 136.94 56.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 176.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.31 -18.08 27.37 Favored Glycine 0 N--CA 1.435 -1.387 0 C-N-CA 120.077 -1.058 . . . . 0.0 113.907 -175.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.9 t -156.98 128.61 7.06 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 117.451 0.626 . . . . 0.0 109.57 -178.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 94.5 mt -120.17 119.67 33.93 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.208 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 20.7 p -131.7 107.96 14.29 Favored Pre-proline 0 C--N 1.298 -1.638 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.268 176.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 90.3 Cg_endo -77.73 162.68 89.52 Favored 'Cis proline' 0 C--O 1.242 0.718 0 C-N-CA 123.896 -1.294 . . . . 0.0 111.33 -1.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.45 156.31 42.18 Favored 'Trans proline' 0 C--O 1.243 0.753 0 C-N-CA 122.521 2.147 . . . . 0.0 109.879 176.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -89.65 129.62 36.06 Favored 'General case' 0 C--N 1.288 -2.088 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.13 -177.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.586 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 40.9 p -111.37 80.75 2.71 Favored Pre-proline 0 N--CA 1.424 -1.757 0 O-C-N 123.697 0.623 . . . . 0.0 110.537 176.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.412 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 91.8 Cg_endo -80.25 158.62 23.15 Favored 'Trans proline' 0 N--CA 1.443 -1.458 0 C-N-CA 122.22 1.946 . . . . 0.0 111.776 177.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.445 ' HA3' ' C ' ' A' ' 32' ' ' GLU . . . -86.73 -39.03 7.78 Favored Glycine 0 N--CA 1.425 -2.076 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 176.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.542 ' HB2' ' O ' ' A' ' 94' ' ' ILE . 72.9 p -147.65 160.96 42.1 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.417 HG22 HD23 ' A' ' 29' ' ' LEU . 42.6 t -137.11 142.23 38.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -177.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 36.9 t -145.52 149.1 34.0 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 119.704 -0.799 . . . . 0.0 111.386 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.9 t -116.78 125.2 28.54 Favored Pre-proline 0 N--CA 1.443 -0.78 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.0 143.66 99.38 Favored 'Trans proline' 0 C--O 1.242 0.688 0 C-N-CA 123.222 2.614 . . . . 0.0 112.53 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -70.99 122.0 19.21 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.661 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 93.4 t -96.67 115.39 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 CA-C-O 121.49 0.662 . . . . 0.0 109.57 177.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -101.72 -6.46 23.67 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 113.981 -1.463 . . . . 0.0 110.441 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -58.42 144.74 40.95 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 125.123 1.369 . . . . 0.0 112.034 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.2 m -55.68 -7.52 0.29 Allowed 'General case' 0 CA--C 1.571 1.772 0 C-N-CA 125.708 1.603 . . . . 0.0 113.105 -178.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -64.47 140.92 58.92 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.233 0.54 . . . . 0.0 110.183 178.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.562 ' HB2' ' OE2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -81.19 -28.11 35.08 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.032 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.562 ' OE2' ' HB2' ' A' ' 68' ' ' ARG . 2.4 mp0 -94.35 125.77 39.2 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.3 152.69 42.06 Favored Pre-proline 0 C--N 1.289 -2.058 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.388 174.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.52 134.78 21.04 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 121.505 1.47 . . . . 0.0 110.733 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -129.03 138.33 51.85 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.575 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 87.5 m95 -119.25 133.48 55.73 Favored 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.933 -173.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.507 ' HA ' ' O ' ' A' ' 86' ' ' THR . 24.6 m-85 -113.73 140.0 48.63 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.913 176.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.3 mt -125.31 142.74 51.33 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.583 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 84.8 m-85 -132.35 143.7 50.04 Favored 'General case' 0 C--N 1.32 -0.71 0 O-C-N 123.57 0.543 . . . . 0.0 110.903 -176.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -84.75 0.27 51.2 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.373 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -137.54 163.65 30.65 Favored 'General case' 0 N--CA 1.417 -2.092 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.463 HG23 HD22 ' A' ' 80' ' ' ASN . 32.6 m -75.5 168.95 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 C-N-CA 123.044 0.538 . . . . 0.0 111.151 -176.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.463 HD22 HG23 ' A' ' 79' ' ' VAL . 48.8 m-80 58.06 30.73 19.71 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.894 0.746 . . . . 0.0 111.065 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.592 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 9.6 m-85 59.44 39.14 22.3 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.98 1.312 . . . . 0.0 111.713 177.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 81.0 p -112.28 170.62 8.04 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.548 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.9 -143.67 16.69 Favored Glycine 0 N--CA 1.421 -2.352 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.167 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.583 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 62.6 mtt85 -75.15 140.36 43.31 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 124.17 0.988 . . . . 0.0 108.905 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.2 tt -118.09 137.5 51.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-O 121.016 0.436 . . . . 0.0 109.891 -175.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 87.9 m -130.83 121.47 25.37 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 176.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -109.14 120.65 5.9 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.779 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.415 HD21 HD11 ' A' ' 94' ' ' ILE . 2.7 mm? -115.35 145.36 42.58 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 122.85 0.46 . . . . 0.0 110.757 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -120.2 167.8 13.71 Favored Glycine 0 N--CA 1.429 -1.822 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.284 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -58.25 123.42 15.98 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 123.434 0.694 . . . . 0.0 112.47 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.14 4.65 71.33 Favored Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.247 177.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.5 m -116.93 146.43 42.98 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.7 m -138.23 154.16 49.09 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.542 ' O ' ' HB2' ' A' ' 57' ' ' SER . 41.3 mt -94.58 126.03 47.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 173.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -70.84 -46.24 63.06 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 121.185 0.517 . . . . 0.0 111.391 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.587 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 3.1 m-20 -131.6 96.34 3.95 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.413 ' HA ' HG21 ' A' ' 94' ' ' ILE . 64.6 t80 -63.87 -36.72 84.84 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.302 0.572 . . . . 0.0 110.665 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.5 t -63.81 -27.84 69.45 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.036 -0.983 . . . . 0.0 112.405 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.587 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 30.3 mmtp -90.53 -9.92 45.45 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -177.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.2 m -84.75 7.61 20.01 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.135 -176.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 132.8 -84.69 0.29 Allowed Glycine 0 N--CA 1.421 -2.326 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.479 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -110.24 150.4 28.75 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.586 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -112.52 -9.79 13.76 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.062 177.9 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -107.7 104.05 2.02 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.907 -176.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 68.0 mt -87.01 115.74 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.808 0 CA-C-O 122.476 1.131 . . . . 0.0 108.839 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 44.3 m -86.44 -29.9 22.47 Favored 'General case' 0 N--CA 1.388 -3.573 0 CA-C-N 112.295 -2.229 . . . . 0.0 114.71 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 81.2 p -154.43 158.64 40.28 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 177.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.1 mt -136.22 132.05 49.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -176.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.592 ' HE2' ' CD2' ' A' ' 81' ' ' TYR . 37.3 ttmt -117.71 127.73 54.21 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -96.94 121.25 38.61 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . 0.495 ' SG ' ' HD2' ' A' ' 74' ' ' TYR . 57.2 m -121.29 172.83 7.73 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 124.047 0.939 . . . . 0.0 108.68 -177.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.5 pt -124.09 140.44 47.48 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 176.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -115.0 127.47 55.69 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 61.7 p -79.21 179.76 7.2 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.766 -172.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -67.21 -29.38 69.02 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.945 177.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.544 ' OD1' ' HG2' ' A' ' 118' ' ' LYS . 1.9 p-10 -84.38 -7.81 59.19 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.92 -177.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.06 3.9 58.84 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.384 -0.912 . . . . 0.0 114.426 175.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.544 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 21.7 ptmt -84.03 145.82 28.29 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 118.067 0.934 . . . . 0.0 109.16 176.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 17.1 t -107.51 116.51 51.23 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -101.68 140.95 35.27 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.293 -1.867 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 121.557 0.694 . . . . 0.0 111.324 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 22.9 m -123.37 148.47 46.01 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.813 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.577 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 55.7 tp -103.28 117.17 33.91 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 174.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.51 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 76.1 mt-30 -109.92 124.22 51.0 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.56 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.476 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.4 mp -109.98 123.45 49.68 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.613 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -92.0 152.76 19.84 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 123.729 0.643 . . . . 0.0 110.233 -177.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -75.93 -36.45 59.37 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.353 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -107.84 177.95 4.67 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 96' ' ' ASP . 7.0 p -82.28 173.13 12.37 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.606 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 26.2 p90 46.46 42.11 10.4 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 114.703 1.372 . . . . 0.0 114.703 176.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 68.05 23.26 8.16 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.889 0.876 . . . . 0.0 111.825 177.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.423 ' HE ' ' HB3' ' A' ' 36' ' ' ARG . 4.2 mtp180 -94.85 164.41 12.93 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 177.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.48 -167.35 50.4 Favored Glycine 0 N--CA 1.426 -2.002 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -175.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.6 m -91.98 177.82 6.06 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 174.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 44.6 p90 -140.39 166.14 25.52 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -178.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.51 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 11.8 tt -114.05 152.65 15.69 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -106.99 125.65 51.28 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 93.5 t -123.48 133.7 68.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -119.12 -24.16 6.58 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.089 0.471 . . . . 0.0 110.444 -175.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.23 161.93 29.03 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.82 -175.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.7 m -74.43 144.96 44.05 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.119 0.485 . . . . 0.0 110.8 -178.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.0 p -121.75 137.31 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 177.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -97.12 -23.11 15.48 Favored Glycine 0 C--N 1.292 -1.914 0 C-N-CA 120.07 -1.062 . . . . 0.0 113.173 -177.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.9 m -148.84 128.35 13.12 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 122.317 -0.52 . . . . 0.0 110.565 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 83.7 mt -122.02 118.05 27.85 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 176.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 5.0 m -132.81 112.11 13.57 Favored Pre-proline 0 C--N 1.3 -1.581 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 177.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 71.7 Cg_endo -76.91 161.89 92.6 Favored 'Cis proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.076 -1.635 . . . . 0.0 110.841 -0.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -61.52 157.49 41.23 Favored 'Trans proline' 0 C--O 1.243 0.741 0 C-N-CA 122.508 2.138 . . . . 0.0 110.73 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.432 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 48.6 m0 -89.54 139.22 30.75 Favored 'General case' 0 CA--C 1.484 -1.587 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -178.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 30.1 p -118.47 78.61 14.83 Favored Pre-proline 0 C--N 1.304 -1.371 0 C-N-CA 120.544 -0.462 . . . . 0.0 111.888 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.476 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 85.0 Cg_endo -78.4 157.45 29.19 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.565 2.177 . . . . 0.0 112.996 177.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -93.18 -29.63 10.12 Favored Glycine 0 N--CA 1.431 -1.635 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 177.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.4 p -153.68 151.16 29.34 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.4 t -128.84 142.83 42.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 37.2 t -145.82 149.47 34.38 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.442 176.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 49.0 t -118.81 122.55 29.71 Favored Pre-proline 0 N--CA 1.435 -1.213 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 176.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.3 143.41 83.06 Favored 'Trans proline' 0 C--O 1.244 0.791 0 C-N-CA 122.86 2.373 . . . . 0.0 112.0 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -66.55 125.89 27.18 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 121.465 0.65 . . . . 0.0 110.473 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.401 HG13 ' OD2' ' A' ' 65' ' ' ASP . 59.8 t -101.01 124.2 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.758 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.337 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -120.34 20.63 11.9 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.988 0.899 . . . . 0.0 108.922 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.401 ' OD2' HG13 ' A' ' 63' ' ' VAL . 1.2 m-20 -58.24 145.74 36.44 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 113.982 -1.463 . . . . 0.0 113.187 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.9 m -60.14 -27.11 66.8 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 175.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -56.04 124.67 18.55 Favored 'General case' 0 C--O 1.251 1.156 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.343 173.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -77.54 -27.77 51.71 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.278 -177.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -83.02 125.67 31.7 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-O 122.001 0.905 . . . . 0.0 108.62 178.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 28.4 mmt85 -108.09 153.03 42.02 Favored Pre-proline 0 C--N 1.281 -2.377 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.424 -177.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -85.74 134.76 4.72 Favored 'Trans proline' 0 N--CA 1.441 -1.602 0 C-N-CA 121.281 1.321 . . . . 0.0 112.008 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -129.54 131.0 46.47 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.577 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 86.6 m95 -112.84 132.82 55.11 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.81 -173.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.534 ' HA ' ' O ' ' A' ' 86' ' ' THR . 37.6 m-85 -112.89 142.17 45.87 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.911 176.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.4 mt -125.58 142.65 51.39 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -176.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.524 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 82.5 m-85 -133.13 142.54 48.73 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 123.701 0.626 . . . . 0.0 109.895 -177.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.5 ' HB3' ' CD1' ' A' ' 102' ' ' PHE . 1.7 p-10 -87.89 0.35 55.96 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.566 -178.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -136.48 157.29 47.14 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 174.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.45 HG23 HD22 ' A' ' 80' ' ' ASN . 32.6 m -69.68 164.7 2.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 122.403 0.281 . . . . 0.0 111.674 -174.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.45 HD22 HG23 ' A' ' 79' ' ' VAL . 43.1 m-80 59.83 31.22 20.66 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 123.575 0.75 . . . . 0.0 111.566 178.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.615 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 12.0 m-85 61.12 39.93 15.48 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.853 1.261 . . . . 0.0 111.735 177.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 72.4 p -112.16 171.48 7.48 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.116 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.59 -133.31 11.67 Favored Glycine 0 N--CA 1.428 -1.859 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.307 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.524 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 54.2 mtt180 -89.26 149.4 23.09 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 124.246 1.019 . . . . 0.0 109.058 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.6 tt -125.52 137.02 59.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 121.273 0.559 . . . . 0.0 110.59 -175.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 95.7 m -131.94 125.99 32.97 Favored 'General case' 0 C--N 1.287 -2.112 0 O-C-N 122.1 -0.375 . . . . 0.0 110.415 176.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -111.38 124.46 6.88 Favored Glycine 0 C--N 1.312 -0.784 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.553 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -116.8 144.79 44.06 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 122.967 0.507 . . . . 0.0 110.315 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -114.05 168.07 12.48 Favored Glycine 0 N--CA 1.435 -1.416 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.612 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 33.5 p80 -64.86 128.81 37.34 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 121.218 0.532 . . . . 0.0 111.899 -177.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.31 6.85 65.99 Favored Glycine 0 N--CA 1.426 -1.998 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.604 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.7 m -118.5 146.45 44.51 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 4.3 m -136.36 155.78 49.57 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 52.4 mt -94.01 128.29 45.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -70.81 -48.28 55.0 Favored 'General case' 0 C--N 1.313 -1.009 0 O-C-N 123.536 0.523 . . . . 0.0 110.5 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.46 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 10.6 m-20 -135.37 92.69 2.88 Favored 'General case' 0 CA--C 1.486 -1.488 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.917 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.41 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 65.6 t80 -64.97 -32.26 73.89 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.265 0.555 . . . . 0.0 109.763 177.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.1 t -63.56 -26.62 68.78 Favored 'General case' 0 CA--C 1.552 1.019 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.66 -178.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.46 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 73.7 mmtt -95.23 -6.61 41.14 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.527 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.6 m -84.4 39.44 0.73 Allowed 'General case' 0 C--O 1.244 0.778 0 CA-C-O 121.87 0.843 . . . . 0.0 111.488 -176.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.73 -78.77 1.69 Allowed Glycine 0 N--CA 1.424 -2.116 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.5 ' CD1' ' HB3' ' A' ' 77' ' ' ASP . 26.8 p90 -108.19 145.68 33.87 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -177.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -113.66 -10.46 13.09 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 177.421 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -104.19 110.22 3.55 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.308 -177.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 70.2 mt -95.01 115.7 34.52 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.658 0 CA-C-O 122.387 1.089 . . . . 0.0 108.868 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 57.8 m -86.04 -29.16 23.66 Favored 'General case' 0 N--CA 1.392 -3.357 0 CA-C-N 112.238 -2.255 . . . . 0.0 114.262 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 77.6 p -153.98 155.81 36.28 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.6 mt -134.73 131.15 53.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -176.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.615 ' HE2' ' CD2' ' A' ' 81' ' ' TYR . 34.4 ttmt -117.86 126.34 52.2 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -96.16 130.1 43.29 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 176.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 76.0 m -123.19 170.76 9.91 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 7.5 pt -125.06 142.35 42.24 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 176.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 53.6 tt0 -115.76 128.71 56.06 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.4 p -87.15 178.77 6.8 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.847 -174.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -63.16 -27.05 69.1 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.44 0.696 . . . . 0.0 109.186 174.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -81.05 -8.53 59.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.577 0.704 . . . . 0.0 110.739 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.37 -1.96 77.29 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.432 -0.889 . . . . 0.0 113.792 175.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 113' ' ' GLN . 8.8 ptpt -79.28 147.74 32.4 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.2 t -111.27 115.9 51.1 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -101.78 141.4 34.69 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 75.4 m . . . . . 0 C--N 1.308 -1.202 0 CA-C-O 121.108 0.48 . . . . 0.0 111.993 -175.036 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 . . . . . 0 CA--C 1.505 -0.764 0 CA-C-O 121.816 0.817 . . . . 0.0 110.398 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.3 m -139.05 154.5 48.22 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -176.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.597 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 53.4 tp -110.06 125.62 53.14 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 176.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 74.2 mt-30 -112.68 123.71 50.91 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 121.461 0.648 . . . . 0.0 109.572 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.454 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.4 mp -110.8 124.82 52.75 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.681 177.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -94.07 153.34 18.19 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 123.418 0.449 . . . . 0.0 111.183 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.46 -36.01 58.14 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.064 -176.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -107.44 178.26 4.59 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.548 ' O ' ' HB2' ' A' ' 36' ' ' ARG . 2.6 p -80.67 169.36 17.72 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 119.674 -0.203 . . . . 0.0 110.556 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 35.4 p90 46.65 42.73 11.82 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.17 1.388 . . . . 0.0 114.47 176.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 61.7 33.42 18.01 Favored 'General case' 0 C--O 1.246 0.904 0 C-N-CA 123.979 0.912 . . . . 0.0 112.502 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.548 ' HB2' ' O ' ' A' ' 33' ' ' THR . 5.4 mmm180 -96.23 154.55 17.19 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.807 174.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.53 -165.74 39.12 Favored Glycine 0 N--CA 1.427 -1.964 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.8 m -88.7 171.84 9.69 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 175.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -137.44 166.59 23.47 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -176.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.5 tt -114.61 150.79 16.48 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.45 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 176.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -107.21 125.63 51.36 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.545 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 74.6 t -117.99 133.54 64.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -117.48 -30.05 5.64 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.335 0.588 . . . . 0.0 110.86 -174.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -113.54 163.58 14.75 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.782 -174.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.4 m -79.05 145.19 33.97 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 173.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.426 HG12 ' HB ' ' A' ' 108' ' ' ILE . 12.2 p -120.88 128.7 76.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -89.79 -20.26 44.37 Favored Glycine 0 N--CA 1.427 -1.952 0 C-N-CA 119.543 -1.313 . . . . 0.0 113.342 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.5 m -157.78 114.52 2.91 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.509 0.671 . . . . 0.0 111.471 -178.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 85.5 mt -102.2 119.4 38.74 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.094 177.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 55.7 p -131.28 110.62 15.24 Favored Pre-proline 0 N--CA 1.425 -1.702 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 174.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 3.1 Cg_exo -77.65 162.37 90.24 Favored 'Cis proline' 0 CA--C 1.539 0.75 0 C-N-CA 124.008 -1.247 . . . . 0.0 111.207 -1.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.12 154.97 67.61 Favored 'Trans proline' 0 C--O 1.246 0.888 0 C-N-CA 122.205 1.937 . . . . 0.0 110.89 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.415 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 49.7 m0 -90.26 137.05 32.66 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.352 -177.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 11.4 p -120.16 78.17 25.46 Favored Pre-proline 0 C--N 1.295 -1.787 0 O-C-N 123.672 0.607 . . . . 0.0 110.368 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.454 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 84.8 Cg_endo -78.26 157.4 29.69 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.379 2.053 . . . . 0.0 113.33 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -85.89 -34.91 12.06 Favored Glycine 0 N--CA 1.434 -1.477 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.3 p -150.9 156.26 40.83 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.408 HG22 HD23 ' A' ' 29' ' ' LEU . 38.6 t -130.61 141.84 45.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 37.7 t -146.14 150.4 35.82 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-O 121.248 0.546 . . . . 0.0 110.223 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.6 t -113.85 123.1 33.49 Favored Pre-proline 0 C--N 1.299 -1.607 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 176.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -57.47 136.79 78.11 Favored 'Trans proline' 0 C--O 1.247 0.941 0 C-N-CA 122.735 2.29 . . . . 0.0 111.554 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.472 ' CE2' ' HB3' ' A' ' 64' ' ' ASN . 72.8 t80 -72.71 112.58 8.88 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.286 -177.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 44.7 t -93.84 115.15 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.825 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 175.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.472 ' HB3' ' CE2' ' A' ' 62' ' ' PHE . 27.3 p-10 -109.75 15.46 22.74 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-O 122.305 1.05 . . . . 0.0 108.67 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -75.69 147.31 39.52 Favored 'General case' 0 C--N 1.284 -2.279 0 CA-C-N 113.739 -1.573 . . . . 0.0 112.106 -174.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.0 m -52.33 -21.7 3.81 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 126.999 2.12 . . . . 0.0 114.022 -172.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -58.53 137.04 57.67 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.531 0.681 . . . . 0.0 111.803 -176.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -68.31 -23.3 64.72 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 124.892 1.277 . . . . 0.0 113.002 -171.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.452 ' HG3' HG22 ' A' ' 114' ' ' THR . 19.9 mp0 -109.76 128.48 55.32 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.9 148.81 37.18 Favored Pre-proline 0 C--N 1.298 -1.668 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 174.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -77.44 137.95 17.07 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 C-N-CA 121.657 1.571 . . . . 0.0 112.564 -177.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -131.73 127.79 37.55 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.597 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 77.5 m95 -110.99 138.05 47.87 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -171.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.482 ' HA ' ' O ' ' A' ' 86' ' ' THR . 34.3 m-85 -116.09 142.9 46.19 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.339 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.436 HD21 HD21 ' A' ' 27' ' ' LEU . 19.4 mt -125.68 142.42 51.52 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 -176.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -133.65 139.96 46.78 Favored 'General case' 0 CA--C 1.503 -0.852 0 O-C-N 123.734 0.647 . . . . 0.0 109.498 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.536 ' HB3' ' CG ' ' A' ' 102' ' ' PHE . 3.6 p-10 -77.82 -15.78 58.81 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -177.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.498 ' C ' ' HB3' ' A' ' 106' ' ' SER . 6.0 t-20 -121.43 166.74 13.67 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.1 m -71.71 165.62 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 C-N-CA 122.905 0.482 . . . . 0.0 111.915 -176.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 57.13 31.2 19.59 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.888 0.875 . . . . 0.0 112.322 176.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.467 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 6.5 m-85 59.9 48.82 8.45 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 125.098 1.359 . . . . 0.0 110.895 177.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 81.6 p -120.68 168.46 11.38 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 116.229 -0.442 . . . . 0.0 109.901 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.59 -138.44 14.28 Favored Glycine 0 N--CA 1.421 -2.327 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -81.77 157.04 24.65 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 123.85 0.86 . . . . 0.0 109.616 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.8 tt -129.75 137.1 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 CA-C-O 121.494 0.664 . . . . 0.0 110.805 -175.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 96.9 m -131.99 128.37 38.25 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -114.78 130.28 9.12 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.815 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.505 HD21 HD11 ' A' ' 94' ' ' ILE . 3.7 mm? -121.3 147.56 45.5 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 123.076 0.55 . . . . 0.0 111.161 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.89 168.5 12.81 Favored Glycine 0 N--CA 1.433 -1.517 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.833 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -62.97 122.39 15.89 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.315 0.579 . . . . 0.0 111.769 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.51 -2.63 77.89 Favored Glycine 0 N--CA 1.433 -1.54 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.23 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.0 m -107.07 146.18 31.52 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.1 m -140.88 157.83 44.82 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.505 HD11 HD21 ' A' ' 88' ' ' LEU . 52.1 mt -94.01 132.72 37.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 175.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -71.26 -48.66 49.63 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 121.579 0.704 . . . . 0.0 109.852 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.596 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 13.3 m-20 -132.24 96.48 3.89 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.847 178.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.415 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 61.5 t80 -65.57 -37.32 86.35 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.466 0.65 . . . . 0.0 110.01 175.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.4 t -63.91 -27.93 69.49 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.174 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.596 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 29.1 mmtp -89.19 -7.71 55.04 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 122.044 -0.41 . . . . 0.0 110.341 -178.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.8 m -80.34 -174.37 4.55 Favored 'General case' 0 C--O 1.257 1.493 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -50.26 -66.48 2.34 Favored Glycine 0 CA--C 1.507 -0.447 0 O-C-N 123.38 0.425 . . . . 0.0 113.62 -177.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.536 ' CG ' ' HB3' ' A' ' 77' ' ' ASP . 34.0 p90 -110.83 149.74 30.14 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 119.732 -0.175 . . . . 0.0 110.659 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.03 -12.16 13.25 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.542 177.646 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -112.17 116.19 4.03 Favored Glycine 0 N--CA 1.428 -1.841 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -177.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 70.0 mt -95.46 114.96 33.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.498 ' HB3' ' C ' ' A' ' 78' ' ' ASN . 1.8 t -86.77 -25.08 24.83 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.024 177.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 89.1 p -153.08 155.18 36.33 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 122.325 -0.234 . . . . 0.0 110.474 177.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.426 ' HB ' HG12 ' A' ' 46' ' ' VAL . 47.2 mt -133.02 132.57 58.94 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -175.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.467 ' HE2' ' CD2' ' A' ' 81' ' ' TYR . 37.9 ttmt -116.53 127.53 54.62 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.255 -1.016 . . . . 0.0 108.255 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -95.61 129.16 42.89 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 69.7 m -125.38 172.11 9.89 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 8.0 pt -128.07 143.11 41.93 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 59.7 tt0 -117.09 119.48 35.38 Favored 'General case' 0 C--N 1.277 -2.548 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.452 HG22 ' HG3' ' A' ' 69' ' ' GLU . 32.0 p -81.9 179.97 7.62 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.255 -171.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -65.36 -25.12 67.44 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.764 174.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -80.78 -7.81 59.5 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.852 0.834 . . . . 0.0 110.097 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.24 -9.78 76.63 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.803 175.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.449 ' HE2' ' HG2' ' A' ' 120' ' ' GLU . 19.6 ptmt -73.49 140.03 46.13 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 21.6 t -103.36 112.3 36.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.449 ' HG2' ' HE2' ' A' ' 118' ' ' LYS . 24.7 mt-10 -98.01 138.03 35.93 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 80.1 m . . . . . 0 C--N 1.305 -1.327 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -174.06 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 121.358 0.599 . . . . 0.0 111.584 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.404 ' HG ' ' HE1' ' A' ' 43' ' ' TYR . 14.9 m -123.88 158.96 30.72 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.634 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 57.2 tp -107.24 118.97 38.12 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 171.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 39.4 mt-30 -111.23 124.14 51.61 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.619 -0.832 . . . . 0.0 108.951 -178.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.8 mp -110.24 126.71 54.44 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.115 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -96.38 151.31 19.66 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 123.572 0.545 . . . . 0.0 109.598 -177.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -74.07 -37.75 64.14 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.139 0.495 . . . . 0.0 111.107 -177.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -108.32 177.44 4.79 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.457 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.457 HG22 ' HA ' ' A' ' 96' ' ' ASP . 2.2 p -81.16 172.54 13.54 Favored 'General case' 0 N--CA 1.413 -2.309 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 11.7 p90 47.6 35.4 4.36 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.852 0.861 . . . . 0.0 113.24 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 61.85 38.65 14.52 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.851 1.26 . . . . 0.0 113.591 177.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -103.46 178.17 4.63 Favored 'General case' 0 C--O 1.248 0.981 0 C-N-CA 120.126 -0.629 . . . . 0.0 112.007 175.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.7 -154.79 40.33 Favored Glycine 0 N--CA 1.425 -2.09 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -176.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.4 m -100.57 174.61 6.0 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 172.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -136.87 165.66 25.44 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 16.6 tt -116.21 152.45 17.92 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.483 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -106.8 125.15 50.63 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 98.0 t -120.78 133.94 65.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . 0.404 ' HE1' ' HG ' ' A' ' 26' ' ' CYS . 30.2 m-85 -121.72 -27.73 4.65 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.506 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 10.5 mmpt? -109.72 162.68 14.21 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.655 -173.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.8 m -82.75 141.82 32.09 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 175.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.1 p -120.79 130.54 74.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -89.51 -17.85 53.84 Favored Glycine 0 N--CA 1.43 -1.722 0 C-N-CA 119.722 -1.227 . . . . 0.0 113.308 -176.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.8 p -156.54 130.78 8.61 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 85.5 mt -124.11 117.46 24.71 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 175.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 40.0 m -133.45 113.49 13.18 Favored Pre-proline 0 C--N 1.293 -1.859 0 CA-C-O 120.407 0.146 . . . . 0.0 110.947 175.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 7.3 Cg_exo -75.07 162.22 93.25 Favored 'Cis proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.179 -1.592 . . . . 0.0 111.336 -0.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.58 159.29 24.48 Favored 'Trans proline' 0 C--O 1.245 0.842 0 C-N-CA 122.705 2.27 . . . . 0.0 111.615 177.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.505 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 43.9 m0 -88.93 138.91 30.98 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 21.8 p -116.66 78.52 8.93 Favored Pre-proline 0 C--N 1.3 -1.584 0 O-C-N 123.579 0.55 . . . . 0.0 110.747 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.481 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 92.3 Cg_endo -79.79 153.17 22.7 Favored 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 122.001 1.8 . . . . 0.0 112.589 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.67 -27.11 18.14 Favored Glycine 0 N--CA 1.425 -2.094 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.4 p -155.1 151.73 28.66 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.7 t -132.17 142.65 42.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 35.8 t -145.53 146.78 31.56 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 119.577 -0.849 . . . . 0.0 111.647 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.0 t -113.61 124.66 30.81 Favored Pre-proline 0 N--CA 1.435 -1.209 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 176.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -59.58 145.61 97.56 Favored 'Trans proline' 0 C--O 1.244 0.798 0 C-N-CA 123.115 2.543 . . . . 0.0 112.587 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -74.06 114.75 12.73 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.172 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 91.9 t -95.66 115.73 35.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -110.26 8.16 23.44 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 122.423 1.106 . . . . 0.0 108.713 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.76 145.02 56.55 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.884 -178.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.8 m -67.85 -7.09 25.06 Favored 'General case' 0 CA--C 1.566 1.587 0 C-N-CA 124.995 1.318 . . . . 0.0 110.882 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -51.96 133.47 32.51 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 124.884 1.274 . . . . 0.0 110.311 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.3 tpp180 -70.59 -26.6 63.59 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.179 -172.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -111.33 134.16 53.12 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 122.707 0.403 . . . . 0.0 110.154 176.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.8 153.82 37.95 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 170.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.11 135.12 12.04 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 C-N-CA 121.958 1.772 . . . . 0.0 111.367 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -130.06 136.3 49.21 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.634 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 85.2 m95 -119.21 133.55 55.7 Favored 'General case' 0 C--N 1.291 -1.953 0 C-N-CA 120.134 -0.626 . . . . 0.0 112.241 -173.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.456 ' HA ' ' O ' ' A' ' 86' ' ' THR . 33.7 m-85 -114.9 140.16 49.21 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.143 177.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.6 mt -125.28 142.74 51.32 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -175.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.454 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 78.7 m-85 -133.35 142.28 48.34 Favored 'General case' 0 C--N 1.317 -0.833 0 O-C-N 123.576 0.548 . . . . 0.0 110.423 -175.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -85.27 0.01 53.3 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 120.767 0.317 . . . . 0.0 111.049 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -137.47 158.87 43.47 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.554 HG23 HD22 ' A' ' 80' ' ' ASN . 33.4 m -71.59 166.6 2.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 C-N-CA 122.99 0.516 . . . . 0.0 111.577 -175.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.554 HD22 HG23 ' A' ' 79' ' ' VAL . 64.6 m-80 57.87 30.13 18.6 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.008 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.467 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 9.3 m-85 58.74 47.11 13.3 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 125.019 1.327 . . . . 0.0 111.235 177.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 73.2 p -118.37 173.5 6.78 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.18 -133.34 11.72 Favored Glycine 0 N--CA 1.433 -1.512 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.933 176.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.454 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 56.0 mtt85 -80.83 148.67 29.87 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 123.143 0.577 . . . . 0.0 109.618 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.4 tt -127.27 137.58 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 -177.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 98.2 m -131.24 126.08 34.54 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 176.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -115.16 115.29 3.4 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.491 -0.861 . . . . 0.0 113.745 -177.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -108.32 144.81 35.35 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 122.466 0.306 . . . . 0.0 110.771 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.17 170.76 13.46 Favored Glycine 0 N--CA 1.429 -1.772 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.003 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -64.33 130.75 45.01 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.315 0.578 . . . . 0.0 111.918 -176.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.71 8.23 80.3 Favored Glycine 0 N--CA 1.428 -1.84 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.794 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.3 m -121.32 146.25 47.04 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.9 m -136.33 156.93 47.94 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 50.5 mt -93.59 127.84 45.39 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 172.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -69.07 -46.91 66.64 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.579 0.704 . . . . 0.0 109.447 -177.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.645 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 3.9 m-20 -139.73 98.98 3.59 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.205 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -65.08 -37.75 88.53 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.337 0.589 . . . . 0.0 110.672 178.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.7 t -69.53 -17.93 63.62 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.461 -177.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.645 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 28.9 mmtp -89.95 -6.19 55.94 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.638 -0.664 . . . . 0.0 109.386 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.0 t -85.02 -163.78 0.89 Allowed 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.41 -68.19 1.78 Allowed Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 116.798 -0.183 . . . . 0.0 113.151 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -110.61 147.61 33.91 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 122.488 -0.419 . . . . 0.0 109.917 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -112.43 -0.52 15.28 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.103 177.331 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.505 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -119.19 113.95 2.66 Favored Glycine 0 N--CA 1.436 -1.35 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.812 -176.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 69.2 mt -95.8 116.3 37.17 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.593 0 CA-C-O 122.312 1.053 . . . . 0.0 109.614 -178.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.4 m -85.62 -28.6 24.68 Favored 'General case' 0 N--CA 1.395 -3.193 0 CA-C-N 112.206 -2.27 . . . . 0.0 114.13 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 84.1 p -156.45 156.37 33.67 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 177.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.4 mt -135.18 130.81 51.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -176.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.467 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 37.3 ttmt -117.14 128.19 54.88 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -95.49 129.49 42.64 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 121.631 0.729 . . . . 0.0 109.213 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 82.2 m -125.55 172.68 9.52 Favored 'General case' 0 C--N 1.273 -2.739 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.875 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.404 HG13 ' HB2' ' A' ' 120' ' ' GLU . 7.6 pt -129.03 142.47 43.96 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.477 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -110.91 122.63 48.35 Favored 'General case' 0 C--N 1.278 -2.508 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 82.4 p -77.88 176.54 8.99 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.61 -174.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -66.96 -20.11 65.84 Favored 'General case' 0 C--N 1.316 -0.885 0 O-C-N 122.141 -0.35 . . . . 0.0 111.153 174.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.507 ' OD1' ' HG2' ' A' ' 118' ' ' LYS . 2.1 p30 -86.88 -7.61 58.05 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.264 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 94.17 -0.97 66.87 Favored Glycine 0 N--CA 1.441 -1.003 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.662 175.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.507 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 52.6 pttt -77.87 149.01 34.37 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 119.093 -1.043 . . . . 0.0 109.566 176.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.2 t -109.04 112.04 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.503 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.404 ' HB2' HG13 ' A' ' 112' ' ' ILE . 6.6 mm-40 -93.82 144.8 25.1 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 76.9 m . . . . . 0 C--N 1.289 -2.053 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.287 -175.912 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 121.444 0.64 . . . . 0.0 111.764 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 36.7 m -123.82 154.68 39.24 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.554 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 44.0 tp -105.02 121.92 44.78 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 176.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.5 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 41.0 mt-30 -111.86 124.07 51.59 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.454 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.8 mp -110.26 123.88 50.6 Favored 'General case' 0 N--CA 1.42 -1.927 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.15 177.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -88.85 149.07 23.55 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -74.04 -38.42 64.01 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 120.983 0.42 . . . . 0.0 111.059 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -107.84 177.35 4.84 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.223 -176.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.43 HG22 ' HA ' ' A' ' 96' ' ' ASP . 1.0 OUTLIER -81.72 172.72 13.06 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.936 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.268 21.9 p90 47.49 37.8 6.87 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.793 1.237 . . . . 0.0 113.501 177.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 65.26 27.97 12.05 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 125.109 1.364 . . . . 0.0 113.717 178.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -97.55 172.67 7.58 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.426 0.631 . . . . 0.0 110.656 177.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.41 -166.17 37.92 Favored Glycine 0 N--CA 1.424 -2.158 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.3 m -100.68 176.76 5.2 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 173.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -143.89 165.34 28.01 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 120.469 -0.493 . . . . 0.0 110.843 -174.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 18.2 tt -114.31 152.72 15.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -107.21 125.62 51.35 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 98.7 t -119.71 136.71 55.96 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.384 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 177.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -117.43 -28.01 6.21 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.883 -176.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -107.47 163.04 13.4 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 -173.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.435 ' HB3' ' H ' ' A' ' 110' ' ' ARG . 4.5 p -89.6 141.69 28.37 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 172.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.418 HG12 ' HB ' ' A' ' 108' ' ' ILE . 8.3 p -120.55 132.91 68.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -174.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.96 -1.7 57.19 Favored Glycine 0 C--N 1.313 -0.746 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.456 -176.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.0 t -166.7 129.58 1.86 Allowed 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.067 0.46 . . . . 0.0 109.906 176.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 85.1 mt -122.41 117.78 26.82 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.0 m -133.25 112.8 13.22 Favored Pre-proline 0 C--N 1.288 -2.09 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 174.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.62 161.86 93.58 Favored 'Cis proline' 0 CA--C 1.549 1.249 0 C-N-CA 123.333 -1.528 . . . . 0.0 111.326 -1.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.81 158.33 43.14 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.948 2.432 . . . . 0.0 110.87 177.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.515 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 48.2 m0 -90.23 143.81 26.43 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -178.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 18.3 p -121.48 76.82 35.38 Favored Pre-proline 0 C--N 1.308 -1.203 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.454 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 92.3 Cg_endo -81.18 157.64 20.09 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.806 2.337 . . . . 0.0 112.624 177.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.0 -28.38 11.04 Favored Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.3 p -157.33 154.93 29.78 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.7 t -131.61 145.42 35.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -176.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 39.3 t -145.59 147.36 31.99 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.927 176.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.9 t -112.71 126.79 27.74 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 176.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.405 ' HD3' HE21 ' A' ' 28' ' ' GLN . 22.0 Cg_endo -60.61 150.48 81.73 Favored 'Trans proline' 0 C--O 1.248 1.0 0 C-N-CA 122.983 2.455 . . . . 0.0 112.304 -177.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.548 ' CE1' ' HB2' ' A' ' 64' ' ' ASN . 45.1 t80 -74.36 132.32 41.91 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.956 0.884 . . . . 0.0 111.555 -177.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 99.0 t -123.22 117.78 52.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.548 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 61.7 t30 -118.6 8.25 11.93 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 123.373 1.559 . . . . 0.0 106.842 178.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -60.21 145.03 48.68 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 112.413 -2.176 . . . . 0.0 113.539 -174.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 m -60.73 -7.12 2.06 Favored 'General case' 0 CA--C 1.564 1.509 0 C-N-CA 126.248 1.819 . . . . 0.0 112.568 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -58.54 142.84 47.89 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -74.33 -25.4 59.53 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.866 -174.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.459 ' HG2' HD12 ' A' ' 112' ' ' ILE . 4.5 mp0 -110.71 133.8 53.02 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.87 0.367 . . . . 0.0 111.74 177.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.32 150.33 37.0 Favored Pre-proline 0 C--N 1.307 -1.242 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 168.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -80.28 137.0 11.67 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.025 1.816 . . . . 0.0 111.813 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -132.17 137.72 47.75 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.554 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 89.9 m95 -122.07 132.43 54.49 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.16 0.505 . . . . 0.0 111.981 -174.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' A' ' 86' ' ' THR . 24.2 m-85 -112.74 142.77 44.98 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.434 177.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.5 mt -125.62 142.25 51.61 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -175.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.498 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 93.2 m-85 -132.85 141.47 48.45 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.403 0.62 . . . . 0.0 111.158 -175.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.758 ' HB2' ' CD2' ' A' ' 102' ' ' PHE . 9.0 t70 -85.99 -6.53 59.03 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.544 -177.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -140.06 156.87 46.4 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.727 173.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.738 ' HA ' ' OG ' ' A' ' 107' ' ' SER . 23.6 m -64.46 162.24 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.945 0 C-N-CA 123.655 0.782 . . . . 0.0 112.214 -175.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.44 29.86 17.19 Favored 'General case' 0 CA--C 1.511 -0.551 0 O-C-N 123.859 0.724 . . . . 0.0 109.305 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.455 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 16.1 m-85 56.49 50.93 12.08 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 114.433 -1.258 . . . . 0.0 111.415 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 60.5 p -123.52 177.59 5.58 Favored 'General case' 0 C--O 1.249 1.047 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.762 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.95 -107.96 3.53 Favored Glycine 0 N--CA 1.437 -1.267 0 N-CA-C 111.822 -0.511 . . . . 0.0 111.822 176.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 58.6 mtt85 -114.08 151.86 31.91 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.7 tt -128.65 140.04 50.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 O-C-N 123.712 0.632 . . . . 0.0 111.08 -174.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 24.4 m -132.49 125.42 30.61 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.429 174.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -115.17 107.25 1.73 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.83 -0.7 . . . . 0.0 114.321 -178.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -106.32 145.69 31.34 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 123.045 0.538 . . . . 0.0 111.468 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -123.33 172.64 16.17 Favored Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.678 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -50.23 127.86 18.06 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 124.262 1.025 . . . . 0.0 112.757 -177.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.97 -0.19 88.8 Favored Glycine 0 C--N 1.309 -0.925 0 CA-C-N 115.546 -0.752 . . . . 0.0 113.251 174.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.3 m -110.82 145.9 37.37 Favored 'General case' 0 N--CA 1.421 -1.92 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.543 -177.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.6 m -136.21 156.7 48.3 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 55.2 mt -92.81 135.81 26.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 176.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -70.53 -48.52 55.08 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.506 0.67 . . . . 0.0 110.421 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.579 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 3.2 m-20 -143.23 99.12 3.38 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -178.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -64.85 -38.37 90.76 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 121.263 0.554 . . . . 0.0 110.817 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.5 t -65.96 -21.01 66.39 Favored 'General case' 0 CA--C 1.558 1.257 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.903 -175.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.579 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 30.0 mmtp -92.83 -7.82 45.26 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.8 t -83.49 7.29 17.46 Favored 'General case' 0 C--O 1.25 1.123 0 CA-C-O 121.065 0.46 . . . . 0.0 111.492 -176.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 115.56 -62.51 0.35 Allowed Glycine 0 N--CA 1.436 -1.362 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 177.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.758 ' CD2' ' HB2' ' A' ' 77' ' ' ASP . 22.7 p90 -110.89 142.59 42.74 Favored 'General case' 0 N--CA 1.427 -1.59 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.144 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -114.01 -8.31 13.07 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.515 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -112.55 112.93 3.11 Favored Glycine 0 N--CA 1.422 -2.267 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.954 -174.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 70.1 mt -95.22 115.55 34.42 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 52.3 m -85.43 -26.69 26.22 Favored 'General case' 0 C--N 1.252 -3.652 0 CA-C-N 112.228 -2.26 . . . . 0.0 113.339 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.738 ' OG ' ' HA ' ' A' ' 79' ' ' VAL . 66.6 m -156.29 152.35 27.58 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.215 -0.303 . . . . 0.0 110.794 -177.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.418 ' HB ' HG12 ' A' ' 46' ' ' VAL . 40.3 mt -135.3 130.19 50.74 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.539 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -176.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.455 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 33.9 ttmt -117.53 131.18 56.75 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.435 ' H ' ' HB3' ' A' ' 45' ' ' SER . 55.9 ttp180 -101.42 123.37 45.38 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -177.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 36.1 m -119.71 171.15 8.59 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.459 HD12 ' HG2' ' A' ' 69' ' ' GLU . 8.4 pt -129.35 146.2 34.57 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.427 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 56.4 tt0 -117.79 118.21 31.42 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 17.2 p -78.8 179.67 7.08 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.253 -173.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -58.97 -28.21 66.1 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.635 0.731 . . . . 0.0 110.548 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -77.02 -7.99 56.63 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.9 -176.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.53 6.84 87.04 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.483 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 113' ' ' GLN . 26.2 pttm -87.84 139.28 30.69 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.0 t -103.22 112.44 36.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -102.78 146.01 28.89 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.298 -1.649 0 C-N-CA 119.307 -0.957 . . . . 0.0 109.663 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 N--CA 1.473 0.707 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.4 m -123.32 146.66 47.73 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.614 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 53.8 tp -92.52 121.32 33.85 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 172.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.501 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 65.0 mt-30 -114.17 123.7 50.24 Favored 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.635 -177.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 2.8 mp -110.34 119.08 38.06 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.339 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -82.04 145.01 30.44 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 123.521 0.513 . . . . 0.0 110.21 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -69.27 -39.79 78.17 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.598 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -108.37 177.39 4.81 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.435 HG22 ' HA ' ' A' ' 96' ' ' ASP . 1.1 p -83.1 177.18 8.7 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 122.601 0.36 . . . . 0.0 110.602 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.262 16.6 p90 47.39 42.2 13.76 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.886 1.275 . . . . 0.0 113.881 176.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 63.56 27.97 15.1 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.241 176.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.543 ' HA ' ' NE ' ' A' ' 36' ' ' ARG . 3.7 mmp_? -108.5 166.32 10.86 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.317 0.58 . . . . 0.0 110.969 178.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.38 173.74 47.29 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -177.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.3 p -86.28 154.78 21.01 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 40.8 p90 -117.6 165.84 13.09 Favored 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.218 -176.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.8 tt -114.23 153.26 15.77 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 178.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -105.96 126.03 51.7 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.535 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 92.8 t -123.33 133.4 69.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -118.08 -21.7 8.14 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.055 0.455 . . . . 0.0 110.668 -175.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -129.24 162.18 28.46 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.317 -175.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.454 ' HB3' ' H ' ' A' ' 110' ' ' ARG . 4.2 p -79.02 146.25 33.43 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.839 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.9 p -121.46 137.28 55.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.3 -18.43 39.17 Favored Glycine 0 C--N 1.316 -0.543 0 C-N-CA 119.903 -1.141 . . . . 0.0 113.864 -176.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.3 t -161.18 132.14 5.34 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.1 mt -121.31 118.94 30.77 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.313 178.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.5 m -132.61 110.42 13.5 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 175.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -76.71 160.24 95.28 Favored 'Cis proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.171 -1.595 . . . . 0.0 111.38 0.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.02 158.24 48.73 Favored 'Trans proline' 0 C--O 1.24 0.616 0 C-N-CA 122.31 2.006 . . . . 0.0 110.84 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 52.7 m0 -89.73 136.65 32.91 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 120.351 -0.54 . . . . 0.0 109.881 -177.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 20.2 p -118.73 77.07 14.35 Favored Pre-proline 0 N--CA 1.435 -1.207 0 O-C-N 123.493 0.495 . . . . 0.0 111.757 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.469 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 96.0 Cg_endo -76.4 158.52 36.68 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.387 2.058 . . . . 0.0 111.972 177.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -92.84 -31.58 8.56 Favored Glycine 0 N--CA 1.431 -1.685 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 175.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 94' ' ' ILE . 34.8 p -152.01 153.14 33.44 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.418 HG22 HD23 ' A' ' 29' ' ' LEU . 36.7 t -128.91 142.77 43.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -177.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 37.2 t -145.75 147.29 31.75 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.124 177.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 68.2 t -114.13 121.16 37.14 Favored Pre-proline 0 C--N 1.306 -1.296 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 175.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.03 148.17 78.55 Favored 'Trans proline' 0 C--O 1.246 0.905 0 C-N-CA 122.997 2.465 . . . . 0.0 112.315 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.424 ' CE2' ' HB3' ' A' ' 64' ' ' ASN . 76.4 t80 -71.63 111.56 7.03 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.36 0.6 . . . . 0.0 110.594 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.411 ' H ' ' HB2' ' A' ' 90' ' ' HIS . 48.7 t -94.51 115.29 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.98 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.585 178.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.424 ' HB3' ' CE2' ' A' ' 62' ' ' PHE . 23.7 p-10 -114.73 25.05 11.28 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 125.673 1.589 . . . . 0.0 108.14 178.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.53 ' HB3' ' NH2' ' A' ' 70' ' ' ARG . 16.6 t70 -66.92 146.22 54.63 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 112.867 -1.969 . . . . 0.0 112.396 -176.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.7 m -53.53 -18.49 2.85 Favored 'General case' 0 CA--C 1.57 1.745 0 C-N-CA 125.203 1.401 . . . . 0.0 113.747 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.518 ' HG2' ' OD2' ' A' ' 65' ' ' ASP . 33.4 mmtp -66.52 167.66 10.45 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.773 -0.579 . . . . 0.0 110.132 174.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -106.07 -15.91 14.76 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 175.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.3 mp0 -92.39 128.31 38.2 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.788 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.53 ' NH2' ' HB3' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -106.1 154.18 39.76 Favored Pre-proline 0 C--N 1.291 -1.966 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.306 178.625 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -81.9 135.1 8.64 Favored 'Trans proline' 0 N--CA 1.44 -1.629 0 C-N-CA 121.632 1.555 . . . . 0.0 111.002 178.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -129.12 120.91 26.7 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.614 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 87.0 m95 -106.66 133.93 50.59 Favored 'General case' 0 C--N 1.278 -2.543 0 CA-C-O 121.034 0.445 . . . . 0.0 111.953 -171.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 86' ' ' THR . 29.5 m-85 -112.39 140.56 47.01 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.499 177.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.4 mt -125.6 142.37 51.54 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -177.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 80.5 m-85 -134.48 140.84 46.5 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 123.892 0.745 . . . . 0.0 109.599 -176.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.37 -12.19 59.06 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.51 -177.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.504 ' C ' ' HB3' ' A' ' 106' ' ' SER . 5.1 t-20 -123.25 172.51 8.57 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.8 m -76.23 168.83 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 C-N-CA 123.415 0.686 . . . . 0.0 111.591 -176.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 53.83 30.53 11.53 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.121 0.969 . . . . 0.0 112.431 176.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.555 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 8.2 m-85 63.0 39.44 10.19 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.577 176.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 81.4 p -111.91 170.65 8.0 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.67 -145.31 17.56 Favored Glycine 0 N--CA 1.429 -1.781 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.609 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.515 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 98.0 mtt180 -75.59 147.84 39.29 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 123.128 0.571 . . . . 0.0 109.636 178.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.5 tt -125.38 136.5 60.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 121.705 0.764 . . . . 0.0 110.442 -175.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 93.5 m -131.39 125.16 31.9 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.615 176.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -115.01 118.01 4.19 Favored Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.309 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -112.53 146.0 39.29 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 123.3 0.64 . . . . 0.0 111.146 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -117.94 172.89 14.57 Favored Glycine 0 N--CA 1.434 -1.474 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.127 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.439 ' CD2' ' HG2' ' A' ' 70' ' ' ARG . 2.6 p80 -62.46 132.43 52.47 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 121.272 0.558 . . . . 0.0 111.906 -176.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.8 15.17 79.84 Favored Glycine 0 N--CA 1.43 -1.7 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.766 176.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.8 m -127.22 146.2 50.5 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.7 m -137.55 156.34 48.21 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.436 ' O ' ' HB2' ' A' ' 57' ' ' SER . 46.0 mt -95.31 127.03 47.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 170.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -71.77 -46.34 58.71 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.354 0.597 . . . . 0.0 111.926 177.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.617 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 1.7 m-20 -129.4 96.11 4.2 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.144 178.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -64.69 -35.03 79.73 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.56 0.695 . . . . 0.0 110.34 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.4 t -67.66 -29.32 68.58 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.159 -175.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.617 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 29.4 mmtp -88.39 -6.68 57.54 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -178.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.1 m -80.64 -13.29 59.16 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.882 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 139.02 -70.47 0.46 Allowed Glycine 0 N--CA 1.431 -1.678 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -110.32 146.46 35.7 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -112.4 -9.96 13.8 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.715 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -109.48 115.54 4.27 Favored Glycine 0 N--CA 1.427 -1.932 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.747 -176.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 79.1 mt -98.77 116.27 41.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.504 ' HB3' ' C ' ' A' ' 78' ' ' ASN . 7.6 t -85.82 -29.9 23.4 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.52 177.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 93.6 p -148.57 155.4 41.06 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 121.872 -0.517 . . . . 0.0 111.273 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.1 mt -133.27 133.71 57.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -176.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.555 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 38.9 ttmt -116.13 132.97 56.51 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.454 ' H ' ' HB3' ' A' ' 45' ' ' SER . 46.3 ttp180 -102.77 118.25 36.42 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 64.6 m -120.14 170.23 9.5 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.2 pt -128.63 141.7 45.88 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.536 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 37.1 tt0 -113.02 122.62 48.15 Favored 'General case' 0 C--N 1.268 -2.967 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.483 ' OG1' ' HG2' ' A' ' 118' ' ' LYS . 30.8 p -76.4 -179.19 5.0 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -177.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -59.07 -29.72 67.54 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.31 0.576 . . . . 0.0 110.38 177.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -76.96 -9.1 58.46 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.782 -175.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.66 8.71 84.24 Favored Glycine 0 N--CA 1.421 -2.307 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.14 -176.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.483 ' HG2' ' OG1' ' A' ' 114' ' ' THR . 9.4 ptpp? -84.02 138.38 33.12 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 26.1 t -107.07 112.09 38.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.584 0.707 . . . . 0.0 111.356 -174.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -101.02 153.04 19.88 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 177.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 85.6 m . . . . . 0 C--N 1.294 -1.821 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.331 -175.775 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.458 ' CD2' ' HB3' ' A' ' 71' ' ' PRO . 4.7 m-85 . . . . . 0 CA--C 1.508 -0.641 0 CA-C-O 121.955 0.883 . . . . 0.0 110.289 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.1 m -126.98 153.54 45.75 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.196 -1.366 . . . . 0.0 107.976 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.596 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 53.0 tp -111.58 130.1 55.85 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 107.024 -1.472 . . . . 0.0 107.024 175.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.517 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 73.3 mt-30 -117.42 124.01 47.8 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.701 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.0 mp -110.47 121.93 46.5 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.163 178.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -87.8 151.92 22.51 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 123.577 0.548 . . . . 0.0 110.45 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -74.77 -39.98 61.47 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.091 -178.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -108.46 178.37 4.51 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.46 HG22 ' HA ' ' A' ' 96' ' ' ASP . 2.2 p -80.71 173.38 12.66 Favored 'General case' 0 N--CA 1.413 -2.31 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.594 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.276 21.6 p90 47.11 43.23 14.05 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 124.731 1.212 . . . . 0.0 114.231 177.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 65.97 23.11 11.23 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 124.379 1.072 . . . . 0.0 112.044 175.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.435 ' HA ' ' NE ' ' A' ' 36' ' ' ARG . 5.6 mmp_? -100.48 167.85 10.11 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.385 0.612 . . . . 0.0 112.279 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.02 -166.26 48.3 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -175.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.7 m -90.88 175.37 7.01 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.425 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 37.6 p90 -137.17 165.08 26.95 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 16.7 tt -114.6 152.61 16.21 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 176.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -107.05 124.95 50.39 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 175.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.55 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 94.2 t -114.03 133.64 59.4 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.555 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 177.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -115.06 -33.54 5.36 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.468 0.651 . . . . 0.0 110.028 -174.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.92 161.44 25.38 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.692 -177.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 p -75.72 149.25 38.09 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.465 0.65 . . . . 0.0 112.102 -176.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.409 HG12 ' HB ' ' A' ' 108' ' ' ILE . 10.6 p -121.18 137.38 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.98 -18.9 35.51 Favored Glycine 0 C--N 1.299 -1.478 0 C-N-CA 120.13 -1.033 . . . . 0.0 112.617 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.1 t -159.52 131.38 6.33 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 121.032 0.444 . . . . 0.0 110.159 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 91.1 mt -119.65 118.02 29.84 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.653 177.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 29.2 t -132.77 114.07 14.09 Favored Pre-proline 0 N--CA 1.419 -2.017 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 174.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 60.0 Cg_endo -74.81 161.87 93.88 Favored 'Cis proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.997 -1.668 . . . . 0.0 110.417 -2.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -63.18 156.08 57.54 Favored 'Trans proline' 0 C--O 1.257 1.441 0 C-N-CA 121.85 1.7 . . . . 0.0 110.636 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.481 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 45.5 m0 -89.1 135.4 33.58 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -177.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 15.3 p -116.18 76.58 6.73 Favored Pre-proline 0 C--N 1.292 -1.918 0 O-C-N 123.362 0.413 . . . . 0.0 111.318 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.434 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 85.6 Cg_endo -77.12 157.6 33.94 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 122.5 2.133 . . . . 0.0 112.903 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.69 -33.4 10.09 Favored Glycine 0 N--CA 1.431 -1.665 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.7 p -154.27 144.95 22.4 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.418 HG11 HD11 ' A' ' 75' ' ' LEU . 32.2 t -119.95 142.8 33.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 33.6 t -145.4 147.5 32.32 Favored 'General case' 0 N--CA 1.422 -1.84 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.228 177.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 80.5 t -111.35 122.3 37.97 Favored Pre-proline 0 C--N 1.296 -1.743 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 176.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -58.78 149.23 78.99 Favored 'Trans proline' 0 C--O 1.243 0.764 0 C-N-CA 122.892 2.395 . . . . 0.0 112.246 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -79.02 135.3 36.85 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 82.3 t -113.48 114.06 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 CA-C-O 120.981 0.42 . . . . 0.0 110.348 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -109.35 84.33 1.91 Allowed 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 173.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.7 ' OD1' ' HG2' ' A' ' 67' ' ' LYS . 12.0 t70 -128.27 145.97 50.89 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.633 -172.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.2 m -53.84 -19.52 4.52 Favored 'General case' 0 CA--C 1.59 2.513 0 C-N-CA 125.121 1.368 . . . . 0.0 113.298 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.7 ' HG2' ' OD1' ' A' ' 65' ' ' ASP . 23.5 mmtp -64.13 176.63 0.96 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.724 -0.61 . . . . 0.0 112.272 178.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 66.8 mtm180 -102.68 -29.13 11.71 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.94 0.876 . . . . 0.0 109.642 -176.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.0 134.55 50.75 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.783 -173.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.661 ' NH2' ' HB2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -104.38 153.93 38.71 Favored Pre-proline 0 C--N 1.297 -1.696 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.185 -179.231 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.458 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 93.3 Cg_endo -77.4 140.73 19.58 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.615 1.543 . . . . 0.0 112.122 178.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -133.49 133.78 42.66 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 -178.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.596 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 83.2 m95 -117.3 135.45 53.82 Favored 'General case' 0 C--N 1.288 -2.092 0 O-C-N 121.731 -0.605 . . . . 0.0 112.39 -172.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.424 ' HA ' ' O ' ' A' ' 86' ' ' THR . 33.4 m-85 -113.05 141.93 46.3 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.91 177.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.418 HD11 HG11 ' A' ' 58' ' ' VAL . 19.2 mt -126.11 142.53 51.48 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -177.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.521 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 86.3 m-85 -133.59 141.92 47.89 Favored 'General case' 0 C--N 1.316 -0.884 0 O-C-N 123.72 0.638 . . . . 0.0 110.055 -177.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.438 ' HB3' ' CG ' ' A' ' 102' ' ' PHE . 0.8 OUTLIER -85.45 0.09 53.31 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -178.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -137.73 159.7 41.26 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 174.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.476 HG23 HD22 ' A' ' 80' ' ' ASN . 22.7 m -70.96 166.32 2.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 C-N-CA 122.626 0.37 . . . . 0.0 111.656 -174.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.476 HD22 HG23 ' A' ' 79' ' ' VAL . 56.1 m-80 58.07 30.8 19.82 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.798 0.839 . . . . 0.0 111.769 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.464 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 12.6 m-85 60.13 44.66 12.68 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.421 176.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 74.9 p -115.57 168.28 10.15 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.26 -141.4 17.49 Favored Glycine 0 N--CA 1.426 -2.021 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.807 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.521 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 57.1 mtt180 -77.33 135.85 38.41 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 123.083 0.553 . . . . 0.0 109.771 -177.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.8 tt -115.24 136.75 50.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.348 -175.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 96.9 m -131.9 123.2 26.98 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.172 176.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -110.06 123.89 6.9 Favored Glycine 0 N--CA 1.438 -1.183 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.362 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.417 HD21 HD11 ' A' ' 94' ' ' ILE . 3.3 mm? -115.77 145.66 42.61 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 123.159 0.584 . . . . 0.0 110.511 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.54 167.46 12.53 Favored Glycine 0 N--CA 1.423 -2.218 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.711 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -55.75 125.42 21.15 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 123.815 0.846 . . . . 0.0 112.429 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.16 3.82 84.63 Favored Glycine 0 N--CA 1.431 -1.675 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.336 176.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.9 m -113.57 146.53 39.55 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.4 m -136.75 158.0 45.45 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.417 HD11 HD21 ' A' ' 88' ' ' LEU . 56.1 mt -93.4 132.44 37.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 173.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -70.02 -47.42 62.17 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.605 0.717 . . . . 0.0 110.14 -176.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.46 ' HA ' HG22 ' A' ' 33' ' ' THR . 5.6 m-20 -138.89 102.65 4.61 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 176.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.432 ' HZ ' ' CE2' ' A' ' 102' ' ' PHE . 59.3 t80 -64.66 -32.68 74.46 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.402 0.62 . . . . 0.0 110.399 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.9 t -63.54 -24.94 68.02 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.721 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.454 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 31.8 mmtp -93.67 -5.81 47.76 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 121.308 0.575 . . . . 0.0 109.572 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.8 t -84.71 31.17 0.54 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.302 0.641 . . . . 0.0 110.439 -177.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.7 -71.91 1.73 Allowed Glycine 0 N--CA 1.437 -1.288 0 C-N-CA 121.263 -0.494 . . . . 0.0 111.972 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.438 ' CG ' ' HB3' ' A' ' 77' ' ' ASP . 35.0 p90 -109.96 148.37 31.75 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.577 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.43 -6.99 13.47 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.738 179.668 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -116.95 116.59 3.59 Favored Glycine 0 N--CA 1.429 -1.831 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.377 -176.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 64.9 mt -94.78 115.83 34.6 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.675 0 CA-C-O 122.342 1.068 . . . . 0.0 108.888 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.4 m -85.45 -25.07 27.16 Favored 'General case' 0 N--CA 1.39 -3.436 0 CA-C-N 112.425 -2.171 . . . . 0.0 114.252 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.5 p -158.0 152.88 25.22 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 122.076 -0.39 . . . . 0.0 110.014 176.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.409 ' HB ' HG12 ' A' ' 46' ' ' VAL . 44.8 mt -130.97 131.04 64.32 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -176.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.464 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 36.1 ttmt -116.53 132.82 56.58 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -100.19 129.95 46.27 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 66.7 m -131.0 172.15 12.4 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.7 pt -127.51 140.7 48.39 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -109.16 119.7 40.32 Favored 'General case' 0 C--N 1.276 -2.61 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 71.3 p -74.0 173.6 9.78 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.808 -175.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -66.92 -19.04 65.65 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 121.842 0.83 . . . . 0.0 109.652 175.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -84.68 -8.14 58.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.801 0.81 . . . . 0.0 110.354 177.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.99 -11.53 71.87 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 120.843 -0.694 . . . . 0.0 113.08 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -71.93 134.69 46.15 Favored 'General case' 0 C--O 1.254 1.342 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.7 t -99.51 111.85 30.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -95.29 134.93 37.51 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 48.8 m . . . . . 0 C--N 1.288 -2.103 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 178.782 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 . . . . . 0 CA--C 1.493 -1.246 0 CA-C-O 122.315 1.055 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.545 ' SG ' ' HG3' ' A' ' 61' ' ' PRO . 3.9 p -144.74 160.16 41.68 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 113.681 -1.599 . . . . 0.0 109.82 -178.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.631 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 54.3 tp -111.93 118.53 35.75 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 173.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 66.7 mt-30 -109.33 123.65 49.64 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.251 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.454 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 2.9 mp -110.35 121.73 46.0 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.672 177.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.443 ' CD1' ' HB3' ' A' ' 39' ' ' TYR . 90.4 m-85 -93.12 157.26 16.38 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 123.609 0.568 . . . . 0.0 111.781 -175.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -81.14 -35.13 31.91 Favored 'General case' 0 CA--C 1.494 -1.175 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.865 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -108.23 178.09 4.61 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.469 HG22 ' HA ' ' A' ' 96' ' ' ASP . 3.3 p -81.39 172.07 14.0 Favored 'General case' 0 N--CA 1.401 -2.899 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.35 178.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 21.2 p90 47.26 38.93 7.75 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.892 1.277 . . . . 0.0 114.205 176.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 65.41 22.41 11.94 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.551 1.541 . . . . 0.0 114.506 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.18 173.62 7.63 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.255 0.55 . . . . 0.0 111.485 175.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.18 -152.75 34.87 Favored Glycine 0 N--CA 1.426 -2.021 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 -174.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.7 m -108.78 178.51 4.46 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 173.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.443 ' HB3' ' CD1' ' A' ' 30' ' ' TYR . 29.9 p90 -143.53 166.79 23.82 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.095 0.474 . . . . 0.0 110.157 -177.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.0 tt -114.53 152.81 16.13 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.545 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 176.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -106.84 125.54 51.14 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 176.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.494 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 99.4 t -122.6 134.55 65.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -126.09 -2.85 7.02 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.771 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -139.44 162.54 34.8 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -173.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.45 ' HB3' ' H ' ' A' ' 110' ' ' ARG . 2.8 p -84.42 144.86 28.5 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-O 120.991 0.424 . . . . 0.0 111.599 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.7 p -119.78 137.72 52.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.68 -21.63 30.81 Favored Glycine 0 N--CA 1.433 -1.526 0 C-N-CA 120.072 -1.061 . . . . 0.0 112.389 -177.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.0 p -157.79 129.04 6.66 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-O 121.07 0.462 . . . . 0.0 112.014 -178.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.1 mt -118.5 118.47 31.8 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 175.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 38.5 m -132.27 114.61 14.84 Favored Pre-proline 0 C--N 1.299 -1.6 0 O-C-N 123.393 0.433 . . . . 0.0 110.08 175.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 6.2 Cg_exo -76.91 159.41 95.99 Favored 'Cis proline' 0 C--O 1.246 0.899 0 C-N-CA 122.944 -1.69 . . . . 0.0 110.371 -1.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -62.34 157.66 44.45 Favored 'Trans proline' 0 C--O 1.252 1.209 0 C-N-CA 122.482 2.121 . . . . 0.0 111.349 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.428 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 48.8 m0 -89.47 140.27 29.69 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -177.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.613 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 35.5 p -123.8 73.78 54.68 Favored Pre-proline 0 C--N 1.305 -1.364 0 O-C-N 123.46 0.475 . . . . 0.0 110.561 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.454 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 81.6 Cg_endo -74.2 156.5 46.63 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 122.354 2.036 . . . . 0.0 113.653 -178.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -83.77 -34.28 19.29 Favored Glycine 0 N--CA 1.431 -1.633 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 177.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.0 p -153.83 154.97 34.92 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.3 t -130.45 142.31 44.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 35.5 t -146.07 152.32 39.14 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.696 176.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 95.4 t -117.2 125.21 28.38 Favored Pre-proline 0 C--N 1.313 -0.991 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 176.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.545 ' HG3' ' SG ' ' A' ' 26' ' ' CYS . 5.9 Cg_exo -49.68 141.31 27.49 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 123.471 2.78 . . . . 0.0 113.288 178.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -75.24 113.47 12.64 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 121.676 0.75 . . . . 0.0 109.868 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.468 ' H ' ' HB2' ' A' ' 90' ' ' HIS . 78.4 t -94.54 125.31 47.18 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.513 -179.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -127.88 12.16 6.71 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 124.428 1.08 . . . . 0.0 108.696 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -57.93 147.04 30.18 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.464 1.506 . . . . 0.0 113.28 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.3 m -53.59 -12.9 0.54 Allowed 'General case' 0 CA--C 1.579 2.071 0 C-N-CA 125.568 1.547 . . . . 0.0 112.179 178.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -58.42 161.39 4.48 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.669 1.188 . . . . 0.0 111.182 175.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.78 -28.25 16.69 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -178.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.67 140.77 43.12 Favored 'General case' 0 N--CA 1.417 -2.098 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.631 -174.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -105.99 154.22 39.65 Favored Pre-proline 0 C--N 1.289 -2.027 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.406 ' CD ' HG21 ' A' ' 63' ' ' VAL . 85.0 Cg_endo -81.71 135.18 8.9 Favored 'Trans proline' 0 N--CA 1.44 -1.644 0 C-N-CA 121.309 1.34 . . . . 0.0 110.888 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -128.76 123.54 33.22 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 -177.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.631 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 83.4 m95 -109.33 135.35 50.54 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-O 120.759 0.314 . . . . 0.0 111.843 -172.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 86' ' ' THR . 39.8 m-85 -113.59 141.85 46.68 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.023 177.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.6 mt -125.37 142.2 51.64 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 -176.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.44 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 80.8 m-85 -131.3 141.49 49.96 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 123.468 0.48 . . . . 0.0 110.49 -176.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.58 -21.76 51.96 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.525 -177.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.498 ' C ' ' HB3' ' A' ' 106' ' ' SER . 8.6 t-20 -118.76 168.33 10.84 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.405 HG23 HD22 ' A' ' 80' ' ' ASN . 33.6 m -73.94 168.96 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 C-N-CA 122.575 0.35 . . . . 0.0 110.298 -179.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.405 HD22 HG23 ' A' ' 79' ' ' VAL . 36.5 m-80 55.48 30.42 15.07 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.447 0.699 . . . . 0.0 112.605 178.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.445 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 9.3 m-85 58.96 45.85 14.43 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 124.755 1.222 . . . . 0.0 111.316 176.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.7 p -117.33 167.45 11.23 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.186 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.93 -134.19 12.32 Favored Glycine 0 N--CA 1.424 -2.13 0 N-CA-C 111.344 -0.703 . . . . 0.0 111.344 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.44 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 64.1 mtm180 -81.17 151.39 28.24 Favored 'General case' 0 C--N 1.287 -2.124 0 C-N-CA 123.611 0.764 . . . . 0.0 110.977 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.4 tt -130.5 137.18 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-O 121.275 0.559 . . . . 0.0 110.303 -176.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 98.4 m -132.38 120.51 22.13 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.906 175.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -108.01 127.8 8.85 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.211 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.49 HD21 HD11 ' A' ' 94' ' ' ILE . 3.3 mm? -118.21 145.5 44.93 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 123.074 0.55 . . . . 0.0 110.793 178.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.75 172.93 14.45 Favored Glycine 0 N--CA 1.433 -1.563 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.455 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.468 ' HB2' ' H ' ' A' ' 63' ' ' VAL . 3.0 p80 -61.65 122.32 15.0 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 123.293 0.637 . . . . 0.0 112.287 -175.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.2 2.13 80.73 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.821 176.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.1 m -110.36 146.13 36.33 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.4 m -140.37 154.5 46.74 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.49 HD11 HD21 ' A' ' 88' ' ' LEU . 52.2 mt -93.21 128.79 44.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 173.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -70.26 -47.37 61.59 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 123.539 0.525 . . . . 0.0 110.111 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.616 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 1.6 m-20 -132.97 91.83 2.94 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.761 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -65.46 -33.13 75.22 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.483 0.658 . . . . 0.0 109.429 176.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.7 t -64.31 -28.79 69.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.358 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.616 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 32.2 mmtp -89.57 -6.79 55.97 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 120.61 0.243 . . . . 0.0 110.499 -176.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.3 m -82.21 -175.12 5.5 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.064 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -52.86 -64.11 4.41 Favored Glycine 0 C--N 1.334 0.422 0 O-C-N 123.136 0.272 . . . . 0.0 113.215 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -110.94 143.14 42.07 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 122.505 -0.409 . . . . 0.0 110.462 176.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.613 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -108.93 -9.93 15.1 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.201 -1.036 . . . . 0.0 108.201 175.092 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -108.68 114.01 3.95 Favored Glycine 0 N--CA 1.433 -1.535 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.188 -177.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 71.6 mt -96.92 115.57 36.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.498 ' HB3' ' C ' ' A' ' 78' ' ' ASN . 1.1 t -86.67 -26.48 24.3 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.497 178.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.3 p -150.95 156.68 41.67 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 122.158 -0.339 . . . . 0.0 110.324 178.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.2 mt -135.13 132.28 52.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -176.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.445 ' HE2' ' CD2' ' A' ' 81' ' ' TYR . 32.3 ttmt -117.65 133.92 55.44 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.45 ' H ' ' HB3' ' A' ' 45' ' ' SER . 24.6 ttp180 -102.77 127.73 49.81 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 66.2 m -127.16 171.98 10.95 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.0 pt -129.66 144.87 36.76 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.146 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 177.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.481 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 61.8 tt0 -119.18 122.48 42.1 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 63.4 p -75.35 174.06 10.06 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.404 -175.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -66.36 -28.18 68.46 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.664 0.745 . . . . 0.0 109.525 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -77.12 -7.11 55.2 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.307 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.04 -1.74 61.15 Favored Glycine 0 N--CA 1.438 -1.192 0 N-CA-C 115.534 0.974 . . . . 0.0 115.534 171.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 113' ' ' GLN . 18.5 ptpt -83.73 140.65 31.98 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 118.78 1.29 . . . . 0.0 110.9 -177.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.4 t -101.81 112.06 33.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -99.4 144.79 28.11 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 124.27 1.028 . . . . 0.0 108.241 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 72.8 m . . . . . 0 C--N 1.303 -1.424 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.597 -174.776 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.43 ' CZ ' ' HD3' ' A' ' 71' ' ' PRO . 9.1 m-85 . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 121.137 0.494 . . . . 0.0 112.006 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 63.5 m -123.32 149.63 44.61 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.591 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 49.1 tp -95.62 112.76 24.41 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 174.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.526 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 17.7 mt-30 -111.46 123.17 49.67 Favored 'General case' 0 N--CA 1.422 -1.852 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.745 -177.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.451 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 2.7 mp -110.97 124.71 52.67 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.87 -178.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.416 ' CE1' ' HG2' ' A' ' 35' ' ' GLU . 96.4 m-85 -90.45 155.38 18.96 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 122.623 0.369 . . . . 0.0 110.577 -178.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -75.18 -40.94 58.98 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.897 0.856 . . . . 0.0 109.943 -176.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.483 ' HB2' ' HG3' ' A' ' 36' ' ' ARG . 24.8 mm-40 -108.46 179.01 4.32 Favored 'General case' 0 N--CA 1.421 -1.918 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.403 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.513 HG22 ' HA ' ' A' ' 96' ' ' ASP . 0.8 OUTLIER -81.11 174.94 11.09 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.504 -177.093 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 47.07 34.03 2.64 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 174.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.416 ' HG2' ' CE1' ' A' ' 30' ' ' TYR . 36.1 mt-10 65.35 22.78 12.03 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 124.485 1.114 . . . . 0.0 113.919 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.483 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 35.7 ptt180 -97.71 157.52 16.01 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 118.694 -1.202 . . . . 0.0 108.87 174.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.4 -178.65 41.62 Favored Glycine 0 N--CA 1.424 -2.105 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -175.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.0 m -89.59 169.13 11.59 Favored 'General case' 0 C--N 1.286 -2.163 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.553 177.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.435 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 21.8 p90 -131.78 165.88 22.8 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.466 -177.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 15.0 tt -113.87 150.55 15.88 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -106.59 125.15 50.64 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.503 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 88.4 t -123.97 133.88 68.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -117.46 -31.57 5.2 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -176.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.542 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 11.2 mmpt? -103.56 161.98 13.43 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.914 -173.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.9 p -88.99 143.03 27.14 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 172.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.5 p -121.31 131.05 73.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -177.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.77 -15.25 56.89 Favored Glycine 0 C--N 1.298 -1.53 0 C-N-CA 119.851 -1.166 . . . . 0.0 113.03 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.5 p -154.38 123.98 6.59 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.439 0.637 . . . . 0.0 112.415 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 88.4 mt -116.45 118.71 33.42 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.202 177.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 25.0 p -131.88 107.51 14.0 Favored Pre-proline 0 C--N 1.3 -1.549 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.64 175.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 72.8 Cg_endo -77.93 162.22 89.86 Favored 'Cis proline' 0 C--O 1.249 1.068 0 C-N-CA 123.861 -1.308 . . . . 0.0 111.801 0.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.52 154.58 73.07 Favored 'Trans proline' 0 C--O 1.25 1.123 0 C-N-CA 122.125 1.883 . . . . 0.0 110.586 176.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 49.3 m0 -90.23 137.6 32.21 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 20.5 p -121.22 79.41 35.34 Favored Pre-proline 0 N--CA 1.425 -1.688 0 O-C-N 123.258 0.349 . . . . 0.0 111.027 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.451 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 85.4 Cg_endo -77.16 158.49 33.74 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.884 2.389 . . . . 0.0 112.789 178.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.32 -29.82 9.21 Favored Glycine 0 N--CA 1.43 -1.701 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.1 p -150.96 152.61 33.81 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.411 HG22 HD23 ' A' ' 29' ' ' LEU . 40.5 t -126.71 142.99 41.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -178.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 17.3 t -145.46 138.48 26.19 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 118.525 0.602 . . . . 0.0 110.109 -176.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.7 t -118.33 125.38 27.9 Favored Pre-proline 0 C--O 1.249 1.056 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -62.1 147.16 95.62 Favored 'Trans proline' 0 C--O 1.249 1.061 0 C-N-CA 122.775 2.317 . . . . 0.0 111.031 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.612 ' CE2' ' HB3' ' A' ' 64' ' ' ASN . 34.7 t80 -74.49 136.31 42.24 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-O 121.95 0.881 . . . . 0.0 111.111 -176.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 98.4 t -118.61 115.08 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.166 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.612 ' HB3' ' CE2' ' A' ' 62' ' ' PHE . 24.5 p-10 -121.67 13.44 10.82 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 123.045 1.402 . . . . 0.0 107.332 178.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.74 146.44 41.47 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 111.737 -2.483 . . . . 0.0 111.483 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.4 m -57.46 -8.22 0.77 Allowed 'General case' 0 CA--C 1.579 2.073 0 C-N-CA 124.69 1.196 . . . . 0.0 112.004 177.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -62.49 136.65 58.0 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.104 0.961 . . . . 0.0 108.731 177.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.539 ' HB2' ' OE1' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -84.24 -28.82 26.98 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -177.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.539 ' OE1' ' HB2' ' A' ' 68' ' ' ARG . 3.0 mp0 -97.25 125.08 41.58 Favored 'General case' 0 N--CA 1.415 -2.184 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.484 ' HG2' ' CE1' ' A' ' 90' ' ' HIS . 0.6 OUTLIER -106.75 152.09 40.71 Favored Pre-proline 0 C--N 1.291 -1.955 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.593 179.111 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.43 ' HD3' ' CZ ' ' A' ' 25' ' ' TYR . 74.1 Cg_endo -76.98 134.09 14.3 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 121.089 1.193 . . . . 0.0 110.542 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -133.5 132.82 41.45 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.591 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 89.5 m95 -119.48 133.15 55.82 Favored 'General case' 0 C--N 1.284 -2.275 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.915 -172.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.525 ' HA ' ' O ' ' A' ' 86' ' ' THR . 35.7 m-85 -112.98 141.39 46.87 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.368 177.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.8 mt -125.92 142.16 51.64 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -176.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.544 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 80.2 m-85 -134.45 142.68 47.18 Favored 'General case' 0 CA--C 1.502 -0.874 0 O-C-N 123.796 0.685 . . . . 0.0 110.117 -176.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.409 ' HB3' ' CD1' ' A' ' 102' ' ' PHE . 2.9 p-10 -84.38 -5.82 59.32 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.476 ' C ' ' HB3' ' A' ' 106' ' ' SER . 4.4 t-20 -127.28 167.77 15.67 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 174.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.4 m -73.52 167.37 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 C-N-CA 122.581 0.352 . . . . 0.0 111.627 -176.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 55.92 31.53 18.03 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.237 -0.892 . . . . 0.0 113.226 176.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 62.82 42.83 7.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.857 175.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 69.3 p -118.38 161.7 19.53 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.093 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.98 -144.06 17.12 Favored Glycine 0 N--CA 1.425 -2.065 0 N-CA-C 111.668 -0.573 . . . . 0.0 111.668 177.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.544 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 54.9 mtt180 -72.41 142.84 48.69 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.3 tt -125.4 136.43 60.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-O 121.487 0.66 . . . . 0.0 111.241 -173.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 86.7 m -131.57 123.04 27.1 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.34 176.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -113.69 120.06 5.0 Favored Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.531 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.465 HD21 HD11 ' A' ' 94' ' ' ILE . 3.3 mm? -110.35 147.76 33.29 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 123.673 0.789 . . . . 0.0 111.0 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -121.36 168.41 14.31 Favored Glycine 0 N--CA 1.425 -2.047 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.204 -178.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.484 ' CE1' ' HG2' ' A' ' 70' ' ' ARG . 2.9 p80 -55.12 121.89 9.78 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 124.066 0.946 . . . . 0.0 112.139 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.18 12.37 73.76 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.064 176.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.0 m -125.48 145.9 49.88 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 177.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 22.5 m -144.2 155.84 44.05 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -178.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.465 HD11 HD21 ' A' ' 88' ' ' LEU . 48.7 mt -93.45 125.61 46.0 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.45 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -70.22 -46.76 63.86 Favored 'General case' 0 C--N 1.288 -2.071 0 O-C-N 123.812 0.695 . . . . 0.0 110.353 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.587 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 3.3 m-20 -132.88 93.55 3.22 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.231 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.407 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 54.3 t80 -64.94 -31.66 73.0 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.431 0.634 . . . . 0.0 110.508 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.7 t -63.49 -23.2 67.29 Favored 'General case' 0 CA--C 1.561 1.375 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.631 -178.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.587 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 30.4 mmtp -92.78 -6.31 49.24 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.925 -0.485 . . . . 0.0 109.765 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.8 m -84.85 13.46 5.86 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.379 0.609 . . . . 0.0 111.786 -177.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 104.72 -79.07 0.28 Allowed Glycine 0 N--CA 1.425 -2.05 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.68 178.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.409 ' CD1' ' HB3' ' A' ' 77' ' ' ASP . 27.5 p90 -100.11 147.13 26.0 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -178.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.548 ' H ' ' HD3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -113.3 -14.22 12.84 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.18 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -103.02 110.4 3.71 Favored Glycine 0 N--CA 1.422 -2.271 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.489 -175.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 80.5 mt -93.32 115.65 32.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.476 ' HB3' ' C ' ' A' ' 78' ' ' ASN . 5.3 t -85.99 -29.01 23.85 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.502 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 90.1 p -150.34 156.33 41.31 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.752 -0.203 . . . . 0.0 110.818 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.7 mt -134.01 132.41 56.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -176.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -116.38 131.58 56.91 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -99.5 129.6 45.69 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . 0.422 ' SG ' ' HD2' ' A' ' 74' ' ' TYR . 62.6 m -128.51 172.38 11.21 Favored 'General case' 0 N--CA 1.413 -2.3 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.329 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 70' ' ' ARG . 7.1 pt -131.48 141.98 44.43 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 C-N-CA 123.172 0.589 . . . . 0.0 110.039 177.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.42 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 52.6 tt0 -113.69 119.11 36.3 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 33.8 p -80.19 -178.37 6.54 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.45 -172.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -66.1 -28.85 69.13 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.769 0.795 . . . . 0.0 109.636 177.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -80.1 -6.46 57.73 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.422 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.97 6.17 82.55 Favored Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 115.969 -0.56 . . . . 0.0 113.77 175.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 113' ' ' GLN . 66.0 pttt -82.16 145.08 30.3 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.829 178.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 25.5 t -104.12 111.52 34.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -97.12 144.24 27.16 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 96.8 m . . . . . 0 C--N 1.289 -2.055 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.297 -173.953 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 . . . . . 0 N--CA 1.468 0.463 0 CA-C-O 121.246 0.546 . . . . 0.0 111.718 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.6 m -122.73 145.07 48.73 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.517 HD22 ' CE3' ' A' ' 73' ' ' TRP . 51.5 tp -96.24 116.24 28.69 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 174.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 37.3 mt-30 -108.98 124.21 50.34 Favored 'General case' 0 N--CA 1.428 -1.572 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.315 -177.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.496 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.7 mp -109.66 118.91 37.8 Favored 'General case' 0 N--CA 1.408 -2.526 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.46 177.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.438 ' CD2' ' HB3' ' A' ' 39' ' ' TYR . 95.4 m-85 -87.51 150.3 23.82 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.508 -176.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -72.09 -44.1 63.76 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.835 -175.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -109.8 178.05 4.54 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.902 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.455 HG22 ' HA ' ' A' ' 96' ' ' ASP . 1.9 p -76.74 170.57 16.22 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-O 119.785 -0.15 . . . . 0.0 111.002 -177.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 14.9 p90 47.41 37.05 5.58 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.899 1.28 . . . . 0.0 114.086 177.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 67.72 26.21 7.89 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.615 1.166 . . . . 0.0 112.853 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.471 ' CZ ' ' HB3' ' A' ' 36' ' ' ARG . 8.5 mtp-105 -90.89 162.49 14.76 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 176.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.22 -158.94 36.71 Favored Glycine 0 N--CA 1.424 -2.134 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.3 p -96.44 177.41 5.69 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 174.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.438 ' HB3' ' CD2' ' A' ' 30' ' ' TYR . 38.1 p90 -138.55 166.83 23.32 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.8 tt -113.42 151.56 15.26 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 177.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -106.13 124.87 50.26 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.449 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 92.4 t -123.52 133.55 68.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -122.09 -6.01 8.94 Favored 'General case' 0 C--N 1.31 -1.118 0 O-C-N 123.616 0.573 . . . . 0.0 110.85 -174.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -137.1 162.34 33.66 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.161 -173.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.44 ' HB3' ' H ' ' A' ' 110' ' ' ARG . 3.9 p -86.77 140.2 29.97 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 175.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.2 p -119.53 134.37 63.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -175.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.76 -15.73 48.23 Favored Glycine 0 C--N 1.301 -1.394 0 C-N-CA 120.417 -0.897 . . . . 0.0 113.195 -176.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.7 t -156.61 127.54 6.83 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.442 0.639 . . . . 0.0 111.182 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.5 mt -121.34 117.93 28.19 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.073 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.0 m -132.55 115.41 14.73 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 174.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -75.12 161.92 93.81 Favored 'Cis proline' 0 C--O 1.25 1.089 0 C-N-CA 123.033 -1.653 . . . . 0.0 110.788 -2.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -61.98 156.7 47.8 Favored 'Trans proline' 0 C--O 1.256 1.403 0 C-N-CA 122.129 1.886 . . . . 0.0 110.417 178.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.426 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 45.8 m0 -89.33 135.97 33.29 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -176.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 34.1 p -115.65 81.41 9.15 Favored Pre-proline 0 C--N 1.301 -1.5 0 O-C-N 123.369 0.418 . . . . 0.0 111.165 178.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.496 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 81.3 Cg_endo -81.5 157.7 19.28 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 122.239 1.959 . . . . 0.0 112.583 176.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.06 -30.24 11.42 Favored Glycine 0 N--CA 1.43 -1.747 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 177.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.8 p -155.13 153.52 30.93 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.6 t -130.28 142.7 43.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 49.1 t -145.8 148.12 32.58 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.373 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.422 ' HB ' ' O ' ' A' ' 89' ' ' GLY . 58.7 t -117.39 122.65 30.75 Favored Pre-proline 0 C--N 1.31 -1.133 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 175.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.44 156.39 63.73 Favored 'Trans proline' 0 C--O 1.25 1.075 0 C-N-CA 122.726 2.284 . . . . 0.0 112.577 -177.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -72.84 135.3 45.16 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.386 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 98.4 t -112.19 115.58 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.265 0 CA-C-O 121.743 0.782 . . . . 0.0 111.763 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -112.51 74.54 0.87 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 173.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.432 ' HB3' ' NH2' ' A' ' 70' ' ' ARG . 14.6 t70 -126.99 145.95 50.52 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.191 -170.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -54.37 -18.53 4.21 Favored 'General case' 0 CA--C 1.578 2.044 0 C-N-CA 125.803 1.641 . . . . 0.0 114.429 -178.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.57 ' HB2' ' NH2' ' A' ' 70' ' ' ARG . 75.8 mmtt -65.56 173.79 2.56 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.561 -0.712 . . . . 0.0 111.261 175.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -102.7 -26.82 13.04 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 176.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -92.73 132.31 37.05 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.542 -176.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.57 ' NH2' ' HB2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -104.92 149.77 37.93 Favored Pre-proline 0 C--N 1.3 -1.545 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.626 176.379 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.17 136.18 17.81 Favored 'Trans proline' 0 C--N 1.321 -0.909 0 C-N-CA 121.907 1.738 . . . . 0.0 112.314 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -133.09 130.55 39.46 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.517 ' CE3' HD22 ' A' ' 27' ' ' LEU . 84.4 m95 -116.2 136.91 52.59 Favored 'General case' 0 C--N 1.286 -2.158 0 O-C-N 121.631 -0.668 . . . . 0.0 111.904 -172.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 86' ' ' THR . 41.4 m-85 -115.04 142.3 46.83 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 123.051 0.54 . . . . 0.0 110.426 177.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.8 mt -125.71 142.96 51.25 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -175.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 84.3 m-85 -133.23 145.18 50.31 Favored 'General case' 0 C--O 1.241 0.616 0 O-C-N 123.578 0.549 . . . . 0.0 110.666 -176.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.54 -3.56 58.9 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.794 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.466 ' HA ' HD22 ' A' ' 78' ' ' ASN . 2.1 t-20 -133.26 157.06 46.38 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 119.851 -0.739 . . . . 0.0 109.283 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.492 HG23 HD22 ' A' ' 80' ' ' ASN . 33.9 m -70.81 168.31 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.455 -178.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.492 HD22 HG23 ' A' ' 79' ' ' VAL . 45.7 m-80 59.66 30.23 19.83 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.251 0.621 . . . . 0.0 110.966 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.602 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 16.5 m-85 55.21 44.03 28.33 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 124.781 1.232 . . . . 0.0 112.233 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 59.1 p -117.07 172.85 7.0 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.932 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.68 -136.17 13.5 Favored Glycine 0 N--CA 1.429 -1.767 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.357 178.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 77.6 mtt180 -79.76 153.23 29.35 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.8 tt -133.12 136.82 54.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-O 121.384 0.612 . . . . 0.0 110.785 -175.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 95.5 m -132.39 121.11 22.94 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.999 177.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -108.47 119.76 5.75 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.868 -0.682 . . . . 0.0 114.443 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.4 HD21 HD11 ' A' ' 94' ' ' ILE . 3.4 mm? -110.1 145.53 36.97 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 123.103 0.561 . . . . 0.0 110.596 178.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.422 ' O ' ' HB ' ' A' ' 60' ' ' VAL . . . -119.61 175.67 15.89 Favored Glycine 0 N--CA 1.429 -1.793 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.946 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -60.17 132.81 55.09 Favored 'General case' 0 C--O 1.247 0.95 0 C-N-CA 123.088 0.555 . . . . 0.0 111.86 -178.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.75 16.34 79.25 Favored Glycine 0 N--CA 1.437 -1.266 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.744 177.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.0 m -121.06 145.48 47.73 Favored 'General case' 0 N--CA 1.42 -1.972 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -178.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.9 m -141.98 155.43 45.45 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.4 HD11 HD21 ' A' ' 88' ' ' LEU . 47.7 mt -93.33 130.94 41.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 175.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -70.85 -48.42 54.06 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 123.586 0.554 . . . . 0.0 110.3 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.455 ' HA ' HG22 ' A' ' 33' ' ' THR . 8.2 m-20 -141.57 98.88 3.44 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -63.84 -31.86 73.18 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.481 0.658 . . . . 0.0 110.469 -178.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.9 t -63.4 -22.13 66.7 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.393 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -93.14 -11.04 33.81 Favored 'General case' 0 C--O 1.22 -0.499 0 O-C-N 121.742 -0.599 . . . . 0.0 110.416 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.1 m -78.77 -7.14 57.52 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.42 0.629 . . . . 0.0 110.579 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 123.8 -86.34 0.37 Allowed Glycine 0 N--CA 1.419 -2.478 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -85.73 139.2 31.54 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.584 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -109.43 -6.91 15.28 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.157 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -110.97 113.28 3.41 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.348 -176.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 75.0 mt -97.3 115.31 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.548 0 CA-C-O 122.687 1.232 . . . . 0.0 109.066 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.3 m -85.66 -25.31 26.64 Favored 'General case' 0 N--CA 1.393 -3.296 0 CA-C-N 111.811 -2.45 . . . . 0.0 113.935 178.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.454 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 8.5 t -159.39 153.3 23.21 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -176.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.1 mt -136.3 129.27 46.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -176.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.602 ' HE2' ' CD2' ' A' ' 81' ' ' TYR . 35.3 ttmt -117.23 133.28 56.18 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.44 ' H ' ' HB3' ' A' ' 45' ' ' SER . 55.5 ttp180 -100.49 129.85 46.49 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -178.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 71.0 m -126.34 172.0 10.5 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.4 pt -132.23 140.68 47.22 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -109.09 123.91 49.93 Favored 'General case' 0 C--N 1.266 -3.049 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 69.1 p -74.08 166.58 23.15 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.364 -175.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -67.58 -19.23 65.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 122.169 0.985 . . . . 0.0 109.075 175.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -76.93 -7.57 55.8 Favored 'General case' 0 CA--C 1.561 1.369 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.104 175.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.53 3.96 74.06 Favored Glycine 0 CA--C 1.504 -0.645 0 N-CA-C 114.828 0.691 . . . . 0.0 114.828 172.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.425 ' HE2' ' OE2' ' A' ' 120' ' ' GLU . 21.9 ptmt -94.44 139.73 30.75 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 119.138 -1.025 . . . . 0.0 109.421 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 24.2 t -95.27 111.9 26.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.394 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.425 ' OE2' ' HE2' ' A' ' 118' ' ' LYS . 6.3 mm-40 -94.96 142.69 27.19 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 72.4 m . . . . . 0 C--N 1.278 -2.525 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -177.48 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 121.045 0.45 . . . . 0.0 112.021 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.7 m -123.57 144.65 49.45 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.593 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 56.1 tp -88.73 128.28 35.62 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.439 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 48.1 mt-30 -117.23 123.42 46.58 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.222 -177.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.9 mp -110.82 120.05 41.12 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.893 177.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -89.82 150.41 22.26 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 123.735 0.647 . . . . 0.0 110.461 -176.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -75.34 -36.45 61.03 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.003 0.43 . . . . 0.0 111.17 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -107.99 177.27 4.86 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.452 HG22 ' HA ' ' A' ' 96' ' ' ASP . 1.7 p -82.43 170.45 15.26 Favored 'General case' 0 N--CA 1.407 -2.624 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 29.6 p90 46.83 44.46 14.3 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.803 1.241 . . . . 0.0 114.057 177.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 67.75 22.67 8.82 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.803 0.841 . . . . 0.0 112.615 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 37.4 mtp85 -95.17 161.02 14.29 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 177.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.31 -167.51 41.36 Favored Glycine 0 N--CA 1.423 -2.167 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.775 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 79.4 p -87.9 163.1 16.55 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 176.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 11.4 p90 -129.28 164.95 22.4 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.6 tt -114.95 153.39 16.45 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.038 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -106.75 125.47 51.05 Favored 'General case' 0 N--CA 1.422 -1.856 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 175.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.54 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 97.1 t -118.89 133.41 65.85 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 177.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -116.97 -29.83 5.88 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 123.472 0.482 . . . . 0.0 110.687 -174.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -121.59 163.27 19.2 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.031 -174.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.9 m -75.7 144.01 41.81 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 176.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.6 p -120.95 137.11 55.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.66 -18.71 31.72 Favored Glycine 0 C--N 1.307 -1.044 0 C-N-CA 119.791 -1.195 . . . . 0.0 113.02 -178.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.4 t -153.21 131.6 12.09 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-O 121.053 0.454 . . . . 0.0 110.305 -177.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.2 mt -123.25 117.68 25.86 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.58 177.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 11.0 m -132.61 111.21 13.64 Favored Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 177.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 5.1 Cg_exo -78.08 160.45 92.13 Favored 'Cis proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.109 -1.621 . . . . 0.0 110.527 -0.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.68 157.75 40.72 Favored 'Trans proline' 0 C--O 1.253 1.254 0 C-N-CA 122.126 1.884 . . . . 0.0 111.007 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.451 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 49.8 m0 -90.16 135.7 33.5 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -177.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 34.9 p -117.52 75.09 8.98 Favored Pre-proline 0 C--N 1.296 -1.751 0 O-C-N 123.387 0.429 . . . . 0.0 110.209 178.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.467 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 96.4 Cg_endo -74.73 157.81 43.63 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 122.151 1.901 . . . . 0.0 113.036 -178.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.97 -31.75 11.75 Favored Glycine 0 N--CA 1.427 -1.921 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.1 p -156.46 153.74 29.3 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.4 t -129.37 143.0 42.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 32.2 t -145.59 152.94 40.48 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.331 177.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.3 t -120.92 128.89 25.55 Favored Pre-proline 0 N--CA 1.443 -0.778 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 176.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.0 140.69 85.9 Favored 'Trans proline' 0 C--O 1.244 0.798 0 C-N-CA 123.18 2.587 . . . . 0.0 112.387 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.475 ' CE1' ' HB3' ' A' ' 64' ' ' ASN . 76.0 t80 -74.75 112.44 10.96 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-O 121.413 0.625 . . . . 0.0 110.462 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.3 t -94.16 115.57 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.148 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.485 178.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.475 ' HB3' ' CE1' ' A' ' 62' ' ' PHE . 6.4 p30 -118.88 15.69 13.43 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.194 -1.409 . . . . 0.0 107.194 177.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.652 ' OD1' ' HG2' ' A' ' 67' ' ' LYS . 8.9 t70 -66.51 147.54 53.14 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 112.358 -2.201 . . . . 0.0 109.476 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.2 m -53.13 -23.37 7.96 Favored 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 123.809 0.843 . . . . 0.0 111.812 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.652 ' HG2' ' OD1' ' A' ' 65' ' ' ASP . 42.5 mmtm -54.49 121.23 7.94 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 176.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -73.75 -25.64 60.27 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.976 -174.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -91.7 127.59 37.21 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -99.72 153.57 37.7 Favored Pre-proline 0 C--N 1.286 -2.193 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -83.22 135.18 7.19 Favored 'Trans proline' 0 N--CA 1.442 -1.503 0 C-N-CA 121.503 1.469 . . . . 0.0 111.078 176.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -130.24 132.2 45.86 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.593 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 82.2 m95 -118.78 134.14 55.35 Favored 'General case' 0 C--N 1.286 -2.185 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.831 -173.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 86' ' ' THR . 27.4 m-85 -114.47 140.8 48.42 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.327 178.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.5 mt -125.71 142.34 51.56 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -176.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.504 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 80.5 m-85 -132.84 143.04 49.27 Favored 'General case' 0 C--O 1.247 0.941 0 O-C-N 123.782 0.677 . . . . 0.0 109.791 -176.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.2 -14.75 57.23 Favored 'General case' 0 CA--C 1.491 -1.32 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.262 -178.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -122.17 166.09 15.12 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.5 m -76.29 167.78 2.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 122.747 0.419 . . . . 0.0 110.92 -175.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 56.32 30.43 16.77 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 124.136 0.974 . . . . 0.0 112.82 178.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.441 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 7.0 m-85 63.01 39.34 10.25 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 124.795 1.238 . . . . 0.0 111.198 177.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 78.8 p -112.06 165.07 12.45 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.63 -139.43 14.57 Favored Glycine 0 N--CA 1.435 -1.427 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.441 178.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 55.5 mtt180 -81.88 147.14 29.47 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 123.322 0.649 . . . . 0.0 109.81 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.8 tt -123.19 136.61 59.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-O 121.155 0.502 . . . . 0.0 110.759 -176.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 90.7 m -131.69 121.17 23.83 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.887 177.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -109.44 121.05 5.96 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.444 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.409 HD21 HD11 ' A' ' 94' ' ' ILE . 3.3 mm? -109.86 145.19 37.21 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 120.769 0.318 . . . . 0.0 110.677 178.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -117.76 171.26 13.88 Favored Glycine 0 N--CA 1.42 -2.395 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.073 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -60.88 123.01 16.3 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.722 0.772 . . . . 0.0 112.406 -177.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.31 1.78 71.59 Favored Glycine 0 N--CA 1.429 -1.798 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.961 177.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.3 m -112.43 145.95 39.25 Favored 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -178.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 4.6 m -134.3 158.45 43.73 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.409 HD11 HD21 ' A' ' 88' ' ' LEU . 55.0 mt -94.16 129.39 44.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 170.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -70.36 -46.98 63.03 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 123.597 0.561 . . . . 0.0 110.444 -178.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.618 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 2.0 m-20 -138.48 101.16 4.29 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.38 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -65.24 -38.02 89.05 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-O 120.736 0.303 . . . . 0.0 110.983 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.6 t -65.44 -28.01 68.92 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.855 -177.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.618 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 27.1 mmtp -83.64 -5.98 59.32 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.424 0.631 . . . . 0.0 109.738 -177.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 18.6 m -82.67 -168.89 2.21 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.39 -61.11 7.45 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.136 -178.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -111.26 149.54 30.89 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 122.39 0.276 . . . . 0.0 110.68 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -111.65 -7.72 14.25 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.838 177.26 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -114.93 121.4 5.31 Favored Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.374 -176.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 67.6 mt -100.95 115.99 43.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-O 122.107 0.956 . . . . 0.0 109.083 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.5 m -85.94 -28.81 24.04 Favored 'General case' 0 N--CA 1.406 -2.638 0 CA-C-N 112.716 -2.038 . . . . 0.0 114.257 176.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.9 p -154.22 154.94 34.35 Favored 'General case' 0 C--O 1.237 0.433 0 O-C-N 122.063 -0.398 . . . . 0.0 110.024 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.8 mt -134.12 133.25 55.89 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.608 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -176.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.483 ' HD3' ' HB3' ' A' ' 121' ' ' CYS . 36.2 ttmt -117.11 126.07 52.26 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -95.92 127.96 42.4 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.45 0.643 . . . . 0.0 109.487 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . 0.425 ' SG ' ' HD1' ' A' ' 74' ' ' TYR . 59.7 m -121.94 168.62 11.69 Favored 'General case' 0 N--CA 1.402 -2.868 0 CA-C-N 114.869 -1.059 . . . . 0.0 108.676 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.7 pt -128.37 143.11 42.01 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 176.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -111.21 118.45 35.96 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 63.8 p -77.34 -178.66 5.27 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.485 -171.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -62.6 -36.63 83.36 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.943 174.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.477 ' OD2' ' HG2' ' A' ' 118' ' ' LYS . 2.5 p30 -78.46 -7.06 57.01 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.867 -176.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.0 -5.6 63.62 Favored Glycine 0 CA--C 1.496 -1.123 0 CA-C-N 115.776 -0.647 . . . . 0.0 113.859 173.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.477 ' HG2' ' OD2' ' A' ' 116' ' ' ASP . 6.4 ptpp? -77.66 146.9 35.81 Favored 'General case' 0 CA--C 1.493 -1.24 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.706 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 38.2 t -103.37 111.46 33.21 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -96.99 142.16 29.28 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . 0.483 ' HB3' ' HD3' ' A' ' 109' ' ' LYS . 73.2 m . . . . . 0 C--N 1.297 -1.692 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.139 -175.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.416 ' CD1' ' HB3' ' A' ' 71' ' ' PRO . 5.5 m-85 . . . . . 0 N--CA 1.473 0.685 0 CA-C-O 121.218 0.532 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 7.7 m -124.35 145.34 49.49 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.646 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 61.3 tp -100.12 128.68 46.16 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 176.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.556 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 39.8 mt-30 -118.87 123.95 45.94 Favored 'General case' 0 CA--C 1.492 -1.266 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.534 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.488 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.0 mp -110.76 122.85 48.84 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.881 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.411 ' CD2' ' HB3' ' A' ' 39' ' ' TYR . 93.3 m-85 -92.0 149.59 21.45 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 123.327 0.392 . . . . 0.0 110.304 -178.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.54 -35.24 63.12 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.095 0.474 . . . . 0.0 111.803 -177.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -108.41 178.05 4.61 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.462 HG22 ' HA ' ' A' ' 96' ' ' ASP . 2.3 p -82.26 170.68 15.11 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.26 21.5 p90 46.85 46.71 15.45 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.289 1.036 . . . . 0.0 113.394 178.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 59.55 23.34 12.02 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.954 1.302 . . . . 0.0 114.129 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -92.01 167.37 12.14 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.623 0.725 . . . . 0.0 111.847 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.16 -164.82 46.36 Favored Glycine 0 N--CA 1.426 -1.995 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.7 m -92.71 173.66 7.65 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 175.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.411 ' HB3' ' CD2' ' A' ' 30' ' ' TYR . 18.0 p90 -140.76 161.79 36.95 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.237 0.541 . . . . 0.0 110.129 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.556 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 17.4 tt -114.64 149.53 16.87 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -107.6 125.5 51.4 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 175.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.571 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 95.0 t -117.87 134.06 62.68 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -118.17 -20.97 8.41 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.442 0.639 . . . . 0.0 110.485 -174.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -136.42 162.56 32.7 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.226 -174.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.4 p -72.66 147.38 45.8 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.33 0.586 . . . . 0.0 112.209 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.8 p -122.43 132.14 71.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 176.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.72 -15.3 46.69 Favored Glycine 0 C--N 1.303 -1.297 0 C-N-CA 119.566 -1.302 . . . . 0.0 112.861 -177.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.9 p -155.71 123.35 5.6 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.416 0.627 . . . . 0.0 112.377 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.4 mt -114.34 118.88 35.13 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.348 177.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 19.3 m -132.48 110.61 13.7 Favored Pre-proline 0 C--N 1.303 -1.432 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.837 175.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 5.1 Cg_exo -77.4 161.94 91.56 Favored 'Cis proline' 0 C--O 1.244 0.797 0 C-N-CA 123.229 -1.571 . . . . 0.0 110.927 0.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.07 158.38 30.25 Favored 'Trans proline' 0 C--O 1.25 1.092 0 C-N-CA 122.526 2.15 . . . . 0.0 110.988 177.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 46.9 m0 -89.67 139.13 30.86 Favored 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.089 -177.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 15.4 p -119.34 78.85 19.61 Favored Pre-proline 0 C--N 1.29 -1.993 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.15 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.488 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 93.0 Cg_endo -79.18 157.59 26.39 Favored 'Trans proline' 0 N--CA 1.44 -1.648 0 C-N-CA 121.782 1.655 . . . . 0.0 112.257 176.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -93.73 -27.98 11.93 Favored Glycine 0 N--CA 1.428 -1.878 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 176.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.4 p -153.57 150.94 29.2 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.5 t -123.11 142.84 38.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 15.5 t -142.98 137.71 29.54 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -177.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.9 t -121.43 119.02 29.58 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -65.2 137.41 51.78 Favored 'Trans proline' 0 C--O 1.241 0.673 0 C-N-CA 123.036 2.491 . . . . 0.0 113.136 -178.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -71.78 121.75 19.47 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.25 178.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 86.7 t -95.01 115.0 32.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 176.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -103.12 70.17 1.06 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -126.22 145.3 50.45 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -172.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.4 m -58.66 -24.83 62.0 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.436 -1.257 . . . . 0.0 109.807 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.461 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 4.3 mptp? -53.09 134.31 38.51 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.563 -177.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 50.9 mtp180 -68.51 -27.99 66.61 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -172.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -106.49 128.03 53.77 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.928 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -104.89 147.01 33.76 Favored Pre-proline 0 C--N 1.284 -2.24 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 171.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.416 ' HB3' ' CD1' ' A' ' 25' ' ' TYR . 93.3 Cg_endo -77.52 135.24 14.53 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.748 1.632 . . . . 0.0 112.522 -177.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -129.35 141.27 51.12 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.646 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 90.0 m95 -122.81 132.11 54.06 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -173.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.489 ' HD2' ' SG ' ' A' ' 111' ' ' CYS . 28.0 m-85 -114.37 142.76 45.92 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.108 176.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.7 mt -125.5 142.37 51.54 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 -175.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 92.0 m-85 -130.54 139.79 50.47 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.575 0.703 . . . . 0.0 111.21 -176.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.599 ' HB2' ' CD1' ' A' ' 102' ' ' PHE . 0.8 OUTLIER -81.89 -10.59 59.25 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.314 -178.876 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -135.69 156.92 48.08 Favored 'General case' 0 N--CA 1.416 -2.136 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.823 174.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.506 ' HA ' ' HB2' ' A' ' 107' ' ' SER . 21.5 m -65.3 161.45 3.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.967 -176.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 61.52 30.57 18.81 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.199 0.523 . . . . 0.0 111.278 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 57.57 41.85 25.1 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 124.335 1.054 . . . . 0.0 111.333 176.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 77.9 p -112.35 176.35 5.05 Favored 'General case' 0 C--O 1.252 1.203 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.674 178.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.93 -137.79 18.42 Favored Glycine 0 N--CA 1.424 -2.152 0 N-CA-C 111.761 -0.535 . . . . 0.0 111.761 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.438 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . 53.3 mtt180 -82.72 150.21 26.85 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -177.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.0 tt -128.44 137.31 57.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 O-C-N 123.622 0.576 . . . . 0.0 110.594 -174.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 57.1 m -132.43 124.07 27.91 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 122.231 -0.293 . . . . 0.0 110.319 174.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -115.0 113.43 2.95 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.622 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.42 HD21 HD11 ' A' ' 94' ' ' ILE . 2.4 mm? -106.48 145.63 31.56 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 122.994 0.518 . . . . 0.0 111.285 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -110.33 164.61 12.25 Favored Glycine 0 N--CA 1.427 -1.966 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.625 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -64.03 122.15 15.86 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 123.29 0.636 . . . . 0.0 110.994 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.56 16.94 51.17 Favored Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.525 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.4 m -135.69 146.03 47.34 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 175.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 21.7 m -143.96 157.08 44.57 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.42 HD11 HD21 ' A' ' 88' ' ' LEU . 61.7 mt -94.45 135.21 29.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -70.81 -47.43 59.48 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.525 0.678 . . . . 0.0 110.483 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.462 ' HA ' HG22 ' A' ' 33' ' ' THR . 5.7 m-20 -136.51 100.77 4.45 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.995 -177.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.456 ' CD2' ' HG2' ' A' ' 55' ' ' PRO . 62.6 t80 -64.2 -29.53 70.63 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.259 0.552 . . . . 0.0 110.796 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.9 t -62.91 -18.78 63.49 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.694 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -94.75 -8.96 36.11 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 122.152 -0.343 . . . . 0.0 110.416 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 26.9 t -85.24 28.82 0.7 Allowed 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.772 0.829 . . . . 0.0 110.798 -177.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.88 -70.84 1.78 Allowed Glycine 0 N--CA 1.432 -1.626 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.054 177.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.599 ' CD1' ' HB2' ' A' ' 77' ' ' ASP . 27.0 p90 -110.41 149.42 30.29 Favored 'General case' 0 C--N 1.29 -1.991 0 O-C-N 122.784 -0.245 . . . . 0.0 110.356 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -114.24 -10.09 12.77 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.681 177.0 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -109.18 99.7 1.28 Allowed Glycine 0 N--CA 1.433 -1.552 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.897 -175.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 69.2 mt -87.05 115.17 27.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-O 122.551 1.167 . . . . 0.0 107.964 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 27.8 m -85.94 -23.97 26.75 Favored 'General case' 0 C--N 1.249 -3.763 0 CA-C-N 112.337 -2.21 . . . . 0.0 113.764 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.506 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 9.3 t -158.48 153.45 25.17 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -176.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.2 mt -137.29 130.32 43.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -178.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.559 ' HD2' ' SG ' ' A' ' 121' ' ' CYS . 24.7 ttmt -117.64 133.48 55.9 Favored 'General case' 0 C--N 1.3 -1.543 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -100.47 127.81 46.71 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -177.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . 0.489 ' SG ' ' HD2' ' A' ' 74' ' ' TYR . 29.6 m -119.38 168.3 11.08 Favored 'General case' 0 N--CA 1.417 -2.117 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -176.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.7 pt -127.38 140.29 49.52 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.525 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -112.79 119.08 36.79 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 63.3 p -79.17 177.37 8.87 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.254 -175.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.1 ttpp -66.32 -20.19 66.02 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.572 0.701 . . . . 0.0 109.421 176.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -78.77 -8.34 58.66 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.813 0.816 . . . . 0.0 109.953 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.68 -11.57 68.16 Favored Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.386 176.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -71.82 139.01 48.75 Favored 'General case' 0 C--O 1.253 1.25 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.65 112.27 37.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -104.6 152.7 22.12 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . 0.559 ' SG ' ' HD2' ' A' ' 109' ' ' LYS . 0.9 OUTLIER . . . . . 0 C--N 1.287 -2.119 0 C-N-CA 118.626 -1.23 . . . . 0.0 110.575 -175.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 . . . . . 0 C--O 1.243 0.719 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.411 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 12.0 m -125.54 154.79 41.62 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.604 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 54.4 tp -112.26 122.69 48.43 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 171.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.525 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 78.7 mt-30 -116.04 124.88 51.57 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.759 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 3.6 mp -109.51 126.01 53.09 Favored 'General case' 0 N--CA 1.415 -2.204 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.129 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.417 ' CD1' ' HB3' ' A' ' 39' ' ' TYR . 98.1 m-85 -94.55 147.94 22.76 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 123.783 0.677 . . . . 0.0 110.914 -176.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -72.5 -38.58 68.09 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.979 -177.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -109.74 178.12 4.52 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.407 HG22 ' HA ' ' A' ' 96' ' ' ASP . 6.0 p -79.09 172.63 13.54 Favored 'General case' 0 N--CA 1.422 -1.872 0 C-N-CA 121.507 -0.077 . . . . 0.0 111.026 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.544 ' CE1' ' HG3' ' A' ' 36' ' ' ARG 0.261 31.6 p90 46.56 42.25 10.88 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 176.777 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 67.94 28.89 6.75 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.984 0.914 . . . . 0.0 112.788 176.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.544 ' HG3' ' CE1' ' A' ' 34' ' ' TYR . 23.7 mmt180 -107.06 172.13 6.99 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-O 121.501 0.667 . . . . 0.0 112.249 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.4 -159.88 39.32 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -177.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.0 m -89.66 179.57 5.99 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 172.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 21.8 p90 -149.42 162.92 39.14 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.525 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 15.6 tt -118.09 151.97 20.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.232 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -107.34 125.92 51.8 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 175.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.551 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 93.0 t -117.67 133.96 62.77 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 176.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -117.59 -29.47 5.76 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 120.994 0.426 . . . . 0.0 110.313 -176.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.09 154.91 47.77 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.838 -177.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.2 m -60.31 145.8 46.32 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 123.527 0.731 . . . . 0.0 111.935 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.5 p -120.84 139.04 49.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 176.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.12 -20.31 30.88 Favored Glycine 0 C--N 1.299 -1.484 0 C-N-CA 119.604 -1.284 . . . . 0.0 112.804 -176.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.3 p -157.72 131.14 7.76 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 120.961 0.41 . . . . 0.0 111.789 -176.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.58 117.22 23.82 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 175.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 13.9 t -133.6 113.0 12.9 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.403 176.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 8.1 Cg_exo -75.56 161.23 94.86 Favored 'Cis proline' 0 C--O 1.246 0.924 0 C-N-CA 123.191 -1.587 . . . . 0.0 111.206 -0.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -61.71 158.87 35.29 Favored 'Trans proline' 0 C--O 1.245 0.859 0 C-N-CA 122.986 2.457 . . . . 0.0 111.312 178.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 48.0 m0 -88.56 137.5 32.27 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 5.4 p -117.59 75.53 9.51 Favored Pre-proline 0 C--N 1.292 -1.905 0 O-C-N 123.31 0.381 . . . . 0.0 111.601 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.437 ' HG2' ' CD2' ' A' ' 97' ' ' PHE . 69.8 Cg_endo -74.35 157.94 45.07 Favored 'Trans proline' 0 C--N 1.359 1.12 0 C-N-CA 122.859 2.373 . . . . 0.0 112.875 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.25 -28.67 14.22 Favored Glycine 0 N--CA 1.436 -1.307 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.3 p -156.1 151.67 27.03 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.5 t -128.45 142.4 43.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 35.8 t -145.84 150.06 35.45 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.515 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.6 t -113.58 123.28 33.41 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 175.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.411 ' HD2' ' O ' ' A' ' 26' ' ' CYS . 10.3 Cg_endo -57.27 140.6 93.42 Favored 'Trans proline' 0 C--O 1.247 0.935 0 C-N-CA 122.552 2.168 . . . . 0.0 111.505 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.431 ' CE1' ' HB2' ' A' ' 64' ' ' ASN . 82.1 t80 -74.09 109.54 7.66 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-O 121.385 0.612 . . . . 0.0 110.681 -177.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.442 ' H ' ' HB2' ' A' ' 90' ' ' HIS . 49.1 t -94.19 114.17 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.566 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.431 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 27.0 t-20 -112.75 88.92 2.94 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 172.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.466 ' OD1' ' HG2' ' A' ' 67' ' ' LYS . 3.8 t70 -127.31 145.81 50.66 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.62 -171.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.9 m -62.93 -6.93 4.3 Favored 'General case' 0 CA--C 1.569 1.71 0 C-N-CA 124.444 1.098 . . . . 0.0 111.157 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.466 ' HG2' ' OD1' ' A' ' 65' ' ' ASP . 75.8 mmtt -61.28 153.95 25.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 171.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.543 ' HB2' ' OE2' ' A' ' 69' ' ' GLU . 45.5 mtm180 -89.17 -28.65 19.87 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.733 -177.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.543 ' OE2' ' HB2' ' A' ' 68' ' ' ARG . 9.7 mp0 -105.37 128.9 53.74 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.435 -177.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -102.52 153.96 37.78 Favored Pre-proline 0 C--N 1.291 -1.968 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 176.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -80.58 141.39 13.85 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.467 1.445 . . . . 0.0 112.476 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -133.22 138.15 46.4 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.604 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 84.3 m95 -120.27 136.91 54.51 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.755 -0.59 . . . . 0.0 112.301 -173.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 86' ' ' THR . 37.1 m-85 -116.74 143.29 45.84 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.678 177.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.8 mt -125.96 142.78 51.36 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 -176.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -133.62 141.71 47.77 Favored 'General case' 0 C--O 1.244 0.794 0 O-C-N 123.625 0.578 . . . . 0.0 109.974 -177.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.65 -5.46 59.31 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.918 -177.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -131.76 162.25 30.94 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 175.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.461 HG23 HD22 ' A' ' 80' ' ' ASN . 25.2 m -73.15 167.38 2.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 C-N-CA 122.395 0.278 . . . . 0.0 110.794 -176.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.461 HD22 HG23 ' A' ' 79' ' ' VAL . 48.0 m-80 57.54 30.2 18.34 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.646 0.778 . . . . 0.0 111.968 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.564 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 11.5 m-85 60.1 40.22 18.7 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.401 1.08 . . . . 0.0 111.523 176.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.0 p -111.98 171.28 7.59 Favored 'General case' 0 C--O 1.25 1.095 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.95 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.69 -135.77 13.25 Favored Glycine 0 N--CA 1.427 -1.913 0 C-N-CA 120.881 -0.675 . . . . 0.0 112.105 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -83.48 155.53 23.33 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 123.025 0.53 . . . . 0.0 109.605 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.4 tt -131.66 136.69 56.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 121.318 0.58 . . . . 0.0 110.066 -175.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 76.1 m -132.09 127.62 36.45 Favored 'General case' 0 C--N 1.288 -2.103 0 O-C-N 122.021 -0.424 . . . . 0.0 110.359 175.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -111.1 124.82 7.08 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.81 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.45 HD21 HD11 ' A' ' 94' ' ' ILE . 2.9 mm? -117.76 145.39 44.52 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 123.576 0.751 . . . . 0.0 110.618 177.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -117.3 169.26 13.09 Favored Glycine 0 N--CA 1.433 -1.523 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.92 -178.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.442 ' HB2' ' H ' ' A' ' 63' ' ' VAL . 7.4 p80 -61.13 122.13 14.24 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.449 0.642 . . . . 0.0 112.323 -177.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.56 -1.63 76.05 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.568 177.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.5 m -107.42 146.12 32.1 Favored 'General case' 0 N--CA 1.424 -1.73 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.7 m -137.68 154.51 49.67 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.45 HD11 HD21 ' A' ' 88' ' ' LEU . 50.7 mt -93.49 128.11 45.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 173.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -70.92 -47.54 58.54 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.108 0.48 . . . . 0.0 110.984 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.667 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 3.4 m-20 -132.72 88.87 2.56 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.927 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.437 ' CD2' ' HG2' ' A' ' 55' ' ' PRO . 50.7 t80 -65.47 -30.25 71.01 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.778 0.799 . . . . 0.0 109.666 176.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.2 t -66.91 -24.45 66.1 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.463 -178.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.667 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 30.0 mmtp -93.99 -6.78 44.57 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -178.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 26.6 m -79.73 -171.85 3.04 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.46 -64.89 3.97 Favored Glycine 0 CA--C 1.503 -0.702 0 N-CA-C 112.094 -0.403 . . . . 0.0 112.094 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -110.94 146.74 36.05 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.193 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.558 ' H ' ' HD3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -113.42 -6.54 13.49 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 175.867 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -112.55 119.18 4.86 Favored Glycine 0 N--CA 1.431 -1.648 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.457 -177.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 64.9 mt -103.06 115.41 44.99 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.763 0 CA-C-O 122.426 1.107 . . . . 0.0 109.476 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 37.8 m -85.73 -29.6 23.78 Favored 'General case' 0 N--CA 1.394 -3.248 0 CA-C-N 112.148 -2.297 . . . . 0.0 113.999 177.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.6 p -153.88 154.61 34.2 Favored 'General case' 0 C--O 1.237 0.42 0 O-C-N 121.862 -0.524 . . . . 0.0 109.965 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.8 mt -133.22 131.45 58.24 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -176.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.564 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 38.2 ttmt -117.51 128.33 54.87 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -95.67 129.58 42.83 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 68.4 m -122.56 171.72 8.91 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.357 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.1 pt -129.41 139.3 52.08 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 176.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -110.56 118.87 37.38 Favored 'General case' 0 C--N 1.274 -2.714 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 72.9 p -69.15 170.23 10.48 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.462 -176.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.2 ttpp -67.06 -19.54 65.69 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.635 0.731 . . . . 0.0 109.276 176.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -84.92 -8.17 58.87 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.744 -177.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.21 -10.62 65.54 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.78 -0.646 . . . . 0.0 114.133 175.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -78.32 138.38 38.54 Favored 'General case' 0 C--O 1.249 1.031 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.902 179.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.3 t -102.31 113.35 38.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -95.49 133.86 39.0 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.75 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 63.6 m . . . . . 0 C--N 1.287 -2.118 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -177.777 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.463 ' CZ ' ' HD3' ' A' ' 71' ' ' PRO . 14.5 m-85 . . . . . 0 CA--C 1.509 -0.603 0 CA-C-O 121.5 0.666 . . . . 0.0 110.694 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 18.5 m -123.12 145.32 48.68 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -179.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.591 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 49.7 tp -94.56 124.93 38.88 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 176.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.479 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 16.3 mt-30 -117.42 124.19 48.24 Favored 'General case' 0 N--CA 1.42 -1.929 0 CA-C-O 121.368 0.604 . . . . 0.0 109.469 -177.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.498 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 3.6 mp -109.68 125.65 52.85 Favored 'General case' 0 N--CA 1.421 -1.904 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.73 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.504 ' HA ' ' O ' ' A' ' 38' ' ' SER . 85.6 m-85 -95.24 152.31 18.48 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 123.393 0.433 . . . . 0.0 111.464 -176.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.89 -47.56 65.53 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.378 -177.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -108.17 178.4 4.51 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.781 -176.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.455 HG22 ' HA ' ' A' ' 96' ' ' ASP . 2.4 p -77.02 166.29 23.5 Favored 'General case' 0 N--CA 1.403 -2.799 0 O-C-N 123.28 0.362 . . . . 0.0 110.295 -176.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.408 ' CE2' ' HD3' ' A' ' 36' ' ' ARG 0.262 20.9 p90 47.21 47.59 16.41 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 177.704 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 65.51 22.19 11.82 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.391 1.076 . . . . 0.0 112.19 176.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.408 ' HD3' ' CE2' ' A' ' 34' ' ' TYR . 55.1 mtp180 -91.29 160.17 15.65 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.509 0.671 . . . . 0.0 112.63 178.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.35 -148.0 20.42 Favored Glycine 0 N--CA 1.433 -1.542 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -176.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 17.2 m -111.77 -176.65 2.99 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 177.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 23.4 p90 -143.31 163.15 33.81 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.23 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 15.3 tt -114.35 152.18 16.04 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 177.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -106.84 125.54 51.14 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 87.5 t -120.1 133.18 67.68 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -115.68 -31.72 5.74 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.487 0.66 . . . . 0.0 109.518 -174.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.47 161.89 29.37 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.321 -176.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.4 p -69.01 146.38 52.75 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 123.623 0.769 . . . . 0.0 112.67 -176.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.0 p -121.82 135.65 61.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.9 -18.11 41.58 Favored Glycine 0 N--CA 1.431 -1.687 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.955 -178.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.5 p -158.92 116.66 2.84 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.405 0.621 . . . . 0.0 112.593 -178.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.9 mt -105.19 116.91 32.74 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.431 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.2 m -133.58 114.75 13.37 Favored Pre-proline 0 N--CA 1.42 -1.962 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 172.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -73.99 162.12 92.91 Favored 'Cis proline' 0 C--O 1.248 0.995 0 C-N-CA 123.315 -1.536 . . . . 0.0 110.946 -0.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.54 155.36 66.92 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.914 1.743 . . . . 0.0 109.931 177.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -89.61 133.43 34.62 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.588 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 22.6 p -116.85 77.22 8.41 Favored Pre-proline 0 C--N 1.298 -1.643 0 O-C-N 123.523 0.514 . . . . 0.0 111.759 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.408 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 97.2 Cg_endo -80.29 158.2 22.93 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.66 2.24 . . . . 0.0 113.012 178.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -89.28 -29.57 16.69 Favored Glycine 0 N--CA 1.437 -1.247 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 177.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.0 p -155.25 154.46 32.2 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.0 t -129.16 143.22 41.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 38.6 t -145.58 149.88 35.37 Favored 'General case' 0 N--CA 1.428 -1.558 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.732 176.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.6 t -116.55 123.81 30.14 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 175.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -60.81 149.04 90.11 Favored 'Trans proline' 0 C--O 1.252 1.18 0 C-N-CA 122.798 2.332 . . . . 0.0 112.321 -177.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.547 ' CE2' ' HB3' ' A' ' 64' ' ' ASN . 79.5 t80 -76.14 110.12 10.36 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 121.825 0.821 . . . . 0.0 111.058 -177.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.442 ' H ' ' HB2' ' A' ' 90' ' ' HIS . 66.3 t -94.54 116.31 35.52 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.778 177.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.547 ' HB3' ' CE2' ' A' ' 62' ' ' PHE . 3.7 p-10 -119.28 24.58 10.65 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 122.35 1.071 . . . . 0.0 108.62 178.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -67.93 146.58 53.47 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 113.363 -1.744 . . . . 0.0 111.93 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.2 m -58.71 -8.64 1.37 Allowed 'General case' 0 CA--C 1.57 1.749 0 C-N-CA 125.141 1.377 . . . . 0.0 112.768 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -62.62 138.57 58.52 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -69.21 -29.41 67.37 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.468 0.48 . . . . 0.0 111.509 -173.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -112.02 135.65 52.38 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-O 121.63 0.729 . . . . 0.0 111.612 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.86 148.35 36.36 Favored Pre-proline 0 C--N 1.285 -2.204 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.394 176.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.463 ' HD3' ' CZ ' ' A' ' 25' ' ' TYR . 71.2 Cg_endo -71.59 137.87 31.14 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 121.995 1.797 . . . . 0.0 112.928 -175.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -131.29 123.38 28.22 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.591 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 83.6 m95 -108.55 135.76 49.28 Favored 'General case' 0 C--N 1.281 -2.388 0 O-C-N 122.098 -0.376 . . . . 0.0 111.996 -172.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' A' ' 86' ' ' THR . 41.6 m-85 -113.89 141.91 46.76 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.554 177.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.403 HD21 HD21 ' A' ' 27' ' ' LEU . 22.6 mt -125.35 142.59 51.41 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 -176.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.448 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 84.7 m-85 -131.49 139.72 49.38 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 121.197 0.522 . . . . 0.0 111.178 -175.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.13 -12.85 59.14 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.891 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.435 HD22 ' HA ' ' A' ' 78' ' ' ASN . 2.7 t-20 -123.76 165.76 16.74 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 175.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.7 m -77.14 167.47 2.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 118.036 0.38 . . . . 0.0 110.822 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.51 30.96 20.16 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.667 0.787 . . . . 0.0 111.942 177.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.431 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 5.8 m-85 61.92 40.37 12.56 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.799 175.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.8 p -117.49 176.07 5.34 Favored 'General case' 0 C--O 1.25 1.086 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.629 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.57 -134.03 12.26 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 178.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 52.2 mtm180 -84.38 147.78 26.96 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 122.45 0.3 . . . . 0.0 110.431 176.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.9 tt -124.77 139.24 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 O-C-N 123.654 0.596 . . . . 0.0 110.108 -176.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 67.6 m -131.84 126.44 34.29 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 175.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -111.55 122.12 5.97 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.776 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.466 HD21 HD11 ' A' ' 94' ' ' ILE . 3.7 mm? -112.69 145.07 41.13 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 120.835 0.35 . . . . 0.0 111.041 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -117.06 168.32 12.8 Favored Glycine 0 N--CA 1.424 -2.121 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.705 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.442 ' HB2' ' H ' ' A' ' 63' ' ' VAL . 7.2 p80 -59.72 123.87 18.32 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.335 0.588 . . . . 0.0 111.83 -178.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.08 2.78 77.17 Favored Glycine 0 N--CA 1.43 -1.758 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.387 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.1 m -113.19 145.66 40.61 Favored 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 4.6 m -134.8 158.84 43.14 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.466 HD11 HD21 ' A' ' 88' ' ' LEU . 46.3 mt -93.65 131.94 39.21 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 173.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -70.21 -47.67 60.44 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.276 0.56 . . . . 0.0 109.903 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.59 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 3.2 m-20 -138.25 100.95 4.26 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -64.77 -36.5 84.53 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.404 0.621 . . . . 0.0 110.422 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.3 t -64.45 -23.76 67.39 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.965 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.59 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 28.2 mmtp -91.99 -7.64 48.35 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 122.147 -0.346 . . . . 0.0 110.413 -178.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.2 m -78.12 -13.93 59.67 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.687 0.756 . . . . 0.0 109.872 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 132.14 -85.16 0.29 Allowed Glycine 0 N--CA 1.42 -2.385 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -86.89 141.9 28.42 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 120.542 -0.463 . . . . 0.0 109.924 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.588 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.52 -8.39 13.35 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -108.15 109.15 2.84 Favored Glycine 0 N--CA 1.432 -1.614 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.989 -176.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 66.5 mt -91.64 116.06 32.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 122.336 1.065 . . . . 0.0 109.053 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.9 m -85.85 -28.63 24.3 Favored 'General case' 0 N--CA 1.401 -2.923 0 CA-C-N 112.445 -2.161 . . . . 0.0 114.816 177.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.4 p -156.13 157.36 35.86 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.7 mt -137.48 131.47 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -175.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.431 ' HE2' ' CD2' ' A' ' 81' ' ' TYR . 37.6 ttmt -117.66 133.64 55.74 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -101.27 121.88 42.67 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 120.615 -0.434 . . . . 0.0 109.932 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 65.9 m -119.85 172.14 7.92 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 8.4 pt -127.61 143.22 41.4 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -115.12 120.49 39.97 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 177.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 82.8 p -79.6 176.49 9.66 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.424 -173.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -65.16 -26.85 68.35 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.119 172.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -76.91 -8.71 57.86 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 122.051 0.929 . . . . 0.0 110.211 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.07 -11.54 70.48 Favored Glycine 0 CA--C 1.498 -1.016 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.772 175.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -73.31 141.03 47.14 Favored 'General case' 0 C--O 1.257 1.448 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.889 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 22.6 t -102.13 118.71 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.814 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 177.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -104.3 140.4 37.92 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 69.9 m . . . . . 0 C--N 1.297 -1.704 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.384 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 . . . . . 0 N--CA 1.482 1.175 0 CA-C-O 121.437 0.637 . . . . 0.0 111.543 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.0 m -123.68 145.92 48.62 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.199 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.571 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 57.8 tp -100.03 114.13 27.22 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 175.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 41.2 mt-30 -108.26 124.49 50.38 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.704 -0.798 . . . . 0.0 108.848 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.4 mp -109.41 127.38 54.34 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.032 177.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -94.06 150.37 20.4 Favored 'General case' 0 C--N 1.29 -1.989 0 O-C-N 123.509 0.506 . . . . 0.0 110.148 -176.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -69.88 -43.27 72.17 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 124.055 0.847 . . . . 0.0 109.651 -175.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -114.08 178.88 4.12 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.033 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.441 HG22 ' HA ' ' A' ' 96' ' ' ASP . 2.6 p -74.91 169.72 17.39 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.119 -176.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.456 ' CE2' ' HG3' ' A' ' 36' ' ' ARG 0.258 13.8 p90 47.17 40.16 9.55 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.959 1.304 . . . . 0.0 114.01 177.771 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 62.2 40.43 11.65 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.147 0.979 . . . . 0.0 111.947 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.539 ' HA ' ' NE ' ' A' ' 36' ' ' ARG . 4.3 mmp_? -108.61 162.23 14.34 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.223 0.535 . . . . 0.0 112.162 178.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.26 -163.05 42.72 Favored Glycine 0 N--CA 1.426 -1.967 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -177.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.0 p -89.34 173.84 8.15 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 176.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -140.77 166.01 25.94 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -177.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.8 tt -116.9 152.08 18.69 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 177.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -106.75 125.57 51.18 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 175.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.494 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 97.8 t -122.41 133.04 69.86 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -119.32 -24.49 6.37 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.709 -177.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -115.46 163.14 16.17 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.98 -172.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.9 m -83.1 142.43 31.27 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 176.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.9 p -120.97 129.67 75.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.68 -12.13 59.76 Favored Glycine 0 N--CA 1.432 -1.567 0 C-N-CA 119.672 -1.252 . . . . 0.0 113.795 -178.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 24.4 p -157.7 122.27 4.31 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.279 0.562 . . . . 0.0 112.409 -178.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 72.8 mt -117.82 117.87 30.47 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 175.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 12.3 p -132.46 109.45 13.52 Favored Pre-proline 0 C--N 1.29 -1.991 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.959 176.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 72.4 Cg_endo -75.34 162.06 93.38 Favored 'Cis proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.704 -1.373 . . . . 0.0 111.408 -1.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.76 156.77 59.8 Favored 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 121.975 1.784 . . . . 0.0 111.152 178.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 48.0 m0 -89.27 131.89 35.16 Favored 'General case' 0 CA--C 1.482 -1.668 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.623 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 38.8 p -114.46 78.53 4.86 Favored Pre-proline 0 N--CA 1.43 -1.425 0 O-C-N 123.56 0.537 . . . . 0.0 110.712 178.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.417 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 88.4 Cg_endo -78.21 157.63 29.92 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 122.523 2.149 . . . . 0.0 112.566 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -89.59 -30.85 12.39 Favored Glycine 0 N--CA 1.431 -1.651 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 177.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.2 p -153.25 158.25 41.39 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.9 t -136.87 142.67 37.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -177.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 49.4 t -145.95 147.82 32.12 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.691 176.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.1 t -118.73 124.27 28.52 Favored Pre-proline 0 N--CA 1.441 -0.923 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 175.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -63.03 148.66 93.19 Favored 'Trans proline' 0 C--O 1.247 0.971 0 C-N-CA 122.399 2.066 . . . . 0.0 112.062 -178.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -70.96 119.88 15.73 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-O 121.85 0.833 . . . . 0.0 110.249 -178.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.451 ' H ' ' HB2' ' A' ' 90' ' ' HIS . 93.1 t -95.83 123.35 47.99 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.349 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -116.09 14.96 16.09 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 122.143 0.973 . . . . 0.0 108.617 -178.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.4 ' HB3' ' HG2' ' A' ' 67' ' ' LYS . 1.9 m-20 -64.13 145.54 55.77 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 113.519 -1.673 . . . . 0.0 113.717 -175.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.7 m -64.19 -12.42 40.32 Favored 'General case' 0 C--O 1.255 1.372 0 C-N-CA 125.285 1.434 . . . . 0.0 110.981 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.4 ' HG2' ' HB3' ' A' ' 65' ' ' ASP . 73.3 mmtt -59.67 141.33 55.29 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -78.02 -29.86 49.68 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.629 0.728 . . . . 0.0 109.803 -177.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.411 ' HB2' ' HB ' ' A' ' 112' ' ' ILE . 0.4 OUTLIER -107.37 129.85 54.87 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.686 -179.873 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.76 154.14 39.52 Favored Pre-proline 0 C--N 1.286 -2.159 0 CA-C-N 114.616 -1.174 . . . . 0.0 109.237 -178.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -74.08 134.41 19.46 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 121.578 1.519 . . . . 0.0 111.066 -178.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -129.42 128.51 43.12 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 106.309 -1.738 . . . . 0.0 106.309 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.571 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 87.1 m95 -110.38 130.43 55.55 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-O 121.175 0.512 . . . . 0.0 111.565 -173.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.48 ' HA ' ' O ' ' A' ' 86' ' ' THR . 25.3 m-85 -111.19 142.26 43.62 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.359 176.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.3 mt -125.36 142.14 51.67 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 -176.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.427 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 87.2 m-85 -131.42 139.31 49.38 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.112 0.482 . . . . 0.0 110.814 -175.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.678 ' HB2' ' CD1' ' A' ' 102' ' ' PHE . 5.7 t70 -77.68 -18.06 57.03 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.295 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.454 ' C ' ' HB3' ' A' ' 106' ' ' SER . 9.0 t-20 -126.03 162.38 25.42 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 176.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.3 m -67.78 168.12 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.58 0 C-N-CA 123.076 0.551 . . . . 0.0 111.434 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 55.26 30.22 14.28 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.827 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.53 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 13.3 m-85 60.03 45.9 11.49 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.799 1.239 . . . . 0.0 111.749 175.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.8 p -118.94 176.35 5.33 Favored 'General case' 0 C--O 1.249 1.041 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.462 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.87 -133.77 12.16 Favored Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 121.218 -0.515 . . . . 0.0 111.973 177.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 63.9 mtt85 -81.67 148.07 29.2 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.9 tt -129.16 137.2 57.71 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 O-C-N 123.62 0.575 . . . . 0.0 110.424 -175.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 95.7 m -130.97 122.71 27.35 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -111.19 109.68 2.6 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.713 -0.756 . . . . 0.0 114.629 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -103.07 145.07 30.45 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 122.816 0.446 . . . . 0.0 110.95 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.13 175.9 16.1 Favored Glycine 0 N--CA 1.425 -2.063 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.473 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.451 ' HB2' ' H ' ' A' ' 63' ' ' VAL . 10.0 p80 -66.08 122.13 16.72 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.532 0.682 . . . . 0.0 112.194 -176.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.72 0.95 71.51 Favored Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.623 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.0 m -106.59 146.31 30.84 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 5.6 m -136.07 151.37 49.77 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.8 mt -93.51 127.22 45.71 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 174.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -70.51 -47.27 61.26 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.387 0.613 . . . . 0.0 110.48 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.622 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 2.1 m-20 -135.33 93.63 3.01 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.071 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -65.14 -33.69 76.61 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.202 0.525 . . . . 0.0 110.391 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.8 t -65.26 -23.91 67.17 Favored 'General case' 0 CA--C 1.559 1.318 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.136 -176.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.622 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 30.2 mmtp -92.75 -6.4 49.15 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.941 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.2 m -84.9 38.69 0.72 Allowed 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.344 0.592 . . . . 0.0 111.535 -175.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.88 -73.98 2.25 Favored Glycine 0 N--CA 1.426 -2.028 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.678 ' CD1' ' HB2' ' A' ' 77' ' ' ASP . 16.1 p90 -109.81 148.28 31.77 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -179.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.623 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -113.54 -8.03 13.36 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 120.114 -0.635 . . . . 0.0 109.647 179.196 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -113.31 112.65 2.96 Favored Glycine 0 N--CA 1.432 -1.604 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.351 -174.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 76.1 mt -94.26 115.41 33.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.454 ' HB3' ' C ' ' A' ' 78' ' ' ASN . 3.7 t -86.06 -26.42 25.35 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.947 178.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.5 p -152.08 157.22 41.31 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 122.089 -0.382 . . . . 0.0 110.935 177.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.3 mt -135.9 133.2 50.95 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -175.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.53 ' HE2' ' CD2' ' A' ' 81' ' ' TYR . 33.5 ttmt -122.02 128.34 51.32 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -96.3 121.39 38.04 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 60.6 m -119.16 172.09 7.82 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.411 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 6.9 pt -126.17 139.51 51.36 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 CA-C-O 121.127 0.489 . . . . 0.0 110.147 177.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -112.2 119.06 37.08 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 76.6 p -72.35 -178.55 2.57 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 114.636 -1.166 . . . . 0.0 112.059 -174.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -65.72 -31.05 71.83 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.785 0.803 . . . . 0.0 109.173 175.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -79.46 -8.95 59.48 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.652 -178.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.58 -9.32 77.98 Favored Glycine 0 N--CA 1.427 -1.928 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.787 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -70.01 139.32 52.72 Favored 'General case' 0 C--O 1.255 1.36 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.2 t -102.82 112.91 37.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 121.174 0.512 . . . . 0.0 109.761 -176.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -97.17 135.17 39.5 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.483 -1.634 0 C-N-CA 118.505 -1.278 . . . . 0.0 111.221 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.392 0 N-CA-C 111.746 -0.542 . . . . 0.0 111.746 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.77 41.16 1.13 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 122.086 0.946 . . . . 0.0 109.199 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -77.86 -19.49 54.75 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.452 -1.249 . . . . 0.0 113.37 -174.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 49.7 m -118.6 146.66 44.45 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 122.104 -0.372 . . . . 0.0 111.598 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 30.0 p -123.0 155.71 36.27 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 174.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -100.43 125.55 46.72 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -175.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 64.76 71.51 0.46 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.019 0.927 . . . . 0.0 112.217 -177.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.7 m -144.76 167.76 21.82 Favored 'General case' 0 C--N 1.31 -1.147 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.626 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 59.6 tp -111.96 124.63 52.8 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 169.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 70.5 mt-30 -113.72 124.37 52.13 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.555 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.443 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 3.2 mp -109.84 129.08 55.68 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.015 176.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.444 ' HB3' ' O ' ' A' ' 36' ' ' ARG . 94.9 m-85 -99.59 148.88 23.84 Favored 'General case' 0 C--N 1.294 -1.834 0 O-C-N 123.832 0.708 . . . . 0.0 110.852 -174.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -70.37 -38.1 74.69 Favored 'General case' 0 C--N 1.307 -1.249 0 O-C-N 123.663 0.602 . . . . 0.0 111.275 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -107.98 177.66 4.74 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -177.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.427 HG22 ' HA ' ' A' ' 96' ' ' ASP . 2.6 p -84.28 175.53 9.34 Favored 'General case' 0 N--CA 1.407 -2.612 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.274 15.5 p90 47.29 42.3 13.47 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 177.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 66.82 23.06 10.12 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.757 -1.111 . . . . 0.0 112.887 175.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.444 ' O ' ' HB3' ' A' ' 30' ' ' TYR . 18.1 mtm180 -102.24 173.38 6.39 Favored 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 119.653 -0.819 . . . . 0.0 112.106 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.69 179.8 51.32 Favored Glycine 0 N--CA 1.419 -2.45 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.52 -178.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.2 m -78.4 167.78 20.8 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 174.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 11.0 p90 -140.54 163.53 32.59 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -176.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.3 tt -114.59 152.98 16.16 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.583 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -107.23 125.54 51.26 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 176.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.549 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 84.3 t -117.91 133.38 64.89 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.369 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 176.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -114.81 -31.84 6.0 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 123.337 0.398 . . . . 0.0 110.159 -176.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.99 160.59 33.17 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -177.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.9 m -69.43 139.62 54.05 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 123.645 0.778 . . . . 0.0 112.186 -173.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.1 p -113.71 131.19 66.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 176.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.33 -15.41 51.06 Favored Glycine 0 N--CA 1.433 -1.549 0 C-N-CA 119.546 -1.312 . . . . 0.0 113.154 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.7 p -154.88 124.13 6.35 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.309 0.576 . . . . 0.0 112.474 -178.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 82.8 mt -118.77 117.99 30.37 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.615 175.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 15.0 p -132.84 110.13 13.16 Favored Pre-proline 0 N--CA 1.428 -1.548 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.636 174.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 74.2 Cg_endo -76.5 162.11 92.48 Favored 'Cis proline' 0 C--O 1.252 1.204 0 C-N-CA 123.729 -1.363 . . . . 0.0 111.236 -2.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.76 158.47 37.47 Favored 'Trans proline' 0 C--O 1.244 0.785 0 C-N-CA 122.783 2.322 . . . . 0.0 110.751 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.46 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 47.8 m0 -89.22 138.25 31.59 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 11.0 p -116.74 76.94 8.01 Favored Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 123.576 0.547 . . . . 0.0 111.874 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.466 ' HD2' ' O ' ' A' ' 103' ' ' LYS . 92.8 Cg_endo -76.4 158.57 36.66 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.584 2.189 . . . . 0.0 112.849 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.69 -36.92 8.97 Favored Glycine 0 N--CA 1.435 -1.37 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 175.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.2 p -151.1 159.8 44.27 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.5 t -134.77 143.11 38.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 38.4 t -145.48 148.74 33.58 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.784 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 67.3 t -113.0 121.01 39.31 Favored Pre-proline 0 C--N 1.309 -1.153 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 176.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -57.79 138.4 85.88 Favored 'Trans proline' 0 C--O 1.244 0.799 0 C-N-CA 122.877 2.385 . . . . 0.0 111.498 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.465 ' CE2' ' HB3' ' A' ' 64' ' ' ASN . 40.5 t80 -67.67 136.64 54.67 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-O 121.699 0.761 . . . . 0.0 111.071 -177.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 70.2 t -131.61 114.87 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.465 ' HB3' ' CE2' ' A' ' 62' ' ' PHE . 9.4 p30 -111.95 5.01 18.57 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 175.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.19 145.13 32.52 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 112.615 -2.084 . . . . 0.0 112.931 -172.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.48 -5.64 0.06 Allowed 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 128.991 2.916 . . . . 0.0 115.162 -173.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -59.62 171.55 0.84 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.295 1.038 . . . . 0.0 109.614 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 114' ' ' THR . 28.3 mtm180 -90.7 -28.09 18.56 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 118.093 -1.443 . . . . 0.0 107.955 173.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.449 ' HG2' HD12 ' A' ' 112' ' ' ILE . 18.5 mp0 -103.61 132.26 50.02 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.582 -174.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -106.38 153.78 40.24 Favored Pre-proline 0 C--N 1.289 -2.033 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 169.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.61 135.71 10.52 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 121.648 1.566 . . . . 0.0 113.012 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -133.88 118.58 18.11 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 177.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.626 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 82.9 m95 -107.55 136.77 46.76 Favored 'General case' 0 C--N 1.278 -2.525 0 O-C-N 122.052 -0.405 . . . . 0.0 111.977 -172.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.513 ' HD2' ' SG ' ' A' ' 111' ' ' CYS . 29.3 m-85 -113.52 141.21 47.42 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.765 177.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.415 HD21 HD21 ' A' ' 27' ' ' LEU . 22.5 mt -126.01 142.33 51.57 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 -176.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 88.0 m-85 -131.75 139.63 49.01 Favored 'General case' 0 C--N 1.31 -1.119 0 O-C-N 123.499 0.5 . . . . 0.0 110.993 -176.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.673 ' HB2' ' CD2' ' A' ' 102' ' ' PHE . 11.8 t70 -85.44 0.9 50.88 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 123.673 0.789 . . . . 0.0 111.224 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -136.58 158.49 44.32 Favored 'General case' 0 N--CA 1.423 -1.818 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 172.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.1 m -72.0 169.26 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 C-N-CA 122.316 0.246 . . . . 0.0 110.405 -178.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.48 29.87 19.34 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.168 0.587 . . . . 0.0 110.575 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.436 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 18.9 m-85 56.37 46.82 20.23 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.973 0.909 . . . . 0.0 110.95 177.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 72.9 p -123.32 176.63 6.02 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.475 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.6 -140.8 18.38 Favored Glycine 0 N--CA 1.429 -1.821 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.79 177.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 61.8 mtt180 -73.61 143.46 46.34 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 177.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.1 tt -125.33 137.63 57.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 O-C-N 123.572 0.545 . . . . 0.0 110.269 -174.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 52.0 m -131.79 125.11 31.09 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 121.984 -0.448 . . . . 0.0 110.658 175.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -112.22 124.82 6.89 Favored Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.829 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -119.13 146.0 45.5 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 123.251 0.62 . . . . 0.0 110.251 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.29 166.95 12.39 Favored Glycine 0 N--CA 1.431 -1.664 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.362 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -53.3 124.79 15.6 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 124.337 1.055 . . . . 0.0 112.357 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.34 -6.47 82.39 Favored Glycine 0 N--CA 1.435 -1.424 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.612 175.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.9 m -106.44 146.42 30.55 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -178.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.9 m -139.8 152.3 46.44 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 50.8 mt -93.48 133.76 33.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 176.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -71.1 -47.9 55.43 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.205 0.526 . . . . 0.0 110.36 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.554 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 1.9 m-20 -135.0 100.15 4.49 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.25 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -64.4 -38.93 92.75 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.359 0.6 . . . . 0.0 110.375 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.4 t -65.62 -29.76 70.38 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.641 -1.163 . . . . 0.0 112.192 -175.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.554 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 27.5 mmtp -86.31 -14.88 42.34 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 121.988 -0.445 . . . . 0.0 109.963 -176.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.1 m -77.88 -8.08 57.59 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 144.0 -77.26 0.28 Allowed Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.673 ' CD2' ' HB2' ' A' ' 77' ' ' ASP . 37.8 p90 -110.05 147.89 32.73 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.03 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.539 ' H ' ' HD3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -113.94 -9.9 12.98 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 178.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -109.67 115.71 4.29 Favored Glycine 0 N--CA 1.428 -1.874 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.596 -175.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 64.0 mt -101.17 116.07 44.05 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.7 m -85.28 -26.4 26.65 Favored 'General case' 0 N--CA 1.391 -3.414 0 CA-C-N 112.432 -2.167 . . . . 0.0 114.067 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 77.8 p -156.75 156.35 33.18 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 176.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.3 mt -134.24 133.94 55.32 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.768 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -176.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.436 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 31.9 ttmt -122.52 131.42 53.84 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -96.08 122.23 38.7 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.379 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . 0.513 ' SG ' ' HD2' ' A' ' 74' ' ' TYR . 56.3 m -118.86 167.74 11.43 Favored 'General case' 0 N--CA 1.405 -2.7 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.449 HD12 ' HG2' ' A' ' 69' ' ' GLU . 9.2 pt -127.74 145.82 34.43 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.414 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 61.5 tt0 -122.6 118.93 29.35 Favored 'General case' 0 C--N 1.274 -2.712 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 68' ' ' ARG . 27.1 p -79.78 179.16 7.69 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -175.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -66.25 -19.53 65.85 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.727 0.775 . . . . 0.0 110.203 177.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -83.34 -1.67 53.87 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.84 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.55 -5.63 82.89 Favored Glycine 0 CA--C 1.506 -0.483 0 CA-C-N 116.208 -0.451 . . . . 0.0 113.618 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 113' ' ' GLN . 19.0 ptpt -75.96 134.91 40.07 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 39.4 t -104.71 110.57 31.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -100.3 154.49 18.44 Favored 'General case' 0 C--N 1.287 -2.152 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 1.1 t -143.55 154.89 44.07 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 118.642 -1.223 . . . . 0.0 110.376 -177.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 7.8 tp -111.05 118.98 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.692 0 C-N-CA 119.749 -0.78 . . . . 0.0 109.021 176.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -85.83 104.52 15.58 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 . . . . . 0 C--N 1.287 -2.118 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -178.685 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.683 0 N-CA-C 111.114 -0.795 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.43 9.27 4.07 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.967 0.889 . . . . 0.0 111.423 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -77.38 -10.15 59.28 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.264 174.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 31.2 p -118.84 146.43 44.87 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 173.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 26.2 p -102.58 151.83 21.87 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.4 tptt -87.57 143.19 27.32 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 67.59 39.51 2.78 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 123.862 0.726 . . . . 0.0 111.349 177.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.8 m -124.33 155.09 39.32 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.267 -0.878 . . . . 0.0 108.925 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.606 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 55.2 tp -110.18 117.58 34.06 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 172.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.523 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 77.7 mt-30 -110.22 124.2 51.15 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.579 -0.849 . . . . 0.0 109.618 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 3.2 mp -110.06 125.6 53.12 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.945 178.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -92.91 152.89 19.11 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 123.574 0.546 . . . . 0.0 110.1 -177.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -77.83 -37.9 47.51 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.868 -176.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -108.56 178.31 4.52 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.462 HG22 ' HA ' ' A' ' 96' ' ' ASP . 1.4 p -78.17 169.04 18.92 Favored 'General case' 0 N--CA 1.413 -2.292 0 C-N-CA 122.404 0.282 . . . . 0.0 110.4 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 25.3 p90 46.87 42.51 12.2 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.914 1.286 . . . . 0.0 114.232 176.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 67.65 23.46 8.73 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.414 1.086 . . . . 0.0 112.995 177.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.518 ' HA ' ' NE ' ' A' ' 36' ' ' ARG . 4.4 mmp_? -98.22 165.2 11.99 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.41 -157.8 33.47 Favored Glycine 0 N--CA 1.434 -1.436 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.5 p -85.99 176.64 7.93 Favored 'General case' 0 N--CA 1.421 -1.892 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 174.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.435 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 11.7 p90 -149.36 165.79 30.98 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 13.4 tt -123.03 150.81 27.07 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.747 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -106.88 125.21 50.71 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 174.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.472 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 94.8 t -118.13 133.69 64.13 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -117.86 -26.4 6.5 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.282 0.563 . . . . 0.0 110.569 -176.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -115.73 163.14 16.27 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.334 -174.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.4 ' HB3' ' H ' ' A' ' 110' ' ' ARG . 6.2 p -84.06 143.53 29.67 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 175.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.5 p -120.75 132.38 70.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.56 -16.96 54.12 Favored Glycine 0 N--CA 1.433 -1.536 0 C-N-CA 119.77 -1.205 . . . . 0.0 113.457 -177.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.4 p -157.4 124.29 5.06 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 81.8 mt -117.73 118.65 32.64 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 18.9 m -133.09 116.85 14.56 Favored Pre-proline 0 N--CA 1.42 -1.942 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.154 175.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 58.5 Cg_endo -75.62 160.08 96.49 Favored 'Cis proline' 0 C--O 1.251 1.14 0 C-N-CA 122.779 -1.759 . . . . 0.0 110.438 -4.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.0 157.33 29.61 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 122.69 2.26 . . . . 0.0 111.483 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 48.4 m0 -89.66 132.34 35.19 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -178.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.614 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 41.6 p -113.28 78.67 3.45 Favored Pre-proline 0 C--N 1.304 -1.375 0 O-C-N 123.252 0.345 . . . . 0.0 111.144 177.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.48 ' HG2' ' CD2' ' A' ' 97' ' ' PHE . 73.7 Cg_endo -76.37 153.44 35.43 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 122.198 1.932 . . . . 0.0 112.691 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -87.44 -28.53 24.46 Favored Glycine 0 N--CA 1.431 -1.638 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 178.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.7 p -155.08 154.96 33.21 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.6 t -134.01 142.25 41.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -178.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 31.6 t -146.11 149.64 34.42 Favored 'General case' 0 N--CA 1.433 -1.289 0 C-N-CA 119.637 -0.825 . . . . 0.0 111.52 176.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.7 t -118.03 124.11 28.99 Favored Pre-proline 0 N--CA 1.437 -1.117 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 175.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.89 143.52 79.87 Favored 'Trans proline' 0 C--O 1.246 0.877 0 C-N-CA 122.604 2.203 . . . . 0.0 112.281 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -66.89 136.37 55.29 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.172 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.469 HG12 ' H ' ' A' ' 65' ' ' ASP . 84.5 t -120.61 129.76 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.9 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -121.48 27.59 8.19 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 124.125 0.97 . . . . 0.0 108.818 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.469 ' H ' HG12 ' A' ' 63' ' ' VAL . 7.0 t0 -59.73 144.99 46.67 Favored 'General case' 0 C--O 1.248 1.014 0 C-N-CA 125.887 1.675 . . . . 0.0 111.054 -177.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.3 m -63.74 -14.88 56.33 Favored 'General case' 0 CA--C 1.559 1.316 0 C-N-CA 124.325 1.05 . . . . 0.0 111.315 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.4 ' HG2' ' OD1' ' A' ' 65' ' ' ASP . 33.7 mmtp -63.68 166.68 6.66 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.977 0.418 . . . . 0.0 110.763 175.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 57.3 mtm180 -90.97 -28.53 17.97 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.293 1.044 . . . . 0.0 109.152 -173.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -109.76 131.16 55.32 Favored 'General case' 0 N--CA 1.409 -2.501 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.661 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -106.18 153.96 39.97 Favored Pre-proline 0 C--N 1.301 -1.522 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.485 177.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -71.94 141.94 37.82 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.26 1.974 . . . . 0.0 113.464 -176.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -133.84 144.35 48.89 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.606 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 88.0 m95 -123.76 137.26 54.72 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.5 -0.75 . . . . 0.0 111.968 -175.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.434 ' HA ' ' O ' ' A' ' 86' ' ' THR . 29.6 m-85 -117.81 141.52 48.32 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.38 177.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.8 mt -125.73 143.07 51.2 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.416 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 74.8 m-85 -134.08 143.18 47.86 Favored 'General case' 0 C--O 1.242 0.688 0 O-C-N 123.518 0.512 . . . . 0.0 110.24 -176.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.507 ' HB3' ' CG ' ' A' ' 102' ' ' PHE . 4.3 p-10 -89.17 -0.63 57.6 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.416 HD22 ' HA ' ' A' ' 78' ' ' ASN . 2.9 t-20 -131.21 157.4 43.31 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 174.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.587 HG23 HD22 ' A' ' 80' ' ' ASN . 35.3 m -67.98 169.19 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 120.732 0.301 . . . . 0.0 110.947 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.587 HD22 HG23 ' A' ' 79' ' ' VAL . 64.6 m-80 58.67 30.31 19.73 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 123.825 0.85 . . . . 0.0 111.335 178.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.499 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 13.4 m-85 57.51 38.7 28.13 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 124.659 1.184 . . . . 0.0 111.439 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 72.6 p -111.93 171.27 7.6 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.592 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.32 -138.65 14.78 Favored Glycine 0 N--CA 1.429 -1.833 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 59.1 mtt180 -79.21 153.34 30.06 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.5 tt -128.35 138.71 53.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -177.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 75.2 m -131.52 127.47 37.33 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 175.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -112.38 125.7 7.25 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.149 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.524 HD21 HD11 ' A' ' 94' ' ' ILE . 3.2 mm? -118.2 145.99 44.56 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 123.061 0.544 . . . . 0.0 110.749 178.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -117.45 168.74 12.98 Favored Glycine 0 N--CA 1.428 -1.899 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.95 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 23.5 p80 -62.71 122.17 15.22 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 123.6 0.76 . . . . 0.0 111.895 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.38 17.8 58.21 Favored Glycine 0 N--CA 1.431 -1.669 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.656 177.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.2 m -129.67 146.71 51.43 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.5 m -139.53 152.93 47.32 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.524 HD11 HD21 ' A' ' 88' ' ' LEU . 52.1 mt -93.63 122.15 44.87 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.448 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 171.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -70.57 -46.81 62.78 Favored 'General case' 0 C--N 1.289 -2.063 0 O-C-N 123.67 0.606 . . . . 0.0 110.809 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.647 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 5.4 m-20 -127.06 86.95 2.57 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.159 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.48 ' CD2' ' HG2' ' A' ' 55' ' ' PRO . 69.5 t80 -65.59 -36.17 82.95 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.359 0.599 . . . . 0.0 110.592 177.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.0 t -75.67 -15.85 60.26 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.976 -173.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.647 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 30.7 mmtp -94.35 -8.91 37.48 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.1 m -82.29 -168.16 1.86 Allowed 'General case' 0 C--O 1.248 0.982 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.961 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -54.47 -69.42 1.25 Allowed Glycine 0 C--O 1.242 0.64 0 O-C-N 123.109 0.256 . . . . 0.0 113.112 -177.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.507 ' CG ' ' HB3' ' A' ' 77' ' ' ASP . 42.3 p90 -110.39 146.17 36.28 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.343 179.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.614 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.66 -11.65 12.94 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 176.41 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.34 104.27 2.2 Favored Glycine 0 N--CA 1.44 -1.068 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.462 -176.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 70.4 mt -88.95 115.37 28.67 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.586 0 CA-C-O 122.533 1.159 . . . . 0.0 109.115 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 52.7 m -85.83 -27.44 25.1 Favored 'General case' 0 N--CA 1.395 -3.222 0 CA-C-N 112.108 -2.315 . . . . 0.0 113.934 177.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 81.0 p -157.4 155.58 30.76 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.1 mt -135.09 131.2 52.41 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.64 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -175.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.499 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 38.2 ttmt -117.45 133.51 55.89 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.4 ' H ' ' HB3' ' A' ' 45' ' ' SER . 54.3 ttp180 -100.43 130.02 46.46 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 61.3 m -130.06 172.88 11.27 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.571 -178.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.5 pt -131.77 143.55 39.98 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -113.79 121.1 43.03 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-O 121.382 0.61 . . . . 0.0 109.801 -178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.512 ' OG1' ' HG2' ' A' ' 118' ' ' LYS . 70.6 p -76.91 -179.97 5.8 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 114.316 -1.311 . . . . 0.0 112.155 -174.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -66.4 -30.97 71.45 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.81 172.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -76.76 -8.89 58.15 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.982 0.896 . . . . 0.0 110.199 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.89 -4.48 83.33 Favored Glycine 0 N--CA 1.435 -1.395 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.253 176.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.512 ' HG2' ' OG1' ' A' ' 114' ' ' THR . 10.7 ptmm? -76.13 135.13 39.83 Favored 'General case' 0 C--O 1.258 1.511 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 27.0 t -100.39 111.09 29.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 -177.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -96.69 149.44 21.81 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 -177.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 84.0 m -129.88 169.53 15.07 Favored 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.755 -175.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 5.1 tp -73.37 136.67 24.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 177.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -69.6 109.03 4.09 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 122.39 1.091 . . . . 0.0 109.561 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.564 ' HA ' HE21 ' A' ' 124' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.283 -2.287 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.004 -178.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.506 ' N ' ' HG ' ' A' ' 22' ' ' SER . . . . . . . . 0 N--CA 1.473 1.111 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.36 -9.21 58.36 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 122.07 0.938 . . . . 0.0 110.257 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -83.02 -16.89 45.32 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.73 177.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.506 ' HG ' ' N ' ' A' ' 19' ' ' GLY . 15.0 m -83.02 138.59 33.69 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.2 p -116.38 157.62 24.78 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.07 135.59 43.01 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 68.15 39.14 2.46 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.081 0.552 . . . . 0.0 112.207 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 34.7 m -124.41 145.73 49.31 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.616 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 57.3 tp -99.87 116.18 31.33 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 172.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.45 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 38.0 mt-30 -110.62 124.28 51.58 Favored 'General case' 0 CA--C 1.485 -1.529 0 C-N-CA 119.329 -0.948 . . . . 0.0 109.288 -177.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.444 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.3 mp -109.71 131.21 55.27 Favored 'General case' 0 N--CA 1.409 -2.521 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.238 176.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.536 ' CE2' ' HG3' ' A' ' 35' ' ' GLU . 97.8 m-85 -98.14 154.86 17.45 Favored 'General case' 0 C--N 1.293 -1.858 0 O-C-N 123.354 0.409 . . . . 0.0 110.568 -176.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -77.79 -43.61 30.09 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.481 0.657 . . . . 0.0 109.501 -176.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -108.43 178.45 4.49 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.302 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.625 ' HA ' ' OG ' ' A' ' 57' ' ' SER . 0.5 OUTLIER -83.43 179.94 7.53 Favored 'General case' 0 N--CA 1.401 -2.915 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.582 -177.546 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 48.47 40.42 14.97 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.867 0.867 . . . . 0.0 113.258 176.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.536 ' HG3' ' CE2' ' A' ' 30' ' ' TYR . 1.0 OUTLIER 57.9 23.7 10.08 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 115.232 1.568 . . . . 0.0 115.232 178.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -105.51 173.27 6.38 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 118.012 -1.475 . . . . 0.0 111.016 177.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.23 -177.39 45.84 Favored Glycine 0 N--CA 1.428 -1.873 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 -178.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 44.4 m -84.41 143.67 29.28 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.393 176.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 12.4 p90 -116.13 165.92 12.6 Favored 'General case' 0 C--N 1.272 -2.781 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -174.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.0 tt -114.9 152.08 16.56 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.543 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -106.8 125.55 51.14 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 175.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 94.4 t -122.84 133.46 68.88 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -122.61 -14.2 7.81 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.1 mmtp -110.1 162.24 14.76 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.646 -171.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.442 ' HB3' ' H ' ' A' ' 110' ' ' ARG . 2.3 p -97.98 133.19 42.8 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 171.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.8 p -116.74 137.48 50.45 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 -174.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.35 -18.49 35.95 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 119.755 -1.212 . . . . 0.0 113.321 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.5 p -155.81 121.34 4.91 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 86.0 mt -113.06 118.45 34.82 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.043 -0.981 . . . . 0.0 108.741 176.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.0 m -133.15 112.72 13.3 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 174.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.03 161.84 93.53 Favored 'Cis proline' 0 C--O 1.248 0.997 0 C-N-CA 123.313 -1.536 . . . . 0.0 111.255 -0.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -63.12 158.24 45.0 Favored 'Trans proline' 0 C--O 1.246 0.882 0 C-N-CA 122.387 2.058 . . . . 0.0 110.509 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -89.24 133.58 34.39 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 8.0 p -115.64 77.68 6.33 Favored Pre-proline 0 C--N 1.295 -1.799 0 O-C-N 123.628 0.58 . . . . 0.0 111.031 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.444 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 95.7 Cg_endo -77.65 158.09 32.0 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.286 1.991 . . . . 0.0 112.961 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.89 -39.45 11.77 Favored Glycine 0 N--CA 1.433 -1.55 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 176.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.625 ' OG ' ' HA ' ' A' ' 33' ' ' THR . 55.7 m -149.58 161.21 42.6 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.477 1.111 . . . . 0.0 108.26 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.402 HG22 HD23 ' A' ' 29' ' ' LEU . 38.9 t -135.35 142.33 40.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 48.8 t -146.1 147.99 32.16 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.435 176.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.7 t -116.29 122.34 32.23 Favored Pre-proline 0 N--CA 1.438 -1.066 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.44 ' HD3' HE21 ' A' ' 28' ' ' GLN . 35.5 Cg_endo -64.68 147.41 89.9 Favored 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 122.57 2.18 . . . . 0.0 111.108 -179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -70.1 134.61 48.37 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.427 HG12 ' H ' ' A' ' 65' ' ' ASP . 57.9 t -121.08 123.51 70.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -120.72 26.27 9.21 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.427 ' H ' HG12 ' A' ' 63' ' ' VAL . 9.8 t70 -58.4 144.85 40.46 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.215 -1.357 . . . . 0.0 110.319 -178.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.5 m -60.22 -20.57 59.37 Favored 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 123.3 0.64 . . . . 0.0 111.616 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -58.79 139.5 56.25 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -68.63 -24.14 64.52 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.77 -175.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.41 130.52 55.67 Favored 'General case' 0 N--CA 1.418 -2.032 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.95 154.97 40.68 Favored Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.951 175.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.47 134.91 14.32 Favored 'Trans proline' 0 N--CA 1.446 -1.296 0 C-N-CA 121.779 1.653 . . . . 0.0 110.662 177.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -129.26 143.7 50.95 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.616 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 88.9 m95 -125.47 132.76 52.62 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 120.204 -0.598 . . . . 0.0 112.131 -173.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 86' ' ' THR . 27.2 m-85 -114.98 141.61 47.75 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.893 176.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.8 mt -125.72 142.72 51.37 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -175.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.42 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 77.5 m-85 -133.82 143.03 48.11 Favored 'General case' 0 C--N 1.317 -0.813 0 O-C-N 123.634 0.584 . . . . 0.0 109.923 -177.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.562 ' HB3' ' CG ' ' A' ' 102' ' ' PHE . 2.8 p-10 -88.39 0.87 55.75 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.652 -178.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.472 ' HA ' HD22 ' A' ' 78' ' ' ASN . 2.0 t-20 -134.49 160.12 39.01 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 176.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.495 HG23 HD22 ' A' ' 80' ' ' ASN . 33.8 m -73.18 167.14 2.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-O 120.61 0.243 . . . . 0.0 111.427 -176.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.495 HD22 HG23 ' A' ' 79' ' ' VAL . 64.7 m-80 57.96 31.1 20.15 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 123.771 0.829 . . . . 0.0 111.421 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.566 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 10.9 m-85 59.64 39.37 21.32 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.893 1.277 . . . . 0.0 111.465 177.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 74.3 p -111.58 176.19 5.12 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.12 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.91 -137.43 15.16 Favored Glycine 0 N--CA 1.429 -1.825 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.835 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 56.2 mtt180 -83.81 150.86 25.49 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 123.547 0.739 . . . . 0.0 109.471 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.9 tt -124.84 139.39 51.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 121.179 0.514 . . . . 0.0 110.667 -176.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 90.7 m -131.47 128.2 38.93 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 174.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -115.06 117.43 4.01 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.541 -0.838 . . . . 0.0 113.194 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.434 HD21 HD11 ' A' ' 94' ' ' ILE . 4.0 mm? -109.9 145.55 36.65 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.017 0.437 . . . . 0.0 110.964 178.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -122.58 170.9 15.34 Favored Glycine 0 N--CA 1.419 -2.495 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.467 -177.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -63.6 121.5 14.06 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.299 0.571 . . . . 0.0 111.734 -176.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.6 14.72 61.05 Favored Glycine 0 N--CA 1.434 -1.479 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.908 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.6 m -125.09 146.14 49.6 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.9 m -139.15 160.06 40.69 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.434 HD11 HD21 ' A' ' 88' ' ' LEU . 50.0 mt -94.06 132.18 38.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 173.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -69.93 -48.41 58.57 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.033 0.444 . . . . 0.0 110.563 -177.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.477 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 11.1 m-20 -142.82 93.18 2.48 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.573 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.433 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 49.1 t80 -64.63 -30.06 71.07 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.573 0.701 . . . . 0.0 109.391 178.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.0 t -63.65 -25.07 68.05 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.537 177.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.477 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 34.4 mmtp -94.88 -5.59 44.61 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.936 -0.477 . . . . 0.0 110.837 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.9 m -79.61 -176.84 5.54 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -56.37 -63.8 4.98 Favored Glycine 0 C--O 1.249 1.052 0 CA-C-O 121.017 0.232 . . . . 0.0 112.781 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.562 ' CG ' ' HB3' ' A' ' 77' ' ' ASP . 39.9 p90 -110.92 147.23 35.07 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 177.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.94 -9.89 12.98 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.586 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -107.45 113.62 4.02 Favored Glycine 0 N--CA 1.431 -1.66 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.474 -177.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 62.6 mt -96.94 115.18 35.81 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.641 0 CA-C-O 122.336 1.065 . . . . 0.0 108.919 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.7 m -85.61 -29.68 23.89 Favored 'General case' 0 N--CA 1.392 -3.335 0 CA-C-N 112.242 -2.253 . . . . 0.0 113.685 177.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 89.2 p -153.11 155.52 36.93 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.0 mt -135.29 130.17 50.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -176.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.566 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 35.8 ttmt -117.32 131.15 56.86 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.442 ' H ' ' HB3' ' A' ' 45' ' ' SER . 25.7 ttp180 -101.76 123.14 45.23 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . 0.439 ' SG ' ' HD2' ' A' ' 74' ' ' TYR . 60.0 m -119.69 172.5 7.64 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -177.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.6 pt -128.12 141.95 45.1 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -115.68 120.29 38.89 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 108.39 -0.966 . . . . 0.0 108.39 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 44.1 p -76.93 175.53 9.44 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.799 -174.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -67.51 -20.68 65.47 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.628 0.727 . . . . 0.0 109.043 176.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -77.43 -9.59 58.97 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.512 177.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.28 -9.7 76.81 Favored Glycine 0 N--CA 1.439 -1.163 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.187 176.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -74.56 141.47 44.77 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 117.345 0.573 . . . . 0.0 110.225 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.7 t -106.68 111.28 34.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -105.85 148.09 27.96 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.51 153.21 49.06 Favored 'General case' 0 C--N 1.285 -2.207 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.464 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 7.3 tp -125.53 124.6 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.16 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.371 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.448 ' C ' HD22 ' A' ' 123' ' ' ASN . 0.2 OUTLIER -91.57 108.46 19.92 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 176.269 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 . . . . . 0 C--N 1.287 -2.13 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.459 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.276 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.69 76.64 9.48 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 172.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -80.34 -24.85 39.57 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.142 -174.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.0 m -76.34 125.04 28.47 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 171.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 22.1 p -102.13 149.8 23.91 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.256 -0.978 . . . . 0.0 111.536 -173.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.8 tptt -73.89 139.83 45.26 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.716 -176.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 59.25 37.9 23.55 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.638 0.775 . . . . 0.0 112.935 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 34.5 m -123.08 145.56 48.44 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.499 ' HB3' ' HB ' ' A' ' 42' ' ' VAL . 49.6 tp -93.68 116.8 29.31 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 174.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.498 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 37.0 mt-30 -111.69 124.78 53.05 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -177.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 3.9 mp -109.6 129.06 55.61 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.24 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.556 ' CE1' ' HG3' ' A' ' 35' ' ' GLU . 94.6 m-85 -97.16 153.66 17.84 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 123.907 0.754 . . . . 0.0 111.644 -174.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -74.48 -41.64 60.4 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.058 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -107.83 177.65 4.76 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 56' ' ' GLY . 3.4 p -82.11 173.01 12.55 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 19.2 p90 47.46 38.76 8.19 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.556 ' HG3' ' CE1' ' A' ' 30' ' ' TYR . 0.7 OUTLIER 67.43 25.76 8.49 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 124.805 1.242 . . . . 0.0 113.637 177.229 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.7 mtp85 -90.74 159.22 16.44 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 177.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.99 -136.89 13.74 Favored Glycine 0 N--CA 1.422 -2.242 0 CA-C-N 114.365 -1.288 . . . . 0.0 109.911 178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.2 m -116.68 -179.49 3.7 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 175.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 33.8 p90 -141.36 165.29 27.91 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -178.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 17.3 tt -114.63 152.65 16.24 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 177.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -106.71 126.11 51.87 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.499 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 88.2 t -123.43 133.15 69.98 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 176.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -115.53 -35.7 4.49 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-O 121.604 0.716 . . . . 0.0 109.397 -175.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.25 161.03 24.02 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.113 -177.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.429 ' HB3' ' H ' ' A' ' 110' ' ' ARG . 4.9 p -69.03 147.83 50.98 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 123.579 0.549 . . . . 0.0 111.517 -178.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.4 p -121.4 131.19 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.06 -15.86 55.24 Favored Glycine 0 N--CA 1.432 -1.633 0 C-N-CA 119.749 -1.215 . . . . 0.0 113.08 -178.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.5 p -156.74 127.54 6.74 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 83.3 mt -122.57 118.36 28.02 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.474 177.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 14.5 m -133.5 113.46 13.12 Favored Pre-proline 0 C--N 1.306 -1.302 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.103 174.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 73.2 Cg_endo -75.22 162.1 93.38 Favored 'Cis proline' 0 CA--C 1.539 0.734 0 C-N-CA 123.27 -1.554 . . . . 0.0 111.168 -0.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -63.6 156.84 54.62 Favored 'Trans proline' 0 C--O 1.238 0.505 0 C-N-CA 121.928 1.752 . . . . 0.0 110.695 177.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.401 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 49.2 m0 -89.46 134.83 33.92 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -177.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.62 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 58.0 p -113.87 81.0 5.59 Favored Pre-proline 0 N--CA 1.434 -1.236 0 O-C-N 123.431 0.457 . . . . 0.0 111.199 176.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.42 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 95.7 Cg_endo -79.47 158.42 25.63 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.699 2.266 . . . . 0.0 112.447 177.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.427 ' O ' HG22 ' A' ' 33' ' ' THR . . . -87.93 -35.85 8.8 Favored Glycine 0 N--CA 1.429 -1.814 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 176.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 94' ' ' ILE . 89.4 p -150.3 158.15 43.85 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.451 HG22 HD23 ' A' ' 29' ' ' LEU . 43.2 t -132.09 142.57 42.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 93' ' ' CYS . 38.4 t -145.43 149.55 34.92 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.614 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.1 t -117.28 126.63 27.27 Favored Pre-proline 0 C--N 1.317 -0.808 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.24 142.76 98.97 Favored 'Trans proline' 0 C--O 1.248 1.019 0 C-N-CA 122.851 2.367 . . . . 0.0 111.839 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.452 ' CE1' ' HB3' ' A' ' 64' ' ' ASN . 59.4 t80 -73.48 124.19 25.37 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 122.031 0.92 . . . . 0.0 111.456 -176.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.456 ' H ' ' HB2' ' A' ' 90' ' ' HIS . 91.0 t -109.76 117.67 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 CA-C-N 114.428 -1.26 . . . . 0.0 107.929 178.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.452 ' HB3' ' CE1' ' A' ' 62' ' ' PHE . 4.9 p-10 -122.38 11.31 9.99 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -69.31 145.55 52.94 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 111.664 -2.516 . . . . 0.0 112.631 -173.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 m -53.81 -7.58 0.13 Allowed 'General case' 0 CA--C 1.564 1.496 0 C-N-CA 128.353 2.661 . . . . 0.0 114.816 -175.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.482 ' H ' ' HD2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -66.7 154.36 40.85 Favored 'General case' 0 C--N 1.316 -0.887 0 O-C-N 122.173 -0.329 . . . . 0.0 110.692 -176.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -79.48 -28.4 41.51 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.741 -0.209 . . . . 0.0 111.206 -175.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.424 ' HG2' HD12 ' A' ' 112' ' ' ILE . 9.8 mp0 -110.54 144.75 38.93 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.395 177.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -106.24 151.44 40.2 Favored Pre-proline 0 C--N 1.307 -1.273 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 171.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -78.62 137.3 14.37 Favored 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 122.238 1.958 . . . . 0.0 111.974 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -132.92 132.78 42.4 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.487 ' CE3' HD22 ' A' ' 27' ' ' LEU . 87.2 m95 -116.67 134.88 54.28 Favored 'General case' 0 C--N 1.293 -1.868 0 O-C-N 121.78 -0.575 . . . . 0.0 111.366 -174.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.469 ' HD1' ' SG ' ' A' ' 111' ' ' CYS . 29.0 m-85 -116.07 142.3 46.99 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.617 178.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.2 mt -125.89 142.69 51.4 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -176.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.539 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 81.4 m-85 -134.38 142.55 47.23 Favored 'General case' 0 C--O 1.245 0.82 0 O-C-N 123.719 0.637 . . . . 0.0 110.174 -176.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.45 ' C ' ' HB2' ' A' ' 106' ' ' SER . 0.8 OUTLIER -80.95 -9.95 59.77 Favored 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.58 -179.051 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -127.54 162.31 26.75 Favored 'General case' 0 N--CA 1.427 -1.605 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.426 177.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.413 HG23 HD22 ' A' ' 80' ' ' ASN . 24.5 m -73.19 168.75 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 122.804 0.442 . . . . 0.0 110.588 -176.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.413 HD22 HG23 ' A' ' 79' ' ' VAL . 43.6 m-80 57.66 30.35 18.72 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.612 0.72 . . . . 0.0 111.217 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.401 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 16.2 m-85 59.26 40.3 21.56 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.198 176.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 76.6 p -111.5 175.52 5.39 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.517 -0.473 . . . . 0.0 109.742 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.54 -140.62 16.16 Favored Glycine 0 N--CA 1.422 -2.259 0 C-N-CA 120.363 -0.923 . . . . 0.0 111.508 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.539 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 32.7 mtt180 -82.93 151.87 25.75 Favored 'General case' 0 C--N 1.287 -2.131 0 C-N-CA 123.487 0.715 . . . . 0.0 109.82 -179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.3 tt -122.61 137.2 56.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-O 121.198 0.523 . . . . 0.0 110.251 -177.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 95.2 m -131.62 125.82 33.17 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 175.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -115.05 110.09 2.23 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.625 -0.798 . . . . 0.0 114.63 -176.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.45 HD21 HD11 ' A' ' 94' ' ' ILE . 3.9 mm? -101.92 145.51 29.14 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 120.967 0.413 . . . . 0.0 111.279 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -123.32 169.67 15.58 Favored Glycine 0 N--CA 1.419 -2.478 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.866 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.456 ' HB2' ' H ' ' A' ' 63' ' ' VAL . 7.3 p80 -53.36 122.03 8.8 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 124.056 0.943 . . . . 0.0 113.109 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.39 -5.8 80.69 Favored Glycine 0 CA--C 1.5 -0.857 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.873 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.3 m -106.25 146.39 30.4 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-O 121.219 0.533 . . . . 0.0 109.782 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 59' ' ' CYS . 3.8 m -134.74 159.11 42.35 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.45 HD11 HD21 ' A' ' 88' ' ' LEU . 41.5 mt -93.44 130.43 42.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 175.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -65.8 -47.14 76.08 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.152 0.501 . . . . 0.0 110.066 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.579 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 2.9 m-20 -143.16 99.58 3.47 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 123.719 0.808 . . . . 0.0 108.966 178.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -63.96 -31.85 73.18 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.62 0.724 . . . . 0.0 110.839 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.5 t -63.34 -23.44 67.42 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.735 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.579 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 28.8 mmtp -94.56 -16.1 23.54 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 121.839 -0.538 . . . . 0.0 110.104 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.1 m -63.87 -34.32 77.68 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-O 121.116 0.484 . . . . 0.0 111.283 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 158.67 -67.38 0.28 Allowed Glycine 0 CA--C 1.488 -1.604 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -110.86 149.14 31.02 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.4 -9.64 13.33 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.26 177.229 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -106.25 108.18 2.88 Favored Glycine 0 N--CA 1.438 -1.189 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.017 -176.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 63.0 mt -92.11 116.04 32.4 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.59 0 CA-C-O 122.22 1.01 . . . . 0.0 109.067 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.45 ' HB2' ' C ' ' A' ' 77' ' ' ASP . 4.0 m -85.35 -29.28 24.61 Favored 'General case' 0 N--CA 1.396 -3.136 0 CA-C-N 112.565 -2.107 . . . . 0.0 114.231 176.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.3 p -154.92 155.15 33.78 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 122.191 -0.318 . . . . 0.0 110.239 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.3 mt -133.14 130.68 58.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.401 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 33.1 ttmt -117.71 133.71 55.66 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.429 ' H ' ' HB3' ' A' ' 45' ' ' SER . 58.6 ttt180 -99.8 126.77 45.94 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . 0.469 ' SG ' ' HD1' ' A' ' 74' ' ' TYR . 59.1 m -122.95 171.93 8.87 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -178.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 7.8 pt -127.52 143.49 40.51 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.298 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.586 177.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -117.02 119.45 35.32 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 51.1 p -80.89 178.31 8.49 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 114.228 -1.351 . . . . 0.0 112.363 -172.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -66.51 -23.6 66.27 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 172.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -83.3 -8.17 59.47 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.583 -1.189 . . . . 0.0 109.985 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.96 -11.36 57.51 Favored Glycine 0 N--CA 1.438 -1.186 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.769 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.47 137.05 54.13 Favored 'General case' 0 C--O 1.255 1.364 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 43.3 t -105.58 112.07 37.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -97.77 144.52 27.29 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 94.6 m -130.29 148.56 52.13 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 123.062 0.226 . . . . 0.0 110.903 -173.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 8.8 tp -80.38 121.52 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 CA-C-O 121.983 0.897 . . . . 0.0 110.864 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -90.24 110.31 21.36 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.74 177.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 . . . . . 0 C--N 1.294 -1.813 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.175 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.239 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.05 -5.79 29.08 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.47 0.652 . . . . 0.0 111.776 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -78.62 -24.18 45.48 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.718 177.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.7 m -108.81 134.23 51.78 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.167 -176.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.414 ' HB3' ' HB2' ' A' ' 26' ' ' CYS . 42.9 t -146.07 135.8 23.31 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.14 108.66 8.03 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -177.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.434 ' CE1' HG11 ' A' ' 63' ' ' VAL . 5.0 m-85 68.78 49.66 0.68 Allowed 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.631 0.729 . . . . 0.0 110.694 176.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.414 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 20.0 m -128.74 145.6 51.13 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.582 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 54.9 tp -105.68 127.24 52.94 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 177.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.486 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 71.6 mt-30 -114.73 124.75 52.58 Favored 'General case' 0 CA--C 1.49 -1.358 0 C-N-CA 119.889 -0.724 . . . . 0.0 109.61 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.5 mp -109.86 123.91 50.4 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.214 176.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.411 ' CD1' ' HB3' ' A' ' 39' ' ' TYR . 89.6 m-85 -95.12 151.9 18.8 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 123.832 0.707 . . . . 0.0 110.678 -174.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -74.71 -38.64 62.28 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.113 0.483 . . . . 0.0 110.41 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -108.33 178.17 4.58 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.013 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.496 ' O ' ' HB2' ' A' ' 36' ' ' ARG . 3.9 p -80.84 170.95 15.62 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 27.8 p90 46.8 42.27 11.64 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 66.62 21.97 10.57 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.283 1.033 . . . . 0.0 112.24 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 33' ' ' THR . 8.6 mmm180 -88.23 159.41 18.15 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.521 0.677 . . . . 0.0 111.785 177.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.14 -165.66 47.34 Favored Glycine 0 N--CA 1.428 -1.885 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.516 178.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.1 m -87.05 171.83 10.43 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.411 ' HB3' ' CD1' ' A' ' 30' ' ' TYR . 12.4 p90 -146.78 164.08 33.93 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -176.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 12.7 tt -115.01 152.53 16.61 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.648 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -107.05 124.92 50.35 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.559 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 89.8 t -115.1 132.84 63.16 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.641 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 178.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -114.43 -32.9 5.77 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 121.247 0.546 . . . . 0.0 110.047 -176.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.15 162.73 19.6 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.347 -176.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.6 p -74.74 151.59 39.15 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.147 0.498 . . . . 0.0 111.839 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.1 p -122.81 127.79 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 175.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.92 -14.56 60.69 Favored Glycine 0 C--N 1.301 -1.378 0 C-N-CA 119.368 -1.396 . . . . 0.0 112.906 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.2 p -160.25 125.9 4.04 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 121.086 0.469 . . . . 0.0 112.004 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 79.7 mt -116.01 118.63 33.44 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 18.9 m -132.7 111.25 13.54 Favored Pre-proline 0 C--N 1.288 -2.101 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 174.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 71.8 Cg_endo -76.9 161.86 92.67 Favored 'Cis proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.012 -1.662 . . . . 0.0 111.433 0.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -63.44 158.18 46.68 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 122.33 2.02 . . . . 0.0 111.05 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 49.5 m0 -89.86 138.91 31.09 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 10.5 p -120.62 76.45 27.2 Favored Pre-proline 0 C--N 1.296 -1.756 0 O-C-N 123.555 0.534 . . . . 0.0 111.477 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.479 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 83.6 Cg_endo -77.54 158.03 32.39 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.779 2.319 . . . . 0.0 113.232 179.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.13 -29.93 13.81 Favored Glycine 0 N--CA 1.429 -1.832 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 175.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.8 p -155.46 158.79 39.13 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.8 t -133.76 143.2 39.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 38.9 t -145.47 148.11 32.91 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.787 175.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.8 t -114.61 117.34 42.65 Favored Pre-proline 0 N--CA 1.428 -1.552 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 175.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -56.57 147.25 70.97 Favored 'Trans proline' 0 C--O 1.247 0.975 0 C-N-CA 122.759 2.306 . . . . 0.0 111.909 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -75.58 112.63 12.12 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.447 HG12 ' H ' ' A' ' 65' ' ' ASP . 36.8 t -93.85 114.57 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.677 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -109.7 32.79 4.78 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.318 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.547 ' OD1' ' HG2' ' A' ' 67' ' ' LYS . 6.2 t70 -75.33 144.61 42.29 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 113.832 -1.531 . . . . 0.0 108.007 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 m -56.54 -11.58 1.36 Allowed 'General case' 0 CA--C 1.577 1.984 0 C-N-CA 125.264 1.426 . . . . 0.0 114.203 -174.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.547 ' HG2' ' OD1' ' A' ' 65' ' ' ASP . 15.5 mmtp -67.66 145.02 55.21 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 122.984 0.514 . . . . 0.0 109.696 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -81.39 -14.13 57.52 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 120.826 0.346 . . . . 0.0 111.703 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -104.14 127.86 51.77 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -105.98 150.19 38.97 Favored Pre-proline 0 C--N 1.291 -1.939 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -76.48 140.18 21.29 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 121.771 1.647 . . . . 0.0 112.764 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -133.38 129.29 37.2 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.582 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 82.6 m95 -110.82 139.69 45.9 Favored 'General case' 0 C--N 1.284 -2.26 0 O-C-N 121.897 -0.502 . . . . 0.0 112.162 -172.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.473 ' HD2' ' SG ' ' A' ' 111' ' ' CYS . 35.9 m-85 -117.7 142.51 47.16 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.495 177.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.3 mt -125.59 142.45 51.5 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -176.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.522 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 77.9 m-85 -133.5 141.34 47.73 Favored 'General case' 0 C--N 1.318 -0.765 0 O-C-N 123.64 0.587 . . . . 0.0 109.958 -176.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.422 ' HB3' ' CD2' ' A' ' 102' ' ' PHE . 10.3 p-10 -81.09 -15.19 56.67 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -177.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.43 ' C ' ' HB3' ' A' ' 106' ' ' SER . 5.6 t-20 -125.59 165.16 19.04 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.403 HG23 HD22 ' A' ' 80' ' ' ASN . 34.8 m -68.81 168.51 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 123.146 0.579 . . . . 0.0 111.615 -177.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.403 HD22 HG23 ' A' ' 79' ' ' VAL . 46.0 m-80 56.44 30.25 16.71 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.852 0.861 . . . . 0.0 111.233 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.513 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 11.2 m-85 55.66 48.79 17.76 Favored 'General case' 0 C--O 1.25 1.131 0 C-N-CA 124.596 1.158 . . . . 0.0 110.785 178.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 74.6 p -117.43 168.53 10.28 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.862 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.3 -131.19 10.67 Favored Glycine 0 N--CA 1.416 -2.682 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 66.5 mtt85 -87.25 144.14 26.95 Favored 'General case' 0 C--N 1.279 -2.462 0 C-N-CA 124.332 1.053 . . . . 0.0 109.506 -178.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.4 tt -121.87 136.63 58.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-O 121.301 0.572 . . . . 0.0 110.045 -177.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 94.6 m -132.02 123.9 28.22 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.132 175.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -109.02 130.15 9.88 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.945 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.41 HD21 HD11 ' A' ' 94' ' ' ILE . 3.1 mm? -119.61 145.63 46.25 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 123.335 0.654 . . . . 0.0 110.632 178.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -113.22 166.17 12.11 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.91 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.401 ' HB2' ' H ' ' A' ' 63' ' ' VAL . 8.4 p80 -62.47 122.76 16.55 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.256 0.55 . . . . 0.0 111.796 -178.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 92.15 -0.72 72.55 Favored Glycine 0 N--CA 1.433 -1.512 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.47 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.1 m -112.34 146.54 38.11 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 4.5 m -133.56 160.66 36.82 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.41 HD11 HD21 ' A' ' 88' ' ' LEU . 49.2 mt -93.63 130.98 41.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 173.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -70.39 -47.42 60.92 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.245 0.545 . . . . 0.0 110.938 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.444 ' HA ' HG22 ' A' ' 33' ' ' THR . 5.2 m-20 -143.69 98.42 3.24 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -64.66 -30.04 71.05 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.649 0.738 . . . . 0.0 110.518 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.9 t -63.61 -22.8 67.09 Favored 'General case' 0 CA--C 1.555 1.155 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.9 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -95.36 -6.69 40.49 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.101 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.6 m -70.46 -40.55 73.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.118 0.485 . . . . 0.0 111.026 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 156.91 -65.0 0.31 Allowed Glycine 0 CA--C 1.491 -1.462 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.422 ' CD2' ' HB3' ' A' ' 77' ' ' ASP . 39.7 p90 -109.17 145.55 35.6 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.26 -9.12 13.47 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 119.892 -0.723 . . . . 0.0 109.351 177.741 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.39 106.55 2.57 Favored Glycine 0 N--CA 1.43 -1.73 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.614 -177.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 84.7 mt -91.38 115.08 29.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.43 ' HB3' ' C ' ' A' ' 78' ' ' ASN . 5.1 t -86.41 -26.61 24.65 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.847 177.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 90.1 p -150.81 155.73 39.81 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.344 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.7 mt -136.22 130.89 48.47 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -176.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.513 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 35.9 ttmt -117.52 133.67 55.7 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -101.37 121.93 42.81 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -178.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . 0.473 ' SG ' ' HD2' ' A' ' 74' ' ' TYR . 50.4 m -119.49 172.18 7.82 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -177.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.5 pt -129.02 144.3 38.6 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.401 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 57.3 tt0 -115.21 123.8 49.79 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 45.3 p -77.58 177.14 8.3 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.14 -175.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -66.4 -23.81 66.38 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.657 0.741 . . . . 0.0 109.288 176.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -76.95 -9.42 58.68 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.522 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.22 -1.75 80.31 Favored Glycine 0 N--CA 1.435 -1.379 0 CA-C-N 116.219 -0.446 . . . . 0.0 113.261 177.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 113' ' ' GLN . 7.2 ptpp? -83.81 143.87 29.65 Favored 'General case' 0 CA--C 1.507 -0.703 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.964 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 17.8 t -103.82 112.23 36.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -100.59 149.95 23.21 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 1.7 t -141.78 146.19 35.64 Favored 'General case' 0 CA--C 1.48 -1.732 0 C-N-CA 117.972 -1.491 . . . . 0.0 110.002 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 8.9 tp -128.15 122.95 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.172 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.644 175.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -89.65 122.52 32.86 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 119.168 -1.013 . . . . 0.0 108.732 176.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 . . . . . 0 C--N 1.291 -1.95 0 CA-C-O 118.085 -0.96 . . . . 0.0 110.054 -177.713 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.703 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.68 -38.87 73.78 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.122 0.487 . . . . 0.0 110.576 -177.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -94.97 1.59 55.25 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.536 0.684 . . . . 0.0 110.916 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.5 m -89.2 124.41 34.34 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 175.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 21.5 p -113.8 140.71 48.08 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.64 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.45 ' HE3' ' HA ' ' A' ' 63' ' ' VAL . 9.7 mmmm -71.07 143.04 50.82 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.898 176.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 69.08 33.4 3.4 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-O 121.376 0.608 . . . . 0.0 111.905 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 36.4 m -124.58 145.92 49.33 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.575 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 54.7 tp -98.25 119.68 37.33 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 174.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.468 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 64.6 mt-30 -113.68 124.55 52.58 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 3.6 mp -109.59 131.06 55.41 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.038 177.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -90.81 156.29 18.15 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 123.763 0.664 . . . . 0.0 110.64 -176.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -77.06 -41.42 42.49 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.436 -176.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.445 ' C ' ' HA3' ' A' ' 56' ' ' GLY . 45.4 mt-10 -113.14 177.55 4.59 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.567 ' O ' ' HB2' ' A' ' 36' ' ' ARG . 2.0 p -82.58 174.81 10.7 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 23.4 p90 47.35 40.22 10.32 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.398 1.079 . . . . 0.0 113.617 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 65.46 26.66 11.84 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.59 1.156 . . . . 0.0 111.334 176.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.567 ' HB2' ' O ' ' A' ' 33' ' ' THR . 6.5 mmm180 -89.64 147.65 23.78 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.743 0.783 . . . . 0.0 111.939 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.17 -161.0 28.74 Favored Glycine 0 N--CA 1.419 -2.434 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.35 176.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.2 m -97.43 -177.14 3.72 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.438 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 50.4 p90 -142.16 165.97 25.99 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.4 tt -113.6 153.48 15.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -106.3 125.94 51.62 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.524 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 92.4 t -127.18 133.73 67.54 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 175.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -115.99 -31.86 5.59 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-O 121.113 0.482 . . . . 0.0 109.953 -176.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.43 161.85 33.43 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.512 -176.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.5 m -61.02 143.99 54.26 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.703 -175.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.6 p -121.37 136.94 56.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 176.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.31 -18.08 27.37 Favored Glycine 0 N--CA 1.435 -1.387 0 C-N-CA 120.077 -1.058 . . . . 0.0 113.907 -175.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.9 t -156.98 128.61 7.06 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 117.451 0.626 . . . . 0.0 109.57 -178.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 94.5 mt -120.17 119.67 33.93 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.208 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 20.7 p -131.7 107.96 14.29 Favored Pre-proline 0 C--N 1.298 -1.638 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.268 176.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 90.3 Cg_endo -77.73 162.68 89.52 Favored 'Cis proline' 0 C--O 1.242 0.718 0 C-N-CA 123.896 -1.294 . . . . 0.0 111.33 -1.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.45 156.31 42.18 Favored 'Trans proline' 0 C--O 1.243 0.753 0 C-N-CA 122.521 2.147 . . . . 0.0 109.879 176.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -89.65 129.62 36.06 Favored 'General case' 0 C--N 1.288 -2.088 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.13 -177.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.586 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 40.9 p -111.37 80.75 2.71 Favored Pre-proline 0 N--CA 1.424 -1.757 0 O-C-N 123.697 0.623 . . . . 0.0 110.537 176.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.412 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 91.8 Cg_endo -80.25 158.62 23.15 Favored 'Trans proline' 0 N--CA 1.443 -1.458 0 C-N-CA 122.22 1.946 . . . . 0.0 111.776 177.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.445 ' HA3' ' C ' ' A' ' 32' ' ' GLU . . . -86.73 -39.03 7.78 Favored Glycine 0 N--CA 1.425 -2.076 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 176.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.542 ' HB2' ' O ' ' A' ' 94' ' ' ILE . 72.9 p -147.65 160.96 42.1 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.417 HG22 HD23 ' A' ' 29' ' ' LEU . 42.6 t -137.11 142.23 38.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -177.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 36.9 t -145.52 149.1 34.0 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 119.704 -0.799 . . . . 0.0 111.386 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.9 t -116.78 125.2 28.54 Favored Pre-proline 0 N--CA 1.443 -0.78 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -61.0 143.66 99.38 Favored 'Trans proline' 0 C--O 1.242 0.688 0 C-N-CA 123.222 2.614 . . . . 0.0 112.53 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -70.99 122.0 19.21 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.661 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.45 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 93.4 t -96.67 115.39 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 CA-C-O 121.49 0.662 . . . . 0.0 109.57 177.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -101.72 -6.46 23.67 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 113.981 -1.463 . . . . 0.0 110.441 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -58.42 144.74 40.95 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 125.123 1.369 . . . . 0.0 112.034 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.2 m -55.68 -7.52 0.29 Allowed 'General case' 0 CA--C 1.571 1.772 0 C-N-CA 125.708 1.603 . . . . 0.0 113.105 -178.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -64.47 140.92 58.92 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.233 0.54 . . . . 0.0 110.183 178.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.562 ' HB2' ' OE2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -81.19 -28.11 35.08 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.032 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.562 ' OE2' ' HB2' ' A' ' 68' ' ' ARG . 2.4 mp0 -94.35 125.77 39.2 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.3 152.69 42.06 Favored Pre-proline 0 C--N 1.289 -2.058 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.388 174.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.52 134.78 21.04 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 121.505 1.47 . . . . 0.0 110.733 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -129.03 138.33 51.85 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.575 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 87.5 m95 -119.25 133.48 55.73 Favored 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.933 -173.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.507 ' HA ' ' O ' ' A' ' 86' ' ' THR . 24.6 m-85 -113.73 140.0 48.63 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.913 176.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.3 mt -125.31 142.74 51.33 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.583 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 84.8 m-85 -132.35 143.7 50.04 Favored 'General case' 0 C--N 1.32 -0.71 0 O-C-N 123.57 0.543 . . . . 0.0 110.903 -176.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -84.75 0.27 51.2 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.373 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -137.54 163.65 30.65 Favored 'General case' 0 N--CA 1.417 -2.092 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.463 HG23 HD22 ' A' ' 80' ' ' ASN . 32.6 m -75.5 168.95 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 C-N-CA 123.044 0.538 . . . . 0.0 111.151 -176.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.463 HD22 HG23 ' A' ' 79' ' ' VAL . 48.8 m-80 58.06 30.73 19.71 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.894 0.746 . . . . 0.0 111.065 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.592 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 9.6 m-85 59.44 39.14 22.3 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.98 1.312 . . . . 0.0 111.713 177.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 81.0 p -112.28 170.62 8.04 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.548 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.9 -143.67 16.69 Favored Glycine 0 N--CA 1.421 -2.352 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.167 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.583 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 62.6 mtt85 -75.15 140.36 43.31 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 124.17 0.988 . . . . 0.0 108.905 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.2 tt -118.09 137.5 51.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-O 121.016 0.436 . . . . 0.0 109.891 -175.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.507 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 87.9 m -130.83 121.47 25.37 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 176.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -109.14 120.65 5.9 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.779 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.415 HD21 HD11 ' A' ' 94' ' ' ILE . 2.7 mm? -115.35 145.36 42.58 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 122.85 0.46 . . . . 0.0 110.757 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -120.2 167.8 13.71 Favored Glycine 0 N--CA 1.429 -1.822 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.284 -177.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -58.25 123.42 15.98 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 123.434 0.694 . . . . 0.0 112.47 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.14 4.65 71.33 Favored Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.247 177.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.5 m -116.93 146.43 42.98 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.7 m -138.23 154.16 49.09 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.542 ' O ' ' HB2' ' A' ' 57' ' ' SER . 41.3 mt -94.58 126.03 47.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 173.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -70.84 -46.24 63.06 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 121.185 0.517 . . . . 0.0 111.391 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.587 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 3.1 m-20 -131.6 96.34 3.95 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 177.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.413 ' HA ' HG21 ' A' ' 94' ' ' ILE . 64.6 t80 -63.87 -36.72 84.84 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.302 0.572 . . . . 0.0 110.665 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.5 t -63.81 -27.84 69.45 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.036 -0.983 . . . . 0.0 112.405 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.587 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 30.3 mmtp -90.53 -9.92 45.45 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -177.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.2 m -84.75 7.61 20.01 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.135 -176.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 132.8 -84.69 0.29 Allowed Glycine 0 N--CA 1.421 -2.326 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.479 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -110.24 150.4 28.75 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.586 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -112.52 -9.79 13.76 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.062 177.9 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -107.7 104.05 2.02 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.907 -176.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 68.0 mt -87.01 115.74 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.808 0 CA-C-O 122.476 1.131 . . . . 0.0 108.839 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 44.3 m -86.44 -29.9 22.47 Favored 'General case' 0 N--CA 1.388 -3.573 0 CA-C-N 112.295 -2.229 . . . . 0.0 114.71 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 81.2 p -154.43 158.64 40.28 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 177.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.1 mt -136.22 132.05 49.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -176.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.592 ' HE2' ' CD2' ' A' ' 81' ' ' TYR . 37.3 ttmt -117.71 127.73 54.21 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -96.94 121.25 38.61 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . 0.495 ' SG ' ' HD2' ' A' ' 74' ' ' TYR . 57.2 m -121.29 172.83 7.73 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 124.047 0.939 . . . . 0.0 108.68 -177.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.5 pt -124.09 140.44 47.48 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 176.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -115.0 127.47 55.69 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 61.7 p -79.21 179.76 7.2 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.766 -172.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -67.21 -29.38 69.02 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.945 177.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.544 ' OD1' ' HG2' ' A' ' 118' ' ' LYS . 1.9 p-10 -84.38 -7.81 59.19 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.92 -177.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.06 3.9 58.84 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.384 -0.912 . . . . 0.0 114.426 175.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.544 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 21.7 ptmt -84.03 145.82 28.29 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 118.067 0.934 . . . . 0.0 109.16 176.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 17.1 t -107.51 116.51 51.23 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -101.68 140.95 35.27 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -147.26 160.05 42.94 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 7.8 tp -120.96 119.98 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.335 0 CA-C-O 121.5 0.667 . . . . 0.0 110.21 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -84.05 106.91 16.07 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 . . . . . 0 C--N 1.287 -2.134 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -178.445 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.854 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.39 41.82 0.96 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.664 0.745 . . . . 0.0 109.637 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -76.91 -24.48 52.47 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -178.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.599 ' HA ' HE22 ' A' ' 28' ' ' GLN . 14.3 m -106.63 123.61 48.37 Favored 'General case' 0 N--CA 1.404 -2.727 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.931 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.3 p -105.64 153.78 21.33 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 174.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -83.59 126.61 33.01 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.996 -174.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 74.37 41.25 0.38 Allowed 'General case' 0 N--CA 1.476 0.872 0 O-C-N 124.674 1.234 . . . . 0.0 111.324 177.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 22.9 m -123.37 148.47 46.01 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.813 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.577 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 55.7 tp -103.28 117.17 33.91 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 174.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.599 HE22 ' HA ' ' A' ' 22' ' ' SER . 76.1 mt-30 -109.92 124.22 51.0 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.56 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.476 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.4 mp -109.98 123.45 49.68 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.613 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -92.0 152.76 19.84 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 123.729 0.643 . . . . 0.0 110.233 -177.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -75.93 -36.45 59.37 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.353 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -107.84 177.95 4.67 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 96' ' ' ASP . 7.0 p -82.28 173.13 12.37 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.606 -179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 26.2 p90 46.46 42.11 10.4 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 114.703 1.372 . . . . 0.0 114.703 176.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 68.05 23.26 8.16 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.889 0.876 . . . . 0.0 111.825 177.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.423 ' HE ' ' HB3' ' A' ' 36' ' ' ARG . 4.2 mtp180 -94.85 164.41 12.93 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 177.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.48 -167.35 50.4 Favored Glycine 0 N--CA 1.426 -2.002 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -175.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.6 m -91.98 177.82 6.06 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 174.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 44.6 p90 -140.39 166.14 25.52 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -178.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.51 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 11.8 tt -114.05 152.65 15.69 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -106.99 125.65 51.28 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 93.5 t -123.48 133.7 68.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -119.12 -24.16 6.58 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.089 0.471 . . . . 0.0 110.444 -175.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.23 161.93 29.03 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.82 -175.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.7 m -74.43 144.96 44.05 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.119 0.485 . . . . 0.0 110.8 -178.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.0 p -121.75 137.31 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 177.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -97.12 -23.11 15.48 Favored Glycine 0 C--N 1.292 -1.914 0 C-N-CA 120.07 -1.062 . . . . 0.0 113.173 -177.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.9 m -148.84 128.35 13.12 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 122.317 -0.52 . . . . 0.0 110.565 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 83.7 mt -122.02 118.05 27.85 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 176.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 5.0 m -132.81 112.11 13.57 Favored Pre-proline 0 C--N 1.3 -1.581 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 177.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 71.7 Cg_endo -76.91 161.89 92.6 Favored 'Cis proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.076 -1.635 . . . . 0.0 110.841 -0.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -61.52 157.49 41.23 Favored 'Trans proline' 0 C--O 1.243 0.741 0 C-N-CA 122.508 2.138 . . . . 0.0 110.73 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.432 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 48.6 m0 -89.54 139.22 30.75 Favored 'General case' 0 CA--C 1.484 -1.587 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -178.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 30.1 p -118.47 78.61 14.83 Favored Pre-proline 0 C--N 1.304 -1.371 0 C-N-CA 120.544 -0.462 . . . . 0.0 111.888 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.476 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 85.0 Cg_endo -78.4 157.45 29.19 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.565 2.177 . . . . 0.0 112.996 177.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -93.18 -29.63 10.12 Favored Glycine 0 N--CA 1.431 -1.635 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 177.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.4 p -153.68 151.16 29.34 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.4 t -128.84 142.83 42.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 37.2 t -145.82 149.47 34.38 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.442 176.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 49.0 t -118.81 122.55 29.71 Favored Pre-proline 0 N--CA 1.435 -1.213 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 176.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.3 143.41 83.06 Favored 'Trans proline' 0 C--O 1.244 0.791 0 C-N-CA 122.86 2.373 . . . . 0.0 112.0 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -66.55 125.89 27.18 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 121.465 0.65 . . . . 0.0 110.473 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.401 HG13 ' OD2' ' A' ' 65' ' ' ASP . 59.8 t -101.01 124.2 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.758 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.337 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -120.34 20.63 11.9 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.988 0.899 . . . . 0.0 108.922 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.401 ' OD2' HG13 ' A' ' 63' ' ' VAL . 1.2 m-20 -58.24 145.74 36.44 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 113.982 -1.463 . . . . 0.0 113.187 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.9 m -60.14 -27.11 66.8 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 175.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -56.04 124.67 18.55 Favored 'General case' 0 C--O 1.251 1.156 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.343 173.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -77.54 -27.77 51.71 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.278 -177.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -83.02 125.67 31.7 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-O 122.001 0.905 . . . . 0.0 108.62 178.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 28.4 mmt85 -108.09 153.03 42.02 Favored Pre-proline 0 C--N 1.281 -2.377 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.424 -177.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -85.74 134.76 4.72 Favored 'Trans proline' 0 N--CA 1.441 -1.602 0 C-N-CA 121.281 1.321 . . . . 0.0 112.008 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -129.54 131.0 46.47 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.577 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 86.6 m95 -112.84 132.82 55.11 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.81 -173.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.534 ' HA ' ' O ' ' A' ' 86' ' ' THR . 37.6 m-85 -112.89 142.17 45.87 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.911 176.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.4 mt -125.58 142.65 51.39 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -176.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.524 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 82.5 m-85 -133.13 142.54 48.73 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 123.701 0.626 . . . . 0.0 109.895 -177.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.5 ' HB3' ' CD1' ' A' ' 102' ' ' PHE . 1.7 p-10 -87.89 0.35 55.96 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.566 -178.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -136.48 157.29 47.14 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 174.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.45 HG23 HD22 ' A' ' 80' ' ' ASN . 32.6 m -69.68 164.7 2.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 122.403 0.281 . . . . 0.0 111.674 -174.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.45 HD22 HG23 ' A' ' 79' ' ' VAL . 43.1 m-80 59.83 31.22 20.66 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 123.575 0.75 . . . . 0.0 111.566 178.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.615 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 12.0 m-85 61.12 39.93 15.48 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.853 1.261 . . . . 0.0 111.735 177.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 72.4 p -112.16 171.48 7.48 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.116 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.59 -133.31 11.67 Favored Glycine 0 N--CA 1.428 -1.859 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.307 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.524 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 54.2 mtt180 -89.26 149.4 23.09 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 124.246 1.019 . . . . 0.0 109.058 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.6 tt -125.52 137.02 59.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 121.273 0.559 . . . . 0.0 110.59 -175.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 95.7 m -131.94 125.99 32.97 Favored 'General case' 0 C--N 1.287 -2.112 0 O-C-N 122.1 -0.375 . . . . 0.0 110.415 176.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -111.38 124.46 6.88 Favored Glycine 0 C--N 1.312 -0.784 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.553 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -116.8 144.79 44.06 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 122.967 0.507 . . . . 0.0 110.315 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -114.05 168.07 12.48 Favored Glycine 0 N--CA 1.435 -1.416 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.612 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 33.5 p80 -64.86 128.81 37.34 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 121.218 0.532 . . . . 0.0 111.899 -177.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.31 6.85 65.99 Favored Glycine 0 N--CA 1.426 -1.998 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.604 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.7 m -118.5 146.45 44.51 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 4.3 m -136.36 155.78 49.57 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 52.4 mt -94.01 128.29 45.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -70.81 -48.28 55.0 Favored 'General case' 0 C--N 1.313 -1.009 0 O-C-N 123.536 0.523 . . . . 0.0 110.5 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.46 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 10.6 m-20 -135.37 92.69 2.88 Favored 'General case' 0 CA--C 1.486 -1.488 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.917 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.41 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 65.6 t80 -64.97 -32.26 73.89 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.265 0.555 . . . . 0.0 109.763 177.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.1 t -63.56 -26.62 68.78 Favored 'General case' 0 CA--C 1.552 1.019 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.66 -178.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.46 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 73.7 mmtt -95.23 -6.61 41.14 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.527 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.6 m -84.4 39.44 0.73 Allowed 'General case' 0 C--O 1.244 0.778 0 CA-C-O 121.87 0.843 . . . . 0.0 111.488 -176.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.73 -78.77 1.69 Allowed Glycine 0 N--CA 1.424 -2.116 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.5 ' CD1' ' HB3' ' A' ' 77' ' ' ASP . 26.8 p90 -108.19 145.68 33.87 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -177.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -113.66 -10.46 13.09 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 177.421 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -104.19 110.22 3.55 Favored Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.308 -177.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 70.2 mt -95.01 115.7 34.52 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.658 0 CA-C-O 122.387 1.089 . . . . 0.0 108.868 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 57.8 m -86.04 -29.16 23.66 Favored 'General case' 0 N--CA 1.392 -3.357 0 CA-C-N 112.238 -2.255 . . . . 0.0 114.262 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 77.6 p -153.98 155.81 36.28 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.6 mt -134.73 131.15 53.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -176.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.615 ' HE2' ' CD2' ' A' ' 81' ' ' TYR . 34.4 ttmt -117.86 126.34 52.2 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -96.16 130.1 43.29 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 176.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 76.0 m -123.19 170.76 9.91 Favored 'General case' 0 N--CA 1.408 -2.568 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 7.5 pt -125.06 142.35 42.24 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 176.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 53.6 tt0 -115.76 128.71 56.06 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 52.4 p -87.15 178.77 6.8 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.847 -174.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -63.16 -27.05 69.1 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.44 0.696 . . . . 0.0 109.186 174.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -81.05 -8.53 59.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.577 0.704 . . . . 0.0 110.739 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.37 -1.96 77.29 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.432 -0.889 . . . . 0.0 113.792 175.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 113' ' ' GLN . 8.8 ptpt -79.28 147.74 32.4 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.2 t -111.27 115.9 51.1 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -101.78 141.4 34.69 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 75.4 m -130.54 152.19 50.19 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.108 0.48 . . . . 0.0 111.993 -175.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 8.2 tp -125.16 132.7 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 CA-C-O 121.368 0.604 . . . . 0.0 110.264 177.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -91.74 111.61 23.2 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 176.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 . . . . . 0 C--N 1.305 -1.353 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -176.234 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.588 0 N-CA-C 112.211 -0.356 . . . . 0.0 112.211 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.16 -11.98 61.28 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.173 0.589 . . . . 0.0 111.825 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -77.31 -23.97 50.97 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.188 -0.914 . . . . 0.0 108.975 177.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.6 m -94.97 146.04 24.52 Favored 'General case' 0 N--CA 1.408 -2.57 0 CA-C-O 121.629 0.728 . . . . 0.0 110.548 -175.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 47.3 t -139.0 138.61 37.4 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 104.784 -2.302 . . . . 0.0 104.784 177.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -81.94 97.77 8.24 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.826 -0.749 . . . . 0.0 110.367 -173.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 69.41 67.17 0.26 Allowed 'General case' 0 CA--C 1.505 -0.764 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.398 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.3 m -139.05 154.5 48.22 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -176.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.597 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 53.4 tp -110.06 125.62 53.14 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 176.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 74.2 mt-30 -112.68 123.71 50.91 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 121.461 0.648 . . . . 0.0 109.572 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.454 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.4 mp -110.8 124.82 52.75 Favored 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.681 177.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -94.07 153.34 18.19 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 123.418 0.449 . . . . 0.0 111.183 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -76.46 -36.01 58.14 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.064 -176.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -107.44 178.26 4.59 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.548 ' O ' ' HB2' ' A' ' 36' ' ' ARG . 2.6 p -80.67 169.36 17.72 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 119.674 -0.203 . . . . 0.0 110.556 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 35.4 p90 46.65 42.73 11.82 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.17 1.388 . . . . 0.0 114.47 176.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 61.7 33.42 18.01 Favored 'General case' 0 C--O 1.246 0.904 0 C-N-CA 123.979 0.912 . . . . 0.0 112.502 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.548 ' HB2' ' O ' ' A' ' 33' ' ' THR . 5.4 mmm180 -96.23 154.55 17.19 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.807 174.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.53 -165.74 39.12 Favored Glycine 0 N--CA 1.427 -1.964 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.8 m -88.7 171.84 9.69 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 175.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -137.44 166.59 23.47 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -176.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.5 tt -114.61 150.79 16.48 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.45 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 176.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -107.21 125.63 51.36 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.545 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 74.6 t -117.99 133.54 64.47 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -117.48 -30.05 5.64 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.335 0.588 . . . . 0.0 110.86 -174.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -113.54 163.58 14.75 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.782 -174.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.4 m -79.05 145.19 33.97 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 173.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.426 HG12 ' HB ' ' A' ' 108' ' ' ILE . 12.2 p -120.88 128.7 76.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -89.79 -20.26 44.37 Favored Glycine 0 N--CA 1.427 -1.952 0 C-N-CA 119.543 -1.313 . . . . 0.0 113.342 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.5 m -157.78 114.52 2.91 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.509 0.671 . . . . 0.0 111.471 -178.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 85.5 mt -102.2 119.4 38.74 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.094 177.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 55.7 p -131.28 110.62 15.24 Favored Pre-proline 0 N--CA 1.425 -1.702 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 174.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 3.1 Cg_exo -77.65 162.37 90.24 Favored 'Cis proline' 0 CA--C 1.539 0.75 0 C-N-CA 124.008 -1.247 . . . . 0.0 111.207 -1.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.12 154.97 67.61 Favored 'Trans proline' 0 C--O 1.246 0.888 0 C-N-CA 122.205 1.937 . . . . 0.0 110.89 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.415 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 49.7 m0 -90.26 137.05 32.66 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.352 -177.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 11.4 p -120.16 78.17 25.46 Favored Pre-proline 0 C--N 1.295 -1.787 0 O-C-N 123.672 0.607 . . . . 0.0 110.368 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.454 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 84.8 Cg_endo -78.26 157.4 29.69 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.379 2.053 . . . . 0.0 113.33 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -85.89 -34.91 12.06 Favored Glycine 0 N--CA 1.434 -1.477 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 176.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.3 p -150.9 156.26 40.83 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.408 HG22 HD23 ' A' ' 29' ' ' LEU . 38.6 t -130.61 141.84 45.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 37.7 t -146.14 150.4 35.82 Favored 'General case' 0 N--CA 1.427 -1.587 0 CA-C-O 121.248 0.546 . . . . 0.0 110.223 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.6 t -113.85 123.1 33.49 Favored Pre-proline 0 C--N 1.299 -1.607 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 176.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -57.47 136.79 78.11 Favored 'Trans proline' 0 C--O 1.247 0.941 0 C-N-CA 122.735 2.29 . . . . 0.0 111.554 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.472 ' CE2' ' HB3' ' A' ' 64' ' ' ASN . 72.8 t80 -72.71 112.58 8.88 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.286 -177.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 44.7 t -93.84 115.15 31.96 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.825 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 175.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.472 ' HB3' ' CE2' ' A' ' 62' ' ' PHE . 27.3 p-10 -109.75 15.46 22.74 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-O 122.305 1.05 . . . . 0.0 108.67 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -75.69 147.31 39.52 Favored 'General case' 0 C--N 1.284 -2.279 0 CA-C-N 113.739 -1.573 . . . . 0.0 112.106 -174.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.0 m -52.33 -21.7 3.81 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 126.999 2.12 . . . . 0.0 114.022 -172.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -58.53 137.04 57.67 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.531 0.681 . . . . 0.0 111.803 -176.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -68.31 -23.3 64.72 Favored 'General case' 0 C--N 1.312 -1.026 0 C-N-CA 124.892 1.277 . . . . 0.0 113.002 -171.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.452 ' HG3' HG22 ' A' ' 114' ' ' THR . 19.9 mp0 -109.76 128.48 55.32 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.9 148.81 37.18 Favored Pre-proline 0 C--N 1.298 -1.668 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 174.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -77.44 137.95 17.07 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 C-N-CA 121.657 1.571 . . . . 0.0 112.564 -177.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -131.73 127.79 37.55 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 106.09 -1.818 . . . . 0.0 106.09 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.597 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 77.5 m95 -110.99 138.05 47.87 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -171.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.482 ' HA ' ' O ' ' A' ' 86' ' ' THR . 34.3 m-85 -116.09 142.9 46.19 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.339 177.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.436 HD21 HD21 ' A' ' 27' ' ' LEU . 19.4 mt -125.68 142.42 51.52 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 -176.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -133.65 139.96 46.78 Favored 'General case' 0 CA--C 1.503 -0.852 0 O-C-N 123.734 0.647 . . . . 0.0 109.498 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.536 ' HB3' ' CG ' ' A' ' 102' ' ' PHE . 3.6 p-10 -77.82 -15.78 58.81 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -177.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.498 ' C ' ' HB3' ' A' ' 106' ' ' SER . 6.0 t-20 -121.43 166.74 13.67 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.1 m -71.71 165.62 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.53 0 C-N-CA 122.905 0.482 . . . . 0.0 111.915 -176.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 57.13 31.2 19.59 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 123.888 0.875 . . . . 0.0 112.322 176.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.467 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 6.5 m-85 59.9 48.82 8.45 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 125.098 1.359 . . . . 0.0 110.895 177.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 81.6 p -120.68 168.46 11.38 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 116.229 -0.442 . . . . 0.0 109.901 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.59 -138.44 14.28 Favored Glycine 0 N--CA 1.421 -2.327 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 60.1 mtt180 -81.77 157.04 24.65 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 123.85 0.86 . . . . 0.0 109.616 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.8 tt -129.75 137.1 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 CA-C-O 121.494 0.664 . . . . 0.0 110.805 -175.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 96.9 m -131.99 128.37 38.25 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 174.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -114.78 130.28 9.12 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.815 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.505 HD21 HD11 ' A' ' 94' ' ' ILE . 3.7 mm? -121.3 147.56 45.5 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 123.076 0.55 . . . . 0.0 111.161 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.89 168.5 12.81 Favored Glycine 0 N--CA 1.433 -1.517 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.833 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -62.97 122.39 15.89 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.315 0.579 . . . . 0.0 111.769 -177.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.51 -2.63 77.89 Favored Glycine 0 N--CA 1.433 -1.54 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.23 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.0 m -107.07 146.18 31.52 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.1 m -140.88 157.83 44.82 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.505 HD11 HD21 ' A' ' 88' ' ' LEU . 52.1 mt -94.01 132.72 37.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 175.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -71.26 -48.66 49.63 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 121.579 0.704 . . . . 0.0 109.852 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.596 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 13.3 m-20 -132.24 96.48 3.89 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.847 178.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.415 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 61.5 t80 -65.57 -37.32 86.35 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.466 0.65 . . . . 0.0 110.01 175.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.4 t -63.91 -27.93 69.49 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.174 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.596 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 29.1 mmtp -89.19 -7.71 55.04 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 122.044 -0.41 . . . . 0.0 110.341 -178.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 43.8 m -80.34 -174.37 4.55 Favored 'General case' 0 C--O 1.257 1.493 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -50.26 -66.48 2.34 Favored Glycine 0 CA--C 1.507 -0.447 0 O-C-N 123.38 0.425 . . . . 0.0 113.62 -177.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.536 ' CG ' ' HB3' ' A' ' 77' ' ' ASP . 34.0 p90 -110.83 149.74 30.14 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 119.732 -0.175 . . . . 0.0 110.659 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.03 -12.16 13.25 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.542 177.646 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -112.17 116.19 4.03 Favored Glycine 0 N--CA 1.428 -1.841 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -177.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 70.0 mt -95.46 114.96 33.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.498 ' HB3' ' C ' ' A' ' 78' ' ' ASN . 1.8 t -86.77 -25.08 24.83 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.024 177.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 89.1 p -153.08 155.18 36.33 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 122.325 -0.234 . . . . 0.0 110.474 177.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.426 ' HB ' HG12 ' A' ' 46' ' ' VAL . 47.2 mt -133.02 132.57 58.94 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -175.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.467 ' HE2' ' CD2' ' A' ' 81' ' ' TYR . 37.9 ttmt -116.53 127.53 54.62 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.255 -1.016 . . . . 0.0 108.255 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -95.61 129.16 42.89 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 69.7 m -125.38 172.11 9.89 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 8.0 pt -128.07 143.11 41.93 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 59.7 tt0 -117.09 119.48 35.38 Favored 'General case' 0 C--N 1.277 -2.548 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.452 HG22 ' HG3' ' A' ' 69' ' ' GLU . 32.0 p -81.9 179.97 7.62 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.255 -171.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -65.36 -25.12 67.44 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.764 174.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -80.78 -7.81 59.5 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.852 0.834 . . . . 0.0 110.097 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.24 -9.78 76.63 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.803 175.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.449 ' HE2' ' HG2' ' A' ' 120' ' ' GLU . 19.6 ptmt -73.49 140.03 46.13 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 21.6 t -103.36 112.3 36.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.449 ' HG2' ' HE2' ' A' ' 118' ' ' LYS . 24.7 mt-10 -98.01 138.03 35.93 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 80.1 m -130.59 152.14 50.28 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -174.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 8.1 tp -79.01 122.59 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.822 177.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -85.81 108.33 18.06 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 . . . . . 0 C--N 1.298 -1.672 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.229 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.04 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -164.04 158.08 19.07 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -78.45 -23.98 46.26 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.309 -0.556 . . . . 0.0 110.248 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.6 m -118.64 132.96 56.18 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 20.1 p -102.56 166.34 10.58 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -100.5 130.88 46.64 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 -172.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 70.96 39.91 0.96 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.327 0.651 . . . . 0.0 111.584 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.9 m -123.88 158.96 30.72 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.634 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 57.2 tp -107.24 118.97 38.12 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 171.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 39.4 mt-30 -111.23 124.14 51.61 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.619 -0.832 . . . . 0.0 108.951 -178.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.8 mp -110.24 126.71 54.44 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.115 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -96.38 151.31 19.66 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 123.572 0.545 . . . . 0.0 109.598 -177.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -74.07 -37.75 64.14 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.139 0.495 . . . . 0.0 111.107 -177.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -108.32 177.44 4.79 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.457 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.457 HG22 ' HA ' ' A' ' 96' ' ' ASP . 2.2 p -81.16 172.54 13.54 Favored 'General case' 0 N--CA 1.413 -2.309 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 11.7 p90 47.6 35.4 4.36 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.852 0.861 . . . . 0.0 113.24 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 61.85 38.65 14.52 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.851 1.26 . . . . 0.0 113.591 177.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -103.46 178.17 4.63 Favored 'General case' 0 C--O 1.248 0.981 0 C-N-CA 120.126 -0.629 . . . . 0.0 112.007 175.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.7 -154.79 40.33 Favored Glycine 0 N--CA 1.425 -2.09 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -176.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.4 m -100.57 174.61 6.0 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 172.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -136.87 165.66 25.44 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 16.6 tt -116.21 152.45 17.92 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.483 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -106.8 125.15 50.63 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 98.0 t -120.78 133.94 65.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -121.72 -27.73 4.65 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.506 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 10.5 mmpt? -109.72 162.68 14.21 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.655 -173.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.8 m -82.75 141.82 32.09 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 175.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.1 p -120.79 130.54 74.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -89.51 -17.85 53.84 Favored Glycine 0 N--CA 1.43 -1.722 0 C-N-CA 119.722 -1.227 . . . . 0.0 113.308 -176.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.8 p -156.54 130.78 8.61 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 85.5 mt -124.11 117.46 24.71 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 175.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 40.0 m -133.45 113.49 13.18 Favored Pre-proline 0 C--N 1.293 -1.859 0 CA-C-O 120.407 0.146 . . . . 0.0 110.947 175.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 7.3 Cg_exo -75.07 162.22 93.25 Favored 'Cis proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.179 -1.592 . . . . 0.0 111.336 -0.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.58 159.29 24.48 Favored 'Trans proline' 0 C--O 1.245 0.842 0 C-N-CA 122.705 2.27 . . . . 0.0 111.615 177.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.505 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 43.9 m0 -88.93 138.91 30.98 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 21.8 p -116.66 78.52 8.93 Favored Pre-proline 0 C--N 1.3 -1.584 0 O-C-N 123.579 0.55 . . . . 0.0 110.747 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.481 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 92.3 Cg_endo -79.79 153.17 22.7 Favored 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 122.001 1.8 . . . . 0.0 112.589 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.67 -27.11 18.14 Favored Glycine 0 N--CA 1.425 -2.094 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.4 p -155.1 151.73 28.66 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.7 t -132.17 142.65 42.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 35.8 t -145.53 146.78 31.56 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 119.577 -0.849 . . . . 0.0 111.647 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.0 t -113.61 124.66 30.81 Favored Pre-proline 0 N--CA 1.435 -1.209 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 176.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -59.58 145.61 97.56 Favored 'Trans proline' 0 C--O 1.244 0.798 0 C-N-CA 123.115 2.543 . . . . 0.0 112.587 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -74.06 114.75 12.73 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.172 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 91.9 t -95.66 115.73 35.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -110.26 8.16 23.44 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 122.423 1.106 . . . . 0.0 108.713 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.76 145.02 56.55 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 113.2 -1.818 . . . . 0.0 111.884 -178.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.8 m -67.85 -7.09 25.06 Favored 'General case' 0 CA--C 1.566 1.587 0 C-N-CA 124.995 1.318 . . . . 0.0 110.882 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -51.96 133.47 32.51 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 124.884 1.274 . . . . 0.0 110.311 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.3 tpp180 -70.59 -26.6 63.59 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.179 -172.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.9 mp0 -111.33 134.16 53.12 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 122.707 0.403 . . . . 0.0 110.154 176.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.8 153.82 37.95 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 170.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.11 135.12 12.04 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 C-N-CA 121.958 1.772 . . . . 0.0 111.367 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -130.06 136.3 49.21 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.634 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 85.2 m95 -119.21 133.55 55.7 Favored 'General case' 0 C--N 1.291 -1.953 0 C-N-CA 120.134 -0.626 . . . . 0.0 112.241 -173.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.456 ' HA ' ' O ' ' A' ' 86' ' ' THR . 33.7 m-85 -114.9 140.16 49.21 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.143 177.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.6 mt -125.28 142.74 51.32 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -175.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.454 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 78.7 m-85 -133.35 142.28 48.34 Favored 'General case' 0 C--N 1.317 -0.833 0 O-C-N 123.576 0.548 . . . . 0.0 110.423 -175.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -85.27 0.01 53.3 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 120.767 0.317 . . . . 0.0 111.049 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -137.47 158.87 43.47 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.554 HG23 HD22 ' A' ' 80' ' ' ASN . 33.4 m -71.59 166.6 2.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 C-N-CA 122.99 0.516 . . . . 0.0 111.577 -175.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.554 HD22 HG23 ' A' ' 79' ' ' VAL . 64.6 m-80 57.87 30.13 18.6 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.008 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.467 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 9.3 m-85 58.74 47.11 13.3 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 125.019 1.327 . . . . 0.0 111.235 177.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 73.2 p -118.37 173.5 6.78 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.18 -133.34 11.72 Favored Glycine 0 N--CA 1.433 -1.512 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.933 176.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.454 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 56.0 mtt85 -80.83 148.67 29.87 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 123.143 0.577 . . . . 0.0 109.618 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.4 tt -127.27 137.58 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 -177.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 98.2 m -131.24 126.08 34.54 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 176.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -115.16 115.29 3.4 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.491 -0.861 . . . . 0.0 113.745 -177.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -108.32 144.81 35.35 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 122.466 0.306 . . . . 0.0 110.771 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.17 170.76 13.46 Favored Glycine 0 N--CA 1.429 -1.772 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.003 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -64.33 130.75 45.01 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.315 0.578 . . . . 0.0 111.918 -176.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.71 8.23 80.3 Favored Glycine 0 N--CA 1.428 -1.84 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.794 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.3 m -121.32 146.25 47.04 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.9 m -136.33 156.93 47.94 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 50.5 mt -93.59 127.84 45.39 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 172.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -69.07 -46.91 66.64 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.579 0.704 . . . . 0.0 109.447 -177.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.645 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 3.9 m-20 -139.73 98.98 3.59 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.205 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -65.08 -37.75 88.53 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.337 0.589 . . . . 0.0 110.672 178.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.7 t -69.53 -17.93 63.62 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.461 -177.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.645 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 28.9 mmtp -89.95 -6.19 55.94 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.638 -0.664 . . . . 0.0 109.386 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.0 t -85.02 -163.78 0.89 Allowed 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -61.41 -68.19 1.78 Allowed Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 116.798 -0.183 . . . . 0.0 113.151 -177.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -110.61 147.61 33.91 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 122.488 -0.419 . . . . 0.0 109.917 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -112.43 -0.52 15.28 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.103 177.331 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.505 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -119.19 113.95 2.66 Favored Glycine 0 N--CA 1.436 -1.35 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.812 -176.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 69.2 mt -95.8 116.3 37.17 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.593 0 CA-C-O 122.312 1.053 . . . . 0.0 109.614 -178.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.4 m -85.62 -28.6 24.68 Favored 'General case' 0 N--CA 1.395 -3.193 0 CA-C-N 112.206 -2.27 . . . . 0.0 114.13 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 84.1 p -156.45 156.37 33.67 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 177.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.4 mt -135.18 130.81 51.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -176.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.467 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 37.3 ttmt -117.14 128.19 54.88 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 47.4 ttp180 -95.49 129.49 42.64 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-O 121.631 0.729 . . . . 0.0 109.213 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 82.2 m -125.55 172.68 9.52 Favored 'General case' 0 C--N 1.273 -2.739 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.875 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.404 HG13 ' HB2' ' A' ' 120' ' ' GLU . 7.6 pt -129.03 142.47 43.96 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.477 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -110.91 122.63 48.35 Favored 'General case' 0 C--N 1.278 -2.508 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 82.4 p -77.88 176.54 8.99 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.61 -174.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -66.96 -20.11 65.84 Favored 'General case' 0 C--N 1.316 -0.885 0 O-C-N 122.141 -0.35 . . . . 0.0 111.153 174.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.507 ' OD1' ' HG2' ' A' ' 118' ' ' LYS . 2.1 p30 -86.88 -7.61 58.05 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.264 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 94.17 -0.97 66.87 Favored Glycine 0 N--CA 1.441 -1.003 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.662 175.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.507 ' HG2' ' OD1' ' A' ' 116' ' ' ASP . 52.6 pttt -77.87 149.01 34.37 Favored 'General case' 0 N--CA 1.436 -1.145 0 C-N-CA 119.093 -1.043 . . . . 0.0 109.566 176.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.2 t -109.04 112.04 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.503 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.404 ' HB2' HG13 ' A' ' 112' ' ' ILE . 6.6 mm-40 -93.82 144.8 25.1 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 76.9 m -130.43 162.63 28.72 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.287 -175.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 7.5 tp -75.37 132.13 33.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 177.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -75.34 105.17 6.23 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-O 121.175 0.512 . . . . 0.0 110.378 -177.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 . . . . . 0 C--N 1.3 -1.551 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -177.393 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.901 0 N-CA-C 112.019 -0.433 . . . . 0.0 112.019 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.96 -22.34 64.12 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.639 0.733 . . . . 0.0 110.844 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -76.97 -12.74 59.98 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.432 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 43.7 m -110.68 147.91 33.36 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 7.7 p -102.32 146.86 27.42 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.236 177.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -69.19 127.97 34.99 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.423 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 74.0 39.04 0.54 Allowed 'General case' 0 N--CA 1.483 1.211 0 O-C-N 123.958 0.786 . . . . 0.0 111.764 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 36.7 m -123.82 154.68 39.24 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.554 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 44.0 tp -105.02 121.92 44.78 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 176.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.5 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 41.0 mt-30 -111.86 124.07 51.59 Favored 'General case' 0 CA--C 1.495 -1.151 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.454 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.8 mp -110.26 123.88 50.6 Favored 'General case' 0 N--CA 1.42 -1.927 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.15 177.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -88.85 149.07 23.55 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -74.04 -38.42 64.01 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 120.983 0.42 . . . . 0.0 111.059 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -107.84 177.35 4.84 Favored 'General case' 0 C--N 1.299 -1.612 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.223 -176.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.43 HG22 ' HA ' ' A' ' 96' ' ' ASP . 1.0 OUTLIER -81.72 172.72 13.06 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.936 179.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.268 21.9 p90 47.49 37.8 6.87 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.793 1.237 . . . . 0.0 113.501 177.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 65.26 27.97 12.05 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 125.109 1.364 . . . . 0.0 113.717 178.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -97.55 172.67 7.58 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.426 0.631 . . . . 0.0 110.656 177.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.41 -166.17 37.92 Favored Glycine 0 N--CA 1.424 -2.158 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.3 m -100.68 176.76 5.2 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 173.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -143.89 165.34 28.01 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 120.469 -0.493 . . . . 0.0 110.843 -174.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 18.2 tt -114.31 152.72 15.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -107.21 125.62 51.35 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 98.7 t -119.71 136.71 55.96 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.384 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 177.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -117.43 -28.01 6.21 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.883 -176.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -107.47 163.04 13.4 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 -173.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.435 ' HB3' ' H ' ' A' ' 110' ' ' ARG . 4.5 p -89.6 141.69 28.37 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 172.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.418 HG12 ' HB ' ' A' ' 108' ' ' ILE . 8.3 p -120.55 132.91 68.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -174.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.96 -1.7 57.19 Favored Glycine 0 C--N 1.313 -0.746 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.456 -176.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.0 t -166.7 129.58 1.86 Allowed 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.067 0.46 . . . . 0.0 109.906 176.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 85.1 mt -122.41 117.78 26.82 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.0 m -133.25 112.8 13.22 Favored Pre-proline 0 C--N 1.288 -2.09 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 174.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.62 161.86 93.58 Favored 'Cis proline' 0 CA--C 1.549 1.249 0 C-N-CA 123.333 -1.528 . . . . 0.0 111.326 -1.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.81 158.33 43.14 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.948 2.432 . . . . 0.0 110.87 177.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.515 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 48.2 m0 -90.23 143.81 26.43 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -178.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 18.3 p -121.48 76.82 35.38 Favored Pre-proline 0 C--N 1.308 -1.203 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.454 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 92.3 Cg_endo -81.18 157.64 20.09 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.806 2.337 . . . . 0.0 112.624 177.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.0 -28.38 11.04 Favored Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.3 p -157.33 154.93 29.78 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.7 t -131.61 145.42 35.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -176.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 39.3 t -145.59 147.36 31.99 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.927 176.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.9 t -112.71 126.79 27.74 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 176.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.405 ' HD3' HE21 ' A' ' 28' ' ' GLN . 22.0 Cg_endo -60.61 150.48 81.73 Favored 'Trans proline' 0 C--O 1.248 1.0 0 C-N-CA 122.983 2.455 . . . . 0.0 112.304 -177.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.548 ' CE1' ' HB2' ' A' ' 64' ' ' ASN . 45.1 t80 -74.36 132.32 41.91 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.956 0.884 . . . . 0.0 111.555 -177.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 99.0 t -123.22 117.78 52.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.548 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 61.7 t30 -118.6 8.25 11.93 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 123.373 1.559 . . . . 0.0 106.842 178.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -60.21 145.03 48.68 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 112.413 -2.176 . . . . 0.0 113.539 -174.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 m -60.73 -7.12 2.06 Favored 'General case' 0 CA--C 1.564 1.509 0 C-N-CA 126.248 1.819 . . . . 0.0 112.568 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -58.54 142.84 47.89 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -74.33 -25.4 59.53 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.866 -174.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.459 ' HG2' HD12 ' A' ' 112' ' ' ILE . 4.5 mp0 -110.71 133.8 53.02 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.87 0.367 . . . . 0.0 111.74 177.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.32 150.33 37.0 Favored Pre-proline 0 C--N 1.307 -1.242 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 168.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -80.28 137.0 11.67 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.025 1.816 . . . . 0.0 111.813 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -132.17 137.72 47.75 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.554 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 89.9 m95 -122.07 132.43 54.49 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.16 0.505 . . . . 0.0 111.981 -174.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' A' ' 86' ' ' THR . 24.2 m-85 -112.74 142.77 44.98 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.434 177.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.5 mt -125.62 142.25 51.61 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -175.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.498 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 93.2 m-85 -132.85 141.47 48.45 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.403 0.62 . . . . 0.0 111.158 -175.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.758 ' HB2' ' CD2' ' A' ' 102' ' ' PHE . 9.0 t70 -85.99 -6.53 59.03 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.544 -177.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -140.06 156.87 46.4 Favored 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.727 173.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.738 ' HA ' ' OG ' ' A' ' 107' ' ' SER . 23.6 m -64.46 162.24 2.37 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.945 0 C-N-CA 123.655 0.782 . . . . 0.0 112.214 -175.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.44 29.86 17.19 Favored 'General case' 0 CA--C 1.511 -0.551 0 O-C-N 123.859 0.724 . . . . 0.0 109.305 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.455 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 16.1 m-85 56.49 50.93 12.08 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 114.433 -1.258 . . . . 0.0 111.415 178.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 60.5 p -123.52 177.59 5.58 Favored 'General case' 0 C--O 1.249 1.047 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.762 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.95 -107.96 3.53 Favored Glycine 0 N--CA 1.437 -1.267 0 N-CA-C 111.822 -0.511 . . . . 0.0 111.822 176.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 58.6 mtt85 -114.08 151.86 31.91 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.7 tt -128.65 140.04 50.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 O-C-N 123.712 0.632 . . . . 0.0 111.08 -174.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 24.4 m -132.49 125.42 30.61 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.429 174.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -115.17 107.25 1.73 Allowed Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.83 -0.7 . . . . 0.0 114.321 -178.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -106.32 145.69 31.34 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 123.045 0.538 . . . . 0.0 111.468 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -123.33 172.64 16.17 Favored Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.678 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -50.23 127.86 18.06 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 124.262 1.025 . . . . 0.0 112.757 -177.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.97 -0.19 88.8 Favored Glycine 0 C--N 1.309 -0.925 0 CA-C-N 115.546 -0.752 . . . . 0.0 113.251 174.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.3 m -110.82 145.9 37.37 Favored 'General case' 0 N--CA 1.421 -1.92 0 C-N-CA 120.303 -0.559 . . . . 0.0 109.543 -177.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.6 m -136.21 156.7 48.3 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 55.2 mt -92.81 135.81 26.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 176.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -70.53 -48.52 55.08 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.506 0.67 . . . . 0.0 110.421 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.579 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 3.2 m-20 -143.23 99.12 3.38 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -178.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -64.85 -38.37 90.76 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 121.263 0.554 . . . . 0.0 110.817 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.5 t -65.96 -21.01 66.39 Favored 'General case' 0 CA--C 1.558 1.257 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.903 -175.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.579 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 30.0 mmtp -92.83 -7.82 45.26 Favored 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.8 t -83.49 7.29 17.46 Favored 'General case' 0 C--O 1.25 1.123 0 CA-C-O 121.065 0.46 . . . . 0.0 111.492 -176.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 115.56 -62.51 0.35 Allowed Glycine 0 N--CA 1.436 -1.362 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 177.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.758 ' CD2' ' HB2' ' A' ' 77' ' ' ASP . 22.7 p90 -110.89 142.59 42.74 Favored 'General case' 0 N--CA 1.427 -1.59 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.144 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -114.01 -8.31 13.07 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.515 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -112.55 112.93 3.11 Favored Glycine 0 N--CA 1.422 -2.267 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.954 -174.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 70.1 mt -95.22 115.55 34.42 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 52.3 m -85.43 -26.69 26.22 Favored 'General case' 0 C--N 1.252 -3.652 0 CA-C-N 112.228 -2.26 . . . . 0.0 113.339 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.738 ' OG ' ' HA ' ' A' ' 79' ' ' VAL . 66.6 m -156.29 152.35 27.58 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 122.215 -0.303 . . . . 0.0 110.794 -177.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.418 ' HB ' HG12 ' A' ' 46' ' ' VAL . 40.3 mt -135.3 130.19 50.74 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.539 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -176.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.455 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 33.9 ttmt -117.53 131.18 56.75 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.435 ' H ' ' HB3' ' A' ' 45' ' ' SER . 55.9 ttp180 -101.42 123.37 45.38 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -177.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 36.1 m -119.71 171.15 8.59 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.459 HD12 ' HG2' ' A' ' 69' ' ' GLU . 8.4 pt -129.35 146.2 34.57 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.427 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 56.4 tt0 -117.79 118.21 31.42 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 17.2 p -78.8 179.67 7.08 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.253 -173.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -58.97 -28.21 66.1 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.635 0.731 . . . . 0.0 110.548 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -77.02 -7.99 56.63 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.9 -176.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.53 6.84 87.04 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.483 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 113' ' ' GLN . 26.2 pttm -87.84 139.28 30.69 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.0 t -103.22 112.44 36.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -102.78 146.01 28.89 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -138.88 149.08 44.46 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.307 -0.957 . . . . 0.0 109.663 -179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 6.2 tp -126.32 127.56 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.94 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.416 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.423 ' OD1' ' HE1' ' A' ' 81' ' ' TYR . 7.2 t30 -84.45 104.78 14.75 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 173.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 . . . . . 0 C--N 1.295 -1.792 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.28 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.741 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.84 49.2 1.57 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.984 0.897 . . . . 0.0 109.36 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -81.32 -16.24 53.02 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.777 -1.102 . . . . 0.0 110.706 -177.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.9 m -55.6 125.09 19.59 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.2 p -102.52 157.25 17.06 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.13 0.49 . . . . 0.0 112.129 -173.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -70.19 126.22 29.05 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.498 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 64.51 43.71 4.35 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 175.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.4 m -123.32 146.66 47.73 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.614 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 53.8 tp -92.52 121.32 33.85 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 172.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.501 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 65.0 mt-30 -114.17 123.7 50.24 Favored 'General case' 0 N--CA 1.427 -1.588 0 C-N-CA 119.616 -0.834 . . . . 0.0 109.635 -177.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 2.8 mp -110.34 119.08 38.06 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.339 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -82.04 145.01 30.44 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 123.521 0.513 . . . . 0.0 110.21 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -69.27 -39.79 78.17 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.598 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -108.37 177.39 4.81 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.435 HG22 ' HA ' ' A' ' 96' ' ' ASP . 1.1 p -83.1 177.18 8.7 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 122.601 0.36 . . . . 0.0 110.602 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.262 16.6 p90 47.39 42.2 13.76 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.886 1.275 . . . . 0.0 113.881 176.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 63.56 27.97 15.1 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.241 176.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.543 ' HA ' ' NE ' ' A' ' 36' ' ' ARG . 3.7 mmp_? -108.5 166.32 10.86 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.317 0.58 . . . . 0.0 110.969 178.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.38 173.74 47.29 Favored Glycine 0 N--CA 1.425 -2.049 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -177.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.3 p -86.28 154.78 21.01 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 40.8 p90 -117.6 165.84 13.09 Favored 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.218 -176.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.8 tt -114.23 153.26 15.77 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 178.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -105.96 126.03 51.7 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.535 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 92.8 t -123.33 133.4 69.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 178.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -118.08 -21.7 8.14 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.055 0.455 . . . . 0.0 110.668 -175.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -129.24 162.18 28.46 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.317 -175.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.454 ' HB3' ' H ' ' A' ' 110' ' ' ARG . 4.2 p -79.02 146.25 33.43 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.839 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.9 p -121.46 137.28 55.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.3 -18.43 39.17 Favored Glycine 0 C--N 1.316 -0.543 0 C-N-CA 119.903 -1.141 . . . . 0.0 113.864 -176.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.3 t -161.18 132.14 5.34 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -178.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.1 mt -121.31 118.94 30.77 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.313 178.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.5 m -132.61 110.42 13.5 Favored Pre-proline 0 C--N 1.301 -1.53 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 175.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -76.71 160.24 95.28 Favored 'Cis proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.171 -1.595 . . . . 0.0 111.38 0.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.02 158.24 48.73 Favored 'Trans proline' 0 C--O 1.24 0.616 0 C-N-CA 122.31 2.006 . . . . 0.0 110.84 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 52.7 m0 -89.73 136.65 32.91 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 120.351 -0.54 . . . . 0.0 109.881 -177.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 20.2 p -118.73 77.07 14.35 Favored Pre-proline 0 N--CA 1.435 -1.207 0 O-C-N 123.493 0.495 . . . . 0.0 111.757 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.469 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 96.0 Cg_endo -76.4 158.52 36.68 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.387 2.058 . . . . 0.0 111.972 177.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -92.84 -31.58 8.56 Favored Glycine 0 N--CA 1.431 -1.685 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 175.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 94' ' ' ILE . 34.8 p -152.01 153.14 33.44 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.418 HG22 HD23 ' A' ' 29' ' ' LEU . 36.7 t -128.91 142.77 43.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -177.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 37.2 t -145.75 147.29 31.75 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.124 177.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 68.2 t -114.13 121.16 37.14 Favored Pre-proline 0 C--N 1.306 -1.296 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 175.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.03 148.17 78.55 Favored 'Trans proline' 0 C--O 1.246 0.905 0 C-N-CA 122.997 2.465 . . . . 0.0 112.315 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.424 ' CE2' ' HB3' ' A' ' 64' ' ' ASN . 76.4 t80 -71.63 111.56 7.03 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.36 0.6 . . . . 0.0 110.594 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.411 ' H ' ' HB2' ' A' ' 90' ' ' HIS . 48.7 t -94.51 115.29 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.98 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.585 178.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.424 ' HB3' ' CE2' ' A' ' 62' ' ' PHE . 23.7 p-10 -114.73 25.05 11.28 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 125.673 1.589 . . . . 0.0 108.14 178.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.53 ' HB3' ' NH2' ' A' ' 70' ' ' ARG . 16.6 t70 -66.92 146.22 54.63 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 112.867 -1.969 . . . . 0.0 112.396 -176.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.7 m -53.53 -18.49 2.85 Favored 'General case' 0 CA--C 1.57 1.745 0 C-N-CA 125.203 1.401 . . . . 0.0 113.747 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.518 ' HG2' ' OD2' ' A' ' 65' ' ' ASP . 33.4 mmtp -66.52 167.66 10.45 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.773 -0.579 . . . . 0.0 110.132 174.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -106.07 -15.91 14.76 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 175.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.3 mp0 -92.39 128.31 38.2 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.788 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.53 ' NH2' ' HB3' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -106.1 154.18 39.76 Favored Pre-proline 0 C--N 1.291 -1.966 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.306 178.625 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -81.9 135.1 8.64 Favored 'Trans proline' 0 N--CA 1.44 -1.629 0 C-N-CA 121.632 1.555 . . . . 0.0 111.002 178.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -129.12 120.91 26.7 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.614 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 87.0 m95 -106.66 133.93 50.59 Favored 'General case' 0 C--N 1.278 -2.543 0 CA-C-O 121.034 0.445 . . . . 0.0 111.953 -171.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 86' ' ' THR . 29.5 m-85 -112.39 140.56 47.01 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.499 177.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.4 mt -125.6 142.37 51.54 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -177.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 80.5 m-85 -134.48 140.84 46.5 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 123.892 0.745 . . . . 0.0 109.599 -176.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.37 -12.19 59.06 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.51 -177.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.504 ' C ' ' HB3' ' A' ' 106' ' ' SER . 5.1 t-20 -123.25 172.51 8.57 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.8 m -76.23 168.83 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 C-N-CA 123.415 0.686 . . . . 0.0 111.591 -176.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 53.83 30.53 11.53 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.121 0.969 . . . . 0.0 112.431 176.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.555 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 8.2 m-85 63.0 39.44 10.19 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.577 176.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 81.4 p -111.91 170.65 8.0 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.67 -145.31 17.56 Favored Glycine 0 N--CA 1.429 -1.781 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.609 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.515 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 98.0 mtt180 -75.59 147.84 39.29 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 123.128 0.571 . . . . 0.0 109.636 178.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.5 tt -125.38 136.5 60.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 121.705 0.764 . . . . 0.0 110.442 -175.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 93.5 m -131.39 125.16 31.9 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.615 176.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -115.01 118.01 4.19 Favored Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.309 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -112.53 146.0 39.29 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 123.3 0.64 . . . . 0.0 111.146 -179.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -117.94 172.89 14.57 Favored Glycine 0 N--CA 1.434 -1.474 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.127 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.439 ' CD2' ' HG2' ' A' ' 70' ' ' ARG . 2.6 p80 -62.46 132.43 52.47 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 121.272 0.558 . . . . 0.0 111.906 -176.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.8 15.17 79.84 Favored Glycine 0 N--CA 1.43 -1.7 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.766 176.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.8 m -127.22 146.2 50.5 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.7 m -137.55 156.34 48.21 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.436 ' O ' ' HB2' ' A' ' 57' ' ' SER . 46.0 mt -95.31 127.03 47.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 170.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -71.77 -46.34 58.71 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.354 0.597 . . . . 0.0 111.926 177.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.617 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 1.7 m-20 -129.4 96.11 4.2 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.144 178.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -64.69 -35.03 79.73 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.56 0.695 . . . . 0.0 110.34 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.4 t -67.66 -29.32 68.58 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.159 -175.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.617 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 29.4 mmtp -88.39 -6.68 57.54 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -178.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.1 m -80.64 -13.29 59.16 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.882 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 139.02 -70.47 0.46 Allowed Glycine 0 N--CA 1.431 -1.678 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -110.32 146.46 35.7 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -112.4 -9.96 13.8 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 177.715 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -109.48 115.54 4.27 Favored Glycine 0 N--CA 1.427 -1.932 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.747 -176.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 79.1 mt -98.77 116.27 41.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.504 ' HB3' ' C ' ' A' ' 78' ' ' ASN . 7.6 t -85.82 -29.9 23.4 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.52 177.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 93.6 p -148.57 155.4 41.06 Favored 'General case' 0 C--O 1.236 0.345 0 O-C-N 121.872 -0.517 . . . . 0.0 111.273 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.1 mt -133.27 133.71 57.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -176.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.555 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 38.9 ttmt -116.13 132.97 56.51 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.454 ' H ' ' HB3' ' A' ' 45' ' ' SER . 46.3 ttp180 -102.77 118.25 36.42 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 64.6 m -120.14 170.23 9.5 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.2 pt -128.63 141.7 45.88 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.536 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 37.1 tt0 -113.02 122.62 48.15 Favored 'General case' 0 C--N 1.268 -2.967 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.483 ' OG1' ' HG2' ' A' ' 118' ' ' LYS . 30.8 p -76.4 -179.19 5.0 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -177.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -59.07 -29.72 67.54 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.31 0.576 . . . . 0.0 110.38 177.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -76.96 -9.1 58.46 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.782 -175.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.66 8.71 84.24 Favored Glycine 0 N--CA 1.421 -2.307 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.14 -176.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.483 ' HG2' ' OG1' ' A' ' 114' ' ' THR . 9.4 ptpp? -84.02 138.38 33.12 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 26.1 t -107.07 112.09 38.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.584 0.707 . . . . 0.0 111.356 -174.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -101.02 153.04 19.88 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 177.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 85.6 m -130.02 149.19 51.85 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.331 -175.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 10.3 tp -83.74 128.01 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -177.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -83.13 105.09 13.82 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -178.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 . . . . . 0 C--N 1.286 -2.186 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.404 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.099 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.32 -70.85 0.25 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 117.791 0.796 . . . . 0.0 109.944 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -113.55 -24.46 9.23 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 174.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.0 m -86.09 146.77 26.47 Favored 'General case' 0 N--CA 1.417 -2.088 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.618 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.4 ' HB3' ' HB2' ' A' ' 26' ' ' CYS . 47.9 t -143.13 137.58 29.2 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 178.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -77.26 102.25 6.6 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -177.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.458 ' CD2' ' HB3' ' A' ' 71' ' ' PRO . 4.7 m-85 70.5 50.65 0.38 Allowed 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.289 172.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 14.1 m -126.98 153.54 45.75 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.196 -1.366 . . . . 0.0 107.976 -178.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.596 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 53.0 tp -111.58 130.1 55.85 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 107.024 -1.472 . . . . 0.0 107.024 175.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.517 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 73.3 mt-30 -117.42 124.01 47.8 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.701 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.434 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.0 mp -110.47 121.93 46.5 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.163 178.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -87.8 151.92 22.51 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 123.577 0.548 . . . . 0.0 110.45 -178.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -74.77 -39.98 61.47 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.091 -178.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -108.46 178.37 4.51 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.46 HG22 ' HA ' ' A' ' 96' ' ' ASP . 2.2 p -80.71 173.38 12.66 Favored 'General case' 0 N--CA 1.413 -2.31 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.594 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.276 21.6 p90 47.11 43.23 14.05 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 124.731 1.212 . . . . 0.0 114.231 177.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 65.97 23.11 11.23 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 124.379 1.072 . . . . 0.0 112.044 175.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.435 ' HA ' ' NE ' ' A' ' 36' ' ' ARG . 5.6 mmp_? -100.48 167.85 10.11 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.385 0.612 . . . . 0.0 112.279 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.02 -166.26 48.3 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -175.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.7 m -90.88 175.37 7.01 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.425 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 37.6 p90 -137.17 165.08 26.95 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 16.7 tt -114.6 152.61 16.21 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 176.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -107.05 124.95 50.39 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 175.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.55 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 94.2 t -114.03 133.64 59.4 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.555 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 177.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -115.06 -33.54 5.36 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.468 0.651 . . . . 0.0 110.028 -174.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.92 161.44 25.38 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.692 -177.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 p -75.72 149.25 38.09 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 121.465 0.65 . . . . 0.0 112.102 -176.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.409 HG12 ' HB ' ' A' ' 108' ' ' ILE . 10.6 p -121.18 137.38 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.98 -18.9 35.51 Favored Glycine 0 C--N 1.299 -1.478 0 C-N-CA 120.13 -1.033 . . . . 0.0 112.617 -178.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.1 t -159.52 131.38 6.33 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 121.032 0.444 . . . . 0.0 110.159 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 91.1 mt -119.65 118.02 29.84 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.653 177.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 29.2 t -132.77 114.07 14.09 Favored Pre-proline 0 N--CA 1.419 -2.017 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 174.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 60.0 Cg_endo -74.81 161.87 93.88 Favored 'Cis proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.997 -1.668 . . . . 0.0 110.417 -2.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -63.18 156.08 57.54 Favored 'Trans proline' 0 C--O 1.257 1.441 0 C-N-CA 121.85 1.7 . . . . 0.0 110.636 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.481 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 45.5 m0 -89.1 135.4 33.58 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -177.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 15.3 p -116.18 76.58 6.73 Favored Pre-proline 0 C--N 1.292 -1.918 0 O-C-N 123.362 0.413 . . . . 0.0 111.318 -179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.434 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 85.6 Cg_endo -77.12 157.6 33.94 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 122.5 2.133 . . . . 0.0 112.903 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.69 -33.4 10.09 Favored Glycine 0 N--CA 1.431 -1.665 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.7 p -154.27 144.95 22.4 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.418 HG11 HD11 ' A' ' 75' ' ' LEU . 32.2 t -119.95 142.8 33.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 33.6 t -145.4 147.5 32.32 Favored 'General case' 0 N--CA 1.422 -1.84 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.228 177.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 80.5 t -111.35 122.3 37.97 Favored Pre-proline 0 C--N 1.296 -1.743 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 176.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -58.78 149.23 78.99 Favored 'Trans proline' 0 C--O 1.243 0.764 0 C-N-CA 122.892 2.395 . . . . 0.0 112.246 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -79.02 135.3 36.85 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 82.3 t -113.48 114.06 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 CA-C-O 120.981 0.42 . . . . 0.0 110.348 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -109.35 84.33 1.91 Allowed 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 173.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.7 ' OD1' ' HG2' ' A' ' 67' ' ' LYS . 12.0 t70 -128.27 145.97 50.89 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.633 -172.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.2 m -53.84 -19.52 4.52 Favored 'General case' 0 CA--C 1.59 2.513 0 C-N-CA 125.121 1.368 . . . . 0.0 113.298 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.7 ' HG2' ' OD1' ' A' ' 65' ' ' ASP . 23.5 mmtp -64.13 176.63 0.96 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.724 -0.61 . . . . 0.0 112.272 178.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 66.8 mtm180 -102.68 -29.13 11.71 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.94 0.876 . . . . 0.0 109.642 -176.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.0 134.55 50.75 Favored 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.783 -173.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.661 ' NH2' ' HB2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -104.38 153.93 38.71 Favored Pre-proline 0 C--N 1.297 -1.696 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.185 -179.231 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.458 ' HB3' ' CD2' ' A' ' 25' ' ' TYR . 93.3 Cg_endo -77.4 140.73 19.58 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.615 1.543 . . . . 0.0 112.122 178.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -133.49 133.78 42.66 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 -178.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.596 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 83.2 m95 -117.3 135.45 53.82 Favored 'General case' 0 C--N 1.288 -2.092 0 O-C-N 121.731 -0.605 . . . . 0.0 112.39 -172.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.424 ' HA ' ' O ' ' A' ' 86' ' ' THR . 33.4 m-85 -113.05 141.93 46.3 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.91 177.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.418 HD11 HG11 ' A' ' 58' ' ' VAL . 19.2 mt -126.11 142.53 51.48 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -177.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.521 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 86.3 m-85 -133.59 141.92 47.89 Favored 'General case' 0 C--N 1.316 -0.884 0 O-C-N 123.72 0.638 . . . . 0.0 110.055 -177.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.438 ' HB3' ' CG ' ' A' ' 102' ' ' PHE . 0.8 OUTLIER -85.45 0.09 53.31 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -178.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -137.73 159.7 41.26 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 174.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.476 HG23 HD22 ' A' ' 80' ' ' ASN . 22.7 m -70.96 166.32 2.43 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 C-N-CA 122.626 0.37 . . . . 0.0 111.656 -174.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.476 HD22 HG23 ' A' ' 79' ' ' VAL . 56.1 m-80 58.07 30.8 19.82 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.798 0.839 . . . . 0.0 111.769 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.464 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 12.6 m-85 60.13 44.66 12.68 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.421 176.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 74.9 p -115.57 168.28 10.15 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.26 -141.4 17.49 Favored Glycine 0 N--CA 1.426 -2.021 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.807 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.521 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 57.1 mtt180 -77.33 135.85 38.41 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 123.083 0.553 . . . . 0.0 109.771 -177.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.8 tt -115.24 136.75 50.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.348 -175.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 96.9 m -131.9 123.2 26.98 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.172 176.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -110.06 123.89 6.9 Favored Glycine 0 N--CA 1.438 -1.183 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.362 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.417 HD21 HD11 ' A' ' 94' ' ' ILE . 3.3 mm? -115.77 145.66 42.61 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 123.159 0.584 . . . . 0.0 110.511 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.54 167.46 12.53 Favored Glycine 0 N--CA 1.423 -2.218 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.711 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -55.75 125.42 21.15 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 123.815 0.846 . . . . 0.0 112.429 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.16 3.82 84.63 Favored Glycine 0 N--CA 1.431 -1.675 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.336 176.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.9 m -113.57 146.53 39.55 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.4 m -136.75 158.0 45.45 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.417 HD11 HD21 ' A' ' 88' ' ' LEU . 56.1 mt -93.4 132.44 37.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 173.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -70.02 -47.42 62.17 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.605 0.717 . . . . 0.0 110.14 -176.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.46 ' HA ' HG22 ' A' ' 33' ' ' THR . 5.6 m-20 -138.89 102.65 4.61 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 176.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.432 ' HZ ' ' CE2' ' A' ' 102' ' ' PHE . 59.3 t80 -64.66 -32.68 74.46 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.402 0.62 . . . . 0.0 110.399 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.9 t -63.54 -24.94 68.02 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.721 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.454 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 31.8 mmtp -93.67 -5.81 47.76 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-O 121.308 0.575 . . . . 0.0 109.572 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.8 t -84.71 31.17 0.54 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.302 0.641 . . . . 0.0 110.439 -177.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.7 -71.91 1.73 Allowed Glycine 0 N--CA 1.437 -1.288 0 C-N-CA 121.263 -0.494 . . . . 0.0 111.972 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.438 ' CG ' ' HB3' ' A' ' 77' ' ' ASP . 35.0 p90 -109.96 148.37 31.75 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.577 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.43 -6.99 13.47 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.738 179.668 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -116.95 116.59 3.59 Favored Glycine 0 N--CA 1.429 -1.831 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.377 -176.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 64.9 mt -94.78 115.83 34.6 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.675 0 CA-C-O 122.342 1.068 . . . . 0.0 108.888 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 14.4 m -85.45 -25.07 27.16 Favored 'General case' 0 N--CA 1.39 -3.436 0 CA-C-N 112.425 -2.171 . . . . 0.0 114.252 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.5 p -158.0 152.88 25.22 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 122.076 -0.39 . . . . 0.0 110.014 176.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.409 ' HB ' HG12 ' A' ' 46' ' ' VAL . 44.8 mt -130.97 131.04 64.32 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -176.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.464 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 36.1 ttmt -116.53 132.82 56.58 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -100.19 129.95 46.27 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 66.7 m -131.0 172.15 12.4 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.7 pt -127.51 140.7 48.39 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -109.16 119.7 40.32 Favored 'General case' 0 C--N 1.276 -2.61 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 71.3 p -74.0 173.6 9.78 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.808 -175.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.0 tptt -66.92 -19.04 65.65 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 121.842 0.83 . . . . 0.0 109.652 175.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -84.68 -8.14 58.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.801 0.81 . . . . 0.0 110.354 177.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.99 -11.53 71.87 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 120.843 -0.694 . . . . 0.0 113.08 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -71.93 134.69 46.15 Favored 'General case' 0 C--O 1.254 1.342 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.7 t -99.51 111.85 30.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -95.29 134.93 37.51 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 48.8 m -131.01 156.37 45.24 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 8.9 tp -103.7 120.11 53.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 C-N-CA 119.879 -0.728 . . . . 0.0 110.319 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -72.97 114.13 10.77 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.497 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 . . . . . 0 C--N 1.292 -1.897 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.584 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.13 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.92 -17.94 62.45 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -175.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -77.75 5.25 9.77 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -177.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 57.7 m -52.28 128.93 26.73 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-O 121.963 0.887 . . . . 0.0 113.092 -177.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.0 p -102.56 166.44 10.52 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 114.858 -1.065 . . . . 0.0 109.863 -178.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.404 ' HE2' ' HA ' ' A' ' 63' ' ' VAL . 8.8 mmmm -107.92 -32.28 7.65 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-O 121.766 0.793 . . . . 0.0 111.549 -177.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -121.06 68.58 0.88 Allowed 'General case' 0 C--N 1.279 -2.464 0 CA-C-O 122.315 1.055 . . . . 0.0 110.111 -175.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.545 ' SG ' ' HG3' ' A' ' 61' ' ' PRO . 3.9 p -144.74 160.16 41.68 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 113.681 -1.599 . . . . 0.0 109.82 -178.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.631 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 54.3 tp -111.93 118.53 35.75 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 173.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 66.7 mt-30 -109.33 123.65 49.64 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.251 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.454 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 2.9 mp -110.35 121.73 46.0 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.672 177.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.443 ' CD1' ' HB3' ' A' ' 39' ' ' TYR . 90.4 m-85 -93.12 157.26 16.38 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 123.609 0.568 . . . . 0.0 111.781 -175.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -81.14 -35.13 31.91 Favored 'General case' 0 CA--C 1.494 -1.175 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.865 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -108.23 178.09 4.61 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.469 HG22 ' HA ' ' A' ' 96' ' ' ASP . 3.3 p -81.39 172.07 14.0 Favored 'General case' 0 N--CA 1.401 -2.899 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.35 178.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 21.2 p90 47.26 38.93 7.75 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.892 1.277 . . . . 0.0 114.205 176.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 65.41 22.41 11.94 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.551 1.541 . . . . 0.0 114.506 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.18 173.62 7.63 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.255 0.55 . . . . 0.0 111.485 175.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.18 -152.75 34.87 Favored Glycine 0 N--CA 1.426 -2.021 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 -174.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.7 m -108.78 178.51 4.46 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 173.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.443 ' HB3' ' CD1' ' A' ' 30' ' ' TYR . 29.9 p90 -143.53 166.79 23.82 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.095 0.474 . . . . 0.0 110.157 -177.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.0 tt -114.53 152.81 16.13 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.545 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 176.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -106.84 125.54 51.14 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 176.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.494 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 99.4 t -122.6 134.55 65.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -126.09 -2.85 7.02 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 120.714 -0.394 . . . . 0.0 110.771 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -139.44 162.54 34.8 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -173.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.45 ' HB3' ' H ' ' A' ' 110' ' ' ARG . 2.8 p -84.42 144.86 28.5 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-O 120.991 0.424 . . . . 0.0 111.599 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.7 p -119.78 137.72 52.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.68 -21.63 30.81 Favored Glycine 0 N--CA 1.433 -1.526 0 C-N-CA 120.072 -1.061 . . . . 0.0 112.389 -177.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.0 p -157.79 129.04 6.66 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-O 121.07 0.462 . . . . 0.0 112.014 -178.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.1 mt -118.5 118.47 31.8 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 175.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 38.5 m -132.27 114.61 14.84 Favored Pre-proline 0 C--N 1.299 -1.6 0 O-C-N 123.393 0.433 . . . . 0.0 110.08 175.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 6.2 Cg_exo -76.91 159.41 95.99 Favored 'Cis proline' 0 C--O 1.246 0.899 0 C-N-CA 122.944 -1.69 . . . . 0.0 110.371 -1.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -62.34 157.66 44.45 Favored 'Trans proline' 0 C--O 1.252 1.209 0 C-N-CA 122.482 2.121 . . . . 0.0 111.349 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.428 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 48.8 m0 -89.47 140.27 29.69 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -177.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.613 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 35.5 p -123.8 73.78 54.68 Favored Pre-proline 0 C--N 1.305 -1.364 0 O-C-N 123.46 0.475 . . . . 0.0 110.561 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.454 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 81.6 Cg_endo -74.2 156.5 46.63 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 122.354 2.036 . . . . 0.0 113.653 -178.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -83.77 -34.28 19.29 Favored Glycine 0 N--CA 1.431 -1.633 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 177.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.0 p -153.83 154.97 34.92 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.3 t -130.45 142.31 44.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 35.5 t -146.07 152.32 39.14 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.696 176.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 95.4 t -117.2 125.21 28.38 Favored Pre-proline 0 C--N 1.313 -0.991 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 176.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.545 ' HG3' ' SG ' ' A' ' 26' ' ' CYS . 5.9 Cg_exo -49.68 141.31 27.49 Favored 'Trans proline' 0 C--O 1.245 0.865 0 C-N-CA 123.471 2.78 . . . . 0.0 113.288 178.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -75.24 113.47 12.64 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 121.676 0.75 . . . . 0.0 109.868 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.468 ' H ' ' HB2' ' A' ' 90' ' ' HIS . 78.4 t -94.54 125.31 47.18 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.513 -179.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -127.88 12.16 6.71 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 124.428 1.08 . . . . 0.0 108.696 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -57.93 147.04 30.18 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.464 1.506 . . . . 0.0 113.28 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.3 m -53.59 -12.9 0.54 Allowed 'General case' 0 CA--C 1.579 2.071 0 C-N-CA 125.568 1.547 . . . . 0.0 112.179 178.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -58.42 161.39 4.48 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.669 1.188 . . . . 0.0 111.182 175.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.78 -28.25 16.69 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -178.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.67 140.77 43.12 Favored 'General case' 0 N--CA 1.417 -2.098 0 CA-C-N 114.559 -1.2 . . . . 0.0 112.631 -174.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -105.99 154.22 39.65 Favored Pre-proline 0 C--N 1.289 -2.027 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.406 ' CD ' HG21 ' A' ' 63' ' ' VAL . 85.0 Cg_endo -81.71 135.18 8.9 Favored 'Trans proline' 0 N--CA 1.44 -1.644 0 C-N-CA 121.309 1.34 . . . . 0.0 110.888 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -128.76 123.54 33.22 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 -177.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.631 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 83.4 m95 -109.33 135.35 50.54 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-O 120.759 0.314 . . . . 0.0 111.843 -172.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 86' ' ' THR . 39.8 m-85 -113.59 141.85 46.68 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.023 177.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.6 mt -125.37 142.2 51.64 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 -176.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.44 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 80.8 m-85 -131.3 141.49 49.96 Favored 'General case' 0 CA--C 1.497 -1.079 0 O-C-N 123.468 0.48 . . . . 0.0 110.49 -176.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.58 -21.76 51.96 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.525 -177.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.498 ' C ' ' HB3' ' A' ' 106' ' ' SER . 8.6 t-20 -118.76 168.33 10.84 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.405 HG23 HD22 ' A' ' 80' ' ' ASN . 33.6 m -73.94 168.96 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 C-N-CA 122.575 0.35 . . . . 0.0 110.298 -179.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.405 HD22 HG23 ' A' ' 79' ' ' VAL . 36.5 m-80 55.48 30.42 15.07 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.447 0.699 . . . . 0.0 112.605 178.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.445 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 9.3 m-85 58.96 45.85 14.43 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 124.755 1.222 . . . . 0.0 111.316 176.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.7 p -117.33 167.45 11.23 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.186 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.93 -134.19 12.32 Favored Glycine 0 N--CA 1.424 -2.13 0 N-CA-C 111.344 -0.703 . . . . 0.0 111.344 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.44 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 64.1 mtm180 -81.17 151.39 28.24 Favored 'General case' 0 C--N 1.287 -2.124 0 C-N-CA 123.611 0.764 . . . . 0.0 110.977 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.4 tt -130.5 137.18 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-O 121.275 0.559 . . . . 0.0 110.303 -176.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 98.4 m -132.38 120.51 22.13 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.906 175.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -108.01 127.8 8.85 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.211 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.49 HD21 HD11 ' A' ' 94' ' ' ILE . 3.3 mm? -118.21 145.5 44.93 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 123.074 0.55 . . . . 0.0 110.793 178.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.75 172.93 14.45 Favored Glycine 0 N--CA 1.433 -1.563 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.455 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.468 ' HB2' ' H ' ' A' ' 63' ' ' VAL . 3.0 p80 -61.65 122.32 15.0 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 123.293 0.637 . . . . 0.0 112.287 -175.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.2 2.13 80.73 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.821 176.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.1 m -110.36 146.13 36.33 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.4 m -140.37 154.5 46.74 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.49 HD11 HD21 ' A' ' 88' ' ' LEU . 52.2 mt -93.21 128.79 44.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 173.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -70.26 -47.37 61.59 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 123.539 0.525 . . . . 0.0 110.111 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.616 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 1.6 m-20 -132.97 91.83 2.94 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.761 -179.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -65.46 -33.13 75.22 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.483 0.658 . . . . 0.0 109.429 176.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.7 t -64.31 -28.79 69.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.358 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.616 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 32.2 mmtp -89.57 -6.79 55.97 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 120.61 0.243 . . . . 0.0 110.499 -176.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.3 m -82.21 -175.12 5.5 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.064 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -52.86 -64.11 4.41 Favored Glycine 0 C--N 1.334 0.422 0 O-C-N 123.136 0.272 . . . . 0.0 113.215 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -110.94 143.14 42.07 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 122.505 -0.409 . . . . 0.0 110.462 176.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.613 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -108.93 -9.93 15.1 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.201 -1.036 . . . . 0.0 108.201 175.092 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.428 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -108.68 114.01 3.95 Favored Glycine 0 N--CA 1.433 -1.535 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.188 -177.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 71.6 mt -96.92 115.57 36.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.498 ' HB3' ' C ' ' A' ' 78' ' ' ASN . 1.1 t -86.67 -26.48 24.3 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.497 178.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.3 p -150.95 156.68 41.67 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 122.158 -0.339 . . . . 0.0 110.324 178.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.2 mt -135.13 132.28 52.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -176.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.445 ' HE2' ' CD2' ' A' ' 81' ' ' TYR . 32.3 ttmt -117.65 133.92 55.44 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.45 ' H ' ' HB3' ' A' ' 45' ' ' SER . 24.6 ttp180 -102.77 127.73 49.81 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 66.2 m -127.16 171.98 10.95 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.0 pt -129.66 144.87 36.76 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.146 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 177.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.481 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 61.8 tt0 -119.18 122.48 42.1 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 -179.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 63.4 p -75.35 174.06 10.06 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.404 -175.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -66.36 -28.18 68.46 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.664 0.745 . . . . 0.0 109.525 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -77.12 -7.11 55.2 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.307 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.04 -1.74 61.15 Favored Glycine 0 N--CA 1.438 -1.192 0 N-CA-C 115.534 0.974 . . . . 0.0 115.534 171.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 113' ' ' GLN . 18.5 ptpt -83.73 140.65 31.98 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 118.78 1.29 . . . . 0.0 110.9 -177.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.4 t -101.81 112.06 33.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -99.4 144.79 28.11 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 124.27 1.028 . . . . 0.0 108.241 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 72.8 m -129.64 151.77 49.88 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 120.384 -0.526 . . . . 0.0 111.597 -174.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 6.0 tp -72.97 139.71 19.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.148 178.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -70.86 105.6 3.3 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 . . . . . 0 C--N 1.29 -1.983 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 179.976 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.47 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 59.88 31.31 20.67 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.923 0.889 . . . . 0.0 111.526 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -83.86 -25.39 30.31 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.756 0.788 . . . . 0.0 109.295 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.8 m -91.51 146.93 23.39 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 175.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 19.6 p -103.04 151.67 22.25 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.925 0.869 . . . . 0.0 112.349 -175.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -76.02 135.61 39.96 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.537 -1.21 . . . . 0.0 108.895 -178.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.43 ' CZ ' ' HD3' ' A' ' 71' ' ' PRO . 9.1 m-85 64.87 39.71 5.85 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.137 0.494 . . . . 0.0 112.006 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 63.5 m -123.32 149.63 44.61 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.591 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 49.1 tp -95.62 112.76 24.41 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 174.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.526 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 17.7 mt-30 -111.46 123.17 49.67 Favored 'General case' 0 N--CA 1.422 -1.852 0 C-N-CA 119.575 -0.85 . . . . 0.0 109.745 -177.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.451 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 2.7 mp -110.97 124.71 52.67 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.87 -178.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.416 ' CE1' ' HG2' ' A' ' 35' ' ' GLU . 96.4 m-85 -90.45 155.38 18.96 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 122.623 0.369 . . . . 0.0 110.577 -178.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -75.18 -40.94 58.98 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.897 0.856 . . . . 0.0 109.943 -176.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.483 ' HB2' ' HG3' ' A' ' 36' ' ' ARG . 24.8 mm-40 -108.46 179.01 4.32 Favored 'General case' 0 N--CA 1.421 -1.918 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.403 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.513 HG22 ' HA ' ' A' ' 96' ' ' ASP . 0.8 OUTLIER -81.11 174.94 11.09 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.504 -177.093 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 47.07 34.03 2.64 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 174.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.416 ' HG2' ' CE1' ' A' ' 30' ' ' TYR . 36.1 mt-10 65.35 22.78 12.03 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 124.485 1.114 . . . . 0.0 113.919 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.483 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 35.7 ptt180 -97.71 157.52 16.01 Favored 'General case' 0 N--CA 1.433 -1.312 0 C-N-CA 118.694 -1.202 . . . . 0.0 108.87 174.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.4 -178.65 41.62 Favored Glycine 0 N--CA 1.424 -2.105 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -175.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.0 m -89.59 169.13 11.59 Favored 'General case' 0 C--N 1.286 -2.163 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.553 177.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.435 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 21.8 p90 -131.78 165.88 22.8 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.466 -177.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 15.0 tt -113.87 150.55 15.88 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -106.59 125.15 50.64 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.503 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 88.4 t -123.97 133.88 68.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -117.46 -31.57 5.2 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -176.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.542 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 11.2 mmpt? -103.56 161.98 13.43 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.914 -173.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.9 p -88.99 143.03 27.14 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 172.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.5 p -121.31 131.05 73.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -177.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.77 -15.25 56.89 Favored Glycine 0 C--N 1.298 -1.53 0 C-N-CA 119.851 -1.166 . . . . 0.0 113.03 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.5 p -154.38 123.98 6.59 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.439 0.637 . . . . 0.0 112.415 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 88.4 mt -116.45 118.71 33.42 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.202 177.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 25.0 p -131.88 107.51 14.0 Favored Pre-proline 0 C--N 1.3 -1.549 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.64 175.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 72.8 Cg_endo -77.93 162.22 89.86 Favored 'Cis proline' 0 C--O 1.249 1.068 0 C-N-CA 123.861 -1.308 . . . . 0.0 111.801 0.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.52 154.58 73.07 Favored 'Trans proline' 0 C--O 1.25 1.123 0 C-N-CA 122.125 1.883 . . . . 0.0 110.586 176.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 49.3 m0 -90.23 137.6 32.21 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 20.5 p -121.22 79.41 35.34 Favored Pre-proline 0 N--CA 1.425 -1.688 0 O-C-N 123.258 0.349 . . . . 0.0 111.027 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.451 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 85.4 Cg_endo -77.16 158.49 33.74 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.884 2.389 . . . . 0.0 112.789 178.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.32 -29.82 9.21 Favored Glycine 0 N--CA 1.43 -1.701 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 175.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.1 p -150.96 152.61 33.81 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.411 HG22 HD23 ' A' ' 29' ' ' LEU . 40.5 t -126.71 142.99 41.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -178.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 17.3 t -145.46 138.48 26.19 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 118.525 0.602 . . . . 0.0 110.109 -176.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.7 t -118.33 125.38 27.9 Favored Pre-proline 0 C--O 1.249 1.056 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -62.1 147.16 95.62 Favored 'Trans proline' 0 C--O 1.249 1.061 0 C-N-CA 122.775 2.317 . . . . 0.0 111.031 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.612 ' CE2' ' HB3' ' A' ' 64' ' ' ASN . 34.7 t80 -74.49 136.31 42.24 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-O 121.95 0.881 . . . . 0.0 111.111 -176.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 98.4 t -118.61 115.08 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.166 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.612 ' HB3' ' CE2' ' A' ' 62' ' ' PHE . 24.5 p-10 -121.67 13.44 10.82 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 123.045 1.402 . . . . 0.0 107.332 178.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.74 146.44 41.47 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 111.737 -2.483 . . . . 0.0 111.483 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.4 m -57.46 -8.22 0.77 Allowed 'General case' 0 CA--C 1.579 2.073 0 C-N-CA 124.69 1.196 . . . . 0.0 112.004 177.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -62.49 136.65 58.0 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.104 0.961 . . . . 0.0 108.731 177.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.539 ' HB2' ' OE1' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -84.24 -28.82 26.98 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -177.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.539 ' OE1' ' HB2' ' A' ' 68' ' ' ARG . 3.0 mp0 -97.25 125.08 41.58 Favored 'General case' 0 N--CA 1.415 -2.184 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.484 ' HG2' ' CE1' ' A' ' 90' ' ' HIS . 0.6 OUTLIER -106.75 152.09 40.71 Favored Pre-proline 0 C--N 1.291 -1.955 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.593 179.111 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.43 ' HD3' ' CZ ' ' A' ' 25' ' ' TYR . 74.1 Cg_endo -76.98 134.09 14.3 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 121.089 1.193 . . . . 0.0 110.542 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -133.5 132.82 41.45 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.591 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 89.5 m95 -119.48 133.15 55.82 Favored 'General case' 0 C--N 1.284 -2.275 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.915 -172.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.525 ' HA ' ' O ' ' A' ' 86' ' ' THR . 35.7 m-85 -112.98 141.39 46.87 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.368 177.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.8 mt -125.92 142.16 51.64 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -176.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.544 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 80.2 m-85 -134.45 142.68 47.18 Favored 'General case' 0 CA--C 1.502 -0.874 0 O-C-N 123.796 0.685 . . . . 0.0 110.117 -176.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.409 ' HB3' ' CD1' ' A' ' 102' ' ' PHE . 2.9 p-10 -84.38 -5.82 59.32 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.476 ' C ' ' HB3' ' A' ' 106' ' ' SER . 4.4 t-20 -127.28 167.77 15.67 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 174.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.4 m -73.52 167.37 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 C-N-CA 122.581 0.352 . . . . 0.0 111.627 -176.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 55.92 31.53 18.03 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.237 -0.892 . . . . 0.0 113.226 176.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 62.82 42.83 7.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.857 175.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 69.3 p -118.38 161.7 19.53 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.093 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.98 -144.06 17.12 Favored Glycine 0 N--CA 1.425 -2.065 0 N-CA-C 111.668 -0.573 . . . . 0.0 111.668 177.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.544 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 54.9 mtt180 -72.41 142.84 48.69 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.3 tt -125.4 136.43 60.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-O 121.487 0.66 . . . . 0.0 111.241 -173.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 86.7 m -131.57 123.04 27.1 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.34 176.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -113.69 120.06 5.0 Favored Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.531 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.465 HD21 HD11 ' A' ' 94' ' ' ILE . 3.3 mm? -110.35 147.76 33.29 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 123.673 0.789 . . . . 0.0 111.0 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -121.36 168.41 14.31 Favored Glycine 0 N--CA 1.425 -2.047 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.204 -178.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.484 ' CE1' ' HG2' ' A' ' 70' ' ' ARG . 2.9 p80 -55.12 121.89 9.78 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 124.066 0.946 . . . . 0.0 112.139 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.18 12.37 73.76 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.064 176.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.0 m -125.48 145.9 49.88 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 177.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 22.5 m -144.2 155.84 44.05 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -178.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.465 HD11 HD21 ' A' ' 88' ' ' LEU . 48.7 mt -93.45 125.61 46.0 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.45 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -70.22 -46.76 63.86 Favored 'General case' 0 C--N 1.288 -2.071 0 O-C-N 123.812 0.695 . . . . 0.0 110.353 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.587 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 3.3 m-20 -132.88 93.55 3.22 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.231 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.407 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 54.3 t80 -64.94 -31.66 73.0 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.431 0.634 . . . . 0.0 110.508 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.7 t -63.49 -23.2 67.29 Favored 'General case' 0 CA--C 1.561 1.375 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.631 -178.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.587 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 30.4 mmtp -92.78 -6.31 49.24 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.925 -0.485 . . . . 0.0 109.765 -179.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.8 m -84.85 13.46 5.86 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.379 0.609 . . . . 0.0 111.786 -177.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 104.72 -79.07 0.28 Allowed Glycine 0 N--CA 1.425 -2.05 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.68 178.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.409 ' CD1' ' HB3' ' A' ' 77' ' ' ASP . 27.5 p90 -100.11 147.13 26.0 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -178.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.548 ' H ' ' HD3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -113.3 -14.22 12.84 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 177.18 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -103.02 110.4 3.71 Favored Glycine 0 N--CA 1.422 -2.271 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.489 -175.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 80.5 mt -93.32 115.65 32.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.476 ' HB3' ' C ' ' A' ' 78' ' ' ASN . 5.3 t -85.99 -29.01 23.85 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.502 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 90.1 p -150.34 156.33 41.31 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.752 -0.203 . . . . 0.0 110.818 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.7 mt -134.01 132.41 56.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -176.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -116.38 131.58 56.91 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 40.0 ttt180 -99.5 129.6 45.69 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . 0.422 ' SG ' ' HD2' ' A' ' 74' ' ' TYR . 62.6 m -128.51 172.38 11.21 Favored 'General case' 0 N--CA 1.413 -2.3 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.329 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 70' ' ' ARG . 7.1 pt -131.48 141.98 44.43 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 C-N-CA 123.172 0.589 . . . . 0.0 110.039 177.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.42 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 52.6 tt0 -113.69 119.11 36.3 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 33.8 p -80.19 -178.37 6.54 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.45 -172.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -66.1 -28.85 69.13 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.769 0.795 . . . . 0.0 109.636 177.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -80.1 -6.46 57.73 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.422 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.97 6.17 82.55 Favored Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 115.969 -0.56 . . . . 0.0 113.77 175.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 113' ' ' GLN . 66.0 pttt -82.16 145.08 30.3 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.829 178.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 25.5 t -104.12 111.52 34.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -97.12 144.24 27.16 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 178.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 96.8 m -129.84 153.43 48.28 Favored 'General case' 0 C--N 1.289 -2.055 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.297 -173.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 10.5 tp -125.26 127.95 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.449 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -92.26 128.64 38.18 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 . . . . . 0 C--N 1.293 -1.888 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -176.742 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.97 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.59 76.67 8.11 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 173.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.509 ' HB3' ' OH ' ' A' ' 39' ' ' TYR . 12.5 m-20 -87.85 -24.52 23.67 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.191 -171.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.0 m -74.56 123.81 25.48 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.413 ' O ' ' HG3' ' A' ' 61' ' ' PRO . 15.5 p -104.37 151.85 22.99 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 120.566 -0.454 . . . . 0.0 111.371 -176.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.6 tptt -68.32 131.41 45.29 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.655 -178.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 65.47 38.91 5.38 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 124.104 0.877 . . . . 0.0 111.718 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.6 m -122.73 145.07 48.73 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.517 HD22 ' CE3' ' A' ' 73' ' ' TRP . 51.5 tp -96.24 116.24 28.69 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 174.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 37.3 mt-30 -108.98 124.21 50.34 Favored 'General case' 0 N--CA 1.428 -1.572 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.315 -177.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.496 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.7 mp -109.66 118.91 37.8 Favored 'General case' 0 N--CA 1.408 -2.526 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.46 177.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.438 ' CD2' ' HB3' ' A' ' 39' ' ' TYR . 95.4 m-85 -87.51 150.3 23.82 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.508 -176.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -72.09 -44.1 63.76 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.835 -175.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -109.8 178.05 4.54 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.902 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.455 HG22 ' HA ' ' A' ' 96' ' ' ASP . 1.9 p -76.74 170.57 16.22 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-O 119.785 -0.15 . . . . 0.0 111.002 -177.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 14.9 p90 47.41 37.05 5.58 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.899 1.28 . . . . 0.0 114.086 177.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 67.72 26.21 7.89 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.615 1.166 . . . . 0.0 112.853 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.471 ' CZ ' ' HB3' ' A' ' 36' ' ' ARG . 8.5 mtp-105 -90.89 162.49 14.76 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 176.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.22 -158.94 36.71 Favored Glycine 0 N--CA 1.424 -2.134 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.3 p -96.44 177.41 5.69 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 174.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.509 ' OH ' ' HB3' ' A' ' 21' ' ' ASP . 38.1 p90 -138.55 166.83 23.32 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.8 tt -113.42 151.56 15.26 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 177.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -106.13 124.87 50.26 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.449 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 92.4 t -123.52 133.55 68.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -122.09 -6.01 8.94 Favored 'General case' 0 C--N 1.31 -1.118 0 O-C-N 123.616 0.573 . . . . 0.0 110.85 -174.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -137.1 162.34 33.66 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.161 -173.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.44 ' HB3' ' H ' ' A' ' 110' ' ' ARG . 3.9 p -86.77 140.2 29.97 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 175.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.2 p -119.53 134.37 63.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -175.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.76 -15.73 48.23 Favored Glycine 0 C--N 1.301 -1.394 0 C-N-CA 120.417 -0.897 . . . . 0.0 113.195 -176.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.7 t -156.61 127.54 6.83 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.442 0.639 . . . . 0.0 111.182 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.5 mt -121.34 117.93 28.19 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.073 177.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.0 m -132.55 115.41 14.73 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 174.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -75.12 161.92 93.81 Favored 'Cis proline' 0 C--O 1.25 1.089 0 C-N-CA 123.033 -1.653 . . . . 0.0 110.788 -2.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -61.98 156.7 47.8 Favored 'Trans proline' 0 C--O 1.256 1.403 0 C-N-CA 122.129 1.886 . . . . 0.0 110.417 178.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.426 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 45.8 m0 -89.33 135.97 33.29 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -176.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 34.1 p -115.65 81.41 9.15 Favored Pre-proline 0 C--N 1.301 -1.5 0 O-C-N 123.369 0.418 . . . . 0.0 111.165 178.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.496 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 81.3 Cg_endo -81.5 157.7 19.28 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 122.239 1.959 . . . . 0.0 112.583 176.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.06 -30.24 11.42 Favored Glycine 0 N--CA 1.43 -1.747 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 177.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.8 p -155.13 153.52 30.93 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.6 t -130.28 142.7 43.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 49.1 t -145.8 148.12 32.58 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.373 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.422 ' HB ' ' O ' ' A' ' 89' ' ' GLY . 58.7 t -117.39 122.65 30.75 Favored Pre-proline 0 C--N 1.31 -1.133 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 175.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.413 ' HG3' ' O ' ' A' ' 23' ' ' CYS . 39.7 Cg_endo -65.44 156.39 63.73 Favored 'Trans proline' 0 C--O 1.25 1.075 0 C-N-CA 122.726 2.284 . . . . 0.0 112.577 -177.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -72.84 135.3 45.16 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.386 178.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 98.4 t -112.19 115.58 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.265 0 CA-C-O 121.743 0.782 . . . . 0.0 111.763 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -112.51 74.54 0.87 Allowed 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 173.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.432 ' HB3' ' NH2' ' A' ' 70' ' ' ARG . 14.6 t70 -126.99 145.95 50.52 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.191 -170.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -54.37 -18.53 4.21 Favored 'General case' 0 CA--C 1.578 2.044 0 C-N-CA 125.803 1.641 . . . . 0.0 114.429 -178.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.57 ' HB2' ' NH2' ' A' ' 70' ' ' ARG . 75.8 mmtt -65.56 173.79 2.56 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.561 -0.712 . . . . 0.0 111.261 175.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -102.7 -26.82 13.04 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 176.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -92.73 132.31 37.05 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.542 -176.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.57 ' NH2' ' HB2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -104.92 149.77 37.93 Favored Pre-proline 0 C--N 1.3 -1.545 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.626 176.379 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.17 136.18 17.81 Favored 'Trans proline' 0 C--N 1.321 -0.909 0 C-N-CA 121.907 1.738 . . . . 0.0 112.314 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -133.09 130.55 39.46 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.517 ' CE3' HD22 ' A' ' 27' ' ' LEU . 84.4 m95 -116.2 136.91 52.59 Favored 'General case' 0 C--N 1.286 -2.158 0 O-C-N 121.631 -0.668 . . . . 0.0 111.904 -172.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 86' ' ' THR . 41.4 m-85 -115.04 142.3 46.83 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 123.051 0.54 . . . . 0.0 110.426 177.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 21.8 mt -125.71 142.96 51.25 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 -175.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 84.3 m-85 -133.23 145.18 50.31 Favored 'General case' 0 C--O 1.241 0.616 0 O-C-N 123.578 0.549 . . . . 0.0 110.666 -176.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.54 -3.56 58.9 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.794 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.466 ' HA ' HD22 ' A' ' 78' ' ' ASN . 2.1 t-20 -133.26 157.06 46.38 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 119.851 -0.739 . . . . 0.0 109.283 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.492 HG23 HD22 ' A' ' 80' ' ' ASN . 33.9 m -70.81 168.31 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.455 -178.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.492 HD22 HG23 ' A' ' 79' ' ' VAL . 45.7 m-80 59.66 30.23 19.83 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.251 0.621 . . . . 0.0 110.966 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.602 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 16.5 m-85 55.21 44.03 28.33 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 124.781 1.232 . . . . 0.0 112.233 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 59.1 p -117.07 172.85 7.0 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.932 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.68 -136.17 13.5 Favored Glycine 0 N--CA 1.429 -1.767 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.357 178.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 77.6 mtt180 -79.76 153.23 29.35 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.8 tt -133.12 136.82 54.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-O 121.384 0.612 . . . . 0.0 110.785 -175.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 95.5 m -132.39 121.11 22.94 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.999 177.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -108.47 119.76 5.75 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.868 -0.682 . . . . 0.0 114.443 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.4 HD21 HD11 ' A' ' 94' ' ' ILE . 3.4 mm? -110.1 145.53 36.97 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 123.103 0.561 . . . . 0.0 110.596 178.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.422 ' O ' ' HB ' ' A' ' 60' ' ' VAL . . . -119.61 175.67 15.89 Favored Glycine 0 N--CA 1.429 -1.793 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.946 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -60.17 132.81 55.09 Favored 'General case' 0 C--O 1.247 0.95 0 C-N-CA 123.088 0.555 . . . . 0.0 111.86 -178.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.75 16.34 79.25 Favored Glycine 0 N--CA 1.437 -1.266 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.744 177.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.0 m -121.06 145.48 47.73 Favored 'General case' 0 N--CA 1.42 -1.972 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -178.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.9 m -141.98 155.43 45.45 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.4 HD11 HD21 ' A' ' 88' ' ' LEU . 47.7 mt -93.33 130.94 41.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 175.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -70.85 -48.42 54.06 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 123.586 0.554 . . . . 0.0 110.3 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.455 ' HA ' HG22 ' A' ' 33' ' ' THR . 8.2 m-20 -141.57 98.88 3.44 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -63.84 -31.86 73.18 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.481 0.658 . . . . 0.0 110.469 -178.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.9 t -63.4 -22.13 66.7 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.393 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -93.14 -11.04 33.81 Favored 'General case' 0 C--O 1.22 -0.499 0 O-C-N 121.742 -0.599 . . . . 0.0 110.416 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.1 m -78.77 -7.14 57.52 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.42 0.629 . . . . 0.0 110.579 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 123.8 -86.34 0.37 Allowed Glycine 0 N--CA 1.419 -2.478 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -85.73 139.2 31.54 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.584 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -109.43 -6.91 15.28 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.157 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -110.97 113.28 3.41 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.348 -176.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 75.0 mt -97.3 115.31 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.548 0 CA-C-O 122.687 1.232 . . . . 0.0 109.066 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 58.3 m -85.66 -25.31 26.64 Favored 'General case' 0 N--CA 1.393 -3.296 0 CA-C-N 111.811 -2.45 . . . . 0.0 113.935 178.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.454 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 8.5 t -159.39 153.3 23.21 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -176.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.1 mt -136.3 129.27 46.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -176.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.602 ' HE2' ' CD2' ' A' ' 81' ' ' TYR . 35.3 ttmt -117.23 133.28 56.18 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.44 ' H ' ' HB3' ' A' ' 45' ' ' SER . 55.5 ttp180 -100.49 129.85 46.49 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -178.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 71.0 m -126.34 172.0 10.5 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 178.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.4 pt -132.23 140.68 47.22 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -109.09 123.91 49.93 Favored 'General case' 0 C--N 1.266 -3.049 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 69.1 p -74.08 166.58 23.15 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.364 -175.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -67.58 -19.23 65.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 122.169 0.985 . . . . 0.0 109.075 175.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -76.93 -7.57 55.8 Favored 'General case' 0 CA--C 1.561 1.369 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.104 175.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.53 3.96 74.06 Favored Glycine 0 CA--C 1.504 -0.645 0 N-CA-C 114.828 0.691 . . . . 0.0 114.828 172.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.425 ' HE2' ' OE2' ' A' ' 120' ' ' GLU . 21.9 ptmt -94.44 139.73 30.75 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 119.138 -1.025 . . . . 0.0 109.421 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 24.2 t -95.27 111.9 26.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.394 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.425 ' OE2' ' HE2' ' A' ' 118' ' ' LYS . 6.3 mm-40 -94.96 142.69 27.19 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 72.4 m -130.19 162.63 28.47 Favored 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -177.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 7.4 tp -73.58 128.02 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 172.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -68.45 104.37 1.89 Allowed 'General case' 0 CA--C 1.49 -1.351 0 CA-C-O 121.827 0.822 . . . . 0.0 110.519 -178.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 . . . . . 0 C--N 1.293 -1.864 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 -179.727 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.213 0 N-CA-C 111.548 -0.621 . . . . 0.0 111.548 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -131.22 110.07 10.87 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -80.73 -24.21 38.92 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.503 0.668 . . . . 0.0 110.097 -177.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.8 m -102.87 129.16 49.48 Favored 'General case' 0 N--CA 1.416 -2.14 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 174.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.533 ' O ' ' HG3' ' A' ' 61' ' ' PRO . 54.0 t -102.73 134.69 45.7 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -73.65 112.04 9.36 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 123.28 0.632 . . . . 0.0 110.556 -173.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 70.17 33.86 2.54 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 123.817 0.698 . . . . 0.0 112.021 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 6.7 m -123.57 144.65 49.45 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.593 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 56.1 tp -88.73 128.28 35.62 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.474 ' NE2' ' H ' ' A' ' 23' ' ' CYS . 48.1 mt-30 -117.23 123.42 46.58 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.222 -177.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.9 mp -110.82 120.05 41.12 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.893 177.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -89.82 150.41 22.26 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 123.735 0.647 . . . . 0.0 110.461 -176.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -75.34 -36.45 61.03 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.003 0.43 . . . . 0.0 111.17 -179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -107.99 177.27 4.86 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.452 HG22 ' HA ' ' A' ' 96' ' ' ASP . 1.7 p -82.43 170.45 15.26 Favored 'General case' 0 N--CA 1.407 -2.624 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 29.6 p90 46.83 44.46 14.3 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.803 1.241 . . . . 0.0 114.057 177.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 67.75 22.67 8.82 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.803 0.841 . . . . 0.0 112.615 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 37.4 mtp85 -95.17 161.02 14.29 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 177.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.31 -167.51 41.36 Favored Glycine 0 N--CA 1.423 -2.167 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.775 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 79.4 p -87.9 163.1 16.55 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 176.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 11.4 p90 -129.28 164.95 22.4 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.6 tt -114.95 153.39 16.45 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.038 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -106.75 125.47 51.05 Favored 'General case' 0 N--CA 1.422 -1.856 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 175.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.54 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 97.1 t -118.89 133.41 65.85 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 177.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -116.97 -29.83 5.88 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 123.472 0.482 . . . . 0.0 110.687 -174.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -121.59 163.27 19.2 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.031 -174.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.9 m -75.7 144.01 41.81 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 176.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.6 p -120.95 137.11 55.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.66 -18.71 31.72 Favored Glycine 0 C--N 1.307 -1.044 0 C-N-CA 119.791 -1.195 . . . . 0.0 113.02 -178.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.4 t -153.21 131.6 12.09 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-O 121.053 0.454 . . . . 0.0 110.305 -177.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.2 mt -123.25 117.68 25.86 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.58 177.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 11.0 m -132.61 111.21 13.64 Favored Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 177.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 5.1 Cg_exo -78.08 160.45 92.13 Favored 'Cis proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.109 -1.621 . . . . 0.0 110.527 -0.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -61.68 157.75 40.72 Favored 'Trans proline' 0 C--O 1.253 1.254 0 C-N-CA 122.126 1.884 . . . . 0.0 111.007 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.451 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 49.8 m0 -90.16 135.7 33.5 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -177.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 34.9 p -117.52 75.09 8.98 Favored Pre-proline 0 C--N 1.296 -1.751 0 O-C-N 123.387 0.429 . . . . 0.0 110.209 178.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.467 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 96.4 Cg_endo -74.73 157.81 43.63 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 C-N-CA 122.151 1.901 . . . . 0.0 113.036 -178.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.97 -31.75 11.75 Favored Glycine 0 N--CA 1.427 -1.921 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 177.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.1 p -156.46 153.74 29.3 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.4 t -129.37 143.0 42.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 32.2 t -145.59 152.94 40.48 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.331 177.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.3 t -120.92 128.89 25.55 Favored Pre-proline 0 N--CA 1.443 -0.778 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 176.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.533 ' HG3' ' O ' ' A' ' 23' ' ' CYS . 30.9 Cg_endo -62.0 140.69 85.9 Favored 'Trans proline' 0 C--O 1.244 0.798 0 C-N-CA 123.18 2.587 . . . . 0.0 112.387 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.475 ' CE1' ' HB3' ' A' ' 64' ' ' ASN . 76.0 t80 -74.75 112.44 10.96 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-O 121.413 0.625 . . . . 0.0 110.462 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.3 t -94.16 115.57 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.148 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.485 178.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.475 ' HB3' ' CE1' ' A' ' 62' ' ' PHE . 6.4 p30 -118.88 15.69 13.43 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.194 -1.409 . . . . 0.0 107.194 177.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.652 ' OD1' ' HG2' ' A' ' 67' ' ' LYS . 8.9 t70 -66.51 147.54 53.14 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 112.358 -2.201 . . . . 0.0 109.476 179.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.2 m -53.13 -23.37 7.96 Favored 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 123.809 0.843 . . . . 0.0 111.812 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.652 ' HG2' ' OD1' ' A' ' 65' ' ' ASP . 42.5 mmtm -54.49 121.23 7.94 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 176.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -73.75 -25.64 60.27 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.976 -174.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -91.7 127.59 37.21 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -99.72 153.57 37.7 Favored Pre-proline 0 C--N 1.286 -2.193 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -83.22 135.18 7.19 Favored 'Trans proline' 0 N--CA 1.442 -1.503 0 C-N-CA 121.503 1.469 . . . . 0.0 111.078 176.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -130.24 132.2 45.86 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.593 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 82.2 m95 -118.78 134.14 55.35 Favored 'General case' 0 C--N 1.286 -2.185 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.831 -173.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 86' ' ' THR . 27.4 m-85 -114.47 140.8 48.42 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.327 178.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.5 mt -125.71 142.34 51.56 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 -176.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.504 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 80.5 m-85 -132.84 143.04 49.27 Favored 'General case' 0 C--O 1.247 0.941 0 O-C-N 123.782 0.677 . . . . 0.0 109.791 -176.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.2 -14.75 57.23 Favored 'General case' 0 CA--C 1.491 -1.32 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.262 -178.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -122.17 166.09 15.12 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 34.5 m -76.29 167.78 2.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 122.747 0.419 . . . . 0.0 110.92 -175.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 56.32 30.43 16.77 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 124.136 0.974 . . . . 0.0 112.82 178.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.441 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 7.0 m-85 63.01 39.34 10.25 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 124.795 1.238 . . . . 0.0 111.198 177.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 78.8 p -112.06 165.07 12.45 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.63 -139.43 14.57 Favored Glycine 0 N--CA 1.435 -1.427 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.441 178.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 55.5 mtt180 -81.88 147.14 29.47 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 123.322 0.649 . . . . 0.0 109.81 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.8 tt -123.19 136.61 59.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-O 121.155 0.502 . . . . 0.0 110.759 -176.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 90.7 m -131.69 121.17 23.83 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.887 177.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -109.44 121.05 5.96 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.444 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.409 HD21 HD11 ' A' ' 94' ' ' ILE . 3.3 mm? -109.86 145.19 37.21 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 120.769 0.318 . . . . 0.0 110.677 178.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -117.76 171.26 13.88 Favored Glycine 0 N--CA 1.42 -2.395 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.073 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -60.88 123.01 16.3 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.722 0.772 . . . . 0.0 112.406 -177.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.31 1.78 71.59 Favored Glycine 0 N--CA 1.429 -1.798 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.961 177.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.3 m -112.43 145.95 39.25 Favored 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -178.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 4.6 m -134.3 158.45 43.73 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.409 HD11 HD21 ' A' ' 88' ' ' LEU . 55.0 mt -94.16 129.39 44.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 170.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -70.36 -46.98 63.03 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 123.597 0.561 . . . . 0.0 110.444 -178.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.618 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 2.0 m-20 -138.48 101.16 4.29 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.38 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -65.24 -38.02 89.05 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-O 120.736 0.303 . . . . 0.0 110.983 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.6 t -65.44 -28.01 68.92 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.855 -177.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.618 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 27.1 mmtp -83.64 -5.98 59.32 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.424 0.631 . . . . 0.0 109.738 -177.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 18.6 m -82.67 -168.89 2.21 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -60.39 -61.11 7.45 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.136 -178.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -111.26 149.54 30.89 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 122.39 0.276 . . . . 0.0 110.68 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -111.65 -7.72 14.25 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.838 177.26 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 53' ' ' TRP . . . -114.93 121.4 5.31 Favored Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 121.102 -0.57 . . . . 0.0 112.374 -176.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 67.6 mt -100.95 115.99 43.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-O 122.107 0.956 . . . . 0.0 109.083 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.5 m -85.94 -28.81 24.04 Favored 'General case' 0 N--CA 1.406 -2.638 0 CA-C-N 112.716 -2.038 . . . . 0.0 114.257 176.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.9 p -154.22 154.94 34.35 Favored 'General case' 0 C--O 1.237 0.433 0 O-C-N 122.063 -0.398 . . . . 0.0 110.024 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.8 mt -134.12 133.25 55.89 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.608 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -176.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.483 ' HD3' ' HB3' ' A' ' 121' ' ' CYS . 36.2 ttmt -117.11 126.07 52.26 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -95.92 127.96 42.4 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.45 0.643 . . . . 0.0 109.487 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . 0.425 ' SG ' ' HD1' ' A' ' 74' ' ' TYR . 59.7 m -121.94 168.62 11.69 Favored 'General case' 0 N--CA 1.402 -2.868 0 CA-C-N 114.869 -1.059 . . . . 0.0 108.676 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.7 pt -128.37 143.11 42.01 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 176.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -111.21 118.45 35.96 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 63.8 p -77.34 -178.66 5.27 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.485 -171.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -62.6 -36.63 83.36 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.943 174.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.477 ' OD2' ' HG2' ' A' ' 118' ' ' LYS . 2.5 p30 -78.46 -7.06 57.01 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.867 -176.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.0 -5.6 63.62 Favored Glycine 0 CA--C 1.496 -1.123 0 CA-C-N 115.776 -0.647 . . . . 0.0 113.859 173.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.477 ' HG2' ' OD2' ' A' ' 116' ' ' ASP . 6.4 ptpp? -77.66 146.9 35.81 Favored 'General case' 0 CA--C 1.493 -1.24 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.706 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 38.2 t -103.37 111.46 33.21 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -96.99 142.16 29.28 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . 0.483 ' HB3' ' HD3' ' A' ' 109' ' ' LYS . 73.2 m -130.36 171.62 12.74 Favored 'General case' 0 C--N 1.297 -1.692 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.139 -175.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 6.3 tp -107.67 121.9 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 175.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -91.68 116.05 28.56 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 . . . . . 0 C--N 1.302 -1.481 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.192 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.75 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 63.25 18.19 10.8 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.136 1.374 . . . . 0.0 111.381 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -101.09 -16.7 16.99 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.627 -176.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.412 ' HA ' ' HB3' ' A' ' 61' ' ' PRO . 12.5 p -118.71 142.41 47.71 Favored 'General case' 0 N--CA 1.418 -2.039 0 CA-C-O 121.19 0.519 . . . . 0.0 111.649 178.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.455 ' HB3' ' HB2' ' A' ' 26' ' ' CYS . 54.0 t -146.06 135.97 23.49 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -73.09 106.77 5.1 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.743 -174.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.416 ' CD1' ' HB3' ' A' ' 71' ' ' PRO . 5.5 m-85 71.62 41.33 0.72 Allowed 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.843 177.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.455 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 7.7 m -124.35 145.34 49.49 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.646 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 61.3 tp -100.12 128.68 46.16 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 176.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.556 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 39.8 mt-30 -118.87 123.95 45.94 Favored 'General case' 0 CA--C 1.492 -1.266 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.534 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.488 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.0 mp -110.76 122.85 48.84 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.881 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.411 ' CD2' ' HB3' ' A' ' 39' ' ' TYR . 93.3 m-85 -92.0 149.59 21.45 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 123.327 0.392 . . . . 0.0 110.304 -178.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -74.54 -35.24 63.12 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.095 0.474 . . . . 0.0 111.803 -177.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -108.41 178.05 4.61 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.462 HG22 ' HA ' ' A' ' 96' ' ' ASP . 2.3 p -82.26 170.68 15.11 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . 0.26 21.5 p90 46.85 46.71 15.45 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.289 1.036 . . . . 0.0 113.394 178.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 59.55 23.34 12.02 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.954 1.302 . . . . 0.0 114.129 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -92.01 167.37 12.14 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.623 0.725 . . . . 0.0 111.847 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.16 -164.82 46.36 Favored Glycine 0 N--CA 1.426 -1.995 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.7 m -92.71 173.66 7.65 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 175.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.411 ' HB3' ' CD2' ' A' ' 30' ' ' TYR . 18.0 p90 -140.76 161.79 36.95 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.237 0.541 . . . . 0.0 110.129 -178.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.556 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 17.4 tt -114.64 149.53 16.87 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -107.6 125.5 51.4 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 175.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.571 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 95.0 t -117.87 134.06 62.68 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -118.17 -20.97 8.41 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.442 0.639 . . . . 0.0 110.485 -174.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -136.42 162.56 32.7 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.226 -174.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.4 p -72.66 147.38 45.8 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.33 0.586 . . . . 0.0 112.209 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.8 p -122.43 132.14 71.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 176.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.72 -15.3 46.69 Favored Glycine 0 C--N 1.303 -1.297 0 C-N-CA 119.566 -1.302 . . . . 0.0 112.861 -177.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.9 p -155.71 123.35 5.6 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.416 0.627 . . . . 0.0 112.377 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.4 mt -114.34 118.88 35.13 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.348 177.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 19.3 m -132.48 110.61 13.7 Favored Pre-proline 0 C--N 1.303 -1.432 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.837 175.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 5.1 Cg_exo -77.4 161.94 91.56 Favored 'Cis proline' 0 C--O 1.244 0.797 0 C-N-CA 123.229 -1.571 . . . . 0.0 110.927 0.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.07 158.38 30.25 Favored 'Trans proline' 0 C--O 1.25 1.092 0 C-N-CA 122.526 2.15 . . . . 0.0 110.988 177.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 46.9 m0 -89.67 139.13 30.86 Favored 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.089 -177.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 15.4 p -119.34 78.85 19.61 Favored Pre-proline 0 C--N 1.29 -1.993 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.15 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.488 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 93.0 Cg_endo -79.18 157.59 26.39 Favored 'Trans proline' 0 N--CA 1.44 -1.648 0 C-N-CA 121.782 1.655 . . . . 0.0 112.257 176.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -93.73 -27.98 11.93 Favored Glycine 0 N--CA 1.428 -1.878 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 176.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.4 p -153.57 150.94 29.2 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.5 t -123.11 142.84 38.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 15.5 t -142.98 137.71 29.54 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -177.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.9 t -121.43 119.02 29.58 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.412 ' HB3' ' HA ' ' A' ' 22' ' ' SER . 23.5 Cg_endo -65.2 137.41 51.78 Favored 'Trans proline' 0 C--O 1.241 0.673 0 C-N-CA 123.036 2.491 . . . . 0.0 113.136 -178.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -71.78 121.75 19.47 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.25 178.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 86.7 t -95.01 115.0 32.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 176.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -103.12 70.17 1.06 Allowed 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -126.22 145.3 50.45 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -172.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.4 m -58.66 -24.83 62.0 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.436 -1.257 . . . . 0.0 109.807 175.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.461 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 4.3 mptp? -53.09 134.31 38.51 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.563 -177.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 50.9 mtp180 -68.51 -27.99 66.61 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -172.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -106.49 128.03 53.77 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.928 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -104.89 147.01 33.76 Favored Pre-proline 0 C--N 1.284 -2.24 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 171.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.416 ' HB3' ' CD1' ' A' ' 25' ' ' TYR . 93.3 Cg_endo -77.52 135.24 14.53 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.748 1.632 . . . . 0.0 112.522 -177.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -129.35 141.27 51.12 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.646 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 90.0 m95 -122.81 132.11 54.06 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -173.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.489 ' HD2' ' SG ' ' A' ' 111' ' ' CYS . 28.0 m-85 -114.37 142.76 45.92 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.108 176.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 22.7 mt -125.5 142.37 51.54 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 -175.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 92.0 m-85 -130.54 139.79 50.47 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.575 0.703 . . . . 0.0 111.21 -176.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.599 ' HB2' ' CD1' ' A' ' 102' ' ' PHE . 0.8 OUTLIER -81.89 -10.59 59.25 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.423 -1.262 . . . . 0.0 112.314 -178.876 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -135.69 156.92 48.08 Favored 'General case' 0 N--CA 1.416 -2.136 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.823 174.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.506 ' HA ' ' HB2' ' A' ' 107' ' ' SER . 21.5 m -65.3 161.45 3.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.967 -176.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 61.52 30.57 18.81 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.199 0.523 . . . . 0.0 111.278 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 57.57 41.85 25.1 Favored 'General case' 0 C--O 1.244 0.766 0 C-N-CA 124.335 1.054 . . . . 0.0 111.333 176.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 77.9 p -112.35 176.35 5.05 Favored 'General case' 0 C--O 1.252 1.203 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.674 178.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.93 -137.79 18.42 Favored Glycine 0 N--CA 1.424 -2.152 0 N-CA-C 111.761 -0.535 . . . . 0.0 111.761 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.438 ' HB2' ' HB3' ' A' ' 77' ' ' ASP . 53.3 mtt180 -82.72 150.21 26.85 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -177.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.0 tt -128.44 137.31 57.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 O-C-N 123.622 0.576 . . . . 0.0 110.594 -174.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 57.1 m -132.43 124.07 27.91 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 122.231 -0.293 . . . . 0.0 110.319 174.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -115.0 113.43 2.95 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.622 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.42 HD21 HD11 ' A' ' 94' ' ' ILE . 2.4 mm? -106.48 145.63 31.56 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 122.994 0.518 . . . . 0.0 111.285 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -110.33 164.61 12.25 Favored Glycine 0 N--CA 1.427 -1.966 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.625 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -64.03 122.15 15.86 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 123.29 0.636 . . . . 0.0 110.994 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.56 16.94 51.17 Favored Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.525 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.4 m -135.69 146.03 47.34 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 175.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 21.7 m -143.96 157.08 44.57 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.42 HD11 HD21 ' A' ' 88' ' ' LEU . 61.7 mt -94.45 135.21 29.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -70.81 -47.43 59.48 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.525 0.678 . . . . 0.0 110.483 177.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.462 ' HA ' HG22 ' A' ' 33' ' ' THR . 5.7 m-20 -136.51 100.77 4.45 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.995 -177.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.456 ' CD2' ' HG2' ' A' ' 55' ' ' PRO . 62.6 t80 -64.2 -29.53 70.63 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.259 0.552 . . . . 0.0 110.796 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.9 t -62.91 -18.78 63.49 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.694 179.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -94.75 -8.96 36.11 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 122.152 -0.343 . . . . 0.0 110.416 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 26.9 t -85.24 28.82 0.7 Allowed 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.772 0.829 . . . . 0.0 110.798 -177.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.88 -70.84 1.78 Allowed Glycine 0 N--CA 1.432 -1.626 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.054 177.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.599 ' CD1' ' HB2' ' A' ' 77' ' ' ASP . 27.0 p90 -110.41 149.42 30.29 Favored 'General case' 0 C--N 1.29 -1.991 0 O-C-N 122.784 -0.245 . . . . 0.0 110.356 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -114.24 -10.09 12.77 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.681 177.0 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -109.18 99.7 1.28 Allowed Glycine 0 N--CA 1.433 -1.552 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.897 -175.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 69.2 mt -87.05 115.17 27.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-O 122.551 1.167 . . . . 0.0 107.964 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 27.8 m -85.94 -23.97 26.75 Favored 'General case' 0 C--N 1.249 -3.763 0 CA-C-N 112.337 -2.21 . . . . 0.0 113.764 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.506 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 9.3 t -158.48 153.45 25.17 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -176.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.2 mt -137.29 130.32 43.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -178.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.559 ' HD2' ' SG ' ' A' ' 121' ' ' CYS . 24.7 ttmt -117.64 133.48 55.9 Favored 'General case' 0 C--N 1.3 -1.543 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -100.47 127.81 46.71 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -177.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . 0.489 ' SG ' ' HD2' ' A' ' 74' ' ' TYR . 29.6 m -119.38 168.3 11.08 Favored 'General case' 0 N--CA 1.417 -2.117 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -176.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.7 pt -127.38 140.29 49.52 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.525 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -112.79 119.08 36.79 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 63.3 p -79.17 177.37 8.87 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.254 -175.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.1 ttpp -66.32 -20.19 66.02 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.572 0.701 . . . . 0.0 109.421 176.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -78.77 -8.34 58.66 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.813 0.816 . . . . 0.0 109.953 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.68 -11.57 68.16 Favored Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.386 176.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -71.82 139.01 48.75 Favored 'General case' 0 C--O 1.253 1.25 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.65 112.27 37.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -104.6 152.7 22.12 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . 0.559 ' SG ' ' HD2' ' A' ' 109' ' ' LYS . 0.9 OUTLIER -135.41 156.4 48.98 Favored 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 118.626 -1.23 . . . . 0.0 110.575 -175.586 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 9.4 tp -125.48 134.74 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.549 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -92.61 104.9 17.15 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 . . . . . 0 C--N 1.303 -1.417 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.024 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.339 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.3 -11.3 60.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.777 0.798 . . . . 0.0 110.79 -178.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -80.08 -8.24 59.29 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.166 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.5 m -112.6 124.61 52.93 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 176.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.5 p -138.71 156.92 46.99 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.319 0.581 . . . . 0.0 111.113 -176.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -75.99 118.34 18.65 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.114 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 69.97 53.22 0.37 Allowed 'General case' 0 C--O 1.243 0.719 0 CA-C-N 114.979 -1.01 . . . . 0.0 112.697 171.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.411 ' O ' ' HD2' ' A' ' 61' ' ' PRO . 12.0 m -125.54 154.79 41.62 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.604 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 54.4 tp -112.26 122.69 48.43 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 171.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.525 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 78.7 mt-30 -116.04 124.88 51.57 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.759 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 3.6 mp -109.51 126.01 53.09 Favored 'General case' 0 N--CA 1.415 -2.204 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.129 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.417 ' CD1' ' HB3' ' A' ' 39' ' ' TYR . 98.1 m-85 -94.55 147.94 22.76 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 123.783 0.677 . . . . 0.0 110.914 -176.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -72.5 -38.58 68.09 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.979 -177.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -109.74 178.12 4.52 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.407 HG22 ' HA ' ' A' ' 96' ' ' ASP . 6.0 p -79.09 172.63 13.54 Favored 'General case' 0 N--CA 1.422 -1.872 0 C-N-CA 121.507 -0.077 . . . . 0.0 111.026 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.544 ' CE1' ' HG3' ' A' ' 36' ' ' ARG 0.261 31.6 p90 46.56 42.25 10.88 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 176.777 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 67.94 28.89 6.75 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.984 0.914 . . . . 0.0 112.788 176.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.544 ' HG3' ' CE1' ' A' ' 34' ' ' TYR . 23.7 mmt180 -107.06 172.13 6.99 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-O 121.501 0.667 . . . . 0.0 112.249 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.4 -159.88 39.32 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 -177.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.0 m -89.66 179.57 5.99 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 172.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.44 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 21.8 p90 -149.42 162.92 39.14 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.525 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 15.6 tt -118.09 151.97 20.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.232 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -107.34 125.92 51.8 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 175.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.551 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 93.0 t -117.67 133.96 62.77 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 176.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -117.59 -29.47 5.76 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 120.994 0.426 . . . . 0.0 110.313 -176.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.09 154.91 47.77 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.838 -177.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.2 m -60.31 145.8 46.32 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 123.527 0.731 . . . . 0.0 111.935 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.5 p -120.84 139.04 49.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 176.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.12 -20.31 30.88 Favored Glycine 0 C--N 1.299 -1.484 0 C-N-CA 119.604 -1.284 . . . . 0.0 112.804 -176.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.3 p -157.72 131.14 7.76 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 120.961 0.41 . . . . 0.0 111.789 -176.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.58 117.22 23.82 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 175.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 13.9 t -133.6 113.0 12.9 Favored Pre-proline 0 N--CA 1.434 -1.252 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.403 176.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.462 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 8.1 Cg_exo -75.56 161.23 94.86 Favored 'Cis proline' 0 C--O 1.246 0.924 0 C-N-CA 123.191 -1.587 . . . . 0.0 111.206 -0.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -61.71 158.87 35.29 Favored 'Trans proline' 0 C--O 1.245 0.859 0 C-N-CA 122.986 2.457 . . . . 0.0 111.312 178.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 48.0 m0 -88.56 137.5 32.27 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 5.4 p -117.59 75.53 9.51 Favored Pre-proline 0 C--N 1.292 -1.905 0 O-C-N 123.31 0.381 . . . . 0.0 111.601 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.437 ' HG2' ' CD2' ' A' ' 97' ' ' PHE . 69.8 Cg_endo -74.35 157.94 45.07 Favored 'Trans proline' 0 C--N 1.359 1.12 0 C-N-CA 122.859 2.373 . . . . 0.0 112.875 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.25 -28.67 14.22 Favored Glycine 0 N--CA 1.436 -1.307 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.3 p -156.1 151.67 27.03 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.5 t -128.45 142.4 43.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 35.8 t -145.84 150.06 35.45 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.515 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.6 t -113.58 123.28 33.41 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 175.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.411 ' HD2' ' O ' ' A' ' 26' ' ' CYS . 10.3 Cg_endo -57.27 140.6 93.42 Favored 'Trans proline' 0 C--O 1.247 0.935 0 C-N-CA 122.552 2.168 . . . . 0.0 111.505 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.431 ' CE1' ' HB2' ' A' ' 64' ' ' ASN . 82.1 t80 -74.09 109.54 7.66 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-O 121.385 0.612 . . . . 0.0 110.681 -177.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.442 ' H ' ' HB2' ' A' ' 90' ' ' HIS . 49.1 t -94.19 114.17 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.566 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.431 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 27.0 t-20 -112.75 88.92 2.94 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 172.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.466 ' OD1' ' HG2' ' A' ' 67' ' ' LYS . 3.8 t70 -127.31 145.81 50.66 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.62 -171.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.9 m -62.93 -6.93 4.3 Favored 'General case' 0 CA--C 1.569 1.71 0 C-N-CA 124.444 1.098 . . . . 0.0 111.157 176.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.466 ' HG2' ' OD1' ' A' ' 65' ' ' ASP . 75.8 mmtt -61.28 153.95 25.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 171.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.543 ' HB2' ' OE2' ' A' ' 69' ' ' GLU . 45.5 mtm180 -89.17 -28.65 19.87 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.733 -177.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.543 ' OE2' ' HB2' ' A' ' 68' ' ' ARG . 9.7 mp0 -105.37 128.9 53.74 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.435 -177.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -102.52 153.96 37.78 Favored Pre-proline 0 C--N 1.291 -1.968 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 176.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -80.58 141.39 13.85 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.467 1.445 . . . . 0.0 112.476 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -133.22 138.15 46.4 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.604 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 84.3 m95 -120.27 136.91 54.51 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.755 -0.59 . . . . 0.0 112.301 -173.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 86' ' ' THR . 37.1 m-85 -116.74 143.29 45.84 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.678 177.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.8 mt -125.96 142.78 51.36 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 -176.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -133.62 141.71 47.77 Favored 'General case' 0 C--O 1.244 0.794 0 O-C-N 123.625 0.578 . . . . 0.0 109.974 -177.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.65 -5.46 59.31 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.918 -177.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -131.76 162.25 30.94 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 175.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.461 HG23 HD22 ' A' ' 80' ' ' ASN . 25.2 m -73.15 167.38 2.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 C-N-CA 122.395 0.278 . . . . 0.0 110.794 -176.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.461 HD22 HG23 ' A' ' 79' ' ' VAL . 48.0 m-80 57.54 30.2 18.34 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.646 0.778 . . . . 0.0 111.968 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.564 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 11.5 m-85 60.1 40.22 18.7 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.401 1.08 . . . . 0.0 111.523 176.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 68.0 p -111.98 171.28 7.59 Favored 'General case' 0 C--O 1.25 1.095 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.95 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.69 -135.77 13.25 Favored Glycine 0 N--CA 1.427 -1.913 0 C-N-CA 120.881 -0.675 . . . . 0.0 112.105 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -83.48 155.53 23.33 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 123.025 0.53 . . . . 0.0 109.605 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.4 tt -131.66 136.69 56.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 121.318 0.58 . . . . 0.0 110.066 -175.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 76.1 m -132.09 127.62 36.45 Favored 'General case' 0 C--N 1.288 -2.103 0 O-C-N 122.021 -0.424 . . . . 0.0 110.359 175.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -111.1 124.82 7.08 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.81 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.45 HD21 HD11 ' A' ' 94' ' ' ILE . 2.9 mm? -117.76 145.39 44.52 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 123.576 0.751 . . . . 0.0 110.618 177.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -117.3 169.26 13.09 Favored Glycine 0 N--CA 1.433 -1.523 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.92 -178.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.442 ' HB2' ' H ' ' A' ' 63' ' ' VAL . 7.4 p80 -61.13 122.13 14.24 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.449 0.642 . . . . 0.0 112.323 -177.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.56 -1.63 76.05 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.568 177.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.5 m -107.42 146.12 32.1 Favored 'General case' 0 N--CA 1.424 -1.73 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 3.7 m -137.68 154.51 49.67 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.45 HD11 HD21 ' A' ' 88' ' ' LEU . 50.7 mt -93.49 128.11 45.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 173.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -70.92 -47.54 58.54 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.108 0.48 . . . . 0.0 110.984 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.667 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 3.4 m-20 -132.72 88.87 2.56 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.927 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.437 ' CD2' ' HG2' ' A' ' 55' ' ' PRO . 50.7 t80 -65.47 -30.25 71.01 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.778 0.799 . . . . 0.0 109.666 176.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.2 t -66.91 -24.45 66.1 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 114.92 -1.036 . . . . 0.0 111.463 -178.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.667 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 30.0 mmtp -93.99 -6.78 44.57 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -178.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 26.6 m -79.73 -171.85 3.04 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.46 -64.89 3.97 Favored Glycine 0 CA--C 1.503 -0.702 0 N-CA-C 112.094 -0.403 . . . . 0.0 112.094 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -110.94 146.74 36.05 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.193 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.558 ' H ' ' HD3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -113.42 -6.54 13.49 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 175.867 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -112.55 119.18 4.86 Favored Glycine 0 N--CA 1.431 -1.648 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.457 -177.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 64.9 mt -103.06 115.41 44.99 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.763 0 CA-C-O 122.426 1.107 . . . . 0.0 109.476 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 37.8 m -85.73 -29.6 23.78 Favored 'General case' 0 N--CA 1.394 -3.248 0 CA-C-N 112.148 -2.297 . . . . 0.0 113.999 177.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.6 p -153.88 154.61 34.2 Favored 'General case' 0 C--O 1.237 0.42 0 O-C-N 121.862 -0.524 . . . . 0.0 109.965 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.8 mt -133.22 131.45 58.24 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -176.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.564 ' HE2' ' CD1' ' A' ' 81' ' ' TYR . 38.2 ttmt -117.51 128.33 54.87 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -95.67 129.58 42.83 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 68.4 m -122.56 171.72 8.91 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.357 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.1 pt -129.41 139.3 52.08 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 176.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -110.56 118.87 37.38 Favored 'General case' 0 C--N 1.274 -2.714 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 72.9 p -69.15 170.23 10.48 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.462 -176.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.2 ttpp -67.06 -19.54 65.69 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.635 0.731 . . . . 0.0 109.276 176.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -84.92 -8.17 58.87 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.744 -177.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.21 -10.62 65.54 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.78 -0.646 . . . . 0.0 114.133 175.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -78.32 138.38 38.54 Favored 'General case' 0 C--O 1.249 1.031 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.902 179.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.3 t -102.31 113.35 38.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -178.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -95.49 133.86 39.0 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.75 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 63.6 m -136.91 158.45 44.42 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 7.4 tp -73.76 118.99 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.894 0 N-CA-C 106.36 -1.719 . . . . 0.0 106.36 171.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -81.11 104.77 11.82 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.466 -175.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 . . . . . 0 N--CA 1.429 -1.499 0 N-CA-C 104.003 -2.592 . . . . 0.0 104.003 178.82 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.461 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 70.75 4.44 5.01 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.788 1.235 . . . . 0.0 113.534 176.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -88.03 -23.75 23.69 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 122.089 0.947 . . . . 0.0 109.269 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.6 p -102.91 139.73 38.1 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.015 174.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.508 ' O ' ' HG3' ' A' ' 61' ' ' PRO . 44.4 t -102.1 134.09 45.91 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 -177.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.5 mmtm -77.03 120.51 22.24 Favored 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -176.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.463 ' CZ ' ' HD3' ' A' ' 71' ' ' PRO . 14.5 m-85 66.52 35.82 5.31 Favored 'General case' 0 CA--C 1.509 -0.603 0 O-C-N 124.563 1.165 . . . . 0.0 110.694 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.458 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 18.5 m -123.12 145.32 48.68 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.591 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 49.7 tp -94.56 124.93 38.88 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 176.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.479 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 16.3 mt-30 -117.42 124.19 48.24 Favored 'General case' 0 N--CA 1.42 -1.929 0 CA-C-O 121.368 0.604 . . . . 0.0 109.469 -177.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.498 ' O ' ' HA ' ' A' ' 39' ' ' TYR . 3.6 mp -109.68 125.65 52.85 Favored 'General case' 0 N--CA 1.421 -1.904 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.73 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.504 ' HA ' ' O ' ' A' ' 38' ' ' SER . 85.6 m-85 -95.24 152.31 18.48 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 123.393 0.433 . . . . 0.0 111.464 -176.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.89 -47.56 65.53 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.378 -177.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -108.17 178.4 4.51 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.781 -176.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.455 HG22 ' HA ' ' A' ' 96' ' ' ASP . 2.4 p -77.02 166.29 23.5 Favored 'General case' 0 N--CA 1.403 -2.799 0 O-C-N 123.28 0.362 . . . . 0.0 110.295 -176.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.408 ' CE2' ' HD3' ' A' ' 36' ' ' ARG 0.262 20.9 p90 47.21 47.59 16.41 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 177.704 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 65.51 22.19 11.82 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.391 1.076 . . . . 0.0 112.19 176.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.408 ' HD3' ' CE2' ' A' ' 34' ' ' TYR . 55.1 mtp180 -91.29 160.17 15.65 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.509 0.671 . . . . 0.0 112.63 178.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.35 -148.0 20.42 Favored Glycine 0 N--CA 1.433 -1.542 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -176.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 30' ' ' TYR . 17.2 m -111.77 -176.65 2.99 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 177.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 23.4 p90 -143.31 163.15 33.81 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.23 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 15.3 tt -114.35 152.18 16.04 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 177.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -106.84 125.54 51.14 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 87.5 t -120.1 133.18 67.68 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 177.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -115.68 -31.72 5.74 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 121.487 0.66 . . . . 0.0 109.518 -174.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.47 161.89 29.37 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.321 -176.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.4 p -69.01 146.38 52.75 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 123.623 0.769 . . . . 0.0 112.67 -176.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.0 p -121.82 135.65 61.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -92.9 -18.11 41.58 Favored Glycine 0 N--CA 1.431 -1.687 0 C-N-CA 119.851 -1.166 . . . . 0.0 112.955 -178.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.5 p -158.92 116.66 2.84 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.405 0.621 . . . . 0.0 112.593 -178.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.9 mt -105.19 116.91 32.74 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.431 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.2 m -133.58 114.75 13.37 Favored Pre-proline 0 N--CA 1.42 -1.962 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 172.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -73.99 162.12 92.91 Favored 'Cis proline' 0 C--O 1.248 0.995 0 C-N-CA 123.315 -1.536 . . . . 0.0 110.946 -0.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.54 155.36 66.92 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 121.914 1.743 . . . . 0.0 109.931 177.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -89.61 133.43 34.62 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.588 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 22.6 p -116.85 77.22 8.41 Favored Pre-proline 0 C--N 1.298 -1.643 0 O-C-N 123.523 0.514 . . . . 0.0 111.759 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.408 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 97.2 Cg_endo -80.29 158.2 22.93 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.66 2.24 . . . . 0.0 113.012 178.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -89.28 -29.57 16.69 Favored Glycine 0 N--CA 1.437 -1.247 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 177.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.0 p -155.25 154.46 32.2 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.0 t -129.16 143.22 41.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 38.6 t -145.58 149.88 35.37 Favored 'General case' 0 N--CA 1.428 -1.558 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.732 176.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.6 t -116.55 123.81 30.14 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 175.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.508 ' HG3' ' O ' ' A' ' 23' ' ' CYS . 26.2 Cg_endo -60.81 149.04 90.11 Favored 'Trans proline' 0 C--O 1.252 1.18 0 C-N-CA 122.798 2.332 . . . . 0.0 112.321 -177.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.547 ' CE2' ' HB3' ' A' ' 64' ' ' ASN . 79.5 t80 -76.14 110.12 10.36 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 121.825 0.821 . . . . 0.0 111.058 -177.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.442 ' H ' ' HB2' ' A' ' 90' ' ' HIS . 66.3 t -94.54 116.31 35.52 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.778 177.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.547 ' HB3' ' CE2' ' A' ' 62' ' ' PHE . 3.7 p-10 -119.28 24.58 10.65 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 122.35 1.071 . . . . 0.0 108.62 178.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -67.93 146.58 53.47 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 113.363 -1.744 . . . . 0.0 111.93 178.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.2 m -58.71 -8.64 1.37 Allowed 'General case' 0 CA--C 1.57 1.749 0 C-N-CA 125.141 1.377 . . . . 0.0 112.768 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -62.62 138.57 58.52 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 177.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -69.21 -29.41 67.37 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.468 0.48 . . . . 0.0 111.509 -173.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -112.02 135.65 52.38 Favored 'General case' 0 N--CA 1.411 -2.405 0 CA-C-O 121.63 0.729 . . . . 0.0 111.612 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.86 148.35 36.36 Favored Pre-proline 0 C--N 1.285 -2.204 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.394 176.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.463 ' HD3' ' CZ ' ' A' ' 25' ' ' TYR . 71.2 Cg_endo -71.59 137.87 31.14 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 121.995 1.797 . . . . 0.0 112.928 -175.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -131.29 123.38 28.22 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.591 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 83.6 m95 -108.55 135.76 49.28 Favored 'General case' 0 C--N 1.281 -2.388 0 O-C-N 122.098 -0.376 . . . . 0.0 111.996 -172.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' A' ' 86' ' ' THR . 41.6 m-85 -113.89 141.91 46.76 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.554 177.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.403 HD21 HD21 ' A' ' 27' ' ' LEU . 22.6 mt -125.35 142.59 51.41 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 -176.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.448 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 84.7 m-85 -131.49 139.72 49.38 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 121.197 0.522 . . . . 0.0 111.178 -175.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.13 -12.85 59.14 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.891 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.435 HD22 ' HA ' ' A' ' 78' ' ' ASN . 2.7 t-20 -123.76 165.76 16.74 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 175.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.7 m -77.14 167.47 2.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 118.036 0.38 . . . . 0.0 110.822 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.51 30.96 20.16 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.667 0.787 . . . . 0.0 111.942 177.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.431 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 5.8 m-85 61.92 40.37 12.56 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.799 175.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.8 p -117.49 176.07 5.34 Favored 'General case' 0 C--O 1.25 1.086 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.629 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.57 -134.03 12.26 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 178.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 52.2 mtm180 -84.38 147.78 26.96 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 122.45 0.3 . . . . 0.0 110.431 176.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.9 tt -124.77 139.24 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 O-C-N 123.654 0.596 . . . . 0.0 110.108 -176.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 67.6 m -131.84 126.44 34.29 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 175.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -111.55 122.12 5.97 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.776 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.466 HD21 HD11 ' A' ' 94' ' ' ILE . 3.7 mm? -112.69 145.07 41.13 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 120.835 0.35 . . . . 0.0 111.041 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -117.06 168.32 12.8 Favored Glycine 0 N--CA 1.424 -2.121 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.705 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.442 ' HB2' ' H ' ' A' ' 63' ' ' VAL . 7.2 p80 -59.72 123.87 18.32 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.335 0.588 . . . . 0.0 111.83 -178.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.08 2.78 77.17 Favored Glycine 0 N--CA 1.43 -1.758 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.387 177.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.1 m -113.19 145.66 40.61 Favored 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 4.6 m -134.8 158.84 43.14 Favored 'General case' 0 N--CA 1.425 -1.719 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.466 HD11 HD21 ' A' ' 88' ' ' LEU . 46.3 mt -93.65 131.94 39.21 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 173.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -70.21 -47.67 60.44 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.276 0.56 . . . . 0.0 109.903 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.59 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 3.2 m-20 -138.25 100.95 4.26 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -64.77 -36.5 84.53 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.404 0.621 . . . . 0.0 110.422 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.3 t -64.45 -23.76 67.39 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.965 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.59 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 28.2 mmtp -91.99 -7.64 48.35 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 122.147 -0.346 . . . . 0.0 110.413 -178.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.2 m -78.12 -13.93 59.67 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.687 0.756 . . . . 0.0 109.872 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 132.14 -85.16 0.29 Allowed Glycine 0 N--CA 1.42 -2.385 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -86.89 141.9 28.42 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 120.542 -0.463 . . . . 0.0 109.924 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.588 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -113.52 -8.39 13.35 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 177.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -108.15 109.15 2.84 Favored Glycine 0 N--CA 1.432 -1.614 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.989 -176.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 66.5 mt -91.64 116.06 32.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-O 122.336 1.065 . . . . 0.0 109.053 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.9 m -85.85 -28.63 24.3 Favored 'General case' 0 N--CA 1.401 -2.923 0 CA-C-N 112.445 -2.161 . . . . 0.0 114.816 177.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.4 p -156.13 157.36 35.86 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.7 mt -137.48 131.47 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -175.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.431 ' HE2' ' CD2' ' A' ' 81' ' ' TYR . 37.6 ttmt -117.66 133.64 55.74 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -101.27 121.88 42.67 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 120.615 -0.434 . . . . 0.0 109.932 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 65.9 m -119.85 172.14 7.92 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 119' ' ' VAL . 8.4 pt -127.61 143.22 41.4 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -115.12 120.49 39.97 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 177.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 82.8 p -79.6 176.49 9.66 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.424 -173.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -65.16 -26.85 68.35 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.119 172.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -76.91 -8.71 57.86 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 122.051 0.929 . . . . 0.0 110.211 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.07 -11.54 70.48 Favored Glycine 0 CA--C 1.498 -1.016 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.772 175.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 51.6 pttt -73.31 141.03 47.14 Favored 'General case' 0 C--O 1.257 1.448 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.889 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 112' ' ' ILE . 22.6 t -102.13 118.71 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.814 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 177.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -104.3 140.4 37.92 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 69.9 m -130.74 147.82 52.44 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 8.2 tp -126.6 135.98 62.14 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 175.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -86.34 104.2 15.64 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.939 0.876 . . . . 0.0 110.112 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 . . . . . 0 C--N 1.292 -1.923 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 177.909 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.53 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.87 32.91 2.23 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -76.95 -5.16 47.47 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.834 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.0 p -106.48 124.12 49.11 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 165.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.9 p -125.95 153.36 44.4 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 119.446 -0.901 . . . . 0.0 111.839 -174.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.2 mmmm -89.36 143.39 26.86 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 69.17 36.95 2.24 Favored 'General case' 0 N--CA 1.482 1.175 0 O-C-N 123.822 0.701 . . . . 0.0 111.543 177.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.0 m -123.68 145.92 48.62 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.199 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.571 ' HB2' ' CD2' ' A' ' 73' ' ' TRP . 57.8 tp -100.03 114.13 27.22 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 175.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 41.2 mt-30 -108.26 124.49 50.38 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.704 -0.798 . . . . 0.0 108.848 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 55' ' ' PRO . 3.4 mp -109.41 127.38 54.34 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.032 177.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -94.06 150.37 20.4 Favored 'General case' 0 C--N 1.29 -1.989 0 O-C-N 123.509 0.506 . . . . 0.0 110.148 -176.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -69.88 -43.27 72.17 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 124.055 0.847 . . . . 0.0 109.651 -175.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -114.08 178.88 4.12 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.033 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.441 HG22 ' HA ' ' A' ' 96' ' ' ASP . 2.6 p -74.91 169.72 17.39 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.119 -176.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.456 ' CE2' ' HG3' ' A' ' 36' ' ' ARG 0.258 13.8 p90 47.17 40.16 9.55 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.959 1.304 . . . . 0.0 114.01 177.771 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 62.2 40.43 11.65 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.147 0.979 . . . . 0.0 111.947 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.539 ' HA ' ' NE ' ' A' ' 36' ' ' ARG . 4.3 mmp_? -108.61 162.23 14.34 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.223 0.535 . . . . 0.0 112.162 178.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.26 -163.05 42.72 Favored Glycine 0 N--CA 1.426 -1.967 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -177.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.0 p -89.34 173.84 8.15 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 176.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -140.77 166.01 25.94 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -177.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 28' ' ' GLN . 14.8 tt -116.9 152.08 18.69 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 177.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -106.75 125.57 51.18 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 175.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.494 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 97.8 t -122.41 133.04 69.86 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -119.32 -24.49 6.37 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.709 -177.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -115.46 163.14 16.17 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.98 -172.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.9 m -83.1 142.43 31.27 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 176.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.9 p -120.97 129.67 75.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.68 -12.13 59.76 Favored Glycine 0 N--CA 1.432 -1.567 0 C-N-CA 119.672 -1.252 . . . . 0.0 113.795 -178.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 24.4 p -157.7 122.27 4.31 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 121.279 0.562 . . . . 0.0 112.409 -178.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 72.8 mt -117.82 117.87 30.47 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 175.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 51' ' ' PRO . 12.3 p -132.46 109.45 13.52 Favored Pre-proline 0 C--N 1.29 -1.991 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.959 176.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 50' ' ' SER . 72.4 Cg_endo -75.34 162.06 93.38 Favored 'Cis proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.704 -1.373 . . . . 0.0 111.408 -1.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.76 156.77 59.8 Favored 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 121.975 1.784 . . . . 0.0 111.152 178.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 48.0 m0 -89.27 131.89 35.16 Favored 'General case' 0 CA--C 1.482 -1.668 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.623 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 38.8 p -114.46 78.53 4.86 Favored Pre-proline 0 N--CA 1.43 -1.425 0 O-C-N 123.56 0.537 . . . . 0.0 110.712 178.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.417 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 88.4 Cg_endo -78.21 157.63 29.92 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 122.523 2.149 . . . . 0.0 112.566 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -89.59 -30.85 12.39 Favored Glycine 0 N--CA 1.431 -1.651 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 177.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.2 p -153.25 158.25 41.39 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.9 t -136.87 142.67 37.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -177.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 49.4 t -145.95 147.82 32.12 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.691 176.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.1 t -118.73 124.27 28.52 Favored Pre-proline 0 N--CA 1.441 -0.923 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 175.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -63.03 148.66 93.19 Favored 'Trans proline' 0 C--O 1.247 0.971 0 C-N-CA 122.399 2.066 . . . . 0.0 112.062 -178.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -70.96 119.88 15.73 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-O 121.85 0.833 . . . . 0.0 110.249 -178.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.451 ' H ' ' HB2' ' A' ' 90' ' ' HIS . 93.1 t -95.83 123.35 47.99 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.349 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -116.09 14.96 16.09 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 122.143 0.973 . . . . 0.0 108.617 -178.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.4 ' HB3' ' HG2' ' A' ' 67' ' ' LYS . 1.9 m-20 -64.13 145.54 55.77 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 113.519 -1.673 . . . . 0.0 113.717 -175.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.7 m -64.19 -12.42 40.32 Favored 'General case' 0 C--O 1.255 1.372 0 C-N-CA 125.285 1.434 . . . . 0.0 110.981 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.4 ' HG2' ' HB3' ' A' ' 65' ' ' ASP . 73.3 mmtt -59.67 141.33 55.29 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 177.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -78.02 -29.86 49.68 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-O 121.629 0.728 . . . . 0.0 109.803 -177.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.411 ' HB2' ' HB ' ' A' ' 112' ' ' ILE . 0.4 OUTLIER -107.37 129.85 54.87 Favored 'General case' 0 N--CA 1.412 -2.344 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.686 -179.873 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.76 154.14 39.52 Favored Pre-proline 0 C--N 1.286 -2.159 0 CA-C-N 114.616 -1.174 . . . . 0.0 109.237 -178.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -74.08 134.41 19.46 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 121.578 1.519 . . . . 0.0 111.066 -178.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -129.42 128.51 43.12 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 106.309 -1.738 . . . . 0.0 106.309 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.571 ' CD2' ' HB2' ' A' ' 27' ' ' LEU . 87.1 m95 -110.38 130.43 55.55 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-O 121.175 0.512 . . . . 0.0 111.565 -173.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.48 ' HA ' ' O ' ' A' ' 86' ' ' THR . 25.3 m-85 -111.19 142.26 43.62 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.359 176.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.3 mt -125.36 142.14 51.67 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 -176.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.427 ' HA ' ' O ' ' A' ' 84' ' ' ARG . 87.2 m-85 -131.42 139.31 49.38 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.112 0.482 . . . . 0.0 110.814 -175.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.678 ' HB2' ' CD1' ' A' ' 102' ' ' PHE . 5.7 t70 -77.68 -18.06 57.03 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.295 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.454 ' C ' ' HB3' ' A' ' 106' ' ' SER . 9.0 t-20 -126.03 162.38 25.42 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 176.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.3 m -67.78 168.12 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.58 0 C-N-CA 123.076 0.551 . . . . 0.0 111.434 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 55.26 30.22 14.28 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.827 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.53 ' CD2' ' HE2' ' A' ' 109' ' ' LYS . 13.3 m-85 60.03 45.9 11.49 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.799 1.239 . . . . 0.0 111.749 175.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 71.8 p -118.94 176.35 5.33 Favored 'General case' 0 C--O 1.249 1.041 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.462 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.87 -133.77 12.16 Favored Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 121.218 -0.515 . . . . 0.0 111.973 177.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 63.9 mtt85 -81.67 148.07 29.2 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.9 tt -129.16 137.2 57.71 Favored 'Isoleucine or valine' 0 C--O 1.245 0.825 0 O-C-N 123.62 0.575 . . . . 0.0 110.424 -175.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 95.7 m -130.97 122.71 27.35 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -111.19 109.68 2.6 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.713 -0.756 . . . . 0.0 114.629 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -103.07 145.07 30.45 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 122.816 0.446 . . . . 0.0 110.95 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -116.13 175.9 16.1 Favored Glycine 0 N--CA 1.425 -2.063 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.473 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.451 ' HB2' ' H ' ' A' ' 63' ' ' VAL . 10.0 p80 -66.08 122.13 16.72 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.532 0.682 . . . . 0.0 112.194 -176.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.72 0.95 71.51 Favored Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.623 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.0 m -106.59 146.31 30.84 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 5.6 m -136.07 151.37 49.77 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 48.8 mt -93.51 127.22 45.71 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 174.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -70.51 -47.27 61.26 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.387 0.613 . . . . 0.0 110.48 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.622 ' HB3' ' HG2' ' A' ' 99' ' ' LYS . 2.1 m-20 -135.33 93.63 3.01 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.071 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -65.14 -33.69 76.61 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.202 0.525 . . . . 0.0 110.391 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.8 t -65.26 -23.91 67.17 Favored 'General case' 0 CA--C 1.559 1.318 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.136 -176.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.622 ' HG2' ' HB3' ' A' ' 96' ' ' ASP . 30.2 mmtp -92.75 -6.4 49.15 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.941 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.2 m -84.9 38.69 0.72 Allowed 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.344 0.592 . . . . 0.0 111.535 -175.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.88 -73.98 2.25 Favored Glycine 0 N--CA 1.426 -2.028 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.678 ' CD1' ' HB2' ' A' ' 77' ' ' ASP . 16.1 p90 -109.81 148.28 31.77 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -179.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.623 ' O ' ' HA ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -113.54 -8.03 13.36 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 120.114 -0.635 . . . . 0.0 109.647 179.196 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -113.31 112.65 2.96 Favored Glycine 0 N--CA 1.432 -1.604 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.351 -174.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 76.1 mt -94.26 115.41 33.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.454 ' HB3' ' C ' ' A' ' 78' ' ' ASN . 3.7 t -86.06 -26.42 25.35 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.947 178.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.5 p -152.08 157.22 41.31 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 122.089 -0.382 . . . . 0.0 110.935 177.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.3 mt -135.9 133.2 50.95 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -175.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.53 ' HE2' ' CD2' ' A' ' 81' ' ' TYR . 33.5 ttmt -122.02 128.34 51.32 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -96.3 121.39 38.04 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 60.6 m -119.16 172.09 7.82 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.411 ' HB ' ' HB2' ' A' ' 69' ' ' GLU . 6.9 pt -126.17 139.51 51.36 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 CA-C-O 121.127 0.489 . . . . 0.0 110.147 177.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -112.2 119.06 37.08 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 76.6 p -72.35 -178.55 2.57 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 114.636 -1.166 . . . . 0.0 112.059 -174.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -65.72 -31.05 71.83 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.785 0.803 . . . . 0.0 109.173 175.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -79.46 -8.95 59.48 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.652 -178.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.58 -9.32 77.98 Favored Glycine 0 N--CA 1.427 -1.928 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.787 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -70.01 139.32 52.72 Favored 'General case' 0 C--O 1.255 1.36 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.2 t -102.82 112.91 37.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 121.174 0.512 . . . . 0.0 109.761 -176.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -97.17 135.17 39.5 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -138.01 157.11 47.03 Favored 'General case' 0 CA--C 1.483 -1.634 0 C-N-CA 118.505 -1.278 . . . . 0.0 111.221 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 5.5 tp -125.43 123.14 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.782 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.063 176.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -73.79 106.15 5.39 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 121.629 0.728 . . . . 0.0 109.359 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 . . . . . 0 C--N 1.284 -2.243 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.384 . . . . . . . . 0 0 . 1 stop_ save_